{
    "26145056-fdfd-4f2d-909e-be84fc53ede8": {
        "text_answer": "yes The evidence shows that there were 5 emesisfree participants in the placebo group and 13 in",
        "label": "Entailment"
    },
    "22384b11-eb42-42da-86b3-dfed559ebb77": {
        "text_answer": "No  Explanation The evidence provides the percentage of subjects with Recurrencefree Survival",
        "label": "Contradiction"
    },
    "b03bae0b-6811-4c4d-a265-98c0f4ae7f1f": {
        "text_answer": "No  The statement is not entailed by the evidence as the secondary trial does not mention gabapentin as an excl",
        "label": "Contradiction"
    },
    "1b2048ba-33c8-43d1-8d8f-bca70ca8d80c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f398c658-74cb-4d2b-894c-d785e4dde994": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the percentage of participants with any treatment emergent ad",
        "label": "Entailment"
    },
    "d4b54b4a-d675-4d59-b489-2c1a025b2b4e": {
        "text_answer": "Yes The statement is entailed by the evidence as nonsmall cell lung cancer and small cell lung cancer are listed as",
        "label": "Entailment"
    },
    "ad00f90a-b69d-4df4-a9f8-d495ac080b38": {
        "text_answer": "Yes  Explanation The evidence shows that there were 13 participants in the aprepitant group",
        "label": "Entailment"
    },
    "7308389a-7cde-4cf2-8f68-cefff152645c": {
        "text_answer": "No  The evidence states that there was 1 occurrence of urinary tract infection out of 50 participants",
        "label": "Contradiction"
    },
    "d88cc7fc-34dc-4e86-a3a0-50192a316624": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial allows the participation of patients diagnosed with m",
        "label": "Contradiction"
    },
    "36eb6a9f-5a3a-4f8f-b242-e669aeaa3547": {
        "text_answer": "Yes The evidence states that participation in the clinical trial is not allowed for patients with active cancermetastatic cancer",
        "label": "Entailment"
    },
    "b9e11a69-3cd1-4669-93ae-b644cbd40e71": {
        "text_answer": "No  The evidence only mentions that nonmetastatic pancreatic cancer is not an eligible tumor",
        "label": "Contradiction"
    },
    "57eb42a8-0c1b-4358-b024-0579811b3db3": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence describes",
        "label": "Contradiction"
    },
    "885733b0-a998-4f2c-b131-e58b2008a8a2": {
        "text_answer": "Yes The primary trial includes a criterion for optimal vitamin D levels 40 ngml but",
        "label": "Entailment"
    },
    "b8f0039d-f476-4aa1-a522-751d93e45147": {
        "text_answer": "No  Explanation  The evidence provided in the text only mentions the results for the coh",
        "label": "Contradiction"
    },
    "c6aa83b0-88fb-475a-8b38-e330d2bdf332": {
        "text_answer": "Yes Both trials involve oral administration of interventions Vitamin B12 and memantine hydrochloride or",
        "label": "Entailment"
    },
    "b590614e-03b9-4e7b-91e9-940058316465": {
        "text_answer": "Yes The primary trial does not exclude patients with 23 cerebral metastases while the secondary trial",
        "label": "Entailment"
    },
    "4a73eb98-e69d-4116-bbed-7e1b6458aa61": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly states",
        "label": "Contradiction"
    },
    "eaf2bb85-799b-47e9-af79-4fc7a54f0fcd": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1692ad17-057d-4d84-bc1b-f9fa773288b2": {
        "text_answer": "No  Explanation  The statement the procedure in the primary clinical trials first coh",
        "label": "Contradiction"
    },
    "f3918549-5e15-44e3-b35b-f7f361845792": {
        "text_answer": "Yes The evidence shows that no adverse event was observed exclusively in cohort 1 meaning that they were all",
        "label": "Entailment"
    },
    "d46fad97-64a3-4553-a586-0dd9878009ec": {
        "text_answer": "Yes The primary and secondary trials involve different patient populations and different outcome measurements",
        "label": "Entailment"
    },
    "be4814f1-b515-4744-8df9-293327502949": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "039ef0fd-7ea1-4820-b08f-99cf35009bc3": {
        "text_answer": "Yes The primary trial explicitly excludes patients receiving warfarin while the secondary trial permits its use under certain conditions",
        "label": "Entailment"
    },
    "2945688b-8ee8-43ce-8ed3-30c0a4fdf489": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary clinical trial involves oral administration of cabergoline",
        "label": "Contradiction"
    },
    "a6eb92cc-e789-4ced-a40c-166bebb09a67": {
        "text_answer": "Irrelevant  Explanation The statement There were no patients in the primary trial or the secondary",
        "label": "Contradiction"
    },
    "5461003b-2108-4302-96ad-d843b5b9e938": {
        "text_answer": "Yes  Explanation The evidence states that there were no adverse events in both cohorts of the",
        "label": "Entailment"
    },
    "0b343459-5c78-4c51-b71b-bfc5aa6d0c6a": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary clinical trial concludes 20",
        "label": "Contradiction"
    },
    "1be9e4b6-a9e2-42b2-9131-4d7557ccd568": {
        "text_answer": "No  Explanation  The statement patients in the primary clinical trial are obliged to have",
        "label": "Contradiction"
    },
    "fb4df065-adca-4ce7-9059-bda1cc4ca1be": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial and the secondary clinical trial there",
        "label": "Entailment"
    },
    "5a286769-0146-41da-8daa-af8c7169023a": {
        "text_answer": "  No the statement is not entailed by the evidence for the primary trial but it is mentioned as a possible",
        "label": "Contradiction"
    },
    "c926dbb4-ab16-46dc-a2be-8d04563ce9d0": {
        "text_answer": "No  Explanation  The statement the secondary trial and the primary trial recorded an equal number of",
        "label": "Contradiction"
    },
    "69b11fe6-3c14-4ac6-a664-916dc341700f": {
        "text_answer": "Yes  Explanation The primary trial does not provide sufficient information about the dosing frequency of MM",
        "label": "Entailment"
    },
    "e688cf8e-7082-43f3-803c-7489148f3cac": {
        "text_answer": "  No the statement is not entailed by the evidence as the secondary trial does not include patients with NUT mid",
        "label": "Contradiction"
    },
    "306374f7-40f9-45d5-a7cf-6cece3889a04": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the doses of erib",
        "label": "Contradiction"
    },
    "c616276b-e187-44ee-a2fb-93704f1a64cc": {
        "text_answer": "No  Explanation  The statement all patients in the primary clinical trial reported experiencing at least one",
        "label": "Contradiction"
    },
    "68f673a5-6ddf-487a-ad88-4903d92e1746": {
        "text_answer": "Yes  Explanation  The statement There were no patients with recorded Aes in the primary trial",
        "label": "Entailment"
    },
    "e7f5c09e-9d3d-4081-a926-9f89647a0e3b": {
        "text_answer": "Yes The evidence states that patients with a solid tumor that is locally advanced or metastatic can participate in both phases",
        "label": "Entailment"
    },
    "687b9bc0-7328-4ecc-9bae-6b63f2df3cdb": {
        "text_answer": "No   Explanation   The statement intervention 1 in the primary trial and",
        "label": "Contradiction"
    },
    "55c1905d-0e17-41b6-89ba-c29df13d2e30": {
        "text_answer": "No  Explanation  The statement each patient in cohort 1 of the primary clinical",
        "label": "Contradiction"
    },
    "1e213f71-5def-460d-b18e-aa58dbbe4463": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "e26430d8-c773-4770-b298-429c286fd5d3": {
        "text_answer": "No  The evidence only mentions breast cancer and does not include leukemia",
        "label": "Contradiction"
    },
    "67b66f39-48c2-495c-9ab0-0beefd9cdcef": {
        "text_answer": "Yes The statement is entailed by the evidence as both study groups undergo 18FFDG and ",
        "label": "Entailment"
    },
    "30234b84-2f15-4ea8-b7ed-af5f4ea40e9c": {
        "text_answer": "Yes The statement does not contradict the evidence as both interventions involve preoperative intravenous administration of",
        "label": "Entailment"
    },
    "2c9e275c-18ef-471f-8ec9-1d73bfb27e20": {
        "text_answer": "Yes The evidence shows that the patients in Arm I Cryotherapy had less severe symptoms higher a",
        "label": "Entailment"
    },
    "4fb8207e-292f-4f97-9587-bf028abd57be": {
        "text_answer": "Yes  Explanation  The statement All Infections and Infestations cases in the primary trial",
        "label": "Entailment"
    },
    "3426bc8a-b9c6-451e-aa76-25e1fc8bff69": {
        "text_answer": "No  The evidence does not provide any information about travel for leisure or visiting people in the primary or secondary trials",
        "label": "Contradiction"
    },
    "c4620792-b333-4232-ba8e-62595917256f": {
        "text_answer": "Yes Arimidex anastrozole is present in the primary trial but not mentioned in the secondary trial",
        "label": "Entailment"
    },
    "a68e6309-12b7-445f-837b-ce8cef67a882": {
        "text_answer": "Yes the statement is not directly about eating disorders but the evidence does not contradict it",
        "label": "Entailment"
    },
    "f81c0c12-c161-4e90-91e4-65a2b255d1c2": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial is not",
        "label": "Contradiction"
    },
    "251e979f-a7ba-4dea-afb7-01b9501ec7cf": {
        "text_answer": "No  Explanation  The statement 96 participants from the Ketorolac 3",
        "label": "Contradiction"
    },
    "71db6876-7205-4e4b-9a89-949045f26ab9": {
        "text_answer": "No  Explanation The statement does not accurately describe the contents of the primary clinical trial as presented in",
        "label": "Contradiction"
    },
    "037ef54b-03fa-49f8-ae4b-ea645d268ea9": {
        "text_answer": "No  Explanation  The statement Cohort 1 of the primary trial received the same",
        "label": "Contradiction"
    },
    "889268e5-7b76-4c17-b567-bd828a9abf3e": {
        "text_answer": "No  Explanation  The statement numerous instances of cardiac and psychiatric aes were",
        "label": "Contradiction"
    },
    "2f7bf983-b072-4d3e-96fb-718475ef0fd2": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence because the primary and",
        "label": "Contradiction"
    },
    "0279dc49-0833-4673-8fb7-a7101a16fa14": {
        "text_answer": "Yes The statement that candidates with an ECOG score of 1 are eligible for both trials is entailed by the",
        "label": "Entailment"
    },
    "9126bd66-8ee7-47a5-84e2-0269efe06362": {
        "text_answer": "Yes The primary trial excludes adults while the secondary trial specifically includes them",
        "label": "Entailment"
    },
    "1b56f68b-a4b1-433c-a634-73ff99fce7aa": {
        "text_answer": "Yes The statement does not contradict the evidence and is consistent with the information provided",
        "label": "Entailment"
    },
    "9349c7c8-7771-4dfc-8981-3c8d84ac5236": {
        "text_answer": "Yes The evidence states that patients with histologically proven DCIS are eligible for the trial",
        "label": "Entailment"
    },
    "0a0a9bd9-b3d0-4af8-b09a-f0e3a1684ef0": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not mention gabapentin or pregabalin",
        "label": "Contradiction"
    },
    "462f7871-9216-4b37-af39-1fb32b2bbf84": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "548ed40c-ccf4-4250-9fd9-c870bcc61b17": {
        "text_answer": "Yes The evidence states that engagement in regular physical activity is not a required component of the intervention for participants in",
        "label": "Entailment"
    },
    "e53898b8-422f-4317-b2f6-c487409b0750": {
        "text_answer": "Yes  Explanation The statement In total there are less cases of anemia in the primary trial",
        "label": "Entailment"
    },
    "098f7c20-8543-4de6-b236-341c4cdea28e": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly reports the percentage 13 of participants with HER",
        "label": "Entailment"
    },
    "9d2b4df6-e802-437f-a844-61e944365df0": {
        "text_answer": "Yes The statement does not mention Hypertension Edema or Dyspnea which were both reported as",
        "label": "Entailment"
    },
    "a02a0c3b-3c6c-45ce-a382-636abd7e1bef": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the outcomes from the placebo",
        "label": "Contradiction"
    },
    "a9f8fa09-52b6-4a39-b62b-3685f41d6c6e": {
        "text_answer": "Yes The statement mentions the use of laserassisted fluorescence angiography which is a method",
        "label": "Entailment"
    },
    "f5a3b01c-743a-4d70-81c8-a5671272d1e0": {
        "text_answer": "No   Explanation   The statement is not directly related to the evidence provided The evidence",
        "label": "Contradiction"
    },
    "af9986f4-5f0c-4b8c-b02a-05ae6f7f4d1b": {
        "text_answer": "No  Explanation  The statement 78 more participants in the dalotuzumab",
        "label": "Contradiction"
    },
    "fe0af3be-4bf7-4e28-ad4c-81082e2ebfbd": {
        "text_answer": "No  Explanation  The statement in the secondary trial all patients receive the same 0",
        "label": "Contradiction"
    },
    "b54c2b24-79e2-4561-bd18-ba18479cd7a3": {
        "text_answer": "No  Explanation The statement was 1p19q deletion analysis performed",
        "label": "Contradiction"
    },
    "52174f7c-e29a-4fc5-b116-eeb9ee0ecc34": {
        "text_answer": "No  Explanation  The statement ability to wash your back is a question about an individual",
        "label": "Contradiction"
    },
    "1f5d055f-5dde-400d-bbad-687e79830586": {
        "text_answer": "No  Explanation  The statement over 97 of patients in the secondary trial and",
        "label": "Contradiction"
    },
    "f4e8530b-843b-422e-8db4-c02378c66512": {
        "text_answer": "No  Explanation  The statement provided makes a comparison between the number of drugs administered and the",
        "label": "Contradiction"
    },
    "0c561a05-4615-4578-aff2-745d9c9761c0": {
        "text_answer": "No  Explanation  The evidence provided in the results does not directly compare the percentage of participants with",
        "label": "Contradiction"
    },
    "1e5ed892-07f9-409a-bc45-edd43978e9b1": {
        "text_answer": "No  Explanation The statement have not received treatment is a response indicating that an individual has not",
        "label": "Contradiction"
    },
    "7774f54f-4f08-4c6d-8fa4-af4979ba5bac": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes a maximum tumor diameter of 1",
        "label": "Contradiction"
    },
    "cfce111d-8810-4915-98ee-1e280271de10": {
        "text_answer": "yes the statement is entailed by the evidence In the primary trial pembrolizumab is given every",
        "label": "Entailment"
    },
    "5861703f-56fc-4e31-ba4e-d97400d71d99": {
        "text_answer": "Yes for febrile neutropenia Answer  No for cholelithiasis",
        "label": "Entailment"
    },
    "4c5fcde7-b882-4ea3-96ba-275af987ea60": {
        "text_answer": "Yes  Explanation The statement for every case of hypertension and pancreatectomy",
        "label": "Entailment"
    },
    "83c63591-6cde-4635-8d33-61dad15c7a21": {
        "text_answer": "No  Explanation  The statement spiradenocylindrocarcinoma is a car",
        "label": "Contradiction"
    },
    "ef245c6c-7858-45cd-a0fd-d272e7aae585": {
        "text_answer": "No  Explanation  The statement group 2 of the primary trial does not receive myalg",
        "label": "Contradiction"
    },
    "87a7f86a-e915-4ea9-a2ba-c8e4d37dfa15": {
        "text_answer": "Yes The secondary trial excludes patients with severe insomnia",
        "label": "Entailment"
    },
    "aad4638b-6c8d-4f55-bf3f-5a3e9d74ef50": {
        "text_answer": "No   Explanation The evidence provided in the trials inclusion criteria does not mention anything about individuals",
        "label": "Contradiction"
    },
    "ad66bfcf-7359-41c6-b4f8-694ed27fbc8e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "89c0759c-7a7e-4c65-b98e-841d2ca21808": {
        "text_answer": "  No   Explanation   The statement patients with a histologicallycy",
        "label": "Contradiction"
    },
    "593bde37-5962-441b-ac10-dbe3120cec99": {
        "text_answer": "Yes  Explanation The statement less than 5 of patients in the primary trial suffered AEs",
        "label": "Entailment"
    },
    "1669453c-bb8e-437d-b5e2-98600980d7d3": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly identifies the only variation between the two interventions as a",
        "label": "Entailment"
    },
    "135763e3-70fd-478d-991c-717d6ed55bb3": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence because both cohorts receive CU",
        "label": "Entailment"
    },
    "72c54a84-aa51-4250-ba38-3646a07391b9": {
        "text_answer": "No  Explanation  The statement tumour lysis syndrome was a condition suffered by multiple",
        "label": "Contradiction"
    },
    "ab957edd-8a87-49e2-a7cf-0a55fb30c54f": {
        "text_answer": "Yes The intervention section of the primary clinical trial does not provide sufficient information to determine the method of administration dosage",
        "label": "Entailment"
    },
    "884486ed-0e11-41be-9792-d2765bd977a2": {
        "text_answer": "  No  Explanation  The statement every individual in the first cohort of the",
        "label": "Contradiction"
    },
    "a77a5845-0747-4291-b6de-4903e453ae6a": {
        "text_answer": "Yes  Explanation  The statement a greater number of patients in the secondary clinical trial were documented",
        "label": "Entailment"
    },
    "19738717-25bb-443f-8c7f-050bbc0c7a06": {
        "text_answer": "No   Explanation   The statement Neither the secondary trial or the primary trial measure",
        "label": "Contradiction"
    },
    "dfea11ab-1a3f-4a76-9fae-96d486f76e10": {
        "text_answer": "Yes The statement is a summary of some of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "bffa5810-1ace-45e0-bf6d-6a3d35d6d4d7": {
        "text_answer": "Yes The evidence does not mention the use of xrays transendocardial injections other than",
        "label": "Entailment"
    },
    "264b1943-377e-4466-ad48-b4ba143f6bdb": {
        "text_answer": "No The statement is not related to the adverse events in the evidence",
        "label": "Contradiction"
    },
    "a6dad239-adab-48d2-b63a-0325c718ddf9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the most encountered adverse event",
        "label": "Contradiction"
    },
    "2f813222-a2b6-488e-96e6-f1a3d8713550": {
        "text_answer": "No  Explanation The statement a total of 35 patients treated with Sunitinib",
        "label": "Contradiction"
    },
    "2b58a234-e92e-475b-a0c9-a947776bf332": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically states that any patient who has received",
        "label": "Entailment"
    },
    "c179c437-ffe9-4120-9390-58d88fb596f3": {
        "text_answer": "No   Explanation  The statement in the primary clinical trial the intervention administered to",
        "label": "Contradiction"
    },
    "ce185781-5c8f-4849-b96c-734228f2a323": {
        "text_answer": "No  The statement is not directly related to the inclusionexclusion criteria provided in the evidence The statement is about",
        "label": "Contradiction"
    },
    "2717fbc9-ffe5-419f-8c2d-ac9505f7cd01": {
        "text_answer": "Yes  Explanation  The statement the secondary trial and the primary trial do not share any inclusion",
        "label": "Entailment"
    },
    "1f77bf31-ae19-4adc-9af1-4c982718bbf6": {
        "text_answer": "Yes  Explanation  The statement in the primary trial no cycle is applied to the intervention",
        "label": "Entailment"
    },
    "1672004b-d668-4441-95b4-eaab6fd70818": {
        "text_answer": "  Yes the patient described in the statement meets the inclusion criteria for both trials based on the provided information However",
        "label": "Entailment"
    },
    "91afbc39-fae6-483e-8b8d-dc4ce8d0ea5c": {
        "text_answer": "No  Explanation The evidence provided only gives the median PFS for each treatment group not the",
        "label": "Contradiction"
    },
    "dbe6803f-8c85-45d2-a9b8-1bbd0e772733": {
        "text_answer": "No  Explanation Both interventions in the primary clinical trial involve the injection of 0",
        "label": "Contradiction"
    },
    "12279abc-fae3-49d8-ac68-95ed47f4de12": {
        "text_answer": "No  Explanation  The statement the serious adverse reactions were reported more frequently in the ad",
        "label": "Contradiction"
    },
    "df141af2-f34d-4e16-aee3-72c015ccc995": {
        "text_answer": "Yes  Explanation The evidence states that during the primary clinical trial there were 5 participants in",
        "label": "Entailment"
    },
    "0dfa4e06-e226-4d46-be1f-90249c1f34d4": {
        "text_answer": "No  Explanation  The statement a higher number of patients in the secondary clinical trial were documented",
        "label": "Contradiction"
    },
    "44ccb908-9444-4137-a227-c47b65207de7": {
        "text_answer": "No  Explanation  The statement 9335 patients in the primary trial and",
        "label": "Contradiction"
    },
    "3e7895ff-0e1a-40d9-830d-bab9c5b59706": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial involves",
        "label": "Contradiction"
    },
    "172e14bc-4f23-4d47-9e94-1d65291ef090": {
        "text_answer": "Yes  Explanation  The statement there is no single common inclusion criteria between the secondary trial and",
        "label": "Entailment"
    },
    "21f268fa-899c-43ab-a7c2-78c0f940f014": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "448d6b4e-e05a-4971-9aea-cabeb8ce2c00": {
        "text_answer": "  No   Explanation   The evidence provided pertains to a clinical trial for individuals",
        "label": "Contradiction"
    },
    "bae24418-25bc-4334-be92-d7f341ac3f14": {
        "text_answer": "Yes The statement does not directly mention the trials mentioned in the evidence but it does not contradict the inclusion criteria for",
        "label": "Entailment"
    },
    "d6cc1a08-fbff-4ef1-b44f-6bc1b1ed0ef2": {
        "text_answer": "Yes  Explanation  The statement more instances of palpitations pericardial eff",
        "label": "Entailment"
    },
    "4763223f-0ecd-4d19-a9ee-d466648ce4ea": {
        "text_answer": "Yes The statement accurately summarizes the distinction in treatment dosages between the two cohorts in the primary clinical trial",
        "label": "Entailment"
    },
    "2771bac1-0b7c-4049-9971-6c3129efb634": {
        "text_answer": "No  The evidence does not provide any information about the use of fentanyl sublingual spray during the primary",
        "label": "Contradiction"
    },
    "d9682530-105c-4e04-a26b-5d5985aac260": {
        "text_answer": "Yes The secondary clinical trial explicitly excludes stage 4 breast cancer patients while the primary clinical trial includes them",
        "label": "Entailment"
    },
    "28e1ae2b-668d-48c5-a17b-169460475af0": {
        "text_answer": "Yes The statement the primary clinical trial involved the administration of the biopath nanoparticle delivery system to thirteen participants",
        "label": "Entailment"
    },
    "f00c0288-b56a-45b4-9908-1c679e5043e8": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 30mg",
        "label": "Entailment"
    },
    "13311b5b-36d8-455d-bf27-8a5adf1c913e": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial includes different eligibility criteria for different study coh",
        "label": "Entailment"
    },
    "6938fd4c-78be-4e24-b385-835d2be9f3c1": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants in",
        "label": "Contradiction"
    },
    "56bdbd86-0233-4eb9-bc63-0199e196966b": {
        "text_answer": "Yes  Explanation The evidence states that less than 087 of the",
        "label": "Entailment"
    },
    "adb18104-31a9-4eef-817b-0ab742bd4093": {
        "text_answer": "No  Explanation The evidence provided only reports the change in total body lean mass from baseline to ",
        "label": "Contradiction"
    },
    "20ee9640-9334-41a2-b8aa-62cc27aeab70": {
        "text_answer": "No  Explanation The statement All the primary trial participants receive higher doses of ALT",
        "label": "Contradiction"
    },
    "ff78e7a6-b997-49b3-be7f-2604a1e00308": {
        "text_answer": "No   Explanation  The statement arimidex is used frequently in both the primary",
        "label": "Contradiction"
    },
    "076f0bbd-6b10-44e1-a7c6-9853d9457509": {
        "text_answer": "No  Explanation The evidence does not provide any information about the use of any specific form of birth",
        "label": "Contradiction"
    },
    "b79be25a-c0ac-442e-adaf-821e42a3349b": {
        "text_answer": "No  The statement is not related to the inclusion or exclusion criteria for the primary or secondary trials provided in the evidence",
        "label": "Contradiction"
    },
    "be30d480-b4d8-4768-8244-3a3d267418d2": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence does not provide",
        "label": "Contradiction"
    },
    "4d1b524f-e8d8-4444-bc99-6631e049fde8": {
        "text_answer": "Yes The evidence does not specify any residence restrictions for Hispanic patients in the primary clinical trial",
        "label": "Entailment"
    },
    "3ab9a40f-bbd8-43ed-a468-7fdbe3d9ce19": {
        "text_answer": "Yes The evidence states that none of the participants in cohorts 1 Normal Vitamin D Levels and",
        "label": "Entailment"
    },
    "ddee09ab-2af9-4c93-a64e-58371896a08e": {
        "text_answer": "Yes  Explanation The statement cohort 1 of the primary clinical trial receives twice the",
        "label": "Entailment"
    },
    "93118a13-cb16-4c4d-8f7a-ad0cb815e179": {
        "text_answer": "Yes  Explanation The statement mentions several different instances of cardiac related AE recorded",
        "label": "Entailment"
    },
    "4eb2221b-a478-4b64-bed8-230e4eab958d": {
        "text_answer": "No   Explanation The statement over 20 of participants in the primary clinical trial encountered",
        "label": "Contradiction"
    },
    "49e76af6-53c7-458d-a091-0aa8edf2f2aa": {
        "text_answer": "No  Explanation  The statement 11 more Participants in the ERpositive",
        "label": "Contradiction"
    },
    "c4a67b84-c8c7-4922-a5fb-5fb9a1a3160a": {
        "text_answer": "Yes Both trials involve oral administration of interventions",
        "label": "Entailment"
    },
    "4e832d71-c3c2-4209-9a57-8bd40ed3b08a": {
        "text_answer": "No   Explanation  The statement were clinical genomics performed is not directly related to",
        "label": "Contradiction"
    },
    "4a06c463-8c8b-454e-9664-bac7871cbb95": {
        "text_answer": "Yes  Explanation  The primary clinical trial and the secondary clinical trial have different outcome measures In",
        "label": "Entailment"
    },
    "adf1424b-3b15-478f-acab-72d4217db886": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no information",
        "label": "Contradiction"
    },
    "31ad3c14-faaa-42e1-93aa-d9f9b8687cae": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "396273f3-1e8f-4aa7-a50e-4c36c243748b": {
        "text_answer": "Yes  Explanation The statement over 320 of patients in the primary trial and the",
        "label": "Entailment"
    },
    "50171a05-0f3d-434e-a43d-9310a845fa3f": {
        "text_answer": "No  Explanation The statement does not directly follow from the evidence provided The evidence only mentions the",
        "label": "Contradiction"
    },
    "c8a83ca7-bc34-4afe-9323-7439ed841bca": {
        "text_answer": "Yes  Explanation The evidence shows that in each arm of the clinical trial there were participants who achieved",
        "label": "Entailment"
    },
    "0a266c52-2a4e-4aed-a04c-85c148f2cd41": {
        "text_answer": "No  Explanation  The evidence provided in the text only reports the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "c67afffa-bf41-4562-bf5e-1ba035fe653c": {
        "text_answer": "Yes  Explanation  The statement biliary colic and Clostridium difficile",
        "label": "Entailment"
    },
    "7b860f15-132f-423e-ac6d-1c73f7a2d0d5": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves preg",
        "label": "Contradiction"
    },
    "fba4a92c-e18b-4029-b3bd-4b967db7faa1": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for the primary clinical trial and the intervention",
        "label": "Contradiction"
    },
    "3cbea791-dc12-4c0e-b672-031b43c49bf2": {
        "text_answer": "No  Explanation  The statement Most patients in cohort 1 of the primary trial",
        "label": "Contradiction"
    },
    "50b6f969-8637-47a1-ab63-9067b009bd2c": {
        "text_answer": "No  The evidence does not mention anything about fentanyl spray being administered to patients during radiation therapy",
        "label": "Contradiction"
    },
    "aca44925-657c-47d1-9325-f3933deee650": {
        "text_answer": "Yes The statement that cohort 2 of the primary clinical trial did not report any AEs and neither",
        "label": "Entailment"
    },
    "f074cadc-99e3-4603-8095-aa09822d174d": {
        "text_answer": "Yes  Explanation  The statement the primary trial is measuring the average time a patient spends",
        "label": "Entailment"
    },
    "6146e7c3-2c76-4881-88bd-1c547c9f732a": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "cc411bc6-900e-4ef3-96ef-09f6e5565a18": {
        "text_answer": "Yes for the secondary trial but No for the primary trial",
        "label": "Entailment"
    },
    "9b50ab6a-abe0-4082-8ebc-0cc297945062": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence mentions the use of laserassisted flu",
        "label": "Contradiction"
    },
    "964f8275-1095-4d48-953d-8d77152cecb8": {
        "text_answer": "No  Explanation The statement all groups receive equal doses of 18FFPPR",
        "label": "Contradiction"
    },
    "2ceabe21-98c6-44e3-9cb2-03d3e73124a7": {
        "text_answer": "No  Explanation The statement if a person smokes they wont be permitted in the",
        "label": "Contradiction"
    },
    "47485ca0-43cb-4525-9417-a8222961e1cd": {
        "text_answer": "Yes The evidence shows that there were no reports of swelling hypothermia or confusion in the adverse",
        "label": "Entailment"
    },
    "1ee86f9f-6119-4cce-a036-324aea1fb251": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "1d8450d1-ac32-4f98-ac75-1d6e212b0879": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded slightly more total adverse events in its",
        "label": "Contradiction"
    },
    "9c180516-eca4-490b-b661-b47c625e3ab9": {
        "text_answer": "Yes  Explanation The statement within the adverse events of both the primary and secondary clinical trials",
        "label": "Entailment"
    },
    "2df3c784-8e32-4d92-9770-63087b7c7f62": {
        "text_answer": "Irrelevant  Explanation The statement is not directly related to the information provided in the evidence The",
        "label": "Entailment"
    },
    "100d5efd-de88-4127-b6c1-cb870fff9e82": {
        "text_answer": "No  The statement does not provide enough information to determine if it is entailed by the evidence as the statement makes",
        "label": "Contradiction"
    },
    "038bc748-0ea5-4d83-b799-b986177f9dbf": {
        "text_answer": "No  Explanation  The statement in the secondary trial all patients receive the same 80",
        "label": "Contradiction"
    },
    "63a60028-ee0a-4f47-a8f2-b5edf081579a": {
        "text_answer": "No  Explanation  The statement patients with considerable cardiovascular impairment are allowed",
        "label": "Contradiction"
    },
    "b11dea7c-ef4b-4042-9267-40934719c44e": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial presented anaemia as the most",
        "label": "Contradiction"
    },
    "a56ade78-3385-4789-b86a-3aef67188d2c": {
        "text_answer": "Yes The statement is about a specific type of adverse event difficulty paying attention and the evidence reports the",
        "label": "Entailment"
    },
    "ad271913-e4a5-4a4a-9b0a-d3ae24415a54": {
        "text_answer": "No  The evidence describes the trabectedin intervention as being administered intravenously not orally",
        "label": "Contradiction"
    },
    "bb01dea7-5b49-41b7-997b-70cc1e980226": {
        "text_answer": "  No  Explanation  The evidence provided in the text does not mention anything about atyp",
        "label": "Contradiction"
    },
    "776b3152-7fa5-480d-8235-cd6e472bf0a6": {
        "text_answer": "Yes  Explanation  The statement adverse events were not reported in the primary clinical trial",
        "label": "Entailment"
    },
    "5099ee2b-f5ea-47be-ba1e-ce2e4462a0c5": {
        "text_answer": "  No   Explanation   The statement luer valve device is a val",
        "label": "Contradiction"
    },
    "37257ef8-1772-4b94-9bb9-0433a83b83fe": {
        "text_answer": "No  Explanation  The statement palpable masses sequence number is an identifier that describes the",
        "label": "Contradiction"
    },
    "e50a24aa-fbee-4cf7-b91b-661c5173c787": {
        "text_answer": "No   Explanation   The statement Any patients that is currently a smoker cannot participate",
        "label": "Contradiction"
    },
    "25cbaa44-4715-417b-9bd0-12fef06053b8": {
        "text_answer": "Yes  Explanation  The statement less than 10 patients in the primary trial suffered A",
        "label": "Entailment"
    },
    "146a72f6-cba2-4056-94a2-21d2e05ac04e": {
        "text_answer": "No  Explanation The statement 25 of cohort 2 patients in the primary",
        "label": "Contradiction"
    },
    "2cf5335c-74b8-4122-bf27-caf0cdf94b8a": {
        "text_answer": "Yes  Explanation The evidence provides information on the number of hot flashes per 24 hours for",
        "label": "Entailment"
    },
    "6432c266-a7b8-4cda-b5b8-7fd13cb023fb": {
        "text_answer": "Yes  Explanation  The statement the groups in the primary clinical trial differed significantly in their",
        "label": "Entailment"
    },
    "8d1ad83d-8298-46fe-971d-3fadc862bd5e": {
        "text_answer": "No  Explanation  The statement the paclitaxel plus bevacizumab",
        "label": "Contradiction"
    },
    "a378ea56-7b9b-4ee9-b304-ff9597744fb7": {
        "text_answer": "No   Explanation  The statement is not directly entailed by the evidence as it does not",
        "label": "Contradiction"
    },
    "1060fd94-b24c-43cb-884e-b10f70e0ea23": {
        "text_answer": "No  Explanation  The statement picalm gene rearrangement is a molecular ab",
        "label": "Contradiction"
    },
    "1c13e304-89af-4ef5-95c6-cabc803d81b8": {
        "text_answer": "No   Explanation   The statement indeterminate extranodal tumor",
        "label": "Contradiction"
    },
    "65f90fcc-a7ce-4d52-b010-b8e482c02f9c": {
        "text_answer": "Yes  Explanation  The evidence shows that there were no serious adverse events lifeth",
        "label": "Entailment"
    },
    "ef2af81d-e19c-49c9-8ff0-309b87eb6f38": {
        "text_answer": "Yes  Explanation The statement the primary trial only has a single adverse event recorded for its",
        "label": "Entailment"
    },
    "47d5620b-1b48-4a55-920f-35879c6e85eb": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the evidence clearly describes the inter",
        "label": "Contradiction"
    },
    "b0b78244-40a7-46d4-888d-1ccfe70d3645": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "840c7b65-e801-4dec-b9dd-b97680e5e3ba": {
        "text_answer": "No   Explanation   The primary clinical trial is using Estring estrogen and",
        "label": "Contradiction"
    },
    "577c7755-64ae-4b78-bbe3-627cef6e3ece": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants in",
        "label": "Contradiction"
    },
    "ffa844c8-752d-48df-aa7a-e0ba58305b12": {
        "text_answer": "No  The statement goes beyond the information provided in the evidence The evidence only mentions specific conditions that would exclude a",
        "label": "Contradiction"
    },
    "012a3705-05f7-4a26-adf2-1ae4244bd576": {
        "text_answer": "No  Explanation  The statement in the question is not entailed by the evidence provided The",
        "label": "Contradiction"
    },
    "18d3b58f-42ca-4178-adb6-4a5f0c9fafde": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial indicates that the average pain intensity score was",
        "label": "Entailment"
    },
    "fd88904b-8a23-46ad-b337-3c7eef4e7bef": {
        "text_answer": "Yes for the statement about pulmonary embolisms in the secondary trial and No for the statement about breast",
        "label": "Entailment"
    },
    "7a831a11-8edd-42ef-81e7-fd8bca5ca0cc": {
        "text_answer": "Yes  The statement is entailed by the evidence as both groups receive the same amount of radiation therapy and a SPECT",
        "label": "Entailment"
    },
    "7e791f30-68d4-4a11-86e4-c2e88d737913": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "ff07ae9a-9106-443b-b584-a7522ec3f71d": {
        "text_answer": "No  Explanation The statement does not follow directly from the evidence provided The evidence only mentions",
        "label": "Contradiction"
    },
    "1e47ae4a-c57b-47fa-9b85-1b15ebdbf1fc": {
        "text_answer": "  No The statement does not directly follow from the evidence provided The evidence pertains to inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "871378d6-a6e5-461c-af83-d82fe8f44f4e": {
        "text_answer": "No   Explanation  The statement is about a genus of bacteria Sutterella and",
        "label": "Contradiction"
    },
    "3c06901b-29be-43be-8da7-c23d80cc4d89": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly support the statement that the occur",
        "label": "Contradiction"
    },
    "e115652e-6728-47a8-bc2e-1866a7c257ec": {
        "text_answer": "Yes The evidence states that neither cohort undergoes any invasive operation or receives neratinib",
        "label": "Entailment"
    },
    "2aa1c4f5-a46c-4004-9a8a-52e2ac476181": {
        "text_answer": "No  The statement is not about the adverse events mentioned in the evidence It is about lordosis which is",
        "label": "Contradiction"
    },
    "f0f8a0a6-1148-4592-a9b4-27c005038900": {
        "text_answer": "Yes  Explanation The evidence states that participants in the primary trial receive epirubicin cycl",
        "label": "Entailment"
    },
    "b9f262d7-23e5-42d1-9020-0e516ce3505c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0b5e78d7-d717-41d0-98e5-564eda711bec": {
        "text_answer": "Yes The primary trial excludes patients with uncontrolled intercurrent illness including insomnia and the secondary trial includes",
        "label": "Entailment"
    },
    "d201eee8-33d1-4ae4-9540-b37fa07536e0": {
        "text_answer": "  Yes the statement is entailed by the evidence as the inclusion criteria state that participants must have a BMI of",
        "label": "Entailment"
    },
    "d9d5a341-26ba-4f5d-a730-14561dea5c17": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial do not suffer any of the",
        "label": "Contradiction"
    },
    "b9a1b80e-4c45-4a78-962b-13dfe98ab56c": {
        "text_answer": "No  Explanation The statement while 2 in 73 participants of the primary clinical trial had",
        "label": "Contradiction"
    },
    "c8bd9404-6d9c-4048-9d19-639aefd4ab08": {
        "text_answer": "No  Explanation  The statement hypokalemic patients are excluded from the primary trial",
        "label": "Contradiction"
    },
    "973b8d05-863f-4978-a197-bd08355b7834": {
        "text_answer": "No   Explanation The evidence provided does not mention anything about radiation therapy being given to the patients in",
        "label": "Contradiction"
    },
    "0bc7c5c7-6e64-4eee-ba84-e2168d64a8ef": {
        "text_answer": "  No the statement is not entailed by the evidence The statement mentions NUT midline carcin",
        "label": "Contradiction"
    },
    "4318ce37-10b6-4318-868e-f533a1fd000e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "d0bcf0db-e64d-4aff-a63b-ba3571ebfad4": {
        "text_answer": "No  The statement about CBT Cognitive Behavioral Therapy being prohibited for the primary trial",
        "label": "Contradiction"
    },
    "e0c92d00-132b-4e76-ba59-2fa14e67bf53": {
        "text_answer": "Yes  The evidence mentions unacceptable toxicity as a reason for discontinuing treatment indicating that",
        "label": "Entailment"
    },
    "c39031be-e4dd-4943-a3fe-97164ac7a5e9": {
        "text_answer": "No  The statement is not entailed by the evidence as the intervention in the secondary trial involves ibrutin",
        "label": "Contradiction"
    },
    "1bf99d45-84a7-41cb-8263-d1ccb489bc66": {
        "text_answer": "Yes  Explanation  The statement The only types of AEs observed in patients from the secondary",
        "label": "Entailment"
    },
    "a7efab48-443a-4728-a4b5-0c837052aab7": {
        "text_answer": "Yes Perjeta pertuzumab is mentioned in the primary trial but is not a part of the secondary",
        "label": "Entailment"
    },
    "e16eb398-b70e-42d2-90d5-d17172fda47f": {
        "text_answer": "No  The evidence does not mention Paraplatin at all in the given clinical trial",
        "label": "Contradiction"
    },
    "ce896357-cc87-4eb3-b588-61c1f99fc5f4": {
        "text_answer": "No  Explanation  The evidence provided in the text states that the patients in the Arm I ",
        "label": "Contradiction"
    },
    "3d081c7c-10e8-490f-8943-260f27175c56": {
        "text_answer": "No  Explanation  The statement Patients with a history of severe anaphylactic reactions",
        "label": "Contradiction"
    },
    "54aa7f2d-b774-4530-ad47-3848ca093433": {
        "text_answer": "No  Explanation  The statement patients in cohort 2 of the primary trial",
        "label": "Contradiction"
    },
    "024c2c6d-e462-439c-baa2-a8639cd68d30": {
        "text_answer": "Yes  Explanation  The statement There were no patients with recorded Aes in the primary trial",
        "label": "Entailment"
    },
    "d8e5f1e2-76e1-405a-9920-c21c7f105eb2": {
        "text_answer": "No  Explanation  The statement throughout the full duration of the trials her2",
        "label": "Contradiction"
    },
    "1ecd0f33-cffb-4c0e-917f-6ae5f8570183": {
        "text_answer": "No  Explanation  The statement the secondary trial had a higher incidence of infection asym",
        "label": "Contradiction"
    },
    "c71fced3-2da3-4471-a72f-0dec2e7bbb02": {
        "text_answer": "yes The primary trial involves a higher dose and longer duration of alpha lipoic acid administration compared to the secondary trial",
        "label": "Entailment"
    },
    "decd387b-7da2-4f7b-8f32-4e009d9f6ee5": {
        "text_answer": "  No  Explanation  The evidence provided in the trial results only reports the number of participants",
        "label": "Contradiction"
    },
    "41b2eac1-36a4-4cd8-a163-c7ab7b3636ee": {
        "text_answer": "No  Explanation  The statement they are given more Herceptin and Docetaxel",
        "label": "Contradiction"
    },
    "72d1b9c7-56d4-487c-8170-752c86b764ec": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "ae1b63ed-25c5-484a-8221-3bee0af17594": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as the evidence only provides",
        "label": "Contradiction"
    },
    "365dc837-fcfb-49f6-8dc3-bb74a0f60507": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "517f5131-6807-4537-ae4c-308be1f98d17": {
        "text_answer": "No  Explanation  The statement There were more adverse events observed in the secondary trial than",
        "label": "Contradiction"
    },
    "ce29883b-654b-4124-ac60-40ff13cb9f3e": {
        "text_answer": "No  Explanation  The statement any patients with a welldocumented allergy to c",
        "label": "Contradiction"
    },
    "4b9aeee6-6ad8-477a-a09a-15fd52c8fec8": {
        "text_answer": "No  Explanation The statement makes an incorrect assumption about the frequency of interventions in the primary and",
        "label": "Contradiction"
    },
    "48206c2e-1f24-4248-8c06-bfac596dcaa5": {
        "text_answer": "Yes The evidence does not mention any Xrays transendocardial injections CT scans",
        "label": "Entailment"
    },
    "fdc63af9-e802-4ef7-8f6d-bec415bf2537": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not allow for the calculation of the",
        "label": "Contradiction"
    },
    "437fedde-1e69-4514-ac5f-d8d532497280": {
        "text_answer": "Yes The statement mentions Stomatitis as the adverse event which is consistent with the evidence that",
        "label": "Entailment"
    },
    "957f4300-757b-40ee-926c-3c7deae05ade": {
        "text_answer": "Yes The evidence explicitly states that individuals with a history of grade 3 or 4 allergic reactions attributed to trast",
        "label": "Entailment"
    },
    "da5c1eb1-b093-45cf-b607-e40504be981b": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial multiple cohorts are given",
        "label": "Contradiction"
    },
    "56f41ab4-6a20-4593-af47-b5cab9dabdd2": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the number of in",
        "label": "Contradiction"
    },
    "35c16ab6-47c9-48ed-b92d-967b89df4869": {
        "text_answer": "No  Explanation  The statement provided is about the type of lymphoma and its most",
        "label": "Contradiction"
    },
    "4d702550-2f94-46be-92f2-ea6659c69ddb": {
        "text_answer": "No  Explanation The statement all patients get a dose of no less than 20mg",
        "label": "Contradiction"
    },
    "490ea7b9-ad4e-4741-8dce-65a050f9a776": {
        "text_answer": "No  Explanation  The statement all participants in the primary clinical trial showed partial or no response",
        "label": "Contradiction"
    },
    "20de5f49-227b-4d5f-9a4e-868354842985": {
        "text_answer": "No  The statement is not entailed by the evidence provided  A woman who has experienced a quadrantectomy",
        "label": "Contradiction"
    },
    "55220fb9-bef7-4c72-bf60-982c0ec903e6": {
        "text_answer": "Yes However the woman would need to meet the specific inclusion and exclusion criteria for each trial",
        "label": "Entailment"
    },
    "9bd55a1f-e5dc-4620-ba52-73b4bf792459": {
        "text_answer": "  No The evidence provided does not allow individuals with a history of pulmonary embolisms to participate in the",
        "label": "Contradiction"
    },
    "a9d72bc6-9396-4a8a-986a-e64587f02e9e": {
        "text_answer": "No  Explanation The statement radiation therapy is not administered to patients in both cohorts",
        "label": "Contradiction"
    },
    "74aebfd6-c201-4c6f-a7af-7e4e0de6b661": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "75cd8c4d-e0e6-4db0-8157-a76ac5bcf555": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial does not mention anything about KRAS",
        "label": "Contradiction"
    },
    "b52201dd-cbd7-4b92-8aae-3d8da980f4a1": {
        "text_answer": "Yes The denosumab dose in Intervention 1 of the primary trial is 120 mg Q4",
        "label": "Entailment"
    },
    "5a17f44e-b8ba-4598-96e3-992b0022b5ca": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes a specific neoadjuvant therapy",
        "label": "Contradiction"
    },
    "3559fa92-e0d7-4e4f-9b1f-7f087fbff0d1": {
        "text_answer": "Yes Both trials involve medical interventions that utilize imaging techniques such as xrays and CT scans",
        "label": "Entailment"
    },
    "0433b29d-6509-420d-ba83-4ddcf8907e2b": {
        "text_answer": "Yes The primary trial reported no adverse events in Cohort 1 and sixteen is a number that fits the",
        "label": "Entailment"
    },
    "ec5c7b6f-dfae-4681-9b8f-4f0b3635d232": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 20mg of",
        "label": "Entailment"
    },
    "06ec7728-efe1-408c-afa8-a6b679a9cd57": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary clinical trial does not provide details regarding the mode of administration",
        "label": "Entailment"
    },
    "cffc1c21-5e4d-485a-a167-32841ff01f4c": {
        "text_answer": "No   Explanation   The statement moderately better is a subjective response indicating",
        "label": "Contradiction"
    },
    "9dd13c76-10e0-4dd0-ad16-42d135f6c2c5": {
        "text_answer": "No  Explanation  The statement cohort 1 of the primary clinical trial experienced multiple",
        "label": "Contradiction"
    },
    "f6bfaa2d-0171-4bbe-a65c-0e3b217ac61f": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement ment",
        "label": "Contradiction"
    },
    "bf140d08-90da-4fb4-90da-b86a87b5bb07": {
        "text_answer": "No  Explanation  The statement the primary trial has a uniform set of inclusionexclusion",
        "label": "Contradiction"
    },
    "8ee8670b-6200-4309-8fd6-545572945b7c": {
        "text_answer": "27 participants out of 25 analyzed had treatmentemergent adverse events with Sunitinib",
        "label": "Entailment"
    },
    "64f9b5b3-cd20-4b90-94b5-14e08a9999f0": {
        "text_answer": "No  Explanation  The statement chest pain has been more frequently observed in patients participating in",
        "label": "Contradiction"
    },
    "f99f83b0-66dd-4c77-b422-113e0cb758bf": {
        "text_answer": "No  The evidence does not provide information on the screening compliance of individual patients before the intervention It only reports the proportion",
        "label": "Contradiction"
    },
    "02addfef-d1b3-4e62-865c-aa0bd1ddfab4": {
        "text_answer": "No  Explanation  The statement the secondary trial and the primary trial share at least one inclusion",
        "label": "Contradiction"
    },
    "8cd22d45-e829-47df-8ae1-cb50a163fc27": {
        "text_answer": "No   Explanation   The statement the primary clinical trial involves treating a patient coh",
        "label": "Contradiction"
    },
    "27950c75-7035-435a-a7df-6f7abd504d30": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the statement is about an",
        "label": "Contradiction"
    },
    "eec36c42-c1fb-45c8-9db9-82f10f4f7af7": {
        "text_answer": "Yes  Explanation  The statement the primary trial results report changes in pain intensity and the secondary",
        "label": "Entailment"
    },
    "902a36e5-a751-44c6-9844-465aaa0f1d75": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence reports no adverse events in over 3",
        "label": "Contradiction"
    },
    "8f319cf4-ec84-4f34-a4d8-2af54adbaab9": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not entail the statement about",
        "label": "Contradiction"
    },
    "0f42fd08-8cba-4861-a89c-bf898270ea29": {
        "text_answer": "No   Explanation The evidence does not provide any information about Paraplatin or its dosage",
        "label": "Contradiction"
    },
    "5a378399-ff09-418f-8797-9e122617d8d6": {
        "text_answer": "No The statement is not entailed by the evidence as the evidence explicitly lists No history of significant psychiatric disorders",
        "label": "Contradiction"
    },
    "894b1c21-f4ab-4145-ac19-9f973184b5bd": {
        "text_answer": "No  Explanation  The primary clinical trial measures tumor diameter in centimeters while the",
        "label": "Contradiction"
    },
    "097ca9f3-901b-4072-b2d5-2e36f5bfccf0": {
        "text_answer": "Yes The statement does not mention talazoparib so it is entailed by the evidence as the intervention described",
        "label": "Entailment"
    },
    "f27c4b19-1479-48ea-92a0-28da5256b7b8": {
        "text_answer": "Yes for the secondary trial only The primary trial does not mention any specific exclusion for brainstem metastases",
        "label": "Entailment"
    },
    "6582c5f8-507a-459d-82e4-b0b8e80be34d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "17660aaf-9218-4119-b00c-f3b863718e97": {
        "text_answer": "No  Explanation  The statement Cohort 1 of the primary trial received the same",
        "label": "Contradiction"
    },
    "232cfca0-08b4-45e3-ac2a-01ce31ecb857": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it does not relate",
        "label": "Contradiction"
    },
    "fa23fd31-c7c2-4887-a982-174f355a2035": {
        "text_answer": "No The statement is not entailed by the evidence as the statement is about pedal spasms which is not",
        "label": "Contradiction"
    },
    "81521795-13b4-46d4-a03e-51ab823e9756": {
        "text_answer": "Yes  Both interventions in the primary trial include trastuzumab Herceptin",
        "label": "Entailment"
    },
    "0164b2f8-a87d-4bb8-8487-6eb1f65b9804": {
        "text_answer": "No  Explanation The statement is not directly related to the evidence provided in the trial results The",
        "label": "Contradiction"
    },
    "e0c8ebce-a242-4619-9e96-7a80e6d157dd": {
        "text_answer": "Yes  Explanation  The statement the primary trial recorded 11 more adverse events than",
        "label": "Entailment"
    },
    "de91b720-a7f8-4c27-8182-f642de29ddee": {
        "text_answer": "Yes for the secondary clinical trial However the primary clinical trial explicitly excludes patients receiving warfarin",
        "label": "Entailment"
    },
    "91e178f6-c6ec-426d-8799-629c2f512038": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly give the recurrence",
        "label": "Contradiction"
    },
    "0aab1829-69a6-4db5-ae99-78b1f9c9cbc0": {
        "text_answer": "Yes The evidence mentions the use of laserassisted fluorescence angiography in both interventions",
        "label": "Entailment"
    },
    "f83654b1-c44c-40eb-a7b1-91db95cb71f6": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial had a higher incidence of recurrent malignancies",
        "label": "Entailment"
    },
    "a0294da5-368d-4341-9084-1d42b995be34": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "079d70f0-b586-466d-aeb0-38f67273c1c6": {
        "text_answer": "Yes The primary trial does not report treatmentemergent adverse events as the outcome measurement and the same is",
        "label": "Entailment"
    },
    "8ef9ed3d-ab31-4ef7-be9a-113b31e3ed2a": {
        "text_answer": "yes the primary and secondary trials both measure pCR The statement about the difference in results between the two arms in the",
        "label": "Entailment"
    },
    "13d66853-9b8a-4d79-b0d9-884c8d744acd": {
        "text_answer": "Yes the trials have unrelated outcome measurements",
        "label": "Entailment"
    },
    "4cc838c3-caee-492c-8092-c74844d68cd1": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include the requirement of a certain performance status for candidate selection",
        "label": "Entailment"
    },
    "51d7f113-1dba-48f0-9e5c-1f16bfcd5394": {
        "text_answer": "No  Explanation The statement the primary clinical trial noted zero cases of hepatotoxicity",
        "label": "Contradiction"
    },
    "87c5ee7a-a65a-4633-9efc-b51e2956db27": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence provides the number of",
        "label": "Contradiction"
    },
    "21ae5802-04f7-4f06-86d6-9ee8ee9cdd84": {
        "text_answer": "  No the statement is not entailed by the evidence as the secondary trial includes patients with triplenegative breast cancer",
        "label": "Contradiction"
    },
    "eef90c1d-1b9c-459e-a895-47b9012a8d1a": {
        "text_answer": "Yes The evidence does not show any adverse event related to eating disorders among the primary clinical trial candidates",
        "label": "Entailment"
    },
    "bcfd2c0f-411a-462a-acd8-7dcd6818c1c6": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary and secondary trials",
        "label": "Contradiction"
    },
    "2dc8c214-bbe5-49b7-a48e-0945fddcd9da": {
        "text_answer": "Yes Both trials include docetaxel as part of their interventions",
        "label": "Entailment"
    },
    "e41035c2-246d-43a1-b2d4-5ff9af1f789e": {
        "text_answer": "No  Explanation  The statement there were 4 more patients that suffered adverse events in",
        "label": "Contradiction"
    },
    "f9ac9b4b-4033-416b-b66c-0ecf23a9a06c": {
        "text_answer": "No  Explanation  The statement the primary clinical trial has observed more instances of mucos",
        "label": "Contradiction"
    },
    "24e7fb4c-e279-4b61-8c7f-6dc6a09e8d55": {
        "text_answer": "  No  Explanation  The statement Patients with malignant ductal car",
        "label": "Contradiction"
    },
    "a031053e-a514-4484-9624-bcddef1628d3": {
        "text_answer": "Yes The evidence mentions decision support for providers for prevention based on risk which could include counseling as a",
        "label": "Entailment"
    },
    "4493c1ed-668a-44d4-9b3e-767f597d4fa8": {
        "text_answer": "No  Explanation The statement mentions Asthenia and Pyrexia but the evidence",
        "label": "Contradiction"
    },
    "42f1e6c1-7775-4513-b810-a5559fcf60be": {
        "text_answer": "No  Explanation  The statement an adult patient diagnosed with ILDDPLD within",
        "label": "Contradiction"
    },
    "260b2917-54c5-43db-8beb-50f4e1bad69c": {
        "text_answer": "No  Explanation  The statement three electroporation injections of ld v93",
        "label": "Contradiction"
    },
    "f866e011-f633-4481-9d58-fff6828d7f83": {
        "text_answer": "Yes  Explanation  The evidence states that out of the 53 participants in the Lapatin",
        "label": "Entailment"
    },
    "b3372685-8147-4004-89f4-f57d35bd8980": {
        "text_answer": "No  Explanation  The evidence provided in the text only shows the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "e3b2d615-a7b7-475e-b757-a8de8cd2c6f7": {
        "text_answer": "No  Explanation  The statement HER2  Patients in the primary trial receive the same",
        "label": "Contradiction"
    },
    "62af11ae-461f-4e31-b104-3467b2210208": {
        "text_answer": "Yes  Explanation  The statement the outcomes of both the primary and secondary clinical trials were not",
        "label": "Entailment"
    },
    "b4fca47f-894d-47b9-a6a2-38867864c1bc": {
        "text_answer": "No   Explanation   The patient with a primary tumour of 03 cm",
        "label": "Contradiction"
    },
    "75fdf74b-e876-43f0-a382-03cf7055464b": {
        "text_answer": "Yes The statement the recorded harmful effects in the primary clinical trial were only noted for patients from cohort 2",
        "label": "Entailment"
    },
    "25efd6b7-dd3c-472e-babe-6d5397241653": {
        "text_answer": " Yes individuals who are significantly overweight are eligible for the primary clinical trial according to the given inclusion criteria However",
        "label": "Entailment"
    },
    "879196dd-c66e-4413-9575-98c95c0b9df1": {
        "text_answer": "Yes  Explanation The evidence shows that 381 of participants in Arm 1 and",
        "label": "Entailment"
    },
    "1a48d67e-c653-4e6f-bc9c-677793433e9b": {
        "text_answer": "Yes  Explanation The evidence clearly states that the number of participants with stable disease was higher at week",
        "label": "Entailment"
    },
    "86823381-4392-4a31-a1cb-b2966dd41c45": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions in",
        "label": "Contradiction"
    },
    "a5c140f2-b2e5-43a5-9a8d-268806caa311": {
        "text_answer": "Yes The evidence states that nonsmall cell lung cancer and small cell lung cancer are included in the list of eligible tum",
        "label": "Entailment"
    },
    "3d7e66cf-6e57-4072-b7f9-96ab99473ac5": {
        "text_answer": "No  Explanation  The statement all of the participants in group 1 of the primary trial",
        "label": "Contradiction"
    },
    "bec4d231-ea9b-4713-b2a1-c7ddb2dc5b0f": {
        "text_answer": "Yes  Explanation The statement both the primary clinical trial and the secondary clinical trial recorded thrombo",
        "label": "Entailment"
    },
    "5a42ca95-0544-4db1-a1f1-67534d54dc69": {
        "text_answer": "Yes  The evidence states that one cohort of the primary clinical trial receives a validated webbased risk",
        "label": "Entailment"
    },
    "d99663b8-44bb-4480-9171-e10fc1ef25b1": {
        "text_answer": "Yes  Explanation The primary clinical trial had only two groups one intervention group receiving pyridox",
        "label": "Entailment"
    },
    "97d2c16b-fa4d-4b91-a69f-6692c681f6cd": {
        "text_answer": "No   The statement is not entailed by the evidence as sunitinib dosing was not continuous throughout",
        "label": "Contradiction"
    },
    "67b2e192-d596-4951-b6d0-75f957072bdb": {
        "text_answer": "No   Explanation  The evidence describes the dosing schedule for vorinostat and radiation",
        "label": "Contradiction"
    },
    "f8f21f2b-9c9c-4f37-8c0d-b48061a14c9d": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as there is no",
        "label": "Contradiction"
    },
    "b0bb79f6-dd52-4821-b739-ffc42d7472da": {
        "text_answer": "No  Explanation The statement the incidence of treatmentemergent adverse events was",
        "label": "Contradiction"
    },
    "f94eab27-5609-47a1-bcd5-d0e1305caab1": {
        "text_answer": "No  Explanation  The statement candidates utterly incapacitated are a requirement for the",
        "label": "Contradiction"
    },
    "943db9fb-b25b-4e58-bf2f-af46b1d9df54": {
        "text_answer": "No  Explanation  The statement hospital admissions were reported during the primary clinical trial",
        "label": "Contradiction"
    },
    "ed8ce995-6417-4392-8608-d20f0087c730": {
        "text_answer": "No  Explanation  The statement pigmentary change in skin is abnormal skin pig",
        "label": "Contradiction"
    },
    "77045e13-70ad-4643-9e8c-7f0deb5d0ed9": {
        "text_answer": "No  Explanation  The statement cohort 1 and 2 of the primary trial",
        "label": "Contradiction"
    },
    "c9e9765e-663a-4421-a353-b0d6de09734d": {
        "text_answer": "Yes  Explanation  The primary clinical trial involves the use of a Contour Profile Tissue Exp",
        "label": "Entailment"
    },
    "83d14b48-ba22-47e0-a7c5-0a0b5f8af134": {
        "text_answer": "No  Explanation  The statement a majority of patients experienced adverse events in the primary clinical",
        "label": "Contradiction"
    },
    "0c0d244d-5d55-42ea-bb07-8ff35bd2c862": {
        "text_answer": "Yes  Explanation The evidence states that cohort 1 practices paced breathing for 1",
        "label": "Entailment"
    },
    "7ab5e41f-6982-43b4-8541-8ff7964d669a": {
        "text_answer": "Yes  Explanation  The statement there were no instances of hypertension dehydr",
        "label": "Entailment"
    },
    "9acd718f-6e45-495a-846d-b248d6690f1c": {
        "text_answer": "Yes The primary trial measures MYMOP score changes in units on a scale but it is not reported as a unit",
        "label": "Entailment"
    },
    "5a916856-536f-444d-87e7-1b2c032c0656": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median with range change in",
        "label": "Contradiction"
    },
    "b0b3e393-7af0-4fe2-bf26-111bddead6e7": {
        "text_answer": "No  Explanation  The evidence provided in the trial results indicates that 53 out of ",
        "label": "Contradiction"
    },
    "24816a21-1c67-4b20-82f0-0891fed68773": {
        "text_answer": "Yes  Explanation The statement patients in the primary clinical trial more frequently experienced symptoms of anem",
        "label": "Entailment"
    },
    "dc561148-4b85-4fee-a632-2662a4c1a74c": {
        "text_answer": "No  Explanation  The statement get anxious about going to doctor is a question about whether an",
        "label": "Contradiction"
    },
    "92935ccc-f20d-4e27-9a5f-cb8d47162de6": {
        "text_answer": "Yes The primary trial requires mammography as an inclusion criterion The secondary trial does not mention mammography as a",
        "label": "Entailment"
    },
    "cd7d5918-4280-48e5-a202-ad7d499a9334": {
        "text_answer": "Yes The primary clinical trial employs a 3week cycle for its treatment intervention while the secondary clinical trial",
        "label": "Entailment"
    },
    "23505a58-2e6a-4220-9148-f3b3102d2a91": {
        "text_answer": "No  Explanation The statement Cohort 1 of the primary trial received the same dose",
        "label": "Contradiction"
    },
    "d07ab8cf-9e2e-4ac2-b8e0-20d9fa9bf16a": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that those currently taking estrogens",
        "label": "Contradiction"
    },
    "147c18a2-2ef0-4cef-9f99-bbcd79b12216": {
        "text_answer": "Yes for both trials regarding the smokeless tobacco use However the evidence does not directly address the eligibility",
        "label": "Entailment"
    },
    "6c29e8c1-36ca-4e6e-b4dc-f1e91b98e546": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes the",
        "label": "Contradiction"
    },
    "6fbe26db-3420-4617-9f84-1663aa9be297": {
        "text_answer": "  Yes for the primary trial and Maybe for the secondary trial   Explanation ",
        "label": "Entailment"
    },
    "d9e7c0cc-0850-4a8e-b389-092dfdc623fc": {
        "text_answer": "No The statement Patients with histologically documented metastatic SCBC are excluded from the primary trial is not",
        "label": "Contradiction"
    },
    "2eabe849-09b8-45e6-aa6b-74450a7ff5df": {
        "text_answer": "No   The statement is not entailed by the evidence as the statement is about treatmentemergent ad",
        "label": "Contradiction"
    },
    "16808fde-01bf-40dd-ae6e-7f208b51636d": {
        "text_answer": "No   Explanation  The evidence provides information about the interventions for vaccine responses against specific diseases",
        "label": "Contradiction"
    },
    "6c2256ce-7c39-4ece-bdf4-fcd05744f234": {
        "text_answer": "No  Explanation  The statement encounter due to other specified problems related to upbring",
        "label": "Contradiction"
    },
    "c6e231b0-ab51-4010-9d8b-d447af0a6306": {
        "text_answer": "No  Explanation The statement does not follow directly from the evidence provided The evidence only mentions",
        "label": "Contradiction"
    },
    "9b1ce2f0-2734-4ae5-988e-dd569c19594e": {
        "text_answer": "No The statement is not entailed by the evidence as there is no mention of nationality ethnicity weight",
        "label": "Contradiction"
    },
    "e07a4aec-7879-4c85-a39e-a1cb17f2fd64": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement is incorrect",
        "label": "Contradiction"
    },
    "5e83904b-39bc-4449-b5c5-c2972d287237": {
        "text_answer": "No  The evidence does not support the statement as intestinal obstructions were not reported as adverse events in either",
        "label": "Contradiction"
    },
    "2a4b11b1-b14f-4fd8-a810-b6ad2f60e9fb": {
        "text_answer": "Yes  Explanation The median change in lean body mass for the group treated with GTx0",
        "label": "Entailment"
    },
    "7f06a038-29e8-4349-8822-876c2ae2e378": {
        "text_answer": "No The statement is not entailed by the evidence as the evidence does not provide any information about the nature of the ad",
        "label": "Contradiction"
    },
    "0cf7be8c-6376-4aff-93a2-2c88104fe061": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "5fc57549-ece0-4ba6-9e5f-fc785aa16f28": {
        "text_answer": "Yes The statement is entailed by the evidence as there are no reported cases of intestinal obstruction or pancy",
        "label": "Entailment"
    },
    "f103c71f-151a-46b1-b24e-c9fa1c90db64": {
        "text_answer": "No   Explanation  The evidence describes the administration method for trabectedin and placebo",
        "label": "Contradiction"
    },
    "bd5d8368-5c1d-41b8-9fb3-f174da18744f": {
        "text_answer": "maybe  Explanation The statement All patients treated with GTx024 1mg in",
        "label": "Entailment"
    },
    "b1bad6e5-5322-4ba2-8350-2496bef85d1c": {
        "text_answer": "No  Explanation  The statement there was at least 1 recorded gastrointest",
        "label": "Contradiction"
    },
    "2205c13a-b236-4117-b41e-78846625c760": {
        "text_answer": "No  Explanation  The evidence provided in the form of adverse events from two separate trials does",
        "label": "Contradiction"
    },
    "9d94e597-591d-409e-a8e2-b205a83533a5": {
        "text_answer": "Yes  Explanation The statement 3 times the number of Hepatotoxicity cases as",
        "label": "Entailment"
    },
    "95421b93-0c5a-45db-9630-804f602204b6": {
        "text_answer": "Yes  Explanation The statement mentions that Uganda is a country in Eastern Africa and that",
        "label": "Entailment"
    },
    "7f3723a3-cdbf-41a6-a956-330e514b5c5c": {
        "text_answer": "Yes  Explanation  The evidence provided indicates that in both armsgroups of the clinical trial",
        "label": "Entailment"
    },
    "ad003c43-9467-4b8e-9a4e-e28c7d6422c3": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ce4406e4-c57a-441a-870c-e2442b0806de": {
        "text_answer": "Yes  Explanation The statement several cardiacrelated adverse events have been noted for",
        "label": "Entailment"
    },
    "20296404-9526-4410-953c-51ea7ae866bd": {
        "text_answer": "No  Explanation  The evidence provided in the given clinical trial does not indicate any notable patterns in",
        "label": "Contradiction"
    },
    "287251c0-2d26-466d-8340-13d9c15196bf": {
        "text_answer": "No   Explanation The statement there was one psychiatric adverse event in the primary trial",
        "label": "Contradiction"
    },
    "709fb55d-517a-45bb-a379-f073a46cbe93": {
        "text_answer": "No  Explanation The statement all patients in the primary trial receive at least 20",
        "label": "Contradiction"
    },
    "ba87189b-e858-4344-927d-a315a0d2576f": {
        "text_answer": "No  Explanation The statement any adult with old diagnosed PRnegative HER2",
        "label": "Contradiction"
    },
    "27180597-864a-4375-97c8-e9e41fd297dc": {
        "text_answer": "  No  Explanation  The statement the primary clinical trial and the secondary clinical trial may",
        "label": "Contradiction"
    },
    "a9600a10-ab9c-4b6d-ad89-30f9d7859a50": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "bc13c987-6166-42c9-b537-1efc6126c3d8": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with localized or nondisseminated breast cancer are",
        "label": "Entailment"
    },
    "581c879a-6d09-4736-8b12-a096d45b315c": {
        "text_answer": "  Yes for the primary trial if she meets all other inclusion criteria and no exclusion criteria and for the secondary",
        "label": "Entailment"
    },
    "7ea784df-2fea-4676-a83f-a0716d2fd49d": {
        "text_answer": "No  Explanation  The statement the number of participants was higher in the primary clinical trial compared",
        "label": "Contradiction"
    },
    "9c2ca035-d531-4d44-876e-6ed9f2d3f76b": {
        "text_answer": "Yes  Explanation  The statement the secondary trial and the primary trial use different units of measure",
        "label": "Entailment"
    },
    "82bcea65-bca6-46f5-9e3b-32098e20c46f": {
        "text_answer": "No  Explanation  The statement gain of chromosome 2p is a cyt",
        "label": "Contradiction"
    },
    "2295bf51-5b26-4cde-9bcf-caeada0181b1": {
        "text_answer": "Yes The evidence does not mention any exclusion criteria based on life expectancy pregnancy status or age",
        "label": "Entailment"
    },
    "51dace9a-0da5-49ed-8d8b-7489416ea9e8": {
        "text_answer": "Yes  Explanation The evidence shows that there were 13 participants in the aprepitant group",
        "label": "Entailment"
    },
    "d323d9da-d286-4fa5-b883-552116910450": {
        "text_answer": "No  Explanation The statement compares the dosages of two different interventions Tamoxif",
        "label": "Contradiction"
    },
    "9ebcda5d-0914-4015-b5d3-9446f9582d01": {
        "text_answer": "No  Explanation  The statement multiple shingles cases were observed in both groups of the",
        "label": "Contradiction"
    },
    "856ab26e-3ce5-4405-b5ce-22557600b74f": {
        "text_answer": "No  Explanation The statement Both cohorts of the primary trial receive the same dos",
        "label": "Contradiction"
    },
    "5887ed1d-aa43-4a18-be3a-9141b675d5af": {
        "text_answer": "No  Explanation  The statement Not a single one of the participants in group 1 of",
        "label": "Contradiction"
    },
    "cefecae9-606f-4be6-94c0-f9d3732968ea": {
        "text_answer": "Yes  Explanation The evidence for the primary trial indicates that women with locally advanced recurrent or",
        "label": "Entailment"
    },
    "45bd641d-3e35-456c-a01b-63fa3e2ebea1": {
        "text_answer": "Yes The statement is entailed by the evidence as Nonsmall cell lung cancer and Small cell lung cancer are listed as",
        "label": "Entailment"
    },
    "6071457e-bfac-4d86-b20b-c37ff82c943f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "c5a577f3-2bf4-4bbf-b1f9-5bd829414790": {
        "text_answer": "Yes the patients meeting the stated criteria for breast tumor size HR status and HER2 negativity are eligible",
        "label": "Entailment"
    },
    "aa2706a4-b145-400f-8e8c-23e70f006360": {
        "text_answer": "No  Explanation The statement in the primary clinical trial the participant count in cohort",
        "label": "Contradiction"
    },
    "6d418558-93db-4116-b142-821c3f8615f2": {
        "text_answer": "No  Explanation  The statement neck pain score 2 is a subjective score of",
        "label": "Contradiction"
    },
    "7d5cd6d5-88a1-4693-b20b-c4960095a330": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial and the secondary trial suffered Th",
        "label": "Contradiction"
    },
    "006c9dd6-c568-4497-81b7-c954568a3b4a": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide information on the doses administered",
        "label": "Contradiction"
    },
    "dbc4f576-220a-482d-a06c-2538c13fdb28": {
        "text_answer": "No  Explanation The statement women aged 20 or 21 are immediately eligible for",
        "label": "Contradiction"
    },
    "ed9856c5-cecd-4d24-a338-28bf547559fe": {
        "text_answer": "No  Explanation The statement the complete cohort of the primary clinical trial is prescribed",
        "label": "Contradiction"
    },
    "d83f5fcf-2a52-4612-b548-060ece7749f9": {
        "text_answer": "Yes  Explanation The statement 2p163 is a chromosome band present",
        "label": "Entailment"
    },
    "61b2e007-6e98-4923-8c07-d22ab6b62870": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fb1605b0-dce6-45fb-bc67-2018e0578a2e": {
        "text_answer": "No  The evidence mentions anorexia in one individual but it does not indicate that most individuals struggled with",
        "label": "Contradiction"
    },
    "11714886-d3a2-496b-a883-6cd394478b03": {
        "text_answer": "No  Explanation  The statement human papillomavirusnegative squamous cell carcin",
        "label": "Contradiction"
    },
    "cd8d5a6a-0365-410c-8f85-815a67c0d11b": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not support the statement as it only",
        "label": "Contradiction"
    },
    "1d725114-1659-46dd-ab68-0c09bc167427": {
        "text_answer": "  Yes The evidence does not list bilateral breast tumor presence as an exclusion criterion",
        "label": "Entailment"
    },
    "4894f59e-9386-448a-a779-f22a453ef049": {
        "text_answer": "No  Explanation  The statement in the primary trial the control group arm 1",
        "label": "Contradiction"
    },
    "faf9f6e7-c9ac-4f15-8a63-1b463b9e1c51": {
        "text_answer": "Yes  Explanation  The statement tumour lysis syndrome was not diagnosed in participants of",
        "label": "Entailment"
    },
    "58c00532-2a20-4940-995f-08223d2736d5": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of pancytopenia in the",
        "label": "Contradiction"
    },
    "c136fce2-0e64-4f51-8483-be0fde4382ef": {
        "text_answer": "Yes   Explanation   The statement all adverse events reported in the primary clinical trial",
        "label": "Entailment"
    },
    "ce7f9154-ce9f-4d2f-8377-940c57315f1c": {
        "text_answer": "No  Explanation  The evidence provided in the text indicates that the mean standardized composite cognitive function",
        "label": "Contradiction"
    },
    "f02e41c3-1eea-4662-9359-fe120c3bc10a": {
        "text_answer": "No  The evidence does not mention any eating disorders among the adverse events reported in the primary clinical trial",
        "label": "Contradiction"
    },
    "21c01e1d-b152-404c-88d6-b697b2a97b68": {
        "text_answer": "No  Explanation  The statement the primary trial registered a higher number of mucositis",
        "label": "Contradiction"
    },
    "dd3899d8-889b-424c-a7c4-8381ce656f18": {
        "text_answer": "No  Explanation  The statement three specific adverse events pancreatitis ch",
        "label": "Contradiction"
    },
    "01650c5a-f268-41c2-b07b-9293a0e4a8f7": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the change in weekly average hot flash score from baseline",
        "label": "Entailment"
    },
    "9ad9b404-b234-41e6-9699-06a8c03bfe08": {
        "text_answer": "No  Explanation  The statement does not directly follow from the evidence provided The evidence describes the",
        "label": "Contradiction"
    },
    "1f8bd45e-480f-4244-9515-e1249b5b842a": {
        "text_answer": "No  Explanation  The evidence provided in the text does not mention anything about adverse events related",
        "label": "Contradiction"
    },
    "6d446eda-4dec-469d-9313-37c70eef8e0a": {
        "text_answer": "No   Explanation   The statement cohort 2 of the primary clinical trial",
        "label": "Contradiction"
    },
    "6003b550-4716-4966-a585-5a69fea20613": {
        "text_answer": "  No the statement is not entailed by the evidence as it only mentions unstable angina neurop",
        "label": "Contradiction"
    },
    "f5a80369-d69d-47d6-836c-60735534ce4e": {
        "text_answer": "No  Explanation The statement requires that all participants receive at least 20mg of MCS",
        "label": "Contradiction"
    },
    "7ce21c0f-ad55-4ff7-a180-5e418fe9afc8": {
        "text_answer": "Yes The secondary trial explicitly states that patients with metastatic disease stage 4 cancer are not eligible for inclusion",
        "label": "Entailment"
    },
    "3d29cec9-8354-4d5b-ae1a-f486ab7aa6ca": {
        "text_answer": "Yes The statement is about the anatomy of the renal system which is not directly related to the intervention M",
        "label": "Entailment"
    },
    "59f54656-5444-4b6d-a011-2921eb624626": {
        "text_answer": "Yes The statement implies that there is a lack of detail in the intervention section of the primary clinical trial regarding the treatment cycle",
        "label": "Entailment"
    },
    "6a3053ef-4495-4c18-9da7-68cf5ed254e0": {
        "text_answer": "No   Explanation  The evidence describes the doses of vorinostat that patients will",
        "label": "Contradiction"
    },
    "54d98b73-9799-4f9a-8581-42792f164d96": {
        "text_answer": "No  Explanation  The statement theraspheres utilized for radioembolization form the",
        "label": "Contradiction"
    },
    "75753b6a-e963-4357-a225-102c1542f73d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement is about a",
        "label": "Contradiction"
    },
    "f377df82-9511-47cc-9176-12491888eb05": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence because the evidence does",
        "label": "Contradiction"
    },
    "b2187410-7c4d-49e2-a987-892fff52269f": {
        "text_answer": "No   Explanation  The statement valvular heart disorder is any heart disorder characterized by",
        "label": "Contradiction"
    },
    "91d1600a-35d7-47a4-b972-edee5eeb6018": {
        "text_answer": "No  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Contradiction"
    },
    "95570634-cfd3-4f4c-8082-8b98a2f13859": {
        "text_answer": "Yes  Explanation  The evidence provided in the results 1 and 2 shows the ORR",
        "label": "Entailment"
    },
    "109ad38c-08ee-40ab-9a9c-65a4db8915b0": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions are administered through injections either intraven",
        "label": "Entailment"
    },
    "47abcc5d-7e6b-4969-9646-eefe68cebc3a": {
        "text_answer": "Yes  Explanation  The statement the secondary trial patients suffered from anemia pneum",
        "label": "Entailment"
    },
    "5b66def6-3282-455a-a879-6e5a68c90c1b": {
        "text_answer": "No  Explanation  The statement participants of the secondary clinical trial are administered three",
        "label": "Contradiction"
    },
    "959eb0d5-7ac9-4c23-a10e-d1b720960a96": {
        "text_answer": "Yes  Explanation The primary clinical trial evaluates the influence of using Hydrophor or Med",
        "label": "Entailment"
    },
    "a3abbf89-df53-45d4-97e1-f358dddbd2a8": {
        "text_answer": "Yes for hypertension and dyspnea but not for edema as there were instances reported in both coh",
        "label": "Entailment"
    },
    "33377a5a-a2d0-4881-b4eb-93fe650e900a": {
        "text_answer": "Yes  Explanation  The evidence provided in the trial results indicates that the mean number of hot fl",
        "label": "Entailment"
    },
    "b83fe708-6ce5-4b18-9d6a-51741249c7df": {
        "text_answer": "Yes The primary trial excludes patients with alcohol or substance abuse or dependence within the past 2 years while the secondary",
        "label": "Entailment"
    },
    "c6fedf8e-7d06-426e-8269-667a68ef06bc": {
        "text_answer": "Yes The primary trial does not involve any drugbased interventions while the secondary trial tests two different drugs PF",
        "label": "Entailment"
    },
    "485b3413-6788-47ad-916e-c5d7fdb28237": {
        "text_answer": "No  The statement is not related to the evidence provided The evidence pertains to the effectiveness of a peer support program",
        "label": "Contradiction"
    },
    "228308ea-2483-4311-a975-ca974ff797c6": {
        "text_answer": "Yes  Explanation The statement Nobody taking part in the primary trial suffered a UTI",
        "label": "Entailment"
    },
    "dfbf536b-7a16-42a0-b7f9-322c5394a01b": {
        "text_answer": "No  Explanation  The statement the most common adverse event in the secondary trial was an",
        "label": "Contradiction"
    },
    "3db98663-b8c7-4869-a46a-e7526caa7436": {
        "text_answer": "Yes for the primary trial only",
        "label": "Entailment"
    },
    "fa5334cc-0f09-4f22-91f8-156c7ab6d964": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "5accf90d-2307-441f-ae8d-d055d9564a26": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0aa5e58e-3ff4-487f-b043-d10452a30a4f": {
        "text_answer": "No  Explanation  The statement no instances of lesions were reported among the participants of group",
        "label": "Contradiction"
    },
    "85d61aaf-5255-4203-9ccf-f9c3da7a352e": {
        "text_answer": "Yes The statement is entailed by the evidence as per the disease characteristics section which states No known brain or CNS",
        "label": "Entailment"
    },
    "4c7b87a1-ac43-4d8c-b6cf-2c95f3a3a074": {
        "text_answer": "No  Explanation Both interventions in the primary clinical trial involve the injection of 0",
        "label": "Contradiction"
    },
    "33529b88-15c5-4e64-b876-f83de0305ce8": {
        "text_answer": "No  Explanation  The statement how much did ringing buzzing whistling no",
        "label": "Contradiction"
    },
    "5199d14c-3a5e-4800-adf2-a065f50886b5": {
        "text_answer": "yes The primary trial only provides armodafinil to a select group while the secondary trial provides a fixed dose",
        "label": "Entailment"
    },
    "b5f68d8f-0c92-4f58-9740-78556c039e58": {
        "text_answer": "  No   Explanation   The statement Patients with NUT midline car",
        "label": "Contradiction"
    },
    "6e644116-4084-4a3d-90dd-82f50a7ccc0c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c0b9a42b-2440-46b5-8fbc-978e2699c76e": {
        "text_answer": "No  The statement is not entailed by the evidence as colorectal cancer is listed among the eligible tumor",
        "label": "Contradiction"
    },
    "5bf5c965-7588-452a-9d36-2503218e56da": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded fewer aes than the primary trial",
        "label": "Contradiction"
    },
    "8f8b46df-4031-4a42-bf67-60d923f2ec29": {
        "text_answer": "No   Explanation   The statement radial growth phase is a morphologic architect",
        "label": "Contradiction"
    },
    "bcc9a793-5002-4cd9-a5b7-af5a1ceca35a": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only pertains to breast cancer and its treatment",
        "label": "Contradiction"
    },
    "98528323-fc08-45b9-8403-4005398ae3a7": {
        "text_answer": "Yes   Explanation  The statement the intervention for the primary clinical trial is administered or",
        "label": "Entailment"
    },
    "4ff85794-0b6a-4fe7-824f-afa6c2fa133e": {
        "text_answer": "No  Explanation The statement Coronary artery stenosis are the most common A",
        "label": "Contradiction"
    },
    "0af2a0f3-dd56-4e3b-9e85-344780cc0877": {
        "text_answer": "No  The evidence provided in the text does not relate to penile pain or CTCAE 50",
        "label": "Contradiction"
    },
    "0f094624-f6e3-479b-bea3-34b5a3acf873": {
        "text_answer": "Yes  Explanation The primary clinical trial lasted for 10 weeks while the secondary clinical trial",
        "label": "Entailment"
    },
    "55635fce-1467-46ba-934d-8234f33e103e": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence allows for female patients with solid tumors that are",
        "label": "Contradiction"
    },
    "869a492c-b4bf-4145-a491-1ee0ea0fe816": {
        "text_answer": "No  The statement about Yttrium is not related to the evidence provided about the breast cancer clinical trial inclusion and excl",
        "label": "Contradiction"
    },
    "53e2327a-6a30-49d0-a5eb-74cc5141abbb": {
        "text_answer": "No  The statement has nothing to do with the evidence provided The evidence is about the eligibility criteria for a",
        "label": "Contradiction"
    },
    "fed2e936-ab4c-42d6-8346-8f1b3ec9cc73": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not indicate that doselimiting",
        "label": "Contradiction"
    },
    "a73a2b32-2cdb-49ec-ac4e-ed2eb976dec1": {
        "text_answer": "Yes The statement is about metastatic bile duct carcinoma which is not mentioned in the evidence",
        "label": "Entailment"
    },
    "f86794bf-be99-43b3-b5e0-a78f5dde96a4": {
        "text_answer": "No  Explanation  The statement the bulk of the adverse events reported in the primary trial",
        "label": "Contradiction"
    },
    "c002edfa-458b-4274-860e-a3c6024c467c": {
        "text_answer": "No  Explanation The statement mental scale is a range of values that characterizes an individual",
        "label": "Contradiction"
    },
    "570eadad-adf1-4e5a-bae7-8455d2a07f0e": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "43a81620-bb60-4515-b31b-4cf8e5f3cc25": {
        "text_answer": "No   Explanation The evidence provided does not support the statement that it was typical for the primary clinical",
        "label": "Contradiction"
    },
    "da4bfd68-6510-4a0d-aa9e-b925d2cef24a": {
        "text_answer": "yes the statement is entailed by the evidence The primary trial results show a difference in pCR rates between the two",
        "label": "Entailment"
    },
    "4234e99e-4e49-459b-9a11-5420d039defd": {
        "text_answer": "Yes  Explanation  The statement the primary trial has fewer total adverse events compared to the",
        "label": "Entailment"
    },
    "29ebe44e-58cf-4141-afaa-9518629c3868": {
        "text_answer": "No  Explanation  The statement patients that have suffered a pulmonary embolism",
        "label": "Contradiction"
    },
    "c6c56d8f-1e0a-4dad-9993-e47e34c146e7": {
        "text_answer": "No  Explanation  The statement the primary clinical trial necessitates a monthly subcutaneous",
        "label": "Contradiction"
    },
    "376fcb2c-1ea0-4b28-a6d2-fde91a124841": {
        "text_answer": "Yes  Explanation The statement in the primary trial there were threefold the number of hepat",
        "label": "Entailment"
    },
    "a1bff44a-8d74-4184-a4d3-228bb55f4530": {
        "text_answer": "No   Explanation  The statement the secondary clinical trial had a higher incidence of ad",
        "label": "Contradiction"
    },
    "786d7c5c-66f2-4ce1-8b3d-c6fdbeb36168": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the inclusion criteria However the patients AN",
        "label": "Entailment"
    },
    "fef8b2f0-3e1f-46de-a53b-f1dffde794e6": {
        "text_answer": "yes but with an important qualification the primary trial includes male participants but the secondary trial specifically focuses on female participants",
        "label": "Entailment"
    },
    "3f777627-6d5d-43c9-8686-677498316865": {
        "text_answer": "No  Explanation The statement 50 of the primary trial patients suffered an increase in blood",
        "label": "Contradiction"
    },
    "7294869d-4998-49a4-a9b5-021476f448b6": {
        "text_answer": "No  The evidence does not mention cognitive behavioral therapy as a component of Intervention 1 It only states that",
        "label": "Contradiction"
    },
    "7cd2b581-31f9-42e8-9945-9317f97be422": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the dosages of erib",
        "label": "Contradiction"
    },
    "36386099-3f11-4037-aa48-dcbb36d7ff23": {
        "text_answer": "Yes The statement is entailed by the evidence as the inclusion criteria clearly state that the primary breast cancer must be HER",
        "label": "Entailment"
    },
    "873c56c9-8544-45f4-bba4-308707b30b93": {
        "text_answer": "  Yes The statement that individuals diagnosed with follicular lymphoma or metastatic melanoma are",
        "label": "Entailment"
    },
    "03204d11-8f0c-41be-9fe7-3361c5549d51": {
        "text_answer": "No  Explanation The placebo intervention is administered on Day 1 with a 3",
        "label": "Contradiction"
    },
    "c9c7d71a-0b59-4277-87fa-32e427e37b40": {
        "text_answer": "  No   Explanation   The statement about a 40yearold",
        "label": "Contradiction"
    },
    "90748020-3e2f-46c8-8e9d-984436a2d752": {
        "text_answer": "  No The statement is not entailed by the evidence as the primary trial allows for nonsmokers only",
        "label": "Contradiction"
    },
    "29412166-6da7-47d8-82b9-efc61e628f05": {
        "text_answer": "No  The statement is not entailed by the evidence as there was one thromboembolic event reported in",
        "label": "Contradiction"
    },
    "d333f58a-6f8d-402c-a44c-36899a155100": {
        "text_answer": "Yes  Explanation  The statement mllt1 gene rearrangement is a molecular",
        "label": "Entailment"
    },
    "777b7b77-83e6-49a0-9988-c2363fbcc17d": {
        "text_answer": "Yes  Explanation  The evidence shows that out of the total number of participants in both trials",
        "label": "Entailment"
    },
    "5aa4da04-c21d-48a4-8888-62675ca63f74": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "8e63dcb6-d289-4782-94a5-9f0aa7343cbd": {
        "text_answer": "Yes  Explanation  The statement no fatalities were reported in the adverse events for both",
        "label": "Entailment"
    },
    "d40740f4-8885-4590-b274-23802a46d9e3": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial and secondary trial both involve testing procedures radiation therapy",
        "label": "Entailment"
    },
    "13f8d256-bec7-419f-bda5-202ea116a215": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence because the adverse events in the",
        "label": "Contradiction"
    },
    "e100136f-281e-4721-9f57-66392982260f": {
        "text_answer": "No  Hyperkalemia is an exclusion criterion in the primary trial but it is not mentioned as",
        "label": "Contradiction"
    },
    "04d8d180-a06f-4eef-9c67-b51babbd8f10": {
        "text_answer": "No  Explanation The statement percentage food eaten score 30 is a subjective score",
        "label": "Contradiction"
    },
    "98d96b95-5e98-49e3-8bd1-b004132c3781": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial welcomes participants of all ages including",
        "label": "Contradiction"
    },
    "c25249a2-5294-4b5e-a39c-3b5c956b9147": {
        "text_answer": "Yes The evidence states that patients with documented allergies to cephalosporin trimethoprims",
        "label": "Entailment"
    },
    "cb5c3a2b-3752-4e0d-9b5e-ae84ffaab109": {
        "text_answer": "Yes The evidence shows an increase in the percentage of patients who were up to date for colorectal breast",
        "label": "Entailment"
    },
    "bebf3648-7a1c-4e73-8d0a-f5715fa173f8": {
        "text_answer": "No  Explanation The statement every patient in the primary clinical trial is administered a minimum of",
        "label": "Contradiction"
    },
    "0723e2a6-a2cd-4b8b-b319-f8a8bf00d819": {
        "text_answer": "No  Explanation The statement about radiationinduced malignant peripheral nerve sheath tumor",
        "label": "Contradiction"
    },
    "d0d25983-0004-4189-9139-c36827fa1e4d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "7bb1cc76-1493-4507-9560-4b4719a5d3fc": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial does not include any information about depression or",
        "label": "Contradiction"
    },
    "c77cef4c-abf2-439e-97a4-abf4e1d57ac8": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial includes various types of",
        "label": "Contradiction"
    },
    "e8be62e0-1f25-49f3-91d8-4fc23848dcd1": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence states that coh",
        "label": "Contradiction"
    },
    "d91d9ce6-365c-4b56-9eef-20922491f504": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it incorrectly states the starting",
        "label": "Contradiction"
    },
    "2e95798d-089f-44b6-a6bf-13161021b7ff": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that Any of the following current",
        "label": "Contradiction"
    },
    "d6aab46f-9e05-43a5-9d57-ca7d34bed983": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as neither the primary",
        "label": "Contradiction"
    },
    "cc2be8ad-6396-41da-a205-45d8bfca37f4": {
        "text_answer": "  No The statement is not entailed by the evidence The primary trial includes breast cancer patients and the secondary trial",
        "label": "Contradiction"
    },
    "bec00746-3a77-4d83-9c3b-d50eabcac1de": {
        "text_answer": "No  Explanation The evidence provided only mentions the interventions and their respective cohorts in",
        "label": "Contradiction"
    },
    "aebbea11-2bed-406c-a63e-02ca9eede262": {
        "text_answer": "No  Explanation  The statement The most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "13386e01-7556-4cec-93ef-c845f8c8e50d": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded 11 more cases of Intest",
        "label": "Contradiction"
    },
    "fbe7ef7c-4dff-403e-9152-04d357ec9bbc": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fd32ab49-3994-4b45-aaf9-da79d4cae211": {
        "text_answer": "No  Explanation  The statement less than 10 patients in the primary trial suffered A",
        "label": "Contradiction"
    },
    "bdfb5379-c659-4a09-b4f1-895468675f2e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c53af3d2-6827-4f10-ae9e-c7639a15b19a": {
        "text_answer": "Yes  Explanation The statement adverse events were not common amongst cohort 1 participants in",
        "label": "Entailment"
    },
    "2a5561f9-399d-4651-9a54-1a15f251c070": {
        "text_answer": "No  Explanation The statement participants in the primary trial receive sunitinib twice",
        "label": "Contradiction"
    },
    "a61c1627-33e6-4a53-8247-484d42328747": {
        "text_answer": "No  Explanation The primary clinical trial includes a minimum tumor size of 2 cm in diameter",
        "label": "Contradiction"
    },
    "dfef1ddd-9351-436d-b1ce-9f22065b495c": {
        "text_answer": "No   Explanation  The statement in both the primary trial and the secondary trial there were",
        "label": "Contradiction"
    },
    "9367129d-51e0-4d62-b2df-35749e117157": {
        "text_answer": "Yes  Explanation The evidence states that the inclusion criteria include unilateral breast cancer which means",
        "label": "Entailment"
    },
    "9a20f7f5-5477-4320-be07-3f2154877863": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "29eca4cf-13e4-4028-bbd1-71955607afb5": {
        "text_answer": "No  Explanation  The evidence provided in the text relates to the results of a clinical trial",
        "label": "Contradiction"
    },
    "1d3bccea-6780-45ae-93d2-651346fbc1dd": {
        "text_answer": "No  Explanation The evidence provided in the trial results only gives the median change in lean body mass",
        "label": "Contradiction"
    },
    "916340c0-cd97-4e2e-bd31-ded7bd2d1a56": {
        "text_answer": "10 out of 25 patients showed progression of disease by the end of week 24 so the statement",
        "label": "Entailment"
    },
    "8b37f698-edfb-4e34-b0da-4a5287506d02": {
        "text_answer": "No  The statement individuals having suffered a stroke transient ischemic attacks or have evidence of an",
        "label": "Contradiction"
    },
    "9c272853-cec0-43f0-9897-4657c5fd0b78": {
        "text_answer": "No  Explanation The primary trial includes a criterion for the primary tumour to have a diameter",
        "label": "Contradiction"
    },
    "8f31a3bf-d5a9-4f2c-95bb-c9ff01de6d42": {
        "text_answer": "Yes  Explanation The evidence states that 20 out of 35 participants in coh",
        "label": "Entailment"
    },
    "21fdf78c-fdbf-4140-9056-d3bfd2e9de27": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the alloMSC",
        "label": "Contradiction"
    },
    "6f0571f4-e1da-4732-9bdf-8c07bea059c1": {
        "text_answer": "No   Explanation   The primary trial measures hot flash activity using a composite score of sever",
        "label": "Contradiction"
    },
    "669ed7b4-398b-4604-8065-04e99611691d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial did have",
        "label": "Contradiction"
    },
    "5d1997bd-e77f-43dd-abd1-eb1da8819d47": {
        "text_answer": "No  Explanation The statement small cell component present is a morphologic finding that refers to",
        "label": "Contradiction"
    },
    "8839dd14-8457-44c0-88a1-8bb0764e326c": {
        "text_answer": "No  Explanation  The statement a larger percentage of participants in the primary trial were reported to",
        "label": "Contradiction"
    },
    "42a68b8b-0bed-49f4-8430-12e031c56471": {
        "text_answer": "No  Explanation The evidence does not provide any information about the presence or absence of a distinguishable gene",
        "label": "Contradiction"
    },
    "4d6b0c89-c9fc-4195-ac3e-c33b28af955e": {
        "text_answer": "Yes The primary clinical trial has different inclusion criteria for individuals aged 1850 and those aged 50",
        "label": "Entailment"
    },
    "fbd56c1d-5153-46c0-bd88-ed90eb1c9345": {
        "text_answer": "No  Explanation  The statement the most common adverse event observed in the primary clinical trial",
        "label": "Contradiction"
    },
    "bc50160f-7490-4c30-b373-9474707b02b3": {
        "text_answer": "Yes  Explanation  The statement 0 adverse events were observed in the primary trial and",
        "label": "Entailment"
    },
    "fd0fa999-2f1c-400d-977d-2d45dd9c358c": {
        "text_answer": "No   Explanation   The statement intervention 1 in the primary trial and",
        "label": "Contradiction"
    },
    "3f26cd3e-2b66-4bbc-94b4-498df2e334e3": {
        "text_answer": "Yes The primary trial does not involve any drugbased interventions while the secondary trial tests different doses of a",
        "label": "Entailment"
    },
    "d1d340f9-f31f-4469-804b-41853562fa57": {
        "text_answer": "No  Explanation  The statement warfarin based treatments are prohibited for the primary trial",
        "label": "Contradiction"
    },
    "7d22f8db-6793-46e2-88ca-2d464ecf9789": {
        "text_answer": "Yes The evidence states that in the primary clinical trial neither the cohort with normal vitamin D levels nor the",
        "label": "Entailment"
    },
    "ba8e855f-8cff-474d-a2dd-d5061a039b47": {
        "text_answer": "Yes The statement mentions the occurrence of Anaemia and Febrile neutropenia in cohort ",
        "label": "Entailment"
    },
    "3c558a0b-1e1a-4d42-af75-266ea0d93662": {
        "text_answer": "Yes  Explanation  The statement 11 more Participants in the ERpositive",
        "label": "Entailment"
    },
    "4c8ee685-13af-44a4-8d1e-30105f8469af": {
        "text_answer": "No   Explanation   The statement haploidentical is a donor who",
        "label": "Contradiction"
    },
    "526a5650-0b61-4e6e-9ddf-4674a6193964": {
        "text_answer": "No  Explanation  The statement unconfirmed progressive disease is a disease process that is increasing",
        "label": "Contradiction"
    },
    "6b90da92-6aaa-431b-b31c-8df9def4a98d": {
        "text_answer": "Yes The ECOG score of 1 is mentioned as an inclusion criterion in both trials The statement does",
        "label": "Entailment"
    },
    "2a13f623-4957-4e7e-9968-03f64bb6f5f3": {
        "text_answer": "Yes The statement is entailed by the evidence as both Intervention 1 and Intervention 2 include anthracy",
        "label": "Entailment"
    },
    "41756298-3326-499e-99f5-f34bcf718cbe": {
        "text_answer": "Yes The evidence provides the inclusion and exclusion criteria for both trials and fibromyalgia thalas",
        "label": "Entailment"
    },
    "f442b08f-4429-412f-99d2-24625bf8bdcd": {
        "text_answer": "  Neutral The statement does not directly relate to the information provided in the evidence  Explanation",
        "label": "Entailment"
    },
    "0add45e1-cc70-4f0d-b2c7-14c67e9cd3ee": {
        "text_answer": "No   Explanation  The statement a frequent adverse event in the secondary trial an",
        "label": "Contradiction"
    },
    "a141432b-385e-4cd4-87e4-acc0e3e9f412": {
        "text_answer": "  No  Explanation  The evidence provided in the trial results does not directly support the statement",
        "label": "Contradiction"
    },
    "47468741-3624-4321-90ee-1c680a293b25": {
        "text_answer": "No  Explanation  The statement mentions 5 total cases of asthenia and 3",
        "label": "Contradiction"
    },
    "e44e25b6-1be6-4c35-a3c9-417c56052939": {
        "text_answer": "No   Explanation  The evidence provided in the trial description does not mention paclitaxel",
        "label": "Contradiction"
    },
    "fd4c7d94-8d93-46b1-b467-3f169c6af30e": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of ER or PR in the inclusion criteria",
        "label": "Contradiction"
    },
    "a842c232-d17b-4257-84ff-02be26716c47": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "f33d7123-34a6-4466-98d2-9c69b18ac544": {
        "text_answer": "Yes The statement is entailed by the evidence as individuals with a history of interstitial lung disease or pneum",
        "label": "Entailment"
    },
    "6bbcd12e-4105-478b-a402-1374ce8a01df": {
        "text_answer": "Yes The evidence states that women of childbearing potential and sexually active fertile men are eligible for the trial",
        "label": "Entailment"
    },
    "3793f6d8-1a56-48aa-b3d3-1216f7bf5d29": {
        "text_answer": "No  Explanation  The statement maculopapular Rash was a common ad",
        "label": "Contradiction"
    },
    "72278411-1c4b-4c70-b6ab-72c4c8449ec4": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial has seen a higher prevalence of b",
        "label": "Entailment"
    },
    "10db152d-ae00-4b31-8c05-a1db1dee76b4": {
        "text_answer": "No  Explanation  In the primary clinical trial the dosage of trastuzumab",
        "label": "Contradiction"
    },
    "282cb769-7825-4b3e-b089-05a6103f60ff": {
        "text_answer": "No  Explanation  The statement A 20 year old female patient with a Newly",
        "label": "Contradiction"
    },
    "892e63ba-619c-4458-8130-89bbac726edb": {
        "text_answer": "No  Explanation The statement the majority of patients in the primary clinical trial experienced a certain type",
        "label": "Contradiction"
    },
    "4a349ab7-7fd2-4979-bf94-4e563c26b7f9": {
        "text_answer": "No  Explanation The statement patients suffering from stage 4 invasive breast carcinoma",
        "label": "Contradiction"
    },
    "0d633cc2-339a-4caf-b252-ce50b826e3e3": {
        "text_answer": "Yes  Explanation The statement an instance of infection was reported in each of the primary and secondary clinical",
        "label": "Entailment"
    },
    "28f840e3-3970-4ec7-ac46-d0503d56ee57": {
        "text_answer": "Yes The primary trial measures tumor response using RECIST criteria but it does not report the percentage of participants who",
        "label": "Entailment"
    },
    "674d7d6c-723a-44db-9e96-10aa21dcefe4": {
        "text_answer": "  Yes The evidence reports the outcome measurement as the proportion of subjects with a discernible pattern for expression of the",
        "label": "Entailment"
    },
    "c04ed14d-5ed2-46a6-9b0c-6a30a3b9a7b2": {
        "text_answer": "No  Explanation  The statement cholelithiasis was less common in primary trial",
        "label": "Contradiction"
    },
    "8983bf9f-d977-4238-91df-2435d2eb4a38": {
        "text_answer": "No  The statement is not entailed by the evidence provided The evidence indicates that there were no cases of acute",
        "label": "Contradiction"
    },
    "9d330063-37a8-4c8e-8ac2-f28c8048d0be": {
        "text_answer": "Yes  Explanation  The statement eyelid oedema and chest pain were the sole",
        "label": "Entailment"
    },
    "5e23cc12-12c7-42e9-ab55-595bb427adad": {
        "text_answer": "Yes The statement that Patients suffering from severe insomnia are excluded from both the primary trial and the secondary trial",
        "label": "Entailment"
    },
    "5f45e043-f49d-42cd-941d-baa17257d46c": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the evidence only reports",
        "label": "Contradiction"
    },
    "5fff07e2-11f3-4a58-aecb-ce4650dd35f6": {
        "text_answer": "Yes The statement that an adult patient diagnosed with diffuse parenchymal lung disease within the last 3 years",
        "label": "Entailment"
    },
    "6b257ade-83bb-428c-a623-056f1ad56594": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only pertains to breast cancer and the requirements for",
        "label": "Contradiction"
    },
    "a146a89a-9519-4515-b36a-b5f365481341": {
        "text_answer": "No  Explanation  The statement the primary clinical trial registered no instances of anaemia",
        "label": "Contradiction"
    },
    "dabe9e76-e44c-45be-87b0-337fde45ab98": {
        "text_answer": "No  Explanation The statement most of the patients participating in the primary clinical trial had a full",
        "label": "Contradiction"
    },
    "ff7079ec-d642-4cc3-8767-62df7a2a8ff7": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "06609fde-0f22-485a-ba1c-78c2677d8783": {
        "text_answer": "Yes The statement is entailed by the evidence as it accurately reflects the reduction in Ki67 expression observed in the T",
        "label": "Entailment"
    },
    "8b3c9b3e-41e8-46fb-b975-db35e552ec6c": {
        "text_answer": "No  Explanation  The statement zero percent of individuals in group 1 of the primary clinical",
        "label": "Contradiction"
    },
    "0cfa6770-4d70-4603-865b-512957909993": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly states",
        "label": "Contradiction"
    },
    "363212ed-da18-4ae4-a7e5-cab37c207a24": {
        "text_answer": "Yes The evidence includes criteria related to worry or concern specifically regarding the subjects ability to swallow and retain oral medication",
        "label": "Entailment"
    },
    "189e7142-d6fd-49d6-8e4f-44383f00781b": {
        "text_answer": "No   Explanation   The statement both the primary and secondary clinical trials accept patients with",
        "label": "Contradiction"
    },
    "b6109c91-afac-46ff-b306-bd9a5f1bba84": {
        "text_answer": "No   Explanation The evidence states that patients with a history of grade 3 or 4 allerg",
        "label": "Contradiction"
    },
    "c2b8b1b0-9d84-498a-b490-e3da298f1087": {
        "text_answer": "Yes The primary trial measures tumor diameter in centimeters while the secondary trial measures response to treatment in participants with",
        "label": "Entailment"
    },
    "09df9e5c-cc03-4c01-858b-0886376e9b7a": {
        "text_answer": "Yes The evidence states that less than 54 of participants had a reduction in CTCs",
        "label": "Entailment"
    },
    "3c596e8f-b1a2-4ded-b15b-99784b540d76": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "56ab098d-56f4-401e-a173-a0c99cd8efd0": {
        "text_answer": "  Yes the statement is entailed by the evidence for the secondary trial but not for the primary trial as it",
        "label": "Entailment"
    },
    "a0f34f76-d0dd-48f3-b916-1722ecb924c2": {
        "text_answer": "Yes The statement does not contradict the evidence and is consistent with it The evidence states that there were no reported ad",
        "label": "Entailment"
    },
    "742cd2e5-1335-4daa-87b0-47727f61d8a1": {
        "text_answer": "Yes  Explanation The evidence states that patients receive oral lapatinib once daily on days 1",
        "label": "Entailment"
    },
    "2062b384-c6c1-4997-a4e4-b6709d123502": {
        "text_answer": "No  Explanation The statement participants in the primary clinical trial were found to have chole",
        "label": "Contradiction"
    },
    "6bb59504-e102-48d6-ac0d-8ce71100b726": {
        "text_answer": "Yes  Explanation The statement Both cohorts of the primary trial receive the same dos",
        "label": "Entailment"
    },
    "08a467b9-3bf6-486f-9975-4e2b67a5b690": {
        "text_answer": "Yes The secondary trial specifically includes patients with diagnosed alterations in the listed genes PTEN BRAF K",
        "label": "Entailment"
    },
    "379dbb6e-e70b-4e6c-83a9-c332b84592dd": {
        "text_answer": "Yes The evidence mentions significant cardiovascular impairment as an exclusion criterion for",
        "label": "Entailment"
    },
    "6b901ca0-1ec8-4d36-b43d-dcc6bf63b70f": {
        "text_answer": "No  Explanation  The statement does not provide any information about the relationship between hexadecad",
        "label": "Contradiction"
    },
    "d921df56-8a29-45a9-bb0b-66ba14dbc193": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "1e2b550a-0da3-48ea-8221-1a8b86e10511": {
        "text_answer": "Yes  Explanation  The statement There are no cases of anorexia hypother",
        "label": "Entailment"
    },
    "5a96ef9e-57ed-4f5a-95b3-db64e3268993": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement mentions my",
        "label": "Contradiction"
    },
    "2660009c-449a-4edb-a64a-20164527c99d": {
        "text_answer": "No  Explanation  The statement none of the patients receiving the sunitinib  doc",
        "label": "Contradiction"
    },
    "5b100056-e657-4b2a-9ecf-8b949233ab50": {
        "text_answer": "No  Explanation  The statement the primary clinical trial reported at least one gastroint",
        "label": "Contradiction"
    },
    "fa664989-b970-41f4-b491-dd2aeb308dd1": {
        "text_answer": "No  Explanation  The statement the only types of adverse events observed in patients from the",
        "label": "Contradiction"
    },
    "bc686408-6e00-414a-b5a4-2bae034aca57": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which states that individuals with a history of inter",
        "label": "Entailment"
    },
    "5e5253e5-fd72-4f2b-84ba-b370545cd182": {
        "text_answer": "Yes The statement mentions Anaemia and Febrile neutropenia which are both adverse events recorded in",
        "label": "Entailment"
    },
    "fe6c20be-e0c6-461c-9e93-cef55bdd7902": {
        "text_answer": "No  Explanation  The statement chemotherapy or radiotherapy patients from the last 2 weeks",
        "label": "Contradiction"
    },
    "6b5a90bf-c45f-4a85-807f-1f184463cf5f": {
        "text_answer": "No  Explanation  The statement after undergoing treatment with aprepitant dex",
        "label": "Contradiction"
    },
    "eb8737bb-19f6-4249-83da-63b05b251084": {
        "text_answer": "No  Explanation  The statement cohort 1 and cohort 2 of",
        "label": "Contradiction"
    },
    "d303ce9d-a00a-4ee7-8147-0bac063ee210": {
        "text_answer": "Yes The adverse event type General disorders and administration site conditions  Other disease progression impacted 2",
        "label": "Entailment"
    },
    "f34e13a3-4463-4cf4-8a15-79872282b90e": {
        "text_answer": "Yes The primary trial specifies Japanese females as applicants while the secondary trial does not have such a specification",
        "label": "Entailment"
    },
    "5cc13d6e-bc37-47d3-8198-8e7af5a8b5a2": {
        "text_answer": "Yes children are not explicitly included in the secondary trial but neither is it stated that they are ineligible",
        "label": "Entailment"
    },
    "4d3272e0-735a-4531-9f23-c0e4660c64a5": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "dd33f2de-6bfc-4a27-95da-630c9f0c0574": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity weight or gender as inclusion or exclusion criteria for either",
        "label": "Entailment"
    },
    "d81e386d-9799-44bc-b006-8fdd7c14103c": {
        "text_answer": "No  Explanation The statement in the question is not entailed by the evidence provided The primary",
        "label": "Contradiction"
    },
    "7bad3ae8-835f-401c-b50d-10e2f2773cc7": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not support the statement as it only",
        "label": "Contradiction"
    },
    "09816bed-e4f7-4b1c-8599-fbc623fa9675": {
        "text_answer": "Yes The secondary trial intervention lasts for 24 weeks which is 10 weeks primary trial ",
        "label": "Entailment"
    },
    "103f19bc-87b9-4017-b2d8-8afd8bc54157": {
        "text_answer": "No  The evidence provided does not mention radiation therapy at all",
        "label": "Contradiction"
    },
    "b1695ed3-b79e-4e1a-8658-52f33b997fea": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b7d7f9f1-1e62-403f-9ceb-234108f7569f": {
        "text_answer": "Yes The primary trial includes stage IIbIIIIV breast cancer patients while the secondary trial excludes patients with",
        "label": "Entailment"
    },
    "2853d135-6a33-4c1f-bf2c-251ef936c5dd": {
        "text_answer": "No  Explanation  The statement 025 of patients in the primary trial suffer increased",
        "label": "Contradiction"
    },
    "d8d3ab61-0fc8-462a-930b-114b2363d70a": {
        "text_answer": "No  The statement is not entailed by the evidence as some adverse events affected less than 100",
        "label": "Contradiction"
    },
    "8e18ed71-8fa4-4d81-841d-ce718daa0f41": {
        "text_answer": "Yes Patients with tumors positive for CCND1 amplification are eligible for the primary clinical trial according to the inclusion",
        "label": "Entailment"
    },
    "4acaf50b-e6af-497a-a0d2-709e5780dd0b": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only reports the number of participants in each",
        "label": "Contradiction"
    },
    "a752838e-30be-4438-913e-e905d2893abc": {
        "text_answer": "Yes The secondary trial does not explicitly list tobacco use as an exclusion criterion",
        "label": "Entailment"
    },
    "4e4b2acf-c921-4f0d-b9e9-6a54fe5d9877": {
        "text_answer": "No  Explanation  The statement none of the participants in group 1 of the primary trial",
        "label": "Contradiction"
    },
    "2a95f6b8-fbdd-47e6-949f-8aee18a2c605": {
        "text_answer": "Yes Both trials include Japanese females as eligible participants",
        "label": "Entailment"
    },
    "e658eb5e-3411-4dcb-bff2-6bad677ac1a7": {
        "text_answer": "No  Explanation The evidence provided in the primary trial relates to the percentage change in serum",
        "label": "Contradiction"
    },
    "3f4231c5-0eae-43eb-b0df-b270cea08476": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial results indicates that the proportion of participants who",
        "label": "Contradiction"
    },
    "6fdb953d-a7b8-41b9-8652-2d8b51bfcaa0": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "99433bba-fce5-4b0a-a076-1f699b51472d": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "9a111f3a-a29a-42fa-bf73-9f178286198c": {
        "text_answer": "Yes  Explanation  The statement tamoxifen 20 mg po daily for",
        "label": "Entailment"
    },
    "8f8be6b6-df75-4757-bc64-b2fbc8849f70": {
        "text_answer": "Yes  Explanation The statement There was one case of shingles recorded in group 2 of",
        "label": "Entailment"
    },
    "4d5acda5-74be-4228-a24e-bcd405ac6af4": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a95eba72-3c28-4c9b-a79f-011f1578907c": {
        "text_answer": "No  Explanation  The statement past treatment with gabapentin or herceptin within",
        "label": "Contradiction"
    },
    "88e7acab-bd9d-4e6c-a241-c538501824e8": {
        "text_answer": "No  Explanation The statement perform chores is a question about an individual performing chores such",
        "label": "Contradiction"
    },
    "985ff367-3936-4e38-92e7-45e1cb9f24ee": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the adverse events noted",
        "label": "Contradiction"
    },
    "1e826f28-5a81-4123-95f7-74418392ed90": {
        "text_answer": "No  Explanation The statement participants in the primary clinical trial receive a diverse drug reg",
        "label": "Contradiction"
    },
    "cdc80bd8-0b1c-4908-9095-74a1a7078e43": {
        "text_answer": "Yes  Explanation The evidence states that in Intervention 2 patients receive 600",
        "label": "Entailment"
    },
    "2fa66862-310e-454e-a0d6-5e3ef0ec1e2d": {
        "text_answer": "Yes  Explanation The evidence states that at Week 12 there were 12 participants",
        "label": "Entailment"
    },
    "4a47dcda-1105-46c5-8f3d-ffbfe5259d70": {
        "text_answer": "No   Explanation   The primary trial measures hot flash activity using a composite score of sever",
        "label": "Contradiction"
    },
    "af1e26a0-09d7-408f-89ec-be5bf4bfc88c": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial patients in the fast shallow",
        "label": "Contradiction"
    },
    "1ec46b05-25a0-45c2-a6aa-31f5a2209ac5": {
        "text_answer": "No  Explanation  The statement global complete response in blood is a score of b0 by",
        "label": "Contradiction"
    },
    "056fccd5-f005-4088-8f9b-c22b87eaa371": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e7e2f4af-f6c2-47cc-b03e-6e69210d14c7": {
        "text_answer": "Yes The evidence shows that the median survival times for both groups are less than 3 years but some patients survived for",
        "label": "Entailment"
    },
    "542ebedc-ffda-406e-9ef5-d2f9edc30ac1": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence regarding the administration of capecitabine in the primary",
        "label": "Entailment"
    },
    "e6fb96bc-d38b-484e-8d2a-fe14f943c599": {
        "text_answer": "  No  Explanation  The statement eligible for the primary clinical trial are patients who",
        "label": "Contradiction"
    },
    "c3d9b60a-a46e-4bde-9e4a-46db5c2d75ba": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial is not",
        "label": "Contradiction"
    },
    "b9f4eb6e-b05b-44e8-b92d-62624cc71935": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the outcome measures of the",
        "label": "Contradiction"
    },
    "be8707c6-9004-4fab-b719-c1ab372a77a1": {
        "text_answer": "No  The statement is not entailed by the evidence as the inclusion criteria do not specify that patients must have invasive",
        "label": "Contradiction"
    },
    "04178e95-d808-4a96-ab85-61eb52c17720": {
        "text_answer": "29 The evidence reports 24 AEs and 11 SAEs for a total of 35",
        "label": "Entailment"
    },
    "74866fee-c33b-4df9-8d5c-28b47182b753": {
        "text_answer": "No   Explanation   The statement the treatment in the primary trial progresses in a",
        "label": "Contradiction"
    },
    "96be8dc9-8873-475f-b91f-e92f3549861b": {
        "text_answer": "Yes  Explanation  The statement the height criterion for the primary clinical trial disqual",
        "label": "Entailment"
    },
    "d82bb7da-6579-43be-969a-206d2235afd3": {
        "text_answer": "Yes  Explanation The statement in the course of the study period more than 15",
        "label": "Entailment"
    },
    "05fbffcf-c1a0-40f9-95dd-8e9010005773": {
        "text_answer": "No   Explanation   The primary and secondary trials report results from different patient cohorts",
        "label": "Contradiction"
    },
    "cbcecc39-a187-40ca-86cf-06d9c75ff972": {
        "text_answer": "Yes The evidence does not explicitly state that all Japanese individuals are eligible for both trials but it does not exclude them either",
        "label": "Entailment"
    },
    "2f30372d-c143-495d-96d9-ad238ff94baf": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence describes the interventions",
        "label": "Contradiction"
    },
    "2db5cad0-f216-4e18-accf-87e3308afc59": {
        "text_answer": "No   The secondary clinical trial is not based on the alterations in MYMOP score but rather on",
        "label": "Contradiction"
    },
    "71f1d2c6-7ab2-45d2-bb54-a0cad79d244b": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement is about PR",
        "label": "Contradiction"
    },
    "1dd07ae9-349c-41e1-b967-fd8691e320e0": {
        "text_answer": "No  Explanation  The statement patients who have received chemotherapy or radiotherapy in the",
        "label": "Contradiction"
    },
    "aa25fae6-9d48-4237-92d0-504cfc8af672": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it makes an incorrect",
        "label": "Contradiction"
    },
    "e53fdbd4-4375-409d-ad00-322822909d5b": {
        "text_answer": "No  Explanation The statement participants in the secondary clinical trial are scheduled for three weekly",
        "label": "Contradiction"
    },
    "7e5ca0bb-bae1-493f-9a30-7f70d544fcf4": {
        "text_answer": "Yes The statement is entailed by the evidence as the statement and the inclusion criteria both require that the participants have breast cancer",
        "label": "Entailment"
    },
    "6c5d5b1a-e7e0-427f-b21b-a9fbc5e2b69e": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence describes",
        "label": "Contradiction"
    },
    "46065ce7-6618-4f08-890c-6bd0f8fa4573": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the primary trial is specifically for",
        "label": "Contradiction"
    },
    "d20c94ae-14d5-4272-96d5-ef649dfade50": {
        "text_answer": "No   Explanation  The statement a majority of the primary clinical trial participants experienced some form",
        "label": "Contradiction"
    },
    "56c00437-a067-4734-9b55-f1041c10190e": {
        "text_answer": "  No  Explanation  The statement patients who have previously experienced serious anaphyl",
        "label": "Contradiction"
    },
    "85cdaaef-3a05-458f-aaf2-d935069cf478": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial intervention 1 and in the",
        "label": "Contradiction"
    },
    "65fc2061-6d0f-46d1-bd13-5959cedf6b03": {
        "text_answer": "No  Explanation  The statement In the primary trial only one cohort receives Armod",
        "label": "Contradiction"
    },
    "ebe96d52-cfbc-403c-ba10-244991ddc449": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial and secondary clinical trial are investigating the",
        "label": "Entailment"
    },
    "840eeabe-3086-4be9-98fc-deaf26b4349b": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not support the statement as it only",
        "label": "Contradiction"
    },
    "a02864dc-e1f8-427e-9df3-531c91d28d50": {
        "text_answer": "No  The evidence does not mention anything about cyclindependent kinase inhibitor protein",
        "label": "Contradiction"
    },
    "05f34052-08b6-4b98-91d3-326b4f77844c": {
        "text_answer": "No   Explanation  The statement only topical treatments will be administered to the patients",
        "label": "Contradiction"
    },
    "4927c9bb-aa2b-4c3c-999b-068e1dca959a": {
        "text_answer": "No   Explanation  The primary trial involves radiation therapy as an intervention but it is not",
        "label": "Contradiction"
    },
    "304f8d66-90f2-40cc-9f18-77c2b8471a40": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial involves",
        "label": "Contradiction"
    },
    "6088eecc-56f9-475b-a27a-a23bc646028b": {
        "text_answer": "No  Explanation  The statement all participants in the primary clinical trial experienced less than 3",
        "label": "Contradiction"
    },
    "ff8c88f9-c698-4ad0-a9ba-0acf6fbf1933": {
        "text_answer": "No  Explanation  The statement sellar schwannoma is an extremely rare sch",
        "label": "Contradiction"
    },
    "f9d5b863-f0cb-4777-81a7-358efd8010d6": {
        "text_answer": "Yes The statement does not specify the exact timing of Dexamethasone administration for cohort 2",
        "label": "Entailment"
    },
    "31b3aa86-f32c-4a10-ae36-6429b25995dc": {
        "text_answer": "  No   Explanation   Anorexia is a specific eating disorder characterized by",
        "label": "Contradiction"
    },
    "da91afa9-21ed-4d4d-a5d9-964dbb334177": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes a",
        "label": "Contradiction"
    },
    "a012091a-9e07-4878-81bf-fee2e3282cbd": {
        "text_answer": "  No The statement Patients with histologically documented metastatic SCBC are excluded from the primary trial",
        "label": "Contradiction"
    },
    "5fcf6210-c07a-4b8e-9944-c2f0714e4d69": {
        "text_answer": "Yes The primary trial participants received lower doses of PF06647020 0",
        "label": "Entailment"
    },
    "800c7053-0dd5-4c99-ba55-c45b121d303c": {
        "text_answer": "Yes  Explanation The statement both interventions utilize laserassisted fluorescence ang",
        "label": "Entailment"
    },
    "cdab084c-4e2b-4f0a-ac8c-868b4bb4ecb5": {
        "text_answer": "No  The statement is not entailed by the evidence provided The evidence describes the interventions for the two stratums",
        "label": "Contradiction"
    },
    "ec5c26e8-0afd-4244-8731-588c4f88e84b": {
        "text_answer": "Yes  Explanation The statement cohort 1 of the primary clinical trial has multiple records of",
        "label": "Entailment"
    },
    "e4575416-926c-4b2d-b4ba-1aa417cae0db": {
        "text_answer": "Yes   Explanation  The statement is entailed by the evidence as both the placebo and",
        "label": "Entailment"
    },
    "66c31a74-8bb0-4625-9ce7-401da56be447": {
        "text_answer": "Yes The evidence does not specifically mention fatigue interfering with duties or responsibilities in relation to the inclusion criteria",
        "label": "Entailment"
    },
    "eff8deaa-08a6-4df3-9140-fe153fbcba6e": {
        "text_answer": "yes the intervention in the secondary trial continues for three times as long as in the primary trial",
        "label": "Entailment"
    },
    "31bb177c-1a8b-4699-a7f2-4c442801770f": {
        "text_answer": "Yes  Explanation The statement the frequency of adverse events was higher in the first cohort",
        "label": "Entailment"
    },
    "c2aea351-6ce5-4d26-9ba5-2632c6367b93": {
        "text_answer": "Yes  Explanation The statement at least one patient in the primary trial suffered several different adverse events",
        "label": "Entailment"
    },
    "3ff8b1f7-4c73-4cb7-acbd-4d7e3b7f31ec": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9cd25233-1d76-4d0d-a571-ce8fee279757": {
        "text_answer": "No  The evidence provided does not allow for the inclusion of morbidly obese or pregnant patients in either trial",
        "label": "Contradiction"
    },
    "340721ab-42f9-4ac3-8608-58007d89b87b": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of respiratory issues in the documented",
        "label": "Contradiction"
    },
    "16aacacc-1ab7-46d2-a59e-ca207cb0282d": {
        "text_answer": "No  Parathyroid carcinoma is not listed as an exclusion criterion in either the primary or",
        "label": "Contradiction"
    },
    "68716599-d21d-433a-9e8d-5113749d4a06": {
        "text_answer": "Yes  Explanation  The statement the total adverse events in the primary trial exceed those in",
        "label": "Entailment"
    },
    "90fc98fa-35bb-48ae-a2f3-b74e6bd0d353": {
        "text_answer": "No  Explanation  The statement more than four different types of adverse events affected patients in",
        "label": "Contradiction"
    },
    "3ac94edb-bccc-44c6-9b1a-4ea79122d154": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial involves the use",
        "label": "Contradiction"
    },
    "0d95a819-09cb-49a0-9ec0-76a64bc50732": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions in",
        "label": "Contradiction"
    },
    "9d9db340-6fee-4ec0-b6cb-7fdfe2d34959": {
        "text_answer": "Yes  Explanation  The statement there were 0 cases of hypertension ed",
        "label": "Entailment"
    },
    "d43e7757-45d0-4f65-9735-6ba05f13337d": {
        "text_answer": "Yes The primary trial excludes patients who have received chemotherapy or radiotherapy within 4 weeks prior to entering the study",
        "label": "Entailment"
    },
    "908f5aed-eb98-47f8-b00d-7ce39707446f": {
        "text_answer": "Yes  Explanation The statement hpv16 infection is an infection caused by human papill",
        "label": "Entailment"
    },
    "b8ffb304-4dd2-4fa9-888e-b851c73513c1": {
        "text_answer": "Yes  Explanation The evidence shows that a larger proportion of participants in both the Collaborative Care Inter",
        "label": "Entailment"
    },
    "47074986-36ac-4ebe-a743-cdf06a70efd8": {
        "text_answer": "No  The statement about Alzheimers patients being ineligible for the trial is not directly related to the",
        "label": "Contradiction"
    },
    "698a471b-ead0-445f-93bb-4badc6382968": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly support the statement that the Bev",
        "label": "Contradiction"
    },
    "0ec15a9a-41f5-44aa-a089-c5f0fe5c9806": {
        "text_answer": "yes for the primary trial no for the secondary trial regarding Her2neu breast cancer requirement",
        "label": "Entailment"
    },
    "09ebfb97-f98c-4555-9e69-85b60af863fa": {
        "text_answer": "Yes The evidence states that patients will take Vorinostat daily during radiation therapy",
        "label": "Entailment"
    },
    "a326e30f-a2c9-4a6e-b497-02cc338735c5": {
        "text_answer": "No  Explanation  The statement A woman who has had a mastectomy for stage",
        "label": "Contradiction"
    },
    "2ce21ccd-8f05-4618-8597-b1ad8be31f59": {
        "text_answer": "Yes The evidence mentions the use of laserassisted fluorescence angiography in both interventions of",
        "label": "Entailment"
    },
    "d1c52b9f-7feb-4d54-af86-7aace67807d4": {
        "text_answer": "yes but with an explanation  The statement is entailed by the evidence but it is important to note that",
        "label": "Entailment"
    },
    "eff637a6-8d7c-47e9-bcba-b4b52159aa4d": {
        "text_answer": "1 No for the statement about superior performance based on the primary trial 2 Not applicable for the statement",
        "label": "Contradiction"
    },
    "5c06c081-87ef-4e9a-ab22-c8c55253fc34": {
        "text_answer": "Yes  Explanation  The statement there were fewer instances of mucositis oral bl",
        "label": "Entailment"
    },
    "74c7adc7-9641-4858-88af-69a2e2cd6dad": {
        "text_answer": "No   Explanation  The statement is not directly entailed by the evidence as it introduces",
        "label": "Contradiction"
    },
    "ab848536-4d43-4af3-9489-59b7608b7ecf": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement as it",
        "label": "Contradiction"
    },
    "62716b99-76d4-4dfe-b0ce-1ad35f768b33": {
        "text_answer": "Yes An ECOG score of 1 falls within the allowed range for both trials 02 for primary trial",
        "label": "Entailment"
    },
    "2fb3af20-adda-4fee-860a-ce376d3a0bb2": {
        "text_answer": "Yes  Explanation The statement In the primary trial results there were more patients with stable disease in",
        "label": "Entailment"
    },
    "4988cb16-7dbb-4847-84e0-4a7957b32c72": {
        "text_answer": "  Yes Primary Trial No Secondary Trial Maybe  Explanation  ",
        "label": "Entailment"
    },
    "ed247cb5-ed15-4c1b-940d-099d16ee7f53": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence describes different dosing",
        "label": "Contradiction"
    },
    "0cab14c5-398c-4e4e-9c6a-65fb70aecb23": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence The statement mentions the CRsR clinical classification",
        "label": "Entailment"
    },
    "9c4db46a-f5c4-46f0-9d28-8b18bbb9583a": {
        "text_answer": "No  Explanation The statement mentions a combined total of 3 cases of asthenia",
        "label": "Contradiction"
    },
    "d68944ff-4237-41b8-9ba1-bdfd9899ba32": {
        "text_answer": "No  Explanation  The statement three cases of shingles were reported across the patient co",
        "label": "Contradiction"
    },
    "d9d506ef-20ed-44e2-9809-07cb0772535b": {
        "text_answer": "Yes  Explanation  The statement All Infections and Infestations cases in the primary trial",
        "label": "Entailment"
    },
    "e15409e3-408c-4ea8-a0aa-9f1072b8a74b": {
        "text_answer": "Yes   Explanation The statement is entailed by the evidence as it accurately reflects the information provided in",
        "label": "Entailment"
    },
    "335235f3-4d27-479e-a5d7-29016a3320a5": {
        "text_answer": "Yes  Explanation The statement multiple adverse events were reported in the primary clinical trial including anem",
        "label": "Entailment"
    },
    "9b120158-866e-4a68-ab9a-4d6241ead464": {
        "text_answer": "No  Explanation  The statement the secondary trial and the primary trial report results using the same",
        "label": "Contradiction"
    },
    "ad1abf74-05c4-439a-b178-f21231744c89": {
        "text_answer": "No  The statement is not about the breast cancer clinical trial and its inclusionexclusion criteria It is about a",
        "label": "Contradiction"
    },
    "1786385e-70c9-4a5b-a19e-0f389be545cc": {
        "text_answer": "No  Explanation  The statement disturbed sleep at its worst is a question about an individual",
        "label": "Contradiction"
    },
    "0bb51a03-72e6-4d48-8010-054e280a960f": {
        "text_answer": "No The statement is not entailed by the evidence as the evidence does not provide any information about adverse events related to",
        "label": "Contradiction"
    },
    "d30d2472-9529-4206-8167-5bace92bb6d0": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial and secondary",
        "label": "Contradiction"
    },
    "96be5169-0334-4849-a77b-111e8eacf7bb": {
        "text_answer": "No  Explanation  The statement multiple adverse events have been recorded in at least one co",
        "label": "Contradiction"
    },
    "47507d4a-ea24-433a-9864-e4b76657335c": {
        "text_answer": "Yes  Explanation  The statement in the patient cohorts of both the primary clinical trial",
        "label": "Entailment"
    },
    "3e16b4a5-6dc6-4a20-a367-c361bc38644e": {
        "text_answer": "Yes  Explanation The evidence shows that the median survival times for both groups A and B",
        "label": "Entailment"
    },
    "4d2b9583-9b62-40cc-b7e7-096c2dd16e0b": {
        "text_answer": "Yes The primary trial specifically includes participants who are resistant to AI therapy while the secondary trial does not mention it as",
        "label": "Entailment"
    },
    "49d0acfc-e7ce-45f5-8e45-08d55f3d0776": {
        "text_answer": "  No  Explanation  The evidence provided in the trial results does not directly measure the primary",
        "label": "Contradiction"
    },
    "b68e076b-9950-438b-96ea-3fc93943e490": {
        "text_answer": "No  Explanation  The statement requiring considerable assistance and frequent medical care is not mentioned",
        "label": "Contradiction"
    },
    "3977a1e3-3371-4577-9dc1-eea3a725469c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "430f4379-7517-4dc9-a9e4-885f2934f872": {
        "text_answer": "No  Explanation  The statement the adverse event most often witnessed in the patient coh",
        "label": "Contradiction"
    },
    "d2c3690c-11a2-40de-b077-acf5f53fdb10": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not include any information about the myb",
        "label": "Contradiction"
    },
    "91a6d0f0-3f3c-4bd7-80a5-f403fd7ef87e": {
        "text_answer": "Yes The evidence does not mention the use of xrays ultrasound CT scans or MR",
        "label": "Entailment"
    },
    "d9b955ea-915d-438f-a9b1-cd1cc08c0dd4": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial indicates that the average pain intensity score for",
        "label": "Entailment"
    },
    "5b174c01-9e6e-4fa0-8c85-c7b72446d0b2": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes two",
        "label": "Contradiction"
    },
    "711fdd40-52ec-401c-90fc-5a11de547ab6": {
        "text_answer": "Yes The evidence does not report any cases of eating disorders among the primary trial candidates",
        "label": "Entailment"
    },
    "fd258898-9438-4474-a89e-7143a96abe06": {
        "text_answer": "No   Explanation  The statement patients will receive a single injection on study day ",
        "label": "Contradiction"
    },
    "4b913a72-0c81-4396-8667-f087259328f6": {
        "text_answer": "Yes  Explanation  The statement no cases of unanticipated deaths or hospitalizations are",
        "label": "Entailment"
    },
    "a1a8bedd-680d-4250-9384-93379de0a2a3": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "514d5612-4c60-4586-89b7-ca89b06ac576": {
        "text_answer": "No  Explanation The primary trial includes a criterion for the primary tumour to have a greater",
        "label": "Contradiction"
    },
    "3eb3c09a-b46f-49bf-84d6-7aeb1ba0d2a5": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "5b3b5c72-175a-42ea-aeab-63cd4298b362": {
        "text_answer": "Yes   Explanation The primary clinical trial and the secondary clinical trial involve different patient populations as indicated",
        "label": "Entailment"
    },
    "58f39f52-0a96-4892-b8e7-2b689448c28f": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that some interventions can be administered intravenously",
        "label": "Entailment"
    },
    "7aa4329c-8f2a-4168-9b6b-f74ea0184356": {
        "text_answer": "No  Explanation  The statement Prior treatment with gabapentin or herceptin within",
        "label": "Contradiction"
    },
    "62db4a46-c4ea-44a1-8dfc-12922748a7b0": {
        "text_answer": "No  Explanation  The statement is not directly related to the evidence provided in the primary trial",
        "label": "Contradiction"
    },
    "2610ce20-2875-4677-a55b-fbd094ca3abb": {
        "text_answer": "Yes The evidence does not mention anything about pd0332991 being administered to cohort",
        "label": "Entailment"
    },
    "0e2c4838-f0ba-4f02-b078-ac3fa2b3c0e3": {
        "text_answer": "Yes  Explanation The evidence states that cohort 1 received a dosage of 0",
        "label": "Entailment"
    },
    "22c47ff5-a9b1-4de2-b5ee-2e5a6f2302d9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial specifically includes only patients",
        "label": "Contradiction"
    },
    "6b48128c-3103-4266-bd7f-3f9d13dc5949": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "75d3b7d9-3863-4b14-8007-8d8ade0440f1": {
        "text_answer": "No  The statement patients with a body mass index bmi of 20 and above are eligible",
        "label": "Contradiction"
    },
    "1279b75a-606f-469e-a6e6-20d4eabd50ba": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes male subjects and the secondary trial includes female",
        "label": "Contradiction"
    },
    "d32ff217-1848-490b-8a99-bc12730318f0": {
        "text_answer": "No  Explanation  The statement the primary trial reported 5 serious adverse events while the",
        "label": "Contradiction"
    },
    "9d742d77-5754-4e6f-a913-90dc71c6b6f5": {
        "text_answer": "No   Explanation  The evidence provided describes two separate interventions in a clinical trial one",
        "label": "Contradiction"
    },
    "af52a2f1-de39-4113-86fa-10e65961b095": {
        "text_answer": "No  Explanation  The statement Any Patients currently taking part in the secondary trial will also",
        "label": "Contradiction"
    },
    "4c0fbabb-2d9e-4da7-8a17-07272c77ece8": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not report any deaths in the secondary trial",
        "label": "Contradiction"
    },
    "98b04dac-b155-4afd-8855-03ed818df5d9": {
        "text_answer": "Yes  Explanation  The statement We cannot compare the adverse events in the primary trial and",
        "label": "Entailment"
    },
    "5b31fcf1-a528-4718-adcb-72df68b4df43": {
        "text_answer": "Yes The statement that the primary and secondary trials recorded the same number of adverse events is entailed by the evidence",
        "label": "Entailment"
    },
    "cc321a3c-a09d-4354-8601-d665f428a831": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial excludes patients with more than three cerebral met",
        "label": "Entailment"
    },
    "fddee10c-dd7d-47fe-b2cf-3ebe94726ea4": {
        "text_answer": "No  Explanation  The primary clinical trial involves the administration of suramin and paclitaxel",
        "label": "Contradiction"
    },
    "6d7c7740-c399-4d73-82c8-2ef0d4739341": {
        "text_answer": "Yes  Explanation  The statement Cohort 1 of the primary trial did not report",
        "label": "Entailment"
    },
    "5b07e1cb-d734-4e43-9911-6328923fbc93": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the most recurrent adverse",
        "label": "Contradiction"
    },
    "47bcd1c5-f95d-4e21-a999-4bd220c5b940": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "baf9254a-880a-4df9-b2fc-c118b6b273f8": {
        "text_answer": "maybe for the secondary trial no for the primary trial  Explanation  The statement ",
        "label": "Contradiction"
    },
    "e1c50f3f-0521-4edc-a2ae-8e0b04b64c54": {
        "text_answer": "No  The evidence does not provide information about radiation therapy doses in either trial",
        "label": "Contradiction"
    },
    "b73bfd5a-18e5-4df7-8e6a-292f8f32208f": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median average change in",
        "label": "Contradiction"
    },
    "44b12aea-350e-4ade-a145-ba619d96a0ca": {
        "text_answer": "Yes The primary and secondary trials both measure pCR as their outcome The primary trial shows a small difference in pCR",
        "label": "Entailment"
    },
    "7ea3fe58-fb27-48f8-9e3a-61af8847d23e": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial maintains identical inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "225ff186-66e8-4880-bba4-e8127bd42834": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "8e4d3482-1501-4f0d-ae76-8924effe7d3c": {
        "text_answer": "Yes  Explanation  The statement no inclusion or exclusion criteria are shared between the primary clinical",
        "label": "Entailment"
    },
    "819893b4-9c57-42b8-938e-f6147e41694d": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 10 times the number",
        "label": "Contradiction"
    },
    "354a388c-18b1-476a-b372-3ac4be472cbc": {
        "text_answer": "No  Explanation  The statement the severity of adverse reactions were somewhat higher in the",
        "label": "Contradiction"
    },
    "31038c96-b97a-4952-aacc-4e7e8bb09cd0": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial both cohorts receive equal dos",
        "label": "Entailment"
    },
    "a828ed30-ae3c-4fbc-be8a-a72dd5e5bc3e": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor of 1 cm in diameter",
        "label": "Contradiction"
    },
    "45daf2f3-8299-46f8-9016-edf2ce4a044a": {
        "text_answer": "Yes The evidence does not specify that the trials are limited to Japanese nationals but it does not exclude nonJ",
        "label": "Entailment"
    },
    "c831a231-8b84-41ca-a825-d11060c44d64": {
        "text_answer": "No  Explanation The primary trial specifically includes women with locally advanced recurrent or metastatic",
        "label": "Contradiction"
    },
    "ee8170da-a81f-42bf-b286-cbb8824040cf": {
        "text_answer": "Yes for the secondary trial The primary trial explicitly excludes patients who have received major surgery within 28 days prior",
        "label": "Entailment"
    },
    "95aa2e47-d35b-45b5-8d80-18f06798b812": {
        "text_answer": "No   Explanation  The evidence provided in the trial description does not mention paclitaxel",
        "label": "Contradiction"
    },
    "c39ec45a-1664-49aa-8356-abbecf045001": {
        "text_answer": "Yes  Explanation  The statement over 97 of patients in the secondary trial and",
        "label": "Entailment"
    },
    "c76186ef-f703-4809-8e01-956bdec01925": {
        "text_answer": "  Yes   Explanation   The statement the primary clinical trial results reveal a higher",
        "label": "Entailment"
    },
    "da278764-ba0c-4a9e-9f44-7fe16af87e5a": {
        "text_answer": "No  Explanation  The statement who needed prescription medicine but family unable to afford it is",
        "label": "Contradiction"
    },
    "7de10e39-c06c-4941-ade6-3e60b864029c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial does report",
        "label": "Contradiction"
    },
    "2b9dbd1a-6de9-4c7e-80af-0a096af26a11": {
        "text_answer": "No   Explanation  The statement in the question is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "c83203cf-4121-4d9d-a662-cd596a5f63d5": {
        "text_answer": "Yes The primary trial includes the exclusion criterion of potassium levels being outside the normal range 3",
        "label": "Entailment"
    },
    "3a9ca481-4b74-4bd3-99f0-1b34cc33ba33": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9d03d248-30a2-44b1-bbef-75809005dc16": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "dfd8e736-5ef2-4d36-b124-9382e72f982d": {
        "text_answer": "Yes  Explanation The evidence provided in the results of the primary trial shows that the mean number of",
        "label": "Entailment"
    },
    "1f23b5f1-2b28-4204-9e44-60f8ddc86963": {
        "text_answer": "Yes  Explanation  The statement adverse events were not reported in cohort 1",
        "label": "Entailment"
    },
    "72626f41-afa0-413c-b495-e4eeb51112fb": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "c3bc7314-8b8f-4d98-90ad-986132951201": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly identifies that there were 4 different types of adverse",
        "label": "Entailment"
    },
    "03a7663e-0937-437a-b095-642e363a6703": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial abstains from using lenalidom",
        "label": "Entailment"
    },
    "1c5b6b0e-8ee8-4569-8bc8-83ab193f8cff": {
        "text_answer": "Yes The evidence states that breast adenocarcinoma is an inclusion criteria for both the primary and secondary trials",
        "label": "Entailment"
    },
    "0e6d3d31-1af3-4701-a410-b2bbb1ce430e": {
        "text_answer": "No  Explanation  The statement There was at least 1 recorded gastrointest",
        "label": "Contradiction"
    },
    "0db120d4-5ebb-4b0f-9040-52b32a966c33": {
        "text_answer": "Yes  Explanation The evidence shows that the mean number of hot flashes per day was lower in the",
        "label": "Entailment"
    },
    "ace11ff3-a7ac-492c-9dbe-5dafc96f81e7": {
        "text_answer": "yes the statement is about survival times and is consistent with the data provided in the evidence However the statement does not",
        "label": "Entailment"
    },
    "16147f31-aa81-4f21-9bd7-f153069a9278": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "edd1533a-dc7c-441d-adcd-f8b020a4fdd3": {
        "text_answer": "No   Explanation  The statement all participants in the primary clinical trial regardless of their",
        "label": "Contradiction"
    },
    "a9d993df-c8e1-4f4f-b470-b23d78f069ed": {
        "text_answer": "Yes The primary trial mentions IV administration of zoledronic acid while the secondary trial mentions oral administration of",
        "label": "Entailment"
    },
    "1f77c906-1f2c-43b4-8bb1-2a2aeb19555e": {
        "text_answer": "Yes  Explanation The statement Most patients in the secondary trial and the primary trial did not suffer any",
        "label": "Entailment"
    },
    "29cdc690-859f-405c-ad87-f4e73fc3e9a8": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts 5 more weeks",
        "label": "Contradiction"
    },
    "920f9642-c8b0-4b1d-9b2a-c12c4801b714": {
        "text_answer": "Yes but with a clarification The primary trial excludes patients with potassium levels outside the normal range while",
        "label": "Entailment"
    },
    "ec1b4763-e8bc-4c2f-be22-6b64b623b072": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not mention leptomeningeal car",
        "label": "Contradiction"
    },
    "2fcef697-683a-4b99-9da3-5527e80c9e5b": {
        "text_answer": "No  Explanation  The statement patients must be diagnosed with a mutation in the one",
        "label": "Contradiction"
    },
    "fc96b587-8bbf-4816-97d9-15cd8fcf755f": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as neither the primary",
        "label": "Contradiction"
    },
    "5284dc53-b471-4c7a-a713-62199869a305": {
        "text_answer": "Yes  Explanation The statement the majority of patients participating in the primary and secondary clinical trials reported experiencing",
        "label": "Entailment"
    },
    "e6ba45db-66f8-4f45-a45a-9217e65c7bbd": {
        "text_answer": "Yes The primary trial excludes individuals who are participating in another clinical trial",
        "label": "Entailment"
    },
    "ca63be25-38a3-4f4a-a6be-0e8b8cb8e5f5": {
        "text_answer": "yes for the secondary trial uncertain for the primary trial  Explanation  The statement ",
        "label": "Entailment"
    },
    "87e90ba6-44b6-4dc9-9bac-9ceb0c8cf6f6": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "0fdae3b5-0326-47fb-a3c2-ff5fd132fb76": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the primary trial is specifically for",
        "label": "Contradiction"
    },
    "487046b0-2368-40da-9cba-407f65177f0b": {
        "text_answer": "No   Explanation  The statement more than 75 of the patients in the",
        "label": "Contradiction"
    },
    "95a5ceca-3b9c-4760-98be-98c78559a161": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial have different inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "bf8e8814-f9d9-422e-ab84-fea4f6c85ede": {
        "text_answer": "No  A woman who has had a lumpectomy is eligible for the secondary trial as long as she meets the",
        "label": "Contradiction"
    },
    "046763cb-f08d-4032-8b54-03bc14cb9d69": {
        "text_answer": "  No   Explanation   Anorexia is a specific eating disorder characterized by",
        "label": "Contradiction"
    },
    "83b91b04-e464-483d-94d2-079690030cb5": {
        "text_answer": "No  Explanation  The statement both the secondary and primary clinical trials observed multiple aes",
        "label": "Contradiction"
    },
    "7e4c273a-fc2f-4589-beb8-4e90f3198962": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence does not mention",
        "label": "Contradiction"
    },
    "dc855f0a-1281-44f9-b68c-89044aaa73af": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement is about the",
        "label": "Contradiction"
    },
    "c10c78c7-51f4-4440-8164-07b059e01fd9": {
        "text_answer": "Yes The evidence does not report any cases of hypertension dehydration or dyspnea in either",
        "label": "Entailment"
    },
    "feca3829-9b38-4738-8bad-e8a0fcf9029f": {
        "text_answer": "No  Explanation  The statement recurrent malignancies graftversus",
        "label": "Contradiction"
    },
    "7eab2fc5-fd40-40bc-a960-90aafe45ef9e": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the given inclusion criteria However the eligibility",
        "label": "Entailment"
    },
    "4afbbadf-10c0-4e7e-87d3-2516aeafbe73": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not indicate that any patient in the",
        "label": "Contradiction"
    },
    "467c8a18-4a72-4ea4-9b8d-ae43d786b5b0": {
        "text_answer": "  Yes The statement is entailed by the evidence as nonsmall cell lung cancer breast cancer and u",
        "label": "Entailment"
    },
    "f0eaf3f3-5c84-4cd8-8a13-ef1af710cf9e": {
        "text_answer": "No  Explanation  The statement Suspected Serious Adverse reactions were more common in",
        "label": "Contradiction"
    },
    "8c7a92ab-80cd-4bb4-8b03-fa5f6776ca5a": {
        "text_answer": "Yes  Explanation  The primary clinical trial exclusion criteria include patients with uncontrolled intercurrent",
        "label": "Entailment"
    },
    "7b1befbe-fec3-4554-89f7-323acfc66d62": {
        "text_answer": "Yes The statement is entailed by the evidence as it accurately reflects the percentage change in Ki67 expression reported in the",
        "label": "Entailment"
    },
    "b8c9f988-e270-467e-b7a8-b71b1ae302ce": {
        "text_answer": "Yes The evidence states that individuals with a CDK46 mutation are eligible to participate in the clinical trial under",
        "label": "Entailment"
    },
    "12ca7fab-5b2d-4889-b4b9-458fc6f08f33": {
        "text_answer": "Yes The primary trial includes a performance status condition ECOG  2 as an eligibility criter",
        "label": "Entailment"
    },
    "a66238c5-3c2f-47a8-8b38-aad66299aed0": {
        "text_answer": "Yes  Explanation The evidence states that cohort 1 patients receive 14mg",
        "label": "Entailment"
    },
    "136c5db2-719f-458f-9d88-f5596886ed96": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence provided as the",
        "label": "Contradiction"
    },
    "2d84efa0-fd43-40fa-a809-f9be6d197371": {
        "text_answer": "yes The statement is entailed by the exclusion criteria listed in the secondary clinical trial evidence Patients with recent chem",
        "label": "Entailment"
    },
    "98923c9c-1126-436a-9263-a9deca239ba6": {
        "text_answer": "Yes   Explanation  The primary trial tests Eribulin Mesylate while the secondary",
        "label": "Entailment"
    },
    "0d49e948-aea6-4067-8f7e-b480e47d3407": {
        "text_answer": "No  Explanation  The statement a young girl with a Newly diagnosed PRpositive",
        "label": "Contradiction"
    },
    "080fe5be-37c4-4d7f-a985-58c520750620": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of Paraplatin in the given",
        "label": "Contradiction"
    },
    "4625018e-c34b-4156-8c63-572712bdbf30": {
        "text_answer": "Yes The statement mentions several cases of Anaemia and Febrile neutropenia were recorded in",
        "label": "Entailment"
    },
    "6d94034f-7e7f-4220-a193-bdd926f8b993": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the secondary trial",
        "label": "Contradiction"
    },
    "dea7a7bb-563c-4b02-9011-16fa165820c4": {
        "text_answer": "Yes The primary trial and the secondary trial measure different outcomes The primary trial measures the change in hot flash activity while",
        "label": "Entailment"
    },
    "387b9e0a-aafd-4140-921b-3609114410cb": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "55eb3029-c826-4cae-a130-7cc8fbc80121": {
        "text_answer": "  No the statement is not entailed by the evidence as it only mentions Venezuela and the requirement for Her2",
        "label": "Contradiction"
    },
    "52b055fd-9e0d-41ad-9eb7-1a724cbc0112": {
        "text_answer": "Yes with the caveat that the primary trial did not directly compare the two groups so no significant differences between them does",
        "label": "Entailment"
    },
    "d9c0a0a4-0bdf-4b77-b442-78d609b06854": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the two cohorts ",
        "label": "Contradiction"
    },
    "61de0370-1d90-4657-b0f1-fff95fc5efa5": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the participants in the primary trial",
        "label": "Contradiction"
    },
    "1108856e-d4cc-488e-a0d8-98274fc38dfd": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary and secondary trials do",
        "label": "Contradiction"
    },
    "840d1cd7-85bd-4d25-a4db-0af6ff989e1d": {
        "text_answer": "Yes The primary trial did not show significant differences between the two algorithms but the secondary trial showed differences between the reflex",
        "label": "Entailment"
    },
    "8667c9e0-5040-46af-b784-4214164c4c0c": {
        "text_answer": "No  Explanation  The statement the primary clinical trial witnessed many psychiatric adverse incidents",
        "label": "Contradiction"
    },
    "f69e913e-7050-463f-aa18-ad022451d483": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions that patients who have received",
        "label": "Entailment"
    },
    "50e74c9b-3673-4222-99f0-63f82e40b288": {
        "text_answer": "No  Explanation  The statement The same number of AEs were reported for both coh",
        "label": "Contradiction"
    },
    "e78237d7-bbb7-4586-9950-5eabb10254f9": {
        "text_answer": "  There is no direct evidence in the provided information to support the statement about the number of treatment emergent adverse events",
        "label": "Contradiction"
    },
    "e9a96af7-c9f7-49cd-a291-2c0abb94719c": {
        "text_answer": "Yes  Explanation The evidence states that out of 21 participants only 9 experienced a reduction",
        "label": "Entailment"
    },
    "f0a41373-f03b-471f-9f0f-381f8b09a950": {
        "text_answer": "No  Explanation  The statement Syncope which occurred in 250",
        "label": "Contradiction"
    },
    "63966dc4-b12e-4e45-befe-50b9c19a702a": {
        "text_answer": "Yes  Explanation The evidence describes two different treatment methods in the primary clinical trial Intervention ",
        "label": "Entailment"
    },
    "a85102e4-fe19-4b6e-8dd5-4cb9ffd64176": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves C",
        "label": "Contradiction"
    },
    "4437aa5b-4b4e-4eb4-a258-e7f17dc8f363": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "04c1483e-d2bb-40a2-b215-ede1e3c7c973": {
        "text_answer": "No  Explanation  Although both trials use the same medications FMX and lapatinib",
        "label": "Contradiction"
    },
    "06929ac9-6df2-4e5b-afd8-656a1f9989d1": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because both the primary and secondary",
        "label": "Contradiction"
    },
    "912414db-d418-4c96-b06b-e26d0ac1992f": {
        "text_answer": "No  Explanation  The statement several cases of Anaemia and Febrile neut",
        "label": "Contradiction"
    },
    "dacc42a9-68cc-4b2c-9377-648486729eed": {
        "text_answer": "Yes The statement is entailed by the evidence as the participants in the primary trial receive epirubicin cycl",
        "label": "Entailment"
    },
    "eb68a94f-7693-4158-b492-7b5a03d85b96": {
        "text_answer": "Yes The statement that patients in the secondary clinical trial encountered adverse events specifically eyelid oedema upper g",
        "label": "Entailment"
    },
    "e83cb970-0b3c-4b61-8a44-49a9a3f61744": {
        "text_answer": "  No   Explanation   The primary clinical trial only includes postmenopaus",
        "label": "Contradiction"
    },
    "47b36e1f-90d5-4a42-b359-95783c7ae965": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as there is no information about",
        "label": "Contradiction"
    },
    "033cc376-5268-43c7-bf06-ca3503971f41": {
        "text_answer": "Yes The evidence states that no distinguishable pattern was detected for the expression of the evaluated genes in cohorts 1",
        "label": "Entailment"
    },
    "d1eb9a24-13e8-43de-ba1c-7b17e35e7ab3": {
        "text_answer": "No  Explanation  The primary trial measures tumor diameter in centimeters cm while",
        "label": "Contradiction"
    },
    "e40080bc-499c-4af9-a437-be6688894d22": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not support the statement that ",
        "label": "Contradiction"
    },
    "2f6605a0-31b3-43e1-9ec7-3e262cb9acf0": {
        "text_answer": "yes The statement mentions some of the exclusion criteria for the primary trial",
        "label": "Entailment"
    },
    "56daf92a-2c6e-4b2d-b532-3035e757e98c": {
        "text_answer": "No  Explanation The statement the most commonly occuring adverse event across the patient coh",
        "label": "Contradiction"
    },
    "7a8f6698-eb2a-4695-b521-7e42522afdba": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide any",
        "label": "Contradiction"
    },
    "44412911-1f34-4841-a795-86eed5a209d7": {
        "text_answer": "Yes  Explanation  The statement All Infections and Fever cases in the primary trial were",
        "label": "Entailment"
    },
    "88490a99-ea34-4aa1-a838-b3a1cffa41a0": {
        "text_answer": "Yes The statement is entailed by the evidence as the statement mentions wound dehiscence which is",
        "label": "Entailment"
    },
    "153e0c8b-e056-4dd9-9337-156752b249c1": {
        "text_answer": "No   Explanation  The evidence provided does not mention the number of adverse events recorded in",
        "label": "Contradiction"
    },
    "e46defaa-44a0-4919-bd9b-aa018de05da1": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the primary and secondary",
        "label": "Contradiction"
    },
    "e9b973a3-aabd-484d-8c7c-0bd2296bf0c5": {
        "text_answer": "No  Explanation  The statement provided does not mention Adverse Events 1 Asthen",
        "label": "Contradiction"
    },
    "6151cf03-78f0-4404-87bc-beacea52cd95": {
        "text_answer": "Yes for the secondary trial regarding pulmonary embolisms and No for the primary trial regarding breast implants",
        "label": "Entailment"
    },
    "979f5a49-0af6-4ea3-a410-d79cf3540d01": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial does not involve",
        "label": "Contradiction"
    },
    "d620b526-d227-42a4-a6cc-800df41f854a": {
        "text_answer": "Yes  Explanation  The statement approximately 50 more participants in the dal",
        "label": "Entailment"
    },
    "4e0fae11-64b8-403f-8001-45ef8078a145": {
        "text_answer": "No  Explanation The statement syncope was the most frequently reported adverse event in both primary",
        "label": "Contradiction"
    },
    "c5feab6a-263d-41c4-8c21-cfa5ffe80a3d": {
        "text_answer": "No  Explanation  The statement participants of the primary clinical trial undergo complete breast",
        "label": "Contradiction"
    },
    "c36a1fe4-cc98-4a41-94c5-88458737d070": {
        "text_answer": "No  Explanation  The statement on average patients from the primary trial survive over 24",
        "label": "Contradiction"
    },
    "a29b69ee-502b-4d86-b028-be9a56bfb7f6": {
        "text_answer": "Yes  Explanation  The statement the paclitaxel plus bevacizumab",
        "label": "Entailment"
    },
    "843b1c8e-8d10-4f20-8514-4ba986071878": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "c6c84bb8-fea8-4ad6-8ec7-1677049d1fe4": {
        "text_answer": "Yes The primary clinical trial has different eligibility criteria for the number and size of cerebral metastases compared",
        "label": "Entailment"
    },
    "aecd2958-c3b4-4d87-82f1-07add215b1e8": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence states that cohort 1 receives Dexameth",
        "label": "Entailment"
    },
    "5feb2522-300c-490a-be54-07b2c99d397e": {
        "text_answer": "No  Explanation  The statement There are several cases of swelling hypothermia",
        "label": "Contradiction"
    },
    "145683a3-f65e-4b4d-98e0-662cbe830c5d": {
        "text_answer": "No  Explanation  The statement the primary trial does not employ any cycle for its intervention",
        "label": "Contradiction"
    },
    "a020a0f1-c729-44ea-a40e-2700cc846d67": {
        "text_answer": "No  The statement is not entailed by the evidence as the clinical trial described in the evidence is for patients with breast",
        "label": "Contradiction"
    },
    "cccd9ad0-9bac-43fb-aaaf-8f99e725c572": {
        "text_answer": "No  The statement is not directly related to the inclusion or exclusion criteria for either trial provided in the evidence The",
        "label": "Contradiction"
    },
    "f8accdcd-5a92-4fff-9e6b-6a2d141b5ee4": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "c5f69124-61d3-46bc-b233-5c38f4b1f5d0": {
        "text_answer": "Yes  Explanation  The statement neither the primary clinical trial nor the secondary clinical trial had",
        "label": "Entailment"
    },
    "29bfa3a7-a8f2-4294-b745-d125cac8e40f": {
        "text_answer": "Yes The statement does not contradict the evidence The evidence only reports the occurrence of adverse events not unexpected",
        "label": "Entailment"
    },
    "cee38f66-699d-4c68-85ec-8ed0ba55fd9d": {
        "text_answer": "No  Explanation  The statement the treatment plan in the primary clinical trial includes administration of one",
        "label": "Contradiction"
    },
    "a171374b-4c87-4b1a-94f9-8f0238cdce4f": {
        "text_answer": "Yes  Explanation The evidence describes a neoadjuvant therapy regimen consisting of epirub",
        "label": "Entailment"
    },
    "fa7b34e2-75e6-4bc4-a154-99be5bd6b381": {
        "text_answer": "Yes The statement is entailed by the evidence as patients in the secondary trial must have a diagnosed alteration in one or",
        "label": "Entailment"
    },
    "5ee999ab-5129-4ea2-a988-b2a223d82acd": {
        "text_answer": "Yes  Explanation The evidence states that both the placebo and memantine interventions are administered",
        "label": "Entailment"
    },
    "8563b314-6b0f-432c-9ffc-203c3dcb0a3f": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "412583db-ce19-451d-a804-3837e4dcaea3": {
        "text_answer": "No  The most common adverse event recorded in the primary trial was nausea or vomiting each with a",
        "label": "Contradiction"
    },
    "478be8bf-505c-44ed-98d6-41b48ab8d9b3": {
        "text_answer": "No  Explanation  The statement cohort 2 from the secondary clinical trial demonstrated superior",
        "label": "Contradiction"
    },
    "670ba789-279e-420d-b45e-c63836169e9b": {
        "text_answer": "No  Explanation  The statement in the primary trial results there were less patients with stable disease",
        "label": "Contradiction"
    },
    "a55a8c7f-7e1a-4bd4-8f2b-9222002f5d27": {
        "text_answer": "Yes   Explanation  The primary trial tests Eribulin Mesylate while the secondary",
        "label": "Entailment"
    },
    "fea6712a-10d7-47bb-88d1-d286e0ba47a1": {
        "text_answer": "No   Explanation  The statement provided does not mention any adverse events in the trials",
        "label": "Contradiction"
    },
    "543c8639-a266-42af-9896-05a77d822c79": {
        "text_answer": "  Primary trial Yes disparities in assessment Secondary trial No uniform results",
        "label": "Entailment"
    },
    "8b7bbb44-a7d7-4317-af85-f78d559e0e63": {
        "text_answer": "Yes The primary trial involves oral administration of cabergoline while the secondary trial involves intravenous administration of pix",
        "label": "Entailment"
    },
    "782c9a26-ba09-4eef-8076-bd8831c9f986": {
        "text_answer": "No  The evidence explicitly states that patients with brain metastases including leptomeningeal carcinom",
        "label": "Contradiction"
    },
    "5e5c4aab-2006-4a00-b11c-3dced5aac12c": {
        "text_answer": "Yes The statement is entailed by the evidence as it accurately reflects the interventions given in each cohort of the",
        "label": "Entailment"
    },
    "db08ca44-cd18-49ff-ae80-4a3f0bb625b5": {
        "text_answer": "No  Explanation  The statement 50 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "8559afe8-c0a0-4c88-81bb-ef29cdb08026": {
        "text_answer": "Yes The evidence indicates that pain was measured daily for 10 weeks suggesting that instances of pain were frequent during the",
        "label": "Entailment"
    },
    "8679e654-7db4-4fd2-8fbc-41028fedb540": {
        "text_answer": "No  Explanation  The statement there are more cases of Biliary colic and Clost",
        "label": "Contradiction"
    },
    "2dfe7dda-41ae-48bc-aac5-1309cb87e4c1": {
        "text_answer": "Yes The evidence does not explicitly state that surface immunoglobulinpositive cells are a requirement for inclusion",
        "label": "Entailment"
    },
    "4703e57c-efe0-4316-a1a5-8ac60b030e84": {
        "text_answer": "Yes  Explanation  The statement recurrent malignancies graftversus",
        "label": "Entailment"
    },
    "17adb81b-92e7-4ed5-b443-287a5df2fb37": {
        "text_answer": "No  The evidence does not mention anything about a her2neu peptide vaccine or sargramostim",
        "label": "Contradiction"
    },
    "be4a58c2-e939-4583-a129-2d0bdba8e3a8": {
        "text_answer": "Yes  Explanation  The primary clinical trial and the secondary clinical trial both report data on adverse",
        "label": "Entailment"
    },
    "f180c18c-f332-4f6b-9367-c349d3518d55": {
        "text_answer": "Yes The statement there were no instances of death or hospitalization is entailed by the evidence as the evidence",
        "label": "Entailment"
    },
    "cedccbca-876d-44b2-bf5a-9c9c5090d46c": {
        "text_answer": "Yes  Explanation  The evidence states that there were no adverse events reported in both coh",
        "label": "Entailment"
    },
    "773e93d2-a81d-48cd-96ec-4b92d537ac35": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence reports that 13 of participants with HER2",
        "label": "Entailment"
    },
    "a546a2b7-a287-47a1-91b1-4368fef15369": {
        "text_answer": "No  Explanation  The statement the dosage of denosumab used in intervention ",
        "label": "Contradiction"
    },
    "cacd8f36-53c3-4002-9d2d-09bd2976bf40": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the given inclusion criteria However the eligibility",
        "label": "Entailment"
    },
    "f6dee97d-0025-4837-97a5-dc7748b859a0": {
        "text_answer": "No   Explanation  The evidence states that the starting dose of bevacizumab",
        "label": "Contradiction"
    },
    "aac508e7-cd87-40ad-afa6-bc977ab393aa": {
        "text_answer": "No  Explanation  The statement there was a complete absence of both gastrointest",
        "label": "Contradiction"
    },
    "2ca3ca9f-96ac-46e7-a1ce-873c580eff25": {
        "text_answer": "No  Explanation  The statement 14 of patients in the primary trial suffer increased ple",
        "label": "Contradiction"
    },
    "7c60cd27-5e72-4cd6-9e2c-de28c0c11fe4": {
        "text_answer": "  Yes for the primary trial and Maybe for the secondary trial  Explanation  ",
        "label": "Entailment"
    },
    "64a7bb90-c51d-4f6b-942e-55322c25e1b8": {
        "text_answer": "Yes The statement is entailed by the evidence as both groups undergo identical imaging procedures with a marginally higher dose",
        "label": "Entailment"
    },
    "539bf07d-199d-4c9b-af16-5f314962bcfc": {
        "text_answer": "No   Explanation The evidence does not state that the final decision for inclusion in the clinical trial is",
        "label": "Contradiction"
    },
    "ac762601-55f3-434a-bf5a-690ed8a3f735": {
        "text_answer": "Yes  Explanation The evidence states that one out of four patients in cohort 2 experienced an",
        "label": "Entailment"
    },
    "25b0a430-e35c-496c-8874-92be378b044b": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the secondary trial",
        "label": "Contradiction"
    },
    "14e1403f-9bb6-40cc-88fe-4b2f110e7b0d": {
        "text_answer": "No  Explanation The evidence describes the patient population and eligibility criteria for the clinical trial",
        "label": "Contradiction"
    },
    "5b23afbf-8b5c-441b-99b2-295c66958545": {
        "text_answer": "Yes for claustrophobia No for osteoporosis The statement is entailed",
        "label": "Entailment"
    },
    "ca97cc92-91e7-426a-b48f-d1729f13ee13": {
        "text_answer": "No  Explanation The evidence provides the median PFS for each treatment group but it does not indicate",
        "label": "Contradiction"
    },
    "3d073609-1a5e-46fb-b43d-c4505c72029d": {
        "text_answer": "  No the statement is not entailed by the evidence for the primary trial as patients with a history of pulmon",
        "label": "Contradiction"
    },
    "d1bbbc84-4136-43c4-b7b6-7e88e7c82730": {
        "text_answer": "No  Explanation  The statement every cohort in the primary clinical trial is subjected",
        "label": "Contradiction"
    },
    "7a4a1281-d17b-4ad5-aa63-7329abdd0cdd": {
        "text_answer": "Yes for infection and asymmetry   Explanation The statement there were fewer cases of infection",
        "label": "Entailment"
    },
    "ca7d916d-c8d4-4e6b-8b92-3d08bbdf7915": {
        "text_answer": "No  Explanation  The statement ce mark is a label which indicates that a product conforms",
        "label": "Contradiction"
    },
    "1fde2a5a-bf6c-41cf-ba82-7cbea262f258": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial states",
        "label": "Contradiction"
    },
    "52ab8ce2-300e-40db-be56-d6e7c608324e": {
        "text_answer": "No  Explanation  The statement an adult who was diagnosed with ilddpld in",
        "label": "Contradiction"
    },
    "5c9037a6-53a8-49ec-8aa5-b6a47dee226d": {
        "text_answer": "Yes The statement is entailed by the evidence as Arm A of the trial uses a different dose of gemcitabine",
        "label": "Entailment"
    },
    "f212e510-214f-4556-99ed-526946750f55": {
        "text_answer": "Yes The evidence shows an increase in the percentage of participants who were up to date for their colorectal breast",
        "label": "Entailment"
    },
    "7e311c72-64a8-49e8-b3c7-952528a9138c": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial is for women undergoing breast reconstruction and the",
        "label": "Contradiction"
    },
    "e12e5ed1-9a64-4183-9b9d-419e6679ab3d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1adf360d-dd5e-4bbd-b5f1-8846f84407a6": {
        "text_answer": "  Yes The primary trial has different inclusion and exclusion criteria for its Phase I and Phase II while the secondary",
        "label": "Entailment"
    },
    "829b14c1-9883-4dc4-93f9-40eadb9f9511": {
        "text_answer": "No   Explanation   The statement whole breast radiation therapy is administered to the",
        "label": "Contradiction"
    },
    "8044ce4d-99e5-4c90-91aa-9c0c85f2c6b4": {
        "text_answer": "Yes Both groups had an overall number of participants analyzed of 1420",
        "label": "Entailment"
    },
    "3942fcf8-27c3-469e-8c6c-b9b2415706fb": {
        "text_answer": "  No   Explanation   The statement Patients with measurable tumors in",
        "label": "Contradiction"
    },
    "21e02160-3372-4816-93d2-b3923672111b": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only reports on the",
        "label": "Contradiction"
    },
    "060ed756-52f8-4b31-ad74-6f6f12d8ca9f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "666ca16f-864e-48b1-9e5e-543759d50b4a": {
        "text_answer": "No  Explanation The statement candidates who are completely independent and physically active engaged in light",
        "label": "Contradiction"
    },
    "7d7cfab4-e501-4292-bf9c-363ccc1bf1dd": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial the group treated with paclit",
        "label": "Entailment"
    },
    "00175c56-59cd-411d-b4e4-b7db0e32fd74": {
        "text_answer": "No  The statement is not about breast cancer and the evidence only pertains to patients with breast cancer considering AI therapy",
        "label": "Contradiction"
    },
    "5b812594-3dcd-42e8-b984-644fe9dcd87e": {
        "text_answer": "Yes  Explanation The evidence provided includes the results of a clinical trial comparing the effects of paced resp",
        "label": "Entailment"
    },
    "96eb2d8a-35d7-4627-9279-5f16363a2e50": {
        "text_answer": "Yes The statement mentions the types of adverse events that occurred in the primary trial which are consistent with the data",
        "label": "Entailment"
    },
    "5e2af84e-3876-4822-80c3-99c7774a5bf9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement mentions 1",
        "label": "Contradiction"
    },
    "97632c52-4213-4973-8655-9ea7f3151231": {
        "text_answer": "No  Explanation  The statement on both the primary and secondary clinical trials syncope emerged",
        "label": "Contradiction"
    },
    "de6b5ea7-b593-43b7-8fe0-358991878e86": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial do not suffer any of the",
        "label": "Contradiction"
    },
    "fa6115aa-a765-4d03-9fd0-61c97d5e282f": {
        "text_answer": "No  Explanation  The evidence provided in the text only reports the mean standardized scores and their",
        "label": "Contradiction"
    },
    "72e970ee-fc31-4753-99be-b6757c4c270d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial intervention involves",
        "label": "Contradiction"
    },
    "5315a569-b1a1-49fc-b10f-70840fe34585": {
        "text_answer": "Yes The statement is entailed by the evidence as there are no reported cases of intestinal obstructions or pancy",
        "label": "Entailment"
    },
    "da3b7aca-a0b1-4e25-8c38-11dc8311dc11": {
        "text_answer": "No  The evidence does not provide information about women with both claustrophobia and osteopor",
        "label": "Contradiction"
    },
    "f41cbb25-7c8f-49ac-af06-5c8f1895ab60": {
        "text_answer": "No  Explanation  The statement Several patients in the secondary trial and the primary trial",
        "label": "Contradiction"
    },
    "7df66c3f-de87-4542-9797-06325684db65": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide information about the type or number",
        "label": "Contradiction"
    },
    "a764d548-7ef1-4ec1-bfaf-958536b7342c": {
        "text_answer": "No   Explanation   The statement wwtr1 gene rearrangement is a",
        "label": "Contradiction"
    },
    "cc6601cf-3aa0-44f7-8476-f3dfc34e7412": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "48e84575-b6e1-4280-a170-df30870b50cf": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide information",
        "label": "Contradiction"
    },
    "e173aa91-e6ec-4059-882b-7f015db6e3b3": {
        "text_answer": "No  The evidence describes the patient population and eligibility criteria for the clinical trial but it does not mention anything",
        "label": "Contradiction"
    },
    "922b377f-efa2-4bee-9689-f019c011057e": {
        "text_answer": "Yes   Explanation  The statement does not directly mention the btc gene product but it does",
        "label": "Entailment"
    },
    "11fd1d6e-0641-4b3d-91ff-9f048584db7b": {
        "text_answer": "No The evidence states that individuals with dementia are excluded from the trial Specifically those with a Mini M",
        "label": "Contradiction"
    },
    "c6d411f9-3d61-459e-b1af-6d8088260804": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "145b92f4-e143-4188-9521-8aade35b2f05": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial do not suffer any of the",
        "label": "Contradiction"
    },
    "6e609d6e-8db0-4adc-bce7-62f7274c10c2": {
        "text_answer": "Yes for the secondary trial However the statement is not directly applicable to the primary trial as it has distinct inclusion criteria",
        "label": "Entailment"
    },
    "4adbcbcc-ae43-46af-a072-815d1e788f29": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with tumors positive for CCND1 amplification CDK",
        "label": "Entailment"
    },
    "8acda3ec-8feb-4630-a560-3e66f86c3f21": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about the number of patients who",
        "label": "Contradiction"
    },
    "e25dfb6a-efaf-4b80-b2b7-316e10b33fe5": {
        "text_answer": "Yes The statement does not explicitly mention the adverse events being related to cell culture images but the evidence provided is about",
        "label": "Entailment"
    },
    "c0131f92-6373-48c8-9bd5-8d4a42f6674e": {
        "text_answer": "No  Explanation  The statement distinct variations were noted in the results from the primary trial",
        "label": "Contradiction"
    },
    "e0d92d90-958e-435b-bb1b-7135ed0b2fac": {
        "text_answer": "No  Explanation  The statement the majority of patients in the primary trial experienced complete response by",
        "label": "Contradiction"
    },
    "136ce42e-bf56-41ff-aed9-fe886636bc1c": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly support the statement that pat",
        "label": "Contradiction"
    },
    "6af06fcc-363f-4275-81f3-8a01c53931e8": {
        "text_answer": "No  The primary trial excludes women with stage IV disease while the secondary trial includes only women without distant metast",
        "label": "Contradiction"
    },
    "1607973a-34ef-455a-b52b-55ea7aaf6634": {
        "text_answer": "Yes  Explanation  The statement There were no cardiac or psychiatric Aes recorded during",
        "label": "Entailment"
    },
    "e012d94f-ee90-40b0-9a4d-e41ec19a512d": {
        "text_answer": "Yes for some parts of the statement The statement mentions some differences in the secondary trial which is supported",
        "label": "Entailment"
    },
    "04d9baea-cc4c-4903-9769-3df78659a73f": {
        "text_answer": "No   The statement is not directly related to the Percentage of Participants With Adverse Events of Primary",
        "label": "Contradiction"
    },
    "c09c08d5-189f-4e15-acb8-2c3cb235aaa6": {
        "text_answer": "Yes  Explanation  The statement The same number of AEs were reported for both coh",
        "label": "Entailment"
    },
    "1eab7c47-2c2a-4746-935b-c3e8891f8a26": {
        "text_answer": "No  The statement is not entailed by the evidence  The primary trial requires a Karnofsky score of",
        "label": "Contradiction"
    },
    "cb3fa68b-c881-4a32-a80f-303e46360d8c": {
        "text_answer": "No  Explanation  The statement the bevacizumab cluster of primary clinical trial",
        "label": "Contradiction"
    },
    "a328634e-824e-413c-a408-ad471e394a07": {
        "text_answer": "No  Explanation  The statement Gender is not a determining factor for eligibility in",
        "label": "Contradiction"
    },
    "f4e0551c-44e9-44f1-9a50-c65075a51715": {
        "text_answer": "No  The evidence states that there are no conditions on hepatic function for participants of the primary trial but",
        "label": "Contradiction"
    },
    "c5c7b6e2-201f-42af-aeb3-3e3152fa0ba2": {
        "text_answer": "No  Explanation  In the primary clinical trial her2 patients received a loading dose of",
        "label": "Contradiction"
    },
    "a44d4aaf-a761-46a1-a803-63d6ede293a5": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded 11 more cases of Intest",
        "label": "Contradiction"
    },
    "e682eada-bed5-4ea5-847a-cbfdb44ef724": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions ",
        "label": "Contradiction"
    },
    "ffacecd7-caae-434a-866d-a3a25d4f00ac": {
        "text_answer": "Yes  Both interventions involve 20 injections of 04ml volume",
        "label": "Entailment"
    },
    "775258b4-fe6f-4487-a162-ce25e5a665c0": {
        "text_answer": "No  Patients with dementia including Alzheimers disease are excluded from the trial based on",
        "label": "Contradiction"
    },
    "86e418cd-3b9d-46fd-b699-c538a29e7c03": {
        "text_answer": "No   Explanation  The intervention in the primary trial lasted for 10 weeks while",
        "label": "Contradiction"
    },
    "d65c3fe7-21a9-484a-a225-1ed3c5e66b5e": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement is about colon cancer and the evidence is about breast",
        "label": "Contradiction"
    },
    "b971e3aa-d16a-4cca-8a69-c3e9793ada80": {
        "text_answer": "  I cannot answer with just one word as the statement does not explicitly mention TNM staging in the evidence provided",
        "label": "Entailment"
    },
    "48ec9126-f671-47ea-a1bd-71a228b20420": {
        "text_answer": "No  Explanation  The statement in the first cohort of the primary clinical trial",
        "label": "Contradiction"
    },
    "8d748876-a5b3-4f80-9f87-de9bec532074": {
        "text_answer": "Yes The percentage of participants with disease progression or death was lower in the bevacizumab cohort",
        "label": "Entailment"
    },
    "343f30bc-9b37-471a-83fc-76089ffc527c": {
        "text_answer": "Yes The statement does not explicitly mention the specific types of adverse events in the trial but it is entailed by",
        "label": "Entailment"
    },
    "677ea4a6-dee8-4a9f-ab36-68724aeb8237": {
        "text_answer": "No  Explanation  The statement childpugh class b7 is a total score of",
        "label": "Contradiction"
    },
    "52e6f629-f30f-4f59-968f-6d6bcc8b14af": {
        "text_answer": "No  Explanation The statement previously undergoing gabapentin or herceptin therapy within the",
        "label": "Contradiction"
    },
    "31332603-d84d-4806-b8bf-4cdc08514591": {
        "text_answer": "Yes The statement 1417 of the primary trial patients suffered an increase in blood bilirubin",
        "label": "Entailment"
    },
    "b34700cb-eba7-431e-9508-75e49298d003": {
        "text_answer": "No  Explanation The statement in the primary clinical trial 50 of participants experienced",
        "label": "Contradiction"
    },
    "a0f404c3-8323-4ef6-a986-04085778b751": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the placebo and",
        "label": "Contradiction"
    },
    "2007fc0f-aa14-48a5-9db7-08d47f756757": {
        "text_answer": "No  Explanation  The statement There was at least 1 recorded gastrointest",
        "label": "Contradiction"
    },
    "0a3eabb5-68f0-4534-834a-d3e75dbb733e": {
        "text_answer": "Yes The statement correctly identifies the difference in dosing between the two interventions",
        "label": "Entailment"
    },
    "b87ab44e-6cbe-4567-98ff-bd820aa7edeb": {
        "text_answer": "Yes  Explanation The evidence states that 13 of the participants with HER2",
        "label": "Entailment"
    },
    "14b9aeb8-afd7-4a20-af71-153c33fc117b": {
        "text_answer": "No  Explanation  The statement candidates receiving warfarinbased therapy are allowed",
        "label": "Contradiction"
    },
    "4a688f54-5b9a-49ad-b6a1-833d1ff96924": {
        "text_answer": "Yes The primary trial has different inclusion and exclusion criteria for its Phase I and Phase II stages while the secondary trial",
        "label": "Entailment"
    },
    "ff38ad83-d613-4797-a2a7-3b2e5e1a318d": {
        "text_answer": "No  The primary clinical trial includes patients with NUT midline carcinoma identified by FISH but the secondary",
        "label": "Contradiction"
    },
    "d88235dd-c37b-4971-9c1f-42b282ff41c1": {
        "text_answer": "Yes However its important to note that the statement only applies to patients with stage 4 breast cancer who meet",
        "label": "Entailment"
    },
    "baf5c643-9960-4f2e-a9b4-70667a5ca685": {
        "text_answer": "No  Explanation  The statement Patients with a Vitamin D deficiency are excluded from",
        "label": "Contradiction"
    },
    "3df24930-167f-4f53-a3e5-fb8205039848": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial specifically requires histologically",
        "label": "Contradiction"
    },
    "ba84127e-5a18-4ff4-a76b-c19ba3edeeb0": {
        "text_answer": "No  Explanation The statement while the first cohort of the primary clinical trial receives de",
        "label": "Contradiction"
    },
    "b7ab0a1b-fa3a-4cf4-ba4a-dda1608215a6": {
        "text_answer": "  Yes the patient described in the statement meets the inclusion criteria for both trials based on the provided information",
        "label": "Entailment"
    },
    "1e349229-5030-4134-99c2-c530a37c3ef2": {
        "text_answer": "No  Explanation  The statement primary open angle glaucoma is a form of gl",
        "label": "Contradiction"
    },
    "0f9e0c7c-a021-4aeb-9309-ab2d6f1d78f8": {
        "text_answer": "No  Explanation  The statement a total of 35 patients treated with Sunitin",
        "label": "Contradiction"
    },
    "558d240e-a51a-4c16-807e-db9031073242": {
        "text_answer": "No  Explanation  The statement there were multiple incidents of sudden deaths and unplanned hospital",
        "label": "Contradiction"
    },
    "f68789cf-7d4d-4186-b3f0-a6b47127379b": {
        "text_answer": "No  Explanation  The evidence provided in the primary clinical trial results does not indicate that all patients",
        "label": "Contradiction"
    },
    "fceee201-8b1b-4cd0-ab16-75fed1f2530f": {
        "text_answer": "Yes  Explanation The statement there was one psychiatric adverse event in the primary trial",
        "label": "Entailment"
    },
    "cded013b-d994-410b-9b42-c4a852978cfc": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial does not include information about the percentage of",
        "label": "Contradiction"
    },
    "9bc581fd-162a-43c2-8c72-69c06d9ba395": {
        "text_answer": "No  Explanation  The statement study subject withdrawal by parent or guardian is an indication",
        "label": "Contradiction"
    },
    "68a2e47e-d66f-45ec-87cd-45403a545e97": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial describes the dosing schedule for Vorin",
        "label": "Contradiction"
    },
    "3cae8899-5172-460e-8ff1-e6e1c8a59f0b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8b30b0d1-a4fd-49cb-9dc8-ce508d3b5524": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence indicates that",
        "label": "Contradiction"
    },
    "2792a2f8-898b-4aee-a617-df468f3a1eaf": {
        "text_answer": "No   Explanation  The evidence describes a combination of multiple medications being administered to participants in",
        "label": "Contradiction"
    },
    "f5031c61-a192-4b2e-ac0f-be5d2aac0b3c": {
        "text_answer": "Yes  Explanation  The evidence provides the percentage of participants in each group ERpositive",
        "label": "Entailment"
    },
    "43e7f79b-7ebb-483e-ba3f-2cbd40c09d89": {
        "text_answer": "No  Explanation  The evidence provided describes the inclusion and exclusion criteria for a clinical trial for",
        "label": "Contradiction"
    },
    "e3c4aff9-78ee-4a66-9735-1cd5370b7925": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial inclusion criteria",
        "label": "Contradiction"
    },
    "dcf21e08-7d8b-45b2-bec3-9f65853fb277": {
        "text_answer": "Yes The primary trial and secondary trial have different inclusion and exclusion criteria and the patients eligible for the secondary trial do",
        "label": "Entailment"
    },
    "77a8c39a-7193-438c-98c1-9e88c1be1ec9": {
        "text_answer": "  No  Explanation  The statement patients who have received chemotherapy or radiotherapy",
        "label": "Contradiction"
    },
    "6aa17b00-284e-408b-a8c3-2e24b6310556": {
        "text_answer": "No  The statement a patient diagnosed with a leptomeningeal carcinoma would not be eligible for",
        "label": "Contradiction"
    },
    "ad1bb75e-6250-4dbe-beff-a702293ce87c": {
        "text_answer": "Yes The statement is entailed by the evidence as gabapentin is an exclusion criterion for the primary trial",
        "label": "Entailment"
    },
    "be5577f7-43cb-40c7-bf6d-4988788d9b24": {
        "text_answer": "No  Explanation The primary trial includes a minimum tumour size of 2 cm while the secondary",
        "label": "Contradiction"
    },
    "9d7e8278-5668-4798-9eb0-bb3ae9db62f0": {
        "text_answer": "No  Explanation  The statement All patients eligible for the secondary trial are also eligible for the",
        "label": "Contradiction"
    },
    "9ef9c9de-3dfa-4cbb-930e-c26190e2d119": {
        "text_answer": "Yes  Explanation The evidence shows that in both Arm 1 and Arm 2 of the clinical trial",
        "label": "Entailment"
    },
    "5b875c96-44e4-4123-921a-546382d4c806": {
        "text_answer": "Yes  Explanation The evidence states that patients receive oral lapatinib once daily on days 1",
        "label": "Entailment"
    },
    "e5f77572-2271-434c-8965-dfdac502ea4e": {
        "text_answer": "No  Explanation The statement the secondary trial participants receive pembrolizumab twice as",
        "label": "Contradiction"
    },
    "beef35bd-14a9-4353-aa30-2fe681726d91": {
        "text_answer": "No   Explanation  The primary trial involves PF0664702",
        "label": "Contradiction"
    },
    "9c4299c7-89e6-4d9c-81db-5d12f182b4d3": {
        "text_answer": "No  Explanation  The primary trial does not use a 4week cycle for its intervention",
        "label": "Contradiction"
    },
    "042bf558-479b-46c4-8553-016eb3bfcda7": {
        "text_answer": "No  The statement is not directly entailed by the evidence as the evidence does not mention HIV vaccine at all",
        "label": "Contradiction"
    },
    "b7a0a223-f9c6-474c-b9e7-ca530c393a53": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e1cf6d73-554a-4e33-8cf2-e19346eab3ce": {
        "text_answer": "Yes The inclusion criteria state that subjects must have a Mini Mental State Examination MMSE score of 2",
        "label": "Entailment"
    },
    "574106ef-1b9c-4540-a89f-5100a9bbe798": {
        "text_answer": "No  The evidence does not specify that AfricanAmerican patients must reside in Texas for the duration of the study in",
        "label": "Contradiction"
    },
    "1f5a106f-d664-4a83-a785-a47eea7b9106": {
        "text_answer": "  No the statement is not entailed by the evidence The secondary trial exclusion criteria include no mention of a",
        "label": "Contradiction"
    },
    "7b84b7dd-2143-41b0-bdf5-92c8ae314d17": {
        "text_answer": "No  Explanation The primary trial includes a criterion stating that the primary tumour diameter should be",
        "label": "Contradiction"
    },
    "e25a03fa-f51c-4c0d-b737-375a968ce6be": {
        "text_answer": "  Yes for the primary trial only as the secondary trial does not mention ertapenem or cip",
        "label": "Entailment"
    },
    "95cb9c0a-0725-4108-aebb-f114f77b577c": {
        "text_answer": "Yes  Explanation The evidence states that out of 21 participants the number of participants with",
        "label": "Entailment"
    },
    "5553674a-4eab-4515-be9e-147eef2f0d09": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as there is no mention of",
        "label": "Contradiction"
    },
    "7eeeed55-fe37-47ae-be62-e50557ccaed1": {
        "text_answer": "Yes  Explanation  The primary trial measures tumor response using RECIST criteria but it",
        "label": "Entailment"
    },
    "94ca00df-c395-4f32-9348-8bcb6b15a2e1": {
        "text_answer": "No  Explanation  The statement the most common adverse event in the secondary trial was an",
        "label": "Contradiction"
    },
    "6abbb566-9561-47d2-aad5-0857550099ea": {
        "text_answer": "No  Explanation The evidence provides the percentage of subjects who experienced recurrencefree survival up to",
        "label": "Contradiction"
    },
    "2a6e2da6-0555-43d1-b063-a81938137be9": {
        "text_answer": "No  The evidence states that patients must have a BMI of 25 kgm2 or greater and",
        "label": "Contradiction"
    },
    "7af8a41a-c4b2-402e-bf50-a14aa2758926": {
        "text_answer": "No  Explanation  The statement provided is not directly entailed by the evidence The evidence discuss",
        "label": "Contradiction"
    },
    "0f79f642-47d6-404b-ade0-8e720c0aa660": {
        "text_answer": "No  Explanation  The statement assent is agreement with a statement or proposal to do something",
        "label": "Contradiction"
    },
    "6b3619d3-21ea-437e-bb0f-f124cf636ca5": {
        "text_answer": "No  The evidence does not mention anything about a HER2neu peptide vaccine admixed with sar",
        "label": "Contradiction"
    },
    "5a77ba85-1a9e-4639-ba29-86b0cdea296b": {
        "text_answer": "  No   Explanation   The statement women suffering from both claust",
        "label": "Contradiction"
    },
    "aa176a26-7dd6-473f-9c35-40a0754336f6": {
        "text_answer": "Yes The statement is entailed by the evidence as the patients in the primary trial will receive multiple injections including d",
        "label": "Entailment"
    },
    "000c067a-a563-425e-9ea1-7057f8d2c39f": {
        "text_answer": "No  Explanation  The statement none of the participants in group 1 of the primary clinical",
        "label": "Contradiction"
    },
    "5fca366e-ecc6-41e4-b621-e3343ff0f07e": {
        "text_answer": "Yes The statement is about the agent administration setting which is not specified in the intervention section of the evidence",
        "label": "Entailment"
    },
    "a5ed681f-ae92-4bc5-856f-4565ab2669f0": {
        "text_answer": "  No the statement is not entailed by the evidence The evidence states that patients must have a potassium",
        "label": "Contradiction"
    },
    "58f0bed2-bc88-4aaf-8572-fb49fc69a87c": {
        "text_answer": "Yes  Explanation The evidence shows that the median change in total body lean mass for patients treated with",
        "label": "Entailment"
    },
    "fe6418cd-e255-4f27-bb63-63b4f37a0f56": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The statement is",
        "label": "Contradiction"
    },
    "93299ed6-4cc9-4369-a4f3-c86f45ab741e": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "e8f582a2-31f8-4b30-a2bb-1d236706333d": {
        "text_answer": "No  Explanation  The statement everyone in the primary clinical trial gets the same dosage",
        "label": "Contradiction"
    },
    "cf9ea9d0-49c4-4c00-a91b-142cd7ec8433": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a45aa828-dfd0-4b82-a1a1-7a8386520fe4": {
        "text_answer": "No  Explanation  The statement the primary trial treats one of its patient cohorts with",
        "label": "Contradiction"
    },
    "e8247d17-f420-4a08-9a2c-c2d8f1524d93": {
        "text_answer": "No  The statement is not entailed by the evidence as the trial is for patients with breast cancer not hepat",
        "label": "Contradiction"
    },
    "aa7a20b6-cec1-448c-ac20-a7b2d8c14a1d": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention section of the clinical trial does provide a comprehensive treatment cycle and",
        "label": "Entailment"
    },
    "0bb34f7b-d21a-4057-876a-25c722e6d50e": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about the number of patients who",
        "label": "Contradiction"
    },
    "b24a7c99-879c-416b-8b54-f44f0bcd4524": {
        "text_answer": "yes for the primary trial regarding overall response rate in Arm A and maybe for the secondary trial regarding time to first",
        "label": "Entailment"
    },
    "3795f873-9d20-4fb3-b77c-ca01ba923c82": {
        "text_answer": "  No   Explanation   The statement patients characterized by extreme obesity",
        "label": "Contradiction"
    },
    "94ee2ae4-cf85-4dfb-90be-2490ad4089ab": {
        "text_answer": "Yes The primary trial intervention is given orally while the secondary trial interventions are administered intravenously Elect",
        "label": "Entailment"
    },
    "750d4e54-f2cf-425c-9a04-dbd5091a0cba": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence regarding the administration of the interventions However the evidence",
        "label": "Entailment"
    },
    "bac5180a-b51f-4a2d-a1d2-eaead122d693": {
        "text_answer": "Yes  Explanation The evidence states that out of 53 participants in the Lapatinib ",
        "label": "Entailment"
    },
    "e54cf8ee-4a0d-4a15-bc72-4072ff0b6e6d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial intervention involves",
        "label": "Contradiction"
    },
    "ec3a1125-3c16-4f3c-8fa3-6a237f4529c9": {
        "text_answer": "No   Explanation  The statement during the primary clinical trial radiation therapy is undert",
        "label": "Contradiction"
    },
    "e4b448ba-15ad-4cf8-9343-782d45166891": {
        "text_answer": "Yes  Explanation  The statement is entailed by the evidence as both trials involve the use of",
        "label": "Entailment"
    },
    "2e2a005f-232f-457a-880e-c3950bc58df6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "dffbf597-b236-4aa5-bd94-b471c9e593ea": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence mentions that",
        "label": "Contradiction"
    },
    "7e3a4e76-6d33-4013-ad8e-7fd3d684136f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial reports the",
        "label": "Contradiction"
    },
    "976f4747-e1a6-4527-a298-490fb57d4615": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "82d350f6-9864-4329-bd5b-8d8155170569": {
        "text_answer": "No   Explanation   The statement None of the primary trial candidates have to perform regular",
        "label": "Contradiction"
    },
    "efe92dca-7dd8-44da-b436-15a3c9f9f729": {
        "text_answer": "No  Explanation  The statement there was one case of shingles recorded in group ",
        "label": "Contradiction"
    },
    "f5650e8f-58b5-4a3a-9da2-ab66d7674b6d": {
        "text_answer": "Yes The evidence does not explicitly state that patients with those tumor stages cannot participate in the trial so it is implied",
        "label": "Entailment"
    },
    "cdce28fc-eb28-4608-8b83-9bc18414caf8": {
        "text_answer": "  No   Explanation  The statement neither the primary clinical trial nor the secondary",
        "label": "Contradiction"
    },
    "51220352-fff0-4e70-b36d-7f9e87498a58": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement mentions fix",
        "label": "Contradiction"
    },
    "03fe5ae7-9f15-4d30-a208-cead95780b13": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the primary clinical trial",
        "label": "Contradiction"
    },
    "5d42d5d3-e80d-49e0-83e5-8724a8ff5401": {
        "text_answer": "No  Explanation  The statement mentions a total of 3 cases of asthenia",
        "label": "Contradiction"
    },
    "e52a3c24-8fed-4bcb-9513-582c604a5414": {
        "text_answer": "No  Explanation  The statement is about the requirements for participating in a clinical trial in a specific",
        "label": "Contradiction"
    },
    "df26264a-98ef-47f9-9493-e2398529e39f": {
        "text_answer": "No  Explanation  The statement Far more patients in the secondary trial were recorded to have",
        "label": "Contradiction"
    },
    "e554ce24-beab-4ed6-b37b-0a28ae28faf0": {
        "text_answer": "Yes  Explanation  The statement the secondary trial patients did not experience anemia p",
        "label": "Entailment"
    },
    "9324259a-88b9-441b-a6ee-ec7f6f5914aa": {
        "text_answer": "No  Explanation  The statement The patient with the longest PFS in the primary trial was",
        "label": "Contradiction"
    },
    "09879638-e324-4f5d-a45e-f62f7e06f301": {
        "text_answer": "  Yes for the secondary trial The primary trial explicitly excludes children and adolescents but the secondary trial",
        "label": "Entailment"
    },
    "86a8919e-ee7f-40ba-9186-9dcbdbb06018": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial does not indicate that the mean survival time",
        "label": "Contradiction"
    },
    "cbb9beea-1961-4049-9a90-53a75da5933e": {
        "text_answer": "Yes  Explanation The evidence states that cohort 1 received a dose of 0",
        "label": "Entailment"
    },
    "ca4fb850-2d8b-4a5f-b990-1d81ae917d63": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it incorrectly states that the dos",
        "label": "Contradiction"
    },
    "f8dbd18d-2b55-4f0f-92a7-db3b1ecc3b6d": {
        "text_answer": "No  Explanation  The statement the primary trial and the secondary trial recorded the same total number",
        "label": "Contradiction"
    },
    "ec2e7860-1d3e-4f95-b00a-bea42d04825a": {
        "text_answer": "Yes The statement mentions that capecitabine is administered orally which is consistent with the evidence that",
        "label": "Entailment"
    },
    "c17afde4-0fee-473c-b969-f7a4e89f049b": {
        "text_answer": "Yes The statement is entailed by the evidence as ER negative and HER2 negative breast cancer are specified in the inclusion",
        "label": "Entailment"
    },
    "328417f9-8f45-4114-82d7-9396b6bc578e": {
        "text_answer": "No   Explanation  The statement Patients in the primary trial will need to receive one",
        "label": "Contradiction"
    },
    "6ffb2b0f-737a-4176-9036-a887a2f4a4b7": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only gives the median average",
        "label": "Contradiction"
    },
    "5b13bca4-0354-4579-a868-d007bef0dbe1": {
        "text_answer": "Yes  Explanation The evidence shows that the percentage of participants with invasive diseasefree survival events",
        "label": "Entailment"
    },
    "8d94a62d-400f-4d9d-92aa-d39dd1f37823": {
        "text_answer": "Yes  Explanation  The statement cohort 1 was the group where all the cases",
        "label": "Entailment"
    },
    "8d813fc8-01ec-4fb7-9191-f5ec7cb735fb": {
        "text_answer": "No  The statement does not mention any scans or attenuation corrections in the evidence It only describes the inter",
        "label": "Contradiction"
    },
    "eaad4acd-8fc1-41c6-92aa-1a4488ffdfed": {
        "text_answer": "Yes  Explanation The statement mentions Infection as an adverse event in both trials",
        "label": "Entailment"
    },
    "0cb2b471-fa4a-4eeb-8dd7-981680465858": {
        "text_answer": "Yes The statement is entailed by the evidence as all the adverse events mentioned in the statement are from cohort",
        "label": "Entailment"
    },
    "f4da0e5f-f0aa-4edf-a08c-afadd05360d5": {
        "text_answer": "Yes The statement is entailed by the evidence as nonsmall cell lung cancer and small cell lung cancer are listed as",
        "label": "Entailment"
    },
    "f859f501-4e35-44c5-88bf-213949f5e5e5": {
        "text_answer": "Yes The evidence states that there are 1530 enrollment slots for patients with metastatic colore",
        "label": "Entailment"
    },
    "b7b355cd-5386-4b3c-bc5d-a9a05e7a83b5": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "10292ba1-dd1f-4191-b534-331f39583181": {
        "text_answer": "Yes for the primary trial only as hypokalemia is an exclusion criterion",
        "label": "Entailment"
    },
    "cd2874dc-b435-4319-8ae9-d413b3f43499": {
        "text_answer": "Yes  Explanation The evidence states that in the primary clinical trial Intervention 1 Arm",
        "label": "Entailment"
    },
    "76b35642-5bf9-4980-beb9-e802493907b6": {
        "text_answer": "No  Explanation The evidence provided in the trial results indicates that there were fewer participants in the place",
        "label": "Contradiction"
    },
    "f13b3dd4-fe4a-4189-b51b-cf72af22deab": {
        "text_answer": "  No   Explanation   The statement a patient that has received an organ trans",
        "label": "Contradiction"
    },
    "56603bed-1e4b-41d2-919c-612ec6e9b4c4": {
        "text_answer": "No  Explanation  The statement over 89100 patients in the primary",
        "label": "Contradiction"
    },
    "306ea03b-8055-4a52-8d81-ed4e18dedd4f": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only mentions metastatic andor advanced",
        "label": "Contradiction"
    },
    "94604a45-9867-4ccd-b38b-de2a3368130e": {
        "text_answer": "No  Explanation  The statement no notable variances were present in the outcomes of the primary",
        "label": "Contradiction"
    },
    "8f20a32b-2aa2-44c4-930e-852cba56151f": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "3fa1e0aa-7c62-4a1e-bd7d-452fa87a7baf": {
        "text_answer": "No  The statement splitting pain is an intense sensation of discomfort or distress that feels like being cut apart",
        "label": "Contradiction"
    },
    "d66e149e-5bb7-4e4b-8078-7f5947a31f60": {
        "text_answer": "  No   Explanation   The patient described in the statement does not meet the inclusion",
        "label": "Contradiction"
    },
    "e7c553e8-8799-4475-9e39-6f79bebc0a48": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial cohort 1 reported mostly beneficial",
        "label": "Entailment"
    },
    "8ddc286d-ac51-4c92-a163-2d9a65b52ae7": {
        "text_answer": "No  Explanation  The statement minor help to transfer is a response indicating that an individual",
        "label": "Contradiction"
    },
    "5baa6e97-00e4-4e2f-b837-661a790cb87f": {
        "text_answer": "No  Explanation  The primary and secondary trials evaluate different interventions and outcomes The primary trial",
        "label": "Contradiction"
    },
    "6f95650b-d11f-4546-bfb2-d46cc39561b2": {
        "text_answer": "No  Explanation  The statement patients suffering from severe insomnia and schizoph",
        "label": "Contradiction"
    },
    "fd23bed1-83e9-44c9-acf7-66df74ba1c98": {
        "text_answer": "Yes The evidence does not provide any conditions on life expectancy pregnancy or age for participants in the primary trial",
        "label": "Entailment"
    },
    "ea0d6370-3322-4925-b524-b9a8bebe4383": {
        "text_answer": "No  Explanation  The primary and secondary trials are studying the same drug empegfilgr",
        "label": "Contradiction"
    },
    "ea893c02-e0eb-4789-bb1e-5501db3be7d7": {
        "text_answer": "Yes The primary trial excludes patients with Vitamin D deficiency but the secondary trial includes healthy participants who may have",
        "label": "Entailment"
    },
    "3cbb65a6-d9f6-4972-8b13-dd19d427f0cb": {
        "text_answer": "Yes  Explanation  The primary clinical trial INTERVENTION 1 compares two",
        "label": "Entailment"
    },
    "40de18f3-3a12-40fb-9ce2-ebcc28391c7d": {
        "text_answer": "No  Explanation  The statement the primary clinical trial reported more adverse events than the secondary",
        "label": "Contradiction"
    },
    "8dc16445-6102-4525-b9ce-ba4e35cc8b01": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not specify eligibility based on menop",
        "label": "Contradiction"
    },
    "aeb95807-2d6b-4915-b52c-0d0fdc82728e": {
        "text_answer": "No  Explanation  The statement cohort 2 in the secondary clinical trial had a",
        "label": "Contradiction"
    },
    "c2d6b8ba-8238-49b7-b9a1-de2ffdabe324": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial have different inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "35a580c0-ce8a-42d1-b8ea-d84b985319c5": {
        "text_answer": "  No The statement is not entailed by the evidence as the inclusion criteria specify that the tumor must be H",
        "label": "Contradiction"
    },
    "fa2d8a93-4cae-4ee5-afdf-1afd04d07c93": {
        "text_answer": "No  Explanation  The statement over 20 of the patients that participated in the",
        "label": "Contradiction"
    },
    "a852b1d2-ce26-48da-ba6d-2386489a967b": {
        "text_answer": "Yes  Explanation The statement occurrences of hepatotoxicity were thrice as",
        "label": "Entailment"
    },
    "9068887d-3b93-4345-9b59-01ceb05725b1": {
        "text_answer": "No  Explanation  The statement for the primary clinical trial adults who have been diagnosed with",
        "label": "Contradiction"
    },
    "c35d641d-7248-47d7-90ff-a3859a846f68": {
        "text_answer": "Yes The evidence states that one participant experienced a maculopapular rash making it a common occurrence",
        "label": "Entailment"
    },
    "2690d684-0905-4af0-8113-fffec885de77": {
        "text_answer": "No  The evidence explicitly states that there should be no meningeal carcinomatosis in the patient M",
        "label": "Contradiction"
    },
    "ee0b2916-1e10-467e-bcf3-41c56aa80921": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial explicitly excludes patients with pulmonary",
        "label": "Contradiction"
    },
    "731e38ac-1da8-4b94-a501-606a49570767": {
        "text_answer": "No  Explanation  The statement cyp3a4 polymorphism positive is an",
        "label": "Contradiction"
    },
    "d6f4c977-a5fa-49c9-ba6c-a40dfe0f3b30": {
        "text_answer": "Yes The evidence does not report any results for the LBH589 and Lapatinib cohort",
        "label": "Entailment"
    },
    "7506e58c-a44a-4410-a519-59a81686fe12": {
        "text_answer": "No  The statement is not entailed by the evidence The primary clinical trial and the secondary clinical trial have different inclusion",
        "label": "Contradiction"
    },
    "d3379655-55b7-4e58-88c2-c3cd3e8cb557": {
        "text_answer": "No  Explanation  The statement Women with Newly diagnosed stage IV breast cancer confirmed",
        "label": "Contradiction"
    },
    "f823a6d1-5d44-4d8c-8f33-14eef364d3b6": {
        "text_answer": "yes but with a qualification the statement is entailed by the exclusion criteria regarding women of childbearing",
        "label": "Entailment"
    },
    "2a45331c-2e6b-43fb-be85-86e22c828c41": {
        "text_answer": "Yes  Explanation The evidence shows that a greater percentage of participants in the bevacizum",
        "label": "Entailment"
    },
    "d3ee2617-a363-4290-a97b-57f6eb1b8efe": {
        "text_answer": "No  Explanation  The statement the entirety of group 1 in the primary clinical trial",
        "label": "Contradiction"
    },
    "d2885dd5-eb3f-4dcd-9980-c02d3c1c6924": {
        "text_answer": "Yes  Explanation The statement one shingles case was reported in the secondary clinical trial specifically",
        "label": "Entailment"
    },
    "aab488c3-ac44-4506-b2b1-541909e30028": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0c105984-77ed-42cc-9d9f-aec464e02d12": {
        "text_answer": "No  Explanation  The statement Candidates for the primary trial and the secondary trial have",
        "label": "Contradiction"
    },
    "216d59a3-b4c1-4a73-a4e2-ee2b97c59b22": {
        "text_answer": "No   Explanation   The primary clinical trial measures the toxicity of infusing HER",
        "label": "Contradiction"
    },
    "fa7b75cd-7f8f-44aa-83dc-618e1bc961a1": {
        "text_answer": "  Yes The evidence states that 53 out of 60 participants in the Lapatinib 10",
        "label": "Entailment"
    },
    "34f34450-a64c-4159-ad9d-8adb58617e79": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial noted only two types of adverse events",
        "label": "Contradiction"
    },
    "6c50344e-493e-46a6-9e03-74495773bab2": {
        "text_answer": "No   Explanation  The statement all patients in the primary clinical trial receive suramin and",
        "label": "Contradiction"
    },
    "a698cb41-106c-4d9c-b4e9-1381f9329079": {
        "text_answer": "No  Explanation The statement both the placebo and trabectedin used in the primary",
        "label": "Contradiction"
    },
    "6bae9ada-fea4-4bb6-bd25-cdb505b3d53f": {
        "text_answer": "Yes  Explanation  The statement over 097 of patients in the secondary trial",
        "label": "Entailment"
    },
    "fc281ab7-f956-47d7-a938-8778fef1bca0": {
        "text_answer": "No  Explanation The statement Candidates for the secondary trial study group receive 3 weekly",
        "label": "Contradiction"
    },
    "5db44a07-6d17-4fa9-9060-1f1af4aaf3af": {
        "text_answer": "Yes The evidence shows that there were a total of 3 vomiting events out of 149 participants",
        "label": "Entailment"
    },
    "327d67d2-35e7-45c3-958a-7955905f2d57": {
        "text_answer": "  Yes for the primary trial pulmonary embolism is a reason for exclusion within 4 weeks",
        "label": "Entailment"
    },
    "86515e2e-b144-430c-b7e2-678733d3b0ec": {
        "text_answer": "Yes The statement is entailed by the evidence as patients are given oral medication twice a day lapatinib and tam",
        "label": "Entailment"
    },
    "f9638af4-2bf2-45b4-8c9e-b46c34373b17": {
        "text_answer": "No  Explanation  The evidence provided in the text does not support the statement that the bev",
        "label": "Contradiction"
    },
    "cf38cb04-b2fd-44bf-9674-dda257a8ad25": {
        "text_answer": "No  Explanation  The statement cardiac biphasic synovial sarcoma",
        "label": "Contradiction"
    },
    "bbb1b8c1-c9b1-40c9-b744-a2ae519032c3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports the median",
        "label": "Contradiction"
    },
    "7dbe6e8e-5971-41e2-bc70-46dc3cb3cd5c": {
        "text_answer": "Yes  Explanation  The statement there are 00 shared inclusionexclusion criteria",
        "label": "Entailment"
    },
    "c18a6d09-906e-4fbe-acf1-93b9a89f717a": {
        "text_answer": "No   Explanation The primary trial measures change in units on a scale while the secondary trial measures",
        "label": "Contradiction"
    },
    "9c0406cd-3585-4cb2-b330-fa9c1426c72c": {
        "text_answer": "No  Explanation The statement every participant in the primary clinical trial was administered oral sunitin",
        "label": "Contradiction"
    },
    "47daf120-3939-4e32-bba5-d86ce54a9cbd": {
        "text_answer": "Yes  Explanation The evidence states that out of the 53 participants analyzed in the Lapatin",
        "label": "Entailment"
    },
    "84e7c52d-eec3-415f-9602-77f607c5620e": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the doses of Abra",
        "label": "Contradiction"
    },
    "19606c86-3376-40ca-b438-20d961329829": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the change in weekly average hot flash score from baseline",
        "label": "Entailment"
    },
    "b12b7e1a-9348-4e57-ac88-44523913fff3": {
        "text_answer": "Yes The primary trial mentions IV administration for zoledronic acid while the secondary trial mentions both IV and",
        "label": "Entailment"
    },
    "a7561afd-f6c4-41cf-8d4a-fa6c26cc10b3": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the effect of AZ",
        "label": "Contradiction"
    },
    "9289ca32-0fa0-44ae-8cc0-49510f2fed23": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial cohort 1 receives less",
        "label": "Entailment"
    },
    "784e0481-d0fd-43b9-8d5a-0a1d2bd4aa26": {
        "text_answer": "No  Explanation  The statement percentage times minute per hour is a unit of measurement expressed",
        "label": "Contradiction"
    },
    "e3801aad-e988-42fb-8266-22a90bdba955": {
        "text_answer": "No  The statement is not entailed by the evidence as the secondary trial measures pain not muscle gains in response",
        "label": "Contradiction"
    },
    "22274495-9d06-43cd-98fd-86d0374b42e9": {
        "text_answer": "No  Explanation  The primary trial is about the diagnostic accuracy of two algorithms in breast cancer diagnosis",
        "label": "Contradiction"
    },
    "d3525b25-3dad-4ed2-8fe7-d0f0abc6be14": {
        "text_answer": "No   Explanation  The statement primary clinical trial employs procedures that utilize ultras",
        "label": "Contradiction"
    },
    "927d72b0-1f55-4803-9a86-40838c08f923": {
        "text_answer": "yes both trials involve injections However the statement could be more specific by mentioning denosumab and radio",
        "label": "Entailment"
    },
    "0e1460ea-4f44-47ff-892a-e3190b498557": {
        "text_answer": "No The statement is not entailed by the evidence as the evidence does not provide any information about the nature of the primary",
        "label": "Contradiction"
    },
    "9bb1e4d4-379d-47f5-a6b9-c6dac40b2727": {
        "text_answer": "No  Explanation The evidence provided in the text describes the results of a clinical trial comparing the effect",
        "label": "Contradiction"
    },
    "1820d3ff-ca2a-47dc-a80e-45e760307261": {
        "text_answer": "No  The evidence describes participants receiving oral doses of enzalutamide not intravenous injections",
        "label": "Contradiction"
    },
    "2db0df9c-be54-419d-9710-54adb741a1a1": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically states that any of the following current",
        "label": "Entailment"
    },
    "0f36a35d-d86b-41d0-9878-df4ef7ad0e9f": {
        "text_answer": "No  Explanation  The statement the infection asymmetry and deflation cases were less preval",
        "label": "Contradiction"
    },
    "e2061005-22e7-4de3-90c2-e4ebfe055b0d": {
        "text_answer": "No  Explanation  The statement the evidence from the primary clinical trial indicates that the overall response",
        "label": "Contradiction"
    },
    "7b29df5c-9189-4c72-b0ad-3ed971c42652": {
        "text_answer": "  No   Explanation   The statement patients suffering from cancer and having conditions",
        "label": "Contradiction"
    },
    "d58edc4e-2e7f-4c35-b24c-cd1239175b1a": {
        "text_answer": "No  Explanation  The statement the primary participants reported no adverse events specifically no occur",
        "label": "Contradiction"
    },
    "02cf528a-17da-4ea6-a65e-7a9efe2cf3cf": {
        "text_answer": "No  Explanation  The statement both the primary and secondary trials used multiple test groups without any",
        "label": "Contradiction"
    },
    "1f9ee295-ce3d-427b-8af2-876edb47bf7f": {
        "text_answer": "Yes   Explanation  The primary trial involves the use of Gefitinib ZD",
        "label": "Entailment"
    },
    "d504ff9e-bdcc-4609-9b57-b1cb4638bfdc": {
        "text_answer": "No  Explanation  The statement the participant count was the same for both cohorts in",
        "label": "Contradiction"
    },
    "cedade64-046d-4e90-ad04-9b0a497fc534": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only mentions the use",
        "label": "Contradiction"
    },
    "73e39e6d-e688-4372-85d4-dbb3cbc7a7cb": {
        "text_answer": "No   Explanation The evidence provided in the text does not mention anything about patients experiencing no pain",
        "label": "Contradiction"
    },
    "f0534dd1-7050-4fc1-971e-5aab8abb5d47": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "6247182c-7b14-46b7-9452-a4072ed79a7b": {
        "text_answer": "Yes The evidence does not mention any unexpected deaths or hospitalizations in either trial",
        "label": "Entailment"
    },
    "a3ba6a16-5f21-477d-9a2a-574a53ab3f2c": {
        "text_answer": "No  The evidence does not mention anything about eating disorders in the primary trial The statement is not related to the given",
        "label": "Contradiction"
    },
    "fc38bc02-5e04-4b3d-bf4d-19fa9a636bd2": {
        "text_answer": "Yes but with a caveat The evidence does not directly report on the number of participants who experienced a decline in cognitive",
        "label": "Entailment"
    },
    "2dbcfe7a-32b5-47e3-a6fc-0f38039de24c": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only reports the number of participants with path",
        "label": "Contradiction"
    },
    "264848be-8491-409f-b19f-0db249bc155a": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "6548c59c-cafc-465f-8f10-4bfc5d147611": {
        "text_answer": "Yes The statement There were no deaths or Hospitalizations in cohort 2 of the primary trial is ent",
        "label": "Entailment"
    },
    "03688964-cf46-485b-99f3-f7c6c5fed3ed": {
        "text_answer": "  No The statement is not entailed by the evidence as the primary trial specifies Japanese females as candidates while",
        "label": "Contradiction"
    },
    "abc13f3b-54fa-4a1c-a063-5f1f00e2ae9a": {
        "text_answer": "No  Explanation The statement patients can not have a history of abdominal fistula",
        "label": "Contradiction"
    },
    "c651d7a4-f39a-44df-84cc-f71c45ced124": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not mention leptomeningeal car",
        "label": "Contradiction"
    },
    "9b9d2ca0-acea-42a6-bd46-78eb4540a107": {
        "text_answer": "No  Explanation The statement the most commonly occuring adverse event across the patient coh",
        "label": "Contradiction"
    },
    "55372cf8-c6a0-4286-8cd5-5e11e070bd79": {
        "text_answer": "No  Explanation  The statement the mymop score change is not a determinant for",
        "label": "Contradiction"
    },
    "4abdde7a-7745-4391-ae23-9d7fb6d837c2": {
        "text_answer": "  Patients with high vitamin D levels did not manifest a noticeable pattern for expression of the group of 4",
        "label": "Entailment"
    },
    "bb5873a3-4c28-49f6-9f70-f3f1d8ac7db2": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement incorrectly assumes that",
        "label": "Contradiction"
    },
    "eda562ff-9676-46f2-9ec3-93eb3cdd7585": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants in",
        "label": "Contradiction"
    },
    "6a211e77-e17f-4739-b685-e6bd83b8d7e3": {
        "text_answer": "No  The evidence does not exclude patients with leptomeningeal carcinomatosis if it is controlled",
        "label": "Contradiction"
    },
    "754d4ae4-5d18-4b63-836a-c011958680ce": {
        "text_answer": "Yes Both trials involve the use of cyclophosphamide However its important to note that the context",
        "label": "Entailment"
    },
    "41219409-bd82-4df0-82aa-d72fc4aec1fd": {
        "text_answer": "No  Explanation The statement provided is not related to the adverse events mentioned in the evidence",
        "label": "Contradiction"
    },
    "61a1a0e2-bd62-43de-b3c9-1c2143417c5a": {
        "text_answer": "Yes Both trials require patients to have a functional ECOG status 2 indicating ambulatory status",
        "label": "Entailment"
    },
    "f11800b6-312b-4f9d-9b18-24a3a6bb67a2": {
        "text_answer": "No  Explanation  The statement neither intervention one nor two in the primary clinical trial em",
        "label": "Contradiction"
    },
    "4e0fbb00-bcbe-4051-a343-58a6cb50eb0b": {
        "text_answer": "Yes However its important to note that the statement only applies to postmenopausal women with early",
        "label": "Entailment"
    },
    "d331f99d-446c-4305-8842-05d6fe2d070c": {
        "text_answer": "Yes The evidence shows that there were no cases of pancytopenia in the primary group of the primary clinical trial",
        "label": "Entailment"
    },
    "abaf9c04-8d6d-43f3-afb5-9bc9d04fb9b5": {
        "text_answer": "No  Explanation  The statement amnion nodosum is an amnion with",
        "label": "Contradiction"
    },
    "e123c707-0e86-43c1-8f9b-971363c07ae0": {
        "text_answer": "No  Explanation  The statement regimen used to treat prostate carcinoma is any",
        "label": "Contradiction"
    },
    "b2caa135-c6ed-46b0-a1e3-6fd60ae12831": {
        "text_answer": "Yes  Explanation The statement the differences between interventions 1 and 2 of the primary",
        "label": "Entailment"
    },
    "19275bdd-9964-4f3b-b2d5-b984203774d5": {
        "text_answer": "Yes  Explanation The statement both the primary clinical trial and the secondary clinical trial reported a minimum of",
        "label": "Entailment"
    },
    "8d728674-1111-495d-ae90-59ced10163a4": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts receive higher doses of Cyclophosphamide",
        "label": "Entailment"
    },
    "88a8b32d-122c-48f9-a305-3d1b8e3fcd85": {
        "text_answer": "Yes The statement is entailed by the evidence as every patient in the trial is required to take Vorinostat daily",
        "label": "Entailment"
    },
    "4bf82041-f1d8-4a90-9bd0-aec991e50966": {
        "text_answer": "No  Explanation  The statement percentage food eaten score 40 is a subjective",
        "label": "Contradiction"
    },
    "b3ed34ea-6461-40ed-955d-693bbc27fd99": {
        "text_answer": "No  Explanation  The statement substance dispersity is a measure of the heterogeneity",
        "label": "Contradiction"
    },
    "53dac2a0-f55a-4987-bab1-695a985eacd1": {
        "text_answer": "No  The interventions in the two trials have different durations but the statement does not specify which trial it is",
        "label": "Contradiction"
    },
    "2cd6db4c-83e4-4ca5-8650-6638521a27a2": {
        "text_answer": "Yes  The statement is entailed by the evidence as the clinical trial involves the administration of multiple injections including d",
        "label": "Entailment"
    },
    "2cf8bdbf-5f09-4f16-8b50-c6369d003a4f": {
        "text_answer": "No  Explanation  The statement t122q23q",
        "label": "Contradiction"
    },
    "b41e6cb3-c92e-4027-b96b-502aeb1f4211": {
        "text_answer": "No  Explanation  The statement 273 the primary trial participants and 0",
        "label": "Contradiction"
    },
    "d5b131c2-0835-4f00-a0ba-2db26d1fe581": {
        "text_answer": "Yes  Explanation  The statement throughout the primary clinical trial there were no reported cases",
        "label": "Entailment"
    },
    "c5fed4a9-da6c-4dcb-b191-930bca7e0ce7": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "6e9f7a1a-21e5-4d5f-b602-a1efb1b51bc7": {
        "text_answer": "Yes The evidence mentions the doses of ALT801 given to each cohort and the",
        "label": "Entailment"
    },
    "61afd69d-529d-49e9-b607-007414946b6c": {
        "text_answer": "Yes The evidence states that there were no urinary tract infections reported during the primary clinical trial",
        "label": "Entailment"
    },
    "dfb4c335-296e-42af-b418-329f39c6b42e": {
        "text_answer": "No  Explanation  The statement both the primary clinical trial and the secondary clinical trials",
        "label": "Contradiction"
    },
    "5051b4e9-21e7-4fa8-a602-de48b103fa19": {
        "text_answer": "  Yes The statement is entailed by the evidence as warfarinbased treatments are explicitly listed as excluded for",
        "label": "Entailment"
    },
    "f61808f1-4431-4b34-8a66-e422c6e97530": {
        "text_answer": "No  Explanation  The statement dysplasia negative is an indication that signs of dys",
        "label": "Contradiction"
    },
    "01d0c4bf-e697-4565-906b-edd21fd2227f": {
        "text_answer": "No  The evidence does not mention anything about schizophrenia",
        "label": "Contradiction"
    },
    "a1e4f5de-9b44-444e-8eff-ae7b040c6f6e": {
        "text_answer": "No  Explanation  The statement women with triple negative stage III breast cancer who have",
        "label": "Contradiction"
    },
    "6f835e44-5cb2-4f42-9b69-8ec81c00a404": {
        "text_answer": "No  Explanation  The statement patients currently in remission are eligible for both the primary",
        "label": "Contradiction"
    },
    "8c9c4150-3bc1-4f06-8bee-2d5bba3ef8b9": {
        "text_answer": "No  Explanation  The statement several cardiac and psychiatric aes were observed",
        "label": "Contradiction"
    },
    "2096d634-b321-40de-b69b-8dad3345331e": {
        "text_answer": "No  Explanation  The statement more people participated in the secondary clinical trial than the primary clinical",
        "label": "Contradiction"
    },
    "a2981a35-ece3-42dc-a735-cd12466392fa": {
        "text_answer": "Irrelevant The statement has nothing to do with the adverse events in the evidence",
        "label": "Entailment"
    },
    "ff95337a-7da9-43f5-bb3c-25cd7c85e5c7": {
        "text_answer": "No  Explanation  The statement 025 of patients in the primary trial suffer",
        "label": "Contradiction"
    },
    "6a969a7c-55f3-4595-a361-db78a910f352": {
        "text_answer": "  No  Explanation  The evidence provided in the primary clinical trial results does not indicate the",
        "label": "Contradiction"
    },
    "6d37ed53-a6e4-403e-8b93-9954a6486dbc": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5af90c4a-80c3-4f11-bbc0-7f84ad544186": {
        "text_answer": "  Yes The statement is entailed by the evidence as the inclusion criteria specify ER negative PR negative and H",
        "label": "Entailment"
    },
    "e92e6dec-b727-475a-b544-568b5773cb81": {
        "text_answer": "No  Explanation The evidence states that participants in the primary clinical trial receive oral lapatinib and",
        "label": "Contradiction"
    },
    "fc35d08f-73a9-47aa-9450-165dcfda17bf": {
        "text_answer": "Yes  Explanation  The statement across both the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "a96f9558-41f8-4515-8fc4-d3b8f326ce05": {
        "text_answer": "No   Explanation  The evidence provided in the primary clinical trial does not mention the use of",
        "label": "Contradiction"
    },
    "6fbc7c06-1134-42b6-bfbc-9e4f28727cba": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement about a",
        "label": "Contradiction"
    },
    "6e6f3848-8d0e-47df-b2f3-1f09cf7da6e4": {
        "text_answer": "No   Explanation  The statement the primary clinical trial and the secondary clinical trial did not",
        "label": "Contradiction"
    },
    "eacc1096-c090-4f21-ad10-005be458b653": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as patients in the primary trial received a different",
        "label": "Entailment"
    },
    "325c6150-352f-4b08-aa67-fed4cd6f68d0": {
        "text_answer": "  No the statement is not directly entailed by the evidence as it does not explicitly mention organ transplant as an",
        "label": "Contradiction"
    },
    "90135397-f63a-412e-9633-0355e1a78154": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial shows that patients in the acup",
        "label": "Entailment"
    },
    "6bc62f08-51ae-44d6-be1d-738c82598de5": {
        "text_answer": "No  Explanation The statement is not an exact representation of the evidence as it omits some of the",
        "label": "Contradiction"
    },
    "f6ad61ca-d223-496b-a067-69625112447c": {
        "text_answer": "No  Explanation  The statement less than 120 of patients in the primary",
        "label": "Contradiction"
    },
    "5261c924-d9ef-43ed-8f2a-6c5b1552cc62": {
        "text_answer": "Yes  Explanation The evidence states that women of childbearing potential WOCBP and",
        "label": "Entailment"
    },
    "bb3e3ca1-1b64-4ddc-9492-1fb11ec9356f": {
        "text_answer": "Yes The statement is entailed by the evidence as both study groups undergo identical imaging procedures with a minor increase in",
        "label": "Entailment"
    },
    "efa989b7-db55-49b8-a124-875a5f7c94ff": {
        "text_answer": "No  Explanation  The statement mentions Asthenia and Pyrexia but the",
        "label": "Contradiction"
    },
    "63a44f77-d6b6-47df-9bea-b7deb99f5658": {
        "text_answer": "No  Explanation  The statement karyocytomegaly and multinucle",
        "label": "Contradiction"
    },
    "fc4ec229-5b69-409e-89c0-2b151f670382": {
        "text_answer": "Yes The evidence does not mention any performance status conditions as inclusion or exclusion criteria for either trial",
        "label": "Entailment"
    },
    "fbde81ad-0d06-4d2a-8baa-eb5eace1b3ec": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial do not have any recorded",
        "label": "Entailment"
    },
    "1172df8a-7da3-4769-8832-32ded72cfcf1": {
        "text_answer": "Yes The primary trial includes a requirement for a specific gene mutation while the secondary trial does not have this requirement explicitly",
        "label": "Entailment"
    },
    "c20768c0-36c2-44ff-9d4f-36d34e02c1a2": {
        "text_answer": "Yes The evidence indicates that zoledronic acid in Intervention 1 of the primary trial and all drugs ",
        "label": "Entailment"
    },
    "04beb33e-ae70-4de2-a805-71650246ea7b": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes tumors that are only 1 cm",
        "label": "Contradiction"
    },
    "262e8bd4-da64-4158-b23d-b875050e66af": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as there is no mention of Par",
        "label": "Contradiction"
    },
    "18e1908f-f449-42a0-916b-7e88c1e7c901": {
        "text_answer": "Yes  Explanation  The statement patients in the primary clinical trial did not suffer from an",
        "label": "Entailment"
    },
    "e4f2bd3a-6976-4a2b-9485-c34bdc812c54": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided in the primary trial",
        "label": "Contradiction"
    },
    "70c0fbc1-8eb8-4634-a595-898784718d09": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the primary trial involves",
        "label": "Contradiction"
    },
    "4960cf63-01e8-4fc5-b6ea-fe10063c6e6c": {
        "text_answer": "Yes  Explanation The statement alisertib isnt included in the treatment of both co",
        "label": "Entailment"
    },
    "ed12f8ae-3bda-46b8-8bf1-5ad6d1527c57": {
        "text_answer": "No  Explanation  The statement received all the services needed is not directly mentioned or",
        "label": "Contradiction"
    },
    "2d0df5b6-0886-4a19-973a-92f4442b39d1": {
        "text_answer": "No   Explanation  The statement corneal deposits were less commonly identified amongst the",
        "label": "Contradiction"
    },
    "f9dfbdb7-3248-450e-a7d4-782f2e68e057": {
        "text_answer": "No  Explanation The statement intravascular ultrasound and transverse radial incisions form",
        "label": "Contradiction"
    },
    "1c7d5749-bf28-4ae8-8408-ccda3f13a18a": {
        "text_answer": "Yes  Explanation  Both the primary and secondary clinical trials mentioned in the evidence provide information on",
        "label": "Entailment"
    },
    "586b08dc-8323-46ff-873f-5d262f7eae35": {
        "text_answer": "No  Explanation  The statement 90 of the adverse events in the secondary trial",
        "label": "Contradiction"
    },
    "74452fe6-e38e-4f1d-a666-765c464ca765": {
        "text_answer": "Yes The statement is entailed by the evidence as the dosage of eribulin in Intervention 1 is higher",
        "label": "Entailment"
    },
    "c81fad5d-aa52-4147-a724-984e7d9c4cc3": {
        "text_answer": "No  Explanation  The statement adverse events that are a result of the secondary clinical trial",
        "label": "Contradiction"
    },
    "b3909182-2942-44c1-96e8-5650e48401df": {
        "text_answer": "No  Explanation  The statement The majority of the adverse events recorded in the primary trial",
        "label": "Contradiction"
    },
    "2d61f68b-3907-4337-bc4c-20f219a1c678": {
        "text_answer": "133 based on the given data the statement does not directly entail that all patients remained metast",
        "label": "Entailment"
    },
    "b5e896cf-e971-4fac-8dc6-a19e2c2d0a72": {
        "text_answer": "Yes The evidence does not include any conditions related to life expectancy pregnancy or age as exclusion criteria",
        "label": "Entailment"
    },
    "2a9b88b7-4d4f-47d5-808b-df5a328935ae": {
        "text_answer": "Yes  Explanation  The statement the secondary clinical trial reported significantly less total adverse incidents in",
        "label": "Entailment"
    },
    "20a73393-6e4f-4096-8025-45d8fbe228b7": {
        "text_answer": "No  Explanation The evidence provided in the form of the primary clinical trial interventions does not ent",
        "label": "Contradiction"
    },
    "1a9f1afc-af2c-4dca-b701-2a04033f47b4": {
        "text_answer": "No  Explanation  The statement a prerequisite for both the primary and the secondary",
        "label": "Contradiction"
    },
    "b4db304d-9445-44e0-9f0a-a4df38c1301b": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not mention any information about Treatment",
        "label": "Contradiction"
    },
    "197c5300-0475-46e0-aa97-cfb145da896d": {
        "text_answer": "No  Explanation  The statement every participant in group 1 of the primary trial were found",
        "label": "Contradiction"
    },
    "a3f8233e-3af4-41f5-a4f4-7676251de646": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves multiple",
        "label": "Contradiction"
    },
    "a3e78ee7-57e9-47e4-a85f-e61451207043": {
        "text_answer": "Yes The statement does not explicitly mention the doses of ALT801 in the cohorts but",
        "label": "Entailment"
    },
    "87840288-7db7-4532-b5a9-ce95221cf918": {
        "text_answer": "Yes  Neither trial includes women with severe claustrophobia IBS Irritable Bowel",
        "label": "Entailment"
    },
    "c9077c20-07f8-4137-b88a-9ef599052884": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the evidence reports a",
        "label": "Contradiction"
    },
    "290508ed-616c-4d7e-b83b-49a2fa895a44": {
        "text_answer": "Yes  Explanation The statement blood and bone marrow related issues predominantly accounted for reported",
        "label": "Entailment"
    },
    "171ca8d1-c986-4446-8ee3-8b8635f4d234": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with tumors positive for CCND1 amplification CDK",
        "label": "Entailment"
    },
    "7cd38d1e-009b-40f6-a8f8-1352ae821aa4": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial is assess",
        "label": "Contradiction"
    },
    "42c07819-8022-4275-8484-6ed9db10115c": {
        "text_answer": "Yes  Explanation The primary clinical trial is comparing the use of two different gels Hydro",
        "label": "Entailment"
    },
    "d735322f-f5fc-489d-bb28-e40451860571": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial involves intraven",
        "label": "Contradiction"
    },
    "063a0207-f4fc-43c1-849e-6d3fc64b009b": {
        "text_answer": "Yes  The evidence does not report any observed thromboembolic events in either trial",
        "label": "Entailment"
    },
    "3ad9820f-4ef2-4624-b08a-b910adf25836": {
        "text_answer": "Yes  Explanation  The statement Ascites was more common for patients in the primary trial",
        "label": "Entailment"
    },
    "a63d1b8c-8ac5-4b17-a8c8-690dae246d1f": {
        "text_answer": "No  The statement is not related to the evidence provided which pertains to different drugbased interventions for cancer",
        "label": "Contradiction"
    },
    "698866bd-4a77-4b0a-9e79-6fb9984692b7": {
        "text_answer": "No  Explanation  The statement arm 1s operative time was less than that",
        "label": "Contradiction"
    },
    "144b54f3-eb81-4c83-a94c-2c01847b9299": {
        "text_answer": "Yes  Explanation  The statement the weekly intake of mm121 and pac",
        "label": "Entailment"
    },
    "b00e3d3a-3046-4996-a028-35e45ce682be": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "75c55f70-aa52-4794-aae7-3a355f1a76e9": {
        "text_answer": "  No   Explanation   The statement Breast cancer patients with estrogen",
        "label": "Contradiction"
    },
    "bce464d0-a0f9-4d17-9caa-6bd247cfdce3": {
        "text_answer": "No  Explanation  The statement device migration problem identified is a device that has moved from its",
        "label": "Contradiction"
    },
    "bd828bb3-e2b2-46e0-a1fb-635d6aade839": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "71e83f04-ecd5-4d79-8062-42bcb68d6f29": {
        "text_answer": "No  Explanation The statement nearly all patients in both the primary and secondary clinical trials specifically",
        "label": "Contradiction"
    },
    "6943a60c-a7c2-46c5-9238-c88db6a2b725": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "3fbecafb-c5f7-4a19-b265-1840a379f81f": {
        "text_answer": "Yes The primary trial measures pCR and the secondary trial measures pathological complete response after neoadjuvant therapy ",
        "label": "Entailment"
    },
    "7ad6c209-8893-4a2d-963d-24666ef93a80": {
        "text_answer": "Yes The statement is entailed by the evidence as both groups undergo the same imaging procedures with a slight difference in",
        "label": "Entailment"
    },
    "bdc8ed3c-63bd-4f71-bcbd-83d11575603d": {
        "text_answer": "Yes Both trials require a certain performance status for participation",
        "label": "Entailment"
    },
    "574ab11b-3216-4b4b-a4aa-cf035483fe05": {
        "text_answer": "No  Explanation The evidence provided in the primary trial indicates that the median overall survival for patients under",
        "label": "Contradiction"
    },
    "90eff3be-13fe-4f5d-82f1-534ae1fe4a81": {
        "text_answer": "No   Explanation   The statement is not directly related to the evidence provided The evidence",
        "label": "Contradiction"
    },
    "617d4baf-29bc-4a82-a0b0-c8d2c0590599": {
        "text_answer": "Yes The statement candidates Capable of only limited selfcare confined to bed or chair more than",
        "label": "Entailment"
    },
    "7ddde4b4-4070-4aff-b971-53bbd0ec9437": {
        "text_answer": "No   Explanation  The statement prefer to hear as many details as possible is",
        "label": "Contradiction"
    },
    "1bc50379-9721-419f-959a-560b3747b8ec": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial have 00",
        "label": "Entailment"
    },
    "603ee9e3-5213-4121-97d8-4369641e9b00": {
        "text_answer": "No  Explanation The evidence provided in the primary trial relates to the percentage change in serum",
        "label": "Contradiction"
    },
    "e1040054-0fe6-4c92-be82-f2b5b79282a5": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the secondary trial intervention section does",
        "label": "Contradiction"
    },
    "0fd90f9b-bf76-4c3c-9964-dc635138217c": {
        "text_answer": "No  Explanation  The statement General symptoms are the most common AE recorded in the primary",
        "label": "Contradiction"
    },
    "632b415b-ebc1-4898-8676-1ef38eecb128": {
        "text_answer": "No   Explanation The statement is not directly related to the evidence provided in the trial interventions",
        "label": "Contradiction"
    },
    "914bc3a7-1468-46df-8d13-f271220b5c84": {
        "text_answer": "Yes Both trials include candidates with an ECOG performance status of 1",
        "label": "Entailment"
    },
    "c6f2c906-4b0a-4b93-99ee-2152df2af3e4": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence pertains to breast cancer and hormonal therapy",
        "label": "Contradiction"
    },
    "f6a1bd73-7581-4284-b039-705aeb0236bf": {
        "text_answer": "Yes  Explanation  The statement a comparison between adverse events in the primary clinical trial and",
        "label": "Entailment"
    },
    "fcedf2b8-b97d-4a57-8ccc-e77c53900b3c": {
        "text_answer": "Yes  Explanation  The statement the incidence of recurrent malignancies graft",
        "label": "Entailment"
    },
    "e52afcaa-e5d8-4a1f-ae39-8572a64b0aee": {
        "text_answer": "Yes  Explanation The statement The AZD0530 175 mg",
        "label": "Entailment"
    },
    "6fd90164-4ae9-4296-88d8-e6eab3811c8a": {
        "text_answer": "No  Explanation  The statement intermediate lipomatous neoplasm is a lip",
        "label": "Contradiction"
    },
    "84915e35-a8c9-4d26-ad09-4b1df48a6df8": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "cbd414d3-c3c6-4d3a-8a7a-67832757ae03": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as it accurately describes the differences in the",
        "label": "Entailment"
    },
    "78dd81db-dbc1-427a-9a3d-09f3e339ac99": {
        "text_answer": "No  Explanation  The statement concern about finances is a question about whether an individual",
        "label": "Contradiction"
    },
    "8cd9c9e7-ff02-4e49-893d-a4e2837bf18f": {
        "text_answer": "No  The statement does not mention the primary trial or the intervention being given in that trial The statement only mentions",
        "label": "Contradiction"
    },
    "9b9256a3-3f1b-4f43-90da-f8ae79096bd5": {
        "text_answer": "No  The primary trial and secondary trial have different inclusion and exclusion criteria  Some patients may meet the criteria for",
        "label": "Contradiction"
    },
    "26731a57-6d43-4738-817a-74da5c372da2": {
        "text_answer": "yes for breast adenocarcinoma in the primary trial and for breast carcinoma in the secondary trial",
        "label": "Entailment"
    },
    "2fde518b-d7c2-4e66-bab7-0cdff22d5ffe": {
        "text_answer": "No  Explanation The evidence provided in the clinical trial description does not entail the statement that the trial",
        "label": "Contradiction"
    },
    "d19b920a-add8-4be3-8e09-96889800fe00": {
        "text_answer": "Yes  Explanation  The primary clinical trial and the secondary clinical trial share the requirement for the ability",
        "label": "Entailment"
    },
    "37aab021-5b76-4b95-88b6-1050e9252803": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions involve preoperative intravenous administration of de",
        "label": "Entailment"
    },
    "2c0f27c0-642c-4669-8f38-3304bd2fdaf3": {
        "text_answer": "Yes  Explanation The statement hepatotoxicity cases were triple the combined count of hy",
        "label": "Entailment"
    },
    "9727b232-81fc-42cc-bd06-05cc81a7453b": {
        "text_answer": "No  Explanation The primary trial includes a minimum tumour size of 2 cm while the secondary",
        "label": "Contradiction"
    },
    "2f606d1d-7dd5-4d18-8ae6-7899efe85487": {
        "text_answer": " No   Explanation  The statement the secondary clinical trial accepts females who are living with",
        "label": "Contradiction"
    },
    "51811b25-079e-44e0-a38a-b9e0735ded90": {
        "text_answer": "Yes  Explanation The statement repetitive adverse events were reported among different patients particularly in the",
        "label": "Entailment"
    },
    "f2640a7c-0890-40e2-a2dc-1dcdeefcd3bf": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes oral medication administration not injectable",
        "label": "Contradiction"
    },
    "4a9efa5a-6bb1-4b34-a2a7-dfa40fdd29b4": {
        "text_answer": "Yes  Explanation The evidence states that 1 out of 4 participants in the second cohort",
        "label": "Entailment"
    },
    "207602e0-9ba8-437e-a8c2-deb34b3eaef9": {
        "text_answer": "yes The primary trial involves multiple interventions including drugs given via different routes and surgery while the secondary trial involves the use",
        "label": "Entailment"
    },
    "e7451698-de0f-49c5-b287-a419652d62e0": {
        "text_answer": "Yes  Explanation The evidence states that 13 of participants with HER2primary breast",
        "label": "Entailment"
    },
    "ca09a15d-86a6-4a7e-9dfb-ff195702e0d4": {
        "text_answer": "25 the number of participants analyzed in the trial is not the same as 35 the number stated in",
        "label": "Entailment"
    },
    "68461786-a85c-4370-8935-cb6680a3c5cb": {
        "text_answer": "No  Explanation The statement individuals with uncontrolled cardiovascular conditions can join the",
        "label": "Contradiction"
    },
    "e945ad07-11b2-48f7-8022-40f0af7883af": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8f74daa8-19d7-4b51-9296-9b61e885690c": {
        "text_answer": "Yes The primary trial excludes patients with alcohol abuse or dependence within the past 2 years while the secondary trial allows",
        "label": "Entailment"
    },
    "9a6bed06-19da-4284-b5fd-e68ddad563c3": {
        "text_answer": "Yes   Explanation  The evidence describes two interventions each with a specific method of administration",
        "label": "Entailment"
    },
    "39ac8702-7670-4a8e-851a-49e41a77c836": {
        "text_answer": "No  Explanation  The statement diarrhea was uncommon among the primary trial participants",
        "label": "Contradiction"
    },
    "e5b93c15-0c68-4b2f-bceb-a905f7116ef3": {
        "text_answer": "No  The statement is not entailed by the evidence as mirtazapine is not mentioned in the inclusion or",
        "label": "Contradiction"
    },
    "25602467-131a-44d1-a3d9-5a4a61a0ea0a": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria listed in the evidence Patients with a history of abdom",
        "label": "Entailment"
    },
    "c634ebf6-2577-4cc6-9e2d-e14da660629d": {
        "text_answer": "No  Explanation The statement is not directly related to the information provided in the evidence The evidence only",
        "label": "Contradiction"
    },
    "a714b4d6-d9d7-4dc7-8efe-50c92616d027": {
        "text_answer": "Yes  Explanation The evidence states that out of 25 participants treated with Sunitinib ",
        "label": "Entailment"
    },
    "585b42d5-c81a-482a-a6bf-b7db6c6edcfb": {
        "text_answer": "423 The statement is not exactly entailed by the evidence but it is related to the baseline data for",
        "label": "Entailment"
    },
    "0f3d96aa-a8ea-430a-ab6a-fe5e41f8b9fb": {
        "text_answer": "Yes  The statement is entailed by the evidence as both intervention groups received Dexamethasone which is",
        "label": "Entailment"
    },
    "606dc2e9-a1a7-400a-8971-bfb2d3a3f3ab": {
        "text_answer": "No  Explanation  The statement the primary clinical trial has a higher incidence of bronch",
        "label": "Contradiction"
    },
    "a0c1da21-1e1f-493b-81e9-4ef133c20090": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "32e81a4f-0434-46d3-8da4-04037c77a56b": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as it contains incorrect information",
        "label": "Contradiction"
    },
    "d7abbd7d-a767-49c0-bc99-1c28074eac21": {
        "text_answer": "No  Explanation  The statement Cohort 1 of the primary trial did not report",
        "label": "Contradiction"
    },
    "796ae946-899b-475c-ab4c-88ba6af1e881": {
        "text_answer": "Yes  Explanation  The statement there were 0 cases of Hypertension Edema",
        "label": "Entailment"
    },
    "eb9c708d-26e5-40a1-a0d3-6b80f689f540": {
        "text_answer": "No  Explanation  The statement hop62 is an adenocarcinoma",
        "label": "Contradiction"
    },
    "ac12ebab-2165-42ac-bd15-a155dd895e00": {
        "text_answer": "No  Explanation  The statement 07 the primary trial participants and 0",
        "label": "Contradiction"
    },
    "c6b00d4d-2940-484b-b305-baaf3c5ccff4": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial is not",
        "label": "Contradiction"
    },
    "cc97aa0a-365f-459a-a65a-557dd1d930cf": {
        "text_answer": "No  Explanation  The statement unknown use of menopausal hormone therapy is a",
        "label": "Contradiction"
    },
    "e028bf17-f183-4afa-b470-f7741f04e41b": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "604c0ae1-7d51-4238-adb7-1a0b1da1b466": {
        "text_answer": "Yes  Explanation The statement a number of cardiacaffiliated adverse instances were logged",
        "label": "Entailment"
    },
    "3ae463ca-9747-4796-805c-b4b56c0be8e9": {
        "text_answer": "No  The statement have trouble communicating thoughts is not related to the evidence provided The evidence only discusses",
        "label": "Contradiction"
    },
    "3d85fd79-27cc-4e06-b4e0-88348ab9ac0a": {
        "text_answer": "Yes  Explanation  The statement there is no overlap in the inclusion and exclusion criteria for",
        "label": "Entailment"
    },
    "9aed7121-8548-40e9-a960-618bf0173df8": {
        "text_answer": "Yes  Explanation The statement the primary clinical trials intervention section includes comprehensive descriptions regarding method",
        "label": "Entailment"
    },
    "8ecb562c-3169-4c07-bb44-d6e716873c08": {
        "text_answer": "  Yes the statement is entailed by the evidence as benign renal pelvis neoplasms including",
        "label": "Entailment"
    },
    "454e1858-76b2-4952-9ac0-820d81dbf966": {
        "text_answer": "No  Explanation  The statement the primary clinical trial demands that patients take a biweek",
        "label": "Contradiction"
    },
    "58161b30-e890-45e5-822d-3172f884ed40": {
        "text_answer": "Yes  Explanation The evidence mentions the use of CT scans and MRIs in the primary",
        "label": "Entailment"
    },
    "7dd6b446-5585-4660-8bc7-e9811af66268": {
        "text_answer": "Yes The evidence states that smokers are excluded from the secondary trial It does not explicitly state it for the primary",
        "label": "Entailment"
    },
    "630dd8d6-eff4-48f9-ac35-c1731b6c4a79": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "fc38a4bc-7c69-4ae2-9dad-f089f15e4d5e": {
        "text_answer": "Yes  Explanation The statement in the context of the primary clinical trial 003",
        "label": "Entailment"
    },
    "804580d2-f170-45ed-bf39-28dc33921b6d": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the statement reports a",
        "label": "Contradiction"
    },
    "014e2dc7-251b-4615-a8fc-38aed023b053": {
        "text_answer": "Yes The statement There were no deaths or Hospitalizations in cohort 2 of the primary trial is ent",
        "label": "Entailment"
    },
    "3d82f108-1f18-426e-a49f-f7fedcb82a7c": {
        "text_answer": "No  Explanation The statement is not directly related to the evidence provided The evidence discusses the",
        "label": "Contradiction"
    },
    "7f90773c-288c-4b5d-bc82-81d7189e6c5d": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence does not mention the",
        "label": "Contradiction"
    },
    "1f3d7969-35e1-4880-8ae5-b97c53c1e536": {
        "text_answer": "Yes  Explanation The statement several patients in the secondary trial experienced only one adverse event",
        "label": "Entailment"
    },
    "77fd9a89-4d9b-40ab-b4ad-fcf554ca68d2": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0b958f19-d411-426c-8144-162c6c15d9d2": {
        "text_answer": "No   Explanation  The statement the number of patients undergoing adverse events was four",
        "label": "Contradiction"
    },
    "2493d396-14df-4cf7-b2b4-3e84d4363a0f": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "ccce8199-a89f-40b4-9c27-755f2d99c98d": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial a single type of adverse event",
        "label": "Entailment"
    },
    "417ed12e-5ae1-4024-9d97-ef152b78f64c": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "5647bdb4-a763-46c0-a7f4-3d69cbc7aa95": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the participants with breast",
        "label": "Contradiction"
    },
    "0f5d87e7-c78c-4579-a111-3f61640c6206": {
        "text_answer": "No  Explanation  The statement syncope was the most prevalent adverse event in both",
        "label": "Contradiction"
    },
    "dfd39b75-1119-400a-a9af-588d7e63b867": {
        "text_answer": "No   Explanation The evidence provided in the adverse events data for both trials does not indicate that",
        "label": "Contradiction"
    },
    "2fc3e471-39c1-4f8a-804f-6b2ad5f711c9": {
        "text_answer": "No  Explanation The statement in the primary clinical trial GTx024 of",
        "label": "Contradiction"
    },
    "57dec3a3-0bce-48c3-972d-e08f32ea9b15": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial had several recorded deaths in the adverse",
        "label": "Contradiction"
    },
    "b16d4167-cb81-44c0-b20d-d1ecbf0bc094": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial intervention",
        "label": "Contradiction"
    },
    "926177b8-d70d-48d4-95c9-4d74de46d9d0": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial results indicates that out of the total",
        "label": "Entailment"
    },
    "4d8b9c01-83b6-4590-9aaf-9389b998ebff": {
        "text_answer": "Yes  The statement is entailed by the evidence as both the placebo and trabectedin are administered intr",
        "label": "Entailment"
    },
    "4bda5405-4218-460a-a8b4-c958dddedfa1": {
        "text_answer": "Yes  Explanation The statement every participant in the secondary clinical trial experienced at least one adverse event",
        "label": "Entailment"
    },
    "5484288d-bc10-458f-a516-d0019792d765": {
        "text_answer": "No  Explanation The primary clinical trial includes candidates with a Karnofsky score of 70",
        "label": "Contradiction"
    },
    "8aef748c-257f-4a74-a391-3cdbdc839c79": {
        "text_answer": "  No the statement is not directly entailed by the evidence as the evidence does not mention 11p1",
        "label": "Contradiction"
    },
    "a1043895-ce9b-4370-94c8-6ce3078e3bbb": {
        "text_answer": "No  Explanation  The statement all negative occurrences experienced during the primary clinical trial concerned",
        "label": "Contradiction"
    },
    "99b10330-04b5-4aa1-bc04-9378fa54c994": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as it",
        "label": "Contradiction"
    },
    "be07b8e7-1858-4182-b37f-56681f56c273": {
        "text_answer": "Yes The evidence does not mention anything about Ki67 expression in either trial",
        "label": "Entailment"
    },
    "9b75f8dd-3667-47be-a7d3-2cca26ae5fbe": {
        "text_answer": "No   Explanation   The statement Women suffering from both claustroph",
        "label": "Contradiction"
    },
    "f086fa4c-a302-455d-82e7-faf8b78fc2f4": {
        "text_answer": "No  The statement is not entailed by the evidence as the placebo is administered as a 3hour",
        "label": "Contradiction"
    },
    "4805b27b-471f-4571-8de9-a7a77f1bd1a4": {
        "text_answer": "No  Explanation The statement not a single ae was reported for either cohort in the",
        "label": "Contradiction"
    },
    "e7505665-3677-4d18-87ec-8483dc002bd1": {
        "text_answer": "No  Explanation The statement does not directly address the interventions being compared in the primary trial",
        "label": "Contradiction"
    },
    "b21d4a81-e82a-4bd7-ac88-5fcc046aafdf": {
        "text_answer": "Yes  Explanation  The statement there were no reported infections in the primary clinical trial nor",
        "label": "Entailment"
    },
    "8e881af0-4e26-43c9-93e8-5e3397f857e1": {
        "text_answer": "  Yes morbidly obese patients are eligible for the primary trial as per the inclusion criteria stated in the",
        "label": "Entailment"
    },
    "ea1eb143-4c11-4e40-9511-46f4e17b9e1d": {
        "text_answer": "No  Explanation The statement regardless of having cancer or not all participants in the primary",
        "label": "Contradiction"
    },
    "7a699c4d-46d7-48a0-915d-43b8c3a1f1f5": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded 11 more cases of Intest",
        "label": "Contradiction"
    },
    "5e92a3fd-5ffa-49db-9978-897321839068": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts follow the same instructional CD for paced breathing",
        "label": "Entailment"
    },
    "d48955a5-78eb-4a53-9495-1a363c7b8e05": {
        "text_answer": "No  Explanation The evidence provides the median PFS for each treatment group but it does not indicate",
        "label": "Contradiction"
    },
    "3b25e9e8-6fe5-40a3-b302-7a32f651b464": {
        "text_answer": "Yes The evidence includes Karnofsky score as an inclusion criterion with a minimum requirement of 80",
        "label": "Entailment"
    },
    "ccd3d27f-e743-4adf-8135-3488117f1178": {
        "text_answer": "Yes  Explanation  The statement cyclophosphamide paclitaxel and peg",
        "label": "Entailment"
    },
    "cbe2e1d0-bb9b-43a2-b965-732f43d9af05": {
        "text_answer": "Yes The statement is entailed by the evidence as some patients with an ECOG score of 1 are eligible for",
        "label": "Entailment"
    },
    "626fbbe0-8d56-40bf-8809-0e5d1d587a4d": {
        "text_answer": "No  The statement is not entailed by the evidence as the secondary trial includes women as well as men and there",
        "label": "Contradiction"
    },
    "cf935264-ef24-4f3a-b60f-1c4cc9d36a54": {
        "text_answer": "No  Explanation The statement one specific adverse event type affected more than half of the patient",
        "label": "Contradiction"
    },
    "60a1579f-8115-4fec-bdba-fd3031f64e19": {
        "text_answer": "No  Explanation  The statement There are more cases of Biliary colic and Clost",
        "label": "Contradiction"
    },
    "7f22f322-c4fb-4001-875b-fe5baefbdc64": {
        "text_answer": "No  Explanation  The statement There was a total of 3 cases of shingles",
        "label": "Contradiction"
    },
    "d942324e-c945-4703-b88e-905c073cfcd5": {
        "text_answer": "Yes  Explanation  The statement there were zero cases of hypertension edema and",
        "label": "Entailment"
    },
    "0a56f64e-6747-4fc7-a05d-6024e7b52cf6": {
        "text_answer": "No   Explanation   The statement the primary trial and the secondary trial do not use",
        "label": "Contradiction"
    },
    "494a6e1b-2bac-4777-9a12-077106690f16": {
        "text_answer": "Yes  Explanation  The statement there are no records of swelling hypothermia",
        "label": "Entailment"
    },
    "17413685-69fd-453f-af49-29982a6c95b6": {
        "text_answer": "No  Explanation The statement does not specify which vaccine each cohort receives against Pneumoc",
        "label": "Contradiction"
    },
    "327cfcfa-5534-4b9c-ab06-57fe595cb887": {
        "text_answer": "Yes  Explanation The statement there were 11 more adverse events reported in the secondary clinical",
        "label": "Entailment"
    },
    "73ac48a2-08b0-4ee5-8651-f65c88c08101": {
        "text_answer": "Yes The primary trial requires participants to be unresponsive to AI therapy but there is no such requirement in the secondary",
        "label": "Entailment"
    },
    "d42f5cb0-e70b-4c8b-ae2e-297254b1d95a": {
        "text_answer": "Yes Both primary and secondary trials investigate the use of Eribulin Mesylate or Axitinib as a medic",
        "label": "Entailment"
    },
    "bae680f2-9b93-494d-b2e7-65a99400af85": {
        "text_answer": "No  The evidence pertains to breast cancer and does not mention prostate cancer or PSAs",
        "label": "Contradiction"
    },
    "66fb10cd-ce81-4c54-aa97-b7167d3115d8": {
        "text_answer": "No  Explanation The statement the presence of 1 cerebral metastasis located within the",
        "label": "Contradiction"
    },
    "5cf29cab-a9e9-4385-a342-1684d424ecd8": {
        "text_answer": "No  Explanation  The statement group 1 of the primary clinical trial did not have any",
        "label": "Contradiction"
    },
    "eaa12be4-b2f0-493a-9ce4-c70f874db211": {
        "text_answer": "No  The statement is not entailed by the evidence as coronary artery stenosis is not listed as an",
        "label": "Contradiction"
    },
    "d4fb8105-81af-42ca-a829-1b77694ce0f1": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary and",
        "label": "Contradiction"
    },
    "1efbc2a0-c0fc-4849-96d7-689fcfb3c4d1": {
        "text_answer": "No  Explanation The statement does not provide enough information to determine if the dosing unit in the",
        "label": "Contradiction"
    },
    "fca1de92-2c1b-4c41-b49f-e07553b6aa83": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial general symptoms are the most frequently",
        "label": "Contradiction"
    },
    "935d23d4-0d67-4d42-8546-db1bab3f4a3d": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary trial",
        "label": "Contradiction"
    },
    "81e4cf84-ba33-46ce-ba44-e7edae2a2788": {
        "text_answer": "No  Explanation  The statement all individuals in group 1 of the primary clinical trial showed",
        "label": "Contradiction"
    },
    "9a78f293-8ab9-4b2d-9224-3f4ae8fc45d5": {
        "text_answer": "  No   Explanation   The evidence provided describes the inclusion and exclusion criteria for",
        "label": "Contradiction"
    },
    "19ae1506-7a41-406e-8f43-8c32df24392b": {
        "text_answer": "No  Explanation The evidence provided in the trial results only gives the median change in lean body mass",
        "label": "Contradiction"
    },
    "9dc3d717-d3b6-4002-b7f7-26e17d2cabc2": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "87c5a93d-fcef-46ca-8267-3d928c13c6f7": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial reported no",
        "label": "Contradiction"
    },
    "1bd849aa-409c-4214-a930-4d187a645466": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the dosage of C",
        "label": "Contradiction"
    },
    "58f223d4-6f38-4ea3-a6fc-5ed8599df2be": {
        "text_answer": "Yes The evidence shows a median reduction of Ki67 expression from 15 to 10 after ",
        "label": "Entailment"
    },
    "f37f99e0-a9eb-450f-850e-7bd96547bab1": {
        "text_answer": "Yes The statement does not directly mention intellectual wellbeing in the evidence but it does not contradict the statement either",
        "label": "Entailment"
    },
    "aa3c3321-c4f3-43b4-9821-767903e333c6": {
        "text_answer": "Yes for the secondary trial  Explanation The secondary trial excludes patients who have received any experimental agents",
        "label": "Entailment"
    },
    "959883cf-50ff-42e8-8da9-9ad0be3e18b6": {
        "text_answer": "Yes The statement does not directly mention the adverse event but it is not in conflict with the evidence The evidence",
        "label": "Entailment"
    },
    "0e4f4030-9d92-4885-905e-3599e26db71a": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence only ment",
        "label": "Contradiction"
    },
    "0cece9f2-8d43-4d06-97bd-fb800bd3e71a": {
        "text_answer": "  No   The primary trial utilizes the visual analog scale VAS to assess pain intensity",
        "label": "Contradiction"
    },
    "91439ad2-cb81-49e5-a783-ebbc2e04d64a": {
        "text_answer": "No  Explanation  The statement anaemia was encountered as a frequent adverse incident in",
        "label": "Contradiction"
    },
    "bc864ba6-4d2b-431b-9b34-7b668eb5c468": {
        "text_answer": "Yes  Explanation  The evidence shows that the percentage of participants with invasive diseasefree survival",
        "label": "Entailment"
    },
    "fe6baecc-71eb-4b15-ba15-66d57539c702": {
        "text_answer": "Yes  Explanation The statement The same percentage of patients suffered adverse events in both coh",
        "label": "Entailment"
    },
    "ff3d1bb2-393e-4798-a128-090e7308f5b1": {
        "text_answer": "Yes but with a caveat The statement ezh2 gene mutation negative is not explicitly mentioned in the",
        "label": "Entailment"
    },
    "34250dad-ad53-42bb-a8d3-80866141d548": {
        "text_answer": "No  Explanation The statement worse than expected is a subjective response indicating something was worse",
        "label": "Contradiction"
    },
    "d98e6c4a-c899-405d-b26e-e3a2e0cb3494": {
        "text_answer": "  No  Explanation  The statement Sexually active men and women who are not",
        "label": "Contradiction"
    },
    "b44a3eb6-01b7-488d-b18a-b3077937cc97": {
        "text_answer": "Yes  Explanation  The statement the recorded adverse events in the primary trial allow for a",
        "label": "Entailment"
    },
    "a1ae68b1-c14f-44b5-bc43-8966858fbf14": {
        "text_answer": "No  Explanation  The statement provided is not directly entailed by the evidence The evidence only",
        "label": "Contradiction"
    },
    "6261a694-0407-4840-8a87-3a0c6f9dea4f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly comb",
        "label": "Contradiction"
    },
    "98e66236-2140-45a7-8bea-e2d17f373def": {
        "text_answer": "No   Explanation  The statement is not directly related to the adverse events listed in the",
        "label": "Contradiction"
    },
    "07e27cba-9e03-4644-a6f3-d05b61b5e4e2": {
        "text_answer": "No  Explanation The statement less than 10 patients in the primary trial suffered Aes",
        "label": "Contradiction"
    },
    "117067e9-9bde-4d49-a4d2-51e9ac9886f6": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement incorrectly combines",
        "label": "Contradiction"
    },
    "8320c826-7a88-43e8-ae24-069d0f6ff886": {
        "text_answer": "Yes  Explanation The statement compared to the secondary clinical trial the primary clinical trial shows",
        "label": "Entailment"
    },
    "354bc4da-42d7-452f-82bb-43e270a24c2f": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any information about mental health ad",
        "label": "Contradiction"
    },
    "c472d895-f7f4-474f-8664-b7af887b1339": {
        "text_answer": "Yes  Explanation  The statement cohort b reported significantly lower adverse events compared to",
        "label": "Entailment"
    },
    "a7960e8d-c8a2-4d32-93ff-bb5902051344": {
        "text_answer": "No  The statement about being stopped in a car for a few minutes in traffic is not related to the inclusion or excl",
        "label": "Contradiction"
    },
    "b67a2d20-b35d-45b7-a594-8946f1f160ab": {
        "text_answer": "Yes The evidence mentions radiotherapy as part of Intervention 1",
        "label": "Entailment"
    },
    "7f7c84c5-cc6b-4d4f-a47c-4d41454fd6d0": {
        "text_answer": "Yes  Explanation The primary clinical trial states that zoledronic acid is given intravenously",
        "label": "Entailment"
    },
    "4e9a0d19-c8b1-4ea4-9c73-2cf93b46f6a4": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants with",
        "label": "Contradiction"
    },
    "44241e4d-31dc-487e-b42c-e8c47e3e82cf": {
        "text_answer": "No  Explanation The statement primary trial candidates receive weekly subcutaneous sc infusions",
        "label": "Contradiction"
    },
    "a7ff54ef-32cc-4cda-b4a2-39d5f6e1559c": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "73052d5e-1a3a-4479-9ada-e69963c84b77": {
        "text_answer": "Yes The evidence states that there were two participants in cohort 2 who experienced doselimiting toxicities",
        "label": "Entailment"
    },
    "f2796825-a4d9-4484-8958-851d99294e3c": {
        "text_answer": "No   Explanation The primary clinical trial uses units on a scale for hot flash activity and the",
        "label": "Contradiction"
    },
    "a5c24bc4-6444-46bb-9da4-fca0d9d6f521": {
        "text_answer": "No  Explanation  The primary clinical trial reports the determination of the Ruxolitinib",
        "label": "Contradiction"
    },
    "aed670bb-54a4-4769-86de-65f566bafebe": {
        "text_answer": "  Yes The evidence does not mention the use of imaging techniques in the interventions for either trial",
        "label": "Entailment"
    },
    "2aef976d-1cb6-4d70-bda2-30a453c37f88": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial demonstrated superior",
        "label": "Contradiction"
    },
    "4d18c0c9-1317-4c04-9b86-f6e7e8906f5e": {
        "text_answer": "No   Explanation   The evidence provided in the primary and secondary trials does not include any",
        "label": "Contradiction"
    },
    "72921dd1-88c7-4aff-a98e-8af859e4f04f": {
        "text_answer": "Yes The evidence indicates that both intervention groups received preoperative Dexamethasone administration The statement does",
        "label": "Entailment"
    },
    "78479579-0089-4132-8de1-f710cb80ac05": {
        "text_answer": "Yes The evidence does not explicitly state that Japanese nationals are the only eligible participants but it does not exclude them either",
        "label": "Entailment"
    },
    "ce1887bc-e9b2-4c21-a5b8-dcbe59d3503e": {
        "text_answer": "  Yes   Explanation   The primary clinical trial measures changes in pain levels using the",
        "label": "Entailment"
    },
    "ad477da6-f950-49b8-a882-0c1dfbc4751f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "547b8239-a47c-4f70-aa08-ff1d92e19af2": {
        "text_answer": "  Yes for the primary trial and No for the secondary trial",
        "label": "Entailment"
    },
    "4ec4fce7-e43e-46c8-ab5a-f5f04df1b940": {
        "text_answer": "yes for the primary trial regarding Arm A and overall response rate but not directly for the secondary trial regarding Denos",
        "label": "Entailment"
    },
    "787e3275-7973-46d4-83de-00d9ebaf7acb": {
        "text_answer": "No  Explanation  The statement do volunteer work is not mentioned in the evidence The",
        "label": "Contradiction"
    },
    "f95439cc-7c35-43a8-ade1-6652fbdf7873": {
        "text_answer": "No  Explanation The statement multiple psychiatric adverse events were noticed in the primary clinical trial",
        "label": "Contradiction"
    },
    "a56a38a8-7782-4909-b417-ebb142f38028": {
        "text_answer": "Yes  Explanation The statement during the primary clinical trial numerous subjects contracted urinary tract",
        "label": "Entailment"
    },
    "2810ed9e-6f0a-4c59-be1a-31e5003fa51d": {
        "text_answer": "yes The evidence mentions several injections including dendritic cell injections in the form of a powder that",
        "label": "Entailment"
    },
    "39346303-4095-4b67-b384-6916ed20fd4c": {
        "text_answer": "Yes  Explanation  The statement the adverse events in both the primary and secondary trial can",
        "label": "Entailment"
    },
    "f1963f67-9164-4e55-bf5e-3ac44e9bae5f": {
        "text_answer": "Yes  Explanation  The primary clinical trial reports the mean tumor diameter in cm for",
        "label": "Entailment"
    },
    "f1315324-edf3-4d7c-a999-c3a668e67930": {
        "text_answer": "No   Explanation  The statement does not mention anything about a marinebased natural product being",
        "label": "Contradiction"
    },
    "f6b492a8-d17f-407f-9345-ed6b7f447eea": {
        "text_answer": "Yes The evidence describes the interventions for two clinical trials one involving Abl Cells and Cyclophosphamide",
        "label": "Entailment"
    },
    "81079f33-7706-4672-a08f-c285df38f870": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the dosage of cetux",
        "label": "Contradiction"
    },
    "49e49c15-d880-4fa1-9582-ba86488ad192": {
        "text_answer": "No  Explanation  The statement 25 of cohort 2 patients in the",
        "label": "Contradiction"
    },
    "7f11c755-66ed-4a7e-a222-0f967b650634": {
        "text_answer": "Yes The statement is entailed by the evidence as every participant in cohort 2 took capecitabine",
        "label": "Entailment"
    },
    "8ef6757e-e789-4a70-9cf3-e2e8050c9f15": {
        "text_answer": "Yes  Explanation  The primary trial and the secondary trial evaluate different patient populations and treatment modalities",
        "label": "Entailment"
    },
    "14045448-a003-4d3d-ace1-bcdf3a7479c2": {
        "text_answer": "Yes  Explanation  The statement the primary trial recorded fewer adverse events than did the secondary",
        "label": "Entailment"
    },
    "ad37e364-d3a8-4fcd-9033-90e7ec7d7fc7": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not mention anything about the severity of",
        "label": "Contradiction"
    },
    "4b5b9e75-1690-4544-86de-d4c0ac02cf57": {
        "text_answer": "No   Explanation   The evidence provided in the trial results does not include information about Rec",
        "label": "Contradiction"
    },
    "fef14a32-224c-4a00-88cb-30bb448a504e": {
        "text_answer": "Yes  Explanation The statement in both the primary and secondary clinical trial at least one infection case",
        "label": "Entailment"
    },
    "4b7eaa17-f5eb-4afe-88b7-98c293ad0100": {
        "text_answer": "No   Explanation The evidence shows that there were a total of 3 vomiting incidents out of",
        "label": "Contradiction"
    },
    "5a54ce72-5d02-48fb-9cc0-2a31123f3583": {
        "text_answer": "No  Explanation  The statement none of the participants of cohort 1 of the",
        "label": "Contradiction"
    },
    "4a6db09e-5bc7-4c5c-8cf8-a89750cd1cc1": {
        "text_answer": "No  Explanation  The evidence provided in the clinical trial outcome measurement only reports the number of participants",
        "label": "Contradiction"
    },
    "e9003121-5fb9-4d34-95b4-011c76402472": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a change",
        "label": "Contradiction"
    },
    "1abf0ac3-be79-4fd6-aa9f-5ae756346da4": {
        "text_answer": "Yes The evidence does not report any unexpected deaths or hospitalizations in either trial",
        "label": "Entailment"
    },
    "50e4558f-a9a2-425b-911f-5bea986e90b4": {
        "text_answer": "No  Explanation  The statement diffuse midline glioma egfrmutant",
        "label": "Contradiction"
    },
    "5abe01fb-1ee1-4905-874e-a0cbec0ee9c9": {
        "text_answer": "  Yes The primary trial excludes patients with malignant ductal carcinoma in situ while the",
        "label": "Entailment"
    },
    "aa3f26b2-4c1c-45e6-b480-962b43324a8a": {
        "text_answer": "No  Explanation  The statement central nervous system angiolipoma is an ang",
        "label": "Contradiction"
    },
    "71fe40dd-6700-4f46-b635-de6407eb1567": {
        "text_answer": "Yes  Explanation  The statement there are 0 shared inclusionexclusion criteria between",
        "label": "Entailment"
    },
    "4ddfaca9-bd5c-427a-a624-8a9d2c763c61": {
        "text_answer": "Yes The statement correctly identifies that the only difference between the two interventions is the dose of durvalumab given",
        "label": "Entailment"
    },
    "13742fb9-874a-4f76-9d17-585c96fbd440": {
        "text_answer": "No  Explanation  The statement the count of adverse effects in the patient cohorts",
        "label": "Contradiction"
    },
    "ce3d0415-1f95-4e20-bea5-5adc05962c9d": {
        "text_answer": "No  Explanation The statement following a month of tak228 plus tamoxif",
        "label": "Contradiction"
    },
    "881871fa-1546-46da-acab-c8b67ef7e5c1": {
        "text_answer": "No  Explanation  The statement patients with a low potassium count are inel",
        "label": "Contradiction"
    },
    "280be8e4-7c13-4ca6-9653-94c7cf061c39": {
        "text_answer": "No  The primary trial has cardiovascular impairment as an exclusion criterion while the secondary trial",
        "label": "Contradiction"
    },
    "2e8f3602-15d2-4970-ad77-07352b50b787": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5c226c5b-0a0a-44f7-a581-b2b8746f28a5": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement ment",
        "label": "Contradiction"
    },
    "644d3ae7-8d7c-40bd-8744-32f0d3311936": {
        "text_answer": "No  Explanation  The statement her2  patients in cohort 2 of the",
        "label": "Contradiction"
    },
    "37f9db0b-4ea9-4952-bf6f-a748ac802a15": {
        "text_answer": "No   Explanation  The evidence provided in the trial results does not indicate that any patient in",
        "label": "Contradiction"
    },
    "348f2b7d-e9b5-41ad-927b-e368bcaca8f5": {
        "text_answer": "No  Explanation  The statement Patients with histologically documented metastatic or unresect",
        "label": "Contradiction"
    },
    "d57cb18c-7375-4a66-81c4-7349cadd8d92": {
        "text_answer": "No  Explanation The statement the individual from cohort 1 recorded the longest progression",
        "label": "Contradiction"
    },
    "93fc8df8-d85f-4f71-9d03-7b7e0e5146ff": {
        "text_answer": "No  Explanation The statement quarter of the participants in the primary clinical trial and 4",
        "label": "Contradiction"
    },
    "dcb23ac7-9632-47fd-87bd-b15b25e4a3d3": {
        "text_answer": "Yes  Paclitaxel is not mentioned in the interventions described in the evidence",
        "label": "Entailment"
    },
    "eac5a5f1-7e63-4351-b7de-eacf6592a5fb": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence provides the",
        "label": "Contradiction"
    },
    "23cc69a0-6ac6-4373-9e9e-97c3e613d5eb": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence because the evidence does",
        "label": "Contradiction"
    },
    "cf33b6d5-f59c-4b24-be84-4aeba15f6c5e": {
        "text_answer": "Yes  Explanation The statement having the ability to offer written informed consent is the only mutual inclusion",
        "label": "Entailment"
    },
    "7552c836-8753-455e-923f-8364d6c63b03": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c3464aef-3ed6-47ad-8196-99f8115916e4": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial use different units of measurement for",
        "label": "Contradiction"
    },
    "fb73159b-0d37-4ea1-aaba-4f540ec395b9": {
        "text_answer": "  No The evidence provided does not mention anything about women aged 16 or 17 being eligible for either",
        "label": "Contradiction"
    },
    "3fda5084-ab27-4f5c-8acb-0be7e7ac93c1": {
        "text_answer": "No   Explanation The statement there were zero reports of AEs among participants in the primary clinical",
        "label": "Contradiction"
    },
    "1655bb9f-adca-4796-9883-a620e978f745": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial witnessed a",
        "label": "Contradiction"
    },
    "55b2acbc-30a6-43ef-bca6-0e7a5b3f6a8f": {
        "text_answer": "Yes  Explanation The evidence describes two interventions with different administration techniques intravenous bisph",
        "label": "Entailment"
    },
    "2037fc58-ce2f-4f44-8ebc-dc9f9d7129cd": {
        "text_answer": "13 refers to the percentage of participants with HER2 primary breast cancer not PR Therefore the",
        "label": "Entailment"
    },
    "ecd4681c-624a-44da-b9e7-4d993b35d2af": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials involve the use of 4Demethyl4",
        "label": "Entailment"
    },
    "3239643a-3052-4344-a7ea-f2d5dff19755": {
        "text_answer": "No   Explanation   The statement children are the main demographic required for participating in",
        "label": "Contradiction"
    },
    "b7c9455e-db3b-438d-bcb0-04bf52fb530d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no information",
        "label": "Contradiction"
    },
    "3ca94519-994e-4921-95ef-fdd1daf0932c": {
        "text_answer": "Yes The woman who has undergone breast conservation therapy would be excluded from both trials The primary trial excludes",
        "label": "Entailment"
    },
    "efbc4408-7a74-4857-8265-d1bf4eab4080": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "4e9c14cb-9c55-4c1a-ae14-f5a6f08e1494": {
        "text_answer": "No  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Contradiction"
    },
    "9bf4a35a-531f-4083-87ac-dec730cfea45": {
        "text_answer": "No  Explanation  The statement the primary trial recorded 11 more instances of intest",
        "label": "Contradiction"
    },
    "49d2b5e7-595e-4762-b7af-9e914bf72917": {
        "text_answer": "Yes  Explanation The statement all patients in the primary clinical trial receive less than 20",
        "label": "Entailment"
    },
    "d8735c6c-1fc9-4fbc-93d2-651a5814d505": {
        "text_answer": "No  Explanation  The statement cardiovascular system findings derived flag is an indication or description",
        "label": "Contradiction"
    },
    "f7d7cc99-97cb-48f0-bc69-78a60d9d21be": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants or 8",
        "label": "Entailment"
    },
    "268ad1eb-851a-484a-873f-b54ab271b063": {
        "text_answer": "No  The statement is not related to the evidence provided The evidence only discusses adverse events from a clinical trial",
        "label": "Contradiction"
    },
    "428340b6-e87b-4e03-920b-f2e3f62f05d6": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it only mentions",
        "label": "Contradiction"
    },
    "aa5dd0d4-1551-4ccc-85a8-ca6c2bcfb871": {
        "text_answer": " Yes  Explanation The statement in the primary trial results there were more patients with stable disease",
        "label": "Entailment"
    },
    "ba355915-f5a7-4b38-bbca-95fe674d63f5": {
        "text_answer": "Yes  Explanation The statement Only three different types of adverse events affected patients in the primary",
        "label": "Entailment"
    },
    "1c31539a-7fd9-4e81-ae88-c0e05a34946a": {
        "text_answer": "No  Explanation The statement does not follow directly from the evidence as the evidence describes different interventions",
        "label": "Contradiction"
    },
    "c367ab4c-6113-4f79-abcc-24e715c18094": {
        "text_answer": "No   Explanation   The statement does not mention any adverse event related to brady",
        "label": "Contradiction"
    },
    "6815208b-ad2d-4564-b723-2d8e44af78b0": {
        "text_answer": "Yes The evidence states that smokers are excluded from the secondary clinical trial Therefore if someone is an active sm",
        "label": "Entailment"
    },
    "14e8dba6-bd13-4f5b-a225-6cd55c3d1243": {
        "text_answer": "yes but with a clarification The statement is entailed by the primary trial evidence regarding alpha lipoic acid",
        "label": "Entailment"
    },
    "12a7a47e-adb9-4c24-8410-03aea3d7d292": {
        "text_answer": "  No The statement is not entailed by the evidence The primary trial includes mammography as a requirement but",
        "label": "Contradiction"
    },
    "3570b51a-d280-41b5-9c59-849436db5934": {
        "text_answer": "Yes The statement is entailed by the evidence as metastatic small cell lung cancer is not included in the list of",
        "label": "Entailment"
    },
    "9e14f099-36f3-4672-b35c-022cc3279c98": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "afc3c380-94da-4686-a5ca-1967217d14d1": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a3a672e2-2900-45dd-ae02-797449f17b66": {
        "text_answer": "No  The primary trial excludes patients with alcohol or substance abuse or dependence within the past 2 years while the",
        "label": "Contradiction"
    },
    "db26f45b-4e0a-4f21-83da-6f22116f7ac5": {
        "text_answer": "yes anemia and pneumonia  Explanation  The statement the incidence of",
        "label": "Entailment"
    },
    "c4aea42a-a9e3-47ba-9a96-12350a3925c9": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "576967ff-d2bb-4d1c-b2a1-8516ceb7a519": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement incorrectly",
        "label": "Contradiction"
    },
    "c3e36213-9a24-4f92-9ff3-12e071aac541": {
        "text_answer": "Yes  Explanation Both the primary and secondary clinical trials involve the use of cyclophospham",
        "label": "Entailment"
    },
    "91db7925-da19-4373-bfba-78ee49b34f99": {
        "text_answer": "No  Explanation  The statement the primary trial uses a 504 hour cycle for",
        "label": "Contradiction"
    },
    "fc6ab4bb-43af-4008-a2dc-0e23dbf9abc0": {
        "text_answer": "Yes However the primary trial excludes patients who have undergone autologous tissue breast reconstruction and intend to under",
        "label": "Entailment"
    },
    "00d9d3c3-938f-4e4c-b532-b11146f1239c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5102bc84-4e28-4ec9-91cf-b5ed615b15bb": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the placebo is",
        "label": "Contradiction"
    },
    "914d236c-c227-4d8d-8565-04a1d25e3b59": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a change",
        "label": "Contradiction"
    },
    "af1a2e8d-2b8e-4690-b32c-9d044d9aa15f": {
        "text_answer": "No   Explanation  The statement is not directly related to the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "f718d65d-3ea1-41b7-adc0-5f481843011c": {
        "text_answer": "Yes The primary trial uses a higher dose of lenalidomide 5mg orally daily compared to the",
        "label": "Entailment"
    },
    "8f537eb8-d8b7-4c56-89bf-ea2e5b0d1326": {
        "text_answer": "No  Explanation  The statement the primary trial uses a 3 week cycle for its intervention",
        "label": "Contradiction"
    },
    "1ea69c5b-83c6-4d54-b17c-0e6df9c49abb": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the prevailing adverse events",
        "label": "Contradiction"
    },
    "763b8082-f1d6-4dfb-ab46-b61d8dae6515": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity weight or gender as eligibility criteria for either trial",
        "label": "Entailment"
    },
    "485e3ce9-e779-4ae5-bdc4-7fbcb1d1eb3c": {
        "text_answer": "No  The statement does not mention any adverse event noted in the clinical trial It only states that the sole ad",
        "label": "Contradiction"
    },
    "88a40578-17e1-499b-8b7b-10a85e2c3d88": {
        "text_answer": "No  Explanation  The statement vital signs sequence number is an identifier that describes the relative",
        "label": "Contradiction"
    },
    "b7178d54-4bb2-4820-b13c-c342075267ff": {
        "text_answer": "No  Explanation  The statement despite the lack of any cardiac or psychiatric a",
        "label": "Contradiction"
    },
    "48788622-6b62-4a88-8d7c-29be1fbd88e8": {
        "text_answer": "No  The evidence does not mention coronary artery stenosis as an adverse event",
        "label": "Contradiction"
    },
    "f05dd895-7d03-45d2-ab9c-69db39c386e5": {
        "text_answer": "No  Explanation  The statement inclusion in the primary clinical trial is restricted to those who",
        "label": "Contradiction"
    },
    "06a1adac-dee0-4d9b-83c6-0996391e40d0": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "993572ab-2275-4def-9723-202249284283": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the most recurring",
        "label": "Contradiction"
    },
    "2312576f-7c8d-4fcd-80e8-42cf3d81dd04": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement compares the dos",
        "label": "Contradiction"
    },
    "61fbddc4-94cb-4105-8090-03dd97a3bc53": {
        "text_answer": "Yes The primary trial includes both male and female patients but the secondary trial only includes female patients",
        "label": "Entailment"
    },
    "9b2023d2-09bd-4362-ae66-afc69497e468": {
        "text_answer": "No   Explanation  The statement is not directly related to the evidence provided The evidence describes",
        "label": "Contradiction"
    },
    "886a066c-520e-4454-bf20-43ad24b6baf9": {
        "text_answer": "Yes  Explanation  The statement Far more patients in the secondary trial were recorded to have",
        "label": "Entailment"
    },
    "e87fee13-1ed3-4eca-8d72-d65fee50abf7": {
        "text_answer": "No  Explanation  The statement a higher number of mucositis oral cases ep",
        "label": "Contradiction"
    },
    "f08d84f8-0448-462c-8f81-770223b92bb8": {
        "text_answer": "yes for the operative time comparison in the primary trial but no for the secondary trial with its different outcome measurement",
        "label": "Entailment"
    },
    "205d3c95-7288-4d9f-9a5c-edc7b09de79d": {
        "text_answer": "No  The inclusion and exclusion criteria for the primary and secondary trials are not identical and there are differences in the",
        "label": "Contradiction"
    },
    "62de4057-c709-4110-9986-642428c1d534": {
        "text_answer": "Yes  Explanation The evidence states that both the placebo and trabectedin are administered",
        "label": "Entailment"
    },
    "b9e51528-b593-40f7-8f49-acfacc756a7f": {
        "text_answer": "Yes for the secondary trial  Explanation  The statement in the primary clinical trial and the",
        "label": "Entailment"
    },
    "05c44353-ab0d-4b2d-98ff-e39aab551229": {
        "text_answer": "No  Explanation The statement in the question does not accurately reflect the information provided in the evidence",
        "label": "Contradiction"
    },
    "c96d223f-7d7e-47aa-b71e-0b56ab6eef81": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the evidence does not mention anything",
        "label": "Contradiction"
    },
    "280cae18-764b-4cc7-ae2a-3b1f05c04cbf": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes the",
        "label": "Contradiction"
    },
    "a9c7619e-8cc5-4c84-b4a4-38ada95388a2": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided as it does not",
        "label": "Contradiction"
    },
    "059a48d5-3bf5-40ac-b06c-3107c0ea7cb9": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence as it makes",
        "label": "Contradiction"
    },
    "3ace09f3-a822-4140-a529-52b08664da77": {
        "text_answer": "No  Explanation  The statement Most patients in cohort 1 of the primary trial",
        "label": "Contradiction"
    },
    "291150cd-0d45-46c7-9a44-d781098bc3eb": {
        "text_answer": "  No the statement is not entailed by the evidence for the secondary trial as it only includes patients with triple",
        "label": "Contradiction"
    },
    "c49dbdfa-801a-4789-9e04-345ed14150ab": {
        "text_answer": "No  Explanation  The statement hemodialysis catheter infection is a local or",
        "label": "Contradiction"
    },
    "4028bb9b-1122-4c10-ab5c-a38205fe6dd2": {
        "text_answer": "No  Explanation  The statement the same proportion of patients experienced negative effects in both groups of",
        "label": "Contradiction"
    },
    "6b568a13-5216-4b83-848a-c64e8a9c340b": {
        "text_answer": "Yes The primary clinical trial does not provide any results for the cohort receiving LBH589 and Lap",
        "label": "Entailment"
    },
    "3852b7ff-e68a-4bc8-917f-4eb9c838862d": {
        "text_answer": "Yes The primary trial does not exclude recipients of organ transplants within the past 6 months if they are amb",
        "label": "Entailment"
    },
    "2a509e67-c521-4406-8122-c91d7a1331ad": {
        "text_answer": "No  Explanation  The statement about skin appendage neoplasms is not directly related to",
        "label": "Contradiction"
    },
    "c5d6c5da-f71c-4454-a333-3ade43aef122": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with small cell lung cancer are explicitly excluded from the trial However",
        "label": "Entailment"
    },
    "fd334e71-2bbe-4138-b578-2ab848686045": {
        "text_answer": "Yes The primary trial does not include CBT Cognitive Behavioral Therapy as a treatment option",
        "label": "Entailment"
    },
    "b3b66b49-6a4c-4c26-b46c-915ab45374ff": {
        "text_answer": "No  The evidence provided does not mention radiation therapy at all",
        "label": "Contradiction"
    },
    "8004fee7-e287-4a54-b66f-44002ebb1b34": {
        "text_answer": "No  The statement is not entailed by the evidence as the trial specifically excludes patients with a history of another m",
        "label": "Contradiction"
    },
    "777fb2a8-9329-4e49-a67b-93d1d7fe2319": {
        "text_answer": "Yes The statement is entailed by the evidence as there is a reported case of wound dehiscence in the ad",
        "label": "Entailment"
    },
    "386515be-dd8a-423d-933b-6c7f99461ebd": {
        "text_answer": "Yes The evidence indicates that patients with stage 4 breast adenocarcinoma that is ER positive PR positive",
        "label": "Entailment"
    },
    "3a36e314-e4f4-4a60-acc9-b9f9933e884c": {
        "text_answer": "No  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Contradiction"
    },
    "c6b37d94-f63f-4cf7-b86c-a8147ff618d9": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement is about tam",
        "label": "Contradiction"
    },
    "ae0dd0fb-c8c9-47bd-ab6b-8236edd68194": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "be268f6b-8123-4cd7-a495-c82453034b67": {
        "text_answer": "No  Explanation  The statement patients suffering from lobular carcinoma in situ and",
        "label": "Contradiction"
    },
    "62581915-0fde-4cfb-8205-7c1b8c8bacbb": {
        "text_answer": "Yes The primary trial uses a higher dose of lenalidomide 5mg daily compared to the dose of",
        "label": "Entailment"
    },
    "36426525-f3e0-426e-aae4-2fc677756ca9": {
        "text_answer": "Yes The statement that 0 adverse events were observed in the primary trial and none of the adverse events in",
        "label": "Entailment"
    },
    "58b45da6-c265-4cef-a6cc-83113439c79e": {
        "text_answer": "No  Explanation  The statement the levels of palpitations pericardial eff",
        "label": "Contradiction"
    },
    "a743b2fa-dd26-4c5f-931d-f5cc8bcf52c2": {
        "text_answer": "No  The evidence does not provide information about epileptic seizures in either trial",
        "label": "Contradiction"
    },
    "0bb7dafe-391e-4adb-a9fe-ac3717421ae8": {
        "text_answer": "  No   Explanation   The statement a woman postmastectomy",
        "label": "Contradiction"
    },
    "20c98ba5-ca61-4afe-af57-6de08705a5cd": {
        "text_answer": "Yes  Explanation  The statement the secondary trial and the primary trial use different outcome measurements and",
        "label": "Entailment"
    },
    "6adaaefe-d699-4bce-87dc-8233140a14fa": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial does not involve muscle gains and the secondary trial",
        "label": "Contradiction"
    },
    "d7aa81f2-8df0-4884-9d6a-e6d21ec79b03": {
        "text_answer": "No  Explanation  The statement patients who have received chemotherapy or radiotherapy in the",
        "label": "Contradiction"
    },
    "869078fe-375b-45b5-ba65-21d04cd304ed": {
        "text_answer": "Yes  Explanation  The statement bone marrow sample is a biological sample containing components collected from",
        "label": "Entailment"
    },
    "5417955e-52aa-4b3b-8e67-2a4c4796846a": {
        "text_answer": "Yes In the primary trial epacadostat is given twice daily BID while in the secondary trial",
        "label": "Entailment"
    },
    "5d6bf9b2-6737-4266-9566-436393cdcfab": {
        "text_answer": "Yes  Explanation The evidence provided in the primary clinical trial results shows that the mean number of daily",
        "label": "Entailment"
    },
    "28375759-dcd0-430d-8035-9571e1bbc07e": {
        "text_answer": "Yes The primary trial uses a lower dose of lenalidomide 5mg daily compared to the secondary trial",
        "label": "Entailment"
    },
    "ae5d8804-eada-4f5c-8889-18a7cc90bb9b": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures tumor diameter in centimeters cm",
        "label": "Entailment"
    },
    "ee16dd43-346c-47c2-b5c1-b3722935918d": {
        "text_answer": "Yes The primary clinical trial does not have age or height as exclusion criteria while the secondary clinical trial excludes participants",
        "label": "Entailment"
    },
    "a154d6bd-fc5d-491f-b2aa-7785024e67a5": {
        "text_answer": "No  Explanation  The primary trial reports the percentage of participants while the secondary trial reports the",
        "label": "Contradiction"
    },
    "00ac087f-fc20-4ff1-be51-f32fa22f4e4e": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the frequency of epacad",
        "label": "Contradiction"
    },
    "61a6a476-9283-4cde-89e7-5f1405f690c1": {
        "text_answer": "No  Explanation The statement Patients participating in the primary trial receive 100 mg",
        "label": "Contradiction"
    },
    "2ea93619-d183-4989-b811-c4666059d456": {
        "text_answer": "Yes   Explanation  In the primary clinical trial patients received a loading dose of 4",
        "label": "Entailment"
    },
    "93eef0e8-7a40-452a-a61e-a9d671dcacbd": {
        "text_answer": "Yes  Explanation The evidence shows that there were no instances of Intestinal obstructions or Pancy",
        "label": "Entailment"
    },
    "97a2b670-3f9b-49e5-abde-d0b477046164": {
        "text_answer": "Yes The evidence does not report any discernible pattern of gene expression for the 40 tested genes among patients in",
        "label": "Entailment"
    },
    "a90d6d85-6942-4653-b23c-126d63b1d2cf": {
        "text_answer": "Yes The primary trial includes patients with stage IIbIIIIV breast cancer while the secondary trial excludes patients",
        "label": "Entailment"
    },
    "75625dfd-7f82-4a99-b97d-50f05751dfdb": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials exclude patients with severe insomnia However it",
        "label": "Entailment"
    },
    "195efca0-b2e3-43c0-abf2-4c6d77d8a449": {
        "text_answer": "No  The statement is not entailed by the evidence as sunitinib was actually administered orally in",
        "label": "Contradiction"
    },
    "56d753e1-4bce-4c3d-a8fb-8abc6119c1a7": {
        "text_answer": "Yes  Explanation The statement fewer than 5 of the patients involved in the primary",
        "label": "Entailment"
    },
    "d260a3cd-28cd-4df8-aa19-1586a1f7b978": {
        "text_answer": "Yes  Explanation The statement both cohorts in the primary clinical trial receive cudc",
        "label": "Entailment"
    },
    "20a9c28d-88d5-4cd8-b346-19a1123ede25": {
        "text_answer": "No  Explanation  The statement all the patients in the primary clinical trial see no symptoms of",
        "label": "Contradiction"
    },
    "fdeba169-13d2-4ed9-a2b2-774194f18370": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not allow individuals with meningeal carcin",
        "label": "Contradiction"
    },
    "fe7217cf-7210-433b-b3ec-5dfff00aa3c4": {
        "text_answer": "No  Explanation  The statement the secondary clinical trials most frequent adverse event witnessed",
        "label": "Contradiction"
    },
    "b70ec50e-cbcd-4edd-a730-267c5b0f3fec": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3b41b926-449f-41e1-beed-6dd4be9e57f1": {
        "text_answer": "Yes The statement is entailed by the evidence as the participants in the primary trial receive four different drugs epirub",
        "label": "Entailment"
    },
    "6f5741c8-88c1-46ef-856c-dae9a3fe5fd6": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants or 8",
        "label": "Entailment"
    },
    "83b92dd1-c68e-443b-b864-3ea87b3b557e": {
        "text_answer": "No  The evidence does not provide any information about the control or progression of the disease for the individuals involved in the",
        "label": "Contradiction"
    },
    "53d37329-6f3e-40fe-82d3-4a2535b117d9": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "28c1cdeb-4f60-4fd7-b2b1-5368a91f9b85": {
        "text_answer": "No  The statement CBT based treatments are prohibited for the primary trial candidates however they may still be eligible",
        "label": "Contradiction"
    },
    "75080502-7163-4189-9194-c96041df76e5": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial has no age restriction is not ent",
        "label": "Contradiction"
    },
    "4c30a588-032f-4b8c-b00a-ee27f8f64b50": {
        "text_answer": "No  The evidence does not mention anything about vaccine administration in the primary clinical trial",
        "label": "Contradiction"
    },
    "37b1b3cc-069a-4597-9375-4e856eeb6f9d": {
        "text_answer": "No  Explanation  The statement in the secondary trial it is acceptable for patients to have",
        "label": "Contradiction"
    },
    "8bcb86b4-494e-4e43-bf93-ef5b1ef6c566": {
        "text_answer": "No  Explanation  The statement ai therapy responsiveness is required for participants to be enrolled",
        "label": "Contradiction"
    },
    "ab098908-d287-4ffa-883c-202a87f5ba63": {
        "text_answer": "No  Explanation The evidence states that patients receive oral lapatinib and tamoxifen once",
        "label": "Contradiction"
    },
    "b96ecdf0-3627-48c9-b01d-4cfdbe13a7cb": {
        "text_answer": "No  Explanation  The statement The LBH589 With Capecitab",
        "label": "Contradiction"
    },
    "f07f2805-df6a-4662-8a1f-757eabf8687a": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it makes a comparison between",
        "label": "Contradiction"
    },
    "a5b66f28-1afc-4cf7-b686-d9de17496983": {
        "text_answer": "Yes  Explanation The statement There were no deaths or Hospitalizations in cohort 2",
        "label": "Entailment"
    },
    "c914522f-a0a8-4154-b1ae-f3df4f684e35": {
        "text_answer": "Yes The primary trial does not specify an age range for inclusion so it does not exclude 18year",
        "label": "Entailment"
    },
    "e7ca1067-1d50-4cb2-affc-2d859f9c20cf": {
        "text_answer": "No  The evidence states the inclusion criteria include a willingness to change diet but it does not state that patients must",
        "label": "Contradiction"
    },
    "4185140f-e9a6-445f-b512-05428d88f966": {
        "text_answer": "No  Explanation  The statement over 15 of patients in the primary trial and",
        "label": "Contradiction"
    },
    "cafc343b-d72e-4210-b145-42df1a42c28d": {
        "text_answer": "Yes  Explanation The total number of adverse events in the primary clinical trial was 5",
        "label": "Entailment"
    },
    "45240146-8a45-480e-a223-397089b029bb": {
        "text_answer": "No  Explanation  The statement 87 the primary trial participants and 20",
        "label": "Contradiction"
    },
    "f80eceb9-5998-4a62-807b-b9ddff8cd350": {
        "text_answer": "Yes  Explanation  The statement all infections and fever cases in the primary clinical trial were",
        "label": "Entailment"
    },
    "a7e702b9-3e27-47ed-bf09-3ce3c3f22b6e": {
        "text_answer": "No  Explanation  The evidence provided does not allow for the calculation of the difference in recurrence",
        "label": "Contradiction"
    },
    "e908994b-ee46-46a8-b478-5d1c45cf7047": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "9c076947-5e32-4a14-874b-e4b993f10756": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "df0874d1-340f-4e10-b7eb-275770f79f6f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a4f1de91-12c1-487c-911d-45099a83a658": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "2a5d71a0-75c6-41d5-bf37-4916c578b0b3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial compares",
        "label": "Contradiction"
    },
    "c08aa0d8-5505-438c-b53a-934bd2ee570d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "09cdd94c-145e-4a72-b281-1fad592fdcfd": {
        "text_answer": "No  The evidence does not support the statement as it indicates that there were no adverse events recorded in both trials for",
        "label": "Contradiction"
    },
    "8cf1ca78-50b9-4ab0-a673-3bb384092c0c": {
        "text_answer": "Yes  Explanation  The statement none of the patients in the primary clinical trial experienced more than",
        "label": "Entailment"
    },
    "5a1bdf90-fb17-47d2-8577-62fafbea13e4": {
        "text_answer": "No  The statement is about colon cancer not breast cancer",
        "label": "Contradiction"
    },
    "f9f9c153-d220-451e-a14d-f19ad7e80cc9": {
        "text_answer": "yes the statement is entailed by the evidence However its important to note that the statement only applies to",
        "label": "Entailment"
    },
    "23a3ae35-9722-40e0-9f6c-c52d41bcd365": {
        "text_answer": "No  Explanation The statement no participant in cohort 1 was able to maintain a progress",
        "label": "Contradiction"
    },
    "85a50c0e-0dcf-4bd9-ac4e-179bc6f99067": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "4ecc7382-526a-4bf5-9c17-92dc78446ea0": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial and the secondary clinical trial do not have",
        "label": "Entailment"
    },
    "0aa16ecc-2e97-4210-9872-5a0566497343": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1a11d957-c721-4cee-b540-e3ab8eaad1d0": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the patients age",
        "label": "Contradiction"
    },
    "1c14ebb0-bff7-4691-8926-1c1b07b4da9a": {
        "text_answer": "No  Explanation  The statement somewhat more socially active as before is not directly",
        "label": "Contradiction"
    },
    "363631c1-e7d3-41e6-b928-09ce7251cb6e": {
        "text_answer": "No  Explanation  The statement anogenital distance decreased is an indication that the an",
        "label": "Contradiction"
    },
    "907ae179-9823-4dba-9fb7-bb00027dbdf1": {
        "text_answer": "Yes The statement the majority of candidates involved in the primary clinical trial did not experience any eating disorders during the course of",
        "label": "Entailment"
    },
    "55e1354d-d4b5-4bd0-92e7-9c461f2e2808": {
        "text_answer": "Yes The statement is entailed by the evidence as the inclusion criteria specify that candidates for the primary clinical trial must have a",
        "label": "Entailment"
    },
    "93e6ed2b-1e3f-4cbe-a49e-cbc74b31e1aa": {
        "text_answer": "Yes the evidence does not explicitly state that the primary clinical trial is open for participation to AfricanAmerican patients but it",
        "label": "Entailment"
    },
    "944bcbb5-e85e-4115-bf71-face27208ab3": {
        "text_answer": "No  Explanation  The statement within the primary clinical trial no adverse events were",
        "label": "Contradiction"
    },
    "1100945c-51b9-4687-b518-d9b426239583": {
        "text_answer": "No  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Contradiction"
    },
    "ebdac536-2654-45d4-896f-98875186b971": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts use the same instructional CD for paced breathing",
        "label": "Entailment"
    },
    "3a04553e-529b-4cff-81f5-38e8ec73dd6b": {
        "text_answer": "No  Explanation  The evidence provided in the text does not entail that the Bevaciz",
        "label": "Contradiction"
    },
    "822bd855-46b1-4290-ac89-f3a92e96f523": {
        "text_answer": "No  Explanation  The evidence provided in the results does not indicate that every participant in coh",
        "label": "Contradiction"
    },
    "458419cf-ea6f-4939-ba2e-856b8d89b985": {
        "text_answer": "No  Explanation  The statement the secondary trial has the same inclusionexclusion criteria for",
        "label": "Contradiction"
    },
    "f519491d-1f9b-4527-aaa3-902c2fb181b5": {
        "text_answer": "Yes  Explanation  The statement most participants in both the primary clinical trial and the secondary clinical",
        "label": "Entailment"
    },
    "9f978634-637c-472f-a588-6f4bb2fb121f": {
        "text_answer": "No  The statement Women suffering from both claustrophobia and IBS or not eligible for",
        "label": "Contradiction"
    },
    "dfc6cbf1-1aa5-4bed-ac39-bbd3a460518b": {
        "text_answer": "No  The statement is not entailed by the evidence The evidence only specifies eligibility criteria for females with",
        "label": "Contradiction"
    },
    "3a8d24f2-6a67-4b23-99a9-5d9b0a54e9c6": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the primary trial has specific inclusion",
        "label": "Contradiction"
    },
    "a1dec8bc-cd32-4f8b-b757-dfd19e8af073": {
        "text_answer": "No   Explanation   The statement does not directly follow from the evidence provided The evidence",
        "label": "Contradiction"
    },
    "57a1a667-ac8e-49d3-95f5-26aca0d8bfa6": {
        "text_answer": "No  Explanation The statement does not directly address the primary trial or the interventions being compared It",
        "label": "Contradiction"
    },
    "47e524f0-a370-4845-848a-89fb6b743c96": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial showed a higher incidence rate of pal",
        "label": "Contradiction"
    },
    "0204ab43-d10d-494c-a0be-3b16d96c34fc": {
        "text_answer": "No   Explanation  The statement in both the primary trial and the secondary trial there were",
        "label": "Contradiction"
    },
    "ba020c81-f851-45b9-b1d2-d319f7c97753": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7aa4c233-3630-4d28-bbd5-4c64fc730a2b": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only reports the number of participants in each",
        "label": "Contradiction"
    },
    "dc41de0b-7f1d-4294-8f3c-c0ba6d2fb4d9": {
        "text_answer": "No  Explanation  The statement Far more patients in the secondary trial were recorded to have",
        "label": "Contradiction"
    },
    "cda1ac5f-5721-4329-bf63-a73ca7247da5": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence for both",
        "label": "Contradiction"
    },
    "07c11057-8ae2-4e40-a8d6-464e2399129e": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial 5 of the patients faced",
        "label": "Contradiction"
    },
    "76ba0bfa-8fd2-45ab-818b-0216aa5d423f": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial and the secondary clinical trial no",
        "label": "Entailment"
    },
    "0f4d6e4c-9315-4cbe-a322-37c6457cf49d": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial intervention 1 is provided intr",
        "label": "Entailment"
    },
    "4499b316-ac50-4534-a223-2adb144ec7f5": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the woman in question does not meet",
        "label": "Contradiction"
    },
    "bf1cfc9e-1932-4b3f-b935-c71fb36e6716": {
        "text_answer": "Yes  Explanation The statement mentions anemia and febrile neutropenia in co",
        "label": "Entailment"
    },
    "3a1fe062-8a0f-48cb-8830-7624b5445778": {
        "text_answer": "No  Explanation The statement movement of swollen area is painful is not directly related",
        "label": "Contradiction"
    },
    "19c38d71-5e6c-4944-9337-04d715487a2f": {
        "text_answer": "No  Explanation  The statement the primary clinical trial and the secondary clinical trial have an equivalent",
        "label": "Contradiction"
    },
    "b24a539a-af29-4a1a-905d-86203ca8c9d4": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary and secondary trials involve",
        "label": "Contradiction"
    },
    "c6a580f1-9ec3-4d4b-9a34-d12f7d446f61": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary clinical trial does not mention the treatment cycle in the intervention section",
        "label": "Entailment"
    },
    "f4632d0c-6ea3-4638-a2f3-ad5103e28229": {
        "text_answer": "Yes The primary trial and the secondary trial test different interventions eribulin mesylate vs axitinib",
        "label": "Entailment"
    },
    "8da24578-8dc7-42e5-821a-90f3e361cfdd": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial specifically excludes women",
        "label": "Contradiction"
    },
    "a0ed6cf5-dd1f-4170-ae33-3c1972b62530": {
        "text_answer": "No  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Contradiction"
    },
    "cb6db7a0-1eab-4ac8-9d3c-9b0bf4e123f2": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as it incorrect",
        "label": "Contradiction"
    },
    "9c2adaba-1ac9-4a7c-a710-14ac7d2056fd": {
        "text_answer": "No   Explanation  The evidence states that Intervention 1 uses a validated web",
        "label": "Contradiction"
    },
    "e244fc3a-53b3-4158-99c5-a45afc726af6": {
        "text_answer": "Yes The evidence states that patients with documented allergies to cephalosporin or trimethoprims",
        "label": "Entailment"
    },
    "7d922494-f6d6-4ade-9614-7111562617f3": {
        "text_answer": "yes for the secondary trial with the specified alcohol consumption limit but not for the primary trial as per its exclusion",
        "label": "Entailment"
    },
    "86e5ab20-18bb-408b-9c3d-92eee2f487d0": {
        "text_answer": "  Partially   Explanation   The statement is partially entailed by the evidence as",
        "label": "Entailment"
    },
    "808a6511-c76d-497c-ad73-037aa5619317": {
        "text_answer": "Yes  Explanation The statement there were no recorded cases of shingles in any group of the",
        "label": "Entailment"
    },
    "3cc54fbb-86c4-44f1-b623-0a613adbc7e8": {
        "text_answer": "No  Explanation The statement having multiple cerebral metastases is necessary for admission to",
        "label": "Contradiction"
    },
    "54986ebe-5830-4e3b-9ac1-28241d07e1c8": {
        "text_answer": "  No the statement is not directly entailed by the evidence as the evidence does not mention anything about virologic",
        "label": "Contradiction"
    },
    "34f9be61-9ee8-475e-9b02-72938355d6a5": {
        "text_answer": "No  Explanation  The statement acute contagious conjunctivitis is acute",
        "label": "Contradiction"
    },
    "58f42b4f-c8f1-4471-a44b-35ac49604a3b": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial provides a duration in days until disease progress",
        "label": "Entailment"
    },
    "36cc43dd-5761-49ef-bd9d-35e54dd5a97b": {
        "text_answer": "Yes The statement is a more specific version of the exclusion criteria mentioned in the evidence The statement specifies a ",
        "label": "Entailment"
    },
    "ea28dc26-75b9-4107-8862-226a46923254": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no information",
        "label": "Contradiction"
    },
    "9b753f6f-9d5d-464a-bc35-c1c0d796fe4d": {
        "text_answer": "Yes  Explanation  Both the primary and secondary trials report their findings using proportions or means",
        "label": "Entailment"
    },
    "4e410d4c-7da8-46ce-b335-678bb3199fbc": {
        "text_answer": "No  Explanation The evidence states that women of childbearing potential WOCBP must",
        "label": "Contradiction"
    },
    "3873ed0e-ceb1-45dc-8efc-690a55d908e6": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial is open for women aged 18",
        "label": "Contradiction"
    },
    "60c313e4-a3f2-4c9d-bef0-104c387a50f5": {
        "text_answer": "Yes  Explanation The evidence provided in the trial results shows that the mean number of hot flashes",
        "label": "Entailment"
    },
    "226a30c1-78f8-4747-adb7-1e99973487c1": {
        "text_answer": "No  Explanation  The statement the medicament under test is mutually the same in the",
        "label": "Contradiction"
    },
    "efa3cd46-9230-4078-b024-6de0386bfe80": {
        "text_answer": "No  The statement is not entailed by the evidence as there are no adverse events in common between the two",
        "label": "Contradiction"
    },
    "7006bd11-9655-4d3e-84a1-6a949fd921e2": {
        "text_answer": "Yes  Explanation  The statement the majority of individuals in the primary and secondary clinical trials did",
        "label": "Entailment"
    },
    "4189cb5a-bff9-4867-b9d7-1bd7791723f3": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial and the secondary clinical trial ad",
        "label": "Entailment"
    },
    "dd153492-5c53-4b8e-b860-71aaba62fa14": {
        "text_answer": "Yes The evidence states that the primary clinical trials intervention is MM111 which is a pharm",
        "label": "Entailment"
    },
    "31c480e3-b528-4810-855e-498a019ba253": {
        "text_answer": "Yes  Explanation  The statement Both cohorts of the primary trial receive the same",
        "label": "Entailment"
    },
    "d33d29d8-6d96-4f24-af22-2e86e73485d8": {
        "text_answer": "No  The evidence does not provide information about dyspnea in the participants of the primary clinical trial",
        "label": "Contradiction"
    },
    "e63ac45b-c34b-4007-820a-30202893fc6f": {
        "text_answer": "Yes The evidence states that there are 1530 enrollment slots for patients with metastatic colore",
        "label": "Entailment"
    },
    "bf170f0a-6640-4b5c-a130-ae405afb15a7": {
        "text_answer": "  I cannot definitively answer with just one word based on the given evidence as the evidence only provides ORR data",
        "label": "Entailment"
    },
    "bec6f047-5652-4c1a-8aec-8ba989cf4aa4": {
        "text_answer": "No  Explanation The statement only individuals with early stage cancer can participate in the secondary clinical trial",
        "label": "Contradiction"
    },
    "8734ab6c-5b2b-4d9f-958b-9b4f8249a6ef": {
        "text_answer": " No the statement is not directly entailed by the evidence provided The evidence only reports the percentage change in betaCTX",
        "label": "Contradiction"
    },
    "38791cb5-fc64-49a6-8db8-69da6c37f327": {
        "text_answer": "No   The statement is not entailed by the evidence as the primary trial results do not report the severity",
        "label": "Contradiction"
    },
    "f2fea6be-a072-4a75-8092-09acdd07d135": {
        "text_answer": "Yes  Explanation The evidence states that in the primary clinical trial the ErC and TC",
        "label": "Entailment"
    },
    "47f5a5c6-964c-40f8-b7b0-2278333f8fe9": {
        "text_answer": "Yes Metastatic nonsmall cell lung cancer is one of the eligible tumor types for the clinical trial",
        "label": "Entailment"
    },
    "53cf056f-91e1-45fb-a65d-7dff9a4b9bac": {
        "text_answer": "No  Explanation  The statement arm 1 of the primary trial indicated a higher operative",
        "label": "Contradiction"
    },
    "c1f0b925-6d1f-48ba-ada3-296bd69573f8": {
        "text_answer": "Yes  Explanation The statement intervention one uses higher doses of radioactive Tc9",
        "label": "Entailment"
    },
    "4eac1391-d7b7-4124-bafb-fa88bc4d8a02": {
        "text_answer": "No  Explanation  The statement the primary clinical trial is open only to female patients while",
        "label": "Contradiction"
    },
    "11a4324a-684e-4c85-a570-38e6f24ca92b": {
        "text_answer": "Yes The evidence shows that there were a total of 86 participants across both groups who achieved a pathologic complete",
        "label": "Entailment"
    },
    "41cc607f-05e2-4377-bca4-328906e47116": {
        "text_answer": "No  The evidence does not provide information on the total number of participants in the trials or the total number of adverse",
        "label": "Contradiction"
    },
    "b033d45a-c039-42de-a073-3c051c6f1e3c": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants or 8",
        "label": "Entailment"
    },
    "82d0df12-0e0b-4721-b54f-ecb6bccdc8c3": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes various types of cancer not just BR",
        "label": "Contradiction"
    },
    "342026c4-e3de-48c7-8688-e214f5ece431": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention segment of the primary clinical trial does not provide information on the",
        "label": "Entailment"
    },
    "0a9675e4-c6cf-44a9-98ed-e50aadfe064a": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "46959de4-38f3-42a8-adf9-c7565c66b442": {
        "text_answer": "No  Explanation  The statement informed consent will allow patients who are in stage 4",
        "label": "Contradiction"
    },
    "0613b4cb-1e87-48b0-8617-338ebb9ccbe8": {
        "text_answer": "No  The statement is not entailed by the evidence The evidence provided does not mention any device named terminator",
        "label": "Contradiction"
    },
    "8078bf53-15fe-414d-837f-abe03ab9e56d": {
        "text_answer": "Yes The evidence does not provide any information that would exclude patients with healthy weight according to BMI standards from either trial",
        "label": "Entailment"
    },
    "6d01a773-922b-483a-94b1-f3bda6f2e498": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not directly support the statement about the percentage",
        "label": "Contradiction"
    },
    "fed9960d-b051-4948-840c-91d09c01aafc": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that No meningeal carcin",
        "label": "Contradiction"
    },
    "b39c5d0f-5813-421d-84cf-d78e3c1d3424": {
        "text_answer": "No  Explanation  The statement the majority of participants in the first cohort of the",
        "label": "Contradiction"
    },
    "5572d454-871c-4458-a2d9-97e7cbb0e03a": {
        "text_answer": "Yes for the Primary Trial only The Primary Trial requires mammography as a prerequisite for participation",
        "label": "Entailment"
    },
    "152fc619-bbb0-40ff-aa3e-5722f62f6a84": {
        "text_answer": "yes but it is not a complete answer as the statement only mentions the length of treatment not the intervention itself",
        "label": "Entailment"
    },
    "d2e30364-0f79-46c7-8faa-7d7f6751c662": {
        "text_answer": "Yes The primary trial includes both male and female subjects while the secondary trial only includes females",
        "label": "Entailment"
    },
    "0cecf602-ca3a-4fc4-a52a-135425f42911": {
        "text_answer": "Yes  Explanation The evidence states that two patients experienced dyspnea shortness of breath which",
        "label": "Entailment"
    },
    "6786fa28-09b7-4bf3-8202-7e810755247e": {
        "text_answer": "Yes  Explanation  The statement there were no recorded gastrointestinal adverse",
        "label": "Entailment"
    },
    "e244bd1b-7ded-4cc5-a1f2-8afd358338b1": {
        "text_answer": "No  Explanation  The statement More patients in cohort 1 of the primary trial",
        "label": "Contradiction"
    },
    "c828ba65-0c7b-4aac-b0a7-35ca653b6e82": {
        "text_answer": "Yes The primary trial reports the MTD of ruxolitinib in combination with paclitaxel while",
        "label": "Entailment"
    },
    "9562c377-c748-46d7-a5f2-eb492d20e477": {
        "text_answer": "Yes The evidence does not report any cases of Hypertension Dehydration or Dyspnea in",
        "label": "Entailment"
    },
    "eebccf7b-8edc-4b99-8355-e936754c1282": {
        "text_answer": "yes both trials include the criterion of age 18 or older for inclusion",
        "label": "Entailment"
    },
    "d579bc9e-ccff-48a6-a296-2d9e8021c765": {
        "text_answer": "No  Explanation  The statement one patient in the primary trial had an incident where a surg",
        "label": "Contradiction"
    },
    "3d6e2ffb-5a89-4f31-9596-65f90e950c5e": {
        "text_answer": "Yes  Explanation The statement a single instance of shingles was documented in group 2 of",
        "label": "Entailment"
    },
    "a38f54f6-d3cb-46aa-b298-cee296e21b3f": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence provides the",
        "label": "Contradiction"
    },
    "c67874fc-c736-4da3-bc73-1e40cbf323c0": {
        "text_answer": "No  Explanation The evidence provided does not mention anything about the percentage of patients who did not experience",
        "label": "Contradiction"
    },
    "14afd2b1-9ac2-45fd-96f7-b65862c818a5": {
        "text_answer": "No  Explanation  The statement mme positive is an indication that mme expression has been",
        "label": "Contradiction"
    },
    "58c19654-e4cf-4c18-99ef-18b024996fcb": {
        "text_answer": "Yes The primary trial evaluates the toxicity of the treatment regimen using the NCI Common Terminology Criteria for",
        "label": "Entailment"
    },
    "e954d7ec-9ad9-4b01-9ae4-55e29fcbf7f4": {
        "text_answer": "Yes  Explanation The statement there was a single psychiatric adverse incident in the primary clinical",
        "label": "Entailment"
    },
    "57d8844c-d168-41c0-ad0c-6030e4c65905": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "b94ebfcb-76f4-4d65-b5e1-ca56249f9f19": {
        "text_answer": "No  Explanation The statement more than half of the patients in the second group experienced severe n",
        "label": "Contradiction"
    },
    "4dcada11-d2e0-453f-aed3-66446ebb4133": {
        "text_answer": "No  Explanation  The statement a single cohort within the primary clinical trial is provided",
        "label": "Contradiction"
    },
    "3d9a7121-da16-4e7b-a02d-1932f46cbb77": {
        "text_answer": "Yes  Explanation The statement the secondary trial patients suffered from anemia pneumonia and",
        "label": "Entailment"
    },
    "429ac312-4d91-4068-9fc3-8bd7b24bc21f": {
        "text_answer": "No  Explanation  The statement Patients with a history of severe anaphylactic reactions",
        "label": "Contradiction"
    },
    "cae6d7c6-1e27-4c94-9428-997ece9e651a": {
        "text_answer": "No  Explanation  The evidence provided in the text does not entail that the Bevaciz",
        "label": "Contradiction"
    },
    "c0c1a75a-a859-477d-bc80-3aac565c6a5b": {
        "text_answer": "No  The statement is not entailed by the evidence as there were no cases of acute myocardial inf",
        "label": "Contradiction"
    },
    "ad5ca7e8-3e5d-43b8-9618-99f56fc70290": {
        "text_answer": "Yes  Explanation  The statement There were no cardiac or psychiatric AEs recorded during",
        "label": "Entailment"
    },
    "8ca66388-46d0-4a5f-9be8-84d35961c823": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement is about participants with",
        "label": "Contradiction"
    },
    "3e0a4b38-bafb-4a0e-a1be-8506f23aa1f6": {
        "text_answer": "Yes  Explanation The statement compared to the secondary clinical trial the primary trial shows a decre",
        "label": "Entailment"
    },
    "b068596b-94a7-42fe-a926-d1c3c62ea26b": {
        "text_answer": "Yes  Explanation  The primary clinical trial and the secondary clinical trial have different outcome measurements despite",
        "label": "Entailment"
    },
    "5e14d0f3-e63e-40e8-93cc-a07c90c226d6": {
        "text_answer": "No  The statement about diffuse laminar endocervical hyperplasia is not mentioned in the",
        "label": "Contradiction"
    },
    "8dac6b6a-0e3d-4a3c-ac59-5096452207de": {
        "text_answer": "Yes The statement mentions the percentage of participants with HER2 Primary Breast Cancer who developed imagable HER",
        "label": "Entailment"
    },
    "f6ce8f5f-f226-4435-9209-9bf54ac7cbaa": {
        "text_answer": "No  Explanation  The statement a 7week duration of tak228",
        "label": "Contradiction"
    },
    "2e35f870-1118-4c57-be71-a1b17e6841e3": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial do not suffer any of the",
        "label": "Contradiction"
    },
    "6e02fc64-787b-47e7-a9d6-173b101baf71": {
        "text_answer": "No  Explanation  The primary clinical trials exclusion criteria do not mention anything about a",
        "label": "Contradiction"
    },
    "1692f569-44d0-4b60-aabe-87dc3f7d3513": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary trials Intervention",
        "label": "Entailment"
    },
    "3c2994b1-74be-4fe4-9262-00a5a8e42caa": {
        "text_answer": "No  Explanation The evidence provided does not include any information about the shortest PFS in the",
        "label": "Contradiction"
    },
    "83457ad0-4ebe-4bd7-abf7-bf629af15e58": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "40d65677-e7f3-46f8-801a-327c8422937b": {
        "text_answer": "No  Explanation The statement psychiatric adverse events affected over half of the patients",
        "label": "Contradiction"
    },
    "6e1c74e3-1b7b-41bf-8ee4-f605d94c0fdf": {
        "text_answer": "No  Explanation  The statement the secondary trial has higher incidents of biliary colic and",
        "label": "Contradiction"
    },
    "0a0778f4-c085-45fe-a085-e079256d634b": {
        "text_answer": "No   Explanation  The evidence provided states that there were no adverse events recorded in both",
        "label": "Contradiction"
    },
    "ea01b3dd-11a6-4e00-aada-a31c2fc4a5dc": {
        "text_answer": "Yes  Explanation The statement the intervention section of the primary clinical trial clearly outlines the method",
        "label": "Entailment"
    },
    "40818dd2-4940-4543-905a-35a3295b3009": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it makes an incorrect comparison between",
        "label": "Contradiction"
    },
    "a62e526a-07c6-472a-acff-891375dd7fb0": {
        "text_answer": "No  Explanation  The statement arm 2 in the primary trial exhibited an increased oper",
        "label": "Contradiction"
    },
    "03fe8107-b0ab-470e-9d1e-a085808ec397": {
        "text_answer": "Yes with the caveat that the evidence only directly measures cognitive function at baseline and 1 year postrandomization",
        "label": "Entailment"
    },
    "8953caa7-492f-4fbb-b5a6-5cff95a5650c": {
        "text_answer": "No  Explanation  The statement rising from floor functional test question is a question associated with",
        "label": "Contradiction"
    },
    "5599d5d8-3a7b-41ce-a00c-6e0b609b618d": {
        "text_answer": "  No   Explanation   The evidence provided does not indicate that any participant in co",
        "label": "Contradiction"
    },
    "05990a1c-be55-4aa4-8e72-970d95776c8a": {
        "text_answer": "No  Explanation The statement the percentage of cells with ki67 expression in patients participating in the",
        "label": "Contradiction"
    },
    "b0eb1f5f-d996-4846-9b4e-12dd88120752": {
        "text_answer": "Yes  Explanation  The statement All AE types in the primary trial affected less than ",
        "label": "Entailment"
    },
    "37c579a2-134b-4ee4-8a9e-e550c2155a16": {
        "text_answer": "Yes  Explanation  The statement 3 or more adverse events occurred in 5 patients participating",
        "label": "Entailment"
    },
    "7bbbfeb0-c4f2-4295-ae6c-3adbf6dc06ad": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "20b34e62-97c2-4ca0-bb1d-7824dab0b8bb": {
        "text_answer": "Yes The evidence does not mention any mental health bodyweight tumor size KarnofskyECO",
        "label": "Entailment"
    },
    "3f5f182d-77ba-423c-8f5b-02ca3ada57c2": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial adverse events like recurrent",
        "label": "Entailment"
    },
    "bb12ebcd-127e-4834-b0f3-9759ed13c5ed": {
        "text_answer": "Yes The primary trial measures changes in pain intensity shifts while the secondary trial measures changes in bone mineral density ",
        "label": "Entailment"
    },
    "35aa67ad-b884-4cec-afdf-bef9cb6619c4": {
        "text_answer": "No   Explanation  The statement Patients in the primary trial will need to receive one",
        "label": "Contradiction"
    },
    "6c41e8b2-2878-44b1-bf2d-6158d8f20dda": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it makes additional assumptions",
        "label": "Contradiction"
    },
    "1938e58d-a90f-48c4-ac79-59da3de8017c": {
        "text_answer": "Yes  Explanation The statement well differentiated neuroendocrine lesion is a neopl",
        "label": "Entailment"
    },
    "f73b494f-624c-487a-b502-f2cbc7ab0475": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement makes an assumption about",
        "label": "Contradiction"
    },
    "97d3ebc2-fda1-4b0b-b7b2-583edca5be69": {
        "text_answer": "Yes  Explanation The evidence states that most participants reported a significant reduction in circulating tumor cells",
        "label": "Entailment"
    },
    "31d67714-a5c1-494f-820e-d47f52480eaf": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement mentions se",
        "label": "Contradiction"
    },
    "98b0e244-cb54-4d99-9384-b7e5e7d43550": {
        "text_answer": "No  Explanation  The statement there were no placebo groups involved in the primary trial",
        "label": "Contradiction"
    },
    "f024fdc1-bee8-4ad8-a80d-9369d52b799a": {
        "text_answer": "No  Explanation The evidence provided only reports the change in total body lean mass for two different dos",
        "label": "Contradiction"
    },
    "9ee19b4a-bcdb-4676-b852-ee3fbb4352b0": {
        "text_answer": "No  Explanation The statement the primary clinical trials interventions consist of only a single",
        "label": "Contradiction"
    },
    "589622f2-6c3b-4e63-ad71-5d8c90cb3413": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b0af496d-fead-41b6-96fd-71dea81c8501": {
        "text_answer": "No  Explanation  The statement there were fewer suspected serious adverse reactions outlined in the ad",
        "label": "Contradiction"
    },
    "0fbbd866-ae4c-458c-8bb4-fe8bb8ee9471": {
        "text_answer": "No  Explanation  The statement the radiation therapy for cohort 2 in the primary",
        "label": "Contradiction"
    },
    "7794c718-f5f9-45a3-b427-9c7b79b261ee": {
        "text_answer": "No  Explanation  The primary and secondary clinical trials have different outcome measurements The primary trial measures",
        "label": "Contradiction"
    },
    "8084d30e-d99a-4b02-88e2-dd8194ef538f": {
        "text_answer": "Yes  Explanation The statement few participants in the primary and secondary clinical trials experienced adverse incidents",
        "label": "Entailment"
    },
    "fccfea25-6459-4cf9-a9cd-eaf2b81428e4": {
        "text_answer": "Yes The primary trial excludes patients with potassium levels outside the normal range and the secondary trial does not mention",
        "label": "Entailment"
    },
    "7d712178-7e9c-48f5-8248-432ff3a50f62": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial describes the administration of suramin and",
        "label": "Contradiction"
    },
    "073d8ed7-d1ff-4fb7-bc5f-b33397ad6b6c": {
        "text_answer": "No  Explanation  The primary trial reports the percentage of participants while the secondary trial reports the",
        "label": "Contradiction"
    },
    "79d98227-bc8b-4d97-b264-9737e368030f": {
        "text_answer": "Yes The statement Patients in the primary and secondary trial suffered Thromboembolic events is entailed",
        "label": "Entailment"
    },
    "e3caa52b-259d-498a-926b-fbfd15eb1bc6": {
        "text_answer": "No  Explanation The evidence provided does not mention anything about the percentage of patients who did not experience",
        "label": "Contradiction"
    },
    "2d36fa83-b68c-420e-873f-e69374d0741f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7c7842f8-26c8-4b9f-8bb1-64f846e5e81e": {
        "text_answer": "Yes  Explanation  The statement while the primary trial explores the impact of a single ther",
        "label": "Entailment"
    },
    "333c097e-628c-4240-aa00-f9621fbbabe1": {
        "text_answer": "No  Explanation  The given statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "d54a3e9d-5602-4cc3-934e-717f1da39792": {
        "text_answer": "Yes  Explanation  The statement The primary trial results report changes in Pain intensity and the secondary",
        "label": "Entailment"
    },
    "87c2f042-077b-4d49-80b0-1603a137520f": {
        "text_answer": "Yes  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Entailment"
    },
    "2ce0822a-fcf8-4010-950c-0d3a8dc2cb00": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5be4dfce-9123-4a08-9397-a2f4d95e8209": {
        "text_answer": "No  Explanation The statement does not mention anything about mental health bodyweight age K",
        "label": "Contradiction"
    },
    "0f90b547-3d71-417f-ba02-deb31f70e5da": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the doses of Abra",
        "label": "Contradiction"
    },
    "75961bc5-20b9-4161-83e0-a59429ce18e9": {
        "text_answer": "No  Explanation  The evidence provided in the trial results indicates that 20 out of ",
        "label": "Contradiction"
    },
    "e02cca6f-2a41-4a5a-bf83-23cdab6ee8dd": {
        "text_answer": "No  Explanation  The statement gammatubulin is a family of globular prote",
        "label": "Contradiction"
    },
    "b20cbb69-8909-4a66-b47c-27192604d187": {
        "text_answer": "No  Explanation  The statement The results from the primary trial indicate that the Arm A intervention",
        "label": "Contradiction"
    },
    "738a5b84-f8e8-411b-9376-377760780e01": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "658e195d-21fc-4bf0-af37-a523ba772f83": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly comp",
        "label": "Contradiction"
    },
    "edfe9572-6cff-4ecb-b34b-19ac297352d7": {
        "text_answer": "yes The primary trial determines the MTD of ruxolitinib in combination with paclitaxel and",
        "label": "Entailment"
    },
    "d4f76af1-2a9e-488a-b871-4b489dea5c02": {
        "text_answer": "Yes for the primary trial there is no mention of ki67 expression in the results for the secondary trial",
        "label": "Entailment"
    },
    "d6f7d14f-dbc6-4268-be40-1a09facf0834": {
        "text_answer": "No  Explanation  The statement Most patients in cohort 1 of the primary trial",
        "label": "Contradiction"
    },
    "4a5400b8-bf7e-40f2-857f-169a7ad3b89f": {
        "text_answer": "No  The statement is not related to the evidence provided which pertains to the inclusion and exclusion criteria for a",
        "label": "Contradiction"
    },
    "9f855b3e-81b0-47a6-af48-b437e0409d77": {
        "text_answer": "Yes The primary and secondary trials both measure pCR as their outcome The primary trial shows a small difference in pCR",
        "label": "Entailment"
    },
    "6906ff3e-0e8c-4332-987d-47816bc462ba": {
        "text_answer": "Yes  Explanation  The statement There were 3 times the number of Hepatot",
        "label": "Entailment"
    },
    "2787f3da-ad73-483d-98b8-a82acec6e5fc": {
        "text_answer": "No   Explanation  The statement all patients in the primary clinical trial receive at least ",
        "label": "Contradiction"
    },
    "97552293-cd61-42c5-95c2-dc98b795f9d5": {
        "text_answer": "No  Explanation The statement Neither of the primary trial cohorts receive any invasive",
        "label": "Contradiction"
    },
    "8549720f-df44-400f-aeb0-98150d2f23b1": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "963f60a5-2446-42f3-9c05-20ef38528d1a": {
        "text_answer": "Yes  Explanation  The evidence states that out of 25 participants treated with sunitin",
        "label": "Entailment"
    },
    "6e6cecbf-ea24-4cf8-83f5-5fd627941028": {
        "text_answer": "Yes The primary trial involves zoledronic acid given IV and the secondary trial involves interventions with graniset",
        "label": "Entailment"
    },
    "847ce4e8-b2df-4acb-b46c-c82baa519124": {
        "text_answer": "No   Explanation  The statement the secondary trial demonstrated a number of such events within their",
        "label": "Contradiction"
    },
    "066d1275-7efd-47d6-aba2-96bc464cbe2f": {
        "text_answer": "No  Explanation  The statement the occurrence of emesis was nonexistent among",
        "label": "Contradiction"
    },
    "086c9c1a-de79-47f1-b75d-32c7a16716ef": {
        "text_answer": "No  Explanation  The statement patients with stage 1 cancer are eligible for the primary",
        "label": "Contradiction"
    },
    "e35505c9-4340-4f19-8756-925d96d65b44": {
        "text_answer": "  No   Explanation   The statement patients who have undergone chem",
        "label": "Contradiction"
    },
    "15b22917-3649-44bd-b7f0-9aa5a6beba6b": {
        "text_answer": "Yes the statement is entailed by the evidence as the primary clinical trial does not mention the use of fentanyl",
        "label": "Entailment"
    },
    "12d86841-a682-4de8-80ab-90cae0b8c124": {
        "text_answer": "No  The statement is not directly related to the evidence provided which focuses on adverse events in clinical trials for un",
        "label": "Contradiction"
    },
    "a930aad6-c334-4a8a-8547-3a07e44afe8b": {
        "text_answer": "No  The statement is not entailed by the evidence as the exclusion criteria specifically states No known hypersens",
        "label": "Contradiction"
    },
    "5e3d1ff7-52f0-4ac5-a9e0-63536903cf84": {
        "text_answer": "Yes The evidence does not specify race or location as exclusion criteria Therefore Caucasian patients residing in",
        "label": "Entailment"
    },
    "4fec37ef-6e27-4b07-a0ba-d35434fe2d36": {
        "text_answer": "  No the statement is not entailed by the evidence The evidence states that a pulmonary hemorrh",
        "label": "Contradiction"
    },
    "c7a78221-6f3c-484f-a281-908ab30a7e31": {
        "text_answer": "No  Explanation The evidence provided in the primary trial relates to the comparison of the effic",
        "label": "Contradiction"
    },
    "b3679900-ab99-4a84-83e0-fc1122a43beb": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "24cca94e-b0db-4015-acc3-061bce8ea0ea": {
        "text_answer": "Yes The statement does not mention Febrile neutropenia or Cholelithiasis but it correctly states",
        "label": "Entailment"
    },
    "de2a7e0a-2046-4502-a23e-38d0753b43ec": {
        "text_answer": "No  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Contradiction"
    },
    "0dc19d61-83e4-4b27-9d03-c485f30fe9f6": {
        "text_answer": "Yes The evidence shows that there were 80 participants with recurrencefree survival in the ketorolac",
        "label": "Entailment"
    },
    "ad4f2e14-4f6a-473d-bc6a-225e2f34159b": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it is about a different topic",
        "label": "Contradiction"
    },
    "8e698117-fcf5-480f-80a0-95a3be887ef8": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial involves the use",
        "label": "Contradiction"
    },
    "9069ac6d-9d0f-4484-adda-bde33d713b7e": {
        "text_answer": "No  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Contradiction"
    },
    "ed92e41d-f81d-462e-9081-c293fb816163": {
        "text_answer": "No   Explanation   The primary and secondary trials involve different patient cohorts and different",
        "label": "Contradiction"
    },
    "9f3b9559-fe63-4698-b886-fe76ecab9784": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial cohort 1 is given",
        "label": "Entailment"
    },
    "0997d5fe-8df2-4b29-983a-3d3d2921e320": {
        "text_answer": "No  Explanation  The statement all of the participants in group 1 of the primary trial",
        "label": "Contradiction"
    },
    "d1125c05-e0b3-4d7b-951e-cd21b5038b0b": {
        "text_answer": "Irrelevant  Explanation  The statement lgals3 antibody is any immunog",
        "label": "Entailment"
    },
    "0c9bef83-0974-4de4-aaa9-2f109fe16d0d": {
        "text_answer": "No  Explanation The statement patients in the primary clinical trial reported no observed change in the percentage",
        "label": "Contradiction"
    },
    "f5b27b4f-8fe1-4cc8-a4d6-aa1459797496": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it makes a comparison",
        "label": "Contradiction"
    },
    "270255e6-c423-4fff-a2aa-78c3c8ef2a8e": {
        "text_answer": "Yes The primary trials Intervention 1 involves IV administration of zoledronic acid while the secondary trial",
        "label": "Entailment"
    },
    "ee74c3c1-33c4-4b0a-81bf-a2ed3ec7e161": {
        "text_answer": "yes the statement is entailed by the evidence as the only difference between the two interventions is the dosage of dur",
        "label": "Entailment"
    },
    "0fb60a4c-16d6-4517-a201-e16f78fd6dae": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as fib",
        "label": "Contradiction"
    },
    "57dae782-9901-446f-93d1-047097623f45": {
        "text_answer": "Yes The statement does not explicitly mention IGF1R as a requirement for eligibility but the evidence does not",
        "label": "Entailment"
    },
    "70d946f2-0c4a-4a00-8090-b0b55dda7b2b": {
        "text_answer": "Yes The evidence states that patients with nonsmall cell lung cancer are eligible for the trial regardless of their ER or",
        "label": "Entailment"
    },
    "c802c0a9-737c-4b94-89c6-e4327a1925dd": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "66ff33e2-be79-4e47-a3f9-68a57f5f377b": {
        "text_answer": "No  The statement is not related to the evidence provided The evidence is about denosumab trials and intra",
        "label": "Contradiction"
    },
    "c12d4dba-17b9-45d6-9a3f-75be190b7795": {
        "text_answer": "Yes for the specific adverse event 1 since both trials recorded 0 adverse events each However it",
        "label": "Entailment"
    },
    "6579100b-45dc-4669-86ec-a3f8ac521c23": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there were no ad",
        "label": "Contradiction"
    },
    "b308b4a7-f3e9-49aa-a84e-8842da7caacf": {
        "text_answer": "Yes  Explanation  The statement patients in the primary clinical trial reported a range of ad",
        "label": "Entailment"
    },
    "256cd40a-7afc-401d-9d02-c013ee3ee68d": {
        "text_answer": "No   Explanation  The evidence provided in the trial description does not mention anything about obligatory",
        "label": "Contradiction"
    },
    "fadac52b-d98b-4511-858e-a7bfb0dda0c0": {
        "text_answer": "No The statement is not related to the evidence provided The evidence is about a primary trial intervention for breast cancer treatment",
        "label": "Contradiction"
    },
    "2a56e9e0-10fe-4a2d-964a-71390b3bb4d4": {
        "text_answer": "  Yes gender is not a determining factor for eligibility in both trials according to the provided inclusion criteria",
        "label": "Entailment"
    },
    "d16f252e-5df6-4e09-8a24-9c56b4b8e16b": {
        "text_answer": "No  Explanation  The statement the azd0530 175 mill",
        "label": "Contradiction"
    },
    "1bec6fcc-5a7e-4d19-81ea-e677715490fe": {
        "text_answer": "No  Explanation  The statement cases of mucositis oral epileptic seiz",
        "label": "Contradiction"
    },
    "4886038c-1def-4bbb-a9c7-dab5784cd471": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence pert",
        "label": "Contradiction"
    },
    "a87b00a3-b6c1-4ee3-a6e0-fbd2eccbea05": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "71a3b934-3bf8-4628-a728-cdf47a27e66c": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial both use the term Max",
        "label": "Contradiction"
    },
    "3ad97e18-2efc-4d4a-aaae-424a3bc3f39c": {
        "text_answer": "Yes The evidence does not explicitly state that patients must have a healthy body mass index but it does not exclude patients based",
        "label": "Entailment"
    },
    "baa46f83-8738-48d2-b9b8-9cc635d9d730": {
        "text_answer": "  No   Explanation   The evidence provides the percentage of subjects who were recurrence",
        "label": "Contradiction"
    },
    "30a0fbf5-af3e-43fd-80f4-41f740a2fdff": {
        "text_answer": "No  The evidence does not provide information about women having both claustrophobia and IBS Ir",
        "label": "Contradiction"
    },
    "6b5cc819-da7b-4e4f-ae2f-7e4db8073860": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial more than 15",
        "label": "Contradiction"
    },
    "8f82b776-0f1c-4059-aab0-9898a9f6bd1a": {
        "text_answer": "Yes  Explanation The primary clinical trial administers pembrolizumab every 3 weeks",
        "label": "Entailment"
    },
    "4d501822-a118-4fe8-b92d-eb5085ab6dcc": {
        "text_answer": "No  Explanation  The statement all participants in the primary clinical trial are administered higher dos",
        "label": "Contradiction"
    },
    "eb088d03-7fdc-48bd-9175-0e7a9cfc7b9a": {
        "text_answer": "  Yes the statement is entailed by the evidence for cohort 1 3 participants as all ",
        "label": "Entailment"
    },
    "c63468c0-324f-4528-b83f-a588ccf7b680": {
        "text_answer": "No  Explanation  The primary trial includes patients with a breast tumor of 1 cm in",
        "label": "Contradiction"
    },
    "54f86209-3c4b-4dfd-b048-e8eeb864300c": {
        "text_answer": "No  Explanation The evidence only states that some individuals in the primary clinical trial receive MCS1",
        "label": "Contradiction"
    },
    "d8e49bf6-27d9-4307-9bcd-56625d93274a": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes the inclusion criterion of a HER2 positive",
        "label": "Entailment"
    },
    "072f2e2d-f4b0-4a32-85e0-8626ee261a63": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not indicate that the group taking L",
        "label": "Contradiction"
    },
    "cff79719-40b1-43fb-bbdd-43dbe9c4191a": {
        "text_answer": "No  Explanation  The primary trial evaluates toxicity of infusing HER2specific",
        "label": "Contradiction"
    },
    "4f66f663-030a-4391-a426-4e6b2f3bc9d2": {
        "text_answer": "Yes  Explanation  The statement the primary trial participants experienced less incidences of diarr",
        "label": "Entailment"
    },
    "38b5ee2a-8baf-427a-944d-a93a1a450104": {
        "text_answer": "Yes  Explanation  The statement more instances of anemia pneumonia and",
        "label": "Entailment"
    },
    "d311aaa2-6b04-4f26-a19a-65e33a673fbe": {
        "text_answer": "Yes The evidence states that there was an adverse event of peripheral neuropathy a type of nerve damage",
        "label": "Entailment"
    },
    "9334239a-f4f1-4192-a35d-93c25c41328d": {
        "text_answer": "Yes In the primary trial Epacadostat is taken twice daily BID while in the secondary trial",
        "label": "Entailment"
    },
    "b7b61d5d-629d-43a4-8d75-5897864b6443": {
        "text_answer": " No  Explanation The evidence provides the percentage of participants in the Lapatinib 10",
        "label": "Contradiction"
    },
    "0b3b3351-166f-465f-b44f-14c1e24c2d06": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial have different inclusion and exclusion",
        "label": "Contradiction"
    },
    "fd173cdb-c283-4b74-922e-583a531edcef": {
        "text_answer": "No  The statement is not entailed by the evidence as it mentions a different genus of bacteria Atopob",
        "label": "Contradiction"
    },
    "a5657dcd-1ee5-44f6-bb21-e718259c4b2e": {
        "text_answer": "Yes  Explanation  The statement There were no deaths or Hospitalizations in cohort ",
        "label": "Entailment"
    },
    "475903fe-9ac8-434b-aa7e-aa7bce562ef0": {
        "text_answer": "  No   Explanation   The primary clinical trial measures pain intensity using a visual analog",
        "label": "Contradiction"
    },
    "c6f5d89a-939b-4e46-8aab-9fc9246498be": {
        "text_answer": "  No   Explanation   The statement a patient who has recently undergone",
        "label": "Contradiction"
    },
    "6558ae62-b251-483d-9082-67a614d76e60": {
        "text_answer": "Yes  Explanation The primary clinical trial had two arms one intervention arm with pyridoxine",
        "label": "Entailment"
    },
    "1dffbb91-6440-4ceb-a33d-c2d783f75936": {
        "text_answer": "No   The statement is not entailed by the evidence as it mentions interventions dacarbazine",
        "label": "Contradiction"
    },
    "6746f51e-6ceb-48b7-aa33-aecd601723b6": {
        "text_answer": "  Yes  Explanation  The statement is entailed by the evidence because in Intervention ",
        "label": "Entailment"
    },
    "19ec40c8-5482-490f-9418-5667705632df": {
        "text_answer": "No  Explanation  The statement the primary trial and the secondary trial recorded the same total number",
        "label": "Contradiction"
    },
    "a55f7123-365b-4119-bf0d-17467c73d0b7": {
        "text_answer": "No   Explanation   The statement There were significantly more patients in cohort ",
        "label": "Contradiction"
    },
    "cca75efb-d5e0-4dba-b9ca-4f59238abb59": {
        "text_answer": "Yes   Explanation  The statement the primary trial intervention is given orally whereas the",
        "label": "Entailment"
    },
    "6c5ebc06-00c4-4cf5-8912-93972ed5a49b": {
        "text_answer": "  No   Explanation   The statement Patients who have received chemotherapy or",
        "label": "Contradiction"
    },
    "e517c026-4c5e-43ac-a734-1bcfd6d8edf1": {
        "text_answer": "Yes The statement that Cohort 1 of the primary trial did not report any AEs however almost all",
        "label": "Entailment"
    },
    "3d100b36-5765-4953-b072-b06f38b6958c": {
        "text_answer": "  Maybe   Explanation   The evidence provides the ORR for each group but",
        "label": "Entailment"
    },
    "b08d9933-4d8d-40f6-9395-d40391501db4": {
        "text_answer": "Yes The statement is entailed by the evidence as the participants in the primary trial receive epirubicin cycl",
        "label": "Entailment"
    },
    "3be36531-265f-4d51-bd65-1e2f46b28eda": {
        "text_answer": "Yes  Explanation Both primary and secondary clinical trials in the evidence present data on the Maximum",
        "label": "Entailment"
    },
    "bc318388-81b9-4bf5-94a7-db6443061abd": {
        "text_answer": "  No The statement is not entailed by the evidence as it contains an incorrect definition of the term interval point",
        "label": "Contradiction"
    },
    "0ed96bc9-14a3-4c52-b977-7cf507956191": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence as it does",
        "label": "Contradiction"
    },
    "48b31ad3-f5d6-4250-9e84-e407d26f6bed": {
        "text_answer": "No  Explanation The statement Patients participating in the primary trial receive oral medication twice a day",
        "label": "Contradiction"
    },
    "dd909039-da2a-4c24-9b6f-1776bc51e3a2": {
        "text_answer": "yes but the statement only applies to the inclusion criteria for informed consent The evidence does not directly address the inclusion or excl",
        "label": "Entailment"
    },
    "174215f6-99d9-482a-8aad-d477060cb062": {
        "text_answer": "No  Explanation The statement does not mention anything about mental health bodyweight size of tum",
        "label": "Contradiction"
    },
    "2ea65099-018a-4230-87a1-e60303486743": {
        "text_answer": "  The statement is not entailed by the evidence for the primary trial as the patient does not meet the ANC",
        "label": "Contradiction"
    },
    "e486bbca-c279-458b-b98b-2b434c9a242d": {
        "text_answer": "No  Explanation  The statement malignant laryngeal neoplasm is",
        "label": "Contradiction"
    },
    "05775941-9ed3-40eb-9c93-ed60a7783838": {
        "text_answer": "No  The statement is not about breast cancer and does not relate to the inclusion criteria for either trial",
        "label": "Contradiction"
    },
    "f45bbf0b-4acd-4166-81a6-6b407cff87ca": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7814620b-23de-463b-8fd1-efdf51ce26b3": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that individuals with a history of interst",
        "label": "Contradiction"
    },
    "2c00f421-96f2-4f3a-a202-27350b15c84f": {
        "text_answer": "No  Explanation  The statement No two patients in the primary trial suffered the same type of",
        "label": "Contradiction"
    },
    "2eed31cc-3968-4b00-8a9e-947c5ecfbc3b": {
        "text_answer": "No   Explanation  The statement Patients in the primary trial will need to receive one",
        "label": "Contradiction"
    },
    "f44e50eb-f7de-403f-8e1c-25ae4cb1f530": {
        "text_answer": "Yes The statement is entailed by the evidence as it is explicitly stated in the evidence that the final eligibility for",
        "label": "Entailment"
    },
    "ed9afe03-8b68-464c-a9f8-0d3a58f64d7f": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include patients with ER positive PR positive or HER",
        "label": "Entailment"
    },
    "3f6d7cbc-5465-4e27-beee-582162fe9972": {
        "text_answer": "No  Explanation  The statement in the secondary clinical trial there were no adverse events",
        "label": "Contradiction"
    },
    "91169f4f-ada3-4bc7-a0ef-8111fccac241": {
        "text_answer": "No  Explanation  The statement the most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "de99de33-5cd3-4f28-8859-9297a230ab94": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial only mentions the use of Vor",
        "label": "Contradiction"
    },
    "7b76950c-8ac8-451f-93d4-bfac4ba36e49": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not mention anything",
        "label": "Contradiction"
    },
    "ce8ecade-8753-4983-83af-47f6e3e87f32": {
        "text_answer": "No  Explanation  The statement while the primary trials entry conditions are identical for all",
        "label": "Contradiction"
    },
    "23f62ab2-9ec8-49f7-a4e7-84f931a1825d": {
        "text_answer": "No   The statement is not entailed by the evidence as it incorrectly states that the exclusion criteria apply",
        "label": "Contradiction"
    },
    "a6f49268-2b84-49ff-a89a-86cb3d16cd07": {
        "text_answer": "No  Explanation  The statement in the primary clinical trials initial cohort",
        "label": "Contradiction"
    },
    "2b0a4d9c-e65c-44d2-bdf6-60877e5d1b41": {
        "text_answer": "No  The evidence states that patients with dementia are excluded from the trial but it does not specifically mention Al",
        "label": "Contradiction"
    },
    "54654fa6-2bce-4ed0-9cdf-ec6cf1de3bd8": {
        "text_answer": "Yes for the secondary trial with the caveat that smoking individuals are not disqualified per se but must meet other",
        "label": "Entailment"
    },
    "57265519-b5e0-41f9-90b3-8a09e57bc282": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "2c7901c7-b03b-4b92-852d-d182187dd2b1": {
        "text_answer": "Yes  Explanation The evidence states that there were a total of 12 participants analyzed in the",
        "label": "Entailment"
    },
    "33641401-b713-4800-86a9-aa7766b456f5": {
        "text_answer": "No  Explanation  The statement in cohort 2 of the primary clinical trial",
        "label": "Contradiction"
    },
    "dfb7dcc6-34da-4de2-8229-3cd02d15bd15": {
        "text_answer": "No  Explanation  The statement mersalyl acid is a mercurial diuret",
        "label": "Contradiction"
    },
    "52ee52ad-c158-48b8-86f1-99589e8150c5": {
        "text_answer": "Yes The evidence states that 13 of the participants with HER2primary breast cancer developed imagable H",
        "label": "Entailment"
    },
    "da51f6ae-703a-4282-a339-22ebaa80709a": {
        "text_answer": "Yes patients with vaginal itching or irritation can still participate in the trial if they have Frontotempor",
        "label": "Entailment"
    },
    "e3a1c267-d715-40ef-b23a-9bfb6285bf6a": {
        "text_answer": "Yes  Explanation  The primary trial describes an intervention involving massage therapy which is a form of",
        "label": "Entailment"
    },
    "0392122c-9612-49dc-83db-b2b6a4a4a8a8": {
        "text_answer": "No  Explanation  The statement the primary clinical trial did not yield any significant differing outcomes",
        "label": "Contradiction"
    },
    "b4bad814-078e-4991-9455-f50ca716580d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes two",
        "label": "Contradiction"
    },
    "26b78b55-df37-4058-a5ef-7634ae3f4fce": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a93f06ed-84a0-487e-bf93-f74cc7cb34ba": {
        "text_answer": "Yes  Explanation  The evidence states that there were no adverse events reported for participants in the",
        "label": "Entailment"
    },
    "56530063-b408-47f2-8421-6be825f5559c": {
        "text_answer": "Yes   Explanation  The evidence states that Intervention 1 is administered intravenously",
        "label": "Entailment"
    },
    "aa62c405-218e-496e-a424-95340f370834": {
        "text_answer": "No  Explanation  The statement the second cohort of the primary clinical trial had fewer",
        "label": "Contradiction"
    },
    "dc867a3f-6005-49f7-bcd8-1c7db27b00c1": {
        "text_answer": "Yes The evidence states that patients with documented allergies to cephalosporin trimethoprims",
        "label": "Entailment"
    },
    "51cd4ccd-2770-4189-ba70-f01147431843": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial involves multiple injections of dendritic cells chem",
        "label": "Entailment"
    },
    "3aaa3da7-8b9c-4853-abd9-f4dc011eaab0": {
        "text_answer": "No  Explanation  The statement about women suffering from both claustrophobia and",
        "label": "Contradiction"
    },
    "34f3e7ee-c8c4-4a97-90da-fafcfd1c7cc0": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes cohorts receiving preoperative intr",
        "label": "Contradiction"
    },
    "ce8a4f39-efff-4fd3-b850-4fc5c30270ef": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "6e125367-3fa8-46b3-a58d-b3baa894bc70": {
        "text_answer": "No  Explanation The statement women aged 60 or 70 are eligible for the",
        "label": "Contradiction"
    },
    "81792c74-a501-4ef9-b7ac-2bda7a980fb1": {
        "text_answer": "Yes  Explanation  The statement the secondary clinical trial and the primary clinical trial utilize diverse methods",
        "label": "Entailment"
    },
    "0938714d-688d-42b5-a605-1153c172aa48": {
        "text_answer": "No  Explanation  The statement several patients in the secondary trial and the primary trial",
        "label": "Contradiction"
    },
    "9fb13507-1f88-4b95-8ff6-a56af67ca8c4": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "2cc2ce51-0ac2-4e55-baf0-d26f88105aa0": {
        "text_answer": "No  Explanation  The statement 00274 of the primary trial participants",
        "label": "Contradiction"
    },
    "b53a2698-dfb0-416d-9f3e-2e800a360b3e": {
        "text_answer": "Yes  The statement correctly identifies the interventions used in each trial",
        "label": "Entailment"
    },
    "f6835e26-4231-4f1a-a5f0-00e6919eb622": {
        "text_answer": "No   Explanation The evidence describes the administration of several intravenous IV and intrad",
        "label": "Contradiction"
    },
    "e5e13d2e-11bd-4f7c-867d-ab3d0e26666b": {
        "text_answer": " No   Explanation  The statement is not entailed by the evidence as the evidence describes",
        "label": "Contradiction"
    },
    "616edea0-8cb7-44c3-a866-af72680d31d3": {
        "text_answer": "No  The statement is not entailed by the evidence The primary clinical trial mentions the use of Abl C",
        "label": "Contradiction"
    },
    "0d63f301-9546-466f-aee9-78eea578b57f": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures tumor diameter in centimeters cm",
        "label": "Entailment"
    },
    "89e0e893-e053-491c-a276-055b30c5da2e": {
        "text_answer": "No  Explanation  The statement patients in the paced respiration intervention group of the",
        "label": "Contradiction"
    },
    "e3fac563-e6bf-418f-b9b2-3bc6e3539da9": {
        "text_answer": "Yes  Explanation The statement the primary disparity between the two interventions in the primary clinical",
        "label": "Entailment"
    },
    "776a17db-8314-4fc6-9de3-0d110db79269": {
        "text_answer": "No  The evidence pertains to a clinical trial for breast cancer patients considering aromatase inhibitor therapy not col",
        "label": "Contradiction"
    },
    "980339cb-7997-4209-b3b5-a4ddc3aff79e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the participants in the primary",
        "label": "Contradiction"
    },
    "93ff9af3-c812-4449-b311-06418b283233": {
        "text_answer": "No   Explanation   The statement provided is not a direct entailment of the evidence",
        "label": "Contradiction"
    },
    "fa11f174-260a-4836-b583-c40d4b10bad4": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 3 times the number of",
        "label": "Contradiction"
    },
    "0025afa1-ef06-42c9-9a6d-0f2aaf94c403": {
        "text_answer": "No   Explanation   The statement is not directly related to the evidence provided in the trial",
        "label": "Contradiction"
    },
    "60ceec88-a7b1-4353-8327-946c05a0a32a": {
        "text_answer": "No  Explanation  The evidence provided in the given text does not mention anything about fibrosis",
        "label": "Contradiction"
    },
    "bde8a5a0-02fc-4b6e-a91a-a56c420d9c3b": {
        "text_answer": "No  Explanation  The primary trial evaluates the toxicity of infusing HER2",
        "label": "Contradiction"
    },
    "4423a0fb-d4df-4046-bb60-04ba702c8623": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial have different outcome measurements The primary trial",
        "label": "Contradiction"
    },
    "f4d3c3ad-6c8c-4c7e-8d90-e321a9fa479d": {
        "text_answer": "No The statement is not entailed by the evidence as it contradicts the inclusion criteria for both trials which specify that participants",
        "label": "Contradiction"
    },
    "50252016-e56e-4dc0-99d0-589c3dfe05e8": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence reports no",
        "label": "Contradiction"
    },
    "851e1a1b-0b8e-4aef-a7e3-f06c036fe537": {
        "text_answer": "No  Explanation The statement cohort 1 of the primary trial is administered ",
        "label": "Contradiction"
    },
    "a89e4c9e-86e0-4d21-b805-2a593ed71a7c": {
        "text_answer": "Yes The statement does not mention Febrile neutropenia or Cholelithiasis so the absence of",
        "label": "Entailment"
    },
    "45745e85-0655-490a-a692-ee9f060f8898": {
        "text_answer": "Yes The statement does not mention UTI specifically but it does not contradict the evidence that no UTIs were",
        "label": "Entailment"
    },
    "d0de0260-eb83-45e9-81cf-02ee5edd3e60": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "b742bc02-cd24-4ae7-b8b8-2a57bbd60d14": {
        "text_answer": "Yes The statement includes all the mentioned exclusion criteria from the evidence except for the history of myocardial infar",
        "label": "Entailment"
    },
    "9484e4d1-8130-4d52-b362-faa1990946e9": {
        "text_answer": "Yes The statement is entailed by the evidence as the doses of Cyclophosphamide given in both interventions",
        "label": "Entailment"
    },
    "c752fd5f-8cf1-435e-8981-7323279b8130": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the outcome measurements",
        "label": "Contradiction"
    },
    "07d56cae-178f-43f3-8f85-c73817786951": {
        "text_answer": "No  Explanation  The statement about a patient diagnosed with stage II lymphoma absolute",
        "label": "Contradiction"
    },
    "49f03133-66cf-4980-8e2b-d7fb001edefd": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary clinical trial does not mention the administration of talazopar",
        "label": "Entailment"
    },
    "06b8d395-0fe7-4206-b118-5e478779cce0": {
        "text_answer": "Yes  Explanation  The statement There were no patients in the primary trial or the secondary trial",
        "label": "Entailment"
    },
    "ca7e6cda-c7dc-4cc7-82d5-732998d7993e": {
        "text_answer": "No  The evidence states the specific inclusion and exclusion criteria for each clinical trial The statement is too broad and does",
        "label": "Contradiction"
    },
    "e68875c8-9905-4821-ac2a-8fe4576a2071": {
        "text_answer": "No  Explanation The statement the primary trial had one test group and one placebo group",
        "label": "Contradiction"
    },
    "10543624-61ff-49dd-970a-5d6c57605f6d": {
        "text_answer": "Yes The statement is about the Punjabi language and does not contradict the evidence which only reports the absence of",
        "label": "Entailment"
    },
    "68a7d226-1e5b-4a29-b492-60e8f621e7bd": {
        "text_answer": "Yes The secondary clinical trial includes a requirement for a diagnosed alteration in one or more of the listed genes for patient inclusion",
        "label": "Entailment"
    },
    "e65ecb06-ff14-432b-826f-9bd26c456215": {
        "text_answer": "Yes  Explanation  The statement cyclophosphamide paclitaxel and",
        "label": "Entailment"
    },
    "7bc71832-7742-4a77-b0ca-d8820db7f9bd": {
        "text_answer": "Yes The statement implies that there is a detailed description and treatment cycle provided in the intervention section of the primary clinical trial",
        "label": "Entailment"
    },
    "215bc845-3485-423b-9c4c-1091cfb1a5cc": {
        "text_answer": "Yes The evidence states that 53 out of 60 participants or 883 in the",
        "label": "Entailment"
    },
    "408eec4d-435f-4edb-99ac-69cd883586b2": {
        "text_answer": "No  Explanation  The primary and secondary trials have different inclusion and exclusion criteria While there",
        "label": "Contradiction"
    },
    "d692776e-c2e9-450b-b0e8-57d84ccb216c": {
        "text_answer": "No  Explanation  The statement the secondary trial promotes oral ingestion of tablets",
        "label": "Contradiction"
    },
    "2b4a5598-2d21-426a-9d85-b0f94efb9bea": {
        "text_answer": "No  Explanation The statement is not about the adverse events in the trials but rather about Port",
        "label": "Contradiction"
    },
    "ee84e692-4923-4cb8-acad-8f27f64f4b9e": {
        "text_answer": "Yes  Explanation  The statement both the primary trial and the secondary clinical trial reported no ad",
        "label": "Entailment"
    },
    "f491f739-e852-496a-ad98-bbcb2f075cb9": {
        "text_answer": "  Yes  Explanation  The evidence shows that all three participants in the first cohort",
        "label": "Entailment"
    },
    "a325de64-fdaa-4c93-8e4a-22a1d502dd88": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Entailment"
    },
    "6d3a9617-a195-48e4-aa19-61a3ecde9ddb": {
        "text_answer": "No  Explanation  The statement Any Patients currently taking part in the secondary trial will also",
        "label": "Contradiction"
    },
    "0881a52f-e84b-43a4-8fda-446a7f2a1390": {
        "text_answer": "  No the statement is not entailed by the evidence for the secondary clinical trial as it only includes patients with BR",
        "label": "Contradiction"
    },
    "173793fc-ca3d-4296-a1c7-14fbde0a7b8c": {
        "text_answer": "Yes The primary trial describes a treatment cycle length of 21 days which is equivalent to one month The secondary",
        "label": "Entailment"
    },
    "0a6d1117-f868-4495-bb04-e5da37c15144": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly describes",
        "label": "Contradiction"
    },
    "4816c2e1-ae3b-4a0a-89b8-27a5cee580d7": {
        "text_answer": "No  Explanation  The statement pancreatic duct is a duct joining the",
        "label": "Contradiction"
    },
    "700f4bd9-6d39-4d3a-a425-bcb34d6712b6": {
        "text_answer": "No  The statement Women suffering from both claustrophobia and osteoporosis are",
        "label": "Contradiction"
    },
    "060b08af-40f5-4d26-8299-6f3d02c8fda7": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as both Intervention 1 and Inter",
        "label": "Entailment"
    },
    "0e80c163-f731-4e3b-9194-211675ca9c53": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts use the same instructional CD for paced breathing",
        "label": "Entailment"
    },
    "baea007a-c303-440b-a66c-0941729f416d": {
        "text_answer": "No  Explanation  The statement was in situ hybridization performed is not directly related to",
        "label": "Contradiction"
    },
    "e1142532-82b5-4f1c-9d7c-33b677b92966": {
        "text_answer": "No  Explanation  The statement the most common adverse event in the primary clinical trial was",
        "label": "Contradiction"
    },
    "3433a50a-b13a-43a5-ba9c-041959f23390": {
        "text_answer": "No  Explanation  The statement 0 participants in group 1 of the primary trial were found",
        "label": "Contradiction"
    },
    "09aef225-50fa-457e-9e8b-fce6aafd4705": {
        "text_answer": "Yes The statement is entailed by the evidence as the patients receive oral medication lapatinib and tamoxifen",
        "label": "Entailment"
    },
    "d51ecd4d-4188-4306-9c41-962c86a12652": {
        "text_answer": "  No children are explicitly excluded from the primary trial The statement only mentions that they are not eligible for the",
        "label": "Contradiction"
    },
    "f87a205c-5de6-4cda-a798-85b7308e25c2": {
        "text_answer": "No  Explanation  The statement missouri is a state in the central midwest united states",
        "label": "Contradiction"
    },
    "0308c864-0730-4a28-9bb4-7a51eba3e438": {
        "text_answer": "No  Explanation  The statement topical solution dosage form is a solution intended for administration",
        "label": "Contradiction"
    },
    "429199a7-de1a-4900-939b-e4f6efadb474": {
        "text_answer": "No  The evidence does not mention anything about central nervous system cysts or eating disorders in the given trial data",
        "label": "Contradiction"
    },
    "285be2fe-e597-4d99-acb9-7504bcfb3d6f": {
        "text_answer": "No  The statement is not entailed by the evidence as acrocephalosyndactyly is",
        "label": "Contradiction"
    },
    "98c65216-ca06-4666-99e3-0d06dc97c01d": {
        "text_answer": "Yes The woman with ongoing therapy for Stage I BC after lumpectomy is excluded from both trials according to their respective excl",
        "label": "Entailment"
    },
    "9ea892eb-1362-4281-aac7-713905f1bb2c": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as there is no",
        "label": "Contradiction"
    },
    "d3df95aa-4564-4503-9322-64f5664ce1c3": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention for adult cancer patients is specifically mentioned in the evidence",
        "label": "Entailment"
    },
    "3921fd1d-1ba6-475c-a6f5-c8f76fe8cbe9": {
        "text_answer": "No  Explanation  The statement the results of the bevacizumab  cap",
        "label": "Contradiction"
    },
    "ae574646-62f1-4b5f-b565-4af6bbafe7a6": {
        "text_answer": "Yes  Explanation The statement compared with the secondary clinical trial the primary trial has less reported",
        "label": "Entailment"
    },
    "83e62365-e433-4411-9a4d-951e08c6b91c": {
        "text_answer": "Yes for the primary trial assuming the patients cancer is a solid tumor malignancy  Ex",
        "label": "Entailment"
    },
    "c0915bad-2882-4f25-a6d5-5f2b71bc8850": {
        "text_answer": "Yes The evidence does not mention any specific restrictions on hepatic function in the inclusion criteria",
        "label": "Entailment"
    },
    "ad52e20e-99a7-4001-b957-12b24a3d1df1": {
        "text_answer": "Yes The statement is entailed by the evidence as the adverse events were recorded for cohort 1 patients in",
        "label": "Entailment"
    },
    "7b9338a5-d3a8-405f-a197-736caf32c455": {
        "text_answer": "No  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Contradiction"
    },
    "0c5d58a3-a565-4b42-ae6f-24bd3be00b06": {
        "text_answer": "No  Explanation The statement is not an accurate representation of the inclusionexclusion criteria in the evidence",
        "label": "Contradiction"
    },
    "0ef97135-5f94-407d-a48d-f40cd6272ed5": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a510de48-5778-4489-8d10-82173320bdad": {
        "text_answer": "Yes   Explanation  The statement intervention one uses higher doses of radioactive T",
        "label": "Entailment"
    },
    "5a736ff9-b224-4cf6-ae71-55a825bff301": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "54fbf052-31df-43af-b20e-8947042351bc": {
        "text_answer": "Yes  The primary trial has a greater number of instances of biliary colic and diarrhea compared to the",
        "label": "Entailment"
    },
    "7a735242-b198-4348-ac48-f318cd704752": {
        "text_answer": "Yes  Explanation The statement the dosage of denosumab used in intervention 1",
        "label": "Entailment"
    },
    "e5d1118c-2e6a-4e00-a63c-041c43256c5e": {
        "text_answer": "No   Explanation   The evidence provided in the trial results does not include any information about",
        "label": "Contradiction"
    },
    "9e960679-ac10-4893-a777-94baac5a89f3": {
        "text_answer": "Yes The evidence states that the intervention for cohort 2 of the primary clinical trial does not include the administration of",
        "label": "Entailment"
    },
    "8b54773e-b9b0-400f-af71-8fd2cbd16473": {
        "text_answer": "No   Explanation  The primary trial involves PF0664702",
        "label": "Contradiction"
    },
    "fdadf425-1eaf-4e63-b034-29afcbe48baf": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence states that the only adverse event recorded in the primary trial",
        "label": "Entailment"
    },
    "54176448-042e-4b40-835e-ddf60eb53f80": {
        "text_answer": "Yes The evidence does not explicitly state that patients of Asian descent living in California cannot be part of the primary clinical trial",
        "label": "Entailment"
    },
    "c7bddafb-404b-40be-80c0-f0b4e08d6466": {
        "text_answer": "Yes The statement is consistent with the evidence as it mentions that there is only one adverse event recorded in the",
        "label": "Entailment"
    },
    "ebaa9747-0c6a-4258-b0b8-121541b4662a": {
        "text_answer": "Yes The evidence does not mention any use of imaging techniques in either clinical trial",
        "label": "Entailment"
    },
    "63da892b-0385-43c5-8ed3-3ce7514ebb55": {
        "text_answer": "Yes  Explanation The statement the adverse events reported for cohort 1 of the primary",
        "label": "Entailment"
    },
    "7e288efd-8755-4393-b372-effd1c3feb91": {
        "text_answer": "No  Explanation  The statement there were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "c94158fd-10f5-4142-a361-5b346ff2c295": {
        "text_answer": "No  Explanation  The statement There are more cases of Biliary colic and Clost",
        "label": "Contradiction"
    },
    "53b41c0c-179c-45ce-90e6-3f444681b41e": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not mention anything about canine sar",
        "label": "Contradiction"
    },
    "474339d0-2bac-4e3a-9aee-1933b96738b0": {
        "text_answer": "Yes  Explanation The primary trial administers a loading dose of 4 mgkg followed by",
        "label": "Entailment"
    },
    "85dcd465-ec0b-42ae-aec6-582831584bbf": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial includes various types of breast cancer not",
        "label": "Contradiction"
    },
    "cfa6601b-af52-4eee-883c-89d42b73e02b": {
        "text_answer": "No  Explanation  The statement the secondary trial patients suffered from anemia pneum",
        "label": "Contradiction"
    },
    "41cbc4ea-37f8-468e-bfd2-f0a71e8856b5": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "5dc5fa82-a4a5-4f16-8ca1-b797546169af": {
        "text_answer": "No  Explanation  The statement severe pain or discomfort that prevented most activities is a",
        "label": "Contradiction"
    },
    "28e19ec3-f22a-4002-9020-02ef29c4386c": {
        "text_answer": "No  Explanation  The statement in cohort 1 of the primary clinical trial",
        "label": "Contradiction"
    },
    "d94a09b9-8201-43f3-9b27-cab0bc473af0": {
        "text_answer": "No  Explanation  The statement The intervention in the secondary trial lasts 3 times longer",
        "label": "Contradiction"
    },
    "1d57af11-9dc3-4589-ae99-fe0e9dab6042": {
        "text_answer": "Yes Both trials include ECOG performance status of 02 indicating patients who are able to take care of",
        "label": "Entailment"
    },
    "072b76ba-9fd5-4313-b484-c353f61ecca9": {
        "text_answer": "Yes The statement is entailed by the evidence as fibromyalgia and thalasemic syndromes are",
        "label": "Entailment"
    },
    "7e57517f-4dc5-4457-bc4e-12f7faef37f4": {
        "text_answer": "Yes  Explanation  The statement anemia pneumonia and stupor were",
        "label": "Entailment"
    },
    "168c59cb-7be6-4f14-acd9-5d731b8464c8": {
        "text_answer": "Yes The primary clinical trial does not involve xrays transendocardial injections CT scans",
        "label": "Entailment"
    },
    "0483c5df-77db-4c42-897e-aca21b207503": {
        "text_answer": "No  Explanation The statement numerous instances of pancytopenia were noted in coh",
        "label": "Contradiction"
    },
    "93cfa70f-2bdc-4e2f-ac51-5e06f2fb07ea": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence pertains to inclusion and exclusion criteria for a",
        "label": "Contradiction"
    },
    "9c60f664-ef13-406d-b26a-e57f6c914cf4": {
        "text_answer": "Yes The evidence does not specify the kras gene mutation status for individual patients but it does state that all patients",
        "label": "Entailment"
    },
    "79a4ea13-6d2a-49e0-8c1d-9c1fcc7e9e3b": {
        "text_answer": "No  Explanation  The statement HER2  Patients in the primary trial receive the same",
        "label": "Contradiction"
    },
    "4e3b9642-3f02-4f4b-bfee-f2e3b1673186": {
        "text_answer": "Yes   Explanation  The statement accurately reflects the information provided in the evidence regarding the different dosing",
        "label": "Entailment"
    },
    "7128da72-a0ed-48cb-b167-c2b6176faa71": {
        "text_answer": "Yes  Explanation  The evidence shows that the median aAUCpa for the Sensory",
        "label": "Entailment"
    },
    "94aea5d0-2afb-40a4-b1c8-574c9f22225e": {
        "text_answer": "yes the evidence provides information on survival but it does not directly address systolic blood pressureforage percentiles",
        "label": "Entailment"
    },
    "dfd43b21-a734-49b1-8a64-d6dea31e9031": {
        "text_answer": "No  Explanation  The statement capnocytophaga is a genus of gramnegative",
        "label": "Contradiction"
    },
    "26be8c11-aebf-4982-b09e-75dead3cdf4a": {
        "text_answer": "No  Explanation  The statement None of the cohort of the primary trial or the",
        "label": "Contradiction"
    },
    "5578e4a3-95d9-4803-8d13-b9c0276f92e0": {
        "text_answer": "Yes  Explanation The statement Both cohorts of the primary trial receive the same dos",
        "label": "Entailment"
    },
    "b6b819ce-57a9-4883-bcf9-f8c9a9bae83e": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence However its important to note that the statement",
        "label": "Entailment"
    },
    "c803b01e-6f64-4412-a3c2-6b1a70d5cf7e": {
        "text_answer": "No  The evidence does not mention anything about a mental health assessment being a requirement for enrollment in the clinical trial",
        "label": "Contradiction"
    },
    "ceb0ef65-5640-491d-a6c6-341e456b0bdd": {
        "text_answer": "Yes for febrile neutropenia Answer No for cholelithiasis",
        "label": "Entailment"
    },
    "d2e42255-bde4-4e21-a914-b4e0c35b6e3d": {
        "text_answer": "No  Explanation  The statement patients with Frontotemporal dementia",
        "label": "Contradiction"
    },
    "a6688fad-488e-4822-a91e-cbfe2117cae1": {
        "text_answer": "Yes  Explanation The evidence provided in the clinical trial results indicates that nine out of the 2",
        "label": "Entailment"
    },
    "bfef0d2b-81c0-4f5f-bf91-a313a0a2dcbb": {
        "text_answer": "No  Explanation  The evidence provided in the text indicates that the participants in the Tamoxif",
        "label": "Contradiction"
    },
    "a630808d-14d5-4ef8-bd2e-73ce5e80f3f1": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "378c5fe6-13ce-488e-a8c0-ec76cf2fb191": {
        "text_answer": "No  Explanation  The statement patients receiving aprepitant in the primary clinical trial",
        "label": "Contradiction"
    },
    "2ae5eea7-46bf-425e-b528-201a718d7f66": {
        "text_answer": "No  Explanation The evidence provided in the trial results only reports the Ki67 expression change from",
        "label": "Contradiction"
    },
    "97322f7f-a311-4718-8a0c-5e4ecdd33f7f": {
        "text_answer": "No  Explanation  The primary clinical trial measures tumor response using RECIST criteria while",
        "label": "Contradiction"
    },
    "8920d439-7233-461b-a343-3c264f0918de": {
        "text_answer": "No  Explanation  The statement Not a single one of the participants in group 1 of",
        "label": "Contradiction"
    },
    "b2b80e2f-f5b4-4997-9209-fd061ff307b9": {
        "text_answer": "Yes  Explanation The statement through transendocardial injection both the placebo and",
        "label": "Entailment"
    },
    "b410caf4-4ea2-414d-8b43-7336d2bb2d9b": {
        "text_answer": "No   Explanation   The primary trial includes a criterion for the primary tumour",
        "label": "Contradiction"
    },
    "38343873-8e16-4852-bfe5-511fbd1be49d": {
        "text_answer": "Yes The evidence shows that there were patients in both groups who survived less than 2 years However the overall median",
        "label": "Entailment"
    },
    "48b186f8-f41c-4582-8dbb-6918ce072ce8": {
        "text_answer": "No  Explanation  The statement Cholelithiasis was twice as common for the",
        "label": "Contradiction"
    },
    "64ea29b0-1d21-4c59-a56e-553765f5e5c8": {
        "text_answer": "No  The statement is not directly related to the eligibility criteria for the primary trial as stated in the evidence",
        "label": "Contradiction"
    },
    "c939c0c9-57b8-4f8a-aba1-e19af522cb12": {
        "text_answer": "No  Explanation  The statement the primary clinical trial observed more cases of palpitations",
        "label": "Contradiction"
    },
    "f1a4fdcb-09ae-4f35-9681-8ee7d0d3b41d": {
        "text_answer": "Yes  Explanation The statement cohort 1 receives more durva in their bi",
        "label": "Entailment"
    },
    "6a489a42-add9-40b7-ba9d-5d46da07b890": {
        "text_answer": "No   Explanation   The statement is not directly related to the evidence provided The evidence",
        "label": "Contradiction"
    },
    "a67f344b-aa15-4e94-819b-515df442eaf0": {
        "text_answer": "  Yes  Explanation  The evidence states that 53 out of 60 participants",
        "label": "Entailment"
    },
    "5780e67e-7318-4574-b20c-a2d3c8730e4a": {
        "text_answer": "Yes The statement is entailed by the evidence as the dosage of Eribulin in Intervention 1 is higher",
        "label": "Entailment"
    },
    "2f61841c-b395-4d2c-9e86-ca09cdd61dcb": {
        "text_answer": "  No the statement is not entailed by the evidence as it is not a direct comparison of the inclusion and excl",
        "label": "Contradiction"
    },
    "9ce6d69e-2ed0-4046-bd5e-5888416fbeb5": {
        "text_answer": "No  Explanation  The statement there were 16 cases of febrile neutrop",
        "label": "Contradiction"
    },
    "b490a735-38d7-49f2-a091-f930c5d1e9f5": {
        "text_answer": "No  The evidence states that persons with dementia are excluded from the trial and Parkinsons disease is",
        "label": "Contradiction"
    },
    "5b6c2caa-eb80-4024-b04c-e6b07685b7d8": {
        "text_answer": "No  Explanation  The statement over 15 of patients in the primary trial and",
        "label": "Contradiction"
    },
    "4714a31c-c7ca-49e2-aa71-6665b65ed04f": {
        "text_answer": "Yes for the primary trial morbidly obese patients are not explicitly mentioned in the inclusion or exclusion criteria",
        "label": "Entailment"
    },
    "5ce6d9b3-235b-4645-bc27-10861b2e5177": {
        "text_answer": "Yes The evidence does not report any cases of surgical incisions reopening following the operation",
        "label": "Entailment"
    },
    "c6f11ac1-ac2e-4740-82aa-a83ffd1cce00": {
        "text_answer": "No  Explanation  The statement there were no psychiatric adverse events reported during the primary",
        "label": "Contradiction"
    },
    "fbb05804-2d6c-4d49-8e06-0fbf2b3770a4": {
        "text_answer": "Yes   Explanation  The statement a single drug makes up the intervention in the primary clinical",
        "label": "Entailment"
    },
    "9f0a6fc9-62c5-404e-aa2f-0e5acf696e14": {
        "text_answer": "No   Explanation  The statement cardiac adverse events were prominently recorded in",
        "label": "Contradiction"
    },
    "cca11232-84c4-44e1-89f1-b57b28643dce": {
        "text_answer": "No  The evidence states that there were no adverse events recorded in the primary trial for Adverse Event 1",
        "label": "Contradiction"
    },
    "d803319b-cf1d-47e9-b7c2-f75ef7972e88": {
        "text_answer": "No  Explanation  The primary clinical trial is focused on measuring the difference in pain intensity using Sum",
        "label": "Contradiction"
    },
    "ad17d770-f8c6-4440-8b95-894a511cab39": {
        "text_answer": " No   Explanation  The statement women diagnosed with claustrophob",
        "label": "Contradiction"
    },
    "adfed785-8da6-4bf4-836f-2dfadf0510b6": {
        "text_answer": "Yes  The primary trial has different inclusion and exclusion criteria for its Phase I and Phase II portions while the secondary",
        "label": "Entailment"
    },
    "aa78eaae-97c9-4f34-97e4-4debfccd1552": {
        "text_answer": "No  Explanation  The statement the zoledronic acid 4 mg group experienced a",
        "label": "Contradiction"
    },
    "a8fa1843-9726-4f19-a026-7155df678098": {
        "text_answer": "No  Explanation  The evidence provided in the adverse events data does not mention anything about hy",
        "label": "Contradiction"
    },
    "832ab731-553d-4d66-a339-1fb60265866a": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "019f248f-f753-495a-b579-9d41f65c5b26": {
        "text_answer": "Yes  Explanation  The statement neither the primary nor the secondary clinical trial have reported any",
        "label": "Entailment"
    },
    "8b6e90d0-d3e2-41db-9d70-ce8b216f3795": {
        "text_answer": "Yes The evidence does not explicitly state that the trial is open to AfricanAmerican participants in Texas specifically but it does",
        "label": "Entailment"
    },
    "27fcd959-e1dd-4c76-8e6c-fdf5fe4d257f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "4d1031f5-19e1-43f3-b75a-5e8208b44bfb": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial did not show significant differences between the groups while the",
        "label": "Entailment"
    },
    "f8858128-03f8-4721-a0f5-5f3fce7ab1c4": {
        "text_answer": "  No The statement is not entailed by the evidence as the statement refers to those having assessable bilateral breast",
        "label": "Contradiction"
    },
    "f9ad6db3-d2bc-474c-b666-a971749f6a83": {
        "text_answer": "  Yes the patient can be considered for the primary trial based on the inclusion criteria However the patients",
        "label": "Entailment"
    },
    "0090fc12-4092-4255-8952-21ebee889ebb": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement refers to",
        "label": "Contradiction"
    },
    "151ebcdf-fc4e-443e-8c2d-5189b65cee5b": {
        "text_answer": "No  Explanation  The statement the secondary trial candidates must meet some Performance Status condition to participate",
        "label": "Contradiction"
    },
    "b49ac921-1516-409d-9e81-14fc5afc75c6": {
        "text_answer": "No  Explanation  The statement malignant oncocyte is a malignant",
        "label": "Contradiction"
    },
    "6ee4b112-4ff6-49d0-a7ec-a9e71d309bb9": {
        "text_answer": "No  Explanation  The statement xxyy syndrome is a rare sex chromosome ab",
        "label": "Contradiction"
    },
    "ef734fea-a713-4fb3-b6e9-0be2dc2b055a": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "d1a7cbaa-161a-4675-b8b7-67ae364be364": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "d4b299e3-f371-4311-9ea6-b3301632d7df": {
        "text_answer": "No  Explanation  The statement is not directly related to the adverse events listed in the evidence",
        "label": "Contradiction"
    },
    "9c5bbe3a-c662-4a0e-88cf-b2f5fc1188f8": {
        "text_answer": "No  Explanation  The statement within the scope of the primary clinical trial the preval",
        "label": "Contradiction"
    },
    "47c91759-a386-407e-9612-dbce68040a7b": {
        "text_answer": "No  The statement is not directly related to the evidence provided which pertains to adverse events in a clinical trial",
        "label": "Contradiction"
    },
    "2db7c3cd-eb62-4ec4-8d89-effa9c9212e0": {
        "text_answer": "No  Explanation  The statement both the primary and secondary clinical trials have recorded instances of an",
        "label": "Contradiction"
    },
    "cd067ee2-ed1d-403b-aa50-d61a3399fda3": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ee7fc1bb-98fe-4f43-9ea0-076b7fc7eeca": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention the number of patients who experienced no",
        "label": "Contradiction"
    },
    "aefb2cc5-3101-416b-bae4-c9a1e7d8f39e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fb140d2c-d2a8-4442-bcbd-669bb9abbf2c": {
        "text_answer": "  No   Explanation   The statement there are no restrictions regarding the participation of",
        "label": "Contradiction"
    },
    "c01a6286-57b2-4851-8c5e-12710eb9d829": {
        "text_answer": "  No the statement about children and adolescents not being eligible for the primary trial due to height requirement is not",
        "label": "Contradiction"
    },
    "5d98b3df-684a-466d-93da-5a672f602db6": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive pembrolizumab twice",
        "label": "Contradiction"
    },
    "128fd57d-cc06-40a3-8eb5-570441a19652": {
        "text_answer": "No  Explanation The statement the interventions implemented in the primary clinical trial skip the use of",
        "label": "Contradiction"
    },
    "10818b02-4a1d-438a-8f90-7aded2b826ec": {
        "text_answer": "No   Explanation  The statement counselor is a person with training to provide",
        "label": "Contradiction"
    },
    "6a696416-b67e-4f78-8677-3fbc4470b4c1": {
        "text_answer": "No  Explanation  The statement age at initial pathologic diagnosis is a question about the",
        "label": "Contradiction"
    },
    "9c253aed-c7ae-42ad-afd2-9c52c9ecab08": {
        "text_answer": "  Yes the patient described in the statement meets the inclusion criteria for both trials based on the provided information",
        "label": "Entailment"
    },
    "63cb536d-5250-4760-b3a8-103bfcc45123": {
        "text_answer": "No  The evidence provided does not mention anything about trabecular pattern or neoplastic cells",
        "label": "Contradiction"
    },
    "3136ac0b-82b2-4819-a5ba-d5816dd0283b": {
        "text_answer": "No   Explanation  The statement all patients in the primary clinical trial encountered aes",
        "label": "Contradiction"
    },
    "d2ac18d1-d427-4afc-b72a-4de7856b17d5": {
        "text_answer": "Yes  Explanation  The statement all cases of gastrointestinal and bloodrelated",
        "label": "Entailment"
    },
    "8b14dd2f-b02e-41be-a2bc-7dcc378ab426": {
        "text_answer": "No  Explanation  The statement The dosage of Denosumab in Intervention ",
        "label": "Contradiction"
    },
    "e1eb6c8e-61e1-474a-a01c-f7d18d2620e9": {
        "text_answer": "No  Explanation  The statement there were 4 more patients that suffered adverse events in",
        "label": "Contradiction"
    },
    "8655fdcd-564c-483a-aa2b-7dac2d84ce57": {
        "text_answer": "No  Explanation The statement patients diagnosed with tumors positive for CCND1 amplification",
        "label": "Contradiction"
    },
    "e8edca4b-3a7c-43b6-aed4-8651d1dee36f": {
        "text_answer": "No  Explanation  The statement infections occurred in over 15 of patients involved",
        "label": "Contradiction"
    },
    "682a4e2d-f4a5-4fee-8399-195f67fcdfcc": {
        "text_answer": "No  Explanation  The statement at different intervals throughout the trials the same dose of tr",
        "label": "Contradiction"
    },
    "4b310647-d605-4946-aeb5-bcfd418e1332": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial both intervention one and two use",
        "label": "Contradiction"
    },
    "cd93653b-f6d1-4e8c-aa04-20a41d0096b9": {
        "text_answer": "Yes The primary trial had 000 anemia cases while the secondary trial had 43",
        "label": "Entailment"
    },
    "e255fdb7-4e8b-4e62-bbb8-875687948bed": {
        "text_answer": "Yes  Explanation The evidence states that during the primary clinical trial there were 5 participants in",
        "label": "Entailment"
    },
    "8b98421d-1cec-41bd-b25e-2e73c362193a": {
        "text_answer": "Yes The evidence does not specify eligibility based on nationality ethnicity psychiatric condition or gender",
        "label": "Entailment"
    },
    "59a0bff2-c254-45f1-a6ae-2d847777db94": {
        "text_answer": "No  Explanation  The statement the primary trial reports the Time to Progression in days for",
        "label": "Contradiction"
    },
    "22f473e7-1aea-4baf-9697-224ea4c6fbdf": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial describes the use of Vorinost",
        "label": "Contradiction"
    },
    "03ee1d82-5208-4511-9163-23adfbc55fa4": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial specifically excludes women",
        "label": "Contradiction"
    },
    "3f532833-d78c-41a1-b364-81228e03027e": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary and secondary trials involve",
        "label": "Contradiction"
    },
    "fd942f9a-9ad7-43f3-aac3-69b01a022811": {
        "text_answer": "No  Explanation  The statement gastric pylorus carcinoma is a car",
        "label": "Contradiction"
    },
    "8fe01416-c839-4ffc-bd21-25d158d502b8": {
        "text_answer": "Yes The evidence states that there was no case of wound dehiscence reported in the primary clinical trial",
        "label": "Entailment"
    },
    "1a3483cd-0a92-456f-ba18-6ce12b3ded0b": {
        "text_answer": "Yes The evidence states that significant cardiovascular impairment is an exclusion criterion for both trials",
        "label": "Entailment"
    },
    "7bf988b4-5e6f-41c4-bef6-7b3549dd58d9": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include patients with ER positive PR positive or HER",
        "label": "Entailment"
    },
    "68b82fb4-066b-4d76-9623-ff8696da3000": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fae99e77-42d1-4003-bb7a-3b98b88f7c27": {
        "text_answer": "No   Explanation  The statement adverse events were documented in both cohorts participating",
        "label": "Contradiction"
    },
    "eb555e01-0a12-45a1-99ad-7d7dafbe8912": {
        "text_answer": "No  Explanation  The statement Cohort A and B of the primary trial are administer",
        "label": "Contradiction"
    },
    "69c802bf-ab3f-4a0a-b995-210db2403a50": {
        "text_answer": "yes The primary trial involves adjusting the dosage of alpha lipoic acid while the secondary trials first",
        "label": "Entailment"
    },
    "f96f9461-2b00-4838-9e04-1d3a8dbeb3f3": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial involves the use of epirubicin 1",
        "label": "Entailment"
    },
    "01effe7e-449f-4f59-a64e-2b38c5c21187": {
        "text_answer": "No  Explanation  The statement 2 out of 73 individuals in the primary clinical trial",
        "label": "Contradiction"
    },
    "ece744da-a8d6-401a-972c-3a9f5cd60b14": {
        "text_answer": "Yes Each individual adverse event was reported in only one patient in the primary clinical trial",
        "label": "Entailment"
    },
    "21d37b8b-4326-40bd-a070-5ad0fbb48e6d": {
        "text_answer": "  No   Explanation   The statement Breast cancer patients with estrogen",
        "label": "Contradiction"
    },
    "1b5e0318-38e0-484f-bffd-d63ff75fe93c": {
        "text_answer": "No   Explanation The statement neither the primary clinical trial nor the secondary clinical trial registered any",
        "label": "Contradiction"
    },
    "f5daafd4-0b8b-4239-b566-e7b2c1b80825": {
        "text_answer": "  No  Explanation  The statement patients who have received chemotherapy or radiotherapy",
        "label": "Contradiction"
    },
    "ce4851a3-948d-4eca-8d86-2a70f3bbd577": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions in",
        "label": "Contradiction"
    },
    "b21fa80a-d451-46c7-8916-bf3029156624": {
        "text_answer": "Yes The evidence explicitly states that patients with a history of grade 3 or 4 allergic reactions attributed to trast",
        "label": "Entailment"
    },
    "3958b171-1f79-4dae-958a-be87bb3b44c0": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary clinical trial involves the use of",
        "label": "Entailment"
    },
    "f498a2b6-b3da-45a2-b9d5-ef87ee43914f": {
        "text_answer": "Yes The statement does not conflict with the inclusion or exclusion criteria in the evidence The statement only pertains to the",
        "label": "Entailment"
    },
    "25551d37-108d-497a-8e75-825d8d707190": {
        "text_answer": "No  The evidence only mentions unilateral breast cancer",
        "label": "Contradiction"
    },
    "5a1445df-c3d7-4d1e-a4d3-e18ac2238a97": {
        "text_answer": "Yes  Explanation  The statement during the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "d17230ee-836d-4153-b940-8e3dd7741964": {
        "text_answer": "No  Explanation  The statement a weekly cycle of 4demethyl4",
        "label": "Contradiction"
    },
    "62d189a0-04ee-44d7-962e-35629b28736c": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial excludes patients with a pulmonary",
        "label": "Contradiction"
    },
    "321c299b-2264-4cc6-988d-faef346ca38a": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not mention",
        "label": "Contradiction"
    },
    "d8af88b9-e015-4eec-b49f-6b2398e38a5d": {
        "text_answer": "No  Explanation  The statement synchronous nodules without dominant lesions",
        "label": "Contradiction"
    },
    "db5f7526-ae64-4a0c-bea4-53b4bfe95d48": {
        "text_answer": "No   Explanation  The statement patients will need to receive one single injection on day",
        "label": "Contradiction"
    },
    "d4f98c24-aad0-4784-9b90-da1a99b9a59b": {
        "text_answer": "Yes  Explanation The evidence shows that a smaller percentage of participants in the ERpositive Lum",
        "label": "Entailment"
    },
    "3137468e-52bf-4bff-a3cc-68f127683f63": {
        "text_answer": "No  Explanation  The statement in comparison to the primary clinical trial the secondary clinical trial",
        "label": "Contradiction"
    },
    "060a4ded-7677-4945-90ff-b6b93204f94c": {
        "text_answer": "  Yes for the primary trial pulmonary embolism is a reason for exclusion within 4 weeks",
        "label": "Entailment"
    },
    "a02d9319-0103-493a-8368-f79dbbe6a223": {
        "text_answer": "No  Explanation  The statement ascites was more likely to occur in patients from the secondary",
        "label": "Contradiction"
    },
    "22aed38a-d9c2-4e5e-b738-07f75968c45a": {
        "text_answer": "No   Explanation  The evidence provided does not indicate the number of patients who experienced adverse",
        "label": "Contradiction"
    },
    "4d8795f1-f8bf-4c27-9eb1-3f7db45c03ec": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide information",
        "label": "Contradiction"
    },
    "f706897d-d54e-4449-8bc7-da0bd6fbad01": {
        "text_answer": "Yes Both trials allow ECOG performance status of 02 including a score of 1",
        "label": "Entailment"
    },
    "e8b222ce-e235-4b8d-b524-521ba583656a": {
        "text_answer": "No  Explanation  The statement the most common adverse event in the primary clinical trial was",
        "label": "Contradiction"
    },
    "3bf96cd4-147b-45f2-b174-e3a375a67e26": {
        "text_answer": "No  The statement is not about breast cancer and hormonal treatment as per the given evidence It is about repeat expansion",
        "label": "Contradiction"
    },
    "b06e2353-00ae-4f10-b072-a4ae5f608d3e": {
        "text_answer": "Yes However its important to note that the statement is not explicitly stated in the evidence but the inclusion criteria",
        "label": "Entailment"
    },
    "15414f62-cb14-4bf8-98aa-0fbd74edd41c": {
        "text_answer": "No  Explanation  The primary trial does show that the intraoperative mammography arm",
        "label": "Contradiction"
    },
    "8c507ad1-b534-4d16-9a1b-5c92a432eb9d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial does evaluate",
        "label": "Contradiction"
    },
    "dbc1b653-7c38-4c7c-bad8-5949d6f909ed": {
        "text_answer": "Yes but with a clarification The statement patients with nonmeasurable unilateral breast cancer are",
        "label": "Entailment"
    },
    "3eb6d0c5-4bc4-4808-b8cb-03b3d5d40a07": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial is utilizing on the investigation of varying quantities",
        "label": "Entailment"
    },
    "2735976f-a517-4b4e-addb-845ef4dc0d33": {
        "text_answer": "No  Explanation  The statement patients having unregulated high blood pressure along with m",
        "label": "Contradiction"
    },
    "4dc9c970-22dc-4117-8169-255a0b3f80d8": {
        "text_answer": "No  Explanation  The statement There were several psychiatric adverse events in the primary trial",
        "label": "Contradiction"
    },
    "043f8072-1e16-4e74-8ad4-50ff1786fb48": {
        "text_answer": "No  Explanation  The statement less than 3 of patients in the primary clinical trial",
        "label": "Contradiction"
    },
    "31837502-2949-4dc4-bfbe-fc54ca5ccb01": {
        "text_answer": "No  Explanation  The statement abnormal involuntary movement scale aims0108",
        "label": "Contradiction"
    },
    "ba589a4b-13ef-43be-8441-438742dd9d5c": {
        "text_answer": "No  Explanation  The statement tumor findings evaluator is a person who determines the",
        "label": "Contradiction"
    },
    "b0c8481b-3041-4b12-b272-11bb5ee7f80e": {
        "text_answer": "No  Explanation  The statement half of primary clinical trials participants and 8",
        "label": "Contradiction"
    },
    "5d657b3f-a074-480e-8698-24c288553369": {
        "text_answer": "Yes The evidence does not mention any interventions involving drugs radiotherapy or CBT in the primary clinical trial",
        "label": "Entailment"
    },
    "145671c6-1b45-49a9-9fc7-8c65e8461115": {
        "text_answer": "Yes The statement does not mention specific adverse events related to cerebral artery but the evidence provided indicates that",
        "label": "Entailment"
    },
    "0e28f749-6c65-46fc-93c0-c3b68c96460e": {
        "text_answer": "Yes The placebo is administered via intravenous infusion on Day 1 while trabectedin is",
        "label": "Entailment"
    },
    "97c738f3-a7ef-4183-9664-5aac4fd64a0e": {
        "text_answer": "Yes  Explanation  The statement the number of participants in the secondary clinical trial exceeded those",
        "label": "Entailment"
    },
    "451e07e2-524d-459e-872c-1c4b3640f511": {
        "text_answer": "No  Explanation The statement feel hopeless is a question about whether an individual feels or",
        "label": "Contradiction"
    },
    "7f3a5491-e157-4fbc-a939-8478889c15dc": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial measures the",
        "label": "Contradiction"
    },
    "67b45a2f-d082-4386-b70e-eb212a1762a0": {
        "text_answer": "Yes The statement is entailed by the evidence as the inclusion criteria for both phases of the clinical trial allow for patients of",
        "label": "Entailment"
    },
    "eeb18145-fc5f-41d7-bce3-245d21000e7b": {
        "text_answer": "No  Explanation  The evidence provided states that 53 out of 60 participants in",
        "label": "Contradiction"
    },
    "ddf14eb0-04ae-431b-b4e8-ba97eddc25b7": {
        "text_answer": "No  The statement is not entailed by the evidence  The primary trial involves injections of Fluciclat",
        "label": "Contradiction"
    },
    "c8c9752f-a60b-4173-bbe7-deb1a894ebe5": {
        "text_answer": "Yes The secondary trial involves the use of a drug PF06647020 with different",
        "label": "Entailment"
    },
    "c3445b55-8b79-4ac0-9ace-25e48c82760c": {
        "text_answer": "  No  Explanation  The statement women aged 18 or 19",
        "label": "Contradiction"
    },
    "2fc8ee27-e602-47ae-a93b-1c8194e3d6ea": {
        "text_answer": "No   Explanation  The evidence describes two interventions in the clinical trial both of which",
        "label": "Contradiction"
    },
    "79ddd80e-a0b2-4450-a0df-892e8b15dd63": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "57bc58fc-44ce-4938-9bfa-4750bac013ac": {
        "text_answer": "No  Explanation  The statement adverse events were commonplace and severe in both the primary",
        "label": "Contradiction"
    },
    "26091849-cc57-4866-8faa-ac9fb64caf69": {
        "text_answer": "No  Explanation  The statement There are less total adverse events in the primary trial than",
        "label": "Contradiction"
    },
    "e3e8c1c5-ae1f-4f90-8584-b24096bb580a": {
        "text_answer": "No  Explanation The statement does not mention anything about the IPSSR risk category being a",
        "label": "Contradiction"
    },
    "21d59751-a53d-4262-8410-9959aa93dea4": {
        "text_answer": "No   Explanation  The statement the number of participants in cohort 1 and",
        "label": "Contradiction"
    },
    "e57df144-6c3e-4855-a2d3-fcbec0396750": {
        "text_answer": "Yes  Explanation  The statement There was at least 1 case of infection in both the",
        "label": "Entailment"
    },
    "ecf58a7c-3e70-4ac2-b37f-d96294786b0d": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide any information",
        "label": "Contradiction"
    },
    "eb853544-9c67-43a4-bbfa-c5e35dec2a33": {
        "text_answer": "Yes The statement does not contradict the evidence and is consistent with it The evidence describes the interventions being administered",
        "label": "Entailment"
    },
    "95759249-3a95-4735-8ef0-13ec3558aa27": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "1dd105a3-5dd4-423a-a40f-ed78e119e698": {
        "text_answer": "Yes  Explanation  The statement in both the primary trial and the secondary trial there were several",
        "label": "Entailment"
    },
    "86609ec7-6d7c-4447-94b4-c9c99d5fd5e1": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 1000",
        "label": "Contradiction"
    },
    "b09ea9c8-e3a2-4c82-bbe8-5e84ea151138": {
        "text_answer": "No  Explanation  The statement the primary trials inclusion and exclusion criteria remain constant",
        "label": "Contradiction"
    },
    "3d35c61e-075e-475e-b3aa-15c04db3a579": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the participants in Arm A received",
        "label": "Contradiction"
    },
    "7ffa3719-812d-4849-b0c7-d34ab22f35f6": {
        "text_answer": "Yes The evidence does not provide sufficient information to make a definitive comparison between the two groups in the secondary trial",
        "label": "Entailment"
    },
    "a2e2d75b-ce3e-4bf6-bfce-c151b9d183d4": {
        "text_answer": "No  Perjeta is not mentioned in the evidence Perjeta is a monoclonal antibody that",
        "label": "Contradiction"
    },
    "43a347ac-a46d-47cd-80d5-7d83b23bcde9": {
        "text_answer": "Yes The evidence states that breast cancer is included in the list of eligible tumors for the clinical trial",
        "label": "Entailment"
    },
    "8fd1a8ed-8b74-4021-8a90-0400817fda1b": {
        "text_answer": "Yes  Explanation The evidence states that there were no adverse events in both cohort 1",
        "label": "Entailment"
    },
    "2cee68da-471f-4c13-811e-9d7ef91d587e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement mentions ",
        "label": "Contradiction"
    },
    "65cfa1ae-05d3-4a90-ad5a-852f3cfdf3fc": {
        "text_answer": "Yes The evidence does not provide units of measure for cm Number of Participants or time in the context of the",
        "label": "Entailment"
    },
    "5865807e-233c-4a7d-a900-de4af3bdaaf5": {
        "text_answer": "No  Explanation  The evidence provided in the text states that the percentage of participants with invasive",
        "label": "Contradiction"
    },
    "786542cd-3793-47a4-b954-9b6c5aa2e652": {
        "text_answer": "No  Explanation  The statement the same three electroporation injections of ld v",
        "label": "Contradiction"
    },
    "623db2b4-6824-42e4-9ad6-39cf3bf14dab": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1c4ca195-bc07-4d75-ac19-f7969a20e168": {
        "text_answer": "No  The evidence does not provide any information about the interventions used in the secondary clinical trial",
        "label": "Contradiction"
    },
    "e7204781-fa14-4418-94a4-2660bcd64eeb": {
        "text_answer": "Yes The primary trial involves surgery and administration of seven distinct drugs via different routes IV PO SC while the",
        "label": "Entailment"
    },
    "efbed283-d725-4f05-8e7a-3cb43ce470e6": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the two groups in the primary",
        "label": "Contradiction"
    },
    "6acfb64a-4e08-4cdb-b52d-f0a5c466de4d": {
        "text_answer": "No  Explanation  The statement The LBH589 With Capecitab",
        "label": "Contradiction"
    },
    "d595c94d-93d0-410b-9089-0e026867561f": {
        "text_answer": "No  Explanation  The statement Most the primary trial candidates suffered from some kind of eating disorder",
        "label": "Contradiction"
    },
    "8093f77e-bb52-47c9-9c58-4be084c8736b": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "2eb882ed-836b-424c-a9b2-06d97f0b2b9e": {
        "text_answer": "No  The evidence does not mention anything about cognitive behavioral therapy being included in the interventions for both cohorts",
        "label": "Contradiction"
    },
    "11daa2f8-2ecf-49f7-aa69-844a2bade4b6": {
        "text_answer": "No  Explanation  The statement Patients in cohort 2 of the primary trial",
        "label": "Contradiction"
    },
    "4c9638ac-5716-4657-9279-f756aea52867": {
        "text_answer": "No  Explanation  The statement participants in the secondary clinical trial only receive a pair",
        "label": "Contradiction"
    },
    "029ee1b5-a81a-4690-9f03-442dcf0f5e9c": {
        "text_answer": "No  Explanation  The statement We cannot compare the adverse events in the primary trial and",
        "label": "Contradiction"
    },
    "ecf95a54-fa38-4492-9597-ce81b5a2b661": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts follow the same instructional CD for paced breathing",
        "label": "Entailment"
    },
    "89558178-d2e5-4376-8656-14ba666b44a3": {
        "text_answer": "No  Explanation  The statement the primary clinical trial does not accept patients who have had an",
        "label": "Contradiction"
    },
    "42ac258c-8420-4a90-b427-d7ca64f246af": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement incorrectly assumes that",
        "label": "Contradiction"
    },
    "dd7bc677-cddb-4619-893e-aa5b801a0b1a": {
        "text_answer": "No  Explanation  The older male patient with nonmetastatic HER2negative",
        "label": "Contradiction"
    },
    "29987f94-8331-4136-92f1-4ea5f5c232b9": {
        "text_answer": "No  Explanation The statement every participant in the primary clinical trial is administered a minimum of",
        "label": "Contradiction"
    },
    "823088ba-be25-4691-aa10-9e86b80fbf8c": {
        "text_answer": "yes anemia and pneumonia were more frequent in the secondary trial stupor was present in the secondary",
        "label": "Entailment"
    },
    "36a5e0dd-7e3a-4362-9726-0836f7a4c64e": {
        "text_answer": "No  Explanation  The evidence provided in the given text does not mention anything about the discern",
        "label": "Contradiction"
    },
    "373e57af-cf54-40c6-9906-eff8eb5d7306": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "018fd266-6def-4792-85e4-0b12108281b3": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary trial does have a place",
        "label": "Entailment"
    },
    "d44338be-9054-466e-8cb6-388fd8024e9d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only compares",
        "label": "Contradiction"
    },
    "0de75f54-db66-4787-b8a0-7cd21198d8a8": {
        "text_answer": "Yes based on the given evidence no patient in either group experienced a pain intensity score of 10 the highest",
        "label": "Entailment"
    },
    "a723722c-a7df-4baa-b02a-3d3f15a03db3": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence because the",
        "label": "Contradiction"
    },
    "6056dc64-7161-4c86-a9ac-04579ea09274": {
        "text_answer": "No  Explanation  The statement requires patients to receive 0120 gr",
        "label": "Contradiction"
    },
    "3f19f518-c46f-4c1f-a738-0066ac81dcc2": {
        "text_answer": "No The evidence provided does not mention anything about Xrays transendocardial injections CT sc",
        "label": "Contradiction"
    },
    "a86b695b-6bfb-4c1f-982c-2e10c1b392ae": {
        "text_answer": "No   Explanation  The evidence provided only gives the median change in lean body mass for each",
        "label": "Contradiction"
    },
    "b7bd2215-d2b2-4cd0-a12a-d12310737373": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence states that patients who have been treated with gab",
        "label": "Contradiction"
    },
    "2909913c-9739-497b-8bbb-481d3b5c4832": {
        "text_answer": "Yes for the primary trial pulmonary embolism is a reason for exclusion within 6 months for",
        "label": "Entailment"
    },
    "33dc8fb6-d0a8-47e4-8052-4a32b5e0c459": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "86ed4db6-24fe-4a88-ba9b-6be3f98e0525": {
        "text_answer": "No  Explanation  The statement The LBH589 With Capecitab",
        "label": "Contradiction"
    },
    "bee98681-7738-44a5-b437-0c172bdd3eeb": {
        "text_answer": "Yes  Both trials involve oral administration of interventions",
        "label": "Entailment"
    },
    "987d8384-9e51-497a-a1f4-2646ec7c94f8": {
        "text_answer": "Yes  The statement is entailed by the evidence as both interventions in the trial include trastuzumab ",
        "label": "Entailment"
    },
    "bfb34bfd-74f8-4f11-b28b-643fe6e79d10": {
        "text_answer": "No  Explanation  The primary trial measures the change in weekly average hot flash score from baseline to",
        "label": "Contradiction"
    },
    "af417420-0bcb-407d-8470-b73cafe31893": {
        "text_answer": "No  Explanation  The statement Patients diagnosed with malignant ductal carcin",
        "label": "Contradiction"
    },
    "511b7c14-9ba0-43ea-98e0-93f217e3ef07": {
        "text_answer": "No  Explanation The statement animal virus is an animal pathogen that is a virus",
        "label": "Contradiction"
    },
    "70c3a676-7000-465c-9d6d-3c53fbf185c0": {
        "text_answer": "No  Explanation  The statement the intervention timeline in the secondary clinical trial is exactly identical",
        "label": "Contradiction"
    },
    "61215857-54c4-4622-afc2-7249194a96f6": {
        "text_answer": "Yes The primary clinical trial specifically includes the requirement of resistance to aromatase inhibitors while the secondary clinical trial does",
        "label": "Entailment"
    },
    "b56f166c-a9b7-4990-bfb8-d13f0e89f76d": {
        "text_answer": "No  Explanation  The statement the protocol in the primary clinical trial consists of at least ",
        "label": "Contradiction"
    },
    "20b96fad-2ca0-4bee-a541-0006c6ff8037": {
        "text_answer": "No  Explanation  The statement 25 of patients in the primary trial suffer Increased",
        "label": "Contradiction"
    },
    "9e2bec72-4318-4cf8-9ed8-82a572ce6d55": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes a breast tumor of only 1",
        "label": "Contradiction"
    },
    "baea8626-3768-47aa-a4ba-e792164302fd": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as it makes no mention of",
        "label": "Contradiction"
    },
    "f2d85883-6334-4948-901e-22cc11da66ac": {
        "text_answer": "Yes The statement is entailed by the evidence as females with ER HER2 breast cancer are included in",
        "label": "Entailment"
    },
    "f1494243-0e25-48d1-b7d8-e92ffed41e1d": {
        "text_answer": "No  Explanation  The statement There were several psychiatric adverse events in the primary trial",
        "label": "Contradiction"
    },
    "5be979ed-e272-48c6-b301-c5464cc07730": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial had a higher turnout than the primary",
        "label": "Contradiction"
    },
    "348ce220-f650-4df2-9593-586ddaabe491": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial showed no difference in the improvement rate of",
        "label": "Entailment"
    },
    "2980900b-74b7-4c96-8ab9-91fc994211d1": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "79bb0bb4-31cf-45e2-8fae-475bfdbd6a09": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no information",
        "label": "Contradiction"
    },
    "e5fb73ea-4e3b-47b2-84ac-a4d403b646ba": {
        "text_answer": "Yes  Explanation The statement most of the adverse events detected in the primary trial were not blood",
        "label": "Entailment"
    },
    "49db6e75-199e-4c15-bb9b-6cf677d9c421": {
        "text_answer": "No  Explanation  The statement in the secondary trial patients are accepted regardless of gene mut",
        "label": "Contradiction"
    },
    "b00e48fb-d5db-46f8-8f16-6f538d178b26": {
        "text_answer": "No  Explanation  The statement a high frequency of cardiac and psychiatric aes were",
        "label": "Contradiction"
    },
    "1c968571-9618-4a86-af59-6e8367b1128f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as it makes an assumption beyond",
        "label": "Contradiction"
    },
    "82aff6ce-3305-4fb1-87c0-28f4a1e8a981": {
        "text_answer": "No   Explanation  The evidence states that participants in the breast cancer trial received doses of",
        "label": "Contradiction"
    },
    "24b44ec0-b0a4-4b5a-9028-164eda456529": {
        "text_answer": "Yes The placebo intervention involves 20 injections of 04ml Buminate solution while the all",
        "label": "Entailment"
    },
    "f3091230-221d-4c82-9d37-06e04c12ba48": {
        "text_answer": "No  Explanation  The statement optic chiasm neoplasm is a benign or",
        "label": "Contradiction"
    },
    "dfcbb31f-65e0-4847-9840-536eff03c1f3": {
        "text_answer": "No  Explanation  The statement only patients who demonstrated positive responses to previous Herceptin treatments",
        "label": "Contradiction"
    },
    "6a2679df-a2a3-40cf-8252-2f8bf8584b8d": {
        "text_answer": "No   Explanation  The statement abdominal examination is an assessment of the abdom",
        "label": "Contradiction"
    },
    "d5383c8a-360f-4e17-af4e-2f0a05fc2b1a": {
        "text_answer": "No  The statement is not entailed by the evidence as the secondary trial measures pain not muscle gains",
        "label": "Contradiction"
    },
    "2dac87e4-2a34-42e1-8aec-d2a23d61269a": {
        "text_answer": "No  Explanation  The statement femtogram per milliliter per microgram is a",
        "label": "Contradiction"
    },
    "4ecc7d3a-ada3-4bda-8236-f0450fc709af": {
        "text_answer": "  No  Explanation  The statement the primary clinical trials results demonstrate that the",
        "label": "Contradiction"
    },
    "c8235719-3fd8-43e9-8ba6-d99393220240": {
        "text_answer": "Yes The evidence does not mention any mental health bodyweight age or previous treatment conditions for eligibility in",
        "label": "Entailment"
    },
    "a8e679cc-cd10-409c-8434-8bb059146815": {
        "text_answer": "No  The statement is not entailed by the evidence as syncope was not the most commonly occurring adverse event across",
        "label": "Contradiction"
    },
    "d5f5e4f5-9a58-485a-8646-649ce93e37c7": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the participants in the",
        "label": "Contradiction"
    },
    "53e8b3b4-40dc-4ffe-b555-a65fd7741dbf": {
        "text_answer": "No  The statement about tert promoter mutation analysis is not mentioned in the evidence provided for either the primary or",
        "label": "Contradiction"
    },
    "d0600d22-c3de-4028-82a5-a42008e2018d": {
        "text_answer": "No  Explanation  The statement abnormal liver function test is atypical results found on",
        "label": "Contradiction"
    },
    "0a144293-fbab-4ba1-ad15-cf05a8624a1c": {
        "text_answer": "Yes The primary trial measures the efficacy of flaxseed on hot flash scores using a daily prospective hot flash",
        "label": "Entailment"
    },
    "c66df8c2-afad-4638-a1c2-5539fc03a2be": {
        "text_answer": "No  The statement is not related to the evidence provided The evidence pertains to the effectiveness of a peer support program",
        "label": "Contradiction"
    },
    "67b93677-87f6-4a11-8dea-66a3c2242b19": {
        "text_answer": "No  Explanation The inclusion criteria state that subjects must have a Mini Mental State Examination ",
        "label": "Contradiction"
    },
    "abed7fca-4cb8-42bb-a206-bf1c54f9af99": {
        "text_answer": "  Yes the statement is not entailed by the evidence as neither trial used Number of Participants With Treatment",
        "label": "Entailment"
    },
    "5ff118a6-d62c-473d-8935-1767a378c92a": {
        "text_answer": "Yes  Some patients in the trial did not receive Active Breathing Coordination and therefore did not undergo a S",
        "label": "Entailment"
    },
    "4eb8855e-766e-4588-a42f-655ca3d80140": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial administer",
        "label": "Contradiction"
    },
    "f4e91f1d-d645-4759-904d-12e509336562": {
        "text_answer": "Yes The evidence shows that the median aAUCpa for the Arm I Cryotherapy group was less negative",
        "label": "Entailment"
    },
    "ca80b7bd-73a6-4c6a-9ab7-3e1dc789f12c": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "e412ecde-3195-42c6-b125-7d2697ea89c1": {
        "text_answer": "Yes  Explanation The primary trial involved PF06647020 at",
        "label": "Entailment"
    },
    "b4fd327d-375e-4021-98af-a59ee4e30c0b": {
        "text_answer": "maybe for the secondary trial with the condition that the patient meets all other inclusion criteria and none of the exclusion criteria",
        "label": "Entailment"
    },
    "911ba31e-f28f-4c5b-8b0e-fa16e58ecc29": {
        "text_answer": "No  Explanation  The statement There are more cases of Bronchopneumonia and General",
        "label": "Contradiction"
    },
    "9b75138c-e074-43f0-866d-9a43ce7be217": {
        "text_answer": "Yes The statement is entailed by the evidence as the patients in the trial receive two oral drugs lapatinib and",
        "label": "Entailment"
    },
    "bcbde299-e3e8-40e6-8cea-d843a44e68d6": {
        "text_answer": "Yes  The evidence states that the intervention includes treatment with partial breast irradiation and the statement specifies that the",
        "label": "Entailment"
    },
    "6ee5619b-ec91-4d55-b57a-a69eb3315c3d": {
        "text_answer": "Yes  Explanation  The statement the primary trial is observing the effects of various doses",
        "label": "Entailment"
    },
    "f7247f7f-056b-4725-b771-4f4388a643aa": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement refers to lapatin",
        "label": "Contradiction"
    },
    "a85e8f5b-fb4f-4adc-a020-d40a42e8be96": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the two IM in",
        "label": "Contradiction"
    },
    "e501b32a-a182-4275-bcdf-88aca4446cf9": {
        "text_answer": "Yes The evidence allows for participation in both trials for patients with ER PR or HER2ne",
        "label": "Entailment"
    },
    "c77be931-75c0-4036-a07d-7d49b5b9fcc6": {
        "text_answer": "Yes The primary trial has different inclusion criteria compared to the secondary trial and the performance status condition is only mentioned in the",
        "label": "Entailment"
    },
    "993a3b60-def6-421c-a8a5-964062336a2c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a change",
        "label": "Contradiction"
    },
    "6cbfc99b-6531-412f-bd30-b4a803983831": {
        "text_answer": "No  Explanation  The primary trial does use a 3week cycle for the administration of",
        "label": "Contradiction"
    },
    "7b76f6bb-6bf2-4bec-8409-9c4b90cc81c8": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial are studying the same drug",
        "label": "Entailment"
    },
    "19cdc906-c8e3-498d-b33e-08ad9037af5d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial recorded",
        "label": "Contradiction"
    },
    "41ef54ae-5826-49c3-85d2-1da610317f26": {
        "text_answer": "Yes  Explanation The evidence states that participants in the primary trial receive epirubicin",
        "label": "Entailment"
    },
    "1a076a19-c76d-4de0-b7de-473c0e278bbe": {
        "text_answer": "No  Explanation  The statement dyspnea was frequently recorded as an adverse event",
        "label": "Contradiction"
    },
    "4023d560-6425-4207-aa76-543be30fd786": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial intervention is not",
        "label": "Contradiction"
    },
    "6ee2e04c-88fc-4447-a477-18b2564aca4e": {
        "text_answer": "No  The patient described in the statement does not meet the eligibility criteria for the trial as they have a life",
        "label": "Contradiction"
    },
    "b6af5ca8-21c0-43c5-898b-53e45b5e122a": {
        "text_answer": "No  Explanation The statement candidates must not undergo any form of imaging test before",
        "label": "Contradiction"
    },
    "4665519b-6dba-440f-9cc3-677ab616ecd6": {
        "text_answer": "No  Explanation  The statement a CT scan not a mammography is needed for",
        "label": "Contradiction"
    },
    "f66e21d9-801f-4613-99da-c033734189e4": {
        "text_answer": "Yes The eligibility for both trials is based on various clinical and biological factors and gender is not explicitly mentioned as",
        "label": "Entailment"
    },
    "ba873942-b869-4596-bbd6-30d54c94e31b": {
        "text_answer": "Yes   Explanation  The evidence states that both interventions involve the injection of 0",
        "label": "Entailment"
    },
    "3558390b-24a7-45e7-84f1-f512e669dcef": {
        "text_answer": "Yes  Explanation  The statement the secondary and primary clinical trials showed a complete absence of recorded",
        "label": "Entailment"
    },
    "84f10108-19b7-499f-9144-b3e6c0b253d5": {
        "text_answer": "No The statement is not directly related to the provided evidence The evidence only discusses the outcome measurements and results of two",
        "label": "Contradiction"
    },
    "94df8c14-d1c9-44cb-9f6d-1706044cbc9a": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the interventions for C",
        "label": "Contradiction"
    },
    "4f9e48d7-08cc-4fa3-a317-4f3f23ebf19d": {
        "text_answer": "No  Explanation  The primary clinical trial does not provide any information about the methods used to gauge",
        "label": "Contradiction"
    },
    "ef6928bd-e4ac-44f6-a7bd-292a728df94b": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly reflects that no cardiac or psychiatric adverse events were",
        "label": "Entailment"
    },
    "a3ad31e2-9017-438a-bbc2-acab87940134": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants or 8",
        "label": "Entailment"
    },
    "5499c5cb-97fa-4905-b163-7f5830cd59b9": {
        "text_answer": "No  Explanation  The statement in group 1 of the primary clinical trial no participants",
        "label": "Contradiction"
    },
    "06695494-b56b-49da-9166-b0aae3f322f3": {
        "text_answer": "Yes The evidence does not provide units of measure for the number of participants or time in seconds or centimeters for either",
        "label": "Entailment"
    },
    "c36a826d-892a-4115-af40-e60050fffd8a": {
        "text_answer": "No   Explanation  The statement more than 95 of patients in the primary",
        "label": "Contradiction"
    },
    "564d9a7d-327b-45be-af87-1971e15a9db4": {
        "text_answer": "No  Explanation  The evidence provided in the results does not mention anything about chromosome band",
        "label": "Contradiction"
    },
    "17414a49-7410-41fe-ab90-99311491d367": {
        "text_answer": "No  Explanation The statement in the question is not entailed by the evidence as the dosage",
        "label": "Contradiction"
    },
    "6ab38a80-a2a5-40f1-a8d5-250db9f54740": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the intervention 1",
        "label": "Contradiction"
    },
    "52db54bd-4dbe-4778-b5c4-30a8e4ce0a1f": {
        "text_answer": "Yes The evidence does not report any discernible pattern for gene expression in either the normal or lownormal Vitamin",
        "label": "Entailment"
    },
    "14678a23-57ea-4d56-a87a-c1a910af9e78": {
        "text_answer": "No  The evidence only reports the number of participants with clinical benefit complete response partial response or stable disease",
        "label": "Contradiction"
    },
    "21c021d2-764d-4028-b945-2aeb525b9888": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial both use pCR as",
        "label": "Entailment"
    },
    "6892893c-5c7b-492b-950f-e155bd928ebe": {
        "text_answer": "Yes The statement does not contradict the evidence and all the information in the statement is included in the evidence",
        "label": "Entailment"
    },
    "98a95bef-b43a-4582-8b58-d0c154824cd0": {
        "text_answer": "No  The evidence states that individuals with a history of interstitial lung disease or pneumonitis are excluded",
        "label": "Contradiction"
    },
    "b799b56b-51cd-4200-852f-f80a347de63e": {
        "text_answer": "No  Explanation  The statement about age limits between 18 and 60 years",
        "label": "Contradiction"
    },
    "6ffedb4b-9ff8-445a-9e5f-872d54ca58fb": {
        "text_answer": "No   Explanation  The statement adverse events were entirely absent in the conduct of the",
        "label": "Contradiction"
    },
    "91d0039d-b186-4f52-b214-1000341d3f2c": {
        "text_answer": "  Yes for the second part of the statement adverse events have been recorded is entailed by the",
        "label": "Entailment"
    },
    "0c5c681e-d64b-41e8-add7-b34f03573370": {
        "text_answer": "  Yes for the primary trial and No for the secondary trial   Explanation ",
        "label": "Entailment"
    },
    "3ce5a661-e1a9-4164-935e-15563602eefc": {
        "text_answer": "No  Explanation  The statement 75 of patients in the primary trial suffer increased ple",
        "label": "Contradiction"
    },
    "2630006c-6708-4c09-a946-aefe1859770d": {
        "text_answer": "No  The primary trial includes both male and postmenopausal female patients while the secondary trial includes only women",
        "label": "Contradiction"
    },
    "c5fe1272-e91c-44cd-888d-359ad43e34c4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there are no instances",
        "label": "Contradiction"
    },
    "4be496e4-ba05-47a1-bc0f-b8627e47becb": {
        "text_answer": "No  Explanation  The statement time to progression in months for a cumulative total of",
        "label": "Contradiction"
    },
    "31b59e3d-4bb8-47ea-a7a1-9d8523245970": {
        "text_answer": "Yes The statement does not directly relate to the inclusion criteria for the trial but there is no exclusion criterion",
        "label": "Entailment"
    },
    "981d8b53-f02f-4845-af5f-a1d5abc2d63c": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial patients must receive a subcut",
        "label": "Contradiction"
    },
    "0cf140db-a8c7-47ee-9753-c46c056fe1b1": {
        "text_answer": "Yes  Explanation  The statement participants receiving the highest weekly mm121",
        "label": "Entailment"
    },
    "08dad9c0-a333-4791-b845-79b549c31890": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement claims that adverse events were reported by more",
        "label": "Contradiction"
    },
    "da125a54-e88c-40a5-8134-0bd021287c6f": {
        "text_answer": "Yes The evidence states that participants in the clinical trial can have measurable or nonmeasurable disease Me",
        "label": "Entailment"
    },
    "3fca106b-449b-416e-a961-bf0dc8999ddb": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "eca5c391-f479-448d-bff8-313a7df673b4": {
        "text_answer": "Yes  Explanation Both trials involve the use of cyclophosphamide Paclitax",
        "label": "Entailment"
    },
    "32775858-8e4c-41e3-87c3-2c60dbc780ee": {
        "text_answer": "No  The patient with a metastasized tumor of 10mm in radius would not be eligible for",
        "label": "Contradiction"
    },
    "ccc2b2e3-5588-4eed-8a05-67fb21c29a9b": {
        "text_answer": "No  Explanation  The statement in the secondary clinical trial patients only experienced adverse events",
        "label": "Contradiction"
    },
    "796289cc-1400-4a5c-9da0-d19104d6aae4": {
        "text_answer": "No  Explanation  The statement the first cohort of the primary clinical trial had more",
        "label": "Contradiction"
    },
    "9b5ee8d1-9b19-4f79-a80f-58422f1f5cee": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the first group receives 60",
        "label": "Entailment"
    },
    "7852457b-3915-431f-adbf-cdba2b736c46": {
        "text_answer": "Yes The statement does not make a claim about adverse events so it is not directly contradicted by the evidence",
        "label": "Entailment"
    },
    "58db966b-cb5c-426f-8b8e-f9e68adc1531": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "d5c262d5-584c-4417-a768-9374cd6c8bc2": {
        "text_answer": "No  Explanation  The statement vomiting was the most prevalent adverse event recorded",
        "label": "Contradiction"
    },
    "388cc99c-4cb3-4ff9-9496-07f4a6bf6ac7": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not compare the effects of acup",
        "label": "Contradiction"
    },
    "a2cdb319-3410-467d-94f0-0908534ebf22": {
        "text_answer": "Yes Both interventions are administered for the same duration of time 12 weeks",
        "label": "Entailment"
    },
    "a9497198-5380-4af2-ace4-eb2e904a855a": {
        "text_answer": "Yes The evidence does not explicitly state that AfricanAmerican patients can participate in the trial but it does not include any",
        "label": "Entailment"
    },
    "bd70ab1b-2bfb-4294-9ca7-01e1e2b670b7": {
        "text_answer": "  No the statement is not entailed by the evidence The evidence provides the inclusion and exclusion criteria for two",
        "label": "Contradiction"
    },
    "56e88bbd-7a3c-4a3b-a6cf-3f9b9e632b53": {
        "text_answer": "Yes The evidence shows that there were no adverse events in both the primary and secondary trials for Adverse Event 1",
        "label": "Entailment"
    },
    "26583828-8ea0-4211-a688-3deda44eeec4": {
        "text_answer": "No  Explanation  The statement both the primary clinical trial and the secondary clinical trial reported hyp",
        "label": "Contradiction"
    },
    "8dd8adde-dac7-4303-8a4b-46e27e36862f": {
        "text_answer": "No  Explanation  The statement The majority of the adverse events recorded in the primary trial",
        "label": "Contradiction"
    },
    "98627f6b-e597-4427-b831-aa8856de321e": {
        "text_answer": "No  The secondary clinical trial does not demand participants to be entirely disabled The inclusion criteria state that patients must have a",
        "label": "Contradiction"
    },
    "d11356c5-cf48-40dc-aa23-46e71f564afd": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "26583790-21ca-4820-9932-67e3d6eeb8b0": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "06be4ae9-c67e-4aad-b5b5-caf3dd9f30a9": {
        "text_answer": "No  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Contradiction"
    },
    "0919109a-9ee1-4fa0-b612-a9902379e48d": {
        "text_answer": "Yes   Explanation  The statement the primary clinical trial saw the use of multiple drugs as",
        "label": "Entailment"
    },
    "402d7814-ace1-4f78-8c96-c3205001c5ee": {
        "text_answer": "No  Explanation The statement cohort 1 and 2 of the primary clinical trial",
        "label": "Contradiction"
    },
    "58165e03-4aa6-4d0c-8256-dbc92ee900c4": {
        "text_answer": "Yes Capecitabine was administered orally every day to every patient in cohort 2 during the",
        "label": "Entailment"
    },
    "8150f869-b9e6-422b-a13a-1bdccee14f19": {
        "text_answer": "No   Explanation   The evidence describes a clinical trial where patients with AIDSrelated",
        "label": "Contradiction"
    },
    "c7960079-5d1b-451e-818f-0890272ddb63": {
        "text_answer": "Yes The primary trial does not involve any drugbased interventions while the secondary trial tests two different drugs PF",
        "label": "Entailment"
    },
    "0d8cdde2-046a-4684-8af5-38cd82935901": {
        "text_answer": "Yes The statement does not specifically mention the numbers in the evidence but it is not contradicted by the evidence either",
        "label": "Entailment"
    },
    "0c973f54-1aad-4349-acf5-607cb1ef2d6a": {
        "text_answer": "No  Explanation  The statement Cholelithiasis was twice as common for the",
        "label": "Contradiction"
    },
    "86722991-04c7-4fdd-914a-f5b71d236a7a": {
        "text_answer": "No  Explanation  The statement 25 of patients in the primary trial suffer Increased",
        "label": "Contradiction"
    },
    "3c164518-76e2-4abf-a39e-4163d49583c7": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement about a",
        "label": "Contradiction"
    },
    "01116b8e-5299-4f9e-9f40-7651edbc8542": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions the",
        "label": "Contradiction"
    },
    "ceb3926f-4777-4cec-8582-7c109185e333": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as there is no mention of the",
        "label": "Contradiction"
    },
    "fd76b8a6-5305-4221-b48b-3a37d551c82a": {
        "text_answer": "No  Explanation The evidence provided in the trial description does not explicitly state that regular physical activities are",
        "label": "Contradiction"
    },
    "bbd40b2c-18a5-4ebb-9c6b-58dbc9a3ba59": {
        "text_answer": "No  Explanation  The evidence provided in the form of the primary clinical trial results does not directly",
        "label": "Contradiction"
    },
    "4acf0568-59ce-4f6c-973b-9c603f65dac4": {
        "text_answer": "No  Explanation  The evidence provided in the primary clinical trial results indicates the number of participants in",
        "label": "Contradiction"
    },
    "575eb6a5-bbeb-46a4-af85-87303a9fc321": {
        "text_answer": "Yes  Explanation  The statement there were no recorded incidents of infections among patients in both",
        "label": "Entailment"
    },
    "2f917847-cad3-4744-891d-33ebe29f257b": {
        "text_answer": "Yes  Explanation The evidence states that two different interventions were used in the primary clinical trial",
        "label": "Entailment"
    },
    "44c3f65f-6b0d-401d-9aad-b323d7511b1c": {
        "text_answer": "Yes Both cohorts receive two IM injections of LD V935 However the timing and sequence",
        "label": "Entailment"
    },
    "c3609a19-01f6-4add-a0af-7d92263d822c": {
        "text_answer": "  Yes  Explanation  The evidence shows that the Neratinib group had a lower",
        "label": "Entailment"
    },
    "204d5293-d6e5-452a-8961-3b76d6be35c9": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "3cd949ea-cd27-4eff-b7b6-0087df3136ba": {
        "text_answer": "Yes the statement cohort 1 of the primary clinical trial reported mild aes is entailed by the",
        "label": "Entailment"
    },
    "8fc0b314-bec3-4206-a917-fc16babf1a4a": {
        "text_answer": "No  Explanation The statement in both groups of the primary clinical trial arimidex",
        "label": "Contradiction"
    },
    "ccc3cd99-a66b-42ce-9a35-21780035ddc5": {
        "text_answer": "Yes The statement does not contradict the inclusion criteria for ECOG performance status in both trials",
        "label": "Entailment"
    },
    "f5fa93e8-a223-459c-8573-853f56953c17": {
        "text_answer": "Yes The primary clinical trial has an openended treatment process while the secondary clinical trial operates on a consistent 4",
        "label": "Entailment"
    },
    "00d64f29-fff0-44bd-b20c-8838ed4a1d93": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide information",
        "label": "Contradiction"
    },
    "1dcd53cf-49bf-4a4e-857d-008139ceb6a9": {
        "text_answer": "Yes The primary trial requires mammography as an inclusion criterion while the secondary trial does not",
        "label": "Entailment"
    },
    "ad0d6636-dd71-4ba9-8741-1cba3d6f0c43": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "bc8cc6fd-446a-4879-a968-5c43a34029cc": {
        "text_answer": "No  Explanation  The statement grade 2 tendon reflex decreased ct",
        "label": "Contradiction"
    },
    "e1e33a46-c88d-497a-b7b6-be14d38d05b2": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary clinical trial includes patients with metastatic or advanced",
        "label": "Contradiction"
    },
    "1e4ebef6-1039-42f3-b753-3efd098052fc": {
        "text_answer": "No  Explanation  The statement the intervention phase in the secondary clinical trial lasts an additional",
        "label": "Contradiction"
    },
    "e83cb60e-ac38-42dd-a094-1ae08500915b": {
        "text_answer": "No  Explanation  The statement 1 case of Anaemia and Febrile neutropen",
        "label": "Contradiction"
    },
    "3c081d55-1536-45ec-ae5b-b7af2a44a8c4": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence states that there was one adverse event in the primary clinical",
        "label": "Entailment"
    },
    "cee12d67-0640-4760-a0f5-fdde8c593a89": {
        "text_answer": "No  The statement is not entailed by the evidence as the trial only includes patients with advanced andor unresect",
        "label": "Contradiction"
    },
    "84781347-ce91-4e60-ba5f-f1bd795d898b": {
        "text_answer": "Yes The evidence does not mention any vaccines being administered to the participants",
        "label": "Entailment"
    },
    "eff79353-72dc-4a94-b856-40b844d2860b": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial specifically includes a size limitation of 1 cm",
        "label": "Contradiction"
    },
    "e6c70cab-b2d6-488d-b9dd-34478f9f4f71": {
        "text_answer": "No  Explanation  The statement despite taking reduced doses of empegfilgrast",
        "label": "Contradiction"
    },
    "d622d9c6-c942-4a53-a249-cd5544e2d9fe": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only includes patients with advanced andor unresect",
        "label": "Contradiction"
    },
    "b994a073-e1a5-424a-9cdf-f0d9ad0c0766": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes a phase specifically for breast cancer patients who are ER positive",
        "label": "Entailment"
    },
    "0aab969d-e626-4857-903c-df2f6849c7c7": {
        "text_answer": "No   Explanation  The statement several adverse events occurred at an incidence",
        "label": "Contradiction"
    },
    "8f4d4e78-5e46-47b6-865c-ad6b689d69e0": {
        "text_answer": "No  Explanation  The statement Far more patients in the secondary trial were recorded to have",
        "label": "Contradiction"
    },
    "e4024f75-2a23-4912-bb63-3d6e982657ea": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of a her2neu pe",
        "label": "Contradiction"
    },
    "fbfafa2b-9b70-4452-9d19-4d58c3c9dfba": {
        "text_answer": "  No   Explanation   The statement A Patient that has a primary tum",
        "label": "Contradiction"
    },
    "7452ab11-09d4-48bc-b275-4681acae5769": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial the group using paclitax",
        "label": "Entailment"
    },
    "4385daf4-23d6-499b-8960-33b8c995884e": {
        "text_answer": "Yes  Explanation  The statement in both the primary trial and the secondary trial there were ",
        "label": "Entailment"
    },
    "97f2cf47-a82b-4d00-9918-a4b400d2ca5e": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the adverse events noted were",
        "label": "Contradiction"
    },
    "b7bc3cb1-b7f4-4276-bfee-9f984109d191": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "13184ac6-2ba9-455b-9e77-834855ff2794": {
        "text_answer": "Yes for febrile neutropenia Answer Partially for cholelithiasis",
        "label": "Entailment"
    },
    "25b01c06-612c-4cfb-b30b-50ebe4d98750": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "ae548af6-b401-4dac-9824-50b2a566e7bd": {
        "text_answer": "Yes  Explanation The statement 18 years olds are excluded from the secondary trial is ent",
        "label": "Entailment"
    },
    "80b58d76-4a9b-461a-836a-bfb79e40b401": {
        "text_answer": "No  Explanation The statement Both cohorts of the primary trial receive the same dos",
        "label": "Contradiction"
    },
    "42d3b148-38d6-4665-9d48-4d6bf935fbd9": {
        "text_answer": "No The statement is not entailed by the evidence as the statement includes a mistake in the time frame for some of the",
        "label": "Contradiction"
    },
    "00102571-e1d6-42c9-b227-f0ac146d411d": {
        "text_answer": "No  Explanation  The statement gin is a Chinese person from the gin ethnic group",
        "label": "Contradiction"
    },
    "596e650e-f860-4055-b3a6-35fcd9fd33b0": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded slightly more total adverse events in its",
        "label": "Contradiction"
    },
    "10a27e75-a4e3-4790-bafa-dfc9b9300a25": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b8e81997-7fd7-4934-9ee8-bb7c647d334c": {
        "text_answer": "No  Explanation The statement all ae types in the primary trial affected less than 0",
        "label": "Contradiction"
    },
    "c89d3665-091c-410b-83b1-0793a3b86d6a": {
        "text_answer": "No  Explanation  The statement The intervention in the primary trial consists of a single drug",
        "label": "Contradiction"
    },
    "0d7d2408-c51f-4b3a-a47f-6f0ee8dedacc": {
        "text_answer": "Yes  Explanation  The statement the primary trial reports the Time to Progression in months for",
        "label": "Entailment"
    },
    "70ddf6e3-dcd9-4296-b73c-593161abcfae": {
        "text_answer": "  No  Explanation  The primary trial excludes patients who are pregnant andor breast",
        "label": "Contradiction"
    },
    "d6cd0501-9b29-41f5-ba8a-6209c8cfad84": {
        "text_answer": "No  Explanation  The statement in the secondary trial all patients receive the same 20",
        "label": "Contradiction"
    },
    "03845d1d-301a-4b2a-8dc4-8b05e09ab6ee": {
        "text_answer": "No  Explanation  The statement The same number of AEs were reported for both coh",
        "label": "Contradiction"
    },
    "383102f6-bd50-4f19-b7cf-0ddda4234e2f": {
        "text_answer": "No  Explanation  The statement biliary colic and clostridium difficile",
        "label": "Contradiction"
    },
    "a88d7c64-ec6f-4fb7-a84d-1047b68bda4f": {
        "text_answer": "Yes  Explanation  The statement in the secondary clinical trial only eyelid oed",
        "label": "Entailment"
    },
    "0c6abdc4-f1cd-46f3-8883-c4bce02c2081": {
        "text_answer": "  No   Explanation   The primary clinical trial uses the Change From Baseline in",
        "label": "Contradiction"
    },
    "6aa80695-37e9-4a46-aa19-2fd1f75d8f11": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement incorrectly comb",
        "label": "Contradiction"
    },
    "c4c63d1d-1704-499c-b298-f5ced3123d03": {
        "text_answer": "Yes  Explanation The statement patients are provided with oral medication which they are to take",
        "label": "Entailment"
    },
    "c90dda31-65a8-4a77-8657-7cdf498b366f": {
        "text_answer": "Yes The exclusion criteria specifically state that any patient who has received antineoplastic chemotherapy androgens",
        "label": "Entailment"
    },
    "6fa670ed-56af-4b06-b7f1-ab7429106d0d": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median with range change in",
        "label": "Contradiction"
    },
    "c2634312-bbf3-4b44-8cdc-23922a16b9fd": {
        "text_answer": "No  Explanation  The statement the number of infection asymmetry and deflation cases",
        "label": "Contradiction"
    },
    "241dc060-83e9-41a9-b937-d9715c16137a": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial results indicates that the participants in the p",
        "label": "Entailment"
    },
    "ff8f336a-0b3a-453d-a396-7624218280aa": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention section of the primary clinical trial does provide a detailed description of",
        "label": "Entailment"
    },
    "100aa305-3df6-42ff-b3ba-68bed68e39b0": {
        "text_answer": "Yes  Explanation  The statement the main focus of the primary trial is on the mean sleep",
        "label": "Entailment"
    },
    "b819fe62-b8ce-4b35-bf5a-e2657f8d0efc": {
        "text_answer": "Yes   Explanation  The statement only one arm of the primary clinical trial makes use of",
        "label": "Entailment"
    },
    "2644ad79-c38a-4415-a340-81ac51d3813f": {
        "text_answer": "Yes  Explanation The statement multiple diverse negative effects were experienced by at least one patient in the primary",
        "label": "Entailment"
    },
    "344ac04d-cddb-4ef8-8a15-54e26ff58a86": {
        "text_answer": "Yes The statement is entailed by the evidence as all adverse events mentioned in the evidence affected only one patient each",
        "label": "Entailment"
    },
    "c32c50b0-6068-41f1-9db0-fd8b3ac53cf6": {
        "text_answer": "Yes The primary trials Intervention 1 involves IV administration and the secondary trials Interventions for both",
        "label": "Entailment"
    },
    "1907f058-1b77-441e-8824-9cf6be7f1243": {
        "text_answer": "Yes  Explanation  The statement in comparison to the secondary trial the primary trial has fewer",
        "label": "Entailment"
    },
    "818a897a-fa50-4f16-8272-8f5ec8e590c1": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as paclitaxel is not",
        "label": "Contradiction"
    },
    "6fc1fe93-0690-4b46-a80e-681e4d7be399": {
        "text_answer": "  Yes The evidence includes the inclusion criterion Willingness to change diet physical activity and weight",
        "label": "Entailment"
    },
    "3ce10e1a-24fe-4575-8f08-583c93fd5274": {
        "text_answer": "  No The statement is not entailed by the evidence as the secondary clinical trial does not involve patients with nut mid",
        "label": "Contradiction"
    },
    "99901cc0-51b6-45c1-9040-14a9785bab49": {
        "text_answer": "  No   Explanation   The statement a confirmed histological or cytological",
        "label": "Contradiction"
    },
    "6b1a58fa-54cd-442b-8f51-1b7135dd2302": {
        "text_answer": "  No The evidence does not mention anything about CBT Cognitive Behavioral Therapy being a",
        "label": "Contradiction"
    },
    "ddc664eb-c81b-4544-b370-bb6db84eacba": {
        "text_answer": "Yes The statement is consistent with the inclusion criteria for ERPR positivity in both trials",
        "label": "Entailment"
    },
    "117c69b5-683c-45a6-b80d-5bc866f2faa1": {
        "text_answer": "Yes The evidence does not specify eligibility based on nationality ethnicity weight or gender",
        "label": "Entailment"
    },
    "3cd01e92-2bff-45d7-9fa3-77c351d2f39a": {
        "text_answer": "No   Explanation  The statement the primary clinical trial presented no adverse events is",
        "label": "Contradiction"
    },
    "d207a9ec-f055-456a-ad6a-7c580cc347e1": {
        "text_answer": "yes  Explanation The statement the only inclusion or exclusion standard that the primary and secondary clinical trials",
        "label": "Entailment"
    },
    "3896374f-f5e1-41a2-9ec0-c108cc3f3ad1": {
        "text_answer": "No  Explanation The statement maculopapular Rash was a common adverse",
        "label": "Contradiction"
    },
    "87f86955-0e57-459a-84aa-4a5feba745af": {
        "text_answer": "  Yes the statement is entailed by the evidence as the inclusion criteria specify ER negative PR negative and H",
        "label": "Entailment"
    },
    "99857433-fe08-4f54-bb86-91b1b1e8f5f4": {
        "text_answer": "Yes  Explanation  The evidence provided in the results shows that the percentage of participants with events ",
        "label": "Entailment"
    },
    "4bc60955-6137-4496-b780-5fb8e90dc3ed": {
        "text_answer": "No  Explanation The statement maculopapular Rash was a common adverse",
        "label": "Contradiction"
    },
    "61c499d7-0a4c-4fac-9098-53e53ddb198d": {
        "text_answer": "No  Explanation  The statement there were 75 cases of hypertension ed",
        "label": "Contradiction"
    },
    "93025279-295b-43e1-8dfd-40877e0288b4": {
        "text_answer": "Yes The evidence does not provide information about the irradiation doses or treatment cycle in the intervention portion of the primary",
        "label": "Entailment"
    },
    "5ecfe0a7-2d7c-4207-b62e-0b28b699951d": {
        "text_answer": "Yes  Explanation The primary clinical trials intervention 1 involves the use of Zoled",
        "label": "Entailment"
    },
    "4a16424c-7755-4b6b-a060-d9ab1cb14db0": {
        "text_answer": "  No The statement about the stopcock valve device has no relation to the inclusion or exclusion criteria for the",
        "label": "Contradiction"
    },
    "10a9dcfe-bbdd-44b2-9bc7-f406a2ff835a": {
        "text_answer": "Yes  Explanation The mean standardized composite cognitive function scores for both the Tamoxifen and O",
        "label": "Entailment"
    },
    "b12a6936-d1ae-48e7-b3f2-575708d784ed": {
        "text_answer": "No  Explanation The statement provided does not mention the number of cases of Asthenia or Py",
        "label": "Contradiction"
    },
    "48ca56cf-908a-436f-8ec5-90fb965ea630": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions nep",
        "label": "Contradiction"
    },
    "8dbf8922-4680-4125-9bc3-f6ea881c5978": {
        "text_answer": "No  Explanation  The statement dehydration was a common side effect observed in both",
        "label": "Contradiction"
    },
    "dfde5d87-d03d-42a9-aa4c-f4e946a75102": {
        "text_answer": "Yes  Explanation The statement in comparison the secondary trial holds fewer anemia cases than the",
        "label": "Entailment"
    },
    "27564603-9271-41f5-8135-067e19c4946a": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it does not relate to",
        "label": "Contradiction"
    },
    "e8b7263b-fd07-4d78-915f-e1b17bdc1390": {
        "text_answer": "No  Explanation  The statement The intervention in the primary trial consists of a single drug",
        "label": "Contradiction"
    },
    "302997fe-466a-4efd-8801-5b07236a5e0c": {
        "text_answer": "No  The statement is not entailed by the evidence as there are no vaccines mentioned in the given clinical trial inter",
        "label": "Contradiction"
    },
    "7d1f03c6-a869-45f0-9eda-4c272781e112": {
        "text_answer": "No   Explanation  The statement anorexia hypothermia and hall",
        "label": "Contradiction"
    },
    "192c6acc-1f20-4f22-a23e-80fadba34726": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a2328e36-4475-4804-96e8-cba90ee13087": {
        "text_answer": "No   Explanation   The statement the primary trial and the secondary trial use the same",
        "label": "Contradiction"
    },
    "99820bab-c465-4d6a-a016-0551261ddb86": {
        "text_answer": "Yes The evidence mentions surgical and imaging procedures which is consistent with the statements reference to",
        "label": "Entailment"
    },
    "1757a756-4aeb-497c-aa4f-304817a34938": {
        "text_answer": "  Yes for the Primary Trial but not directly stated for the Secondary Trial it depends on the",
        "label": "Entailment"
    },
    "1fb98883-c2ef-4acb-948e-aa497dc911ff": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "98877f56-e367-4335-b938-85bd30fb038a": {
        "text_answer": "No  Explanation The statement is not directly related to the evidence provided The evidence describes the dos",
        "label": "Contradiction"
    },
    "c9403b28-c572-4009-ae1a-6bd3e7977f86": {
        "text_answer": "No  Explanation The evidence describes the administration of placebo and trabectedin in separate sessions",
        "label": "Contradiction"
    },
    "ea29786f-2c27-45d3-879d-126b8150f2af": {
        "text_answer": "No  Explanation  The statement the interventions in the primary clinical trial requires participants to take",
        "label": "Contradiction"
    },
    "7a2208d3-e297-4d8c-bfab-12856c200ea6": {
        "text_answer": "No  The statement does not mention carboplatin specifically and the evidence only mentions navelbine in",
        "label": "Contradiction"
    },
    "1ef3ec2f-1b26-4dbe-92ff-8c3dda42f071": {
        "text_answer": "No  Explanation  The statement no adverse events were noted in the patients from the secondary",
        "label": "Contradiction"
    },
    "f2f5115c-a1ad-43cf-b01c-0035f9404a92": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence because in the primary trial the intervention",
        "label": "Entailment"
    },
    "8a308f16-460b-45ac-a0f0-cb36787f1aa7": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any information about the number or",
        "label": "Contradiction"
    },
    "f43f3230-46be-4ed7-a1d7-3e6d73f4fa9b": {
        "text_answer": "No  Explanation  The statement cohort 1 and cohort 2 of",
        "label": "Contradiction"
    },
    "eea61494-780f-4a38-aa12-dd88ef3d520b": {
        "text_answer": "Yes  Explanation  The statement the study groups in the primary clinical trial are being tested with",
        "label": "Entailment"
    },
    "81bf5edb-cf30-4e9e-b816-394fa5b16354": {
        "text_answer": "No  Explanation  The statement none of the participants in group 1 of the primary trial",
        "label": "Contradiction"
    },
    "1adb6e15-a8b1-461a-8782-4295224a3c5f": {
        "text_answer": "No  The evidence states that individuals with dementia are excluded from the trial Vascular dementia is a",
        "label": "Contradiction"
    },
    "eb12190b-96c6-4c5d-8479-1248b462587d": {
        "text_answer": "Yes  Explanation The primary trials intervention duration was 10 weeks while the secondary",
        "label": "Entailment"
    },
    "5ebf97e0-5409-4e82-a837-e0d96bc62b96": {
        "text_answer": "No  Explanation The statement does not directly follow from the evidence provided The evidence only mentions",
        "label": "Contradiction"
    },
    "96259bb4-b459-4f63-b987-6bdb596211a4": {
        "text_answer": "Yes The evidence states that for Phase 2 of the clinical trial breast cancer patients must be ER positive to qualify",
        "label": "Entailment"
    },
    "f891188f-fa94-42d5-a341-2a6ae7d696ac": {
        "text_answer": "No  Explanation The statement there was a difference of four patients who endured adverse events",
        "label": "Contradiction"
    },
    "2f5ae30b-2e0d-420a-a27b-14088d2bc0db": {
        "text_answer": "Yes For one of the cohorts in the primary clinical trial all adverse events were reported as 0",
        "label": "Entailment"
    },
    "8723a112-05c6-4c05-82ab-e09cedffdb4b": {
        "text_answer": "Yes  Explanation The statement only three kinds of adverse events impacted patients participating in the primary",
        "label": "Entailment"
    },
    "176789e8-d2f5-4bb5-b748-ef0ed5c52478": {
        "text_answer": "Yes Neither trial includes severe insomnia as an inclusion criterion",
        "label": "Entailment"
    },
    "a6276d61-5f8c-483b-8f18-a3becebddbe8": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the dosages of cetux",
        "label": "Contradiction"
    },
    "85b158a4-1754-47b2-91b4-5165c38d270c": {
        "text_answer": "Yes   Explanation   The statement the unit of measure reported in the primary clinical trial",
        "label": "Entailment"
    },
    "9340e38d-37ce-4634-9f36-a747f964441c": {
        "text_answer": "No  The statement requiring considerable assistance and frequent medical care is not mentioned in the inclusion or exclusion criteria",
        "label": "Contradiction"
    },
    "6b6150e0-6484-499a-83ae-a9fc6a7d167c": {
        "text_answer": "Yes  Explanation The statement adult acute megakaryoblastic leukem",
        "label": "Entailment"
    },
    "69a761d0-c5b2-42f4-8cb3-271ac92fb006": {
        "text_answer": "Yes  Explanation The evidence states that in Intervention 1 Arm A CUDC",
        "label": "Entailment"
    },
    "f618f294-167b-4647-bc93-b8d41596227c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial does not",
        "label": "Contradiction"
    },
    "dda442a2-b86f-4375-ae81-f1b387ce46c9": {
        "text_answer": "Yes The evidence provided does not include information on treatmentemergent adverse events for either trial",
        "label": "Entailment"
    },
    "1fe68175-6ac4-4439-818f-94758e6bd306": {
        "text_answer": "No  Explanation The evidence provided in the text describes the results of a primary trial comparing the effect",
        "label": "Contradiction"
    },
    "444746eb-7e98-43fc-8bab-50c2a60d2806": {
        "text_answer": "No   Explanation  The evidence provided in the primary clinical trial describes the use of laser",
        "label": "Contradiction"
    },
    "2669332d-8907-4f82-afbf-e7be6b3c81b3": {
        "text_answer": "Yes The primary trial has different inclusion and exclusion criteria compared to the secondary trial",
        "label": "Entailment"
    },
    "635d4169-6adf-4254-9ee5-e9eede3f7bc5": {
        "text_answer": "Yes Both trials require patients to have a functional ECOG  2 status indicating they are ambulatory with",
        "label": "Entailment"
    },
    "23034d6a-8cb6-41b2-8e0d-84194285cb38": {
        "text_answer": "Yes The primary trial does not report the rate of clinical benefit CR PR SD PD beyond the number",
        "label": "Entailment"
    },
    "290fc77b-03cb-4ca6-877f-4117ea462ac6": {
        "text_answer": "  No  Explanation  The evidence provided in the primary trial results does not directly compare the",
        "label": "Contradiction"
    },
    "adfbe24e-4595-4fe3-88d8-8b5f01458993": {
        "text_answer": "No  Explanation The statement contrasting patient cohorts have contributed to the results of the primary",
        "label": "Contradiction"
    },
    "003a36ac-4091-4ca9-96f3-1108302eb9e1": {
        "text_answer": "Yes  Explanation The statement At several points during the trials Patients in the primary trial",
        "label": "Entailment"
    },
    "f329518b-872b-41af-8260-9d231e7ab205": {
        "text_answer": "Yes The primary clinical trial includes both male and female patients but the secondary clinical trial is open only to female patients",
        "label": "Entailment"
    },
    "84166f85-0a62-47fd-8dfa-a01dd778c748": {
        "text_answer": "No  The statement is not directly entailed by the evidence as the two trials measure different outcomes The first trial investig",
        "label": "Contradiction"
    },
    "559c1faa-17b6-42c7-9f63-0cd58df39bfa": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b1cd1f5b-2b10-4bec-8482-a049acc7b674": {
        "text_answer": "No  The statement about thyroid gland lipoadenoma and hepatic function is not mentioned in the evidence",
        "label": "Contradiction"
    },
    "e0c940e7-9a19-4c78-bf0f-4f630f6cfb90": {
        "text_answer": "No  The statement does not mention anything about sdh complex mutation analysis being performed in the trials",
        "label": "Contradiction"
    },
    "7238ddd4-eade-4b88-8933-0c3df5be9875": {
        "text_answer": "No  Explanation  The statement There were no significant differences in the results from the groups in",
        "label": "Contradiction"
    },
    "de8bb37e-838b-4ac0-bd2b-b866feadac64": {
        "text_answer": "Yes The statement does not directly relate to the adverse events in the evidence but the evidence does not contradict the",
        "label": "Entailment"
    },
    "d050c306-4563-403d-96c4-26728b8dc0df": {
        "text_answer": "yes the secondary trial intervention is extended compared to the primary trial However the statement does not specify that it is three",
        "label": "Entailment"
    },
    "01f72f8a-d22e-4509-859a-5df198d04d2f": {
        "text_answer": " Yes the statement is entailed by the evidence as the inclusion criteria state that patients with a BMI of 2",
        "label": "Entailment"
    },
    "4650b6bf-1aed-4407-ac23-7ca5a4c2728d": {
        "text_answer": "No  The statement is not entailed by the evidence provided for the secondary clinical trial as the evidence does not mention anything",
        "label": "Contradiction"
    },
    "9eb7c3cc-b3f5-40cf-8952-148afd8f2b04": {
        "text_answer": "No   Explanation  The statement provided is not directly related to the information given in the evidence",
        "label": "Contradiction"
    },
    "8bd8a0f5-4bc9-4de6-a7d8-2a3acaadc6c4": {
        "text_answer": "No  Explanation  The statement Prior treatment with gabapentin or herceptin within",
        "label": "Contradiction"
    },
    "f098a93b-9d39-4928-87b7-0ad43311c615": {
        "text_answer": "  No   Explanation   The statement more than 34 patients in",
        "label": "Contradiction"
    },
    "bc7b62ad-797e-419e-b5f9-888117aedf6b": {
        "text_answer": "No  Explanation  The statement There are several cases of swelling hypothermia",
        "label": "Contradiction"
    },
    "b3361d9c-9d9f-4966-80e7-629656bfcd1e": {
        "text_answer": "Yes The statement mentions the adverse events observed in the secondary trial that were not observed in the primary trial which",
        "label": "Entailment"
    },
    "09eee297-7801-4d6b-b3f6-17ee4f3418e4": {
        "text_answer": "No  Explanation  The statement image study is a radiographic technique used to evaluate a specific",
        "label": "Contradiction"
    },
    "d225c39d-4bd1-4129-a359-2909af912031": {
        "text_answer": "No  Explanation  The primary clinical trial results do not directly compare the overall response rate between Arm",
        "label": "Contradiction"
    },
    "a02a955a-9890-4347-8a6b-1377008f581b": {
        "text_answer": "  No the statement is not entailed by the evidence The evidence states that patients must have a potassium",
        "label": "Contradiction"
    },
    "439b1eca-f583-4a2b-bd8e-0baae97b4c15": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about patients experiencing no pain",
        "label": "Contradiction"
    },
    "b652609b-4609-481e-a5de-caa0c4432f2f": {
        "text_answer": "Yes   Explanation  The statement the placebo and memantine interventions in the primary",
        "label": "Entailment"
    },
    "be6130d9-49f1-4b4e-82f2-6acc6ee7f176": {
        "text_answer": "No  Explanation  The statement have excessive tearing is not directly related to any of",
        "label": "Contradiction"
    },
    "292a2905-b407-4068-8c2e-e6d596e494ca": {
        "text_answer": "Yes The primary clinical trial explicitly states that any gastrointestinal disease which would impair ability to swallow",
        "label": "Entailment"
    },
    "d401affc-f081-4eee-bd61-d109cc88f6de": {
        "text_answer": "Yes The primary trial excludes patients who are participating in another clinical trial",
        "label": "Entailment"
    },
    "72f49bc3-1624-437d-bf75-e37a24a9c19f": {
        "text_answer": "  Yes for the statement that age at menarche is a risk factor for breast cancer but not for the",
        "label": "Entailment"
    },
    "002bd33d-4038-4b2b-9f56-1bd8e8978d64": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with cerebral metastases within the brainstem are",
        "label": "Entailment"
    },
    "25d927c2-92be-405f-950a-e275c4d00e38": {
        "text_answer": "Yes  Explanation  The statement conditions including recurrent malignancies graftvers",
        "label": "Entailment"
    },
    "fd2a59ea-6b33-4b24-ae04-32a2a40b4029": {
        "text_answer": "No  Explanation The statement does not provide enough information to determine if the vitamin K measurement is",
        "label": "Contradiction"
    },
    "883cad2c-dee5-4530-bdde-5d616d4570ad": {
        "text_answer": "No  Explanation  The statement patients with severe insomnia and schizophren",
        "label": "Contradiction"
    },
    "81694850-fb70-4062-8dab-a52dd8083ebb": {
        "text_answer": "No  Explanation The statement four unique adverse events impacted patients in cohort ",
        "label": "Contradiction"
    },
    "cf45d975-0c29-4cf3-8f21-c245482a2b32": {
        "text_answer": "Yes  Explanation  The primary trial and the secondary trial have different outcome measurements In the primary",
        "label": "Entailment"
    },
    "4fc29a51-2cd7-4c8c-8000-58bd9cb4858d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "64cc1bfb-d23f-47e1-bfcb-7d69cd8458ad": {
        "text_answer": "Yes  Explanation The statement there was a single psychiatric adverse event in the primary trial",
        "label": "Entailment"
    },
    "48a0cb8b-d7c5-42e0-8adc-abd0b8f17301": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "dc55e21c-534b-4045-9c6c-f13919efde18": {
        "text_answer": "No  Explanation  The primary clinical trial involves the use of FMX and MM3",
        "label": "Contradiction"
    },
    "21afdaec-2db5-42b3-b201-b2dee4e23cb7": {
        "text_answer": "Yes  Explanation The statement the primary trial and the secondary trial do not use the same drugs",
        "label": "Entailment"
    },
    "d6381c6b-a7d6-406a-9d52-a660c27c2d49": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials have reported no adverse events for Adverse Events 1",
        "label": "Entailment"
    },
    "3159e9e4-c8a2-4333-b24c-250698ae8ffd": {
        "text_answer": "No  Explanation  The statement cohort 1 of the primary clinical trial was completely",
        "label": "Contradiction"
    },
    "2cde3c46-f21a-4177-afc8-94f851854b98": {
        "text_answer": "Yes There were a total of 3 vomiting events recorded in the primary trial",
        "label": "Entailment"
    },
    "70bfa3c4-2199-4d07-84c9-f41cac594ed4": {
        "text_answer": "Yes  Explanation The statement Cohort 1 of the primary trial received the same dose",
        "label": "Entailment"
    },
    "97fe92c7-779d-4de8-8834-60ed8fe3178f": {
        "text_answer": "No  Explanation  The statement There are no unexpected deaths or Hospitalizations that occurred in the",
        "label": "Contradiction"
    },
    "5829a465-2f7e-4a15-a746-24e4c0f53200": {
        "text_answer": "Yes  Explanation  The statement age restrictions apply to patients participating in the secondary clinical trial",
        "label": "Entailment"
    },
    "88fbd986-643d-4086-8091-e535d1970ab9": {
        "text_answer": "No  Explanation The primary and secondary clinical trials have different inclusion and exclusion criteria The primary trial",
        "label": "Contradiction"
    },
    "0ed8370b-00c3-41d9-9d12-0c0f1259cbf1": {
        "text_answer": " Yes The statement specifies that cohort 2 of the primary clinical trial does not receive antineoplastic",
        "label": "Entailment"
    },
    "a06d2404-8265-4baf-907d-ddba1bb223d0": {
        "text_answer": "Yes The statement does not report any adverse events in Cohort 1 of the primary trial which is consistent",
        "label": "Entailment"
    },
    "df8f9622-e361-4283-bc4a-fef7eaa101b1": {
        "text_answer": "No  Explanation  The statement corresponding author indicator is an indication that the specific author",
        "label": "Contradiction"
    },
    "8b50bdc1-1722-403b-a854-adeaacd02acb": {
        "text_answer": "No  Explanation  The statement Patients with a history of severe anaphylactic reactions",
        "label": "Contradiction"
    },
    "1f742130-d274-4857-bc92-af652963c07b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3cd90294-f295-4725-82d4-e185d03cc2b7": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "0cacd90a-ae93-47cb-b9f2-fa7e03d75270": {
        "text_answer": "No  Explanation The statement several of the primary trial candidates are administered 1",
        "label": "Contradiction"
    },
    "9a137ed3-f905-4367-988c-002fabb77140": {
        "text_answer": "No  Explanation The statement only 5 of patients in cohort 2 report",
        "label": "Contradiction"
    },
    "71268387-6e9d-4875-b193-b60b4e3e7033": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the patients in the primary trial receive",
        "label": "Entailment"
    },
    "54a1eab3-1e8e-4c1c-a30f-f4d677a84c71": {
        "text_answer": "No  Explanation  The statement The results from the primary trial indicate that the Arm A intervention",
        "label": "Contradiction"
    },
    "79f436e1-8238-4d99-824f-6b19bfbd4ec4": {
        "text_answer": "Yes  Explanation The primary trial involves the use of Abl Cells and Cyclophospham",
        "label": "Entailment"
    },
    "5a181517-dbdc-4598-8955-ca1bfa380fa9": {
        "text_answer": "Yes   Explanation The statement accurately reflects the difference in interventions between the two trials In the",
        "label": "Entailment"
    },
    "1cb125fb-0be1-49c6-b68b-64b525278c9c": {
        "text_answer": "Yes  Explanation The statement Across both the primary trial and the secondary trial only one death was",
        "label": "Entailment"
    },
    "726add6d-9f17-4e3e-a43e-8b391fbb953b": {
        "text_answer": "Yes   Explanation The statement is entailed by the evidence as the primary trial involves escalating dos",
        "label": "Entailment"
    },
    "333e2178-1944-4771-9ce5-6c89a1386f5a": {
        "text_answer": "Yes  Explanation The statement all participants in the primary clinical trial irrespective of their",
        "label": "Entailment"
    },
    "c8633493-4879-4e97-9fcf-5e59ca22a79a": {
        "text_answer": "Yes The primary trial includes patients with a breast tumor 1 cm in diameter which falls within the range of ",
        "label": "Entailment"
    },
    "a003e152-72e6-4c28-9f7d-1d2086174992": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants or ",
        "label": "Entailment"
    },
    "594bf055-6c27-4319-b7b6-11ef47fab70c": {
        "text_answer": "Yes  Explanation The statement one instance each of anaemia and febrile neutrop",
        "label": "Entailment"
    },
    "174a00b4-2d77-4734-b02a-3603133fa8fe": {
        "text_answer": "Yes  Explanation  The evidence provided in the results of the clinical trial shows that the percentage of",
        "label": "Entailment"
    },
    "055374e1-939d-4366-835a-edf8e587f45c": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "292a7346-b4f6-4fc1-92a7-80297532eeff": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "892ac2e3-f5f8-42eb-957c-b3ca6af18d3a": {
        "text_answer": "No  Explanation The statement in the question does not accurately describe the dosing regimens in",
        "label": "Contradiction"
    },
    "6c12493c-9eab-4206-aacc-bbb3dc398050": {
        "text_answer": "Yes  Explanation The statement no single type of adverse event noted in the primary clinical trial",
        "label": "Entailment"
    },
    "753d23e6-333c-4ec1-8bc2-a853c29a20e9": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the two clinical trials",
        "label": "Contradiction"
    },
    "c1e836e2-ad18-40b1-b8c4-0f05168d5104": {
        "text_answer": "No  Explanation The statement cohort 2 of the primary clinical trial receives 0",
        "label": "Contradiction"
    },
    "2c817052-b2e7-4199-8b5c-77d285e2231c": {
        "text_answer": "Yes The statement is entailed by the evidence as the inclusion criteria for the clinical trial specifically require a histologically confirmed in",
        "label": "Entailment"
    },
    "561a11dc-abb5-4a2b-9211-4e27419cfc43": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9eb119ec-3ef7-4de4-ab36-5e8d63fdb984": {
        "text_answer": "Yes The statement is about pelvic pain or discomfort which is not explicitly mentioned in the evidence but is included",
        "label": "Entailment"
    },
    "9e31c420-01cc-4232-9793-a3a4b7201fa6": {
        "text_answer": "No  Explanation  The statement liter per meter squared is a unit of concentration equal to",
        "label": "Contradiction"
    },
    "6fa15cf5-6fc4-48f3-a800-5e4699952ddb": {
        "text_answer": "  No   Explanation  The evidence provided does not mention anything about obesity as",
        "label": "Contradiction"
    },
    "54c7e880-a1bf-4206-9573-1c994932ba15": {
        "text_answer": "yes with exceptions for nonhealing surgical wounds in the primary trial",
        "label": "Entailment"
    },
    "804742bb-2d69-45a8-a7a9-b6a269bf8d58": {
        "text_answer": "No  The evidence provides inclusion and exclusion criteria for a clinical trial but it does not mention any specific requirement related",
        "label": "Contradiction"
    },
    "a8932849-e870-422e-a81a-1b43d9622082": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly give the Recurrence",
        "label": "Contradiction"
    },
    "05b6b24d-8753-4029-9464-c825cb52b9f4": {
        "text_answer": "Yes The statement accurately summarizes the difference in interventions between the two cohorts in the clinical trial However",
        "label": "Entailment"
    },
    "e34d6b72-e842-4cd8-a0f4-08c8f4d33be9": {
        "text_answer": " No   Explanation  The inclusion criteria state that participants must have a BMI of ",
        "label": "Contradiction"
    },
    "0bba5705-e808-4f90-b434-a951027f4d0f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "746f0f7a-c7e2-4ac9-a0ca-db2783eec9fa": {
        "text_answer": "No  Explanation  The statement none of the patients treated with sunitinib  doc",
        "label": "Contradiction"
    },
    "9e02f276-1bd0-4373-a049-9a67ee3eac87": {
        "text_answer": "No  Explanation  The statement there were 4 more patients that suffered adverse events in",
        "label": "Contradiction"
    },
    "7e0f7c16-59ff-4a80-833a-7bb82748e80a": {
        "text_answer": "No  Explanation  The statement cohort 1 of the primary clinical trial was administer",
        "label": "Contradiction"
    },
    "00f4aa60-c89a-496d-aa2d-9535fcc79ff0": {
        "text_answer": "Yes  Explanation The evidence provided in the trial results shows that the mean number of hot flashes",
        "label": "Entailment"
    },
    "65edf675-63e7-4b5f-b131-9e5cdf9eeec4": {
        "text_answer": "No  Explanation  The statement The dosage of Denosumab in Intervention ",
        "label": "Contradiction"
    },
    "a116a540-abca-478e-94ea-9997b0434c8b": {
        "text_answer": "Yes  Explanation The statement inppl1 gene mutation is a change in the nucleot",
        "label": "Entailment"
    },
    "ed50607e-8c46-4565-9192-4d5c4ca5fea5": {
        "text_answer": "No  Explanation The statement is about Acute Vomiting in cohort 2 of",
        "label": "Contradiction"
    },
    "321d4cba-47ee-4c74-85b9-072814b6fe6b": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials exclude pregnant patients from participation",
        "label": "Entailment"
    },
    "1f4fe504-06a7-40e6-ad0e-76c903ea80a2": {
        "text_answer": "Yes  Explanation The statement the occurrences of hepatotoxicity were tenfold compared",
        "label": "Entailment"
    },
    "6c3ebd57-b814-49df-bade-ad46362eaa2b": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only specifies the",
        "label": "Contradiction"
    },
    "83c979cb-fb3a-4792-8a63-8f7e544bb8a8": {
        "text_answer": "No  The statement about a patient with diffuse parenchymal lung disease being excluded from the trial is not",
        "label": "Contradiction"
    },
    "f203176f-3d6f-4e37-a07b-9bcf409ed538": {
        "text_answer": "No  The evidence does not state that AfricanAmerican participants in the primary clinical trial must remain inhabitants of Texas for the",
        "label": "Contradiction"
    },
    "c467ce7a-d234-4542-909b-ac94393314ce": {
        "text_answer": "No   Explanation  The evidence states that the patients in the intervention arm will be invited to",
        "label": "Contradiction"
    },
    "60431d29-7e80-4a3e-b433-83f886ea73b6": {
        "text_answer": "No  Explanation  The statement mixture of melanocytic neoplastic components",
        "label": "Contradiction"
    },
    "afc5437d-4c34-46e3-bcb0-742a23ba35e6": {
        "text_answer": "No The evidence does not mention anything about participants from the secondary trial being able to concurrently enroll in the primary",
        "label": "Contradiction"
    },
    "aa861098-a5f8-473e-be7d-eba94ccb4ab1": {
        "text_answer": "No  The patient described in the statement does not meet the eligibility criteria for the primary trial as they have a",
        "label": "Contradiction"
    },
    "1f8901ea-ca2d-4771-95e5-8b75fa7e9994": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence The evidence does not mention any information about the structure or",
        "label": "Entailment"
    },
    "4869e50d-ccc3-4200-b2e0-bf706fc99488": {
        "text_answer": "No  Explanation  The statement patients diagnosed with benign ductal carcinoma",
        "label": "Contradiction"
    },
    "22cf6f40-f022-4482-acdf-eef98748b946": {
        "text_answer": "Yes The primary trial measures changes in pain intensity and the secondary trial measures changes in bone mineral density of the lumbar spine",
        "label": "Entailment"
    },
    "b4a7bcbe-6c7b-4e37-be25-35f2dd042bce": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide information about the number or percentage",
        "label": "Contradiction"
    },
    "97a8ede9-e46f-4b17-be7d-b05e9bd2f86e": {
        "text_answer": "Yes  Explanation  The evidence provided does not mention tumour lysis syndrome as an adverse",
        "label": "Entailment"
    },
    "59c8ac7f-504b-46db-a840-b84fd9969b3d": {
        "text_answer": "No   The evidence provided only indicates the design of two separate clinical trials one evaluating LBH5",
        "label": "Contradiction"
    },
    "d08f014d-7d1b-45a1-b1c2-f68f12591f15": {
        "text_answer": "No   Explanation   The statement Both cohorts of the primary trial contained",
        "label": "Contradiction"
    },
    "6a0e68b7-6099-4fb9-bf11-35885b715348": {
        "text_answer": "Yes The statement is consistent with the inclusion criteria stating that patients must have had a requirement for hormonal treatment after a previous",
        "label": "Entailment"
    },
    "f53c5344-36d7-459f-9f84-300e19decced": {
        "text_answer": "No  Explanation The evidence states that there were 5 participants in the placebo group who experienced",
        "label": "Contradiction"
    },
    "cf4c4c98-b8b0-4ab8-85a8-1269da4d9fd8": {
        "text_answer": "Yes  Explanation  The statement There are 0 shared inclusionexclusion criteria between the",
        "label": "Entailment"
    },
    "ebe5f6c9-355c-4d69-8b0d-5ac8d5f861a1": {
        "text_answer": "No  Explanation  The statement mentions several psychiatric adverse events including",
        "label": "Contradiction"
    },
    "90e72a43-b0ee-4656-b679-a6025ef5d4c2": {
        "text_answer": "Yes  Explanation  The statement the results of the secondary clinical trial and the primary clinical trial",
        "label": "Entailment"
    },
    "89f8f42e-0ac7-4fc4-bbd3-d58ffb933005": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence describes",
        "label": "Contradiction"
    },
    "7af1ab1f-5170-496e-ba41-61d54113c9c6": {
        "text_answer": "yes with the condition that sexually active fertile men use an acceptable method of birth control to avoid pregnancy for the entire",
        "label": "Entailment"
    },
    "70b8c9a1-dcd5-459b-b138-d341132d2b5e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only reports a",
        "label": "Contradiction"
    },
    "91ce9f54-322f-4796-930e-0f85cf65d115": {
        "text_answer": "Yes  Explanation The statement cohort a and b of the primary trial are given two",
        "label": "Entailment"
    },
    "2c4fbaa0-f62c-4a7b-9d9d-7b61a8383ec4": {
        "text_answer": "yes the evidence relates to iDFS but it does not mention anything about granuloma assessment Therefore",
        "label": "Entailment"
    },
    "23cb11b4-6a85-4a6f-9e72-920eff085459": {
        "text_answer": "No  Explanation The evidence provided in the text does not contain any information about the longest PFS",
        "label": "Contradiction"
    },
    "33b59cbc-c52d-4e5c-8f77-f2d8a6fa491c": {
        "text_answer": "No  Explanation  The statement several recorded adverse events have been associated with the",
        "label": "Contradiction"
    },
    "e9e1b48b-55a2-479b-93cd-33db74d3053c": {
        "text_answer": "Yes The statement is entailed by the evidence as laserassisted fluorescence angiography is mentioned as",
        "label": "Entailment"
    },
    "cb418196-3bf8-4a86-9c90-819eb43ede13": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence reports that adverse events were observed in cohort ",
        "label": "Entailment"
    },
    "d16039bf-c0d3-488f-8890-cb5b5d909ab8": {
        "text_answer": "Yes  Explanation The statement only one cohort in the primary trial is given daily ar",
        "label": "Entailment"
    },
    "eb3891b2-5320-4b6e-9a9f-08c7aa8bdd29": {
        "text_answer": "Yes The primary trial does not exclude patients with metastases within the brainstem but the secondary trial does",
        "label": "Entailment"
    },
    "0c9b06e1-9dab-4937-b22e-0d372a5fd92d": {
        "text_answer": "Yes   Explanation  The statement in the primary clinical trial high doses of alpha",
        "label": "Entailment"
    },
    "4a56cd2d-ce04-4515-a033-f140e44cf955": {
        "text_answer": "Yes  Explanation The statement the first cohort of the primary clinical trial saw a single case",
        "label": "Entailment"
    },
    "284bab9f-a986-4a27-9fe3-ac989cefcf4e": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the evidence does not provide",
        "label": "Contradiction"
    },
    "e5746ae9-641d-4549-a164-811aa126a2e5": {
        "text_answer": "Yes  Explanation The evidence states that 53 out of 60 participants in the Lapatin",
        "label": "Entailment"
    },
    "510ae9ab-feae-4c57-a8c3-02e8764e6faa": {
        "text_answer": "No  The statement about a stepson and claustrophobiaosteoporosis does not",
        "label": "Contradiction"
    },
    "539adaf8-43ce-4c8f-9ed5-df5b030132c3": {
        "text_answer": "No  The statement is not entailed by the evidence as the participants in the primary clinical trial receive oral medication daily",
        "label": "Contradiction"
    },
    "df3a590c-02f9-4dc2-84da-da4d5534c542": {
        "text_answer": "Yes The evidence states that neither cohort received invasive surgery or Neratinib Therefore the statement that",
        "label": "Entailment"
    },
    "f995d440-b2ff-491e-bc11-038f63b8681e": {
        "text_answer": "No The statement is not entailed by the evidence as the patient described in the statement does not meet the inclusion criteria for",
        "label": "Contradiction"
    },
    "d6cde3f8-ef3c-4d8a-8afb-d3e9f8c5c1f8": {
        "text_answer": "Yes The evidence states that the trial excludes patients with dementia which includes Alzheimers disease",
        "label": "Entailment"
    },
    "dbb49ce0-7aed-4573-9b13-1db31e9df94d": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the secondary trial",
        "label": "Contradiction"
    },
    "198d43b9-ed80-463e-bbdc-d2d565fb61aa": {
        "text_answer": "  No The statement is not entailed by the evidence as the primary trial explicitly states that participants must be aged greater",
        "label": "Contradiction"
    },
    "679f8ab4-38a4-4c6c-b85f-800e645e5bb8": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention the number of participants in each group",
        "label": "Contradiction"
    },
    "93850158-9371-4320-aefc-c31e15a5d983": {
        "text_answer": "  Yes the primary trial has separate inclusion and exclusion criteria for its phases while the secondary trial has the same",
        "label": "Entailment"
    },
    "7bdf850e-2f84-40f0-9b80-5bf9984be081": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it does not mention",
        "label": "Contradiction"
    },
    "10acc981-00c5-4c74-b2ce-58bc69406955": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial has a multitude of adverse events recorded",
        "label": "Entailment"
    },
    "e42e5fc5-cdf8-40c3-9cf7-44ff5bdff413": {
        "text_answer": "No  Explanation  The statement neither the primary nor the secondary trial imposes restrictions based",
        "label": "Contradiction"
    },
    "5a90093d-2964-4935-b8af-236bfff8d4de": {
        "text_answer": "No  The evidence does not mention paclitaxel at all",
        "label": "Contradiction"
    },
    "1cda1a1d-3ca1-4838-9054-bcab763bb5d0": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any information about adverse events",
        "label": "Contradiction"
    },
    "15d7d028-69c2-4e01-b85c-cff568f34cc1": {
        "text_answer": "  No   Anorexia is a medical condition characterized by a persistent lack of appetite and significant weight",
        "label": "Contradiction"
    },
    "0bc4c4b5-bdb3-4b4b-9122-e52dcb57ec61": {
        "text_answer": "No  The evidence provided does not mention anything about gynecologic cancer or sexual relationships",
        "label": "Contradiction"
    },
    "5d04737b-c113-4934-94b6-ea9d8dd6318b": {
        "text_answer": "No  Explanation  The statement At several points during the trials Patients in the primary trial",
        "label": "Contradiction"
    },
    "9d9fc91e-b6a2-4ab8-bb28-a0a182574d90": {
        "text_answer": "No  Explanation The statement Sunitinib was administered orally every day to",
        "label": "Contradiction"
    },
    "e6b528a8-9d23-420b-b1a1-63bd831b7c03": {
        "text_answer": "No   Explanation The statement every patient in the primary clinical trial had fully healed surgical",
        "label": "Contradiction"
    },
    "205bc80b-db03-469f-85b8-290a4be79af8": {
        "text_answer": "Yes  Explanation The statement cohort 1 of the secondary trial receives lower weekly mm",
        "label": "Entailment"
    },
    "1a15db80-85f2-4d35-b325-1e01fdfb453d": {
        "text_answer": "No  Explanation  The evidence provided in the given trial results does not support the statement that the",
        "label": "Contradiction"
    },
    "52ae60f0-ea78-473d-9e82-78f2d1fc81bf": {
        "text_answer": "No  Explanation  The statement Diagnosis of 23 cerebral met",
        "label": "Contradiction"
    },
    "f008bad4-fa46-4187-b784-434238a5992b": {
        "text_answer": "No  Explanation  The statement higher doses of alt801 are",
        "label": "Contradiction"
    },
    "0ebc75cd-f87b-46a6-aaa3-9b511cdb90ae": {
        "text_answer": "No  The statement Patients with a histologicallycytologically confirmed diagnosis of a resectable Non",
        "label": "Contradiction"
    },
    "f52235c3-a9c6-4eb2-a9c6-929afe1bf49a": {
        "text_answer": "Yes assuming the cohorts refer to the two sets of data ie Adverse Events",
        "label": "Entailment"
    },
    "6bf5cffc-eb10-45ae-9e9f-b5b5d60be392": {
        "text_answer": "No  Explanation  The statement In total there are less cases of anemia in the",
        "label": "Contradiction"
    },
    "62c8e736-58fd-472f-bef0-c957b8055237": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 30 times the number",
        "label": "Contradiction"
    },
    "cc369e33-07e2-441d-b4fd-8233478ba98a": {
        "text_answer": "No  The evidence does not mention anything about severe malnutrition as an exclusion criterion for the clinical trial",
        "label": "Contradiction"
    },
    "77f689bc-c9fc-45ab-9966-aea06482863a": {
        "text_answer": "Yes The evidence does not explicitly state whether or not the secondary clinical trial is open to children",
        "label": "Entailment"
    },
    "fc35b082-3d3c-4ccc-971b-1f008c224a28": {
        "text_answer": "No  Explanation The statement participants in the primary trial receive 14 different drugs",
        "label": "Contradiction"
    },
    "28efc57b-6732-4778-84e9-81d1cea1a43e": {
        "text_answer": "No  Explanation  The statement aggravated malignant neoplasm is a m",
        "label": "Contradiction"
    },
    "a4ddb589-176d-4a2f-bdf2-3c5973a09a4d": {
        "text_answer": "Yes The statement is entailed by the evidence as none of the adverse events mentioned in the evidence are related to the",
        "label": "Entailment"
    },
    "47ff584c-f344-45ab-afec-1c1561453a36": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial found no traces of anaemia fe",
        "label": "Entailment"
    },
    "0f0501ba-557e-4111-8473-ec54b624a47f": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement incorrectly states that",
        "label": "Contradiction"
    },
    "825832eb-2b69-42a2-80b1-f210915da77c": {
        "text_answer": "Yes The evidence does not mention Hypertension Dehydration or Dyspnea in either coh",
        "label": "Entailment"
    },
    "9a337e6e-70b7-420d-9679-cc0baf5a5ba8": {
        "text_answer": "No  Explanation  The evidence provided does not mention tumour lysis syndrome in either the primary",
        "label": "Contradiction"
    },
    "9cc10a0d-5cb3-49b0-99c9-586837640270": {
        "text_answer": "Yes The statement correctly identifies the differences between interventions 1 and 2 in the primary trial",
        "label": "Entailment"
    },
    "bde45f5a-8909-48eb-b331-715583659654": {
        "text_answer": "Yes  Explanation The evidence states that there were 11 participants who experienced serious treatmentemer",
        "label": "Entailment"
    },
    "ac50c12b-4055-428b-8d8b-0136aca85f10": {
        "text_answer": "No  Explanation  The statement a higher percentage of patients suffered from adverse events in co",
        "label": "Contradiction"
    },
    "1023b3b0-b190-4ad2-b849-a7ba384be1f8": {
        "text_answer": "No   Explanation  The statement cohort 1 of the primary clinical trial is",
        "label": "Contradiction"
    },
    "be705668-6d11-46eb-bd96-9d20f01b936d": {
        "text_answer": "No  Explanation  The statement Diarrhoea was more common for the primary trial participants",
        "label": "Contradiction"
    },
    "beff7121-1697-41a7-bf43-998005d5c68e": {
        "text_answer": "Yes Perjeta pertuzumab is not mentioned in the secondary trial",
        "label": "Entailment"
    },
    "cd250e97-c2b4-48cd-bcbe-55ea06fa9662": {
        "text_answer": "Yes However the woman would need to meet the specific inclusion and exclusion criteria for each trial",
        "label": "Entailment"
    },
    "c4e967e1-c656-4d32-b8b5-c0b74a94bf02": {
        "text_answer": "Yes  Explanation The primary trial used lenalidomide in a dose of 5mg",
        "label": "Entailment"
    },
    "9c15d42d-2fcc-4c69-86b2-f75e29d732d4": {
        "text_answer": "No  Explanation  The statement one patient in the primary trial had an incident where a surg",
        "label": "Contradiction"
    },
    "1641b323-b136-4104-81e5-744ceac933de": {
        "text_answer": "Yes  Explanation The statement all ae types witnessed in the primary clinical trial affected less than",
        "label": "Entailment"
    },
    "6033e8d9-c7d5-4b36-b6da-80fdb98de034": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes a breast tumor of only 1",
        "label": "Contradiction"
    },
    "e8702a99-36bb-4f4f-b2ff-3fa6d49d034e": {
        "text_answer": "Yes The statement is entailed by the evidence as the first intervention uses a starting dose of 25 mg daily for",
        "label": "Entailment"
    },
    "961aaf91-e07d-4723-860e-23593727c303": {
        "text_answer": "No   Explanation  The statement intervention 1 in the primary clinical trial and",
        "label": "Contradiction"
    },
    "45e2f6cb-6ab2-424e-bd21-c2086ab6def3": {
        "text_answer": "No  Explanation  The statement the bevacizumab  capecitab",
        "label": "Contradiction"
    },
    "526f99de-e377-42e4-a7ae-a42b797aa536": {
        "text_answer": "No  Explanation  The evidence provided in the results of the clinical trial states that there were ",
        "label": "Contradiction"
    },
    "f8f0d036-16aa-4a9f-816e-c52940709126": {
        "text_answer": "No  Explanation  The evidence provided in the given text does not make any statement about mouth sensitivity",
        "label": "Contradiction"
    },
    "b6902408-8d60-438b-bb38-416d4a4d76fb": {
        "text_answer": "No   Explanation  The evidence describes the eligibility criteria for patients in a primary trial",
        "label": "Contradiction"
    },
    "449b619f-902b-446d-ac1e-f73be62ac2ab": {
        "text_answer": "Yes  Explanation  The statement the primary trial noted a higher incidence of adverse events",
        "label": "Entailment"
    },
    "c114301e-f64f-468b-95f7-8debdc840a74": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence does not provide information",
        "label": "Contradiction"
    },
    "7d60c7dd-fb79-4e95-a662-32de2036683f": {
        "text_answer": "Yes  Explanation The evidence states that there were a total of 12 participants analyzed in the",
        "label": "Entailment"
    },
    "99a6cb19-b6d8-4cb7-84e1-be559854caa6": {
        "text_answer": "No  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Contradiction"
    },
    "06024cb1-ce64-432e-b1d9-f3df2f95b025": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial both cohort a and",
        "label": "Contradiction"
    },
    "e4cdcf39-a01c-45f5-a382-d0e8a96a0be6": {
        "text_answer": "Yes  Explanation  The statement the primary trial has unified criteria for all phases while the",
        "label": "Entailment"
    },
    "fb758700-bd95-4857-a58e-1ee8d88c0d71": {
        "text_answer": "No  Explanation  The statement the primary clinical trial does not deliver any information on the m",
        "label": "Contradiction"
    },
    "4a64f808-b518-4666-9f78-56a2d6dd7093": {
        "text_answer": "Yes The evidence states that there were 234 participants in cohort 1 and 241 in",
        "label": "Entailment"
    },
    "2e42ac97-e353-4bbc-b61e-391e0c092689": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "36cb2716-6b66-49bd-bb22-7119bd022e28": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does provide",
        "label": "Contradiction"
    },
    "88951a9e-179e-4284-9f98-141eb3d76369": {
        "text_answer": "Yes  Explanation  The statement Aes were not recorded for the primary trial or the secondary",
        "label": "Entailment"
    },
    "1027bd72-7cce-4903-9838-733046143102": {
        "text_answer": "Yes The evidence shows that both groups had a median survival time greater than 2 years but there were patients in each",
        "label": "Entailment"
    },
    "effa7535-9810-4bf3-92bd-64aba7878bf6": {
        "text_answer": "No  Explanation  The evidence provided in the text only states that there were six participants analyzed in",
        "label": "Contradiction"
    },
    "eeb1a073-304f-41e4-b1f7-e2381eabf50f": {
        "text_answer": "No  The evidence provided does not mention radiation therapy at all",
        "label": "Contradiction"
    },
    "666c3ebb-3f79-4795-b5e7-4584815f498d": {
        "text_answer": "Yes The primary trial measures pain intensity while the secondary trial measures bone mineral density",
        "label": "Entailment"
    },
    "9e8aeaf6-36db-4f09-b7a6-7a5e41d14215": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "811978a1-2715-4174-84af-07a0ca3686e8": {
        "text_answer": "No  The statement is not related to the inclusionexclusion criteria in the evidence",
        "label": "Contradiction"
    },
    "bed73866-02e7-49d2-a66a-215e0a0d1b83": {
        "text_answer": "No  Explanation  The statement adverse event attributed to disease is an indication that an ad",
        "label": "Contradiction"
    },
    "910d3110-1fa1-4488-a481-085a18d1670a": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts receive the same radiation therapy dose with the only",
        "label": "Entailment"
    },
    "da901268-f433-47ff-9119-69d36ce3c4d0": {
        "text_answer": "No  Explanation  The statement the primary trial requires patients to receive 120 mill",
        "label": "Contradiction"
    },
    "c8109cb7-4cf5-469b-ba02-5d610579cc89": {
        "text_answer": "No  Explanation The statement both the secondary trial and primary trial yield similar results despite varied inter",
        "label": "Contradiction"
    },
    "3a85c9cb-b4e8-46cb-84c5-e618f0307b26": {
        "text_answer": "No  Explanation  The evidence provided does not include any data or results related to the comparison of",
        "label": "Contradiction"
    },
    "d0168033-35eb-4032-b6e5-f81d9d3a9f7a": {
        "text_answer": "Yes  Explanation  The evidence shows that the median aAUCpa for the Arm I ",
        "label": "Entailment"
    },
    "90783994-6867-4dfe-bbd0-71c4004d9a20": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement makes an assumption about",
        "label": "Contradiction"
    },
    "5d1e61bb-42f4-430c-843a-c6e80d121655": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts receive the same dosage of CUDC",
        "label": "Entailment"
    },
    "a9e1aa54-a19a-47d1-8d55-caef2035160e": {
        "text_answer": "No  Explanation  The statement mentions five adverse events notably cerebral hem",
        "label": "Contradiction"
    },
    "c6ff494c-5fa8-414d-8a32-15713193c9a3": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial includes the results of two groups",
        "label": "Entailment"
    },
    "1b48209c-3fcd-40d3-a647-f54b7e6179d2": {
        "text_answer": "Yes  Explanation The statement is consistent with the information provided in the evidence The evidence states that the",
        "label": "Entailment"
    },
    "7fb4b7a6-dee2-404f-a55f-18c8db378060": {
        "text_answer": "  Yes the patient is eligible for both trials based on the provided information according to the inclusion criteria However it",
        "label": "Entailment"
    },
    "61acc1f3-e02a-49ca-8ac8-42453619e78c": {
        "text_answer": "Yes with the exception of lymphoma incidents",
        "label": "Entailment"
    },
    "bf233363-7c05-475d-b248-d71303dec4e2": {
        "text_answer": "  Yes   Explanation   The statement all cohorts of the primary clinical",
        "label": "Entailment"
    },
    "8203056c-37a1-4fbf-a3cf-ddf28608d1ad": {
        "text_answer": "No  The evidence does not mention anything about neoplastic meningitis or lip infections The evidence only spec",
        "label": "Contradiction"
    },
    "e8cc1118-7a1a-46ba-aa08-cfb7f414a753": {
        "text_answer": "  Part A No the statement about kat6a gene rearrangement is not directly mentioned in the evidence",
        "label": "Contradiction"
    },
    "b73bde4f-21c4-48bd-82d3-0447d22cbd1c": {
        "text_answer": "No  Explanation  The statement hypokalemic patients are most welcomed to participate in the",
        "label": "Contradiction"
    },
    "68bae1de-1bee-486e-a50e-30ab9a4c705a": {
        "text_answer": "No  Explanation  The statement cardiac and psychiatric aes were frequently reported in the",
        "label": "Contradiction"
    },
    "664a5c0e-406c-4050-85d3-f2f489e5098b": {
        "text_answer": "Yes The evidence does not mention any vaccines being given to the participants",
        "label": "Entailment"
    },
    "90eca162-5617-44e3-909b-c8304af0d763": {
        "text_answer": "  No   Explanation   The statement Patients with NUT midline car",
        "label": "Contradiction"
    },
    "a8268e5e-d758-4dcf-8dd9-78c2016bc7f6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1480180d-d754-4fbd-bed9-70a50835c098": {
        "text_answer": "No  Explanation  The evidence provided in the text only shows the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "d8896ee9-9d44-485b-9b75-e25f4a56aa8d": {
        "text_answer": "No   Explanation The statement over 50 of patients in the primary trial suffered a",
        "label": "Contradiction"
    },
    "57d27d0b-626b-474b-9e10-60cbdd237d92": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "2e054c61-23f1-46df-9c49-44e5f076163d": {
        "text_answer": "Yes  The statement does not explicitly mention Herceptin by name but Herceptin is a type of trast",
        "label": "Entailment"
    },
    "ac4e121f-e159-49e0-84cb-83218232ebbb": {
        "text_answer": "No  Explanation  The statement Patients can not have a history of abdominal fist",
        "label": "Contradiction"
    },
    "a0d99371-52e5-4d30-81d5-ad65feba2e4e": {
        "text_answer": "No  The statement Patients with measurable tumors in both breasts are excluded from the primary trial is not",
        "label": "Contradiction"
    },
    "8e205d62-f220-45ba-9324-f8ee359236b1": {
        "text_answer": "Yes   Explanation  The primary clinical trial had only two groups one receiving the intervention ",
        "label": "Entailment"
    },
    "e493c4b0-1bd6-446f-a432-2703b7775620": {
        "text_answer": "maybe  Explanation The statement all participants who were administered with 1mg gtx0",
        "label": "Entailment"
    },
    "23ccac08-3764-496a-a790-4a1f5079909e": {
        "text_answer": "No  The statement is not entailed by the evidence The secondary trial candidates do not need to be completely disabled to",
        "label": "Contradiction"
    },
    "9ae8aa57-7196-4f5b-9911-33233705eac8": {
        "text_answer": "No   Explanation   The patient with a primary tumor 3mm in size",
        "label": "Contradiction"
    },
    "91a4429b-767a-493a-b1f3-f3a1ccf5ab6c": {
        "text_answer": "Yes The evidence states that some patients receive MCS110 at a dosage of 1 mgkg every",
        "label": "Entailment"
    },
    "5f294eee-f332-4c58-a43f-076a06a04dd5": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not mention anything about the route of administration of",
        "label": "Contradiction"
    },
    "03d015fe-1903-4b94-b495-4f23c40862db": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "63aa9e40-98df-4f09-a508-d0b03b9f93f1": {
        "text_answer": "No  Explanation  The statement less than 0050 of patients in the",
        "label": "Contradiction"
    },
    "dcfb970a-f5b0-41c1-a5ec-99d17734c17c": {
        "text_answer": "Yes The statement does not directly appear in the evidence but the evidence does state that female patients with breast cancer are eligible",
        "label": "Entailment"
    },
    "0e935403-0cb2-40ff-b78b-6ba7eaf9621e": {
        "text_answer": "Yes The statement is about the percentage of participants with HER2 Primary Breast Cancer who developed imagable HER",
        "label": "Entailment"
    },
    "277c0ee2-5d34-4c87-80eb-6f5b630109ec": {
        "text_answer": "No  Medulloblastoma is not a type of breast cancer The evidence only pertains to breast cancer patients",
        "label": "Contradiction"
    },
    "ef02754d-00ec-4f2d-bf7a-0a6d414b2476": {
        "text_answer": "No  Explanation  The statement There was at least 1 case of infection in both the",
        "label": "Contradiction"
    },
    "6848420c-ff9c-4003-bf9c-894b993c6720": {
        "text_answer": "No  Explanation  The statement the total number of anemia cases in the primary trial",
        "label": "Contradiction"
    },
    "481d1201-72b1-41b4-82cc-78b79ea8938a": {
        "text_answer": "No  Explanation  The statement does not follow directly from the evidence provided The evidence describes two",
        "label": "Contradiction"
    },
    "c6039c02-dcb4-433b-a0a5-4d6beb33b8fa": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ee74199e-c159-41f6-9130-8410b237c32f": {
        "text_answer": "Yes  Explanation  The statement the number of biliary colic and diarrhoea",
        "label": "Entailment"
    },
    "93bb8a0e-e84c-4730-b559-22d912103993": {
        "text_answer": "Yes The primary trial uses a higher dose of Lenalidomide 5mg daily compared to the secondary trial",
        "label": "Entailment"
    },
    "98d47cf2-ead0-4ab0-8f13-cb2215710dc8": {
        "text_answer": "No  The evidence does not provide any information about the type of surgery undergone by the primary clinical trial coh",
        "label": "Contradiction"
    },
    "91a67bbf-1ae1-4a86-92fb-dcac5e8298d1": {
        "text_answer": "Yes  Explanation  The statement no infections or fever cases were reported for patients in co",
        "label": "Entailment"
    },
    "95a261bd-f102-4ce8-887b-afa14d1e2856": {
        "text_answer": "Yes The evidence shows a reduction in Ki67 expression from a median of 15 at baseline to 1",
        "label": "Entailment"
    },
    "a6236585-ed05-4deb-bfcd-29eb410bd892": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the trials report",
        "label": "Contradiction"
    },
    "8a1d2587-95fa-4e7a-81db-1eb2561da680": {
        "text_answer": "Yes  Explanation The evidence states that both the placebo and trabectedin are administered",
        "label": "Entailment"
    },
    "b86e9d5c-8de2-428a-ba76-d0955ecb75fa": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "164f2ab2-b768-4ec0-befc-a9807ba379ff": {
        "text_answer": "Yes  Explanation The statement adverse incidents were prevalent among patients in the first cohort",
        "label": "Entailment"
    },
    "6450428b-bd2a-4ba5-aa5c-c86284dafa98": {
        "text_answer": "No  Explanation  The statement Any Patients currently taking part in the secondary trial will also",
        "label": "Contradiction"
    },
    "9bde44ff-5060-430d-9716-c34888483b9f": {
        "text_answer": "Yes The statement does not mention any specific adverse event so it is not contradicted by the evidence The evidence",
        "label": "Entailment"
    },
    "038e3e32-ae9c-4580-80b1-8d1c2d9d9bb9": {
        "text_answer": "  No the statement is not entailed by the evidence The primary trial includes patients with allergies to metron",
        "label": "Contradiction"
    },
    "86fd4794-aa66-4739-86c6-cf5bfcd911fe": {
        "text_answer": "No   Explanation  The evidence provided in the text does not indicate that all individuals involved in",
        "label": "Contradiction"
    },
    "71b2f727-f6ac-40e2-a92a-8bb89959e51e": {
        "text_answer": "No   Explanation   The primary trial measures the change in hot flash activity weekly",
        "label": "Contradiction"
    },
    "6e50b114-9a16-4710-8d95-91401b387221": {
        "text_answer": "Yes  Explanation  The statement the secondary clinical trial has age limitations for patients however",
        "label": "Entailment"
    },
    "9edc1688-da47-48ff-b475-b894e925dec7": {
        "text_answer": "No  The statement about patients that have a history of pulmonary embolisms and currently have breast impl",
        "label": "Contradiction"
    },
    "32ce7a8e-20c4-42d9-a4d4-e3b5d580331e": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the percentage of participants who",
        "label": "Contradiction"
    },
    "fac1b066-b96a-470f-8239-89c1cba6572d": {
        "text_answer": "No  The evidence only mentions individuals with unilateral breast cancer and lymphedema in the upper extrem",
        "label": "Contradiction"
    },
    "47db0ed8-8607-4442-827c-20eb9e8db776": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence specifies that there should be no brain metast",
        "label": "Contradiction"
    },
    "33621096-b0c2-4478-9662-45ba56f9da8d": {
        "text_answer": "Yes The statement mentions the specific adverse events observed in the secondary trial that were not observed in the primary trial",
        "label": "Entailment"
    },
    "01f7a296-d0c6-4530-800d-5985bcf7218c": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly describes the administration of capecitabine in the first",
        "label": "Entailment"
    },
    "455d059c-c3c4-4a09-be0d-a14b9568a0d2": {
        "text_answer": "Yes   Explanation  The statement cohort 1 of the primary trial is administer",
        "label": "Entailment"
    },
    "7f2ecb22-ab29-4dfa-b9f6-b09cb7d4c56b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e4ae61e2-fb24-41dc-9eb6-0102ee8d22d8": {
        "text_answer": "No  Explanation The evidence only specifies that the final eligibility for the clinical trial is",
        "label": "Contradiction"
    },
    "d0212d75-c952-4ad3-ae36-bbf675eae985": {
        "text_answer": "No  Explanation  The statement Over 50 of patients in cohort ",
        "label": "Contradiction"
    },
    "0d414333-1c03-4a79-91d7-1a34323e7e59": {
        "text_answer": "No  The statement is not entailed by the evidence as arimidex is not mentioned in the primary trial at",
        "label": "Contradiction"
    },
    "fe470456-ea60-433f-905c-21189377531a": {
        "text_answer": "  The statement is not entailed by the evidence as the evidence does not mention anything about the ophthalmic route",
        "label": "Contradiction"
    },
    "8b89865c-9af5-4fe0-8f9d-c56240ff7a90": {
        "text_answer": "No  The evidence includes performance status criteria as exclusion criteria in both trials",
        "label": "Contradiction"
    },
    "895d29b8-16bf-4539-b8f9-a7ffec42ce94": {
        "text_answer": "Yes for hypertension and dyspnea No for edema The evidence states that there were no cases",
        "label": "Entailment"
    },
    "2e16531b-70c8-4302-8747-761859ad7946": {
        "text_answer": "No  Explanation  The evidence provided in the results does not indicate that all participants in coh",
        "label": "Contradiction"
    },
    "e2a5803b-3991-4eb2-b428-56d91d9bca99": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial indicates that the average pain intensity score for",
        "label": "Entailment"
    },
    "3befd95f-b342-45a0-99b4-3f6996b664cf": {
        "text_answer": "yes The primary and secondary trials both measure pCR as an outcome The primary trial shows a difference in pCR rates",
        "label": "Entailment"
    },
    "796002e1-bc19-4298-a035-c853aee3e5c3": {
        "text_answer": "No   Explanation  The evidence provided does not mention any adverse events for the primary clinical",
        "label": "Contradiction"
    },
    "31d0a955-493b-4577-931c-ca3cda7a2a0b": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence only ment",
        "label": "Contradiction"
    },
    "6ad0142c-56d0-4994-b906-898198240c8c": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "3fe01e39-b6e5-465e-b76b-8048169a72bb": {
        "text_answer": "No   Explanation  The statement about tritylcysteine is not mentioned in the",
        "label": "Contradiction"
    },
    "62384871-8eb2-414b-8cc9-e756a188e19e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "a62aed40-ac98-4cdc-a7b2-4b1c57e6010b": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial compares two different interventions one with Nab",
        "label": "Entailment"
    },
    "067bc726-4646-40f8-aa6f-af44d315046e": {
        "text_answer": "Yes  Explanation  The statement no gastrointestinal adverse events were observed",
        "label": "Entailment"
    },
    "69848bb3-c093-4bf4-91eb-f941109b1cd6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "838e1a74-56e5-4dde-aeba-f26d2d3f8983": {
        "text_answer": "No  Explanation The evidence provided in the trial results only reports the median change in total body lean",
        "label": "Contradiction"
    },
    "1b314250-0177-4a73-a7f8-a9524ae44cfd": {
        "text_answer": "Yes eating disorders were not common based on the provided evidence However the statement does not directly address the question about sexual",
        "label": "Entailment"
    },
    "33668f2b-29b5-49e2-a0ee-4718913ea856": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement claims that",
        "label": "Contradiction"
    },
    "78d9d746-c05b-42e9-9156-d97a9f132589": {
        "text_answer": "No  Explanation  The statement during various stages of the trials primary clinical trial participants",
        "label": "Contradiction"
    },
    "8db59161-2a2e-4ade-9e23-538bf3b3ec77": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the interventions for C",
        "label": "Contradiction"
    },
    "275b4f49-8849-451b-972d-a597662de036": {
        "text_answer": "No  Explanation  The statement neutropenia was a common adverse effect in co",
        "label": "Contradiction"
    },
    "fffc74c9-56a5-45e7-ba89-a2c91da05110": {
        "text_answer": "yes The evidence shows that there were 5 emesisfree participants in the placebo group and 13 in",
        "label": "Entailment"
    },
    "5f2bbf7f-2e76-4ae9-8e79-e6361d05ef47": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ee2fe2ab-dc6f-434e-b0dd-1deee5fb3d31": {
        "text_answer": "Yes The primary trial has the requirement of resistance to AI therapy while the secondary trial does not mention it as a crit",
        "label": "Entailment"
    },
    "ff2a48f8-c4ab-4a13-9ca2-5d46ce4bd6c9": {
        "text_answer": "No  Explanation  The statement none of the adverse events in the secondary trial affected more",
        "label": "Contradiction"
    },
    "0ef8fead-d77e-4aa4-8e40-ca20ac2ea325": {
        "text_answer": "No  Explanation  The statement Cohort 1 of the primary trial received the same",
        "label": "Contradiction"
    },
    "e7bcb619-8ec0-45cf-acce-9d20e7258c95": {
        "text_answer": "Yes  Explanation  The statement the total number of adverse events were different in the patient",
        "label": "Entailment"
    },
    "be556bfc-7cc6-44fc-a505-52a8d55bbb5e": {
        "text_answer": "No The statement is not entailed by the evidence as the trials measure different outcomes FSH levels in the primary trial",
        "label": "Contradiction"
    },
    "08920163-ef22-4242-b9bf-b70af58c91c2": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "77f1bdb0-c7eb-41ba-b05e-e8914b68370a": {
        "text_answer": "Yes The evidence states that fibromyalgia is an exclusion criterion for the secondary trial Additionally",
        "label": "Entailment"
    },
    "2f07cc03-880c-43c4-b50f-c1cdf9ebf0dc": {
        "text_answer": "Yes  Explanation  The statement there were 0 cases of hypertension de",
        "label": "Entailment"
    },
    "292d0dd3-1b9c-4291-b367-0cc1666178db": {
        "text_answer": "No  Explanation  The statement the primary trial requires patients to receive 120 mill",
        "label": "Contradiction"
    },
    "332d5cb3-14c3-44d3-b2ee-899259c79a4b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "bf103149-cfe0-453f-9b83-d06c0a8958a0": {
        "text_answer": "Yes The evidence states that one of the inclusion criteria for the primary trial is that the subject has metastatic colore",
        "label": "Entailment"
    },
    "0a26f239-60ec-4aa7-81e8-de47c20def59": {
        "text_answer": "No  Explanation  The statement there were 50 cases of hypertension ed",
        "label": "Contradiction"
    },
    "1cdbbd44-21df-4279-9e3c-ff501f1361ec": {
        "text_answer": "Yes  Explanation  Both trials report on the determination of the Maximum Tolerated D",
        "label": "Entailment"
    },
    "c67c581d-7aa5-4a90-b640-dcdf8d69e870": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "66d9fdb8-ea66-43e2-b497-340bc7832155": {
        "text_answer": "Yes The evidence states that 13 of participants with HER2 primary breast cancer who underwent H",
        "label": "Entailment"
    },
    "f5cdf7ed-828f-4e45-9699-b5f80c7b1863": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "063e3d67-dc20-453d-a437-f56447bfa49f": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence describes",
        "label": "Contradiction"
    },
    "9426014b-4962-4dcc-8328-ca29428d6ed3": {
        "text_answer": "No  Explanation  The statement 119 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "8820e8d9-5bea-461f-8622-5ec4b6388a79": {
        "text_answer": "Yes  Explanation  The statement while the secondary clinical trial excludes 18year",
        "label": "Entailment"
    },
    "3f1c8f3a-f9dd-4819-b6db-2931e0c3f288": {
        "text_answer": "No  The evidence does not specify that AfricanAmerican patients in the primary clinical trial must be based in Texas The",
        "label": "Contradiction"
    },
    "766e3e18-5567-48e2-9656-12c1b3ead63f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3015f97a-8a45-4a05-a5cf-9c5eaa49e667": {
        "text_answer": "No   Explanation  The primary trial describes a treatment cycle length of 21 days",
        "label": "Contradiction"
    },
    "0cf2969d-0228-4267-8e5a-12dc22a12ae9": {
        "text_answer": " No  Explanation The evidence provided describes two separate cohorts Phase 2 Triple",
        "label": "Contradiction"
    },
    "236451bf-52bd-4530-ba81-100e63b0030f": {
        "text_answer": "Yes The statement specifically mentions stomatitis as the adverse event which is consistent with the evidence that there was",
        "label": "Entailment"
    },
    "47dbd397-7aa3-4c9b-9241-d148a255902a": {
        "text_answer": "No  Explanation  The statement 0 of the participants in group 1 of the primary",
        "label": "Contradiction"
    },
    "bd587160-ea9e-41d4-b2c4-54815327d2fb": {
        "text_answer": "Yes The primary trial includes breast adenocarcinoma as a cancer type for Phase 2 and the secondary",
        "label": "Entailment"
    },
    "fcef015e-f82c-4cac-a7c1-61a81f0eac3b": {
        "text_answer": "No  Explanation  The statement Hypokalemic patients are excluded from the primary trial but",
        "label": "Contradiction"
    },
    "87fda661-4348-4078-b3e7-915893241ab0": {
        "text_answer": "No  Explanation  The statement Suramin and Paclitaxel are administered to all",
        "label": "Contradiction"
    },
    "1d75f8ad-2c35-4481-b6f7-58db73eeea7b": {
        "text_answer": "Yes The statement mentions the cbfa2t3 gene which is mentioned in the evidence as being related to",
        "label": "Entailment"
    },
    "ac3dfb95-6558-4815-b5ed-4887505dedf8": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial noted a higher prevalence of muc",
        "label": "Contradiction"
    },
    "41e2d2b1-9637-4667-b032-86c844a94b93": {
        "text_answer": "Yes  Explanation  The statement the secondary clinical trial does not permit the participation of individuals who",
        "label": "Entailment"
    },
    "dcea72d4-afb6-4565-8d92-fd259ed8ee15": {
        "text_answer": "Yes The primary trial includes the statement The participant has not undergone major surgery within 28 days prior to",
        "label": "Entailment"
    },
    "71698d59-3bbe-4e8f-85c8-bf2110727155": {
        "text_answer": "Yes  Explanation  The statement Only 4 different types of adverse events affected patients in",
        "label": "Entailment"
    },
    "38e2c25f-97c9-4112-b571-b832e29e7c7e": {
        "text_answer": "No  Explanation  The statement only cohort 2 receives an increased dose of ",
        "label": "Contradiction"
    },
    "aab9225d-d2bc-4004-bcaf-4f69a9e7991b": {
        "text_answer": "No  Explanation  The primary clinical trials exclusion criteria do not mention organ transpl",
        "label": "Contradiction"
    },
    "9d291a23-1696-4208-a5d4-7b2e1dd48831": {
        "text_answer": "No  Explanation  The statement grade 1 esophageal fistula ct",
        "label": "Contradiction"
    },
    "80a26581-a95c-4c22-864f-93425b1fc165": {
        "text_answer": "Yes  Explanation The evidence shows that a larger percentage of participants in both the Collaborative Care",
        "label": "Entailment"
    },
    "294df8e3-8ba1-41e7-acdc-6448bfab99f1": {
        "text_answer": "No  Explanation  The statement every patient in the primary clinical trial experienced multiple adverse events",
        "label": "Contradiction"
    },
    "1b70762f-83fb-4c93-98ac-7f5d8852fc16": {
        "text_answer": "Yes  Explanation The evidence states that there were a total of 12 participants analyzed in the trial",
        "label": "Entailment"
    },
    "32781bed-ab99-4837-a7f8-d3ab0b978384": {
        "text_answer": "Yes but incomplete The statement is correct that tp53 mutation analysis was not performed during the study but",
        "label": "Entailment"
    },
    "e7bc1f65-d4e4-4f87-9a2c-ab56c35368ae": {
        "text_answer": "No   Explanation  The statement 157 the primary trial participants and ",
        "label": "Contradiction"
    },
    "636ec547-3ea0-41d4-a46f-92d4780b2ffd": {
        "text_answer": "Yes The statement that the primary and secondary trials recorded the same number of adverse events is entailed by the evidence",
        "label": "Entailment"
    },
    "d13b1dc9-46cf-471b-b2b1-fa93b235e954": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants in",
        "label": "Contradiction"
    },
    "b753305c-ea26-492d-b45e-760dc4f69b9a": {
        "text_answer": "No  Explanation The statement Patients participating in the primary trial receive 100 mg",
        "label": "Contradiction"
    },
    "e0265a05-590e-4f77-8e94-8bcdd1d9757e": {
        "text_answer": "No  Explanation  The statement there were no recorded cases of palpitations peric",
        "label": "Contradiction"
    },
    "b3dd4df2-abff-4e7f-89ce-57b109d25bf2": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because it makes incorrect assumptions about",
        "label": "Contradiction"
    },
    "88857141-6207-4828-b8d4-09d7cc4498c3": {
        "text_answer": "Yes for the secondary trial  Explanation The secondary trial excludes patients who have received any experimental agents",
        "label": "Entailment"
    },
    "027aec87-187e-4c41-9a39-4c453dd1e0ad": {
        "text_answer": "Yes  Explanation The statement in the secondary clinical trials group 2 one incident of",
        "label": "Entailment"
    },
    "28363fb8-16ff-4a26-b29c-ca41d1ed2e6e": {
        "text_answer": "No  The evidence states that one participant experienced a urinary tract infection",
        "label": "Contradiction"
    },
    "bcbe90f9-602b-45bc-aa97-28e50238e2fb": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it introduces new",
        "label": "Contradiction"
    },
    "4c79deb2-4d30-470e-959c-e3cf05af0b88": {
        "text_answer": "No  Explanation  The statement less than 2 of patients in the secondary trial and",
        "label": "Contradiction"
    },
    "77aeeff2-38c4-41ce-8526-55ab056504f9": {
        "text_answer": "  Yes The statement is entailed by the evidence as the trial includes patients with locally advanced andor metast",
        "label": "Entailment"
    },
    "5f44bd33-3921-479c-9a16-e2af73e72101": {
        "text_answer": "Yes The evidence shows that both groups had negative standardized scores indicating below average cognitive function on average at the 1",
        "label": "Entailment"
    },
    "7adf46ec-7d70-4767-936f-b7d89f93cdd6": {
        "text_answer": "No  Explanation  The statement the secondary trial on the other hand does not have a",
        "label": "Contradiction"
    },
    "c132218c-a01a-406c-b1a1-7d66cc8877bd": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the most commonly occurring",
        "label": "Contradiction"
    },
    "4fcc0d4c-0772-47c8-ad68-80d10fbeaa0d": {
        "text_answer": "No  Explanation  The statement the primary and secondary clinical trials had syncope as the most",
        "label": "Contradiction"
    },
    "c2bcdabf-3336-424c-bf5f-13f0b522fa2b": {
        "text_answer": "No  Explanation  The statement the primary clinical trial frequently reports general symptoms as the most common",
        "label": "Contradiction"
    },
    "f7fc247a-5390-4e3f-9254-b16ecdda5851": {
        "text_answer": "No  Explanation  The statement 16p133 is a chromosome",
        "label": "Contradiction"
    },
    "f57d4f1e-c5ba-4b65-8407-5a5be29e28b4": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide information about the size of the re",
        "label": "Contradiction"
    },
    "05e6adb2-0549-4564-84c7-79e4a19d0e99": {
        "text_answer": "No  Explanation  The statement 14 adverse events were observed in the primary clinical trial",
        "label": "Contradiction"
    },
    "80da21c8-478e-41a2-befc-384403e43ff4": {
        "text_answer": "Yes The evidence mentions that alloMSCs are administered via transendocardial injections and",
        "label": "Entailment"
    },
    "d28a4294-8d88-4473-b302-51c771571ffb": {
        "text_answer": "Yes  Explanation The primary trial does not provide information on the dosing frequency of MM",
        "label": "Entailment"
    },
    "3eb3c1f5-b395-43e5-a8e5-cf613ac87f30": {
        "text_answer": "Yes The primary trial includes breast adenocarcinoma as a qualifying cancer type for both Phase 1 and",
        "label": "Entailment"
    },
    "7f1301ad-2bc6-426b-86da-8a5c80dfba0c": {
        "text_answer": "No  The statement about Documented allergy to cephalosporin trimethoprims",
        "label": "Contradiction"
    },
    "ab0a9eb7-2f28-425a-aa06-2389f0c1e9f7": {
        "text_answer": "Yes  Explanation  The primary clinical trial focuses on measuring tumor diameter in centimeters",
        "label": "Entailment"
    },
    "4b545fd1-a4d1-486a-aece-201400e9c1f5": {
        "text_answer": "None of the patients in cohorts 1 and 2 showed a discernible pattern for expression of the genes",
        "label": "Entailment"
    },
    "bbb06e30-afa0-40c0-9594-b8c293cd5207": {
        "text_answer": "No  Explanation  The statement the lions share of patients from the primary clinical trial",
        "label": "Contradiction"
    },
    "bef15be3-6cf6-426a-a70a-d5d99a1c42af": {
        "text_answer": "No  Explanation  The statement Neither the secondary trial nor the primary trial measure the Change",
        "label": "Contradiction"
    },
    "5f76619b-30cd-47bc-99b9-aab25ce87366": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial there wasnt any recorded",
        "label": "Entailment"
    },
    "1eb531b0-d0fc-41b7-a6d4-1b774affc30a": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not specify that a patient who completed a cycle",
        "label": "Contradiction"
    },
    "a9d41a93-5857-4a56-89f2-46cf6bef36e1": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median with range change in",
        "label": "Contradiction"
    },
    "7f3b898a-e7d1-4cc2-bf62-a8366ea7cf80": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "fe37b4ad-fe84-429b-89ce-f5a881215b56": {
        "text_answer": "Yes The primary trial includes women aged 20 years or older and the secondary trial includes women and men aged ",
        "label": "Entailment"
    },
    "f2076a4f-6170-46ca-9e08-8d0f9589bb06": {
        "text_answer": "No   Explanation  The statement The majority of patients in the primary trial experienced complete response",
        "label": "Contradiction"
    },
    "6a6f23a1-354d-4c1a-b457-e3ce15564e69": {
        "text_answer": "Yes The primary trial has different inclusion criteria for different study groups while the secondary trial has the same inclusion criteria for all",
        "label": "Entailment"
    },
    "e970c950-ccf6-4c0c-8573-84634162fdf3": {
        "text_answer": "No  The evidence explicitly states that smokers and those with alcohol use within the past 2 years are excluded from",
        "label": "Contradiction"
    },
    "552c3a00-fa13-4e27-89a8-2ef4823317cd": {
        "text_answer": "No   Explanation  The evidence provided in the primary clinical trial does not mention the use of",
        "label": "Contradiction"
    },
    "65c91814-cbda-4db3-a680-4bc3fe0855a8": {
        "text_answer": "Yes  Explanation  The statement in the primary trial the same inclusion and exclusion criteria",
        "label": "Entailment"
    },
    "6af06b3f-dbbc-4679-a4a3-fe4b3757fdc0": {
        "text_answer": "Yes  Explanation  The evidence states that there are 234 participants in cohort",
        "label": "Entailment"
    },
    "cb9a1bc3-cc8d-4d0d-a335-eb5c5071289f": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not support the statement that ",
        "label": "Contradiction"
    },
    "c01b910d-2463-4bf8-bb67-f950aca11411": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8df26566-8724-4ca3-b6be-f43b9b188724": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence pertains to breast cancer and the statement is about",
        "label": "Contradiction"
    },
    "e3222534-b084-405b-bd5a-32fbd2a663c4": {
        "text_answer": "No  Explanation The statement participants will receive their single injection on the first day of",
        "label": "Contradiction"
    },
    "1943100e-196d-4022-a38a-9ae0dd816294": {
        "text_answer": "Yes  Explanation The evidence states that both interventions involve the injection of 04 to",
        "label": "Entailment"
    },
    "728c430c-a48c-44a3-a598-38f96ddabaea": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "b0308df2-5725-4b3a-9c80-0d5390bf3149": {
        "text_answer": "Yes The evidence shows that the median survival for both groups was over 2 years and over 50 patients from",
        "label": "Entailment"
    },
    "8d60b35c-e6df-4e22-a92e-b9c782b9ed1b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "217b0362-9dd0-4f10-8ca5-c097688bb738": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "42eaaa23-bd07-4a89-ba9f-dffe36e31ddb": {
        "text_answer": "No  Explanation The statement is not directly related to the evidence provided The evidence only mentions",
        "label": "Contradiction"
    },
    "7e01558a-26ed-4ebf-aa18-d5d1c876c194": {
        "text_answer": "No  Explanation The statement doctor and I shared responsibility for deciding which treatment is best for",
        "label": "Contradiction"
    },
    "0a1f17fb-d58d-46e3-a726-bf7ef647e88e": {
        "text_answer": "Yes  Explanation The statement positive fish or IHC 3 results confirming a diagnosis",
        "label": "Entailment"
    },
    "e9204795-c6e7-4215-a230-2958d48a6ac2": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial does not report the incidence of",
        "label": "Entailment"
    },
    "ab29d2f1-5d52-475b-be8a-a3b82c49a44a": {
        "text_answer": "Yes The evidence shows that 381 of participants in Arm 1 and 333",
        "label": "Entailment"
    },
    "3317bb44-031e-4444-b6b9-7b538727efa3": {
        "text_answer": "Yes  Explanation  The statement in neither the primary clinical trial nor the secondary clinical trial were",
        "label": "Entailment"
    },
    "dbcb7763-d671-465e-8704-4bd5cd5ec7ef": {
        "text_answer": "No  Explanation  The statement there were multiple adverse events recorded in the primary trial and",
        "label": "Contradiction"
    },
    "b681145e-4fd6-42ae-8250-b6d915e7a0cf": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial have different inclusion criteria The primary trial",
        "label": "Contradiction"
    },
    "a0ad7d49-26f2-42ac-a384-e6362ccae8d7": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "572557f8-fcc1-4448-aa44-a09e7c5244e8": {
        "text_answer": "Yes The primary trial has less stringent inclusion criteria regarding performance status and previous chemotherapy treatment compared to the secondary trial",
        "label": "Entailment"
    },
    "ee0e333a-4b42-4078-a126-d3a1101f7f4c": {
        "text_answer": "No   The primary trial measures the summed pain intensity differences SPID at 30 minutes after",
        "label": "Contradiction"
    },
    "0f631563-09e1-48db-a6c3-1cc06009e139": {
        "text_answer": "Yes  Explanation  The evidence shows that in both trials all patients experienced at least 3",
        "label": "Entailment"
    },
    "1e1830e7-f7bd-4bf4-99c4-c36f6da015e3": {
        "text_answer": "No  Explanation  The statement does not provide enough information to determine if the intestinal route",
        "label": "Contradiction"
    },
    "e875a6e2-1058-4954-a864-7f1b35508362": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "0b90fb4c-0de2-478b-95d2-2f0b555398ad": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention mentioned in the evidence only includes therapeutic and lifestyle changes",
        "label": "Entailment"
    },
    "e56bca0a-a541-4a59-ba79-0f17cd0cdcb6": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial explicitly states that patients",
        "label": "Contradiction"
    },
    "f0fbd167-6b00-4152-889e-7df794aa0619": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "94857a77-b822-4cb8-989b-b6efb0a105e0": {
        "text_answer": "No  Explanation  The statement both trials saw a considerable number of adverse events throughout their",
        "label": "Contradiction"
    },
    "31f16856-c47c-40f3-b9a8-c414f07710ec": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "f6ca1a5e-853d-4669-8c13-89b54a42c460": {
        "text_answer": "Yes The evidence does not mention any information about NRAS gene mutations in the given cohorts which implies",
        "label": "Entailment"
    },
    "90599dbb-bf85-4e56-9a16-fbcd4fbb22f6": {
        "text_answer": "Yes  The statement is entailed by the evidence as trastuzumab Herceptin is mentioned in",
        "label": "Entailment"
    },
    "7f0ff0a3-ccf0-4ea7-9c5b-b631da541d07": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3de4fd70-62c3-4310-a163-507e49af0e73": {
        "text_answer": "No  Explanation The primary clinical trial includes a criterion for a primary tumor greater than ",
        "label": "Contradiction"
    },
    "70539b18-50b0-43f7-b676-2143de2dc3e8": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e7572377-d468-4b13-815a-f43887747c18": {
        "text_answer": "No  Explanation The evidence provided in the form of the primary clinical trial interventions only mentions",
        "label": "Contradiction"
    },
    "a60074c0-d7a6-47cc-b980-ee1c0a791f66": {
        "text_answer": "Yes Both interventions use the same dose of nabPaclitaxel 125 mgm",
        "label": "Entailment"
    },
    "3ce48a99-7310-4a2f-8853-e46db55af26e": {
        "text_answer": "Yes but the statement is not an exact representation of the evidence as it combines the presurgical and post",
        "label": "Entailment"
    },
    "aef90851-f30f-4d13-b6d6-8f52afaaa302": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "42aa56a7-2e3b-4932-bdde-a0ed438111c1": {
        "text_answer": "No  Explanation The statement is not about the adverse events related to the difficulty of bending",
        "label": "Contradiction"
    },
    "bfa5809e-c1d4-49b8-b3d1-37fd6f7b077f": {
        "text_answer": "Yes The primary trial excludes patients with allergies to specific agents including doxycycline but the secondary trial",
        "label": "Entailment"
    },
    "7b819ac1-92e6-41ce-881c-0f4581a690ee": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "dcad163d-b572-4dcc-a052-8bfb81f05ad5": {
        "text_answer": "Yes In the primary trial participants received 02 mgkg or 05 mgkg of",
        "label": "Entailment"
    },
    "4e9ce538-8418-4432-b3e7-8f3ecfefee6d": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly compare the ORR between the",
        "label": "Contradiction"
    },
    "a06166e6-12c9-49ba-ad3a-7fcfb5234174": {
        "text_answer": "Yes  Explanation  The primary trial and the secondary trial have different outcome measurements In the primary",
        "label": "Entailment"
    },
    "82cea870-dbc3-4ebf-824c-0cebd7e95205": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "2677ff54-f67c-44c1-9aa8-64efd3357f65": {
        "text_answer": "No The statement Patients that have a history of pulmonary embolisms and currently have breast implants cannot",
        "label": "Contradiction"
    },
    "ac265234-e392-49b4-b46b-a0a54e54f88b": {
        "text_answer": "No  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Contradiction"
    },
    "a01bb73a-e620-4bb5-995b-9433d10090ab": {
        "text_answer": "Yes The primary trial does not involve drugbased treatments but the secondary trial does test two separate drugs",
        "label": "Entailment"
    },
    "3d52b3c6-d110-4442-8a2f-1cf87b1092c5": {
        "text_answer": "  No The statement about anal cancer pmx tnm finding v6 is not directly related to the inclusion",
        "label": "Contradiction"
    },
    "56e9308b-f718-4831-8e56-4b18982e4a2c": {
        "text_answer": "Yes The evidence does not specify eligibility based on nationality ethnicity weight or gender",
        "label": "Entailment"
    },
    "c3f4b547-8d11-42ba-800c-7ccbe1283741": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only mentions ER positive and HER2 negative",
        "label": "Contradiction"
    },
    "5718421a-fc98-4df0-a866-21d4718ebf78": {
        "text_answer": "Yes   Explanation   The statement the administration of trastuzumab in the",
        "label": "Entailment"
    },
    "c3c644d4-1964-454a-af82-4e82c2567f6e": {
        "text_answer": "Yes  Explanation The statement all groups in the primary trial study are subjected to the same",
        "label": "Entailment"
    },
    "c4a0d86a-f8a8-4c2a-a28a-25147f35a682": {
        "text_answer": "Yes  Explanation  The statement all the instances of infections and fever observed in the primary",
        "label": "Entailment"
    },
    "1af24416-2f14-423b-bd1c-b6f604cae64a": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide any information",
        "label": "Contradiction"
    },
    "09deff91-1b05-470a-aecd-60ce772b9a8e": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the evidence only mentions breast",
        "label": "Contradiction"
    },
    "5bdc0c5e-236f-4dbf-92cd-8f582a16b2fd": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because  1",
        "label": "Contradiction"
    },
    "e530eed4-ee8b-4a7f-bb36-5ce9ea7ddebe": {
        "text_answer": "No  The statement is not entailed by the evidence as there were no cases of acute myocardial",
        "label": "Contradiction"
    },
    "c392fd36-941e-4809-8d9e-16e3aa1c945c": {
        "text_answer": "No  Explanation  The statement compared to the secondary clinical trial the primary clinical trial",
        "label": "Contradiction"
    },
    "dd58a7e3-370e-4e61-9071-6155962cd180": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "151ae668-d1e7-4dd1-beb2-75dd7efbae4c": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it is incomplete and incorrect",
        "label": "Contradiction"
    },
    "d475c476-8172-47a0-bf91-7ef5d0f6d081": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "48b5fa7f-b2c7-41f9-adc5-ca55ae919f3d": {
        "text_answer": "Yes  Explanation  The statement different patient features are evaluated in the results of the primary",
        "label": "Entailment"
    },
    "1d60de45-bc33-4178-96e6-d0fa20e51fed": {
        "text_answer": "No  Explanation  The statement transparent is allowing the passage of light such that images can",
        "label": "Contradiction"
    },
    "18303bbd-059e-4161-8cc6-9569a71308f5": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as both Intervention 1 and Inter",
        "label": "Entailment"
    },
    "3a0c092c-7e18-4108-ae66-552f7069831f": {
        "text_answer": "No  Explanation  The statement Across both the primary trial and the secondary trial over ",
        "label": "Contradiction"
    },
    "4eacff65-65e6-4bf9-bc94-419c48e854e8": {
        "text_answer": "Yes  Explanation  The statement adverse events experienced by patients in the primary clinical trial do",
        "label": "Entailment"
    },
    "9c6f062e-a260-4c3a-ac91-fc5de6de176d": {
        "text_answer": "yes The primary and secondary trials both use pCR as the outcome metric and there are differences in pCR rates between",
        "label": "Entailment"
    },
    "0416a45e-2ea6-4f82-8bc6-05cc37b941f8": {
        "text_answer": "No   Explanation The primary trial does not have a 6day cycle for its intervention",
        "label": "Contradiction"
    },
    "57526ef1-a6b9-419e-86c9-0a2d6db7ad23": {
        "text_answer": "  No   Anorexia is a medical condition characterized by a persistent lack of appetite and significant weight",
        "label": "Contradiction"
    },
    "50dae016-a6b4-4ee6-a66a-bf35587cd835": {
        "text_answer": "Yes The evidence shows that the median survival times for both groups are over 2 years but it also indicates that at",
        "label": "Entailment"
    },
    "43297eae-d154-4417-8bd4-3c4aae66e6bd": {
        "text_answer": "No  Explanation  The statement the record shows that the primary clinical trial experienced 4 more",
        "label": "Contradiction"
    },
    "c21d4d07-87ea-46ba-b930-9fd3fb0797a5": {
        "text_answer": "Yes The evidence states that smokers are excluded from the secondary clinical trial Therefore if a patient is currently engaged",
        "label": "Entailment"
    },
    "65f9af41-9bb8-438a-b967-94acfd0e08a9": {
        "text_answer": "Yes The evidence does not provide any outcome data for the LBH589 and Lapatinib cohort",
        "label": "Entailment"
    },
    "3131f532-99b5-433e-9375-8af120cd4c0f": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement mentions my",
        "label": "Contradiction"
    },
    "bfb9d912-39ea-4a7a-b3eb-51e9d1b5f436": {
        "text_answer": "Yes  Explanation The primary clinical trial explicitly lists a history of allergic reactions attributed to compounds of",
        "label": "Entailment"
    },
    "06bf2ef1-129f-47cf-b51f-75e51f1eb66a": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial all of the recorded individual ad",
        "label": "Entailment"
    },
    "fb41d62d-4f75-463d-b71a-0b31dd0ade96": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions in the trial provide the same amount of nab",
        "label": "Entailment"
    },
    "e875dcbd-dc31-47c4-87bf-a94b0c1696b1": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial measure different outcome measures The",
        "label": "Contradiction"
    },
    "9640278e-af41-482e-8390-d20bc7388149": {
        "text_answer": "yes with conditions The statement is entailed by the evidence but it also includes additional criteria for sexually active fert",
        "label": "Entailment"
    },
    "ad11786a-e01b-466c-9e44-31f1be35c79c": {
        "text_answer": "Yes The evidence does not report any fatalities or hospital admissions in either trial",
        "label": "Entailment"
    },
    "325db761-416f-4aab-80e8-e3271a11200b": {
        "text_answer": "Yes The evidence does not mention any vaccines being administered to the participants",
        "label": "Entailment"
    },
    "56ac01ed-cfba-4ab5-9082-dbe4a4418e9d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0931fd2b-2ce8-4285-9c02-63318e60efc3": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "b0709ec3-ea6b-4f70-a24e-d23480df5b14": {
        "text_answer": "Yes  Explanation The statement while the primary clinical trial presents the time taken for progression recorded",
        "label": "Entailment"
    },
    "f2beb95f-ac83-48f1-936b-70d45d51880c": {
        "text_answer": "No   Explanation  The placebo was administered as a 3hour intraven",
        "label": "Contradiction"
    },
    "286e098d-ca31-41ce-b8a9-f8bcf99447f0": {
        "text_answer": "No  Explanation  The statement anemia is more prevalent in the primary trial when",
        "label": "Contradiction"
    },
    "115aa2c8-f52f-4a62-9b8a-6f6e593bd208": {
        "text_answer": "Yes  Explanation The statement primary clinical trials second cohort has an additional ",
        "label": "Entailment"
    },
    "425f9738-1b09-446e-8c8c-5004ed91351d": {
        "text_answer": "Yes  Explanation  The statement all the instances of infections and infestations in the",
        "label": "Entailment"
    },
    "53416cd6-ac0b-43c1-824f-719d43ad5af4": {
        "text_answer": "No  Explanation  The statement various participants of group 1 in the primary clinical trial",
        "label": "Contradiction"
    },
    "b4e6d7be-cb1b-4000-812e-d49098f0aaf0": {
        "text_answer": "Yes The evidence states that there was at least one hospitalization and one death in cohort 2 of the primary",
        "label": "Entailment"
    },
    "438a978d-ac7e-4260-bb24-d2129cb3dfc6": {
        "text_answer": "Yes for severe insomnia  Explanation The statement Patients suffering from severe insomnia",
        "label": "Entailment"
    },
    "d5586986-90bb-4302-98c1-0507aa208d2d": {
        "text_answer": "  Yes  Explanation  The primary clinical trial involves the use of a Contour Profile T",
        "label": "Entailment"
    },
    "b80c867f-7c46-4ac1-a9c4-b56ce0173c2a": {
        "text_answer": "Yes   Explanation  The statement in the primary clinical trial various drugs were used as",
        "label": "Entailment"
    },
    "cafb9767-9320-40fc-a862-53530450f96f": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as it",
        "label": "Contradiction"
    },
    "8c4891f7-e0af-4ddb-8754-0638ece12c58": {
        "text_answer": "Yes  Explanation  The evidence provided includes the results of a clinical trial comparing the effectiveness of two",
        "label": "Entailment"
    },
    "7ae03d8b-6087-4df3-a0e1-d1932d86528c": {
        "text_answer": "No  Explanation  The statement Far more patients in the secondary trial were recorded to have",
        "label": "Contradiction"
    },
    "3b13cd45-eae5-4039-8a8a-a73c55fde5dc": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "dfc9042c-745d-46a2-9706-3efe0b24c20c": {
        "text_answer": "No  Explanation  The statement most patients experienced multiple severe adverse events post participation in the",
        "label": "Contradiction"
    },
    "ddfc4bce-b6b0-4817-a171-db6bd5e095bd": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity psychiatric condition or gender as inclusion or exclusion criteria",
        "label": "Entailment"
    },
    "b957f1f2-8dc3-4d00-802d-26cd8fa3b9f4": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor of 1 cm in diameter",
        "label": "Contradiction"
    },
    "dcfc0053-b963-4542-ae02-228d3d2bd98e": {
        "text_answer": "Yes  Explanation The statement The Interventions in the primary trial included different medications but are administer",
        "label": "Entailment"
    },
    "b54f065f-7b3e-42b0-8dc6-61dc466f7f59": {
        "text_answer": "Yes  Explanation  The primary clinical trial and the secondary clinical trial both assess patient outcomes with",
        "label": "Entailment"
    },
    "160afbf4-14b4-4e83-b324-4d3102b8f72c": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly compare the outcomes of the Bev",
        "label": "Contradiction"
    },
    "eae19a7f-ca02-482d-942f-223d74881c40": {
        "text_answer": "yes for the primary trial regarding pulmonary embolism exclusion and no for the secondary trial regarding breast",
        "label": "Entailment"
    },
    "c0db0110-c67a-40e6-8bfc-b7e016509778": {
        "text_answer": "Yes The evidence states that patients with significant cardiovascular impairment including congestive heart failure clinically",
        "label": "Entailment"
    },
    "7caa5dd0-cd09-4559-a243-736304ce22e4": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence because the",
        "label": "Contradiction"
    },
    "a14e5115-a6ff-4253-9260-736c943bd47e": {
        "text_answer": "  No  Explanation  The statement patients who have received chemotherapy or radiotherapy",
        "label": "Contradiction"
    },
    "0f17aa12-6aea-430e-b4e8-2a21f2832582": {
        "text_answer": "Yes The statement is entailed by the evidence as these alterations are listed as exclusion criteria for patients with any tum",
        "label": "Entailment"
    },
    "bdb61718-ee5f-4e2a-9c78-850e788c139f": {
        "text_answer": "  Part A No the primary trial explicitly excludes patients with a pulmonary embolism within the past",
        "label": "Contradiction"
    },
    "df783937-3936-4f0b-a3f9-96a977497c6f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8e88537e-5eb0-4e85-a6cd-58e374d027b6": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only mentions the",
        "label": "Contradiction"
    },
    "b1cb1388-9a0f-4dfd-8890-a3d2bced6ab4": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial 96 participants from the",
        "label": "Contradiction"
    },
    "8c1414dd-20b2-415e-8d0e-1f9b8e7951d1": {
        "text_answer": "Yes  Explanation The evidence provided in the text does not mention the use of entericco",
        "label": "Entailment"
    },
    "4f4360c0-38f9-4cea-89bb-8bf2a3fd0a4a": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the statement mentions nothing about",
        "label": "Contradiction"
    },
    "c48550ef-7210-4834-9047-969a7898d519": {
        "text_answer": "Yes The evidence does not report any cases of eating disorders among the participants",
        "label": "Entailment"
    },
    "2a0b1a83-299d-404d-96e5-67ee65173dde": {
        "text_answer": "yes  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Entailment"
    },
    "faf8436a-2459-4718-be81-10b0649ff87a": {
        "text_answer": "No The statement is not entailed by the evidence as the primary trial includes patients aged greater than 20 years and",
        "label": "Contradiction"
    },
    "bf00cf4b-27eb-4c1a-88e2-f86df10f2727": {
        "text_answer": "  No  Explanation  The evidence provided in the primary trial results does not directly state or",
        "label": "Contradiction"
    },
    "98c16e6f-17a1-436f-833f-4f69e14f52db": {
        "text_answer": "No  Explanation  The evidence provided in the text only compares the effectiveness of acupunct",
        "label": "Contradiction"
    },
    "c43583e4-da5f-42b3-ad3d-7ba8b6b28f2b": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded 11 more cases of Intest",
        "label": "Contradiction"
    },
    "7c093c8a-8233-4dbb-87ba-03a1a049a7e8": {
        "text_answer": "Yes The statement is entailed by the evidence as the patients in Intervention 1 receive radiation therapy for a longer duration",
        "label": "Entailment"
    },
    "67498e27-5a2e-4495-adb7-5cd8f51aae65": {
        "text_answer": "No  Explanation  The statement the dosage of tamoxifen in intervention 1",
        "label": "Contradiction"
    },
    "5ca1c4e8-73e3-4329-9644-bfb986b6673e": {
        "text_answer": "Yes  Explanation  The statement encounter due to other problems related to physical environment is an",
        "label": "Entailment"
    },
    "36e4b948-e72f-43d9-8084-b3d2e879620b": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "9b1d58dd-30d8-4df2-856e-4cae783cbd6e": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions in",
        "label": "Contradiction"
    },
    "92ea43b9-05d5-47a4-a78d-87bcb3326810": {
        "text_answer": "No  The evidence reports one participant experiencing a rash maculopapular which is a type of r",
        "label": "Contradiction"
    },
    "0629bf04-f185-49b2-905e-e9a3932dbb0a": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "dc2d7205-d6ce-4d9c-96d2-e5a80fa906c0": {
        "text_answer": "No  Explanation  The statement recurrent malignancies graftversus",
        "label": "Contradiction"
    },
    "02adb741-194d-4472-b4b8-a3b546dc0484": {
        "text_answer": "No  Explanation  The statement patients participating in the primary clinical trial tended to have",
        "label": "Contradiction"
    },
    "55cc22eb-91ad-423f-8d3e-e4b5ef61ed7d": {
        "text_answer": "Yes The patients eligibility for both trials depends on the other inclusion criteria being met as well",
        "label": "Entailment"
    },
    "41a0138d-7084-40d9-99ae-24db9e84acce": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "6846ee30-4c0c-4340-9c13-3892edc3baea": {
        "text_answer": "Yes The evidence does not provide information about Hypertension Dehydration or Dyspnea in either",
        "label": "Entailment"
    },
    "3974c3ec-d3b5-4313-ae4b-4332ee5865ab": {
        "text_answer": "No  The primary trial requires a Karnofsky score of 70 or better while the secondary trial requires",
        "label": "Contradiction"
    },
    "e8e3fedb-075d-440e-bf2e-baec76f96cca": {
        "text_answer": "Yes The evidence states that Nonsmall cell lung cancer and Small cell lung cancer are included in the list of eligible tum",
        "label": "Entailment"
    },
    "c441ac74-f9ef-493c-bcfb-03959f9bf7e3": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not directly support the statement about",
        "label": "Contradiction"
    },
    "867cde11-ffad-4494-bdea-2457651a7de7": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a change",
        "label": "Contradiction"
    },
    "fe5179d1-0090-4c87-9287-9bb26139acd0": {
        "text_answer": "No  Explanation The statement about as socially active as before is not directly related to the",
        "label": "Contradiction"
    },
    "6561c528-4e6f-4e1f-8d65-9fa11d3c8838": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial does not",
        "label": "Contradiction"
    },
    "a2b4f24d-e4ff-49b5-a21f-61ba1e5b0b32": {
        "text_answer": "Yes  Explanation The statement over 40 more participants in the ERpositive",
        "label": "Entailment"
    },
    "dac129a3-974e-4918-95e5-11bbc0207e02": {
        "text_answer": "No  Explanation  The evidence provided in the text does not support the statement that all participants",
        "label": "Contradiction"
    },
    "ac0de5f6-14ed-44a1-9112-bce1b197553b": {
        "text_answer": "No  Explanation  The statement trichomonas infection is an infection that is caused by",
        "label": "Contradiction"
    },
    "ef1d6dfa-2cd0-4e19-99b7-a813d6952706": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "11cb71ed-1304-42f0-b416-3679c3e9e1b3": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it introduces new",
        "label": "Contradiction"
    },
    "0f37bc77-1f82-44ce-ae7e-2a6b833e774a": {
        "text_answer": "No  Explanation  The statement provided does not directly relate to the information given in the evidence",
        "label": "Contradiction"
    },
    "d9dff3a0-537b-4297-bc58-766d366ba5a0": {
        "text_answer": "No  Explanation  The statement 97 of patients in the primary trial did not experience",
        "label": "Contradiction"
    },
    "0d382bbc-1c8d-4d05-b0dd-8501755ce9dd": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial experienced hospital",
        "label": "Contradiction"
    },
    "1a84148c-2d33-4804-922e-9a3419890897": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "b3527d60-eb66-465d-845a-e234e5b0a084": {
        "text_answer": "No  Explanation  The statement primary clinical trial does not allow participants who smoke but the",
        "label": "Contradiction"
    },
    "3d2d011f-aff9-45c6-87e9-359b6d265c98": {
        "text_answer": "No  Explanation The statement patients who have received chemotherapy or radiotherapy in the last ",
        "label": "Contradiction"
    },
    "e9653ffb-8fe5-47a3-810f-6831216f9893": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as there is no information provided in",
        "label": "Contradiction"
    },
    "97d1e0d2-2f6f-45f1-8e85-33c92d71f0bf": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence reports that one patient 909",
        "label": "Contradiction"
    },
    "2cf8046e-2d49-4989-aca0-9e11795978cb": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement incorrectly confl",
        "label": "Contradiction"
    },
    "c7e44ec4-ddeb-4d8b-97aa-0361308300b8": {
        "text_answer": "Yes  Explanation The statement cohorts a and b are both given two different treatments",
        "label": "Entailment"
    },
    "c6ca9f93-1abb-4c01-bdfb-aa17c5028ec8": {
        "text_answer": "No   Explanation   The statement a young girl with a Newly diagnosed PR",
        "label": "Contradiction"
    },
    "16634eb4-f12b-4d17-8401-070a7b7d052b": {
        "text_answer": "No  Explanation  The statement have discomfort when urinating is not directly related to",
        "label": "Contradiction"
    },
    "36e73055-3f34-4e5b-94a0-cfbac5dc3ff9": {
        "text_answer": "No  Explanation  The statement have trouble saying what i mean in conversation is not a",
        "label": "Contradiction"
    },
    "ec164af8-13b9-4545-b3ba-24260adfe9db": {
        "text_answer": "Yes The evidence states that the primary clinical trial is accepting up to 30 patients with metastatic colorect",
        "label": "Entailment"
    },
    "29bed237-ccbb-460b-a50b-fbdc9e52fdd1": {
        "text_answer": "Yes  Explanation  The statement All AE types in the primary trial affected less than ",
        "label": "Entailment"
    },
    "34c7862b-3725-4ed8-9e67-1513300323a7": {
        "text_answer": "Maybe  Explanation  The evidence provided in the form of the two clinical trial results only shows the",
        "label": "Entailment"
    },
    "c0b2f348-06b9-4e92-9257-a32c38b072cf": {
        "text_answer": "No The statement is not entailed by the evidence as the secondary trial only mentions female patients",
        "label": "Contradiction"
    },
    "512b8ed3-f0ca-4e11-ab4a-eebe4217ad7e": {
        "text_answer": "Yes  Explanation The primary clinical trial measures the change in hot flash activity using a daily prospective hot",
        "label": "Entailment"
    },
    "568b4d2b-204c-4606-a75f-058a5870c84c": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it introduces an",
        "label": "Contradiction"
    },
    "7ba4c342-8897-4815-9bb3-eea917b3769e": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial administer",
        "label": "Contradiction"
    },
    "f988fa4a-02f0-41f6-9e27-453604dd3ecc": {
        "text_answer": "Yes The statement the adverse events recorded were of the same number is entailed by the evidence since the number",
        "label": "Entailment"
    },
    "0f77fc34-7285-4374-879d-b96166cfc29e": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence states that participants will take vorinostat",
        "label": "Contradiction"
    },
    "e648aa7a-3013-4d37-9bf5-51e75c7d4202": {
        "text_answer": "No  Explanation  The statement infections affected more than 15 of patients in",
        "label": "Contradiction"
    },
    "7723c9e5-e80e-4ef6-b56d-ee26f8423d90": {
        "text_answer": "No   The statement is not entailed by the evidence as the primary trial does not report the severity of",
        "label": "Contradiction"
    },
    "6b4bc07c-bfc3-4750-b802-7100efeb60a7": {
        "text_answer": "Yes   Explanation  The statement the interventions in the primary clinical trial are similar in",
        "label": "Entailment"
    },
    "320ec115-31c3-47bf-a819-93d514b91eb3": {
        "text_answer": "No  Explanation  The statement None of the participants in group 1 of the primary trial",
        "label": "Contradiction"
    },
    "19ca7182-94ba-4b70-bd4e-1a65bd428f91": {
        "text_answer": "  No   Explanation   The statement candidates for the primary trial must",
        "label": "Contradiction"
    },
    "1d1f2f55-c9b7-4a8b-bea7-b8ea291d96d5": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes patients with T1 N1 M1 tumors",
        "label": "Entailment"
    },
    "919dbcc0-8d31-4161-8692-45533e52d60e": {
        "text_answer": "No  Explanation  The statement no adverse events were reported in the primary clinical trial",
        "label": "Contradiction"
    },
    "33efdbc8-175b-4021-b192-acd8d37cedd1": {
        "text_answer": "No  Explanation  The statement 125 of patients in the primary trial suffer increased",
        "label": "Contradiction"
    },
    "a555a807-ceeb-4237-bd26-25e5a3db9128": {
        "text_answer": "No   Explanation  The statement Suramin and Paclitaxel are administered to",
        "label": "Contradiction"
    },
    "96892eae-9630-45eb-bc5f-6c7605d8dd1c": {
        "text_answer": "  Yes for the primary trial and No for the secondary trial with qualifications  Explan",
        "label": "Entailment"
    },
    "afeed01c-f21a-4926-9028-d2b9a2226c9f": {
        "text_answer": "Yes The statement is entailed by the evidence as there is no mention of paclitaxel in either intervention described in",
        "label": "Entailment"
    },
    "0c05d756-82d5-4f8f-afe7-845857c1e9d3": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of inhalation as a method of",
        "label": "Contradiction"
    },
    "a954a34f-0eb2-4c28-8673-f4c0a337bd00": {
        "text_answer": "No  Explanation  The statement HER2  Patients in the primary trial receive the same",
        "label": "Contradiction"
    },
    "5119953d-f226-4e3d-96c9-a05862188b6d": {
        "text_answer": "Yes  Explanation  The statement neither the primary nor the secondary trial reported any cases of",
        "label": "Entailment"
    },
    "e0393f5c-7dec-4018-8917-b055823aec4b": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as Atara Biotherapeut",
        "label": "Contradiction"
    },
    "24e662f6-3ac7-489b-91fa-890994a805b4": {
        "text_answer": "No  The evidence does not state that only Hispanic patients can participate in the primary clinical trial The evidence outlines",
        "label": "Contradiction"
    },
    "f4cf0fc1-5b69-49a1-8ba6-454063ff63ce": {
        "text_answer": "Yes for both primary and secondary trials regarding the absence of thromboembolic events However its",
        "label": "Entailment"
    },
    "349365cf-1c22-4e72-b321-b15b505e50cb": {
        "text_answer": "Yes The evidence does not provide any information about the measurement of Change in Ki67 Expression in Tumors in either",
        "label": "Entailment"
    },
    "14632f5e-6eb4-4771-9567-cbde0f19c4af": {
        "text_answer": "No The statement is not directly related to the evidence provided in the trial results The evidence only reports the proportion of participants",
        "label": "Contradiction"
    },
    "c648cc67-b490-4cfe-be5e-4706b94ac0df": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial as well as secondary clinical trial",
        "label": "Entailment"
    },
    "8b9a4f04-25f6-45d2-a4fe-52e5bd3d22de": {
        "text_answer": "Yes  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Entailment"
    },
    "6cce2cb8-3ed9-40e9-a412-cb75b688ac59": {
        "text_answer": "Yes  Explanation  Both trials include patients who are 18 years of age or older",
        "label": "Entailment"
    },
    "1649a4de-bc0d-4908-88ac-515b88be60b3": {
        "text_answer": "No  Explanation  The statement the primary trial reported no adverse occurrences and",
        "label": "Contradiction"
    },
    "5784fb28-1da8-483c-a56b-61b68fb2a8f5": {
        "text_answer": "Yes The primary trial describes a treatment cycle lasting 21 days one month while the secondary trial does not specify",
        "label": "Entailment"
    },
    "0b4536c8-2868-4d1a-bc26-d16b31eed34f": {
        "text_answer": "No  The statement is not entailed by the evidence as candidates with an ECOG score of 4 are",
        "label": "Contradiction"
    },
    "2dce1806-9ce1-4448-9888-052def540a43": {
        "text_answer": "Yes  Explanation The statement a single psychiatric adverse event was reported in the primary clinical",
        "label": "Entailment"
    },
    "e6bbed17-0fdf-4008-b56e-4d901490ce1a": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial both use pCR as",
        "label": "Entailment"
    },
    "be50f0ae-0c2b-42be-9306-78a1da6b4e09": {
        "text_answer": "No  The primary clinical trial does not mention any height requirements while the secondary clinical trial does not specify height as an",
        "label": "Contradiction"
    },
    "79cd8b63-fe24-4e8b-9a15-0e054fb09dba": {
        "text_answer": "No  Explanation  The primary clinical trial measures changes in patientspecified and reported symptoms on",
        "label": "Contradiction"
    },
    "367bc142-7412-43c6-b946-6127aff25f9a": {
        "text_answer": "  No the statement is not directly entailed by the evidence as the evidence only reports on the percentage change in beta",
        "label": "Contradiction"
    },
    "4087e09b-d0a1-4c3a-8411-b1938bf51b95": {
        "text_answer": "Yes  Explanation  The statement in the secondary clinical trial and the primary clinical trial more",
        "label": "Entailment"
    },
    "7df6c8c9-fb22-4197-aba7-d6540a691eec": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial uses ",
        "label": "Contradiction"
    },
    "5cd571da-1a17-4513-b0b8-7ef1ced9a52f": {
        "text_answer": "Yes In the primary trial PF06647020 was given at higher doses ",
        "label": "Entailment"
    },
    "3805ddb3-dbdf-4f10-8434-271503114961": {
        "text_answer": "No  Explanation  The statement the gender of a patient dictates whether they qualify for the",
        "label": "Contradiction"
    },
    "79385974-de52-4d05-b6b1-dc1086d484d9": {
        "text_answer": "No The statement is not entailed by the evidence as the statement is about hypothyroidism which is not mentioned",
        "label": "Contradiction"
    },
    "f6f6058f-688b-4ce6-8fec-612f57b1f3ec": {
        "text_answer": "No  Explanation The primary trial includes people with a breast tumor that is 1 cm in diameter",
        "label": "Contradiction"
    },
    "df0234b5-3b00-4036-ac6c-5cb2d1eeafdf": {
        "text_answer": "yes The evidence states that MLN8237 is administered in the form of entericcoated table",
        "label": "Entailment"
    },
    "448df56a-bcc3-491e-8626-dc8d439013b2": {
        "text_answer": "No  Explanation  The statement there were several fatalities in the second cohort of",
        "label": "Contradiction"
    },
    "4872d505-a3f8-44bb-a023-aa41e27b49b3": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the percentage change in ser",
        "label": "Contradiction"
    },
    "b1b73c84-818f-40f9-8e6b-a749dc415b71": {
        "text_answer": "Yes  Explanation The statement one or more participants in the primary clinical trial experienced numerous adverse outcomes",
        "label": "Entailment"
    },
    "4cd89e87-f0c1-4064-ab16-d945db457c41": {
        "text_answer": "No   Explanation   The statement first cousin once removed is a child of your first",
        "label": "Contradiction"
    },
    "21031398-5d47-4ad9-ad19-16c790eaf061": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only reports the median average",
        "label": "Contradiction"
    },
    "b45f25ba-463e-458a-9e48-edd0d50bc6cb": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial cohort 1 has",
        "label": "Entailment"
    },
    "7a5cbc82-ec49-44f5-9c95-4c6475f3ee3e": {
        "text_answer": "Yes  Explanation The primary trial includes women with locally advanced recurrent or metastatic ER",
        "label": "Entailment"
    },
    "640ffbc4-cf15-4ab2-bf90-620e815f2694": {
        "text_answer": "Yes  Explanation The evidence shows that both groups had a median survival time greater than 2 years",
        "label": "Entailment"
    },
    "e5f60086-55a3-4432-9e9d-74690054db5d": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not mention anything about",
        "label": "Contradiction"
    },
    "648ed723-14eb-4c58-85f9-9a6f6089b493": {
        "text_answer": "No   The statement is not entailed by the evidence as the primary trial assesses the severity of pain",
        "label": "Contradiction"
    },
    "641b6edf-2ed6-494a-9d37-7c7f04ccd6a0": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only reports the percentage change in serum",
        "label": "Contradiction"
    },
    "fb13dfb3-66cd-45f6-98a8-c0712283954f": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement is about spinal cord glioma which is",
        "label": "Contradiction"
    },
    "599e8d04-e80f-4f54-9486-bcf5a39a1d37": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "a11f4223-9416-4cf8-8712-ebbddf8c4353": {
        "text_answer": "No   Explanation  The evidence provided does not mention the number of adverse events that occurred",
        "label": "Contradiction"
    },
    "d0fe5818-5954-41ea-9bcf-4ce7deba5ceb": {
        "text_answer": "Yes The secondary trial excludes patients with allergies to cephalosporin and trimethoprims",
        "label": "Entailment"
    },
    "89c78515-344a-4974-a01f-de5a0441ada0": {
        "text_answer": "No   Explanation The statement There are no conditions on hepatic function for participants of the",
        "label": "Contradiction"
    },
    "277b5179-05cc-48df-8f23-98b42ccad0b9": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as both trials administer the",
        "label": "Contradiction"
    },
    "46278ed1-1bc8-4161-b9d9-9f5a001b6aac": {
        "text_answer": "No  Explanation  The statement apgar score version 1  respiration or respir",
        "label": "Contradiction"
    },
    "0967b501-90dd-4ba4-bebc-8db1e9695431": {
        "text_answer": "Yes The inclusion criteria state that subjects must have a Mini Mental State Examination MMSE score of 2",
        "label": "Entailment"
    },
    "256c210a-d33f-4708-8d86-2cb636227c4d": {
        "text_answer": "No  Explanation  The statement infection asymmetry and nausea were observed more",
        "label": "Contradiction"
    },
    "55c933c1-1de0-4a15-9a17-e1216cb84b4b": {
        "text_answer": "No  Explanation  The statement Candidates for the primary trial and the secondary trial have",
        "label": "Contradiction"
    },
    "0c73bdd4-7244-433c-8b5e-bf335f21701c": {
        "text_answer": "No  Explanation The statement There were several psychiatric adverse events in the primary trial",
        "label": "Contradiction"
    },
    "dbd5f70e-0fa9-4b5e-af0e-0ad9efc49bc6": {
        "text_answer": "Yes The evidence does not mention any imaging studies as part of the interventions in either trial",
        "label": "Entailment"
    },
    "316e0b04-f14e-47cd-b847-6af5add81e4e": {
        "text_answer": "Yes  Explanation  The evidence provides information about the number of adverse events in both the primary",
        "label": "Entailment"
    },
    "9c8c3b78-d272-4ce9-947b-f9283c79e818": {
        "text_answer": "No  Explanation  The statement The same percentage of patients suffered adverse events in both co",
        "label": "Contradiction"
    },
    "c76fe4c2-5f55-4e85-8528-943d90e99dd0": {
        "text_answer": "  Yes the statement is entailed by the evidence The evidence states that 18 year olds are excluded",
        "label": "Entailment"
    },
    "555d74d4-755a-44b9-9bec-f8adda634c38": {
        "text_answer": "Yes for the secondary trial No for the primary trial",
        "label": "Entailment"
    },
    "c21d49da-c66f-45cc-af8a-22174568d0dd": {
        "text_answer": "Yes The evidence shows that more than 13 of the participants in both cohorts experienced Pathologic Complete",
        "label": "Entailment"
    },
    "5d0a21d6-cf35-48c3-9128-9d3f9cd03d23": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the adverse events",
        "label": "Contradiction"
    },
    "04b2b1f2-5d87-4b89-8fcd-c1c988bd22de": {
        "text_answer": "Yes  Explanation  The statement across the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "5902b596-40d0-4be7-8242-f313f6832fec": {
        "text_answer": "No  Explanation  The statement patients with a documented allergy to celecoxib",
        "label": "Contradiction"
    },
    "d0691186-857a-4876-8f49-732e033a86c7": {
        "text_answer": "Yes  Explanation The evidence provides data on the number of participants analyzed and the mean standard deviation",
        "label": "Entailment"
    },
    "201c2df5-585d-4d20-a19b-c2b12db5dc5f": {
        "text_answer": "No  Explanation  The statement Smokers are excluded from the primary trial but may be",
        "label": "Contradiction"
    },
    "6cc1c5e4-b45a-486f-be8d-1c49abc327c9": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "705457d9-78b2-466d-9a3e-db4b11e99daa": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence indicates that there were no adverse events recorded",
        "label": "Contradiction"
    },
    "6f947c20-ecd9-4c6b-b1e3-5d536d4b33cd": {
        "text_answer": "No  Explanation  The evidence provided in the text does not indicate that all participants in the primary",
        "label": "Contradiction"
    },
    "70dec4df-4dbd-41cc-ba31-6437c7058987": {
        "text_answer": "Yes  Explanation The evidence states that 286 131",
        "label": "Entailment"
    },
    "0f449a63-8d5d-4c60-96f8-bb32423f079d": {
        "text_answer": "Yes  Explanation The statement clinical study anchor is a planned activity within a clinical study that",
        "label": "Entailment"
    },
    "2493a4e6-18a1-41c7-8feb-81928df2b542": {
        "text_answer": "No  Explanation  The statement xq271 is a chromosome band",
        "label": "Contradiction"
    },
    "80b0b7be-91b4-40ba-a4db-d19f0b1865d7": {
        "text_answer": "Yes but with a caveat The statement is entailed by the evidence if we interpret improved to",
        "label": "Entailment"
    },
    "8bd3b6aa-d1b5-4f4a-a16a-434d56764ee5": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as myocardial infar",
        "label": "Contradiction"
    },
    "30f7d44a-34d9-4d98-9802-2c8a7c625e48": {
        "text_answer": "Yes The primary trial specifically includes HR HER2 breast cancer with a tumor size of 1 cm",
        "label": "Entailment"
    },
    "a98a4204-8591-48d3-9349-723b4ccc4f3c": {
        "text_answer": "  Yes for the primary trial only The evidence states that patients with a pulmonary hemorrhage",
        "label": "Entailment"
    },
    "0d8ce6e1-e0bb-42b6-a8ec-0d2679b908ad": {
        "text_answer": "No  Explanation  The statement there were 4 additional adverse incidents recorded in the primary",
        "label": "Contradiction"
    },
    "10ae9352-5088-4431-8a48-a6891f5d03b7": {
        "text_answer": "No  Explanation  The statement irrespective of a patients qualifications based on",
        "label": "Contradiction"
    },
    "c22306e0-54e6-4324-abed-0a38d9c7f1b9": {
        "text_answer": "No   Explanation   The primary trial reports the percentage of participants with a response within ",
        "label": "Contradiction"
    },
    "8747d88a-efc9-42ae-ba7c-5e25c8693b34": {
        "text_answer": "Yes The evidence indicates that pain was measured and reported by patients throughout the 10week trial However the",
        "label": "Entailment"
    },
    "fdf14cde-dd7c-4b38-a127-5d857fb22bab": {
        "text_answer": "  No  Explanation  The evidence provided in the trial results only reports the median change in",
        "label": "Contradiction"
    },
    "d846c22f-adab-4189-b662-056541a723c2": {
        "text_answer": "No  Explanation  The statement perineal artery is an artery arising from",
        "label": "Contradiction"
    },
    "73981f59-887e-4778-a78a-0bf7b7a405b7": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement is false The primary trial actually has fewer",
        "label": "Contradiction"
    },
    "c4b6e4a0-1377-444e-853d-d62b67802ed2": {
        "text_answer": "Yes The evidence mentions surgical and imaging procedures in the intervention section of the clinical trial",
        "label": "Entailment"
    },
    "f9ab104f-3d67-4912-aaf5-bb43ecd0c52d": {
        "text_answer": "No  Seminal vesicle cystadenoma is not a type of metastatic cancer as stated in the",
        "label": "Contradiction"
    },
    "40dd90a2-f57d-467e-bc6c-c9a8a50a330f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7aef8aaf-9fc3-49b2-95e7-ed9b227cdd27": {
        "text_answer": "No  Explanation  The statement neisseria gonorrhoeae pen",
        "label": "Contradiction"
    },
    "4046d097-cbc9-48ef-9e90-d9a427fa6d19": {
        "text_answer": "Yes  Explanation The primary trial involves two different interventions each with distinct combinations of drugs",
        "label": "Entailment"
    },
    "126ef758-8ce5-4e45-859d-acece8b261e1": {
        "text_answer": "No  Explanation  The statement the secondary trial documented a higher prevalence of mucos",
        "label": "Contradiction"
    },
    "1aedac43-a4c7-4c14-b217-8d76e853c76f": {
        "text_answer": "No   Explanation   The evidence provided in the trial description does not mention anything about the",
        "label": "Contradiction"
    },
    "40d1e2c2-9a6f-42a6-b75d-a67e9945a38d": {
        "text_answer": "Yes  Explanation The statement All patients in the primary trial receive at least 20mg",
        "label": "Entailment"
    },
    "94935617-b333-4eb3-bd06-a5884fa45989": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "59b5ce7e-13af-4377-8923-c096f79bcade": {
        "text_answer": "No  Explanation  The statement 16p1313p13",
        "label": "Contradiction"
    },
    "d53cf5fe-1104-4b05-886c-bb5499cdc047": {
        "text_answer": "No   Explanation  The statement All of the adverse events recorded in the primary trial",
        "label": "Contradiction"
    },
    "18876a8c-2536-4148-b563-c5a68daa7fac": {
        "text_answer": "No  Explanation  The statement Across both the primary trial and the secondary trial over ",
        "label": "Contradiction"
    },
    "f58fda4c-f4fd-44a7-8a0f-5d3a16929709": {
        "text_answer": "Yes the statement is entailed by the evidence as the evidence includes an adverse event of wound dehisc",
        "label": "Entailment"
    },
    "105ed693-cbe0-47a4-ba39-f361032d9ed7": {
        "text_answer": "Yes Both interventions use the same dosage and frequency for Doxorubicin Cyclophosphamide",
        "label": "Entailment"
    },
    "db3d7616-8500-411a-9b43-b9b6e0925957": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial describes the administration of suramin and",
        "label": "Contradiction"
    },
    "f19797c7-afb1-4480-ab8f-c798a86d2849": {
        "text_answer": "No  Explanation  The evidence provided states that 53 out of 60 participants in",
        "label": "Contradiction"
    },
    "bea94e26-3706-492c-af45-d35ef7e43ff1": {
        "text_answer": "Yes the statement is entailed by the Evidence as there are no recorded adverse events for Adverse Events 1",
        "label": "Entailment"
    },
    "591e7319-16cd-46db-be86-7c78e8d471c8": {
        "text_answer": "yes The primary trial reports pCR rates of 565 47864",
        "label": "Entailment"
    },
    "cbb4daf6-f35a-4832-b071-a17ffbe86e13": {
        "text_answer": "Yes The statement several adverse events occurred during the primary clinical trial is entailed by the evidence since",
        "label": "Entailment"
    },
    "874a2beb-d0b1-4b5f-9f37-5b49ba5a1067": {
        "text_answer": "Yes  Explanation The evidence shows that neither biliary colic nor Clostridium difficile",
        "label": "Entailment"
    },
    "21c183ca-7f70-4ddb-9599-d371ee544055": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence shows that in the primary",
        "label": "Contradiction"
    },
    "5e93b7d7-89d9-47cd-98b4-5897823889fa": {
        "text_answer": "No  Explanation  The statement cohort 1 of the primary trial is given an",
        "label": "Contradiction"
    },
    "452458d2-6372-4ac9-a7f9-0be77cc28eea": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "97b0957c-3b60-4671-9c9d-37eacba40f93": {
        "text_answer": "No  Explanation  The statement footfootpad is a laboratory specimen consisting of the",
        "label": "Contradiction"
    },
    "705e4626-c95b-4191-b9f1-02ae897cef70": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because it makes an incorrect assumption about",
        "label": "Contradiction"
    },
    "12f2ffff-1010-43bb-ac5d-5725d3d159b4": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "d8f0b3e8-ca61-4874-a4e0-1328029bce88": {
        "text_answer": "No  Explanation  The inclusion criteria for the primary and secondary clinical trials are not the same",
        "label": "Contradiction"
    },
    "9228fe22-ca97-4ca9-ad78-f8dba1ac27b0": {
        "text_answer": "No  The statement is not entailed by the evidence as the inclusion criteria specify patients with advanced andor unresect",
        "label": "Contradiction"
    },
    "8367e2fc-f384-43c0-af4e-d4ec41281b2e": {
        "text_answer": "No  Explanation  The statement Most patients in cohort 1 of the primary trial",
        "label": "Contradiction"
    },
    "fe73dc46-7c3a-45cd-a5fa-db03aa8dd28c": {
        "text_answer": "Yes Anorexic patients can meet the inclusion criteria for the primary trial as long as they meet all other criteria and",
        "label": "Entailment"
    },
    "723d5448-24c6-4679-98c1-3c67bb12fea4": {
        "text_answer": "Yes The ECOG performance status of 0 to 2 is a common inclusion criterion in both trials",
        "label": "Entailment"
    },
    "07f85ee2-4e95-4648-a492-4011837ddc7f": {
        "text_answer": "No   Explanation   The evidence provided only discloses the design of the primary clinical",
        "label": "Contradiction"
    },
    "8bd62043-2cb9-42f0-80c1-2ec39020d9af": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "b6b719ca-e7f3-4254-a1a0-2946acbcd2fd": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not directly support the statement about a greater",
        "label": "Contradiction"
    },
    "b88356ec-038f-4f5c-bf14-750059dbba4f": {
        "text_answer": "No  Explanation  The statement The most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "55d65365-bf85-4213-9ead-be1c498a4a72": {
        "text_answer": "No   Explanation  The statement three weekly sc injections are administered to the participants",
        "label": "Contradiction"
    },
    "36a25cf0-0cca-457d-bd85-8ba89b2ff602": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it incorrectly states",
        "label": "Contradiction"
    },
    "d432512b-0bb4-435c-b32c-7ae0564a63c8": {
        "text_answer": "No  Explanation  The statement only a small percentage of patients on sunitinib ",
        "label": "Contradiction"
    },
    "9c74310c-3096-4eaf-bed2-aec926b5c850": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not support the statement as it only",
        "label": "Contradiction"
    },
    "a855848e-4097-4755-90e0-e612f1bfc54c": {
        "text_answer": "No  Explanation  The statement Not a single one of the participants in group 1 of",
        "label": "Contradiction"
    },
    "70eac1ab-54b0-460d-abda-86f0c5d04483": {
        "text_answer": "yes The statement mentions unstable angina chemotherapy within 2 weeks and grade 2 or higher ne",
        "label": "Entailment"
    },
    "38e4b093-2121-486f-bcfb-d250ea9978e4": {
        "text_answer": "  Yes the statement is not directly contradicted by the evidence The primary trial explicitly excludes children while the",
        "label": "Entailment"
    },
    "92fe4c4d-da02-4327-a2a1-86e731ba4fd9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the dosages of carbop",
        "label": "Contradiction"
    },
    "8eb9d0d2-5c33-4ff6-adf6-e96ddf7be7a6": {
        "text_answer": "Yes The evidence states that patients with a history of clotting disorder including pulmonary embolism are",
        "label": "Entailment"
    },
    "48b25d6c-3b89-425b-960e-9d55471a5f37": {
        "text_answer": "No  Explanation  The evidence provides the percentage of participants in each group who demonstrated a decrease in",
        "label": "Contradiction"
    },
    "53a45460-701f-420e-853a-f5ccb8545030": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "79515622-bb43-4721-a164-dd2002713dc1": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only provides the",
        "label": "Contradiction"
    },
    "ee42e602-9409-49fa-a454-7a2637ed9d7a": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not indicate that any participants in the normal",
        "label": "Contradiction"
    },
    "3109bf56-61b7-4f43-9e38-fa3b69378214": {
        "text_answer": "No  Explanation  The statement None of the cohort of the primary trial or the",
        "label": "Contradiction"
    },
    "95f4ce83-19b7-424d-93b9-27a6c3fe8c6d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence states that",
        "label": "Contradiction"
    },
    "3acf4a18-725c-444e-bf7e-e3eb9a0878e7": {
        "text_answer": "No  The statement is not related to the evidence provided which pertains to a clinical trial comparing the effectiveness of different",
        "label": "Contradiction"
    },
    "9b230310-d16f-47a4-bf3b-341d2de6f9c4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial is",
        "label": "Contradiction"
    },
    "0b6e68b2-9f05-407b-bd00-feb9d3ce7abc": {
        "text_answer": "No  Explanation  The statement primary clinical trial participants were twice as likely to have chole",
        "label": "Contradiction"
    },
    "f9f0ba74-16e0-4790-afa0-b7616b256e5e": {
        "text_answer": "No  The primary trial has no mention of Performance Status as an inclusion criterion",
        "label": "Contradiction"
    },
    "88e8a071-e139-4547-9fd8-f3311d0770ef": {
        "text_answer": "No   Explanation   The patient described in the statement does not meet the minimum tumour",
        "label": "Contradiction"
    },
    "00c165f5-4c14-4aab-a4a8-9b8010bd5858": {
        "text_answer": "No  Explanation  The statement the primary clinical trial does not consider gender in determining elig",
        "label": "Contradiction"
    },
    "330f241a-9f7d-469d-8986-5687fdd5fb70": {
        "text_answer": "No  Explanation  The statement neither trial uses the same drugs dosages or",
        "label": "Contradiction"
    },
    "bca3c321-d798-427d-90a7-8c786d91947c": {
        "text_answer": "  No   Explanation   The patient described in the statement does not meet the inclusion",
        "label": "Contradiction"
    },
    "0a7569de-fb79-41f8-acc6-fd155a26e3c8": {
        "text_answer": "  No The statement is not entailed by the evidence provided The evidence only mentions exclusion criteria for the",
        "label": "Contradiction"
    },
    "7d57f1d1-e523-4220-95a9-f4ce33d7f157": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0348dacb-819e-4e1f-98c3-d45d6c057f60": {
        "text_answer": "Yes The statement mentions some of the exclusion criteria from the evidence",
        "label": "Entailment"
    },
    "bcbc612f-11c9-40ba-9376-c098a9b738f4": {
        "text_answer": "No  The secondary clinical trial does not employ muscle growth as an indicator of physical therapys effectiveness Instead it",
        "label": "Contradiction"
    },
    "d035a6bb-0d8f-4a6b-b725-f8b2535883eb": {
        "text_answer": "No   Explanation  The evidence provided describes two interventions both of which involve the use",
        "label": "Contradiction"
    },
    "a8760238-f938-4525-bd13-ecb0948de8bc": {
        "text_answer": "Yes The evidence does not mention the use of drugs radiotherapy or CBT Cognitive Behavioral",
        "label": "Entailment"
    },
    "ad24cf4c-11da-465c-b008-ba96dc8bcdd4": {
        "text_answer": "Yes for the secondary trial",
        "label": "Entailment"
    },
    "04dfaa5a-359d-4aba-a56d-4b19f041ce39": {
        "text_answer": "No  Explanation The statement A Patient that has a primary tumour with a diameter of ",
        "label": "Contradiction"
    },
    "103134aa-c3f2-4ebb-8919-72bdb5611b07": {
        "text_answer": "No   Explanation The statement no adverse events were reported in both the primary clinical trial and",
        "label": "Contradiction"
    },
    "bca56f4d-9c3c-4615-8b56-3f6ca86d047b": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence describes two different inter",
        "label": "Contradiction"
    },
    "82e2e80d-2a88-4d12-82a9-4d77d1bf0bb6": {
        "text_answer": "No  Explanation The evidence provided in the primary trial does not mention anything about the appetite or food",
        "label": "Contradiction"
    },
    "be3df611-66ac-4f40-ae04-68b5d1c0ae02": {
        "text_answer": "maybe  Explanation  The statement a female patient aged 20 recently diagnosed with er",
        "label": "Entailment"
    },
    "23f84ae0-fd01-4799-8872-118e22a015e8": {
        "text_answer": "Yes  Explanation The statement Only three different types of adverse events affected patients in the primary trial",
        "label": "Entailment"
    },
    "972438ce-59d8-476c-a8a3-b61fba56e982": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "07687788-b44f-4f2a-9117-6b55cbdc3f7a": {
        "text_answer": "Yes The interventions in both trials use 4demethyl4cholestryloxycar",
        "label": "Entailment"
    },
    "9e1d8e36-9749-4f70-b0e3-d173892dfcd0": {
        "text_answer": "No  Explanation  The statement immigrant from a high tuberculosis prevalent",
        "label": "Contradiction"
    },
    "e6d5d1ca-f1f6-481a-b309-78adf96e656c": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial includes a minimum tum",
        "label": "Contradiction"
    },
    "db52c7f4-cfb8-40d2-83f2-3514cb04794b": {
        "text_answer": "Maybe The statement is not directly entailed by the evidence as the evidence only provides information about adverse events in the",
        "label": "Contradiction"
    },
    "82582964-823a-4765-b22c-201660fcca08": {
        "text_answer": "No  Explanation The statement women aged 30 or 35 are eligible for the",
        "label": "Contradiction"
    },
    "bb9c00c0-3a87-41c2-bfb5-183f7b44fcbc": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "260a9ba1-ca1b-4e87-83d1-b128e73e1e38": {
        "text_answer": "  No The statement is not entailed by the evidence The evidence does mention different inclusion criteria for different patient groups",
        "label": "Contradiction"
    },
    "e04edb9d-dc0e-44c4-abb9-3260b400e265": {
        "text_answer": "No  Explanation  The primary trial measures the change in units on a scale for vaginal symptoms",
        "label": "Contradiction"
    },
    "64b3c727-779e-4db4-b1fe-1d85105ab7ec": {
        "text_answer": "No  Explanation  The primary and secondary clinical trials measure different outcomes using different metrics The primary",
        "label": "Contradiction"
    },
    "930e7529-e05a-471e-9d52-17f538f610c2": {
        "text_answer": "No  Explanation  The statement the primary trial does not require injection instead using Lym",
        "label": "Contradiction"
    },
    "f0d10d18-11a3-4fae-9a4d-f2277f6e5b43": {
        "text_answer": "No   Explanation The statement there was an equal distribution of adverse events recorded in both the",
        "label": "Contradiction"
    },
    "4efeb043-de46-49cd-8d5d-c4266304fb91": {
        "text_answer": "Yes  Explanation  The primary trial has more restrictive eligibility criteria than the secondary trial",
        "label": "Entailment"
    },
    "8fd48918-38db-4443-a1b8-bf2d7a458857": {
        "text_answer": "No  Explanation  The statement primary clinical trial patients suffered from anemia pneum",
        "label": "Contradiction"
    },
    "5255cd06-123a-4d45-943d-37b6261b1cf7": {
        "text_answer": "No   Explanation The evidence provided in the adverse events data does not mention anything about eating disorders",
        "label": "Contradiction"
    },
    "e4f41907-ef20-40aa-bcab-416243280816": {
        "text_answer": "No  Explanation The statement mentions a 40 average reduction in tumor diameter",
        "label": "Contradiction"
    },
    "5976b8b7-0f88-4e52-8ad7-39609dabbf8e": {
        "text_answer": "Yes  Explanation Both the primary and secondary trials include the use of cyclophosphamide",
        "label": "Entailment"
    },
    "763a61cc-c267-4536-8cfe-a4f97a461e07": {
        "text_answer": "No  Explanation  The evidence provided does not mention tumour lysis syndrome in either the primary",
        "label": "Contradiction"
    },
    "8d685159-80a2-4b2c-8ca3-066d03e1cf66": {
        "text_answer": "No  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Contradiction"
    },
    "bc47f5a1-dc20-4df2-bb3e-fa03695c9840": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial the patients of cohort ",
        "label": "Entailment"
    },
    "91b12db1-76c1-4863-90df-a95d2af8dfc5": {
        "text_answer": "No  Explanation  The statement thyroid gland hyperfunctioning adenoma is a",
        "label": "Contradiction"
    },
    "699bf83a-8890-43ab-96ea-40f2171c9633": {
        "text_answer": "No  Explanation  The statement patients in the primary trial will receive higher doses of",
        "label": "Contradiction"
    },
    "1b67d41e-cff6-46ae-b30d-4c254525e9ef": {
        "text_answer": "No  Explanation  The statement the dosage of zoledronic acid in intervention ",
        "label": "Contradiction"
    },
    "a35f8d94-b561-4644-ad29-2ac0e48ceb79": {
        "text_answer": "No  Explanation  The statement Diagnosis of 23 cerebral met",
        "label": "Contradiction"
    },
    "477389de-84aa-4438-87c9-3abccc80e1cb": {
        "text_answer": "No  Explanation  The statement provided is not directly entailed by the evidence presented The evidence",
        "label": "Contradiction"
    },
    "f98c72d2-3fce-42a5-9585-280e8b877708": {
        "text_answer": "Yes  Explanation The evidence shows that there were 16 participants in Arm 1 and 1",
        "label": "Entailment"
    },
    "14c1e784-1f79-4ba9-8466-c8c638f929db": {
        "text_answer": "No  Explanation  The statement all participants in the primary clinical trial and 16",
        "label": "Contradiction"
    },
    "1dfb4256-8bef-4128-8cd2-30d5c88a4ac8": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "8bdac388-c2bd-4634-9073-6862aaa7a5cf": {
        "text_answer": "Yes  Explanation The statement participants are given four separate drugs is entailed by",
        "label": "Entailment"
    },
    "8529eb83-969c-4075-bfe7-efc47fd33d8d": {
        "text_answer": "Yes Pancreatic cancer is listed as one of the eligible tumor types in the clinical trial",
        "label": "Entailment"
    },
    "da8b6738-7194-4d9d-a077-a4aec72945bb": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7f53b46f-6ab4-4d59-bc28-b13eca3fb3b3": {
        "text_answer": "Yes  Explanation  The statement no patients in the primary clinical trial experienced recorded adverse events",
        "label": "Entailment"
    },
    "e2731b02-ce9d-4bfe-bc8d-9eda951e0e77": {
        "text_answer": "Yes The evidence states that No prior gabapentin or pregabalin is an exclusion criterion for",
        "label": "Entailment"
    },
    "9c8b2041-2a99-4f42-93ec-63daed05fe87": {
        "text_answer": "Yes However the statement does not explicitly appear in the evidence but the inclusion criteria for both trials do not exclude patients",
        "label": "Entailment"
    },
    "5c7ff5f0-5b40-42e1-8f24-a0bfd6a4b2ef": {
        "text_answer": "Yes The statement is entailed by the evidence as both study groups undergo the same imaging procedures with 18",
        "label": "Entailment"
    },
    "e32de0e0-4e26-4c73-a6d6-cc5dfafd97c7": {
        "text_answer": "No  Explanation  The statement 25 of patients in the primary trial suffer Increased",
        "label": "Contradiction"
    },
    "f4f39eeb-0db1-40c3-9d45-5c17dabe4998": {
        "text_answer": "Yes  Explanation The statement on average participants survived beyond two years with over fifty patients",
        "label": "Entailment"
    },
    "ab25ad81-a094-432c-9814-12669bd4cbac": {
        "text_answer": "No  Explanation The statement genetic mutations in pten braf kras",
        "label": "Contradiction"
    },
    "98b0c6c3-73c0-40d9-95d7-48e5340aa2f8": {
        "text_answer": "Yes  Explanation The statement the primary trial and secondary trial both use the same dose of len",
        "label": "Entailment"
    },
    "fcc8d86f-3fba-4398-8c0e-042153fa118e": {
        "text_answer": "No  Explanation The statement decreased bone tissue is a decrease in the amount of bone",
        "label": "Contradiction"
    },
    "99912ce1-aa49-4289-8743-eb1afffe1675": {
        "text_answer": "Yes The statement is about medullary thyroid gland carcinoma in childhood which is consistent with the co",
        "label": "Entailment"
    },
    "8c5d8cfb-c75f-4cb8-af4a-8100726f2a12": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial indicates that the median survival periods for patients",
        "label": "Contradiction"
    },
    "09904e7f-5e34-44b1-9edb-f92c3edcda95": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial shows a shorter operative time in the intra",
        "label": "Entailment"
    },
    "3b1906b0-5212-4341-b6cd-3163456ce44a": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "a24e8008-affe-44f7-a6f1-56e817ffdde3": {
        "text_answer": "No  Explanation  The statement There are no unexpected deaths or Hospitalizations that occurred in the",
        "label": "Contradiction"
    },
    "c5534047-9025-410f-a641-43819cc1ce23": {
        "text_answer": "No  Explanation  The statement There are more cases of Biliary colic and Diarr",
        "label": "Contradiction"
    },
    "12746144-95c9-4656-abdf-8a49f78c7049": {
        "text_answer": "No  Explanation The evidence provided relates to the inclusion and exclusion criteria for a clinical trial involving",
        "label": "Contradiction"
    },
    "e8d33476-b6f1-4337-8072-c07e4f223275": {
        "text_answer": "Yes The evidence states that both arms of the trial only receive CUDC101 without any additional therapeut",
        "label": "Entailment"
    },
    "24630f41-fd07-4b3d-a0f6-66282c5c3a07": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial has reported marginally higher total adverse",
        "label": "Contradiction"
    },
    "b3f59657-9278-41be-b740-433b0d38fdd5": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes patients with T0T1 N1 M1",
        "label": "Entailment"
    },
    "956a23c9-f76f-4492-9f00-acdbaf6ac083": {
        "text_answer": "No  Explanation  The statement The majority of the adverse events recorded in the primary trial",
        "label": "Contradiction"
    },
    "b45a503d-d4db-4f8d-aefa-37cf2bbc6011": {
        "text_answer": "Yes  Explanation The statement among the participants of the primary clinical trial maculop",
        "label": "Entailment"
    },
    "a1d9b33e-fe46-421d-87e8-e0ecbfed7686": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "136bc454-b432-45f9-909b-e588f2dc6c60": {
        "text_answer": "No  Explanation  The evidence provided in the results of the primary clinical trial indicates that 3",
        "label": "Contradiction"
    },
    "9f382aed-4a54-40c2-92ca-fb17411e4923": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement makes a comparison",
        "label": "Contradiction"
    },
    "1d66b8cc-1e7e-4a88-bd39-695528aa5894": {
        "text_answer": "Yes for the secondary trial with the amended exclusion criteria However the primary trial does not mention anything about ins",
        "label": "Entailment"
    },
    "f9a8b80a-3191-4f53-865b-1ab2154174ad": {
        "text_answer": "No  Explanation The statement in the primary clinical trial under a tenth of the participants",
        "label": "Contradiction"
    },
    "d3ccfad5-d5c9-4bdb-a69e-dca916dc5da5": {
        "text_answer": "  Yes for the primary trial and Maybe for the secondary trial   Explanation ",
        "label": "Entailment"
    },
    "0cecee52-d87e-419a-a970-e79733613a87": {
        "text_answer": "No  The evidence does not specify that only Caucasian patients are eligible for the primary clinical trial The inclusion",
        "label": "Contradiction"
    },
    "f4d73533-5e6a-403c-ad63-3882890b7e94": {
        "text_answer": "Yes  Explanation  The statement we are unable to make a comparison of the adverse events",
        "label": "Entailment"
    },
    "be63170c-5a52-4d85-b824-54ceca90684a": {
        "text_answer": "No  The evidence does not mention claustrophobia as an exclusion criterion for either trial",
        "label": "Contradiction"
    },
    "cb36e435-6dc9-4e7b-939b-9da6ceef2a49": {
        "text_answer": "No  Explanation The placebo is administered on Day 1 while Trabected",
        "label": "Contradiction"
    },
    "7c0a99c5-b76f-438c-a93b-15d3340cd430": {
        "text_answer": "No  Explanation  The evidence provided in the text only reports the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "383e310f-a7a5-49f5-ae10-ddf49eee92df": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it goes beyond the information provided",
        "label": "Contradiction"
    },
    "429f2754-6edc-4969-99f3-7507b76e443a": {
        "text_answer": "Yes The primary trial did not show significant differences between the two groups but the secondary trial did show some significant differences between",
        "label": "Entailment"
    },
    "f2b4adf3-ccbc-4bea-94a6-50887d7aeea0": {
        "text_answer": "No  Explanation The evidence provided in the clinical trial results indicates that the median survival times for patients",
        "label": "Contradiction"
    },
    "da91286b-3029-475f-a919-e33629a5a972": {
        "text_answer": "No  Explanation  The statement There was at least 1 recorded gastrointest",
        "label": "Contradiction"
    },
    "dbf8020d-57c3-45fb-ab31-5c97f293a248": {
        "text_answer": "  Yes for both trials",
        "label": "Entailment"
    },
    "d54a1b83-ecd6-4160-a839-1bddf6a12cc5": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial includes",
        "label": "Contradiction"
    },
    "c19b9a3f-acda-4e83-80db-0f4d3383d909": {
        "text_answer": "Yes  Explanation The statement in the primary trial there were 05 times the number",
        "label": "Entailment"
    },
    "427a4e1a-14ee-441a-b2af-b45b01356921": {
        "text_answer": "No  Explanation The statement persons with stage 4 cancer cannot take part in the secondary clinical",
        "label": "Contradiction"
    },
    "f0ca21dc-bf98-4c8b-b08e-d0821905846a": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial shows that patients in the acupunct",
        "label": "Entailment"
    },
    "137f2083-e958-4c81-a4c8-338c90dda9c9": {
        "text_answer": "No   Explanation   The statement in the primary clinical trial a regimen of",
        "label": "Contradiction"
    },
    "f693e25f-c128-48d1-883d-488248b8347d": {
        "text_answer": "No  Explanation  The primary trial describes a treatment cycle length of 21 days not",
        "label": "Contradiction"
    },
    "1fece1ef-3bb6-407c-a09c-d615922822db": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "31b0b1db-0d40-44fe-aa76-ce3cdca8e31b": {
        "text_answer": "  No Anorexia is a medical condition characterized by a lack of appetite and significant weight loss which is",
        "label": "Contradiction"
    },
    "fb8e290e-f73a-46e1-86b1-3a1d13eab0ab": {
        "text_answer": "No  The statement about a patient with ILDDPLD within the last 3 years being eligible for the",
        "label": "Contradiction"
    },
    "77c27725-099d-4d66-947c-f03e9193b6bf": {
        "text_answer": "No  Explanation  The evidence provided in the given context does not mention anything about mgmt promot",
        "label": "Contradiction"
    },
    "dc60304d-6fd2-4b12-9108-b5ce78454d42": {
        "text_answer": "Yes  Explanation  The statement There are less total adverse events in the primary trial than",
        "label": "Entailment"
    },
    "2884c912-af96-4bac-9b0e-29f1d0876abc": {
        "text_answer": "No   Explanation   The statement does not directly relate to the interventions mentioned in the",
        "label": "Contradiction"
    },
    "f83fe0ea-4d77-4db1-a66d-eb0df033a592": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only pertains to breast cancer and its treatment",
        "label": "Contradiction"
    },
    "d904b234-fed6-473e-bd40-8f37f4a4e440": {
        "text_answer": "Yes   Explanation  The primary trial tests Eribulin Mesylate while the secondary",
        "label": "Entailment"
    },
    "1046f15f-8bef-4d73-99a1-34ab32da6ea6": {
        "text_answer": "No  Explanation  The statement there was a total of 3 cases of shingles",
        "label": "Contradiction"
    },
    "ffbff911-ea0e-4f8b-97fd-a54b8f88007a": {
        "text_answer": "No  Explanation  The statement periodontitis is an acute or chronic inflammat",
        "label": "Contradiction"
    },
    "1022a719-eef0-4fbe-ac15-b0398adbf45b": {
        "text_answer": "Yes  Explanation  The statement There are no cases of anorexia hypother",
        "label": "Entailment"
    },
    "dd0571e3-088c-4dc7-a47a-175210514286": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the placebo and Allo",
        "label": "Contradiction"
    },
    "e137a0db-0a15-4dd0-9fa2-3a8558c7ef0a": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide any",
        "label": "Contradiction"
    },
    "0cc7e297-b7df-4260-9ddf-f406bb3c2485": {
        "text_answer": "No  Explanation  The statement over 97 of patients in the secondary trial and",
        "label": "Contradiction"
    },
    "8c51b6e1-ee26-44a5-b63b-3c180b7dddd2": {
        "text_answer": "No  Explanation  The statement there were profound differences in the results from the groups in the",
        "label": "Contradiction"
    },
    "b3fc2b80-128b-4236-b1d5-a89b93e54b48": {
        "text_answer": "Yes some patients in the GTx024 1mg group gained lean body mass but not all of",
        "label": "Entailment"
    },
    "972a66e9-09cc-4091-8c60-fa8f458955aa": {
        "text_answer": "Yes  Explanation The evidence states that the first patient group receives 600 mgm",
        "label": "Entailment"
    },
    "5a954b09-cbc7-47dd-891c-4c998eb72979": {
        "text_answer": "No  The evidence does not provide information about which vaccines were administered to participants in cohort 1 of",
        "label": "Contradiction"
    },
    "1cbd0ac2-bfb8-4649-afea-ae028707f190": {
        "text_answer": "No  Explanation  The statement lymphedema conditions of patients in the primary clinical",
        "label": "Contradiction"
    },
    "8dc6e902-3dae-4bea-ba4b-605df19fabc1": {
        "text_answer": "No  Explanation  The statement the intervention of the primary clinical trial involves the use of ther",
        "label": "Contradiction"
    },
    "0f6ce079-990e-446e-95e9-8c4644291924": {
        "text_answer": "Yes The primary trial requires mammography as a mandatory inclusion criterion The secondary trial does not explicitly mention mammography",
        "label": "Entailment"
    },
    "06e6eb2b-8300-413b-9c70-51fadbc68bbc": {
        "text_answer": "Yes The statement does not mention specific adverse events only that no individual adverse event affected more than one patient",
        "label": "Entailment"
    },
    "fb011e19-d4fb-4e6c-b7c9-7a7238f78970": {
        "text_answer": "Yes  Explanation  The primary trial measures tumor response using RECIST criteria but it",
        "label": "Entailment"
    },
    "fc211cd7-389a-4040-9c92-e06672257460": {
        "text_answer": "No  Explanation  The statement patients in the primary clinical trial that received paclitax",
        "label": "Contradiction"
    },
    "230818a6-3a37-4bb6-933b-39a7e9a45054": {
        "text_answer": "Yes The evidence states that patients with active cancer or metastatic cancer are excluded from the clinical trial Therefore patients",
        "label": "Entailment"
    },
    "fa510ac9-2d92-4396-a150-18dd46a31260": {
        "text_answer": "No  Explanation  The statement the primary clinical trial and the secondary clinical trial documented identical numbers",
        "label": "Contradiction"
    },
    "6b8445e6-9bc6-4a57-ab24-05d99e082061": {
        "text_answer": "Yes The evidence states that there were 92 participants in the Paclitaxel Plus Bevacizumab Plus",
        "label": "Entailment"
    },
    "966e1258-879d-4e8d-88ec-777a743e191d": {
        "text_answer": "Yes The evidence does not report any patient in either trial with less than 3 different adverse events and the statement",
        "label": "Entailment"
    },
    "0e57fc4c-1a5b-4f88-900e-122c03fcedb4": {
        "text_answer": "Yes The primary trial had 000 anemia cases and the secondary trial had 4",
        "label": "Entailment"
    },
    "980fb8cd-9ba0-4bac-a2ae-0aea58c2f837": {
        "text_answer": "Yes The primary trial had 75 participants in the waitlist control group and the secondary trial had 16",
        "label": "Entailment"
    },
    "4b529950-5a15-4904-8f87-1aa68f408b8d": {
        "text_answer": "No  The statement is not entailed by the evidence as the trial specifically includes patients who are considering aromatase inhib",
        "label": "Contradiction"
    },
    "f0d4e862-c9a1-48f4-9e4f-ddc67b35bbe0": {
        "text_answer": "Yes  Explanation  The statement the secondary trial and the primary trial use different outcome measurements and",
        "label": "Entailment"
    },
    "c2ba74e0-9674-4974-a0ea-74651dbdbbf6": {
        "text_answer": "yes regarding the EORTC CIPN20 Sensory Neuropathy Subscale aAUC",
        "label": "Entailment"
    },
    "5e3fa8fd-a886-411d-8de0-fcbf6ef953fb": {
        "text_answer": "No  The statement about colon nonhodgkin lymphoma being an extranodal non",
        "label": "Contradiction"
    },
    "db5cde14-102d-432e-981d-8b88ae65a830": {
        "text_answer": "No   Explanation  The statement mentions 7 cases of asthenia and 2",
        "label": "Contradiction"
    },
    "fe9b1db5-8600-469a-ba9f-c0aab4630041": {
        "text_answer": "  Yes the statement is entailed by the evidence The primary trial does not specify an age range for participation",
        "label": "Entailment"
    },
    "5c253fd8-303a-4b91-b21f-e7e77c30f14a": {
        "text_answer": "Yes The evidence states that there are 234 participants in cohort 1 and 241 participants",
        "label": "Entailment"
    },
    "10f7c7cf-b7e2-4d21-8870-1fdbcc7937f5": {
        "text_answer": "Yes  Explanation The statement In the primary trial the placebo intervention and the Memantine intervention",
        "label": "Entailment"
    },
    "9fad2ea9-39ad-4c5b-afbe-82d9c40dbeee": {
        "text_answer": "No  Explanation  The statement Morbidly obese and pregnant patients can be eligible",
        "label": "Contradiction"
    },
    "c7037258-f24b-40dd-9ce8-5026b019bfbe": {
        "text_answer": "Yes  Explanation  The statement neither intestinal obstructions nor pancytopen",
        "label": "Entailment"
    },
    "8ffc6641-8eb9-4e6d-8926-0356539e0ba6": {
        "text_answer": " No   Explanation  The evidence describes two separate clinical trials one for Gliob",
        "label": "Contradiction"
    },
    "11f26a4a-7ff7-4cbd-b5c7-b95cfea182df": {
        "text_answer": "No   Explanation   The statement 273 the primary trial participants and",
        "label": "Contradiction"
    },
    "169ae179-8a24-4f8f-82b6-47ed449d8e2e": {
        "text_answer": "yes the statement is entailed by the evidence as the primary trial is about childhood cancer gliosarcoma",
        "label": "Entailment"
    },
    "9b0c9133-a13c-4687-bf43-546312ce1a2f": {
        "text_answer": "No  The statement is not entailed by the evidence The evidence only pertains to patients with breast cancer who have",
        "label": "Contradiction"
    },
    "8c2ec196-18f6-4a3f-b2fd-6eb6f65d1c60": {
        "text_answer": "No  Explanation  The statement for entry into the primary clinical trial participants are required to",
        "label": "Contradiction"
    },
    "f0e6f9c3-4f87-4a91-af2e-9bb7cc2de985": {
        "text_answer": "Yes  Explanation The primary clinical trial and the secondary clinical trial involve different pharmacological interventions",
        "label": "Entailment"
    },
    "4c4e621c-abe5-4a19-b517-31778992b424": {
        "text_answer": "No  Explanation  The evidence states that 53 out of 60 participants in the",
        "label": "Contradiction"
    },
    "b6084ccd-2ece-4e27-b783-64ade24880bb": {
        "text_answer": "No  Explanation  The statement retinopathy of prematurity stage 2 intr",
        "label": "Contradiction"
    },
    "5e74a97b-ae6e-478b-bcf1-f681159ea1f7": {
        "text_answer": "No  Explanation  The evidence provided in the results 1 does not give the number of participants",
        "label": "Contradiction"
    },
    "bd8a6fc5-ffc7-460f-a82c-9656047eafbc": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "3a452f00-375b-48c4-96dd-48986c0c0064": {
        "text_answer": "No  Explanation  The primary trial includes patients with a breast tumor 1 cm in diameter",
        "label": "Contradiction"
    },
    "af5daeb0-69f5-4d1c-93a5-7a76dfb4b5e7": {
        "text_answer": "No  The evidence describes two different interventions in the primary clinical trial one involving an educational DVD and a lay health",
        "label": "Contradiction"
    },
    "09af4485-0e64-4a6c-83d3-1e7231151faa": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial results does not mention the number of participants",
        "label": "Contradiction"
    },
    "3647e40b-92d1-4e99-aedf-8416c91576c8": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions in the primary clinical trial make use of laserass",
        "label": "Entailment"
    },
    "54f0a585-98f8-49c2-a6b3-2700b3fc19ff": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "269ac84f-d5a9-475f-8c43-361a6cdb5225": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the change in units on a scale for the sever",
        "label": "Entailment"
    },
    "92639a0e-c3b4-4057-8bb5-aeaf1d60c39b": {
        "text_answer": "Yes The evidence does not report any unexpected deaths or hospital stays in either trial",
        "label": "Entailment"
    },
    "b36dca2b-8c53-4f4d-b956-0d86194d2d2d": {
        "text_answer": "No  Explanation  The statement diarrhea was equally common in both primary and secondary",
        "label": "Contradiction"
    },
    "4d604e71-ced3-43a1-baf7-276573a3a901": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence only mentions",
        "label": "Contradiction"
    },
    "c7320872-347d-445f-a939-9554e7ee9973": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence because both cohorts receive the same",
        "label": "Entailment"
    },
    "e6e3ecde-9d81-41a2-849e-de26c1b9bafc": {
        "text_answer": "Yes  Explanation  The primary trial includes the Karnofsky performance status KPS",
        "label": "Entailment"
    },
    "81d8da2f-add7-4c32-bc69-8eb22266f71e": {
        "text_answer": "Yes  Explanation The statement the first cohort of the primary clinical trial didnt",
        "label": "Entailment"
    },
    "89c76808-d0fb-4c78-8364-344d6b65754b": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as both study groups ",
        "label": "Contradiction"
    },
    "d2057876-3991-462d-b5fd-de01cc252790": {
        "text_answer": "  Yes   Explanation   The statement cohort 2 of the primary",
        "label": "Entailment"
    },
    "d5786123-b433-4fdd-abad-4410de2695c9": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f49abd8e-7440-40ec-a512-c2420c9a207b": {
        "text_answer": "No   Explanation   The statement is not directly related to the inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "373d0081-e7cf-4a06-bdd0-b58bcd4fe34c": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the evidence clearly describes the inter",
        "label": "Contradiction"
    },
    "c158ee0a-2ff1-483d-a906-6dcbb76fae47": {
        "text_answer": "Yes  Explanation The primary clinical trial involves administering pembrolizumab every 3",
        "label": "Entailment"
    },
    "dee869cc-6f3c-45a5-9672-d8ab6a545212": {
        "text_answer": "13 not 1  Explanation The statement only 1 of the patients in",
        "label": "Entailment"
    },
    "a6dd31e3-d055-4343-9d7f-8d141f7c7007": {
        "text_answer": "No  Explanation  The statement 492 more Participants in the dalot",
        "label": "Contradiction"
    },
    "ae134e5a-97f7-4c42-9135-ea44d3d45939": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence only compares",
        "label": "Contradiction"
    },
    "3ebd71b1-9b66-438a-9623-27aaf0725786": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity mental conditions or gender as eligibility criteria for the",
        "label": "Entailment"
    },
    "466321f2-f997-47c7-a166-faeffe581547": {
        "text_answer": "No  Explanation  The statement response table is a table of data specifically regarding response The",
        "label": "Contradiction"
    },
    "aadd13d6-3100-41ef-947f-6b29d3118d67": {
        "text_answer": "No  The evidence does not provide any information about bodyweight requirements for the clinical trial",
        "label": "Contradiction"
    },
    "5a515d1f-131f-4dc9-9179-97f41957904a": {
        "text_answer": "Yes The statement is not entailed by the evidence for the primary clinical trial as the primary trial requires participants to be res",
        "label": "Entailment"
    },
    "b3a79047-9f6a-43d4-88e6-8c8a26b3a47f": {
        "text_answer": "Yes  Explanation  The statement only patients within cohort 1 had cases of in",
        "label": "Entailment"
    },
    "d42bd39b-e72e-418b-bd8a-6f1769fde12d": {
        "text_answer": "Yes The evidence includes the Karnofsky score as an inclusion criterion with a minimum requirement of 60",
        "label": "Entailment"
    },
    "36aac65a-5d56-4abd-b278-e9e3de78d480": {
        "text_answer": "Yes  Explanation The statement patients take oral medicine on a twice daily schedule for the duration",
        "label": "Entailment"
    },
    "1a1826f4-79d9-4df0-a8d8-fe9c3d75d783": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial will receive higher doses of",
        "label": "Contradiction"
    },
    "b9b156ee-526a-49ac-aa99-78f02a24dbaf": {
        "text_answer": "  No   Explanation   The statement Patients with NUT midline car",
        "label": "Contradiction"
    },
    "8719ae55-97f1-4d19-8e9c-85c086898291": {
        "text_answer": "Yes The evidence shows that the percentage of participants who were up to date with colorectal breast and c",
        "label": "Entailment"
    },
    "0428ab54-eddd-4ee8-a58f-45ec7d7630f7": {
        "text_answer": "No  Explanation The evidence provided in the text only reports the median aAUCpa for each",
        "label": "Contradiction"
    },
    "a4c5aecb-d375-43b7-bee0-dea9651fb7d6": {
        "text_answer": "Yes  Both trials use the unit of measure cm for tumor diameter and cm for tumor diameter",
        "label": "Entailment"
    },
    "7d36e2e7-cf12-4281-8db5-2c30f23b427b": {
        "text_answer": "  The statement is not entailed by the evidence as it adds information not present in the exclusion criteria for the secondary",
        "label": "Contradiction"
    },
    "cc177dab-2d93-40dd-8b7f-ac1755325605": {
        "text_answer": "Yes The evidence states that patients with stage 4 breast adenocarcinoma that is ER positive PR positive",
        "label": "Entailment"
    },
    "c7f3e0a2-44e0-4da9-a3ac-665d3e80f111": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "51ea9225-4ef8-4bf6-878a-2476cb59b916": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "d88d1ea7-3d60-4234-896b-2060dee299f7": {
        "text_answer": "Yes  Explanation The evidence states that cohort 1 practices paced breathing for 1",
        "label": "Entailment"
    },
    "920775c5-aa23-4be9-8aa1-241ecef90b51": {
        "text_answer": "No  Explanation  The statement group 2 of the primary trial does not receive any dos",
        "label": "Contradiction"
    },
    "bfeb1617-a5a5-40f7-8f09-f20c40a4cee0": {
        "text_answer": "Yes  Explanation The statement paternal half sibling is a relative with whom you share",
        "label": "Entailment"
    },
    "24480821-2a6d-4359-bfb8-348ca85dffbb": {
        "text_answer": "Yes The evidence does not report any results for the LBH589 and Lapatinib cohort",
        "label": "Entailment"
    },
    "9313b787-6fe7-4eb7-93cb-13ce8cfe92f0": {
        "text_answer": "No  Explanation The statement every patient in the primary clinical trial who received 1mg of",
        "label": "Contradiction"
    },
    "f48fabb1-f814-4f89-acf9-7ff95948b8d9": {
        "text_answer": "Yes  Explanation The evidence states that out of 25 participants who were treated with sunit",
        "label": "Entailment"
    },
    "0ef3e1a1-d303-46de-8940-07746737fe87": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence because the",
        "label": "Contradiction"
    },
    "3c2830d4-9341-4c0d-8ed3-51eb47d2cd17": {
        "text_answer": "No  The statement is not entailed by the evidence as there were no reported cases of cholelithiasis",
        "label": "Contradiction"
    },
    "e2fcdf94-c0b2-4d75-a40d-2c2ec8200208": {
        "text_answer": "Yes The evidence does not report any patient experiencing the worst pain imaginable for 10 weeks",
        "label": "Entailment"
    },
    "e9146895-e9b0-49cb-b05e-9264b682cece": {
        "text_answer": "Yes  Explanation The statement adverse events were reported by fewer than 5 of the participants",
        "label": "Entailment"
    },
    "6920329b-7559-415e-9346-c06909526421": {
        "text_answer": "Yes The evidence does not report any cases of Febrile neutropenia or Cholelithiasis in either",
        "label": "Entailment"
    },
    "a74afb52-7b03-4c41-b57b-7473ef025c18": {
        "text_answer": "  No   Explanation   The statement nut midline carcinoma cas",
        "label": "Contradiction"
    },
    "5acf1755-279a-400a-9a2e-c71daaeeab0d": {
        "text_answer": "No  Explanation  The statement play doubles tennis is not related to the given evidence",
        "label": "Contradiction"
    },
    "87f63f2e-5648-4b9f-9f25-a5adb80dcb1d": {
        "text_answer": "No  Explanation  The statement 0 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "65ef313d-74d5-4e56-a6c8-6a3768774a55": {
        "text_answer": "Yes The statement is entailed by the evidence as the interventions are administered through different routes intravenous for",
        "label": "Entailment"
    },
    "51a15c75-5a89-48c3-a93d-4f464e915ba2": {
        "text_answer": "Yes  Explanation The statement There was one psychiatric adverse event in the primary trial which",
        "label": "Entailment"
    },
    "487dd970-35e7-4a7d-8bb6-e8fa98f574aa": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not mention claustrophobia",
        "label": "Contradiction"
    },
    "25f963fe-42f5-4294-9489-17d8fd17b4f2": {
        "text_answer": "Yes  Explanation  The statement patients with a confirmed allergy to cephalos",
        "label": "Entailment"
    },
    "caab457d-0650-4010-9d8e-4c8e474070ff": {
        "text_answer": "No  Explanation  The statement several cases of Anaemia and Febrile neut",
        "label": "Contradiction"
    },
    "e12077dc-2ef2-4276-b755-4664b0a0f0ea": {
        "text_answer": "No  Explanation  The statement every member in both the primary and secondary clinical trials is given",
        "label": "Contradiction"
    },
    "5a91060d-576b-405f-a8a6-c74cc3c24c62": {
        "text_answer": "No  Explanation The statement over 70 of the participants had a decrease in circul",
        "label": "Contradiction"
    },
    "7febdcf0-e8ff-4511-a96b-c160e3dd127e": {
        "text_answer": "Yes  Explanation  The statement in comparison to the primary clinical trial the secondary clinical trial",
        "label": "Entailment"
    },
    "42dca69f-0e7b-4945-9123-90e576db8c25": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves den",
        "label": "Contradiction"
    },
    "65dbfec2-08fb-4853-9e50-79ec4c97500f": {
        "text_answer": "No  The statement is not entailed by the evidence as the clinical trial is for metastatic invasive breast cancer",
        "label": "Contradiction"
    },
    "7b71a3ac-e8b3-4e8f-ac95-c3dfe88676d5": {
        "text_answer": "No  Explanation  The statement 203 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "44b1585a-3a5f-4ff7-a523-04923546b2c0": {
        "text_answer": "No  Explanation The evidence only states that some patients received MCS110 at a dose",
        "label": "Contradiction"
    },
    "d21d3871-d8c2-4a0a-b99f-291a721a1a18": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures tumor diameter in centimeters cm",
        "label": "Entailment"
    },
    "a1cf2da3-a2a8-4fa1-9812-5f50a75994ad": {
        "text_answer": "No  Explanation  The statement The majority of the adverse events recorded in the primary trial",
        "label": "Contradiction"
    },
    "1b3e5b01-1b05-4025-9100-2c6e6e7faf20": {
        "text_answer": "Yes  Explanation The evidence shows that the percentage of participants with invasive diseasefree survival events",
        "label": "Entailment"
    },
    "efe8b336-1781-4777-a1a0-fe34c59c63ab": {
        "text_answer": "No   Explanation  The statement is not directly related to the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "0e7c3f86-cbc8-478d-b89c-1f75b53323fe": {
        "text_answer": "No   Explanation The evidence provided only gives the median PFS for each treatment group not the",
        "label": "Contradiction"
    },
    "dc8fb0ce-165a-4d79-afb2-25a85f7c40b6": {
        "text_answer": "No  Explanation  The evidence provided in the given trial results does not support the statement that the",
        "label": "Contradiction"
    },
    "bb0cf2c6-fbb2-4ca2-9f44-9ae8c5a9f63e": {
        "text_answer": "No  Explanation  The statement in the question makes a comparison between the number of drugs administered",
        "label": "Contradiction"
    },
    "ed8ee6d6-5a37-4338-af72-e87bb50ec4d9": {
        "text_answer": "No   Explanation  The statement a majority of individuals in the primary clinical trial demonstrated complete",
        "label": "Contradiction"
    },
    "fbd6b437-ba96-46fd-933f-8299e0efb0e5": {
        "text_answer": "Yes The statement is entailed by the evidence as the number of participants in the vaccine arm of the trial is stated as",
        "label": "Entailment"
    },
    "1cbc4e95-3407-4aab-bb7d-ba3abd1882f3": {
        "text_answer": "No  Explanation The statement is not directly related to the evidence provided in the trial results The",
        "label": "Contradiction"
    },
    "4f45090f-0954-43a7-9f56-60c5283459bd": {
        "text_answer": "No  Explanation  The statement Participants must be resistant to AI therapy and m",
        "label": "Contradiction"
    },
    "b20dadde-0f33-42ca-aa3e-c9333cdffe89": {
        "text_answer": "No  Explanation  The statement there was a higher incidence of serious adverse reactions documented",
        "label": "Contradiction"
    },
    "12586895-bb1c-4772-ab01-94163d0393ab": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the most common adverse event in",
        "label": "Contradiction"
    },
    "2758e742-d065-4813-bfd2-881fe16826bd": {
        "text_answer": "No  The statement is not entailed by the evidence as it adds an additional requirement ER or PR positivity",
        "label": "Contradiction"
    },
    "da24d6fd-1363-489b-ac5a-f44dbe622c5d": {
        "text_answer": "No  Explanation  The statement Hypokalemic patients are excluded from the primary trial",
        "label": "Contradiction"
    },
    "a198b3a9-ee15-4f4a-b587-d6ddb86efa73": {
        "text_answer": "yes the statement is entailed by the evidence as both trials involve exposure to radiation However its important to",
        "label": "Entailment"
    },
    "0f434232-d1a2-4d35-a49c-dd52c8353b9f": {
        "text_answer": "No   Explanation   The statement the majority of patients in the primary trial experienced complete",
        "label": "Contradiction"
    },
    "22b968d1-4ffd-4562-aeb0-e1e022212b08": {
        "text_answer": "No  Explanation  The statement Not a single one of the participants in group 1 of",
        "label": "Contradiction"
    },
    "116c9dea-44ba-402e-8948-67ee9bb4f942": {
        "text_answer": "No  Explanation The statement Both cohorts of the primary trial receive the same dos",
        "label": "Contradiction"
    },
    "bea08563-704d-4475-9dbd-d7617d1a6a63": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial are studying the same drug",
        "label": "Entailment"
    },
    "64df451c-f868-49e6-9b4e-a325e62ce837": {
        "text_answer": "Yes The evidence does not mention any vaccines being administered to the participants",
        "label": "Entailment"
    },
    "a9aae47f-ecbe-49ea-983b-73c8b6a95506": {
        "text_answer": "Yes The statement there were zero adverse instances recorded in the primary clinical trial while in the secondary clinical trial",
        "label": "Entailment"
    },
    "dcad8706-4bfe-4076-9bd5-babca4f63beb": {
        "text_answer": "No  The statement is not entailed by the evidence The statement implies that there were adverse events in the primary",
        "label": "Contradiction"
    },
    "af55082d-0ff1-419f-861f-80dbd05a9ade": {
        "text_answer": "Yes  Explanation  The statement the primary trial uses separate inclusion and exclusion criteria for its",
        "label": "Entailment"
    },
    "d3630897-ec5d-4c22-b2cd-5a8355dfdd88": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include patients with ER positive PR positive or HER",
        "label": "Entailment"
    },
    "9367299b-070b-4902-b857-bca1c45b6fd1": {
        "text_answer": "Yes  Explanation The statement detailed information about the administration procedure dosage and treatment",
        "label": "Entailment"
    },
    "186e198a-63dc-4ac9-8ae0-7790f32ec792": {
        "text_answer": "yes  Explanation The statement is entailed by the evidence as the primary trial involves a higher dose",
        "label": "Entailment"
    },
    "65910ca9-d27b-4350-9213-1cb7aea575a2": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence does not mention any exclusion criteria based on mental health",
        "label": "Entailment"
    },
    "50d67398-cd3f-4d6e-afeb-419ae6f64c0d": {
        "text_answer": "No  The primary clinical trial is not suitable for those with triple positive breast cancer as it only includes those with invas",
        "label": "Contradiction"
    },
    "7270c176-7bf2-4b0d-941d-912f5a3ed62c": {
        "text_answer": "Yes  Explanation  The statement 0 adverse events were observed in the primary trial and",
        "label": "Entailment"
    },
    "e74e47e7-4627-4dd9-aedd-cbc5b5cdd669": {
        "text_answer": "No  Explanation  The statement mucositis oral bladder infection and",
        "label": "Contradiction"
    },
    "b464cd26-7734-455c-85c1-04a4ec324c55": {
        "text_answer": "No   Explanation   The statement Any patients that have undergone Antineopl",
        "label": "Contradiction"
    },
    "22031bc7-9954-4b2b-b905-a5d34e0eea98": {
        "text_answer": "Yes The evidence states that 13 of participants with HER2primary breast cancer developed imagable HER",
        "label": "Entailment"
    },
    "3b29fe26-bf01-4e85-aa0e-33e83b1db660": {
        "text_answer": "  Yes the statement is entailed by the evidence regarding the primary clinical trial but it does not directly address the",
        "label": "Entailment"
    },
    "8183a43e-0284-483d-a22c-08502b0ebc8a": {
        "text_answer": "No  Explanation The statement does not follow directly from the evidence provided The evidence only reports the",
        "label": "Contradiction"
    },
    "f5cb1b5d-53b5-464b-a160-17cd59481705": {
        "text_answer": "No  Explanation  The statement cohort 1 in the primary clinical trial is treated",
        "label": "Contradiction"
    },
    "28a88ea8-4cea-404c-9ad7-cb1be9c19d7f": {
        "text_answer": "Yes  Explanation The evidence provided in the primary trial interventions clearly states that neither arm A nor",
        "label": "Entailment"
    },
    "d47eb708-7ca4-4894-bc28-e276e61c0333": {
        "text_answer": "Yes  The evidence does not mention any vaccines being administered in the trial",
        "label": "Entailment"
    },
    "646691ba-ad29-479f-81dc-131d9710c23b": {
        "text_answer": "Yes The primary trial does not exclude patients with cerebral metastases within the brainstem but the secondary",
        "label": "Entailment"
    },
    "70cd062f-8f49-47ac-80c0-d3608a574517": {
        "text_answer": "Yes The primary trial and secondary trial have different outcome measurements TEAEs vs objective response but they both involve",
        "label": "Entailment"
    },
    "01593a0d-0547-4ed6-8ad6-6c5ecdbeb74a": {
        "text_answer": "No   Explanation  The evidence describes two different interventions each with a different administration route",
        "label": "Contradiction"
    },
    "edb0a92a-08c0-4083-864e-26d845000fa6": {
        "text_answer": "No  The statement is not entailed by the evidence as the Phase 1 trial is open to both male and female",
        "label": "Contradiction"
    },
    "52c84a93-a09f-47b5-b928-385830350390": {
        "text_answer": "No  The evidence describes two different surgical interventions for breast reconstruction and the use of laserassisted flu",
        "label": "Contradiction"
    },
    "32c2dfce-b209-49f3-9f03-5e39b97b18c4": {
        "text_answer": "Yes The evidence states that patients with histologically proven DCIS are eligible for the clinical trial",
        "label": "Entailment"
    },
    "7064d383-b7a5-44a0-a9aa-3fae7b7ded9c": {
        "text_answer": "No  Explanation  The statement dont really enjoy food is not mentioned in the",
        "label": "Contradiction"
    },
    "c958d134-cecd-4212-9043-bc1d5131d555": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence pertains to breast cancer and hormonal treatments",
        "label": "Contradiction"
    },
    "a72ddea5-ee4b-4895-bd8c-10b4a143c3f8": {
        "text_answer": "Yes  Explanation  The statement 07 the primary trial participants and 0",
        "label": "Entailment"
    },
    "54c35538-e933-40b0-bf84-299e0b291ef3": {
        "text_answer": "Yes  Explanation  The statement infections and fever cases in the primary clinical trial were exclusively",
        "label": "Entailment"
    },
    "3c9a4b79-1f51-477a-a5b6-b69f76aeedf8": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial measure different outcomes The primary trial measures",
        "label": "Contradiction"
    },
    "cfef163a-3390-4b89-9a6f-7c351262625d": {
        "text_answer": "  Patients with deficient vitamin D levels were not specifically mentioned in the evidence The evidence only reports the results",
        "label": "Entailment"
    },
    "d1e7f535-40de-425b-9478-7d09f3d4cf06": {
        "text_answer": "Yes The primary trial includes breast adenocarcinoma as a qualifying cancer type for Phase 2 and",
        "label": "Entailment"
    },
    "2cc09c00-1375-4603-a6ee-dd5ceb87733a": {
        "text_answer": "Yes The statement is entailed by the evidence as metastatic small cell lung cancer is one of the types of cancer",
        "label": "Entailment"
    },
    "37b9368c-1aae-4acd-ad7a-ffe4422c9e5d": {
        "text_answer": "No   Explanation   The statement is about Brucella a specific genus of bacteria",
        "label": "Contradiction"
    },
    "395c6ba7-5123-4d61-a803-be3345d0ab23": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial reported a ten times higher number of hepat",
        "label": "Entailment"
    },
    "e9972d7c-b9f7-4846-9708-1e1f63e96e83": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence specifies starting doses of 25",
        "label": "Contradiction"
    },
    "c355603f-22d8-4363-ac79-6e591b4fcfac": {
        "text_answer": "Yes  Explanation The statement there were more cases of Infection Asymmetry and Def",
        "label": "Entailment"
    },
    "9bea0473-ca9d-4a63-befe-db1825744484": {
        "text_answer": "No  Explanation  The statement there was no significant difference in the results produced by coh",
        "label": "Contradiction"
    },
    "9f81f8a6-84d2-40b3-b8c5-3616f2f638a8": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence clearly states",
        "label": "Contradiction"
    },
    "fb1cfb53-fb70-4131-9ed0-00b5f93ecf26": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence includes the adverse event wound dehiscence",
        "label": "Entailment"
    },
    "dfe9c306-0a1f-4940-b9bb-00a238abc818": {
        "text_answer": "No  Explanation The primary trial includes a criterion for the primary tumour to have a diameter",
        "label": "Contradiction"
    },
    "bd791a1a-f4e4-43fb-8be0-ad1bced0aa60": {
        "text_answer": "No  The evidence states that the trial does not admit patients with meningeal carcinomatosis but it",
        "label": "Contradiction"
    },
    "6032e3ab-9d85-4c3b-aeb1-a93f45ba4735": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "55365a7b-df7e-4586-aeff-3ed268a4979f": {
        "text_answer": "Yes  Explanation  The statement in both the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "92e676b6-34f9-4b11-bfad-b45cf8942d2a": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial has witnessed an unexpected death and hospitalizations",
        "label": "Contradiction"
    },
    "df39cd99-7291-4749-a7d5-ff760b7c3fc2": {
        "text_answer": "No  Explanation  The statement cohort 2 of the secondary trial produced better results",
        "label": "Contradiction"
    },
    "9011533a-e400-4b32-96d4-a60ddc58ddbe": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the drug regimen",
        "label": "Contradiction"
    },
    "43a12cb4-7a50-4e64-b01f-1d1bfb5c4ba9": {
        "text_answer": "No  Explanation  The statement the primary trial had no documented adverse events unlike the",
        "label": "Contradiction"
    },
    "e96067c7-ab5d-4afc-b70c-f892aef0dce4": {
        "text_answer": "No  The statement about neoplastic meningitis being eligible for the primary trial is not entailed by the evidence",
        "label": "Contradiction"
    },
    "01982a9a-3299-4be8-8201-0397508b2f88": {
        "text_answer": "No  Explanation The evidence provided in the text does not indicate that numerous patients in the",
        "label": "Contradiction"
    },
    "1a4794c9-035c-4e78-b2e5-d8104428bdc0": {
        "text_answer": "Yes for the exclusion of cerebral metastases in the secondary trial  Explanation The",
        "label": "Entailment"
    },
    "4ce3082f-28f9-4e23-8808-dde496f77535": {
        "text_answer": "No  Explanation  The statement adverse events observed during the secondary clinical trial exceeded those",
        "label": "Contradiction"
    },
    "9c7ccf99-0768-4a8a-bde9-bb3cb9b65c67": {
        "text_answer": "Yes  Explanation  The statement no infections and infestations cases were registered in the",
        "label": "Entailment"
    },
    "90474244-ea60-4670-b586-8ca32b80af7f": {
        "text_answer": "Yes The evidence indicates that all the adverse events were reported in the first cohort",
        "label": "Entailment"
    },
    "9121985c-34cf-4378-b6ad-3b7a522c9ba5": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial and the secondary trial suffered Th",
        "label": "Contradiction"
    },
    "52d479a4-9cd7-4fb6-b37f-f455c6c81402": {
        "text_answer": "Yes  Explanation  The statement cohort 1 participants in the primary clinical trial exhib",
        "label": "Entailment"
    },
    "880b2544-5c9d-4ce7-8d26-1081c7851cb9": {
        "text_answer": "Yes The primary trial does not mention any drug interventions or related assessments while the secondary trial focuses on two distinct",
        "label": "Entailment"
    },
    "0744abca-2e7d-4e4a-a325-642ba6d16135": {
        "text_answer": "Yes  Explanation The evidence shows that there were 13 participants in the aprepitant group",
        "label": "Entailment"
    },
    "87273b6d-f10d-4638-ab87-bceade2d6510": {
        "text_answer": "Yes The secondary trial explicitly lists severe insomnia as an exclusion criterion for both the primary and secondary trials",
        "label": "Entailment"
    },
    "64e22fa4-990b-4196-874a-a5ecf04cf3fb": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the secondary trial does not",
        "label": "Contradiction"
    },
    "6232508a-0f99-485f-9b84-af5692dac27b": {
        "text_answer": "No  Explanation The statement after four weeks of treatment with tak228 plus tamox",
        "label": "Contradiction"
    },
    "fd2867fb-a94f-42ce-87a1-aebdcfd015b8": {
        "text_answer": "Yes The evidence mentions that the intervention involves both surgical and imaging procedures The statement is a restatement",
        "label": "Entailment"
    },
    "413156ec-dbfb-4c78-9518-cbde7d4765da": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the outcome measurement in the",
        "label": "Contradiction"
    },
    "4fec2620-4ede-44a4-adc9-54b525e89387": {
        "text_answer": "Yes The evidence shows that no adverse events related to cardiology or psychology were reported in either trial",
        "label": "Entailment"
    },
    "75c25f91-4918-40d6-b84d-d5be844b97ef": {
        "text_answer": "Yes  Explanation The statement an increased blood bilirubin was recorded in 36",
        "label": "Entailment"
    },
    "86a5a47e-a2cb-461e-bcc5-8f71620376b8": {
        "text_answer": "No  Explanation  The statement There were no significant differences in the results from the groups in",
        "label": "Contradiction"
    },
    "31ec9b33-fa24-4cd9-9341-c54adaa250cd": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "2f6221cf-15f0-4da7-b800-d65f4dd001d7": {
        "text_answer": "No  The performance status is an inclusion criterion in the secondary trial with a minimum requirement of a Zub",
        "label": "Contradiction"
    },
    "c41ed5cf-4629-4a4f-b564-197d705ec9cc": {
        "text_answer": "No   Explanation  The statement There were 0 adverse events in the primary trial",
        "label": "Contradiction"
    },
    "e547ee04-f454-4ec3-b2fb-9ea04c97bdab": {
        "text_answer": "Yes The statement mentions numerous adverse events and skin infections both of which are present in",
        "label": "Entailment"
    },
    "64839cde-9ad9-4363-9d78-7a2621bc7ec4": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that capecitabine was administered orally",
        "label": "Entailment"
    },
    "8bc0e440-faca-4386-8718-e306978edb67": {
        "text_answer": "  No   Explanation   The statement minor salivary gland is",
        "label": "Contradiction"
    },
    "974d4228-3dd6-42ab-b4e6-1b3f8e9ecdc5": {
        "text_answer": "No  Explanation The statement an additional collaborative care intervention was provided to cohort ",
        "label": "Contradiction"
    },
    "6c31de8a-736c-4741-99d3-fcd0c921e83f": {
        "text_answer": "Yes  Explanation The statement compared to the secondary clinical trial the frequency of pericard",
        "label": "Entailment"
    },
    "0a44470c-bf27-4795-aa25-f30a58771625": {
        "text_answer": "Yes The statement is consistent with the results of the primary trial regarding the reduction in Ki67 expression in breast cancer tum",
        "label": "Entailment"
    },
    "647c8d22-6888-4f04-a70b-0245b68a6fab": {
        "text_answer": "Yes The primary trial excludes patients with a life expectancy of less than 1 year while the secondary trial includes",
        "label": "Entailment"
    },
    "07dab01c-f419-4079-bd0d-491740c5ec95": {
        "text_answer": "No  Explanation  The statement several patients in the primary clinical trial experienced identical ad",
        "label": "Contradiction"
    },
    "16505ccd-8394-4c6e-8ab2-bbf56583c6be": {
        "text_answer": "Yes  Explanation The evidence states that in Intervention 1 the dose of cyclophosph",
        "label": "Entailment"
    },
    "9022a69a-98fa-45ab-8a03-3a6e81102d03": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with tumors exhibiting CCND1 amplification CDK",
        "label": "Entailment"
    },
    "e5e7bbc4-cce7-41e3-b973-ac14fdff5600": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement incorrect",
        "label": "Contradiction"
    },
    "66a9e527-8f35-4c41-be7f-ad854d0066f9": {
        "text_answer": "No  Explanation  The statement occurrence date range validation code is a coded value",
        "label": "Contradiction"
    },
    "8a79949b-06e3-4943-a63d-248e1a432a7b": {
        "text_answer": "No  The evidence states that there are 1530 enrollment slots for metastatic colorect",
        "label": "Contradiction"
    },
    "7758b88c-2f21-4b63-b76d-010298f50aa7": {
        "text_answer": "No  Explanation The statement cohort 1 of the primary clinical trial is administered",
        "label": "Contradiction"
    },
    "9a749008-f77d-49bf-b529-82d049a8f446": {
        "text_answer": "No  Explanation  The evidence provided in the form of the primary clinical trial results does not directly",
        "label": "Contradiction"
    },
    "5c2d33e2-9759-4060-9bdd-7ecda4123cda": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "03837d34-3ddb-4bfc-a993-b27e2d16f427": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "47512f16-9809-4150-a101-1fb7256c5bf3": {
        "text_answer": "No  The secondary trial measures pain not muscle gains",
        "label": "Contradiction"
    },
    "c5fb4937-5177-47c9-8ce2-1fdec2a17942": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "72d62a11-d0ff-4e2b-8bb9-22a1858b4914": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because  1",
        "label": "Contradiction"
    },
    "607586af-260d-46ef-88ce-b8672e4aaa25": {
        "text_answer": "No  Explanation  The statement Pericardial effusions were more common for patients in",
        "label": "Contradiction"
    },
    "877e791d-73b6-4af2-945c-29f54005c405": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the patient cohorts and trials",
        "label": "Contradiction"
    },
    "ce40b0b9-d8d4-45f4-a2dc-4adb8e7103ac": {
        "text_answer": "Yes  Explanation The statement More patients in cohort 1 of the primary trial suffered",
        "label": "Entailment"
    },
    "bc1a73c0-825c-48dd-b6cf-e440ae0bb782": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence indicates that patients will take vorinostat daily",
        "label": "Contradiction"
    },
    "0d7caeea-5417-4eb2-9d92-3d3ada73ece7": {
        "text_answer": "Yes  Explanation  The statement adverse events affecting more than 1 of participants did",
        "label": "Entailment"
    },
    "38acc5fa-c86b-4734-bdb6-7acbcd3c37c4": {
        "text_answer": "No  Explanation  The statement in the question is not entailed by the evidence provided The",
        "label": "Contradiction"
    },
    "94023f3a-38d4-4b1b-a65a-9536480ff4c4": {
        "text_answer": "No  Explanation  The statement how often did fatigue limit work is a question about how",
        "label": "Contradiction"
    },
    "3f0e9340-88df-433f-8bdb-e32523b86a86": {
        "text_answer": "No  Explanation  The statement a dosage of zoledronic acid 12",
        "label": "Contradiction"
    },
    "9a7f95d5-8fb7-4f77-a921-00a2633e8cc4": {
        "text_answer": "No   Explanation The evidence provided does not mention the number of participants who had undergone c",
        "label": "Contradiction"
    },
    "ffa6aa2b-661d-4e25-a893-6e03dea7e39e": {
        "text_answer": "Yes The primary trial measures tumor response using RECIST criteria but it does not report the percentage of participants experiencing",
        "label": "Entailment"
    },
    "ef79f4a4-d4ec-4a2a-a2a6-41ad41235927": {
        "text_answer": "No   Explanation  The evidence describes the dosing schedule for Vorinostat during radiation",
        "label": "Contradiction"
    },
    "ceb02a85-73a3-4c00-823e-fb88bc91d239": {
        "text_answer": "No  Explanation The statement Smokers are excluded from the primary trial but may be eligible for",
        "label": "Contradiction"
    },
    "f9e4988c-a325-40bc-8220-e7d0c404fd37": {
        "text_answer": "Yes  Explanation The statement None of the individual adverse event types recorded in the primary trial",
        "label": "Entailment"
    },
    "2a2a6190-619e-478b-a97d-5a253a8f916c": {
        "text_answer": "No  The statement patients with a recent history of abdominal fistula or gastrointestinal per",
        "label": "Contradiction"
    },
    "13eb7b14-5252-4004-8c72-56e3d5d3ca8a": {
        "text_answer": "Yes The statement a 5 decrease in the percentage of cells expressing ki67 was observed is ent",
        "label": "Entailment"
    },
    "87a42ef9-ff00-41f8-ba0a-9ca84498f7eb": {
        "text_answer": "No  Explanation The evidence provides the percentage of subjects in the clinical trial who demonstrated recurrencefree",
        "label": "Contradiction"
    },
    "5bc078b0-0b64-4d47-a015-26c3f03c864e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "733d9f9f-9a01-4643-ab99-ac6086ad5cbc": {
        "text_answer": "No  Explanation  The statement the duration of the memantine intervention in the primary clinical trial",
        "label": "Contradiction"
    },
    "318ded6f-e96c-4a4f-8f4b-ff19f2e86c16": {
        "text_answer": "Yes  Explanation  The statement there are no recorded instances of coronary artery sten",
        "label": "Entailment"
    },
    "81a3bd04-5dff-45a6-a4eb-7a41c59b0023": {
        "text_answer": "No  Explanation  The statement there were no significant differences in the results from the groups in",
        "label": "Contradiction"
    },
    "2aac2b30-f74d-4435-b7e6-ec5cd5923da3": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial only four distinct adverse events",
        "label": "Entailment"
    },
    "3e6a3ebb-face-44fe-8bb1-cbd399f4e215": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5e8286c8-3e7c-4b71-b824-103d031ac6b4": {
        "text_answer": "Yes The statement mentions Stomatitis as the only adverse event which is consistent with the evidence that reports",
        "label": "Entailment"
    },
    "d1424cd8-4dab-40a8-91b1-3ae5d1f57d56": {
        "text_answer": "No  Explanation  The statement several mortalities and admissions to the hospital",
        "label": "Contradiction"
    },
    "78f50c70-09e5-4328-8ddf-f7e743527132": {
        "text_answer": "No   Explanation  The statement is not directly entailed by the evidence as the statement is",
        "label": "Contradiction"
    },
    "b7501704-ccba-40f8-852e-c157006483df": {
        "text_answer": "No  Explanation The statement all patients in the primary trial receive at least 20kg",
        "label": "Contradiction"
    },
    "0f0f75f2-7da8-4705-b260-62c5f542b91e": {
        "text_answer": "No  Explanation  The statement in the primary trial only five cohorts received armod",
        "label": "Contradiction"
    },
    "d8fa557b-e20a-4b49-be9c-b55a6bde385a": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial measures the",
        "label": "Contradiction"
    },
    "33cd5bbd-a795-467e-b08f-cf59702922cc": {
        "text_answer": "Yes The primary and secondary trials both measure pCR and there is a difference in pCR rates between the two trials",
        "label": "Entailment"
    },
    "34199309-5388-4ed1-956d-17e9c7afaaef": {
        "text_answer": "No   The statement is about refugees from high tuberculosis prevalent areas but the evidence provided does",
        "label": "Contradiction"
    },
    "1ce7b426-1be9-4684-b0a5-54d557d3b320": {
        "text_answer": "No  Explanation  The statement the frequencies of recurrent malignancies graft",
        "label": "Contradiction"
    },
    "a6e81477-f863-4a83-9007-fd2f1f5c6781": {
        "text_answer": "No   Explanation  The statement Breast Cancer and Ovarian Perit",
        "label": "Contradiction"
    },
    "4a383701-3a27-4973-8c8c-4f697bde7484": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the drug intervention for",
        "label": "Contradiction"
    },
    "9a499642-970d-48b1-b0b4-96760793ba72": {
        "text_answer": "Yes The evidence does not mention any specific requirement regarding liver function in the inclusion or exclusion criteria",
        "label": "Entailment"
    },
    "4e929375-b7c0-4a81-baa9-9c21d95366b7": {
        "text_answer": "Yes  Explanation  The primary clinical trial INTERVENTION 1 compares two",
        "label": "Entailment"
    },
    "75cdd5c7-ad36-4ab3-8fe2-6d0e84ab8f0a": {
        "text_answer": "No   Explanation  The statement provided is not entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "d7637d6e-ba2c-4fdc-936d-57c3bf938eff": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the statement incorrectly",
        "label": "Contradiction"
    },
    "edd794e6-12c6-4d30-80ac-009951273d44": {
        "text_answer": "No  Explanation  The statement women with recurrent stage I breast cancer confirmed as",
        "label": "Contradiction"
    },
    "620b6390-df07-45fe-9ef9-55a32521c740": {
        "text_answer": "Yes  Explanation  The statement Diarrhoea was more common for the primary trial participants",
        "label": "Entailment"
    },
    "5b94480e-aa25-491e-ae37-a2b2939eafaf": {
        "text_answer": "No  Explanation The primary trial and the secondary trial have different inclusion and exclusion criteria While some",
        "label": "Contradiction"
    },
    "c6194284-d44f-45c1-9477-754736bbf1a3": {
        "text_answer": "No  Explanation The primary trial includes individuals with a breast tumor size of 1 cm while",
        "label": "Contradiction"
    },
    "feca7444-9108-45e9-b722-4f0a207376c7": {
        "text_answer": "Yes However its important to note that patients with a vitamin D deficiency are excluded from the primary trial",
        "label": "Entailment"
    },
    "c78f1ce0-7597-415d-b5c3-203e696b48d5": {
        "text_answer": "No  Explanation  The statement in the primary trial results there were fewer patients with stable disease",
        "label": "Contradiction"
    },
    "b80c2589-c792-4391-995c-6763270469dd": {
        "text_answer": "No  Explanation  The evidence provided in the clinical trial results does not indicate whether or not patients",
        "label": "Contradiction"
    },
    "cef48380-fe4b-4b71-931c-5b0dbfe1cf29": {
        "text_answer": "No   Explanation The primary clinical trial is not unrestricted in the number of participants and is",
        "label": "Contradiction"
    },
    "d9a63f26-68c3-431f-851f-131f7a547902": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any information about psychological health issues",
        "label": "Contradiction"
    },
    "884bc204-4928-430b-b44d-1e33ef66731d": {
        "text_answer": "Yes The primary trial explicitly excludes participants who have undergone major surgery within 28 days prior to the study",
        "label": "Entailment"
    },
    "9e19e98e-3ce1-4b01-9080-ad34e68f0acb": {
        "text_answer": "Yes  Explanation  The evidence states that out of 25 participants who received sunitin",
        "label": "Entailment"
    },
    "58429d01-0c6a-4ae1-b8ce-73ee8a8e775d": {
        "text_answer": "Yes The primary trial includes the exclusion criterion History of bone marrowstem cell transplantation",
        "label": "Entailment"
    },
    "87be81ce-d5b1-4905-9452-2e0e2d4b7b2c": {
        "text_answer": "No  Explanation The statement participants in the primary trial receive four different drugs throughout the",
        "label": "Contradiction"
    },
    "519fe8b4-596f-4db6-af13-80d9746041a6": {
        "text_answer": "No  The evidence does not mention an age limit in the inclusion criteria",
        "label": "Contradiction"
    },
    "76d498ce-037c-4f7e-8cbb-450d8f6019ec": {
        "text_answer": "Yes The statement is entailed by the evidence as the inclusion criteria for both phases of the primary trial specify that participants must",
        "label": "Entailment"
    },
    "e2a5ecca-6d4a-438b-a42c-46657ccb4050": {
        "text_answer": "No  Explanation  The evidence provided in the results does not contain any information about the age in",
        "label": "Contradiction"
    },
    "808d2233-0c0d-4221-bfae-e54fdcf31ce4": {
        "text_answer": "No  Explanation  The statement There were no significant differences in the results from the groups in",
        "label": "Contradiction"
    },
    "fb616088-52c2-4dae-84e5-8a1a3fa9b64f": {
        "text_answer": "No  Explanation  The statement liter per hour per kilogram per meter squared is a",
        "label": "Contradiction"
    },
    "f2d7cf41-2cd1-4d03-a153-18764cf7da09": {
        "text_answer": "  No  Explanation  The statement is not directly entailed by the evidence provided The",
        "label": "Contradiction"
    },
    "1748cec0-92de-44af-9d49-bf45518c24bc": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials had no adverse events that occurred in more than 1",
        "label": "Entailment"
    },
    "939de4be-2f3d-4e0d-a5b9-a80f6469bd22": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as there is no mention of T",
        "label": "Contradiction"
    },
    "3cb08dda-e0dc-48e5-87fa-e24386d6dab2": {
        "text_answer": "Yes The statement is a more specific version of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "e7be25fe-5915-4c38-b3c0-4e4acd5edd5c": {
        "text_answer": "Yes The statement is entailed by the evidence as patients with tumors positive for CCND1 amplification CDK",
        "label": "Entailment"
    },
    "95840c1a-9e38-4fe5-939c-e6f9aa107ced": {
        "text_answer": "No  Explanation  The statement each adverse event reported in the primary clinical trial was account",
        "label": "Contradiction"
    },
    "6e5e4b46-3bc7-4ae1-8668-9b4f2f72f791": {
        "text_answer": "No The statement is not entailed by the evidence as the evidence explicitly states that the primary trial includes patients aged greater than",
        "label": "Contradiction"
    },
    "454c83f7-949e-46bf-bd9a-5f14e6ba4713": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of gabapentin or pregabalin",
        "label": "Contradiction"
    },
    "4678ba70-3ec1-487b-a641-bdbd790892ac": {
        "text_answer": "No  Explanation  The statement 274 the primary trial participants and ",
        "label": "Contradiction"
    },
    "5f36a4ca-cd2f-4c38-8040-9b36da0ebbe4": {
        "text_answer": "No  The evidence does not mention any specific weight range for American patients in the primary clinical trial",
        "label": "Contradiction"
    },
    "358cd111-420a-401d-bd92-e459d3725026": {
        "text_answer": "  No   Explanation   The evidence provided does not mention anything about obesity",
        "label": "Contradiction"
    },
    "e8351b8b-d707-4766-b875-777557f0653f": {
        "text_answer": "Yes  Explanation  The statement Pericardial effusions were more common for patients in",
        "label": "Entailment"
    },
    "ab3fc92f-0d8a-472f-b652-e10bcd03ff19": {
        "text_answer": "Yes The evidence does not indicate that any adverse event type affected more than one patient in the primary trial",
        "label": "Entailment"
    },
    "494a4094-5a05-4c7d-b7a7-60baeb210e5a": {
        "text_answer": "Yes  Explanation  The statement There are no unexpected deaths or Hospitalizations that occurred in the",
        "label": "Entailment"
    },
    "e5d16f98-79d0-44e1-9fc0-7bb6ae9a038d": {
        "text_answer": "Yes The statement is entailed by the evidence as cohort 2 received twice the dose of Enzalut",
        "label": "Entailment"
    },
    "5ce6e37b-2c84-44e1-8c5e-e441cec64872": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "1e32317b-5301-461d-bdd9-0acb2e076522": {
        "text_answer": "Yes The evidence states that adverse events were documented in both trials",
        "label": "Entailment"
    },
    "04c5ba38-d98e-4fd7-b5f4-ea4706f26355": {
        "text_answer": "Yes The statement correctly identifies the difference in dosing between the two interventions in the trial However it does",
        "label": "Entailment"
    },
    "9f97138b-399f-42bf-9afe-e7195db4e5b4": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "ae583e53-d445-4b4a-b49a-c440881180e7": {
        "text_answer": "No  Explanation  The statement candidates are given lower weekly doses of mm",
        "label": "Contradiction"
    },
    "fa5e894c-13be-4786-ac47-16d31de8a7ce": {
        "text_answer": "No  Explanation  The statement distress over family problem with family health issues is a question",
        "label": "Contradiction"
    },
    "67bce826-0ca5-477c-8802-2511317e675d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "bbda33ff-3d5b-445e-afec-a20518fd2c79": {
        "text_answer": "Yes  Explanation  The statement There are less total adverse events and less types of ad",
        "label": "Entailment"
    },
    "68d0da33-c4ad-4649-bb63-08290cd4d4e2": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "fc7722bc-9fed-46cf-881d-265c3f3762b4": {
        "text_answer": "No  Explanation  The statement 273 the primary trial participants and 0",
        "label": "Contradiction"
    },
    "a9cbf72a-fd01-403d-8afa-d9d6a69622a0": {
        "text_answer": "Yes The statement does not provide any new information about the adverse events but it is not in contradiction with the",
        "label": "Entailment"
    },
    "41c54be8-c257-49dc-b21b-0184595c1277": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial administers to cohort 1 a",
        "label": "Entailment"
    },
    "4417c4c8-522f-4e46-8b8d-310995182d70": {
        "text_answer": "Yes The evidence states that there were 234 participants in cohort 1 and 241 in",
        "label": "Entailment"
    },
    "7b74835d-12ba-4d02-a09c-817f33abd3b2": {
        "text_answer": "Yes The evidence does not explicitly state that patients with stage 4 cancer are eligible for both trials but it does not",
        "label": "Entailment"
    },
    "3dab8f67-6eca-4ace-ba49-0bd33547b004": {
        "text_answer": "Yes  Explanation The statement while most patients in the first cohort of the primary clinical trial",
        "label": "Entailment"
    },
    "359a101f-e771-4fac-b2f7-a5486fb19344": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the comparison of the eff",
        "label": "Contradiction"
    },
    "cbbd5644-6e63-4f6d-b948-fe52b5df89c7": {
        "text_answer": "No  Explanation The evidence provided only reports the median PFS for each treatment group not the maximum",
        "label": "Contradiction"
    },
    "2fb19f2c-7bda-446c-bf0c-8e9842e89c97": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the intervention in the",
        "label": "Contradiction"
    },
    "be93f6ab-df27-4f10-a485-24823f7056fc": {
        "text_answer": "No  Explanation  The statement Cholelithiasis was twice as common for the",
        "label": "Contradiction"
    },
    "effcbfa0-9271-4463-9e48-5523d5cedeb6": {
        "text_answer": "No  Explanation The evidence provided only outlines the inclusion and exclusion criteria for a clinical trial",
        "label": "Contradiction"
    },
    "1f309606-5b98-4320-ab02-24e782e7250d": {
        "text_answer": "No   Explanation   The primary trial and the secondary trial report their results using different units",
        "label": "Contradiction"
    },
    "f0a1bf43-c080-446d-815a-c588c7563e89": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for the primary clinical trial and mentions",
        "label": "Contradiction"
    },
    "de3effdb-0854-48a8-b66c-b61378ec7a6f": {
        "text_answer": "No   Explanation  The evidence provided does not mention any radiation therapy being administered to the",
        "label": "Contradiction"
    },
    "d2673e8f-15c9-4476-b8b6-2567822d5cd4": {
        "text_answer": "No  Explanation The evidence provided in the text relates to the outcome of a clinical trial comparing",
        "label": "Contradiction"
    },
    "cbba3546-5b88-42d0-882d-024d5f267d97": {
        "text_answer": "Yes  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Entailment"
    },
    "5c535bb9-8464-4820-b872-506057f2cd87": {
        "text_answer": "No  Explanation The evidence provided in the trial results only reports the median change in lean body mass",
        "label": "Contradiction"
    },
    "94328fa0-182a-4275-929c-bc10f899ba5d": {
        "text_answer": "  Yes for the secondary trial statement about pulmonary embolism No for the primary trial statement",
        "label": "Entailment"
    },
    "a668e3be-6b87-468e-99b5-48ad77bed972": {
        "text_answer": "No  Explanation  The statement photovoice is a qualitative method in which participants",
        "label": "Contradiction"
    },
    "59d62015-4627-4fef-acba-984ff4ad2964": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes a clinical trial for cancer treatment using chemotherapy",
        "label": "Contradiction"
    },
    "e4b57c09-4069-463e-9db3-70860f520524": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence because the statement ment",
        "label": "Contradiction"
    },
    "4e68783f-fc2b-4efb-88da-b5d081ff5541": {
        "text_answer": "No  Explanation  The statement unfavorable outcomes were reported in equal measure from patients",
        "label": "Contradiction"
    },
    "d7abc723-e08e-442e-82e4-3e369341b72a": {
        "text_answer": " No The primary trial does not mention anything about pediatric cancer patients under the age of 18 and",
        "label": "Contradiction"
    },
    "60f6302e-f888-4bc2-b689-f0620024f93e": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial cohort 1 experienced",
        "label": "Entailment"
    },
    "837329c4-d046-4997-ad41-f230d3db7255": {
        "text_answer": "Yes  Explanation  The statement There were no cardiac or psychiatric AEs recorded during",
        "label": "Entailment"
    },
    "4dcbfb0d-cb67-4d74-a21a-0920159dfafc": {
        "text_answer": "Yes  Explanation  The statement both the primary clinical trial and the secondary clinical trial did not",
        "label": "Entailment"
    },
    "3bde4a4f-fece-4422-a55a-461fa027c18a": {
        "text_answer": "No   Explanation   The statement Perjeta is used in both cohorts",
        "label": "Contradiction"
    },
    "31546be8-dcef-4300-a21d-831c25e5b92a": {
        "text_answer": "No  Explanation  The statement none of the adverse events in the secondary trial affected more",
        "label": "Contradiction"
    },
    "d3a0e851-28c4-4382-bb3e-8c40bc16ae7a": {
        "text_answer": "Yes  Explanation  The statement diarrhea was noted as a more common symptom",
        "label": "Entailment"
    },
    "05aafe0b-c62a-4dda-a60a-52929cb81b7f": {
        "text_answer": "Yes The evidence states that these conditions are exclusion criteria for the clinical trial",
        "label": "Entailment"
    },
    "74308ad0-4b9d-4632-9580-5e280dedbc77": {
        "text_answer": "Yes The evidence states that for Phase 2 of the trial patients with breast cancer must be ER positive andor",
        "label": "Entailment"
    },
    "6333ef7c-fdfe-4f90-b763-4d826c08975c": {
        "text_answer": "Yes  Explanation  The statement in both the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "66030da0-0335-44c8-97dd-a620f3d9961f": {
        "text_answer": "No  Explanation  The statement insomnia patients irrespective of the severity of",
        "label": "Contradiction"
    },
    "72130361-5d83-4dbb-98ce-8e9a6f2541e4": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the outcome measurements in the",
        "label": "Contradiction"
    },
    "72b75fca-541f-4311-a38d-9f1d73220418": {
        "text_answer": "No  Explanation  The statement notice change in the way food tastes is a question about whether",
        "label": "Contradiction"
    },
    "66bf512a-c3fd-46a8-8a0b-4d64fde85082": {
        "text_answer": "No  Explanation  The statement unmutated immunoglobulin heavy chain variable",
        "label": "Contradiction"
    },
    "9e3cf2a2-6713-4d07-adde-e334b49ca6ec": {
        "text_answer": "Yes The primary trial candidates receive fewer total doses of MM121 and Paclitaxel per cycle",
        "label": "Entailment"
    },
    "e59036ac-08b6-44ed-ad46-292a3bb8a937": {
        "text_answer": "Yes The statement no fatalities or hospital stays occurred in the second cohort of the primary clinical trial is",
        "label": "Entailment"
    },
    "c01204e3-a0fd-4153-a27d-d17c0bb4773b": {
        "text_answer": "Yes  Explanation The evidence shows that the percentage of participants who were up to date for colorect",
        "label": "Entailment"
    },
    "21b261e7-4b78-4c70-ba0c-b98c5c082bee": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only compares the percentage change in beta",
        "label": "Contradiction"
    },
    "29c084b6-6c7c-4f6b-abcc-6740b951f139": {
        "text_answer": "No  Explanation  The statement in cohort 2 the primary clinical trial had",
        "label": "Contradiction"
    },
    "0feb3694-da20-4a30-b85d-e9dc4cdb55c3": {
        "text_answer": "No  Explanation  The statement the primary and the secondary trial reported an equal number of int",
        "label": "Contradiction"
    },
    "551f61b2-c709-4c51-b705-d2415e40ae40": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial assess different patient populations and different outcomes",
        "label": "Contradiction"
    },
    "dc9267c3-b1ab-45d1-8a22-a9ec8e7ba673": {
        "text_answer": "Yes  Explanation The evidence shows that a larger percentage of participants in both the Collaborative Care Inter",
        "label": "Entailment"
    },
    "72d13f98-6915-4a80-9810-c06d0e204b1e": {
        "text_answer": " Yes   Explanation  The evidence provides the percentage change in betaCTX at week 4",
        "label": "Entailment"
    },
    "2e9d87da-10f2-4530-b200-87bb72cd9335": {
        "text_answer": "No  Explanation  The statement individuals suffering from malignant ductal car",
        "label": "Contradiction"
    },
    "d542b63b-a355-4a0e-8ec9-3c74bb1e0dcb": {
        "text_answer": "Yes  Explanation The evidence states that at Week 12 there were no participants with a",
        "label": "Entailment"
    },
    "2f1db1ac-f8d0-4087-856e-dfcff97c75a5": {
        "text_answer": "  No the statement is not entailed by the evidence The primary trial excludes individuals with a pulmonary",
        "label": "Contradiction"
    },
    "bd2b336d-30ae-4151-a920-9506a013ab14": {
        "text_answer": "No  Explanation The statement lipase unit is a dosing unit based on lipase activity",
        "label": "Contradiction"
    },
    "d5fe5d1e-b4c8-46d1-879f-06f14157c3ee": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes postmenopausal women with hormonerequ",
        "label": "Entailment"
    },
    "9ed2eb80-3810-40fc-b26a-d2e93feb061d": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity weight or gender as eligibility criteria for either trial",
        "label": "Entailment"
    },
    "dad4efbe-c7ae-4507-8a04-853a132b497a": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c574fb87-713c-43cd-a147-215f98ff6d35": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fca56898-5587-4c6a-ae87-86dfae3a4961": {
        "text_answer": "Yes The statement General symptoms are the most common AE recorded in the primary trial is entailed by the evidence",
        "label": "Entailment"
    },
    "5a25fa73-5358-4d36-acc0-ea23cb358a4d": {
        "text_answer": "Yes  Explanation  The evidence provided indicates that there were no instances of doselimiting toxic",
        "label": "Entailment"
    },
    "475425c4-cfbf-4742-86ad-b09806d19687": {
        "text_answer": "No  The statement is not entailed by the evidence as coronary artery stenosis is not listed as an",
        "label": "Contradiction"
    },
    "8e66baf7-890a-4a73-9542-814980f89689": {
        "text_answer": "Yes The participants in the primary clinical trial received a lower dose of PF06647020",
        "label": "Entailment"
    },
    "0935ad04-3112-4443-8f3a-6b3a07ac9d33": {
        "text_answer": "No   Explanation   The patient with a primary tumour of 03 cm",
        "label": "Contradiction"
    },
    "e44f0355-dac8-4405-b3b1-ceb87cbb121d": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that there should be no meningeal",
        "label": "Contradiction"
    },
    "128e4316-cd80-4dff-9d54-3030e9921c77": {
        "text_answer": "No  Explanation  The statement cases of mucositis oral thromboem",
        "label": "Contradiction"
    },
    "5acd7311-862e-440b-aecd-64f015c7deb6": {
        "text_answer": "Yes The trial compares two different interventions one with nabPaclitaxel and gemcitab",
        "label": "Entailment"
    },
    "5cf2e65a-45cd-490e-8933-23bf36558b11": {
        "text_answer": "No  Explanation  The evidence provided in the results does not indicate that every patient in each co",
        "label": "Contradiction"
    },
    "7f6d7fd9-8aed-472d-af54-b288d16c2135": {
        "text_answer": "No  Explanation  The evidence provided does not mention Tumour lysis syndrome as an ad",
        "label": "Contradiction"
    },
    "56c99670-a2ba-42ca-b870-e3d98f2f4169": {
        "text_answer": "No  Explanation  The statement the inclusion of a patient into the primary clinical trial is dependent",
        "label": "Contradiction"
    },
    "eab0f794-5caa-49fc-b951-7db4b7169a46": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria listed in the evidence Patients with a history of abdom",
        "label": "Entailment"
    },
    "c4b53dae-5bcf-4356-825d-0701f5c9b545": {
        "text_answer": "No  Explanation The statement in the primary clinical trial the number of hypertension and",
        "label": "Contradiction"
    },
    "057e1439-4666-4373-a5b4-539c6cd24469": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial whole breast radiation therapy is given",
        "label": "Contradiction"
    },
    "4bf53370-da92-4333-bae7-3b35ab56b86e": {
        "text_answer": "No  Explanation  The primary clinical trial explicitly lists history of clotting disorder hyper",
        "label": "Contradiction"
    },
    "963bd695-f26a-4891-931e-9b417a7c81c0": {
        "text_answer": "No  Explanation  The statement the primary clinical trial reported a higher incidence of infection",
        "label": "Contradiction"
    },
    "662dd235-76f6-4ab6-b4c8-5537e6f7ffb3": {
        "text_answer": "No  Explanation  The statement four or more positive lymph nodes is an indication that",
        "label": "Contradiction"
    },
    "fb4e9c92-aa61-4691-b1fe-3cbb4a183f6d": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "09684ae5-162a-43ba-9735-6c9bce05cd5f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "847dd934-e3d0-44c6-8964-d1eb14b0d7a2": {
        "text_answer": "No  Explanation  The evidence provided in the text indicates that the patients in the Tamoxif",
        "label": "Contradiction"
    },
    "d9444db3-e6d5-43d4-ba21-b934f8e0f77e": {
        "text_answer": "No   Explanation   The statement microscopic findings group identifier is a character",
        "label": "Contradiction"
    },
    "3f6f3ca0-d14d-4fdb-9be8-19859181aaa9": {
        "text_answer": "No  Explanation  The statement after being treated with aprepitant dexam",
        "label": "Contradiction"
    },
    "2acdad0e-1a86-49d6-817d-cddb655073ac": {
        "text_answer": "No  The statement is not related to the evidence provided which pertains to adverse event data from two coh",
        "label": "Contradiction"
    },
    "402d2312-d5b6-4763-9246-4e094a7d6739": {
        "text_answer": "No  Explanation The statement a participant in cohort 2 endured the longest p",
        "label": "Contradiction"
    },
    "c0e3960b-923b-460f-a6e1-0b16f32af78f": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the number of adverse events",
        "label": "Contradiction"
    },
    "d1b9ab7c-2229-405c-be0e-01d822ac5aa1": {
        "text_answer": "  No   Explanation   The statement Breast cancer patients with estrogen",
        "label": "Contradiction"
    },
    "01bbbed8-5b22-4017-b6c5-f8a32bd6ab20": {
        "text_answer": "No   Explanation  The statement in the primary clinical trial all interventions are delivered",
        "label": "Contradiction"
    },
    "418be5f3-61b5-4bae-a274-c2213e3cc7cf": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "d15f343f-8edf-484e-bc6c-bbcbbf8c9118": {
        "text_answer": "No  Explanation  The statement pain has interfered with normal work is not",
        "label": "Contradiction"
    },
    "9532e5a5-0e29-4914-8cf5-5aff881ffa8a": {
        "text_answer": "Yes  Explanation The evidence provided in the primary clinical trial includes the number of participants analyzed for each",
        "label": "Entailment"
    },
    "dba63c59-7efc-48de-a02e-69b1b5beb08d": {
        "text_answer": "Yes  Explanation  The statement is entailed by the evidence as the primary clinical trial involves testing",
        "label": "Entailment"
    },
    "da6c4a2b-18ad-44d9-9021-71c4f9b22fff": {
        "text_answer": "No  Explanation  The primary trial measures the change in serum levels of Follicle St",
        "label": "Contradiction"
    },
    "fc24dc2a-3257-433f-91ed-fc3d3ec369b3": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts 105",
        "label": "Contradiction"
    },
    "cc11b6a5-855a-4291-b41d-e63367ea3b88": {
        "text_answer": "Yes The primary and secondary clinical trials both use pCR as an outcome measurement The primary trial has slightly different pCR",
        "label": "Entailment"
    },
    "25bc284b-0476-4950-96e5-3b08a2a1c33c": {
        "text_answer": "No the statement is not entailed by the evidence as the primary trial explicitly excludes patients with a pulmonary hem",
        "label": "Contradiction"
    },
    "4f886133-596d-449a-92c3-7472e2602982": {
        "text_answer": "No  Explanation  The statement Patients with a breast tumor 02",
        "label": "Contradiction"
    },
    "b95564b8-cdbe-45d0-be91-764d6768e5f9": {
        "text_answer": "No  Explanation  The statement the primary trial candidates receive less weekly MM12",
        "label": "Contradiction"
    },
    "b32a43a7-cac0-4434-bdb2-4c4d8b26d947": {
        "text_answer": "  No the statement is not entailed by the evidence In the primary trial participants cannot have any alcohol or",
        "label": "Contradiction"
    },
    "8f078a17-14cd-4bbc-a9b6-b377ffa077b5": {
        "text_answer": "No  Explanation  The statement There was at least 1 recorded gastrointest",
        "label": "Contradiction"
    },
    "ce486acd-8aae-475c-b95e-131fc0809e15": {
        "text_answer": "No  Explanation The statement provided does not directly relate to the information given in the evidence The",
        "label": "Contradiction"
    },
    "d083c9b8-decf-41ac-a3b0-ba8b6eedb32d": {
        "text_answer": "  Maybe   Explanation   The evidence provided does not directly compare the ORR between",
        "label": "Entailment"
    },
    "4a5a5c6f-b9b3-48a4-a79a-582dc83323e3": {
        "text_answer": "Yes The primary trial explicitly states that patients who require use of coumarinderivative anticoagulants",
        "label": "Entailment"
    },
    "5b8f9c72-6729-4b0f-9956-617021d55805": {
        "text_answer": "  No   Explanation   The statement patients with endocarcinoma",
        "label": "Contradiction"
    },
    "1a47637c-31f0-42c0-9729-7ab8c66fafb4": {
        "text_answer": "No  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Contradiction"
    },
    "c79f4ed7-5e39-48ad-bc32-fef9ace77a76": {
        "text_answer": "No  Explanation  The statement neither the primary clinical trial nor the secondary clinical trial co",
        "label": "Contradiction"
    },
    "4d33c738-d007-4e43-8d51-6c98c40631df": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "d7170cb2-d8a5-4c65-9122-bc6bcf13caeb": {
        "text_answer": "No  Explanation The statement her2neu negative by immunohistochem",
        "label": "Contradiction"
    },
    "b76d27c5-45ec-4695-8480-1128862ea21b": {
        "text_answer": "No  The statement is not entailed by the evidence as the placebo in the primary clinical trial was administered",
        "label": "Contradiction"
    },
    "8fcaece4-a0c7-44bf-82b0-50e494825b81": {
        "text_answer": "No  Explanation  The evidence provided states that 53 out of 60 participants in",
        "label": "Contradiction"
    },
    "37f74912-6578-4304-9f9c-6b3c4c217e97": {
        "text_answer": "No  Explanation The statement provided does not directly relate to the information given in the evidence The",
        "label": "Contradiction"
    },
    "35802b7b-4d8e-4f1a-bab8-20eea1f4aa3f": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "58fa0ef4-0355-42bc-8378-fef98752b05e": {
        "text_answer": "Yes   Explanation The statement is entailed by the evidence as it accurately reflects the information provided in",
        "label": "Entailment"
    },
    "95928e94-237c-4e85-98d4-9dc5371c5069": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence as the evidence",
        "label": "Contradiction"
    },
    "1b229af4-937d-4ae0-8c39-12064d16b246": {
        "text_answer": "Yes  Explanation  The evidence shows that patients in Arm I Cryotherapy had a",
        "label": "Entailment"
    },
    "f569ce38-1e3f-4e8d-a9d7-e4a35a18c90c": {
        "text_answer": "No The statement is not directly related to the evidence provided which pertains to the inclusion and exclusion criteria for a",
        "label": "Contradiction"
    },
    "966efbd3-dce6-400c-b5bc-87ca468c7225": {
        "text_answer": "No  Explanation The evidence provided in the primary trial relates to the percentage change in serum",
        "label": "Contradiction"
    },
    "d2757370-ae03-4046-a888-e30b9aa1551f": {
        "text_answer": "  No  Explanation  The statement individuals with fluorescent in situ hybrid",
        "label": "Contradiction"
    },
    "cc439508-491f-4c5a-9304-5ddf9d266506": {
        "text_answer": "Yes The evidence shows that both groups had below average standardized scores on the cognitive function test indicating a deterioration",
        "label": "Entailment"
    },
    "d2c665aa-c13e-4d5d-95f8-d85c5c9f3ef9": {
        "text_answer": "No The statement has nothing to do with the evidence provided The evidence only reports the occurrence of adverse events in",
        "label": "Contradiction"
    },
    "936b5904-9a93-4aaf-8d20-03e0a4fb3223": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "7326be65-0450-4fb7-88d3-5d926d65db74": {
        "text_answer": "No  Explanation  The statement only patients prescribed gtx024 3",
        "label": "Contradiction"
    },
    "692ea096-a2cf-4732-a141-b349cfd460d6": {
        "text_answer": "Yes  Explanation  The statement urinary tract infections were a frequent side effect among participants",
        "label": "Entailment"
    },
    "96dedf4b-abc0-41ea-b12a-9a8afce9708d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "74c47731-5e97-400b-bf85-52ae0b8b5e09": {
        "text_answer": "No  Explanation The statement requires that each patient receives at least 20000",
        "label": "Contradiction"
    },
    "e4eba352-415f-44bd-8fe0-244240a80513": {
        "text_answer": "Yes  Explanation The evidence states that 20 out of 35 participants in coh",
        "label": "Entailment"
    },
    "ce26a25e-c6ff-4bba-bd54-b0e069440746": {
        "text_answer": "No   Explanation  The statement not a single instance of a maculopap",
        "label": "Contradiction"
    },
    "4f0e91c8-87f4-4af4-b47d-c5a8e459713d": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it only mentions",
        "label": "Contradiction"
    },
    "4d8bdd85-b621-4334-9aff-9ab0b69172e5": {
        "text_answer": "Yes The evidence does not mention any mental health body weight tumor size KarnofskyECO",
        "label": "Entailment"
    },
    "2b2a038c-37d7-42a6-817a-5392b1e94613": {
        "text_answer": "Yes  Explanation  The statement the incidence of aes was reported to be higher amongst",
        "label": "Entailment"
    },
    "530798af-a5d0-4de8-8183-b2ef6068c90a": {
        "text_answer": "Yes The statement is entailed by the evidence as both groups receive the same radiation therapy intensity and undergo SPECT sc",
        "label": "Entailment"
    },
    "55e361f9-9360-4de4-a301-6b504913b094": {
        "text_answer": "Yes The secondary clinical trial had more participants 163 than the second cohort of the primary clinical trial",
        "label": "Entailment"
    },
    "f191be61-8e8d-495c-b5e3-1bf3cc89904a": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence reports median",
        "label": "Contradiction"
    },
    "b2572b63-5246-4be3-84ee-c37f18da106d": {
        "text_answer": "Yes  Explanation The statement cohort 1 in the primary clinical trial received a higher",
        "label": "Entailment"
    },
    "328dcbbe-1a4a-46f1-afad-df84cebcde05": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes the administration of oral lapatinib and",
        "label": "Contradiction"
    },
    "992db0e7-c7c4-413c-874f-c8e53d481fab": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the doses of M",
        "label": "Contradiction"
    },
    "c51c390c-f844-492c-9844-53e31e01124d": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial and the secondary clinical trial a",
        "label": "Contradiction"
    },
    "ea25b3f7-4ef8-4e5f-b3e8-3cbf0da93a12": {
        "text_answer": "No   Explanation   The statement Patients with measurable bilateral breast cancer are",
        "label": "Contradiction"
    },
    "15c27d36-ca02-48e2-8e08-d9c6b52042c6": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes individuals with metastatic disease M1",
        "label": "Entailment"
    },
    "890c305f-bd6d-4db4-adf5-2aaf8e28d6c6": {
        "text_answer": "No  Explanation  The statement The most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "93c0565f-98d6-4f6b-92a6-8464567027c7": {
        "text_answer": "Yes  Explanation  The primary clinical trial focuses on Time to Progression TTP as",
        "label": "Entailment"
    },
    "32c13f2f-7902-444f-8f99-c3ea2ecac0d0": {
        "text_answer": "No  Explanation  The statement the primary clinical trial records more types of adverse events",
        "label": "Contradiction"
    },
    "33603672-b61c-4ddd-8e57-d38876de9132": {
        "text_answer": "Yes  Explanation  The statement there was no repetition in the type of adverse event",
        "label": "Entailment"
    },
    "2e753155-acb5-417c-9169-9ec7ccc4d8ac": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "356f845b-f5e9-46f8-8374-fb598e246876": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts follow the same instructional CD for paced breathing",
        "label": "Entailment"
    },
    "74b96ae6-3e1a-4f1c-bbf0-a79ed0e4ee75": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "2fafc6ea-da6d-4160-829d-1f599da46818": {
        "text_answer": "Yes the statement is about a different condition gingival polyp and is not entailed by the evidence provided",
        "label": "Entailment"
    },
    "74bde0ca-3313-40ab-95f3-55d2adea4f89": {
        "text_answer": "  No   Explanation   The statement patients diagnosed with benign fibro",
        "label": "Contradiction"
    },
    "fd0b22b0-c86d-4460-bf53-310901404ef5": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f2d20a53-59b4-42bf-8d21-1ead0e113107": {
        "text_answer": "No  The evidence does not mention schizophrenia as an exclusion criterion for either trial",
        "label": "Contradiction"
    },
    "f45b251f-2fec-44b7-8fc0-dd0d06a44d3b": {
        "text_answer": "Yes  Explanation  The statement In both the primary trial and the secondary trial there were ",
        "label": "Entailment"
    },
    "151bb6d0-e4bf-4eea-8842-5fe4e1782782": {
        "text_answer": "No  Explanation  The statement recurrencefree survival was experienced by 96",
        "label": "Contradiction"
    },
    "315f4573-d5b1-4cbc-9efb-74c27a98dc6d": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include patients with ER positive PR positive or HER",
        "label": "Entailment"
    },
    "3cbaa580-dfe1-4331-902c-5be850db2f24": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "80b93d64-be3c-45e0-8524-b8042e84bdc7": {
        "text_answer": "No  Explanation  The statement patients in the primary trial recorded the most instances of chest",
        "label": "Contradiction"
    },
    "57663242-4e73-409f-a7f9-1738e13298ab": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "df344680-ab21-4889-bba7-7db757b72bae": {
        "text_answer": "Yes  Explanation The statement cohort 1 and 2 in the primary clinical trial",
        "label": "Entailment"
    },
    "f50bcaa7-7424-4977-ac06-f47e545e2e00": {
        "text_answer": "No  Prostate cancer is not listed as a eligible cancer type in the provided clinical trial evidence",
        "label": "Contradiction"
    },
    "46ac728d-deb3-4559-bc71-1729c70c26e7": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial involves",
        "label": "Contradiction"
    },
    "665afeee-f623-4c57-8550-a5dbe71430cb": {
        "text_answer": "No  Explanation  The statement individuals partaking in the secondary clinical trial are administer",
        "label": "Contradiction"
    },
    "786bc355-6b8f-455c-b6b2-470350231601": {
        "text_answer": "Yes  Explanation  The statement comprehensive records of adverse events are available for",
        "label": "Entailment"
    },
    "72ea65df-6381-4672-a40c-f55cee100091": {
        "text_answer": "Yes The statement mentions stomatitis as the adverse event which is consistent with the evidence that the sole ad",
        "label": "Entailment"
    },
    "b9b69888-f771-4a3a-b6f0-825510997cca": {
        "text_answer": "Yes  Explanation The statement cohort 1 of the primary trial is administered less",
        "label": "Entailment"
    },
    "7714e6f7-814a-4088-9116-60f5ceef4336": {
        "text_answer": "  No   Explanation   The statement a patient recuperating from an organ trans",
        "label": "Contradiction"
    },
    "57bca704-dcff-4526-b677-bb1c1b1a7945": {
        "text_answer": "No   Explanation The primary clinical trial reports its results in units on a scale and the secondary",
        "label": "Contradiction"
    },
    "b27a5fe7-77f8-4d11-9e05-0609faf8b985": {
        "text_answer": "Yes The evidence includes exclusion criteria for sexually active fertile men whose partners are women of childbearing potential",
        "label": "Entailment"
    },
    "15577bb6-3b4d-4373-ae58-eb0bf0c34954": {
        "text_answer": "Yes The primary trial explicitly states that warfarin is not permitted while the secondary trial permits its use under certain",
        "label": "Entailment"
    },
    "99e5ad48-5bb8-4716-a1fc-0a332acf2e5e": {
        "text_answer": "Yes Both trials evaluate the incidence of adverse events of primary interest The primary trial focuses on toxicity of inf",
        "label": "Entailment"
    },
    "6d92ea7c-a85d-4d9d-9599-b2203e9c3585": {
        "text_answer": "No  Explanation  The primary trial had two test groups Intervention 1 and Intervention",
        "label": "Contradiction"
    },
    "b5976fd8-b3cf-4879-bead-2410a6e1f1f1": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement The",
        "label": "Contradiction"
    },
    "4d7a11a9-ec69-4b35-9fea-d1a78d8fe4b8": {
        "text_answer": "No  Explanation  The statement there were several cases of febrile neutropenia",
        "label": "Contradiction"
    },
    "c291c60f-fb5e-4c0d-83dc-a8fe9eee445c": {
        "text_answer": "Yes The statement that all the primary trial candidates must have a HER2 positive tumor confirmed by either positive F",
        "label": "Entailment"
    },
    "ebe02c33-affe-41d7-aad7-86ea86912217": {
        "text_answer": "Yes  Explanation  The evidence provided states that the average pain intensity was measured using a 0",
        "label": "Entailment"
    },
    "d464fa4d-58ea-47ff-b4fa-19fbedb40740": {
        "text_answer": "No  The evidence does not provide information about the cervical cancer screening status of participants in cohort 1",
        "label": "Contradiction"
    },
    "bfee9542-f923-4084-a92d-216413a99395": {
        "text_answer": "No   Explanation   The statement the primary trial and the secondary trial do not use",
        "label": "Contradiction"
    },
    "b126d49e-2ab0-4bb9-8677-b3662b784e0d": {
        "text_answer": "Irrelevant  Explanation The statement cohort 1 of the primary trial receives higher",
        "label": "Entailment"
    },
    "f435b92a-cceb-404d-a485-da95bb2189ec": {
        "text_answer": "  No The statement about an individual feeling as though they have to strain to produce voice is not related to the inclusion",
        "label": "Contradiction"
    },
    "81cad78a-c25f-4aab-ae6f-aee9f21e0c01": {
        "text_answer": "Yes The statement does not directly relate to the interventions mentioned in the evidence but the evidence does not contradict the",
        "label": "Entailment"
    },
    "2e22a621-745f-422e-a66e-2a85f8ff1a25": {
        "text_answer": "No  Explanation The evidence provides the percentage of subjects who experienced recurrencefree survival but it",
        "label": "Contradiction"
    },
    "bf41ff3e-3801-4cb7-8e09-0400100a4010": {
        "text_answer": "Yes  Explanation The statement Ascites was more common for patients in the primary trial",
        "label": "Entailment"
    },
    "c08cf531-fbbe-4ec3-ae13-f10d13368a82": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions a",
        "label": "Contradiction"
    },
    "c696105a-b6a3-4d13-9410-2b3f05346f96": {
        "text_answer": "No  Explanation The statement the second cohort of the primary clinical trial has 7",
        "label": "Contradiction"
    },
    "d8079e7e-45eb-4387-a0e3-eb0777802644": {
        "text_answer": "Yes The primary trial and secondary trial measure different outcome measures The primary trial measures the percentage of participants with treatmentem",
        "label": "Entailment"
    },
    "a2d03d44-c447-45d2-932e-efe3694a8940": {
        "text_answer": "Yes  Both interventions in the primary trial include trastuzumab Herceptin",
        "label": "Entailment"
    },
    "b1d81c75-d076-45f3-8de6-6a23fc4f3832": {
        "text_answer": "No   Explanation   The statement pituitary neuroendocrine tumor",
        "label": "Contradiction"
    },
    "2e64e934-f058-4730-af09-ddf7547a0112": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "79162d9d-6591-44ef-aaea-4bd58c4811da": {
        "text_answer": "No   Explanation  The evidence describes the dosing schedule for vorinostat and radiation",
        "label": "Contradiction"
    },
    "da24c082-7e08-4ed0-b72c-ee85098d7b3a": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not support the statement that the Na",
        "label": "Contradiction"
    },
    "193ae24d-ca9a-4bd6-8a98-279c75d32c9b": {
        "text_answer": "Yes  Explanation The statement there were three cases of shingles reported is entailed by",
        "label": "Entailment"
    },
    "accef831-f126-4f90-bc47-182fd9699098": {
        "text_answer": "No  Explanation The primary trial does not exclude patients with a history of major surgery within 28",
        "label": "Contradiction"
    },
    "9eee5184-a09a-41a2-b031-a7ea1863c5ce": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trials second cohort four different",
        "label": "Entailment"
    },
    "f12a3e2a-478e-4104-8f1a-c2d72efab4a3": {
        "text_answer": "No  Explanation The statement double is a twofold increase is not directly related to the",
        "label": "Contradiction"
    },
    "99e16f2b-e690-4684-9dff-cf37877c796c": {
        "text_answer": "No  Explanation  The evidence provided in the clinical trial outcome measurement describes the number of participants who",
        "label": "Contradiction"
    },
    "3caa266c-8ad2-4297-8de5-c65b78e94fd1": {
        "text_answer": "No  Explanation The evidence only mentions the phases and the negative or positive status for HER",
        "label": "Contradiction"
    },
    "97e4a19d-31b9-476a-b8d3-707f817283e1": {
        "text_answer": "Yes The evidence does not mention any vaccines being administered to the participants in the primary trial",
        "label": "Entailment"
    },
    "fdc23b5d-a94a-4aa3-bb87-38d7f2c0102c": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "6b531884-77d9-4cdc-bab7-324596ec998e": {
        "text_answer": "No  Explanation The primary trial does not provide information about the dosage of dexmedet",
        "label": "Contradiction"
    },
    "73eb2425-76f4-4868-8c33-0a2dab6af8f6": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial its demonstrated that the",
        "label": "Contradiction"
    },
    "e504c08b-c348-4307-9cfe-d20f7003ec15": {
        "text_answer": "No  Explanation  The statement There were no patients with recorded Aes in the primary trial",
        "label": "Contradiction"
    },
    "5f33e3b5-efa2-407c-9409-383024b8c652": {
        "text_answer": "Yes The evidence states that patients with histologically proven DCIS are eligible for the trial",
        "label": "Entailment"
    },
    "7bbb79b9-9550-4a8b-a0a8-3af8ece50e04": {
        "text_answer": "Yes  Explanation  The statement pericardial effusions were more common for patients in",
        "label": "Entailment"
    },
    "85f5396f-e7f8-4697-95d2-67b82d43fce4": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as both cohorts receive the",
        "label": "Contradiction"
    },
    "71c0cfa6-88a6-4efa-8204-7252f6e6ef57": {
        "text_answer": "Yes The evidence mentions that the interventions are administered through different routes IV and subcutaneous injection but",
        "label": "Entailment"
    },
    "a2408386-b61c-4cce-9c71-befb482270e0": {
        "text_answer": "Yes The evidence provided does not include information about the count of participants with treatmentemergent adverse events as the",
        "label": "Entailment"
    },
    "bd4ef9b9-41e1-47cb-b8bd-eb0dfe32badf": {
        "text_answer": "No   Explanation   The statement poorly differentiated angiosarcoma",
        "label": "Contradiction"
    },
    "12ca4131-cbd9-45e4-8738-7ec607080cbe": {
        "text_answer": "Yes based on the given evidence none of the 49 participants with HER2primary breast cancer developed imag",
        "label": "Entailment"
    },
    "1a80bab2-1079-4730-bba6-b8414e4cfcc8": {
        "text_answer": "No The statement is not entailed by the evidence as the young female with PRpositive and HER2",
        "label": "Contradiction"
    },
    "1c57cb03-2d38-4b0e-a4b1-cda77a609a9e": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes candidates with an ECOG score",
        "label": "Contradiction"
    },
    "397ae58e-dc5b-4c06-b8ce-29215ed5bcb9": {
        "text_answer": "No  The statement is not entailed by the evidence as coronary artery stenosis is not mentioned in the",
        "label": "Contradiction"
    },
    "812d038b-d9c4-457d-8527-ed43ee902202": {
        "text_answer": "Yes  Explanation The evidence states that there were a total of 12 participants analyzed in the",
        "label": "Entailment"
    },
    "36debc88-2f09-4ae8-9a37-5bee270f5f8c": {
        "text_answer": "Yes The evidence does not provide information about the number or duration of treatment cycles for partial breast irradiation in the intervention",
        "label": "Entailment"
    },
    "49cccbde-abb6-45a4-80ba-47dcdd6b760e": {
        "text_answer": "Yes The primary trial exclusion criteria include significant cardiovascular impairment and the secondary trial exclusion criteria include",
        "label": "Entailment"
    },
    "95cf915e-97df-4ece-bd27-52a72bb4ed68": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any information about fgf3",
        "label": "Contradiction"
    },
    "5cd9bd06-f069-44f3-9b2b-69d92eecc07a": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial indicates that the average pain intensity score",
        "label": "Entailment"
    },
    "61547cc4-08c1-41c9-94f3-c45ebba67e5b": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial includes patients with Nonsmall cell lung cancer and Small cell",
        "label": "Entailment"
    },
    "ccc4b1dc-30f5-46d4-9251-6bb1dbe514ce": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a significant",
        "label": "Contradiction"
    },
    "5296c4b2-ae8f-4321-abb1-071d8a5e9f50": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "dfdcc220-60e9-4ade-a21a-2dea12500959": {
        "text_answer": "No   Explanation   The primary clinical trial evaluates the toxicity of infusing H",
        "label": "Contradiction"
    },
    "848665ec-85f5-4b64-aa71-ba24195e7463": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "40fc3a97-0a5d-4f19-ba94-7c4668d0538d": {
        "text_answer": "Yes Arimidex is used in Intervention 1 of the primary trial but it is not mentioned in the",
        "label": "Entailment"
    },
    "6688e7ec-6e04-49d3-b3c2-0bfb041297dc": {
        "text_answer": "Yes  Explanation  The statement 500 mg of Fulvestrant is given in",
        "label": "Entailment"
    },
    "067c3f74-9009-45dc-a97a-0de2a17722cc": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only mentions specific therapies that are excluded ",
        "label": "Contradiction"
    },
    "1c3d0ec2-e54e-4b44-9b61-6300e5e2736f": {
        "text_answer": "No  Explanation  The evidence provided describes the inclusion and exclusion criteria for a clinical trial for",
        "label": "Contradiction"
    },
    "871e4e1f-9d73-46d0-9eda-04099b38ea4b": {
        "text_answer": "  Yes  Explanation  The geometric mean percentage change in betaCTX at Week 4 for",
        "label": "Entailment"
    },
    "10b5153d-7bb1-45a0-9765-1df8e3dfbd88": {
        "text_answer": "No  Explanation The statement the appearance of maculopapular rash was a",
        "label": "Contradiction"
    },
    "013a39b4-3f7c-427c-8665-134bf9edc4a5": {
        "text_answer": "No  Explanation The statement mentions 3 total cases of asthenia and 5 total",
        "label": "Contradiction"
    },
    "c1fee61a-1d3e-4d83-a0a9-8360e912714c": {
        "text_answer": "No  Explanation  The statement more palpitations pericardial effusions and",
        "label": "Contradiction"
    },
    "857ea0f3-1f62-417e-93ef-00e121cc3e60": {
        "text_answer": "Yes The evidence states that both groups in the primary clinical trial are not given interventions that include counselling risk analysis",
        "label": "Entailment"
    },
    "2e844546-8fe8-440c-afdd-504e84d4acc4": {
        "text_answer": "Yes  Explanation The statement unlike the primary clinical trial which had no adverse events on",
        "label": "Entailment"
    },
    "50c57a74-1e0e-45fe-8a00-217ff1322d99": {
        "text_answer": "No  The primary trial excludes current smokers while the secondary trial does not mention anything about smoking status",
        "label": "Contradiction"
    },
    "13fb11f0-9307-4576-887c-75896dd7bfd1": {
        "text_answer": "No  The statement is not entailed by the evidence as one participant in the trial did experience a urinary tract infection",
        "label": "Contradiction"
    },
    "dd10e477-9de3-43b9-8db3-5c9661514c5e": {
        "text_answer": "Yes  Explanation  The percentage of participants in the primary clinical trial who experienced adverse events was",
        "label": "Entailment"
    },
    "74302b73-7dad-4eb7-b9f2-757d0508d85d": {
        "text_answer": "Yes The evidence does not explicitly state that candidates undergoing CBT cognitive behavioral therapy treatments will not",
        "label": "Entailment"
    },
    "7664aa4a-a4ae-4fe3-81a0-d977d197fde1": {
        "text_answer": "Yes  Explanation  The statement less than 10 of patients were affected by all",
        "label": "Entailment"
    },
    "8d6af699-f5b7-41c2-a84f-28fa45e648c9": {
        "text_answer": "No  Explanation  The statement the majority of patients in the primary clinical trial experienced headaches",
        "label": "Contradiction"
    },
    "19356a21-1163-41b2-8780-7e8e7c956454": {
        "text_answer": "No   Explanation  The evidence states that there were no adverse events recorded in both trials",
        "label": "Contradiction"
    },
    "b685be77-9c55-4948-99cc-2a249739a233": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "29968695-9fd4-4fce-b2ba-1879f50c8c57": {
        "text_answer": "No   Explanation  The statement in the primary trial there were 3 times the number",
        "label": "Contradiction"
    },
    "7534e96f-f5c9-4adf-a9cb-efa76fd43257": {
        "text_answer": "Yes The statement specifically mentions stomatitis as the adverse event which is consistent with the evidence that stomat",
        "label": "Entailment"
    },
    "f8630eaf-1381-4ba1-ba97-68b86755e0fd": {
        "text_answer": "No  Explanation  The statement the secondary trial has distinct inclusion criterion for potential participants",
        "label": "Contradiction"
    },
    "5ccef9c9-dfe2-465e-8cc4-c6cdc310f74a": {
        "text_answer": "No   Explanation The statement more than 10 patients in the primary clinical trial experienced a",
        "label": "Contradiction"
    },
    "816acfa2-5f8d-4f30-9425-5880f3d72414": {
        "text_answer": "  Yes for claustrophobia No for osteoporosis in the primary",
        "label": "Entailment"
    },
    "eec99f26-cf8e-407d-bb6a-7f9d053fe187": {
        "text_answer": "Yes However its important to note that the statement only applies to the ECOG performance status criterion",
        "label": "Entailment"
    },
    "facb2d1c-1f65-4c84-9c93-209ce87d18a7": {
        "text_answer": "No  Explanation The patient with a primary tumour measuring 33mm in diameter would not qualify",
        "label": "Contradiction"
    },
    "4f89c108-d732-49bd-b21a-c3566400b519": {
        "text_answer": "Yes  Explanation The statement Diarrhoea was more common for the primary trial participants than",
        "label": "Entailment"
    },
    "52f841b6-f451-455e-9ec5-2541cf02bb13": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial indicates that the average pain intensity score for",
        "label": "Entailment"
    },
    "df991d6e-570f-4371-9b5e-00e9f3f4707d": {
        "text_answer": "No  Explanation The evidence provided in the text describes a randomized controlled trial comparing the effectiveness of",
        "label": "Contradiction"
    },
    "41617f3f-76b1-41ca-b7c7-f902f84cd816": {
        "text_answer": "  No Contact dermatitis is not mentioned in the inclusion or exclusion criteria of the primary trial",
        "label": "Contradiction"
    },
    "2a32321e-12f1-453f-b0d4-d0b10b80e293": {
        "text_answer": "Yes The evidence states that patients with any tumor type that has CCND2 amplification are eligible for the clinical trial",
        "label": "Entailment"
    },
    "40535d67-a16d-48eb-932e-3d8d2ff57281": {
        "text_answer": "Yes The primary trial involves more interventions including surgery than the secondary trial which only includes two pharmaceuticals",
        "label": "Entailment"
    },
    "3657b15f-ab73-479c-8b00-c2189fc4d984": {
        "text_answer": "Yes  Explanation The statement several patients experienced the same type of adverse event during",
        "label": "Entailment"
    },
    "63bd708a-66ae-41fc-872d-277417bc2576": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary trial",
        "label": "Contradiction"
    },
    "b03fe494-c036-4988-ae85-d5e548b57aea": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial does have separate inclusion and exclusion criteria for its phases",
        "label": "Entailment"
    },
    "686121cf-e252-49b2-9e46-f4cb6ebac7f8": {
        "text_answer": "Yes Both trials include women aged 18 and above",
        "label": "Entailment"
    },
    "4246dc90-5b23-4170-8b6a-bd1459f776b9": {
        "text_answer": "Yes The statement does not specifically mention the investigator status but it is not in conflict with the evidence provided The",
        "label": "Entailment"
    },
    "2f57e639-546c-4e7a-b562-77338563d472": {
        "text_answer": "Yes The evidence states that 13 of the participants with HER2 primary breast cancer developed imagable H",
        "label": "Entailment"
    },
    "18c281a1-43bd-47f5-9534-feddfcf0a282": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as both cohorts receive the same",
        "label": "Entailment"
    },
    "a3ae0081-3bd8-408b-b11d-415711be2ddc": {
        "text_answer": "No  Explanation  The statement mllt6 gene rearrangement is a molecular",
        "label": "Contradiction"
    },
    "96a69ac4-9248-4ede-bc27-2f032f0e2294": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial involves multiple injections of dendritic cells chem",
        "label": "Entailment"
    },
    "6e3e407e-901f-443e-9785-d19b184ff462": {
        "text_answer": "Yes The evidence does not report any patient experiencing the most unbearable pain 10 on the scale for ten",
        "label": "Entailment"
    },
    "9827f954-40d9-4b55-bb92-02624a0d6a75": {
        "text_answer": "No   Explanation   The statement Group 2 of the primary trial receives 0",
        "label": "Contradiction"
    },
    "aba3d5b6-63f0-4eaa-a345-2e9624932e9b": {
        "text_answer": "Yes The evidence states that patients with measurable or nonmeasurable disease are eligible for the clinical trial",
        "label": "Entailment"
    },
    "2c4acb3d-7009-4a19-ac0e-703a96740738": {
        "text_answer": "Yes The statement is entailed by the evidence as it specifies that only the intervention arm of the study will view the",
        "label": "Entailment"
    },
    "4128c0f0-7d9f-44e7-ba5a-66919c502fdd": {
        "text_answer": "No  Explanation  The statement negligible or no adverse events were reported in both",
        "label": "Contradiction"
    },
    "f3598d65-2288-40bd-abe1-45eaa69ee03e": {
        "text_answer": "No  The placebo is administered on Day 1 and trabectedin is administered on Day 2",
        "label": "Contradiction"
    },
    "9dd03978-dc7f-4c73-a199-92f7247dbf29": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "57bf60c1-b440-4fa1-854e-91d2947360e3": {
        "text_answer": "Yes  Explanation The statement 300 the number of hepatotoxicity cases",
        "label": "Entailment"
    },
    "996df3c5-d5a6-4cfc-9407-cb9a59388007": {
        "text_answer": "Yes The statement is entailed by the evidence as the educational DVD is specifically mentioned as being shown only to the intervention arm",
        "label": "Entailment"
    },
    "0dd1c6d6-5a35-452e-b058-ea0da7bd9f3a": {
        "text_answer": "Yes Some patients diagnosed with breast cancer may not be eligible for any study groups in both trials due to their specific conditions and",
        "label": "Entailment"
    },
    "a111fa2e-4d53-4b24-8929-ee37b97bed05": {
        "text_answer": "No The evidence does not provide any information regarding the nationality of the participants for either the primary or secondary clinical trials",
        "label": "Contradiction"
    },
    "fbe4e8b0-f258-448d-8926-3ac4757ee020": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the first cohort receives",
        "label": "Contradiction"
    },
    "6ad65d9b-8610-4f09-a760-caedb0a4037d": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not report the number of adverse events",
        "label": "Contradiction"
    },
    "6add1cab-1458-4cca-a419-7bfc5acdc1cc": {
        "text_answer": "No  Explanation  The statement the primary clinical trial does not conduct any drugrelated tests",
        "label": "Contradiction"
    },
    "9020a95d-874e-4bee-97bb-9b31bbcdd50d": {
        "text_answer": "No  Explanation  The statement the patient who exhibited the most extended progression free survival",
        "label": "Contradiction"
    },
    "f0cbb267-5a5b-412e-a474-2ad091a031d7": {
        "text_answer": "No  Explanation  The statement in the secondary trial all patients receive the same 10",
        "label": "Contradiction"
    },
    "b5b61f90-60b8-404f-872e-a58c84dbf43a": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e3629df4-61d3-42e0-af44-62cb2782c5c2": {
        "text_answer": "Yes  Explanation  The statement less adverse incidents took place during the course of the secondary",
        "label": "Entailment"
    },
    "7f7f7885-c57a-42f3-9799-99159d400077": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary clinical trials intervention segment does not provide information on the",
        "label": "Entailment"
    },
    "65a1b098-171e-4a2e-87a7-7d29b4a7d6ba": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "cbf72855-5886-46d7-b084-43cb6f2a0e2e": {
        "text_answer": "No  Explanation The statement presurgical consumption of tamoxifen 2",
        "label": "Contradiction"
    },
    "f0ff3265-a75f-4a9f-8c0e-ff03057647eb": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "584c33f0-3bca-4276-a3f1-2c68e39898ac": {
        "text_answer": "No  Explanation  The statement in the secondary clinical trial a single adverse event impact",
        "label": "Contradiction"
    },
    "d5abfad6-a8c3-409f-b434-33e55c0848cb": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "96e242e7-e1dc-4465-bb90-6f9ef0ab0f2a": {
        "text_answer": "Yes The evidence states that none of the participants in the primary clinical trial are prescribed talazoparib on a",
        "label": "Entailment"
    },
    "bd18948b-345b-48be-a1a0-45c4ee688747": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial does not mention",
        "label": "Contradiction"
    },
    "e5a8197e-dc1f-4258-9da2-f530eade84fe": {
        "text_answer": "No  Explanation  The statement feeling nervous anxious or on edge is not related to",
        "label": "Contradiction"
    },
    "dfd33619-98ec-43e0-83c4-a22bae9f1b52": {
        "text_answer": "No  Explanation  The statement millimole per liter per microgram per kilogram per",
        "label": "Contradiction"
    },
    "ad3c8700-e49c-404e-af40-e9329033f2a7": {
        "text_answer": "No  The evidence states that one patient 909 experienced an increase in blood bilirubin levels",
        "label": "Contradiction"
    },
    "6cf2337d-c486-405c-be2b-97c29d8425dc": {
        "text_answer": "No  Explanation  The statement the most common adverse event in the secondary trial was an",
        "label": "Contradiction"
    },
    "5e6797ef-370c-4b35-9e1d-37e694b538a6": {
        "text_answer": "No  Explanation  The statement 25 of patients in the primary trial suffer Increased",
        "label": "Contradiction"
    },
    "52d2dcbc-8b57-43eb-bc12-8b7df8c3d8ba": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "40f8f9a6-a042-4f99-bbd9-5f3c3279045d": {
        "text_answer": "No   Explanation   The statement methotrexate is administered to",
        "label": "Contradiction"
    },
    "475fbb72-9858-40cf-b7f0-50236d032582": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial allows participation of patients irrespective of",
        "label": "Contradiction"
    },
    "9137a91a-d493-42f7-a1e5-9b39928036d6": {
        "text_answer": "Yes The primary trial excludes patients who have received chemotherapy or radiotherapy within 4 weeks prior to entering the study",
        "label": "Entailment"
    },
    "72154344-5c84-49cd-b39e-4010fb73756a": {
        "text_answer": "No   Explanation   The statement for patients with breast cancer eligibility can",
        "label": "Contradiction"
    },
    "ca8c2bae-ba14-4791-b995-e1555696d182": {
        "text_answer": "No  Explanation The statement exposure to gabapentin or herceptin within the last",
        "label": "Contradiction"
    },
    "437a782b-7dc2-4904-ac68-3a532b98f2e2": {
        "text_answer": "No  Explanation  The statement out of the participants 5 had experienced three or more",
        "label": "Contradiction"
    },
    "947b0d76-6214-46c7-ac3c-f5794e0cfcb3": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial does not state the number of participants within each",
        "label": "Entailment"
    },
    "561d1a70-6bd1-42f7-9e2a-73b9622a449c": {
        "text_answer": "Yes  Explanation  The primary trial had one intervention group Pyridoxine and one",
        "label": "Entailment"
    },
    "8601ec47-bccd-45d7-b823-ff39719683e5": {
        "text_answer": "No  Explanation  The evidence provided in the given primary clinical trial results does not entail that",
        "label": "Contradiction"
    },
    "620be964-dbff-4793-a75e-7644f7c57fb5": {
        "text_answer": "No  The evidence does not mention anything about neurokinin1 receptor antagonists being administered to participants",
        "label": "Contradiction"
    },
    "b35e0f7c-9162-4752-98dc-b41bac62e99c": {
        "text_answer": "No  Explanation  The statement in both sections of the primary clinical trial patients reported ad",
        "label": "Contradiction"
    },
    "dea24187-160a-4d6c-a724-e8cb01494d68": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement compares the",
        "label": "Contradiction"
    },
    "cf959db3-df50-4724-a747-413a35bb171b": {
        "text_answer": "Yes The evidence does not mention any use of drugs radiotherapy or CBT in the interventions for phary",
        "label": "Entailment"
    },
    "3cf9b40b-ffa4-4b08-9039-9481c7d6cd76": {
        "text_answer": "No  Explanation  The statement There were more cases of Infection Asymmetry and",
        "label": "Contradiction"
    },
    "52f7d88d-78f0-4e5a-8fb9-e423679f2c61": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial ment",
        "label": "Contradiction"
    },
    "901dac1a-6a67-4883-a883-06c5a91f85c1": {
        "text_answer": "No  The evidence does not indicate that there were over 100 total adverse events in either the primary or",
        "label": "Contradiction"
    },
    "c89ba7c0-93b6-4601-82f0-557aa23f24cc": {
        "text_answer": "Yes The primary trial specifically states that patients must be postmenopausal which excludes children and adolescents",
        "label": "Entailment"
    },
    "18c8db1c-2d31-481b-923d-0415861bd6d6": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary and",
        "label": "Contradiction"
    },
    "8db48a95-bc22-4f5e-b9e3-a50a275481a3": {
        "text_answer": "Yes The evidence states that those with metastatic breast cancer and participating in a taxanebased chemotherapy are excluded",
        "label": "Entailment"
    },
    "4092de53-28a9-457c-91cf-f87f4abf4dc1": {
        "text_answer": " No   Explanation  The evidence provided in the trial results does not support the statement that",
        "label": "Contradiction"
    },
    "f1c2db2e-dc72-4a69-a3b6-a8d846a6f7ee": {
        "text_answer": "Yes The primary trial includes a criterion for vitamin D deficiency but the secondary trial does not",
        "label": "Entailment"
    },
    "16710aab-1003-447f-bf01-7275e653d263": {
        "text_answer": "No   Explanation   The patient described in the statement does not meet the inclusion criteria for",
        "label": "Contradiction"
    },
    "e9639699-8cb1-4b2b-9901-443fedb90158": {
        "text_answer": "No  Explanation  The statement mentions swelling hypothermia and confusion",
        "label": "Contradiction"
    },
    "b6643c69-48aa-452a-91f8-b45c83ccf01e": {
        "text_answer": "No  Explanation The statement Only 2 patients in the primary trial did not have Recur",
        "label": "Contradiction"
    },
    "3df0eb9e-b9d9-4f8b-af9a-2d6259e1ed9c": {
        "text_answer": "Yes The evidence states that laserassisted fluorescence angiography is used for monitoring perfusion at three",
        "label": "Entailment"
    },
    "c667d986-5b21-4855-8f51-109296357a9e": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence indicates that sunitinib and capec",
        "label": "Contradiction"
    },
    "2d7737fc-95e6-4392-8a2e-d896e65ba3e6": {
        "text_answer": "No  Explanation  The statement the primary trial observes less adverse events in total than",
        "label": "Contradiction"
    },
    "e25b66fb-c20a-4868-b2c3-780c859d629b": {
        "text_answer": "No  Explanation  The statement during the primary clinical trial 96 individuals from",
        "label": "Contradiction"
    },
    "7e695451-7e2e-43b4-8762-0ac27fb978b2": {
        "text_answer": "  No  Explanation  The evidence provided does not indicate whether or not the expression pattern of",
        "label": "Contradiction"
    },
    "b5c0af13-187b-4f3f-8e46-c06d2df27d1c": {
        "text_answer": "Yes The statement is entailed by the evidence as fibromyalgia and thalasemic syndromes are",
        "label": "Entailment"
    },
    "73677475-c59f-4327-b231-57cd7136dd94": {
        "text_answer": "No   Explanation   The statement cholelithiasis was a common ad",
        "label": "Contradiction"
    },
    "22401c29-1796-455c-ac34-59d3afb99fe9": {
        "text_answer": "No  Explanation  The statement every participant in group 1 of the primary trial were diagnosed",
        "label": "Contradiction"
    },
    "af3d4568-37c3-4c9b-8b22-38d9e3087754": {
        "text_answer": "Yes The primary trial measures pCR pathological complete response and the secondary trial measures pCR after preoperative",
        "label": "Entailment"
    },
    "7ae95d8e-af13-452e-a4e0-d4ba7c066a9c": {
        "text_answer": "Yes The evidence states that patients with a history of grade 3 or 4 allergic reactions attributed to trastuz",
        "label": "Entailment"
    },
    "18f56de9-cf7d-467a-9e95-ca80d8c651a2": {
        "text_answer": "No   Explanation The statement there was one psychiatric adverse event in the primary trial",
        "label": "Contradiction"
    },
    "2f11c1f5-4e9c-4848-8de1-9df7d4403848": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9229abbd-f6e6-4747-bf4c-7c1257115667": {
        "text_answer": "No  Explanation  The statement did the individual have multiple known primary tumors at initial mel",
        "label": "Contradiction"
    },
    "09ac056f-fdf4-4684-99d2-8581ddc09d3b": {
        "text_answer": "Yes  Explanation  The statement there are 15 shared inclusionexclusion criteria between",
        "label": "Entailment"
    },
    "4a54e780-0828-40c0-9f30-1ed06b66275a": {
        "text_answer": "Yes The statement mentions that two patients experienced doselimiting toxicity which is consistent with the evidence that two",
        "label": "Entailment"
    },
    "3a4198ab-ae79-4200-b073-860b2e86813d": {
        "text_answer": "  Yes for the primary trial regarding pulmonary embolisms and No for the secondary trial regarding breast",
        "label": "Entailment"
    },
    "b200a0d8-1c63-49a2-bf1c-280e9d6a2968": {
        "text_answer": "No  Explanation The statement all ae types in the primary trial affected less than 0",
        "label": "Contradiction"
    },
    "cea1bf06-b100-4328-aee1-638ef92d2784": {
        "text_answer": "No  Explanation  The secondary clinical trial does not report the maximum tolerated dose MTD",
        "label": "Contradiction"
    },
    "3c9c99d8-4604-4de9-98e6-81a675fe0558": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it contains an incorrect",
        "label": "Contradiction"
    },
    "524f9dd3-ec1a-44fa-b440-59eaa49fe204": {
        "text_answer": "No  Explanation  The statement refractory acute myelomonocytic le",
        "label": "Contradiction"
    },
    "f7c36a91-5d42-46b9-b0cb-db7a57d37c04": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial the administration of eribulin to",
        "label": "Entailment"
    },
    "a44a34b5-9f9e-4957-bb5e-5bb7bf834ecc": {
        "text_answer": "No  The statement mentions grade 1 stomal ulcer which is not listed as an exclusion crit",
        "label": "Contradiction"
    },
    "f90e818c-2a5c-44c9-9445-1d34a0c2e551": {
        "text_answer": "Yes The primary trial includes women aged 20 years or older but the secondary trial includes women and men aged ",
        "label": "Entailment"
    },
    "c31609ed-47a9-4a4a-94f1-92757a79033c": {
        "text_answer": "Yes The statement is entailed by the evidence as the trial separates the administration of the pneumococcus vaccine",
        "label": "Entailment"
    },
    "34b41276-f5fe-4adf-8178-808e139d9d52": {
        "text_answer": "  No   Explanation   The statement patients without any evidence of solid tum",
        "label": "Contradiction"
    },
    "a6fa44b8-fb1b-4571-aadd-284cbe4f37d8": {
        "text_answer": "No  Explanation  The statement mold mix antigen ige antibody measurement is a",
        "label": "Contradiction"
    },
    "f2d5970e-568d-40ca-9258-65015ff4a828": {
        "text_answer": "No   Explanation  The statement none of these describe me is not directly mentioned or",
        "label": "Contradiction"
    },
    "45d94eb6-d3a6-47ae-8c80-75fb02520ef2": {
        "text_answer": "No  Explanation  The statement 100 of the participants in group 1 of",
        "label": "Contradiction"
    },
    "a6f84772-606c-4977-87e2-aa4de18ac07a": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "c975a46b-6980-4cc4-886d-674f5f2c6773": {
        "text_answer": "No  Explanation The evidence provided in the clinical trial results indicates that 98 out of ",
        "label": "Contradiction"
    },
    "5e45f9e6-6a4f-4cf6-b24a-8755f700943f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8d6dfb9e-cb56-4746-bdb6-45cbb5aadb03": {
        "text_answer": "yes  Explanation The statement is entailed by the evidence as it correctly summarizes the interventions",
        "label": "Entailment"
    },
    "821e8e07-ec33-4f99-8f6e-6d7d50d23d8c": {
        "text_answer": "  Neutral The statement does not directly follow from the evidence but it is not contradictory either",
        "label": "Entailment"
    },
    "9dcb0637-50ed-4e98-b6e8-fa95fae80471": {
        "text_answer": "Yes  Explanation The evidence states that the dosages of doxorubicin cycloph",
        "label": "Entailment"
    },
    "ee93ea09-f0a8-42ab-880d-8284fe0d716e": {
        "text_answer": "yes but with qualification the statement implies a comparison of the percentage of participants with a decrease in GFS between the",
        "label": "Entailment"
    },
    "ae6c4238-c27f-45c1-92e0-6d1164c6accf": {
        "text_answer": "yes regarding the Ki67 expression change not the vaginal dryness",
        "label": "Entailment"
    },
    "44ff230b-fe8f-44de-9f48-e6ab10e91b68": {
        "text_answer": "Yes  Explanation The evidence shows that the percentage of participants with invasive diseasefree survival events",
        "label": "Entailment"
    },
    "b1f92a23-fa4b-4cf6-9df1-b38794ab00ba": {
        "text_answer": "No  The statement is not related to the evidence provided which pertains to inclusion and exclusion criteria for a clinical",
        "label": "Contradiction"
    },
    "5fbee4f6-43fc-45a7-88c4-3dcd5ff21053": {
        "text_answer": "No  The statement A patient diagnosed with a leptomeningeal carcinoma would not be eligible for",
        "label": "Contradiction"
    },
    "5c5a882c-4840-4e2e-83f8-341283caa359": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "5cc29d9f-f81c-41c0-8a55-a98264f040c7": {
        "text_answer": "No  The statement is about metastatic neuroendocrine carcinoma in general while the evidence pertains",
        "label": "Contradiction"
    },
    "ad6c7a37-2ab2-428a-8ac5-d2462d920c11": {
        "text_answer": "No  The evidence does not specify that the trials are limited to participants from the United Kingdom",
        "label": "Contradiction"
    },
    "af9dbcc2-f6ab-4e1e-aac7-a1f0bccd4d86": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "50e1ebd6-d51b-4e86-9748-a0d97a411b62": {
        "text_answer": "Yes The statement does not contradict the evidence and does not add any conditions related to mental health bodyweight tum",
        "label": "Entailment"
    },
    "d7bcab45-fcd5-46bb-9317-b75573e0373f": {
        "text_answer": "No  Explanation  The evidence provided in the text describes the results of a clinical trial comparing the",
        "label": "Contradiction"
    },
    "5d512914-5625-4734-b828-f20f41ef1a98": {
        "text_answer": "Yes The statement bothered by tingling hands or feet is not mentioned in the adverse events of either",
        "label": "Entailment"
    },
    "fbefc569-ec7c-41d6-9d12-39533f6e0fc2": {
        "text_answer": "No  Explanation  The primary trial describes a treatment cycle length of 21 days not",
        "label": "Contradiction"
    },
    "c5426d56-93e6-435b-8e77-19419e66c3d4": {
        "text_answer": "No  The evidence explicitly states that there should be no meningeal carcinomatosis for a patient to be",
        "label": "Contradiction"
    },
    "7e69da7b-d7e2-4166-ba1c-520947f7b596": {
        "text_answer": "No  Explanation The statement mentions numerous incidences of anaemia and",
        "label": "Contradiction"
    },
    "ff11f88f-a4cb-481e-bf56-afa5c0adda19": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded slightly more total adverse events in its",
        "label": "Contradiction"
    },
    "49f55eb1-1f11-4d89-9888-810dff7b4926": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial patients who received acupunct",
        "label": "Contradiction"
    },
    "5975fc5c-37b0-4c9e-b546-afa0915ba928": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8a308bd1-0164-4734-bdeb-f955327b4314": {
        "text_answer": "No  Explanation  The evidence provided in the text describes the results of a clinical trial comparing the",
        "label": "Contradiction"
    },
    "fc839312-3b01-43e3-8cad-f1107759f462": {
        "text_answer": "No   Explanation   The statement is not directly related to the evidence provided The evidence",
        "label": "Contradiction"
    },
    "7f1d39e0-4892-447d-90b9-b2c672e59c79": {
        "text_answer": "Yes The evidence does not mention anything about mental health bodyweight age or previous treatments being inclusion or exclusion",
        "label": "Entailment"
    },
    "ec8bde60-164e-45f7-819d-84b7af4ff04e": {
        "text_answer": "Yes  The primary trial uses sublingual application of Vitamin B12 while the secondary trial uses oral application",
        "label": "Entailment"
    },
    "0f6d115f-8b84-46cc-a95f-51af051029e3": {
        "text_answer": "No  Explanation  The statement is not directly related to the evidence provided The evidence describes inter",
        "label": "Contradiction"
    },
    "7b5d47fb-446d-481f-9785-3ff8b467fa69": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "86cc51ee-ff9e-4396-9c2a-85feaa52c215": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "a5631fa6-2f92-4be7-a055-4c7b3abcdb4d": {
        "text_answer": "Yes  Explanation The statement recurring patterns of the same adverse event were observed across",
        "label": "Entailment"
    },
    "fb5aff7f-4a77-4300-acc4-99a01a6696d1": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ef6ae88d-2d86-4786-8cec-5fad1c1671b8": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about the percentage of patients who",
        "label": "Contradiction"
    },
    "590f240e-7499-432e-aa3c-f54eda69ed46": {
        "text_answer": "yes but with a qualification the women of childbearing potential WOCBP must use an acceptable",
        "label": "Entailment"
    },
    "3c56fe49-cda1-4f0f-8597-63f1e8d6237c": {
        "text_answer": "No  Explanation  The statement mechanical ventilation required is an indication that a patient",
        "label": "Contradiction"
    },
    "03a73488-c2a3-437c-b4b7-d26832eaafe8": {
        "text_answer": "Yes  Explanation The statement the number of patients who experienced adverse events in different cohorts",
        "label": "Entailment"
    },
    "2c519a1e-668f-4731-941e-21dadeb2031d": {
        "text_answer": "Yes The statement is entailed by the evidence as the participants in each arm of the trial receive different doses of chem",
        "label": "Entailment"
    },
    "a6718ad8-0ba6-4513-aae0-92610b1421e6": {
        "text_answer": "Yes  Explanation  The statement there are no cases of bronchopneumonia and general",
        "label": "Entailment"
    },
    "28b11be9-1e77-49c5-8cd2-fb9a95a35b58": {
        "text_answer": "Yes  Explanation The statement does not directly mention the use of pIHGC or GP in",
        "label": "Entailment"
    },
    "1624bc79-6ba3-449b-afd6-0234b760664e": {
        "text_answer": "Yes The statement that Any patients that have undergone Antineoplastic chemotherapy Androgens Est",
        "label": "Entailment"
    },
    "45571dd6-2532-4086-af29-0b8558423b26": {
        "text_answer": "No  Explanation  The statement patients with confirmed stage 1 and 2 breast ad",
        "label": "Contradiction"
    },
    "0f4882ae-b6f3-4c11-b4ad-a3fc1aeb6f94": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence provides the inclusion and excl",
        "label": "Contradiction"
    },
    "b586fc1f-656e-477b-89d5-84aa4cb55814": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly reflects that no adverse events of type 1 were recorded",
        "label": "Entailment"
    },
    "985e4878-0637-4b32-a96f-626ff2f7cbd4": {
        "text_answer": "No  The statement preoperative iv antiemetics were administered does not necessarily mean that preoperative",
        "label": "Contradiction"
    },
    "e0983a0e-1008-4845-bc61-082077d3d3d3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only reports a",
        "label": "Contradiction"
    },
    "57c87de4-06c1-4d6f-9ed8-ed09e82cd3c7": {
        "text_answer": "No  Explanation  The statement significant differences were observed among the groups participating in the",
        "label": "Contradiction"
    },
    "138e64ea-8b97-4101-b3cf-2b808a8dbc88": {
        "text_answer": "Yes The evidence states that there were no reports of increased pleural effusion in cohort 2 of the primary",
        "label": "Entailment"
    },
    "c43d1ac6-f3d2-44f6-870d-fb91f3365c5b": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not include information about Treatment Emer",
        "label": "Contradiction"
    },
    "2e2e15a3-327e-4c79-9ad2-f7978f4f7cdf": {
        "text_answer": "No  Explanation  The statement The Paclitaxel Plus Bevacizumab Plus",
        "label": "Contradiction"
    },
    "4d5b9d90-2c58-499e-8943-eacac7580eb1": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it introduces a new topic",
        "label": "Contradiction"
    },
    "3ed3f0f5-20e7-4cd1-8c4c-79ba7603fb85": {
        "text_answer": "  No the statement about t113 is not directly related to the inclusion or exclusion criteria",
        "label": "Contradiction"
    },
    "ee049505-21d4-4255-823c-10d79a91db59": {
        "text_answer": "Yes  Explanation  The statement adverse events were experienced by less than 10 participants",
        "label": "Entailment"
    },
    "b0b151a2-65f7-476a-9a2a-915bd963516d": {
        "text_answer": "Yes  Explanation The statement several participants in the primary clinical trial developed a urinary tract",
        "label": "Entailment"
    },
    "de3550b8-5014-4f01-897e-07780353ec9a": {
        "text_answer": "No  Explanation  The statement the occurrence of biliary colic and clostrid",
        "label": "Contradiction"
    },
    "0a068f7d-0892-428d-889b-153d579cba78": {
        "text_answer": "No  Explanation The primary clinical trial is for postmenopausal women with early stage breast",
        "label": "Contradiction"
    },
    "1917f075-87da-430b-adf7-bb1579d145fb": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f891df0b-cb3d-4ee8-8294-f139ecc8a018": {
        "text_answer": "No  Explanation The statement 102 of the primary trial participants with pr primary",
        "label": "Contradiction"
    },
    "ff9b4b7a-e2c7-470d-9a7f-6f2b9669da64": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "77b0fb73-3157-4ceb-a366-7ae4f143e2b3": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "4dc8e4d2-0265-4de1-98df-bcfb33c044e3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the secondary trial does not",
        "label": "Contradiction"
    },
    "1ddf526c-beb2-43e1-846e-a133e321a66a": {
        "text_answer": "Yes The evidence does not explicitly state a life expectancy requirement but the exclusion of patients with a history of adj",
        "label": "Entailment"
    },
    "587623da-f061-478f-8196-ce7ec5558d5c": {
        "text_answer": "Yes The primary trial does not report the percentage of participants with tumor response experiencing clinical benefit using RECIST criteria",
        "label": "Entailment"
    },
    "a785048d-15ef-4c72-9d18-6c1db1df2620": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results only reports the number of participants in",
        "label": "Contradiction"
    },
    "8d502fe8-e084-480e-94ee-30ce69aca083": {
        "text_answer": "No  Explanation  The statement all ae types in the primary trial affected fewer than ",
        "label": "Contradiction"
    },
    "a1537e33-5b8e-4e7e-a18f-09fc3c436094": {
        "text_answer": "No  Explanation  The statement the primary trial treats one of its patient cohorts with",
        "label": "Contradiction"
    },
    "a83e8ca3-620b-47ab-a47b-3fc1fc4038c2": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "1824af8a-6f79-49bd-8df3-5751b1e65adb": {
        "text_answer": "No  Explanation The statement Women of childbearing potential and Sexually active fertile",
        "label": "Contradiction"
    },
    "82d23e4a-cdf8-4ab4-b2fa-7ea99d98d5a4": {
        "text_answer": "yes The statement mentions conditions that are exclusion criteria for the secondary trial which are also listed in the evidence",
        "label": "Entailment"
    },
    "c258ef31-d79a-4ddd-b3c0-81742b7f632f": {
        "text_answer": "Yes  Explanation The statement the secondary clinical trial has a higher incidence of biliary colic",
        "label": "Entailment"
    },
    "5c7eee11-ee31-4adf-b2e6-8fe51a39a13b": {
        "text_answer": "No  Explanation  The statement 561 more participants in the dalotuz",
        "label": "Contradiction"
    },
    "9006f1c5-2818-4edf-85e4-77d532b10820": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "33472836-f751-4de3-8b21-92e2d9e3d7ed": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts receive the same dosage and frequency of Dox",
        "label": "Entailment"
    },
    "c5b0eaf3-50c0-4115-8da5-91af0310a7b2": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "beae10d7-7132-4875-8bc6-4e996d20eb90": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only reports the percentage change in betaCTX",
        "label": "Contradiction"
    },
    "c5a5aed2-c471-41a4-940c-9fa644e5a9fc": {
        "text_answer": "No  Perjeta pertuzumab is mentioned in the secondary trial as a potential novel radiotr",
        "label": "Contradiction"
    },
    "2de24fb7-9ebe-419e-af16-5d9ed2b808ef": {
        "text_answer": "No  The patient described in the statement does not meet the inclusion criteria for the primary trial as they have a life",
        "label": "Contradiction"
    },
    "409e7b50-f5db-4321-9a39-3853131ade7d": {
        "text_answer": "No  Explanation  The statement a quarter of the participants are witnessing worsened ple",
        "label": "Contradiction"
    },
    "f1b4c0aa-df9b-4d75-9c65-f06709df664a": {
        "text_answer": "No  The statement a patient with frequent smoking habits is eligible for participation in the primary clinical trial is not ent",
        "label": "Contradiction"
    },
    "1605cfcf-22e5-4a48-a89a-cd7b44e3109f": {
        "text_answer": "No  Explanation  The statement deafness is an inherited or acquired condition characterized by the",
        "label": "Contradiction"
    },
    "7b73381b-500c-4056-9c4c-4334a6e0b9b4": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials use pCR as the outcome measure and there are differences in",
        "label": "Entailment"
    },
    "4a454653-60b6-47dd-a2ba-780d1dfbacaf": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial each patient experienced a unique type",
        "label": "Contradiction"
    },
    "bc9d1c66-4743-474d-9e82-b9e8438a8e86": {
        "text_answer": "Yes  Explanation  The statement the secondary clinical trial necessitates that patients are above a",
        "label": "Entailment"
    },
    "eada8d1a-7396-44e7-8f30-03814c7479fb": {
        "text_answer": "  No  Explanation  The statement there were no lesions found on any of the",
        "label": "Contradiction"
    },
    "c80808f0-b1fd-45e1-99b4-154860b05038": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not include any information about immun",
        "label": "Contradiction"
    },
    "ae6b9c00-10a6-437a-a83b-b46fce724269": {
        "text_answer": "Yes  Explanation The evidence shows that there were 5 participants in the placebo group who were analyzed",
        "label": "Entailment"
    },
    "41e9e8e9-6fec-49fa-ae36-7daa737de66c": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial requires",
        "label": "Contradiction"
    },
    "171827b1-29bc-4e7b-a70a-3d03d4ae7dad": {
        "text_answer": "Yes  Explanation The statement the differences between interventions 1 and 2 of the primary",
        "label": "Entailment"
    },
    "2107eaac-f0e5-47a2-a7cb-b6d27aa47d23": {
        "text_answer": "No  Explanation  The statement all candidates in cohort 1 of the primary clinical",
        "label": "Contradiction"
    },
    "d478ad25-2445-48f1-9308-2d6025dfead2": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not directly support the statement about a patient",
        "label": "Contradiction"
    },
    "9e3d3c08-d9ee-449d-b4c8-957d666315a1": {
        "text_answer": "No  Explanation  The statement no aes were observed in patients from the secondary clinical trial",
        "label": "Contradiction"
    },
    "ad2ac39b-960a-463d-b3ab-955916e20a97": {
        "text_answer": "No  Explanation The statement each group from the secondary clinical trial takes 500 mg of",
        "label": "Contradiction"
    },
    "20307fc02-18bb-4910-9992-43a811bf7a1f": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not support the statement that ",
        "label": "Contradiction"
    },
    "3b940a21-1adf-4820-a178-9517bb60d6f0": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "38ea3ca5-d5b1-4432-b6f6-52e8ca0d3e41": {
        "text_answer": "No  Explanation  The evidence provided in the results does not allow for a direct comparison of the",
        "label": "Contradiction"
    },
    "428f149b-1b45-4ad0-a5d3-0c885fec2767": {
        "text_answer": "Yes  Explanation  The statement the intervention provided in the secondary clinical trial reports on the M",
        "label": "Entailment"
    },
    "6204ed3f-bad3-4db0-8db9-9f73efd78e8f": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the evidence only reports the",
        "label": "Contradiction"
    },
    "38da1202-fb8c-46d0-9779-db075423a422": {
        "text_answer": "Yes  The statement is entailed by the evidence as it correctly describes the patient characteristics for each cohort in the",
        "label": "Entailment"
    },
    "85bde7b9-9e2e-41e1-a8d5-9ff85e8900e6": {
        "text_answer": "No  Explanation  The statement thoracic surgery is a branch of medicine dealing with",
        "label": "Contradiction"
    },
    "3edf7faa-74f7-4d02-bb9b-d5d421f2cca4": {
        "text_answer": "No  Explanation  The statement sdha protein variant is a variation in the amino acid",
        "label": "Contradiction"
    },
    "00539969-3b0f-4c9f-be8a-0ce964c7d5fa": {
        "text_answer": "No   Explanation  The statement is not directly related to the evidence provided The evidence only",
        "label": "Contradiction"
    },
    "12ed5e10-5988-494c-8a88-6e4e30ddd355": {
        "text_answer": "No  Explanation  The evidence provided in the given primary clinical trial does not indicate any information about",
        "label": "Contradiction"
    },
    "cc31b936-223f-4378-9028-315601fba09e": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "e3fd6c0c-a119-4bb5-b82b-366830537c70": {
        "text_answer": "No  Explanation The statement cohort 2 of the primary trial is administered twice",
        "label": "Contradiction"
    },
    "bc7d8745-f12d-4a54-a922-fb72f4bd01f0": {
        "text_answer": "  No the statement is not entailed by the evidence for the primary trial However it is mentioned as a",
        "label": "Contradiction"
    },
    "d46a61dd-b28a-476e-981e-f3d1cca2739c": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial measure different outcome measures The primary trial",
        "label": "Contradiction"
    },
    "7ba72ade-08b1-4062-86f4-2a93ec724780": {
        "text_answer": "No  Explanation  The evidence provided in the results 1 does not give the number of participants",
        "label": "Contradiction"
    },
    "38c5a69a-ad2f-4f2c-b234-74c93e8f6c72": {
        "text_answer": "Yes The evidence states that only the intervention arm of the study will receive the educational DVD",
        "label": "Entailment"
    },
    "a0b10912-a394-4892-88f8-7dfbc771052b": {
        "text_answer": "No  Explanation The statement The patient with the longest PFS in the primary trial survived ",
        "label": "Contradiction"
    },
    "90e07508-8860-4e21-bffe-77d51f0749db": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not mention the number",
        "label": "Contradiction"
    },
    "af3f07a1-e8c0-4ce1-a0b2-5789bca86cd6": {
        "text_answer": "  No the statement severely anxious or depressed is a response indicating that an individual has or had severe anxiety",
        "label": "Contradiction"
    },
    "d3bf6a5f-bce2-47f5-be7a-6c97b2bf88ef": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the first cohort is",
        "label": "Contradiction"
    },
    "d130905f-48af-4f05-9d02-92c980b46c75": {
        "text_answer": "No  Explanation  The statement suramin and paclitaxel are given to every participant",
        "label": "Contradiction"
    },
    "282a33db-aed6-4daa-bea6-299f424914bb": {
        "text_answer": "No  Explanation  The statement over 15 of patients in the primary trial and",
        "label": "Contradiction"
    },
    "f1e9c350-baed-4c5d-a760-b5b8a69e6706": {
        "text_answer": "Yes The evidence does not explicitly state that AfricanAmerican patients are excluded so they are eligible",
        "label": "Entailment"
    },
    "022c87c6-e5c0-4401-92f7-2570af8f8ac1": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence does not provide",
        "label": "Contradiction"
    },
    "4e91cee2-910e-4f08-8a85-1f13545391c3": {
        "text_answer": "No  Explanation The evidence provided in the form of the two interventions describes different groups of participants",
        "label": "Contradiction"
    },
    "7432cb06-a4a3-4f9c-afc8-533e39b7337f": {
        "text_answer": "Yes  Explanation The statement the number of adverse events recorded in the primary trial and the",
        "label": "Entailment"
    },
    "703e6942-968d-4cdf-8e98-45cc571effd0": {
        "text_answer": "No  Explanation  The statement the adverse events section of the primary clinical trial did not",
        "label": "Contradiction"
    },
    "9d7a1491-f931-47dd-9177-72bc90006fd2": {
        "text_answer": "No  The statement prior severe anaphylactic reactions to trastuzumab do not disqualify",
        "label": "Contradiction"
    },
    "d73e5604-bcf0-465f-b147-7ed3cb036e4c": {
        "text_answer": "No  Explanation  The statement rod device is any rodshaped device is not directly",
        "label": "Contradiction"
    },
    "570b88e9-5036-4ea8-80db-0f48696700af": {
        "text_answer": "No  Explanation The statement All the primary trial participants receive higher doses of ALT",
        "label": "Contradiction"
    },
    "141ee099-c8ae-4db1-9082-6fc138ad8093": {
        "text_answer": "Yes   Explanation  Both the primary and secondary trials have a duration of 10",
        "label": "Entailment"
    },
    "0fc55b5a-e5cc-40d1-a0fe-e4ce3ffd8172": {
        "text_answer": "No  Explanation  The statement patients suffering severely from sleep disorders other than insomnia",
        "label": "Contradiction"
    },
    "f8fe88c6-ebd4-49ad-b381-b6017fdaf070": {
        "text_answer": "Yes The primary trial measures changes in serum levels of Follicle Stimulating Hormone FSH",
        "label": "Entailment"
    },
    "dce94e19-6a0a-4fc9-ab35-ad4eb378622b": {
        "text_answer": "Yes The statement is entailed by the evidence as metastatic nonsmall cell lung cancer head and neck cancer",
        "label": "Entailment"
    },
    "1cc9db7e-8214-46cd-bbe3-7ff873be5589": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it introduces an un",
        "label": "Contradiction"
    },
    "fccade16-a6ed-4bc1-b767-d5d1ab20b780": {
        "text_answer": "No   The primary trial evaluates the summed pain intensity differences SPID at 30 minutes",
        "label": "Contradiction"
    },
    "0a279b67-be5a-4f7d-a21b-b178a556f8ae": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial description does not mention anything about H",
        "label": "Contradiction"
    },
    "94ebad4c-4b9c-4fb7-b7cc-a088b46b56f7": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 00",
        "label": "Entailment"
    },
    "1fef627f-f239-4ad3-8bec-4141e2b36dfd": {
        "text_answer": "No  Explanation  The evidence provided in the text does not contain any information about a dele",
        "label": "Contradiction"
    },
    "685d9609-ec5f-4dcb-9783-e9d7b061eaf5": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement is about seg",
        "label": "Contradiction"
    },
    "a9e14c3b-bf03-4ca1-b9d9-4693b231902c": {
        "text_answer": "Yes regarding the changes in lymphedema between the acupuncture and waitlist groups not",
        "label": "Entailment"
    },
    "ec2edea0-23ee-487c-bfbb-ef6fb517e744": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the Karnofsky score requirement",
        "label": "Contradiction"
    },
    "b5cc8685-0fb5-4819-a7cb-960980d95272": {
        "text_answer": "Yes The evidence states that patients must have evidence of a solid tumor that is locally advanced andor metastatic",
        "label": "Entailment"
    },
    "47bb2ffb-2cee-418b-acd6-cdecee318d70": {
        "text_answer": "Yes  Explanation The evidence states that fewer than 50 of participants in",
        "label": "Entailment"
    },
    "7b507eae-bfd5-4546-993b-6dd936ab41e5": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about patients experiencing no pain",
        "label": "Contradiction"
    },
    "02365d25-1a64-4415-aae7-c0254d234fa9": {
        "text_answer": "yes the statement is entailed by the evidence but it is not a perfect match to the given text as the statement",
        "label": "Entailment"
    },
    "8858a62b-91a2-4f2c-a1f1-e54ea15e5861": {
        "text_answer": "No  The statement is not entailed by the evidence as there were no cases of acute myocardial",
        "label": "Contradiction"
    },
    "80140ee4-3ead-44cc-a7a2-b6af0798c1b1": {
        "text_answer": "No  Explanation The statement every patient in the primary clinical trial that received gtx0",
        "label": "Contradiction"
    },
    "6a0bfa75-3e83-4c73-8e5a-2dc4cad866c3": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence states that there is only one adverse event recorded for the",
        "label": "Entailment"
    },
    "3dc3b5d7-3bad-4494-9e97-e6f27bf52c07": {
        "text_answer": "No   Explanation  The statement is not directly entailed by the evidence as the evidence does",
        "label": "Contradiction"
    },
    "ddf4fc68-7920-4212-ac8b-7453ebeb49fb": {
        "text_answer": "Yes The statement is entailed by the evidence as both study groups undergo the same imaging procedures with 18",
        "label": "Entailment"
    },
    "c6a921cd-f18d-4fea-a543-54784444279c": {
        "text_answer": "No  Explanation  The statement across the primary trial multiple deaths were recorded in the ad",
        "label": "Contradiction"
    },
    "99a8a2b3-84ad-4c45-9371-e731cc5942db": {
        "text_answer": "No  Explanation The evidence provided in the primary trial only reports the number of participants with a reduction",
        "label": "Contradiction"
    },
    "414dbb63-9c4c-44e9-96f5-c54b5d341f82": {
        "text_answer": "No  Explanation  The statement patients in both cohort 2 of the primary",
        "label": "Contradiction"
    },
    "f205a6e1-26d3-4a63-bea1-126428af787b": {
        "text_answer": "No  Explanation  The statement the primary clinical trial had a higher prevalence of recurring",
        "label": "Contradiction"
    },
    "cf080a87-de94-4d6b-9d18-89a5f5003316": {
        "text_answer": "Yes  Explanation The statement participants in the primary trial are given a higher weekly dos",
        "label": "Entailment"
    },
    "c4e419c4-f227-4c0c-b8b5-c8e0f62585a7": {
        "text_answer": "No  Explanation  The statement the results from the primary clinical trial suggest that the arm b",
        "label": "Contradiction"
    },
    "18b0cc37-3189-4ea0-970e-81a6b79dba7f": {
        "text_answer": " No   Explanation  The evidence provided in the results does not indicate that any participant in",
        "label": "Contradiction"
    },
    "0c992694-2b3d-4fa1-b822-ecc5f1ceb2e9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the statement is about a different",
        "label": "Contradiction"
    },
    "c640af56-cef3-432a-87f2-b2b446b7ab96": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the secondary trial does not provide",
        "label": "Contradiction"
    },
    "e70d1cc6-b4e5-4fc6-a26f-9b9dd76ef54f": {
        "text_answer": "  Not Entirely  Explanation  The statement not known if 10q",
        "label": "Entailment"
    },
    "0cd83002-1e58-4b84-ac34-e4299d4573ab": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial there were patients who did not",
        "label": "Entailment"
    },
    "fdd9ccc8-95c0-48d9-bc4d-3ef7469dbb9a": {
        "text_answer": "Yes  Explanation  The statement There are no unexpected deaths or Hospitalizations that occurred in the",
        "label": "Entailment"
    },
    "a491bf7b-7327-48cd-ac0f-708a50c385b7": {
        "text_answer": "No  The statement is not entailed by the evidence as the inclusion criteria specify a HER2 positive tumor ",
        "label": "Contradiction"
    },
    "379e6494-403f-4469-9ee4-9e3d12c0d562": {
        "text_answer": "No  Explanation  The evidence provided in the text only reports the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "90c0e27d-dcb3-4014-ae46-b1f4640093b7": {
        "text_answer": "No  The statement is not entailed by the evidence as the number of adverse events is different between the two co",
        "label": "Contradiction"
    },
    "3693ad36-964f-4377-93a3-6137083b22dd": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement about a",
        "label": "Contradiction"
    },
    "f543a317-1f30-46b9-849e-67396ae072de": {
        "text_answer": "Yes Both trials involve oral administration of interventions",
        "label": "Entailment"
    },
    "fae9affd-c763-49c0-ae6d-88852f5774af": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence as the evidence",
        "label": "Contradiction"
    },
    "6e78e878-1154-43b8-b93a-c1b68aef70c8": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that all patients were prescribed sunitinib and",
        "label": "Entailment"
    },
    "89e52784-5ddd-405e-b794-95ef5b5766eb": {
        "text_answer": "No  The statement is not directly related to the evidence provided The evidence discusses interventions used in breast reconstruction and",
        "label": "Contradiction"
    },
    "c4a45d2b-0e4b-4cd2-80ef-176d487d8180": {
        "text_answer": "Yes  Explanation The statement participants in the primary clinical trial experienced diarrhea more",
        "label": "Entailment"
    },
    "396511cd-a922-4ba6-9c33-bc2f20bfdebd": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the operative time of arm",
        "label": "Contradiction"
    },
    "29d8fc44-5636-4633-9651-2d30521a2755": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only gives the median average",
        "label": "Contradiction"
    },
    "fa80610a-3dd0-49e7-97f3-7efbdf636ca5": {
        "text_answer": "No  Explanation  The statement the primary clinical trial recorded slightly more total adverse events among",
        "label": "Contradiction"
    },
    "48fdcfb8-5519-42cd-8496-f8f2e0e38808": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b1774ca3-1bc7-4643-a115-09e813115e9f": {
        "text_answer": "  The statement is not entailed by the evidence for the primary trial as the patient does not meet the minimum bone mar",
        "label": "Contradiction"
    },
    "c389c3cc-2e76-4219-996d-3aa5a925fec7": {
        "text_answer": "Yes  Explanation  The primary trial measures tumor diameter in centimeters cm while",
        "label": "Entailment"
    },
    "f03664fa-20b3-4102-b1e2-fe901d028f65": {
        "text_answer": "No  Explanation The statement women aged 18 or 19 are eligible for the",
        "label": "Contradiction"
    },
    "bfc4e387-9404-498e-903b-5ca9f88dcc3b": {
        "text_answer": "Yes  Explanation  The statement results from the primary trial show that tamoxifen ",
        "label": "Entailment"
    },
    "812ba472-cd7c-410e-9a4c-88dc1795d5be": {
        "text_answer": "Yes The statement does not explicitly appear in the evidence but the ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "a911fcee-0621-4f06-a511-b8323ab8440c": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "55fed266-9982-4062-b7fa-5ec9279441e4": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ee441983-976c-41d7-aa66-19037a3f5f5b": {
        "text_answer": "Yes The statement includes some of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "a079229c-d371-4c18-b2b3-20b0068a4c50": {
        "text_answer": "No  Explanation  The statement there were several instances of shingles in both the primary",
        "label": "Contradiction"
    },
    "ed6b3dc1-1cdb-4da6-ad5c-d5073abd31ea": {
        "text_answer": "Yes The statement does not mention any specific conditions regarding mental health bodyweight age or previous treatments as exclusion",
        "label": "Entailment"
    },
    "2882972d-2466-4eb1-9be2-14f0ebed2102": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement incorrectly",
        "label": "Contradiction"
    },
    "0e3228de-973b-4ce4-9d67-e46392d6f0a6": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the evidence only mentions the",
        "label": "Contradiction"
    },
    "5bdba14a-5c7f-4913-b543-9c791965c237": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median change in lean body mass for",
        "label": "Contradiction"
    },
    "3f5b9c7d-ae3e-4484-88c7-c7562c2f974a": {
        "text_answer": "No  Explanation  The evidence states that 53 out of 60 participants or",
        "label": "Contradiction"
    },
    "13178eb4-e1c0-4fa0-8008-f4a4617220aa": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e928035e-e614-46e3-a3f7-94341043b14e": {
        "text_answer": "No  The statement is not directly related to the inclusion criteria in the evidence provided for the primary or secondary trials The",
        "label": "Contradiction"
    },
    "7074d2ad-2b70-4e46-a617-f49ddbd8588e": {
        "text_answer": "Yes The statement less than 5 of patients in the primary trial suffered from grade 1 psychiatric disorders ",
        "label": "Entailment"
    },
    "cf9d27be-b128-4621-9734-8e9fb3197105": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement makes incorrect assumptions",
        "label": "Contradiction"
    },
    "6528eb91-c678-4508-8d1f-db13bce8d182": {
        "text_answer": "No  The statement does not mention Paraplatin in the context of the trial interventions and there is no",
        "label": "Contradiction"
    },
    "4d824080-17e3-4df5-9ef0-f6b0e3496f31": {
        "text_answer": "Yes  Explanation The statement an increased number of adverse events were reported among participants in coh",
        "label": "Entailment"
    },
    "04a0ccc3-e60d-462a-a31e-802e0f54e1d8": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "cf19cee6-27d6-4d4b-ab20-52e35883d817": {
        "text_answer": "No  Explanation The statement women aged 25 or 30 are eligible for the",
        "label": "Contradiction"
    },
    "b2710f8c-602b-4831-8775-f8df3703761a": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary and secondary trials involve",
        "label": "Contradiction"
    },
    "22a2488f-5559-40e9-a85b-484a1aacd263": {
        "text_answer": "No  Explanation  The statement maculopapular Rash was a common ad",
        "label": "Contradiction"
    },
    "77c7c86b-30a5-487b-8abc-d3aafff69a5e": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 50mg",
        "label": "Entailment"
    },
    "0abf8fc8-9361-4b86-a3ca-fb6bdfbc5b5d": {
        "text_answer": "Yes The statement malfunction only no ae report is a report of a device malfunction that does not",
        "label": "Entailment"
    },
    "a411d500-0770-42d9-8621-ca6b4b63553e": {
        "text_answer": "No  Explanation  The evidence provided does not allow for a direct comparison of the percentage decrease in",
        "label": "Contradiction"
    },
    "cb869aa7-63a3-4a2c-8dd9-2e38496fbaef": {
        "text_answer": "Yes The evidence states that individuals who have participated in another clinical trial within 30 days prior to screening or during the",
        "label": "Entailment"
    },
    "d15bf489-0548-4cbc-b64c-2252a53b5f33": {
        "text_answer": "No  The primary trial and the secondary trial address different patient populations and have different inclusionexclusion criteria The statement",
        "label": "Contradiction"
    },
    "80676e7e-a6bc-4f8e-b50e-888847db5b91": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial only reports the percentage change in betaCTX",
        "label": "Contradiction"
    },
    "cfcd5908-e439-4d01-bd0a-0fcaf3730db8": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "de3bd9a7-c733-43d3-9f7d-3bf3c98a42f9": {
        "text_answer": "No  Explanation  The primary trial administers Botulinum Toxin Type A to Group",
        "label": "Contradiction"
    },
    "6cf62ed7-1dd2-4df0-80f7-979f74b55e72": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial has registered 11 surplus cases",
        "label": "Contradiction"
    },
    "8e2d4c96-5d2f-4710-9333-26d8d1dcb8fb": {
        "text_answer": "Yes  Explanation  The statement primary clinical trial exhibited a lower frequency of recurrent m",
        "label": "Entailment"
    },
    "c0dc65fc-1c17-4594-a168-c9c2da2802b6": {
        "text_answer": "No   Explanation  The statement there was not a single adverse event reported during the",
        "label": "Contradiction"
    },
    "dc4765a3-6168-4594-969b-3ce5ea7dc02a": {
        "text_answer": "No  Explanation  The statement Cohort A and B of the primary trial are administer",
        "label": "Contradiction"
    },
    "bc92cff7-39b3-4088-bb3a-9e61c4d32b8b": {
        "text_answer": "Yes  Explanation The evidence states that Results 1 ArmGroup Title Apre",
        "label": "Entailment"
    },
    "586425fa-eb66-46c1-8792-f7a35c1a5ca5": {
        "text_answer": "No  The evidence does not provide information about hypertension in the primary clinical trial",
        "label": "Contradiction"
    },
    "0d9f0b9b-fc32-413e-ba9b-f8d4e5c1ce4b": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials include patients with ER positive PR positive or HER",
        "label": "Entailment"
    },
    "37bba0bf-5ecd-4007-a2c4-bf9e13dccd2e": {
        "text_answer": "No  The statement is not entailed by the evidence as dasatinib is not mentioned in the evidence at all",
        "label": "Contradiction"
    },
    "696f4947-40d7-4e3d-b64e-9e0fd6c5fbd8": {
        "text_answer": "Yes The evidence does not report any adverse events for cohort 2 and the statement is about non",
        "label": "Entailment"
    },
    "e2e8bb00-df98-49c2-a81b-e18ae21516aa": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the placebo and Allo",
        "label": "Contradiction"
    },
    "6016f882-27d2-47a7-9149-142c9fb17acf": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "895a6e40-efe3-4994-b598-6791eaf90e87": {
        "text_answer": "Yes for the secondary trial assuming the womans other eligibility criteria are met The primary trial elig",
        "label": "Entailment"
    },
    "a7e93d6e-e8d0-4b87-b2a1-be2b821e5a94": {
        "text_answer": "No  Explanation  The statement the paclitaxel plus bevacizumab",
        "label": "Contradiction"
    },
    "d4eb3cf4-eeff-42c3-8036-54ec85061299": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as the evidence does not provide",
        "label": "Contradiction"
    },
    "8be0e7b4-f74d-4205-a543-1247762bb467": {
        "text_answer": "No  Explanation The statement The intervention in the secondary trial lasts 15 more weeks",
        "label": "Contradiction"
    },
    "ed0b5b7f-b257-4b42-8f93-7c908fd071ea": {
        "text_answer": "Yes The primary trial excludes participants who have responded to aromatase inhibitors AI while the secondary trial does",
        "label": "Entailment"
    },
    "a5e9916a-b5de-4fd4-bf78-b1c1e43bc544": {
        "text_answer": "Yes  Explanation The evidence states that both intervention groups received dexamethasone before their",
        "label": "Entailment"
    },
    "f21a1764-d1cc-49cc-b22d-e3d1b99c2233": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence indicates that there are actually 0 adverse",
        "label": "Contradiction"
    },
    "12903135-4650-492b-b2c9-1f5c159af477": {
        "text_answer": "Yes The primary trial does not exclude individuals with a diagnosis of prostate lung or breast cancer and the secondary",
        "label": "Entailment"
    },
    "f896c335-0023-429c-b596-e7a30addbb2e": {
        "text_answer": "No  Explanation  The statement There are more cases of Bronchopneumonia and General",
        "label": "Contradiction"
    },
    "d9cff591-e319-46a0-bc70-a25224cd5b49": {
        "text_answer": "Yes The statement Morbidly obese patients are eligible for the primary trial is entailed by the evidence",
        "label": "Entailment"
    },
    "523d79a3-ee67-4b2a-a1cb-20ed4ed45dc6": {
        "text_answer": "No  Explanation  The statement 492 more Participants in the dalot",
        "label": "Contradiction"
    },
    "1b82cbd2-8f68-4c23-974c-b9ebc4fe52aa": {
        "text_answer": "Yes  Explanation The evidence states that the neoadjuvant therapy consists of epirub",
        "label": "Entailment"
    },
    "7c1aaf25-a7c2-410d-bc13-fe6192698184": {
        "text_answer": "No  The evidence states that there were no adverse events in both cohorts",
        "label": "Contradiction"
    },
    "038fbad1-abee-46f3-90a8-5caee61bae07": {
        "text_answer": "Yes  Explanation The primary clinical trial does not involve the use of MM121",
        "label": "Entailment"
    },
    "f95708f6-04c7-469b-bba1-658c1d6eed45": {
        "text_answer": "Yes The evidence mentions several cardiacrelated adverse events in the primary trial",
        "label": "Entailment"
    },
    "ca22d431-ad09-4f5b-8b27-751c76e704c8": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it introduces new",
        "label": "Contradiction"
    },
    "5c00eee7-bb33-45e5-97c6-4cfc34946cdf": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "df8bb8da-6aec-4678-97f3-cb122188ea9b": {
        "text_answer": "No  Explanation  The statement Cohort A and B of the primary trial are administer",
        "label": "Contradiction"
    },
    "4094d002-a140-4eea-aa50-5005989e2057": {
        "text_answer": "Yes The evidence shows an increase in the percentage of participants who were up to date for colorectal breast",
        "label": "Entailment"
    },
    "9f61fc3f-f0a5-4434-b0a7-cbb0703fe063": {
        "text_answer": "Yes  Explanation  The Contour Profile Tissue Expander intervention in the primary trial does not",
        "label": "Entailment"
    },
    "e2abe23e-d9a8-4329-a41b-26c90266f6d3": {
        "text_answer": "No  Explanation  The evidence provided in the text relates to the results of a clinical trial",
        "label": "Contradiction"
    },
    "3821922a-4d8a-4e54-8381-bb754a78c1ed": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it makes an incorrect assumption about",
        "label": "Contradiction"
    },
    "2f94cda8-a8c2-4fb3-a98d-f7e6e651b6d0": {
        "text_answer": "Yes The statement is entailed by the evidence as it accurately reflects the reduction in Ki67 expression observed in the T",
        "label": "Entailment"
    },
    "5b94573b-9254-48e4-a384-0212f39451a8": {
        "text_answer": "No  Explanation  The statement representative examples of middle ear disorders include infection ch",
        "label": "Contradiction"
    },
    "8a8136f1-9f1d-497e-bb50-44fe94475817": {
        "text_answer": "No  The primary trial includes patients with a breast tumor of 1 cm in diameter while the secondary trial includes",
        "label": "Contradiction"
    },
    "ce7d929e-90d6-4048-8124-e6df1a2f594a": {
        "text_answer": "Yes  The statement is entailed by the evidence as both cohorts use the same instructional CD for paced",
        "label": "Entailment"
    },
    "6fce98e9-e48f-4b14-8a94-37c1ab124eed": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "95354d90-513a-4766-a860-307afa28fb7b": {
        "text_answer": "Yes  Explanation  The statement anemia pneumonia and stupor",
        "label": "Entailment"
    },
    "1d121088-e2ff-4927-a989-d7b5de578714": {
        "text_answer": "No   The primary trial measures the summed pain intensity differences SPID at 30 minutes after",
        "label": "Contradiction"
    },
    "f8457301-53ba-4316-a6a5-36462bf8167c": {
        "text_answer": "Yes The evidence does not explicitly state that patients with a BMI in the overweight category are excluded from the trials",
        "label": "Entailment"
    },
    "dad36f27-f531-458c-a36f-c22182af3771": {
        "text_answer": "  No The statement about people with chronic lymphocytic leukemia or choriocarc",
        "label": "Contradiction"
    },
    "8dd6a2dd-74f9-4bac-af44-c816fd960f74": {
        "text_answer": "Maybe The statement is not directly entailed by the evidence as some of the adverse events listed in the evidence do",
        "label": "Contradiction"
    },
    "16e96301-3e68-453f-82db-f93117edfdfd": {
        "text_answer": "No   Explanation  The statement does not mention anything about paclitaxel or its use",
        "label": "Contradiction"
    },
    "b93384b1-a925-460d-ba66-78967a500d8c": {
        "text_answer": "No  Explanation  The statement intermediate locally aggressive blood vessel neoplasm",
        "label": "Contradiction"
    },
    "1720fcdf-eba7-4ef7-bf37-6445504af807": {
        "text_answer": "No  Explanation  The statement is not directly related to the evidence provided The evidence only comp",
        "label": "Contradiction"
    },
    "67f1754a-420c-4605-a41d-784c4d1e77b0": {
        "text_answer": "Yes  Explanation The statement there was a total of 3 cases of shingles across both",
        "label": "Entailment"
    },
    "2c618027-fde9-4d2f-8552-bc071708d627": {
        "text_answer": "No  The evidence does not support the statement as it documents a total of 1 adverse event resulting in death in",
        "label": "Contradiction"
    },
    "10860cc9-5a8f-4e81-bb2a-42697541e8b0": {
        "text_answer": " No The statement is not entailed by the evidence as the statement mentions ER positive PROGENITOR",
        "label": "Contradiction"
    },
    "eb7d6866-d56b-437c-a48c-78478afdfac8": {
        "text_answer": "Yes  Explanation The statement the secondary clinical trial noted fewer adverse events in its patient co",
        "label": "Entailment"
    },
    "9e5f2149-4cff-4df0-a5d0-4b99ff30fb1c": {
        "text_answer": "  No The primary trial measures changes in pain intensity up to 30 minutes after dosing while the secondary",
        "label": "Contradiction"
    },
    "50b3880d-9a23-42a3-8987-253f0ce999d3": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions involve the same dosages and frequencies of Doxor",
        "label": "Entailment"
    },
    "017ff04d-5509-4f54-863c-10201351e15d": {
        "text_answer": "No  Explanation The evidence does not provide any information about the proportion of participants with Normal Vitamin D",
        "label": "Contradiction"
    },
    "8aca5f0b-c998-4e51-9e53-e23294e61867": {
        "text_answer": "Yes The primary trials Intervention 1 involves IV administration and the secondary trials Intervention 1",
        "label": "Entailment"
    },
    "08049ea6-03f6-457a-b74e-0012e02dc768": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement makes a comparison",
        "label": "Contradiction"
    },
    "38c2a394-f21b-4ae8-8941-aeccf896609b": {
        "text_answer": "Yes The primary trial explicitly states that warfarin is not permitted The secondary trial allows its use under certain conditions",
        "label": "Entailment"
    },
    "f8e8c733-3fc0-4699-814f-b5d505c71435": {
        "text_answer": "yes but it is an incomplete statement The statement correctly identifies a difference between the two cohorts but",
        "label": "Entailment"
    },
    "3a4cc297-6f5a-489c-a841-95e2b3971167": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement is about candidates having colon cancer and being unrespons",
        "label": "Contradiction"
    },
    "807c9531-c049-40a5-a170-3f8924335381": {
        "text_answer": "Yes The evidence does not provide any information about the permanence or transience of arthropathy specifically mentioned in",
        "label": "Entailment"
    },
    "af6ce175-76e3-4d1a-ab77-6c7f3a258580": {
        "text_answer": "Yes  Explanation  The statement cohort 2 of the primary clinical trial reported no",
        "label": "Entailment"
    },
    "aba20d88-1ea5-401e-b155-d1b901dddc77": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary clinical",
        "label": "Contradiction"
    },
    "f47966a1-7067-43a3-9461-11c8ed7b18a6": {
        "text_answer": "No  The evidence indicates that patients in both groups had pain measured on a daily basis for 10 weeks but",
        "label": "Contradiction"
    },
    "6f0485c9-9cb5-4861-9baf-f6a9a9acd975": {
        "text_answer": "Yes  Explanation The statement all participants in the primary clinical trial are subjected to the same",
        "label": "Entailment"
    },
    "aad1e89e-afc2-4999-8cb2-302e0d686331": {
        "text_answer": "Yes  Explanation  The statement since first time questionnaire was answered is a question about the",
        "label": "Entailment"
    },
    "0c03c804-4144-4d84-b740-8f6040f15acc": {
        "text_answer": "No  Explanation  The statement A 20 year old female patient with a Newly",
        "label": "Contradiction"
    },
    "458e3e14-613b-40c5-a62f-5698a7d0c9b0": {
        "text_answer": "yes The evidence shows that the median survival time for both groups is over 2 years but there are some patients in",
        "label": "Entailment"
    },
    "12911f01-5f14-445b-a93a-0cca2cfe9b4c": {
        "text_answer": "No  Explanation  The statement There were no significant differences in the results from the groups in",
        "label": "Contradiction"
    },
    "030afaab-4125-4b2c-ac40-5d7a4cacaf52": {
        "text_answer": "No   Explanation  The statement deep candida infection without candidemia is mentioned",
        "label": "Contradiction"
    },
    "10867d73-4951-42cf-9bdf-2a0f6d27ff10": {
        "text_answer": "No  Explanation  The statement the incidence of ascites and pneumocystis",
        "label": "Contradiction"
    },
    "c09d08df-1042-47ca-9c54-83be4f9f691a": {
        "text_answer": "Yes The evidence does not report any instances of febrile neutropenia or cholelithiasis in",
        "label": "Entailment"
    },
    "90cecb95-9f89-4747-81c3-96545edaf3f4": {
        "text_answer": "No  There are multiple patients who suffered the same type of adverse event eg 3 patients had",
        "label": "Contradiction"
    },
    "0744e505-8c33-48b6-bd82-b201fdcc9679": {
        "text_answer": "Yes The statement is descriptive and does not directly conflict with the information provided in the evidence",
        "label": "Entailment"
    },
    "102bbdcd-14ea-4dd5-a0bb-4cea343bb6ed": {
        "text_answer": "No  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Contradiction"
    },
    "13b40eaf-ad55-439f-9d93-a00a7bee3516": {
        "text_answer": "Yes The evidence does not explicitly state that the trial specifically welcomes AfricanAmerican patients but it does not contain any",
        "label": "Entailment"
    },
    "3611645a-e832-4b38-a1db-9c66aca8baf6": {
        "text_answer": "Yes  Explanation The statement 25 of the patients involved in the primary clinical trial report the",
        "label": "Entailment"
    },
    "8773e9c2-3030-4221-b663-b21d49ae1721": {
        "text_answer": "Yes The primary trial does not report the clinical benefit rate based on RECIST criteria among the participants and",
        "label": "Entailment"
    },
    "eca37c79-e36b-446d-bd9a-4cf546fc9ab7": {
        "text_answer": "Yes for Adverse Events 2 only The statement is not entailed by the Evidence for Adverse Events ",
        "label": "Entailment"
    },
    "460e894b-61c8-4935-bde6-6800b1a440a2": {
        "text_answer": "Yes  Explanation The evidence states that participants in the primary clinical trial would receive multiple injections including",
        "label": "Entailment"
    },
    "6d328d56-d579-4a87-b2bf-e3f3d8bd2c4f": {
        "text_answer": "No  Explanation  The evidence provided in the text does not support the statement that individuals in the",
        "label": "Contradiction"
    },
    "8480a497-4ae7-4d4a-9b19-68667f70dc22": {
        "text_answer": "No  Explanation  The statement most of the reported adverse events were related to blood and",
        "label": "Contradiction"
    },
    "60c5afb6-a250-4e59-bccd-3729a9a97a6b": {
        "text_answer": "Yes   Explanation  The evidence describes two different interventions each with its own administration schedule",
        "label": "Entailment"
    },
    "8af5402d-9065-412b-a7dc-053dfce01c63": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive pembrolizumab twice",
        "label": "Contradiction"
    },
    "52d4cfdf-7677-4f4c-8020-4f5271393df9": {
        "text_answer": "Yes  Explanation The evidence states that patients receive oral lapatinib and oral tamoxifen",
        "label": "Entailment"
    },
    "7d3e5dce-744f-4f7b-81f8-085c7ce2bee0": {
        "text_answer": "Yes with a caveat the statement is entailed by the results for the group receiving ovarian function suppression",
        "label": "Entailment"
    },
    "e6577f53-5752-4fd5-bcfb-2d4f03b2ce60": {
        "text_answer": "Yes  Explanation The median change in lean body mass for the group treated with GTx0",
        "label": "Entailment"
    },
    "d1200239-9391-41b1-a73e-5590855243bc": {
        "text_answer": "No  Explanation  The statement participants in the primary clinical trial are administered higher",
        "label": "Contradiction"
    },
    "5c9e6daf-915c-48b4-b1d4-2e302e0164d4": {
        "text_answer": "Yes  Explanation The evidence states that an overwhelming majority of participants showed a decline in circulating tum",
        "label": "Entailment"
    },
    "c8b6ed79-b613-4ed4-b2ad-2e2ca4f5dcd4": {
        "text_answer": "No   Explanation  The statement no adverse events have been recorded for the patient co",
        "label": "Contradiction"
    },
    "3e96ec18-39ff-46f9-9c67-0b6e70003e24": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions include the same dosages and frequencies of Docetax",
        "label": "Entailment"
    },
    "8fe97ae1-baa6-48ba-a97e-a59585b2b268": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial encountered numerous",
        "label": "Contradiction"
    },
    "d08f5261-afae-42c3-9d0a-39739ae40ccf": {
        "text_answer": "No  Explanation The placebo intervention is provided daily for 81 days the same number",
        "label": "Contradiction"
    },
    "5f4eaa1c-4e83-402c-a1ed-4d398f51ec1d": {
        "text_answer": "Yes   Explanation  The statement multiple drugs are demanded in the treatment protocol of the primary",
        "label": "Entailment"
    },
    "5a7d5563-2920-418c-a2fb-46ada378c860": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "93d37103-4625-42a6-b8a2-7ce2d5673324": {
        "text_answer": "No   Explanation   The statement while the secondary clinical trial allows the participation of patients",
        "label": "Contradiction"
    },
    "58614e8d-770e-4bfe-b74b-e2d429ef072f": {
        "text_answer": "No   Explanation   The statement Perjeta is used in both cohorts",
        "label": "Contradiction"
    },
    "f8a3e02a-d5d0-4a12-9d82-e811f7be3502": {
        "text_answer": "  No the statement is not entailed by the evidence Smokers are excluded from the primary trial and",
        "label": "Contradiction"
    },
    "376c9806-25fd-4b1c-962a-b14c2ca6d9b3": {
        "text_answer": "No  The evidence states that patients with dementia are excluded from the trial Alzheimers disease is",
        "label": "Contradiction"
    },
    "ef637aff-9f52-4e17-a4d7-77e6cdb740c6": {
        "text_answer": "No  Explanation  The statement patients with stage 4 invasive breast carcinoma",
        "label": "Contradiction"
    },
    "dcc038bf-f819-4713-9356-3e966d30291d": {
        "text_answer": "No   Explanation  The statement is not related to the evidence provided The evidence pertains",
        "label": "Contradiction"
    },
    "95aebead-f222-4a09-b0e0-31557235953f": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts half as long as",
        "label": "Contradiction"
    },
    "9eb03f1d-28b2-427e-bbf2-917fcf5ccf74": {
        "text_answer": "No  Explanation  The statement not a single one of the participants in group 1 of",
        "label": "Contradiction"
    },
    "0a1cb41e-a5f8-42ca-bec7-f9bc1291037c": {
        "text_answer": "Yes  Explanation The statement The dosage of Zoledronic Acid in Intervention",
        "label": "Entailment"
    },
    "6c56960a-80c2-40f6-8ba7-8e96a6bdcb98": {
        "text_answer": "Yes  Explanation  The statement both the primary clinical trial and the secondary clinical trial reported all",
        "label": "Entailment"
    },
    "5942877d-3edd-4949-9128-b17a68194753": {
        "text_answer": "Yes based on the given evidence both Arm 1 and Arm 2 had a total of 42 participants each",
        "label": "Entailment"
    },
    "5af06b76-49a3-4342-92ef-2d15ecddc2c7": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial provides the",
        "label": "Contradiction"
    },
    "382c5afb-42ce-4711-90c2-c72f34f03729": {
        "text_answer": "Yes The statement the least frequently reported adverse event across the patient cohorts of the primary trial and the secondary",
        "label": "Entailment"
    },
    "770041f3-701c-4e9f-8df4-5b78a0e4a076": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 003 times",
        "label": "Contradiction"
    },
    "074f66e7-18df-4ee9-a33c-127062dcb51f": {
        "text_answer": "Yes The primary trial has different inclusion and exclusion criteria for its Phase I and Phase II while the secondary trial has",
        "label": "Entailment"
    },
    "22b44925-9577-462a-bf8b-cd3e5ba5ecb1": {
        "text_answer": "No  The evidence mentions adequate liver function as an inclusion criterion but it does not state",
        "label": "Contradiction"
    },
    "edb8f244-cc5e-4cc5-b473-3b93f8640e65": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial did have",
        "label": "Contradiction"
    },
    "97c98ddb-37f4-4e14-82c0-0685e500222c": {
        "text_answer": "No  Explanation  The statement have raw or sore skin is a question about whether an individual",
        "label": "Contradiction"
    },
    "8548c61d-2a2f-4498-a7b8-828adbd9e613": {
        "text_answer": "No  Explanation The evidence states that patients receive 100 mgm2 of lap",
        "label": "Contradiction"
    },
    "506c27c5-380f-41f7-9f90-81d843d7d140": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary trial involves the administration of",
        "label": "Entailment"
    },
    "cbf31ee8-3c01-46f5-9698-f44da41fd1fa": {
        "text_answer": "Yes The evidence states that there were no adverse events in both cohorts making the statement of equal number of",
        "label": "Entailment"
    },
    "14236a59-be4c-4b17-844b-7c26a0650dc8": {
        "text_answer": "No  Explanation  The statement is about the Adverse Events related to Alzheimers",
        "label": "Contradiction"
    },
    "6142265a-a110-42be-b03f-088d346e2389": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 10 times the number",
        "label": "Contradiction"
    },
    "7f832fbe-bf0f-44d1-820f-2398ce83404e": {
        "text_answer": "No  Explanation  The statement none adverse events were observed in the primary trial and",
        "label": "Contradiction"
    },
    "7f17692d-e7de-4365-9da1-83f563fde703": {
        "text_answer": "No  The secondary trial and the primary trial report results from different patient cohorts and different outcome measurements",
        "label": "Contradiction"
    },
    "05530068-7a95-46f6-88d2-84e53ee2ff35": {
        "text_answer": "No  Explanation  The statement General symptoms are the most common AE recorded in the primary",
        "label": "Contradiction"
    },
    "4ae87355-7844-42a5-ad5b-a00c8103d102": {
        "text_answer": "Yes The evidence states that there are 1530 enrollment slots for subjects with metastatic colore",
        "label": "Entailment"
    },
    "f2f2b835-ac2d-43f6-827f-4341fb7d5fd1": {
        "text_answer": "50 or more Yes  Explanation The evidence states that 53 out of ",
        "label": "Entailment"
    },
    "73849f1e-31c6-40c5-ab5c-35d0990ceac2": {
        "text_answer": "Yes The primary trial excludes patients with malignant ductal carcinoma in situ while the secondary trial",
        "label": "Entailment"
    },
    "5933fba5-8565-47ef-a491-1a1531dc1ab3": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts 3 times shorter",
        "label": "Contradiction"
    },
    "80249c01-a69c-490c-ab1f-74ead64dd3df": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial does not report any instances of patients experiencing",
        "label": "Entailment"
    },
    "bb80e4aa-fb7d-4455-8fff-95607f45dab0": {
        "text_answer": "No  Explanation The statement about the perfect match probe is not related to the inclusion or exclusion criteria",
        "label": "Contradiction"
    },
    "f0594802-c304-4dc7-88c8-282554c1e7d7": {
        "text_answer": "No   Explanation  The primary trial administers Vitamin B12 sublingually ",
        "label": "Contradiction"
    },
    "ea0e2918-08bd-4013-9915-66f8fe425e31": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the participants in Arm A received",
        "label": "Contradiction"
    },
    "1357d4a3-909e-4b71-aa5a-ce11869ec91e": {
        "text_answer": "No  The statement is not entailed by the evidence as nausea was not mentioned in the adverse events for",
        "label": "Contradiction"
    },
    "36603238-a220-4848-b9e6-90d61b28eb28": {
        "text_answer": "Yes The evidence states that patients must be assessable for the primary outcome measure which includes having a G8 score and",
        "label": "Entailment"
    },
    "73bc9024-02aa-46b8-913b-c2739a3a66e8": {
        "text_answer": "Yes The primary clinical trial is open exclusively to Japanese female patients while the secondary clinical trial has no such restrictions on national",
        "label": "Entailment"
    },
    "a056e319-f42c-4d3d-80f0-a8348be4eb9d": {
        "text_answer": "  No the statement is not directly entailed by the evidence as the evidence does not mention anything about mllt",
        "label": "Contradiction"
    },
    "65203e16-ff68-4833-9f92-0f63e432c09e": {
        "text_answer": "No  The statement about a suprapharyngeal lymph node is not mentioned in the evidence provided",
        "label": "Contradiction"
    },
    "0af975f2-157a-472d-a30e-9ad614342146": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the statement mentions poly",
        "label": "Contradiction"
    },
    "10a1605b-bfd7-4196-9912-19b28f271ebd": {
        "text_answer": "Yes The primary trial includes a criterion for a primary tumour greater than 2 cm diameter and the statement",
        "label": "Entailment"
    },
    "56d7443e-3522-40e2-bb3a-413fb5edea4e": {
        "text_answer": "No  The evidence does not mention anything about the involvement of a patients first of kin in the final entry determination",
        "label": "Contradiction"
    },
    "fabf3f7a-48df-4940-93e2-8cbe976c4246": {
        "text_answer": "Yes  Explanation  The statement there were 0 cases of Hypertension Edema",
        "label": "Entailment"
    },
    "4229278c-db31-4842-8c04-1d5b30b39037": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it makes an incorrect assumption about",
        "label": "Contradiction"
    },
    "da4a10c9-b04c-4439-84f5-918325786672": {
        "text_answer": "  No  Explanation  The statement individuals who have had severe anaphyl",
        "label": "Contradiction"
    },
    "eaa447d4-2621-47ca-b543-5d1d956fec02": {
        "text_answer": "Yes The primary trial includes patients with severe insomnia as an inclusion criterion while the secondary trial excludes",
        "label": "Entailment"
    },
    "789e28a0-3116-4b32-be0f-807ffce7f552": {
        "text_answer": "Yes The evidence does not provide any information about thyroglobulin antibody status in relation to the interventions but",
        "label": "Entailment"
    },
    "56358f96-8cad-40a1-a59f-4746ebde10d3": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary clinical trial includes detailed participant information for each co",
        "label": "Entailment"
    },
    "b25a8f34-96ce-4ea1-a140-bf5b0ffe7f52": {
        "text_answer": "Yes The evidence states that both intervention and control groups do not receive drugs radiotherapy or CBT",
        "label": "Entailment"
    },
    "fb3c3307-16bd-4454-b8ee-6427743bc1ed": {
        "text_answer": "Yes The statement is a more specific version of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "78aec7ae-20b1-413b-9cb7-9757274ff1aa": {
        "text_answer": "  Yes The evidence states that morbidly obese patients BMI 40 kgm2",
        "label": "Entailment"
    },
    "61e35a8d-77bb-4fef-b9fa-ad0380508fc9": {
        "text_answer": "Yes The evidence shows that there were more participants with stable disease at week 12 12 compared to week",
        "label": "Entailment"
    },
    "9da65ef3-87a1-433d-943b-a2ecc45252e1": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial the ORR demonstrated by the",
        "label": "Entailment"
    },
    "0cff9aa1-3486-4c0c-bda1-8850b3dc932e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "946b0905-73d8-4e13-867f-12ea3c67c52e": {
        "text_answer": "  Yes  Explanation  Both Arm 1 and Arm 2 of the primary trial",
        "label": "Entailment"
    },
    "f48699d6-6352-4c94-9ef3-fe5060d07aeb": {
        "text_answer": "No  Explanation  The statement There were more adverse events observed in the secondary trial than",
        "label": "Contradiction"
    },
    "9d99fc21-4f9a-4c4a-b260-d8c17d1cbdd2": {
        "text_answer": "Yes The evidence does not provide any information about adverse events related to ntrk2 fusion in the given trials",
        "label": "Entailment"
    },
    "469e2131-ef6a-4478-8e87-f785804bf8a4": {
        "text_answer": "Yes  Explanation  The statement over 99999 of patients in",
        "label": "Entailment"
    },
    "e386c5e7-d098-479c-b160-aa3dab13a8df": {
        "text_answer": "yes the statement is about screening status which is the outcome measure in the evidence However the statement does not directly",
        "label": "Entailment"
    },
    "203914a5-0e0b-4e11-a138-6793a23218c8": {
        "text_answer": "Yes  Explanation The statement in the second group of the primary clinical trial there were no",
        "label": "Entailment"
    },
    "2efa0e5d-84cd-4854-9558-6105af976610": {
        "text_answer": "  No   Explanation   The statement patients who have received chemotherapy or",
        "label": "Contradiction"
    },
    "bad9c481-e20c-49a7-b6b6-4e09991419c2": {
        "text_answer": "Yes The primary trial measures pCR pathological complete response and the secondary trial measures pCR after preoperative",
        "label": "Entailment"
    },
    "15ac7da3-01f5-4c67-a59a-d41619758b62": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence mentions adequate liver function as an",
        "label": "Contradiction"
    },
    "84942825-f636-4dcf-af2e-172012c0cc9d": {
        "text_answer": "Yes  Explanation The evidence states that in the primary trial cohort 1 receives ",
        "label": "Entailment"
    },
    "e78805f7-1b81-4cd9-a3c7-591886fd5d70": {
        "text_answer": "Yes  Explanation The evidence states that in the primary trial Intervention 1 Arm A",
        "label": "Entailment"
    },
    "f6ce492e-e69c-4908-9b04-b0234a364e95": {
        "text_answer": "Yes The evidence does not provide any information about the medications specifically being used on chromosome 17p13",
        "label": "Entailment"
    },
    "9bc01b3d-99a3-47bf-9183-012d6686acc5": {
        "text_answer": "No   Explanation The statement there were 100 cases of hypertension de",
        "label": "Contradiction"
    },
    "9bec84f1-9ea0-4a5c-a3d7-b368a302ad4a": {
        "text_answer": "No  Explanation  The statement both the azd0530 175",
        "label": "Contradiction"
    },
    "dd9dfad7-d09d-49d3-ad2d-fe7421d3a8a0": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the number of injections for the",
        "label": "Contradiction"
    },
    "70d381b6-0605-4369-8342-5ee2fb69d878": {
        "text_answer": "Yes The evidence states that patients with histologically proven DCIS are eligible for the clinical trial",
        "label": "Entailment"
    },
    "a263d5ff-4c27-4881-9209-87b1c1d69f94": {
        "text_answer": "Yes The primary clinical trial specifically mentions resistance to aromatase inhibitors AI therapy which is not mentioned",
        "label": "Entailment"
    },
    "a83ed07f-5ce3-44db-83d4-1629e6838c4a": {
        "text_answer": "Yes The primary trial requires mammography as an inclusion criterion but the secondary trial does not list mammography as",
        "label": "Entailment"
    },
    "a3c50e76-dadb-4b34-8245-0fe0de3d19cb": {
        "text_answer": "Yes The statement is about a question asked by a doctor and the evidence does not provide any information about the outcome measures",
        "label": "Entailment"
    },
    "62dbb697-f709-40c2-a4b9-8ed098473bde": {
        "text_answer": "  No The statement is not entailed by the evidence The primary trial includes females with breast cancer while the",
        "label": "Contradiction"
    },
    "c484c0e8-0530-47cb-89dc-da4c4a7f4c0b": {
        "text_answer": "Yes  Explanation  The primary trial is comparing the use of Hydrophor and Medi",
        "label": "Entailment"
    },
    "58726c08-13a9-4168-afc3-14f8e7397f5b": {
        "text_answer": "No  Explanation  The statement a young girl with a Newly diagnosed PRpositive",
        "label": "Contradiction"
    },
    "fea83da0-5960-4547-b662-fe6d139fe3f9": {
        "text_answer": "No  Explanation  The evidence provided in the text only reports the percentage of participants with disease progress",
        "label": "Contradiction"
    },
    "791790a6-187b-4e4b-be5f-9e5304e9ec2c": {
        "text_answer": "No  Explanation  In the primary trial HER2 patients receive a loading dose of",
        "label": "Contradiction"
    },
    "046aa480-39cc-4333-a815-bc4ec3ebfa7d": {
        "text_answer": "No  The evidence describes the inclusion and exclusion criteria for a clinical trial but it does not specify that the trial",
        "label": "Contradiction"
    },
    "73fd9671-363f-4bfa-91ad-1c8bacdf84ef": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "aa9da5b8-f5de-4a49-a93c-9e354cdef066": {
        "text_answer": "Yes  Explanation  The statement no adverse outcomes were recorded in more than 1",
        "label": "Entailment"
    },
    "93381895-c0d3-40d1-96a0-b1aa23f65151": {
        "text_answer": "Yes  Explanation  The evidence provided in the text states that there are no reported results for the",
        "label": "Entailment"
    },
    "286cb14c-39e1-4987-9de2-78de7e78a017": {
        "text_answer": "No  Explanation  The statement out of 73 participants in the primary clinical trial",
        "label": "Contradiction"
    },
    "4a9c4fbc-53cf-4eff-b7ba-37a0f21386b4": {
        "text_answer": "No   Explanation The statement no adverse events were reported in primary clinical trial among any of",
        "label": "Contradiction"
    },
    "9c96be3d-39cf-4c1d-ae87-764621c1e0ca": {
        "text_answer": "No  The statement is not entailed by the evidence as it does not relate to the inclusion or exclusion criteria for",
        "label": "Contradiction"
    },
    "c68e5909-668a-4b35-bf32-815624bf44da": {
        "text_answer": "No  Explanation The statement in the primary clinical trial 150 mgm",
        "label": "Contradiction"
    },
    "dec08a3f-8124-4d8a-b5cf-00231c2b5cec": {
        "text_answer": "No  The statement candidates for the primary clinical trial can have a her2 negative tumor result according to",
        "label": "Contradiction"
    },
    "9645eddb-eb1c-43ca-a899-a35db801217e": {
        "text_answer": "No  Explanation  The primary trial does require written informed consent as an inclusion criterion",
        "label": "Contradiction"
    },
    "af3815c2-6d92-410b-ae62-5552ea998792": {
        "text_answer": "No  Explanation The evidence provided in the trial results indicates that the median overall survival for the mid",
        "label": "Contradiction"
    },
    "8bf215f3-5795-4b6b-b193-354c87bc9496": {
        "text_answer": "No  Explanation The statement at least one patient treated with gtx024 ",
        "label": "Contradiction"
    },
    "76f87500-dd58-4086-9991-90e4f8206abf": {
        "text_answer": "No  Explanation  The statement the primary trial uses a 10 month cycle for its",
        "label": "Contradiction"
    },
    "ffb8a143-9dd7-4e61-8967-b0744c2dfa49": {
        "text_answer": "Yes The primary trial measures changes in pain intensity and the secondary trial measures changes in bone mineral density of the lumbar spine",
        "label": "Entailment"
    },
    "3ed31a8a-dce6-4a6c-b1a6-143db3702546": {
        "text_answer": "No  Explanation The statement mcl1 inhibitor is any agent that inhibits m",
        "label": "Contradiction"
    },
    "1c594930-3c65-42d3-86ed-a0a8f46d369c": {
        "text_answer": "Yes The statement does not mention Febrile neutropenia or Cholelithiasis so the absence of",
        "label": "Entailment"
    },
    "43989f85-a059-4dc7-a805-16e081706b2f": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7ccf8aef-b43b-4d01-9c86-7728378b2aeb": {
        "text_answer": "Yes The statement is entailed by the evidence as metastatic small cell lung cancer is listed as one of the eligible",
        "label": "Entailment"
    },
    "3fd8c503-c6fa-45f1-8836-88a5b77873a3": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "65bc201c-2957-4d21-88f1-05c2413a6e56": {
        "text_answer": "No  Explanation  The statement foxr2 gene rearrangement is a molecular ab",
        "label": "Contradiction"
    },
    "7b71e96e-63ed-43c9-9d9d-5abad0b53d32": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "88148e83-625a-4004-8a2c-e4dec21c73e7": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement is about a",
        "label": "Contradiction"
    },
    "308848e8-55ef-4799-9251-7dc54ddf0ac3": {
        "text_answer": "No  Explanation  The statement less than 10 patients in the primary trial suffered A",
        "label": "Contradiction"
    },
    "d118efb5-ea31-49ca-8e20-686c85081e94": {
        "text_answer": "No  Explanation  The statement Cholelithiasis was twice as common for the",
        "label": "Contradiction"
    },
    "67f9627e-ec2e-49b5-bb2e-2adbb5debfef": {
        "text_answer": "Yes   Explanation The primary clinical trial lasted for 10 weeks while the secondary clinical trial",
        "label": "Entailment"
    },
    "46c9f061-408a-4845-b1ac-01b9c8eb5606": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial reported more",
        "label": "Contradiction"
    },
    "20e22430-cc26-4cc4-b644-30dea07896e7": {
        "text_answer": "No  Explanation The evidence only mentions that Intervention 1 is for TripleNeg",
        "label": "Contradiction"
    },
    "3cbf5587-220b-4759-a93b-8dbd5e144939": {
        "text_answer": "Yes The trial specifically excludes patients with no known brain or CNS metastases and no measurable",
        "label": "Entailment"
    },
    "98300332-951a-4da5-bdd9-42b17fd489b0": {
        "text_answer": "No  Explanation  The statement 33 more participants in the dalotuzum",
        "label": "Contradiction"
    },
    "fd531ca0-8537-4395-abed-00fbc69c00a7": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that candidates for the primary trial must have breast cancer and",
        "label": "Entailment"
    },
    "1ad82f60-7f4e-4e29-967f-c83e64180807": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only reports the",
        "label": "Contradiction"
    },
    "2e9395d7-1b38-4fc4-b0f4-121f89c1cfc2": {
        "text_answer": "Yes Cohort 2 received a half dose of enzalutamide 80 mg compared to",
        "label": "Entailment"
    },
    "a993a4e8-00bf-47c9-95d2-a63d4666658e": {
        "text_answer": "Yes The primary trial uses sublingual administration of Vitamin B12 while the secondary trial uses oral administration of",
        "label": "Entailment"
    },
    "f9759341-1ed2-4e44-8d4d-952bb366892f": {
        "text_answer": "Yes The statement mentions historical data and Adverse Events AEs observed in patients from",
        "label": "Entailment"
    },
    "f5a91b94-a81e-4c40-91df-b144e30df80b": {
        "text_answer": "No  Explanation  The statement primary trial participants never receive epacadostat while",
        "label": "Contradiction"
    },
    "62441471-f329-4540-9d4e-dc34c4d08d59": {
        "text_answer": "No  The statement is not entailed by the evidence The secondary trial includes patients who are ambulatory with a",
        "label": "Contradiction"
    },
    "f77c9775-9421-4d65-8860-c78a684fd886": {
        "text_answer": "No  Explanation  The statement Patients who have received chemotherapy or radiotherapy in the",
        "label": "Contradiction"
    },
    "12c5e376-9a01-4581-9d78-db71f92ef23d": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it introduces new concepts ",
        "label": "Contradiction"
    },
    "11de406a-fdd7-401a-a6b9-0c0b47bdf7f6": {
        "text_answer": "Yes  Explanation  The statement all the AEs recorded for cohort 1 of",
        "label": "Entailment"
    },
    "0d4acb50-cf28-4eb1-bd3f-1511d068e3a1": {
        "text_answer": "No  Explanation  The evidence provides the percentage of participants in each group who demonstrated a decrease in",
        "label": "Contradiction"
    },
    "e6bba244-c154-4143-a5f2-5f8b1c304a97": {
        "text_answer": "No  Explanation  The statement Suspected Serious Adverse reactions were more common in",
        "label": "Contradiction"
    },
    "374ebee5-982e-4ff5-bdf9-49414d417303": {
        "text_answer": "  No   Explanation   The statement women who have claustro",
        "label": "Contradiction"
    },
    "f1b7b902-d67b-489f-9c93-de59c708d2fa": {
        "text_answer": "Yes The primary trial measures adverse events number of participants with treatmentemergent AEs while the secondary",
        "label": "Entailment"
    },
    "002e96b7-152f-4860-b61c-21327c2e6b23": {
        "text_answer": "  Yes the patient meets the inclusion criteria for both trials based on the provided information However its important",
        "label": "Entailment"
    },
    "267240f0-f381-4c67-adf6-3121eea9396d": {
        "text_answer": "No  Explanation  The evidence provided in the given text only mentions the details of two different",
        "label": "Contradiction"
    },
    "4ecece61-2e46-482f-a765-ac677ea3e19c": {
        "text_answer": "Yes The primary trial has different inclusion criteria for different study groups while the secondary trial has the same inclusion criteria for all",
        "label": "Entailment"
    },
    "37df336b-2fc4-4986-957b-5f62219c5bd4": {
        "text_answer": "No  The evidence provided does not mention anything about a cocktail of drugs being administered to participants in the primary clinical",
        "label": "Contradiction"
    },
    "dbffbeee-66da-4e88-8a57-c4d08e214048": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "18395ec3-337c-4e51-aef9-5b91423999ed": {
        "text_answer": "No  Explanation  The statement The results from the primary trial indicate that the Arm A intervention",
        "label": "Contradiction"
    },
    "f7de4d97-31e4-48e0-ab1a-1e3d8a152e8b": {
        "text_answer": "Yes  Explanation The statement Most patients in the secondary trial and the primary trial did not suffer any",
        "label": "Entailment"
    },
    "334b5f86-50c5-4711-994d-31ed67dd4282": {
        "text_answer": "Yes The secondary trial includes women aged 18 or older who are also eligible for the primary trial as long as",
        "label": "Entailment"
    },
    "43ee44cf-35e5-4830-ab1f-d4f040487801": {
        "text_answer": "Yes with the condition that the disease other than ILDPDL is not a malignancy",
        "label": "Entailment"
    },
    "0f31bc6a-a228-49c2-afff-4177ef850272": {
        "text_answer": "Yes  Explanation  The primary trial had 13 participants analyzed while the secondary trial had",
        "label": "Entailment"
    },
    "929ad524-174d-4586-b088-3b512e88bb8f": {
        "text_answer": "Yes  Explanation  The evidence provided in the results shows that none of the participants in coh",
        "label": "Entailment"
    },
    "94b71d5a-37d7-485b-96b7-e0979141893b": {
        "text_answer": "No  Explanation  The statement the first cohort of the primary clinical trial was given",
        "label": "Contradiction"
    },
    "ac0df9a5-d909-40a6-9b57-391fef615fe9": {
        "text_answer": "No  Explanation  The statement both the patients in the primary clinical trial and the secondary clinical",
        "label": "Contradiction"
    },
    "2bd35e15-a310-4660-8963-7f672733bb22": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "3278109c-54b8-4842-8a59-4dae9fac6280": {
        "text_answer": "Yes The evidence does not provide any information about the subject status sequence number but it does not contradict the statement that",
        "label": "Entailment"
    },
    "1d66459b-4624-4ea0-9cda-992c4146a454": {
        "text_answer": "No  The statement is not entailed by the evidence as gabapentin or pregabalin are not mentioned in the",
        "label": "Contradiction"
    },
    "04901c04-5a0e-46cb-8684-96ff864921fe": {
        "text_answer": "  No  Explanation  The patient meets some of the inclusion criteria for the secondary trial",
        "label": "Contradiction"
    },
    "a2ac2860-6f2d-4459-9c8e-748dddcc35e7": {
        "text_answer": "  No   Explanation   The statement patients with a history of breast cancer",
        "label": "Contradiction"
    },
    "8db20184-7510-432f-aa95-c9f2c91326fd": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the evidence does not",
        "label": "Contradiction"
    },
    "489c9279-ebca-4ff2-ae61-c8ff4275f3ac": {
        "text_answer": "Yes based on the information provided in Results 2 all participants in the placebo group experienced emesis",
        "label": "Entailment"
    },
    "7d8d8409-5282-464a-a666-849f3eb36b6e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5bdb26f3-2166-41b4-bc39-a4d78e81d04f": {
        "text_answer": "No   Explanation  The statement is not related to the evidence provided in the primary trial",
        "label": "Contradiction"
    },
    "96aaaf64-1a1e-4a5b-a2db-f99e2c199bec": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the inclusion criteria However the eligibility for",
        "label": "Entailment"
    },
    "7313a53a-9a67-4b81-ad79-4df7d1ced976": {
        "text_answer": "No  Explanation  The statement have pain is not directly related to the adverse events",
        "label": "Contradiction"
    },
    "0de24040-4a99-4f16-8bba-6f2e78018aad": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial armodafinil p",
        "label": "Contradiction"
    },
    "88b8e438-87f4-418b-903a-efe0f5a83882": {
        "text_answer": "No   Explanation   The statement provided is not entailed by the evidence as it contains",
        "label": "Contradiction"
    },
    "c7c9fef0-9243-4cd8-8b8e-e9ab459b7420": {
        "text_answer": "Yes The primary trial measures the effect of sulforaphane supplements on urinary isothiocyanate concentration",
        "label": "Entailment"
    },
    "f22453a4-5cb5-4180-8af7-a9f701d766d7": {
        "text_answer": "Yes  Explanation  The statement cohort 1 of the primary clinical trial has no",
        "label": "Entailment"
    },
    "a8bb394a-d996-4174-8800-a38db8905fce": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because  1",
        "label": "Contradiction"
    },
    "7d78fd1d-3d73-460c-a1b6-c0d9bf3a60a9": {
        "text_answer": "No  Explanation The statement Patients participating in the primary trial receive 100 mg",
        "label": "Contradiction"
    },
    "80e6c613-24ab-4d10-bed6-49388de175d4": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the length of the interventions",
        "label": "Contradiction"
    },
    "5da1c2df-9374-4de9-b43a-c19a03d5652c": {
        "text_answer": "Yes for Phase 1 of the primary trial Maybe for the secondary trial depending on the specific tumor type",
        "label": "Entailment"
    },
    "1a76bce8-07e2-4b30-adc8-3c095f0d62b3": {
        "text_answer": "Yes  Explanation The primary trial involves patients receiving 2 mgkg of trastuzum",
        "label": "Entailment"
    },
    "594df991-cd8d-4ca0-9fe9-5c21a73a0bf3": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c870de83-33d4-4ea6-9482-afe2d7a47480": {
        "text_answer": "No  Explanation  The statement participants of the primary trial are not required to receive",
        "label": "Contradiction"
    },
    "3b8d5e1e-4c1e-4e6e-9890-8851c275cc0f": {
        "text_answer": "No  Explanation  The statement a number of psychiatric adverse events were noted in the",
        "label": "Contradiction"
    },
    "c4487f90-2a8e-4740-9d56-8fedbd7fb044": {
        "text_answer": "No   The primary trial measures the summed pain intensity differences SPID at 30 minutes after",
        "label": "Contradiction"
    },
    "05056fdd-25bc-40ce-831b-e969e95eaa55": {
        "text_answer": "Yes  Explanation The evidence states that unacceptable toxicity was a reason for discontin",
        "label": "Entailment"
    },
    "e2979c27-0eb6-487d-a940-646685e1934b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "857f643d-b77b-4a11-94c7-7e05a7e3b0ef": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial administer",
        "label": "Contradiction"
    },
    "fae264c6-e28a-42ba-9951-f27cdf917815": {
        "text_answer": "  No The statement is not entailed by the evidence as patients with thalasemic syndromes are excluded",
        "label": "Contradiction"
    },
    "5da86b4b-b830-48a4-964d-c20207d55b3a": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as NUT midline carcinoma",
        "label": "Contradiction"
    },
    "ec1b0aa0-0d0b-45b9-9ba5-ad8b941d8647": {
        "text_answer": "  Yes the patient is eligible for both trials based on the provided information However its important to note",
        "label": "Entailment"
    },
    "1b2512ba-9857-4fde-a25b-b4768b1ad748": {
        "text_answer": "No  Explanation  The statement inclusion in the secondary trial requires no restrictions on previous treatments",
        "label": "Contradiction"
    },
    "f5fbfac5-bac3-4852-bb93-b262df8d1418": {
        "text_answer": "No  Explanation  The statement before participating in the primary clinical trial candidates are expected to",
        "label": "Contradiction"
    },
    "91aed56a-2b8e-4f23-9885-4f05e6115537": {
        "text_answer": "No  Explanation  The statement acupuncture patients in the primary clinical trial did not",
        "label": "Contradiction"
    },
    "e299d6fb-d590-417b-a9d3-88ee887d9c00": {
        "text_answer": "No  Explanation The statement several psychiatric issues including an eating disorder and sch",
        "label": "Contradiction"
    },
    "948018b7-b40c-499c-bba8-e835222c3c00": {
        "text_answer": "yes The statement is entailed by the exclusion criteria listed in the secondary clinical trial evidence Patients who have under",
        "label": "Entailment"
    },
    "0e0e3540-9217-435a-89d5-395a9c8af579": {
        "text_answer": "No   Explanation  The statement Neither cohort of the primary trial receives any",
        "label": "Contradiction"
    },
    "b9074beb-a639-46ba-966b-b0db266efffc": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial intervention section does not provide information on the method of administration",
        "label": "Entailment"
    },
    "f8895ab6-dbe2-4715-9567-7dfa9c4d46a8": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b5349f06-8e89-4ff7-966e-00333de8b463": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "5bf68801-c079-469b-a0a9-2a3d6fb379ed": {
        "text_answer": "  No   Explanation   The statement patients with a proven histological or",
        "label": "Contradiction"
    },
    "ecfd2566-6a41-4b0d-be72-eb143c114835": {
        "text_answer": "Yes  Explanation The evidence states that in Intervention 1 the dose of cyclophosph",
        "label": "Entailment"
    },
    "af2a7153-f082-457c-be3e-e6716cdabe0d": {
        "text_answer": "Yes some patients in the GTx024 1mg arm gained lean body mass as indicated by a",
        "label": "Entailment"
    },
    "0790e3ed-6c8e-4b03-8eca-d80fa6296385": {
        "text_answer": "Yes Both interventions use standard gamma probes GP in addition to the handheld gamma camera p",
        "label": "Entailment"
    },
    "dce179aa-b35d-42dd-b97b-4c76f2e4d8b7": {
        "text_answer": "No  Explanation  The statement every adverse event documented during the primary clinical trial was linked",
        "label": "Contradiction"
    },
    "0bd4a2c1-4e4a-4752-a9e8-46a9a27885c1": {
        "text_answer": "No  Explanation  The statement atypical lymphocytes present in bone mar",
        "label": "Contradiction"
    },
    "4f1bafd9-361f-4981-b6fd-46af736141b4": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial intervention section does not provide information on the treatment cycle or",
        "label": "Entailment"
    },
    "98e146d6-bc16-460b-92eb-826ddeb79a3d": {
        "text_answer": "yes the statement is entailed by the evidence in terms of the reported median survival times but it does not directly address",
        "label": "Entailment"
    },
    "328b27ff-4e87-40df-824f-73fb1f01b8a7": {
        "text_answer": "  No   Explanation   The statement all cohorts across the primary clinical",
        "label": "Contradiction"
    },
    "1f630d95-82b5-44fa-8f52-b19f1c9b75bb": {
        "text_answer": "Yes  Explanation  The statement the primary trial recorded lower incident rates of infection asymmetry",
        "label": "Entailment"
    },
    "f102f343-80bc-4df9-87db-125fc783937c": {
        "text_answer": "  No   Explanation   The statement describes a specific genetic mutation egfr",
        "label": "Contradiction"
    },
    "35fb0b2d-39d8-43f9-9e47-aceee416803b": {
        "text_answer": "  Yes  Explanation  The evidence states that 20 out of 35 participants",
        "label": "Entailment"
    },
    "5da3a98b-ffa7-4c54-a340-37986d6dcc20": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 10 times the number",
        "label": "Contradiction"
    },
    "202f56bf-1317-4abc-803d-5ec37cd27624": {
        "text_answer": "No   Explanation   The primary clinical trial and the secondary clinical trial are reporting findings from",
        "label": "Contradiction"
    },
    "2ab5044b-9fa6-45ef-8c99-a2cd5e28f512": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the interventions Allo",
        "label": "Contradiction"
    },
    "8f018706-e70d-4fa5-812c-9c8d57b97f46": {
        "text_answer": "Yes The evidence mentions irregular heartbeat or arrhythmia selfreported or in the medical record",
        "label": "Entailment"
    },
    "d8da21ea-52ef-4b97-8344-6214bd3565b3": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions in",
        "label": "Contradiction"
    },
    "073ce8e6-59a6-41e8-a45f-ca91d19dceec": {
        "text_answer": "No  Explanation  The statement patients presently participating in the secondary clinical trial are also",
        "label": "Contradiction"
    },
    "58ce2166-b909-4442-9118-11b9163fa9b1": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only reports a",
        "label": "Contradiction"
    },
    "61db27bd-2dc4-4c90-8d1e-058f61e1b59a": {
        "text_answer": "Yes  Explanation The statement in intervention 1 of the primary clinical trial the denos",
        "label": "Entailment"
    },
    "e0a61eb2-f5c0-4885-94f5-4048944acd1c": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "e93765e3-d596-4009-8fc0-6d8433f19679": {
        "text_answer": "No  Explanation  The statement all patients treated with gtx024 1",
        "label": "Contradiction"
    },
    "491a1da4-e9c1-43d9-ba9b-9e53d7f601f9": {
        "text_answer": "Yes  Explanation The statement participants in the primary clinical trial are administered epac",
        "label": "Entailment"
    },
    "2312391b-799c-4dcc-9ba4-4b98c9c9642b": {
        "text_answer": "Yes  The statement is entailed by the evidence as trastuzumab is only mentioned as part of intervention ",
        "label": "Entailment"
    },
    "650a33d5-ad44-40c8-a41c-1a4e7a5203b5": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the secondary clinical trial does",
        "label": "Contradiction"
    },
    "63acd7b4-dc08-415b-af25-c09e1db4e913": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial uses",
        "label": "Contradiction"
    },
    "904b8443-c768-449d-81d7-e381dc0e0fb7": {
        "text_answer": "Yes  Explanation The evidence states that both the placebo and trabectedin are given as",
        "label": "Entailment"
    },
    "f06f2517-d0fb-4494-a044-fd626c78187f": {
        "text_answer": "No  Explanation  The statement the total adverse events recorded in patients were the same for",
        "label": "Contradiction"
    },
    "2a05996c-d5fb-4aa8-9654-fb1d27180888": {
        "text_answer": "No  Explanation  The statement Patients in cohort 2 of the primary trial",
        "label": "Contradiction"
    },
    "d9a5cbf6-51ae-4c80-a222-534e7507c7f8": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial the number of cases of he",
        "label": "Contradiction"
    },
    "e60df76f-e6d9-4da1-8fe7-e23c8f38365f": {
        "text_answer": "No  Explanation  The statement Prior treatment with gabapentin or herceptin within",
        "label": "Contradiction"
    },
    "38ca4d41-1f13-4735-983d-9ac5b1b816f0": {
        "text_answer": "No  Explanation  The statement the maximum tolerated dose of mm111",
        "label": "Contradiction"
    },
    "4ed1c5fd-58e5-4fe8-97b1-59ed509ccb10": {
        "text_answer": "Yes  Explanation The statement there are several different instances of cardiac related AE recorded for co",
        "label": "Entailment"
    },
    "99925da5-1a89-471d-b3d9-a3e083fc1bda": {
        "text_answer": "Yes The statement is entailed by the evidence as the number of adverse events was higher in cohort 2",
        "label": "Entailment"
    },
    "10b61f57-c5c1-4d29-9838-bb14c4608bf4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence states that",
        "label": "Contradiction"
    },
    "99d85210-19a0-4256-b092-c3a0f6ef322f": {
        "text_answer": "Yes  Explanation  The statement neutropenia occurred less frequently in patients belonging to co",
        "label": "Entailment"
    },
    "0f5ce689-610f-4522-8082-23df226f2a42": {
        "text_answer": "Yes  Both interventions in the clinical trial include the use of trastuzumab Herceptin",
        "label": "Entailment"
    },
    "d5e071e0-4705-474c-8820-9fbc7b377a8d": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not specify that the secondary clinical trial is limited",
        "label": "Contradiction"
    },
    "4192b30d-92ad-47c4-b88e-8f48ea048ee2": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it incorrectly implies that the",
        "label": "Contradiction"
    },
    "8268f272-c82c-4cc3-87dd-8fdf59611a1c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement is about thy",
        "label": "Contradiction"
    },
    "94849f18-76aa-4fdf-9f7b-2fb1c6b5bc9d": {
        "text_answer": "No  Explanation  The primary and secondary trials have different interventions although they both involve the",
        "label": "Contradiction"
    },
    "1de04bd7-e1e7-42a6-a898-ae626a24b25b": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial revealed a higher percentage change in betactx",
        "label": "Entailment"
    },
    "40123001-b9eb-4d75-aa74-83865de37e70": {
        "text_answer": "No  Explanation  The statement There were more cases of Mucositis Oral",
        "label": "Contradiction"
    },
    "6a119107-7a0d-421f-bfea-3671d97ed082": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly support the statement that the Bev",
        "label": "Contradiction"
    },
    "f32516f0-768d-48db-a449-74ac774abbe0": {
        "text_answer": "No  Explanation  The evidence provided in the trial results indicates that there was a difference in the",
        "label": "Contradiction"
    },
    "f178fb19-cc4a-4f58-b81a-aac7270f154b": {
        "text_answer": "Yes  Explanation The primary trial focuses on massage therapy as an intervention which is a non",
        "label": "Entailment"
    },
    "a7999375-da80-4839-940a-bec673fb119f": {
        "text_answer": "No The statement is not entailed by the evidence as the primary trial includes females of all racial and ethnic origins diagnosed with",
        "label": "Contradiction"
    },
    "a108f3f0-f18c-4bb3-87f1-5a1eee525f71": {
        "text_answer": "Yes  Explanation The statement adverse events spanning a variety of types were evenly",
        "label": "Entailment"
    },
    "fd78876b-0b85-41e3-ad9f-8213dd9484ca": {
        "text_answer": "No  Explanation  The statement treatmentemergent adverse events were experienced",
        "label": "Contradiction"
    },
    "f73ec9f6-b18c-4f32-9116-573f5f717e55": {
        "text_answer": "  No The statement is not entailed by the evidence The primary trial includes patients with a primary tumour greater",
        "label": "Contradiction"
    },
    "452f92e1-27bb-4452-8675-c6409ec6003a": {
        "text_answer": "  No The statement is not entailed by the evidence The evidence states that the minimum age for the primary trial",
        "label": "Contradiction"
    },
    "e0a117a2-c519-46f5-9c31-124234272ce1": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial all adverse event types impacted",
        "label": "Entailment"
    },
    "9bd6ad87-470a-4fa3-9e29-bf5ba8c2b463": {
        "text_answer": "Yes  Explanation The statement 300 the number of hepatotoxicity cases",
        "label": "Entailment"
    },
    "2529171f-85e8-4d19-8023-dc1a28416fa1": {
        "text_answer": "Yes  Explanation  The statement there are 5 shared inclusionexclusion criteria between the",
        "label": "Entailment"
    },
    "254e8b1c-de9f-467b-b32a-a41ee97421b9": {
        "text_answer": "No The statement is an exaggeration of the exclusion criteria in the evidence which only requires that there be no history",
        "label": "Contradiction"
    },
    "5db52328-ebdc-4961-bc21-7776db7d7876": {
        "text_answer": "Yes  Explanation The primary trial states that the first intervention group received Zoledronic Acid",
        "label": "Entailment"
    },
    "5f6cacb7-41e6-4d8c-9a43-7bd21202b11f": {
        "text_answer": "  No the statement about intraoperative urinary injury is not explicitly mentioned in the evidence However it",
        "label": "Contradiction"
    },
    "6b0bc5aa-4540-4439-a2e3-c48abb937074": {
        "text_answer": "No  Explanation  The statement all measured patients within the primary clinical trials group ",
        "label": "Contradiction"
    },
    "d61c1b26-cf05-46e8-a156-a264f562dfa8": {
        "text_answer": "  No The statement is not entailed by the evidence The evidence only mentions that patients who have received chem",
        "label": "Contradiction"
    },
    "a127c618-ace8-46cf-9b52-7655f2ccee9c": {
        "text_answer": "  Yes for the secondary clinical trial children and adolescents are not explicitly excluded based on age in the provided",
        "label": "Entailment"
    },
    "01bff32b-6bba-4295-94e9-c3a8430670be": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "24be42f5-01dc-487e-9ada-39d05b6d4e7e": {
        "text_answer": "Yes The primary trial has a 21day cycle for its intervention while the secondary trial does not mention a",
        "label": "Entailment"
    },
    "d91ee458-d6de-4d45-8511-cabb52d2a64e": {
        "text_answer": "No  The eligibility criteria for the primary trial include specific genderbased requirements such as postmenopaus",
        "label": "Contradiction"
    },
    "37a51d40-4b39-4488-b818-7495917d50a0": {
        "text_answer": "Yes The evidence states that there were 2 participants in the second cohort who experienced doselimiting toxicities",
        "label": "Entailment"
    },
    "ffce31e9-2899-42af-8af0-e24be1ace812": {
        "text_answer": "  No   Explanation   The statement women suffering from only osteop",
        "label": "Contradiction"
    },
    "ffd7717b-fec1-4702-87a6-5345e8efe7ba": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a50ad70a-ff4c-4110-bfff-3fc230c44acc": {
        "text_answer": "No  The evidence does not provide information about the length of time since diagnosis or life expectancy of the patients eligible for",
        "label": "Contradiction"
    },
    "4b6aac05-1130-49c4-b5f6-9afe1227459c": {
        "text_answer": "No  Explanation  The primary clinical trial includes the criterion Male subjects in",
        "label": "Contradiction"
    },
    "b9d16baf-ec50-40da-b2a4-68aa7abf1541": {
        "text_answer": "No  Explanation  The statement mentions multiple deaths and hospitalizations in cohort",
        "label": "Contradiction"
    },
    "8101ccf6-e6f4-43ba-b22f-9a13e2ddd279": {
        "text_answer": "maybe  Explanation  The statement The Paclitaxel Plus Bevacizumab Plus Gem",
        "label": "Entailment"
    },
    "6e5ea627-075c-4b44-9605-4d440735d843": {
        "text_answer": "Yes if the individuals hot flashes have returned and they meet all other inclusion criteria However they should not",
        "label": "Entailment"
    },
    "5c11d673-054f-4db7-a2d4-8c6243b3ba45": {
        "text_answer": "  No the statement is not entailed by the evidence The primary trial has a specific eligibility criter",
        "label": "Contradiction"
    },
    "bca4c94d-4a49-4e05-82ed-0d5c9707685b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "42fc9190-b214-42bf-92fc-3678564083ca": {
        "text_answer": "Yes  Explanation  The statement patients suffering from ascites were less common in the primary",
        "label": "Entailment"
    },
    "827af363-cfd3-4233-9029-e8c7e053c661": {
        "text_answer": "No  Explanation  The statement There were more adverse events observed in the secondary trial than",
        "label": "Contradiction"
    },
    "6515b0ad-cba7-4831-9b96-576faaa284f4": {
        "text_answer": "No  Explanation  The statement the denosumab dosage in intervention 1 of",
        "label": "Contradiction"
    },
    "f886baee-f1c6-4887-8068-5c779c6ebb60": {
        "text_answer": "No  Explanation  The statement the individuals in group 2 of the primary clinical trial are",
        "label": "Contradiction"
    },
    "c51a2098-014f-410c-9722-eaadb298983d": {
        "text_answer": "Yes The statement is entailed by the evidence as there are no reported cases of intestinal obstructions or pancy",
        "label": "Entailment"
    },
    "0bca53f6-c609-4c49-a684-a2d71cff7086": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "197bf729-04f4-46f0-a746-8b55c088f0d6": {
        "text_answer": "Yes  Explanation The evidence states that there was a significant change in Ki67 expression in tum",
        "label": "Entailment"
    },
    "a7f12911-d5b9-4cd0-a3c0-e1fb6ded7512": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial more incidents of palpitations",
        "label": "Contradiction"
    },
    "249d272c-cbee-4395-bb73-7e6cde3a4677": {
        "text_answer": "  Yes for the secondary trial but not without qualification for the primary trial   Explan",
        "label": "Entailment"
    },
    "f43b3f3f-f51c-49ff-b659-b3e97bf0ab0d": {
        "text_answer": "  Yes The statement that patients diagnosed with hypopharyngeal squamous cell carcinoma via polymer",
        "label": "Entailment"
    },
    "cd247253-c2d6-4eb6-be06-90ef855748cf": {
        "text_answer": "No   Explanation   The statement for inclusion in the primary trial candidates are required",
        "label": "Contradiction"
    },
    "ae259f29-2da6-43fe-b89e-345be44688e8": {
        "text_answer": "Yes  Explanation The statement cohort 1 of the primary clinical trial received a higher",
        "label": "Entailment"
    },
    "d1216971-8b18-427a-9f6e-de0fcddec7ea": {
        "text_answer": "  No The primary trial includes Japanese females only while the secondary trial does not specify any gender or nationality restrictions",
        "label": "Contradiction"
    },
    "c99a0652-8f34-49d1-b98b-182553c58dbc": {
        "text_answer": "Yes The primary trial involves a consistent dosage of alpha lipoic acid while the secondary trial involves a graduated increase",
        "label": "Entailment"
    },
    "2d320e21-8fce-4f6f-8bf3-dc68f1cb8b0e": {
        "text_answer": "Yes The statement mentions ureter disorders in a general sense and does not specify whether they are neoplastic or",
        "label": "Entailment"
    },
    "d4045883-595f-4855-83ed-ca175a1d5aea": {
        "text_answer": "Yes The secondary trial had 1 occurrence of intestinal perforation in the primary trial but in the",
        "label": "Entailment"
    },
    "29a26ffe-8fcd-4e93-b354-3ca65738c8e5": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial and the secondary clinical trial reported zero deaths",
        "label": "Entailment"
    },
    "8a532b5a-1468-4de5-83ac-50179edb2ac8": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence reports that 5 out of 25",
        "label": "Contradiction"
    },
    "a4e6bb5b-69f1-451b-b278-0ce9c3e43bdf": {
        "text_answer": "25 number of participants analyzed is not the same as 35 number in the statement Therefore No",
        "label": "Contradiction"
    },
    "a3191a50-4395-4bd8-a57a-5404fcfcd8c9": {
        "text_answer": "Yes The evidence states that individuals with ERpositive breast cancer can participate in the Phase 2 stage of the clinical",
        "label": "Entailment"
    },
    "5de4ae02-a1df-430d-a793-803bfefb7b0e": {
        "text_answer": "No  Explanation  The primary clinical trial focuses on the percentage of participants experiencing any treatment emergent",
        "label": "Contradiction"
    },
    "da18ab3b-cf80-4867-b3b9-0dccf4c523a2": {
        "text_answer": "No  Explanation The evidence provided in the primary trial only reports the median average survival",
        "label": "Contradiction"
    },
    "ae8cf6fd-ab5f-4f34-a135-ea8d0c0c58bc": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "403ad287-6e25-4db0-a66b-fe4a7f15a983": {
        "text_answer": "No  Explanation The patient with a primary tumour of 33mm diameter would not be eligible",
        "label": "Contradiction"
    },
    "0069c252-1e8b-4209-af61-11e6ee9d3c2b": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a significant",
        "label": "Contradiction"
    },
    "1cc18d8f-93f5-474e-9178-833b26150681": {
        "text_answer": "No   Explanation   The evidence provided in the primary trial describes the dosing schedule for",
        "label": "Contradiction"
    },
    "4e5fb5c5-d286-4109-a89b-28f399788cae": {
        "text_answer": "No  Explanation  The statement women aged 18 or 19 are eligible",
        "label": "Contradiction"
    },
    "b95b7438-ec16-4d4d-826d-5891e7982b36": {
        "text_answer": "Yes  Explanation  The statement There are no cases of anorexia hypother",
        "label": "Entailment"
    },
    "66816aea-0de7-486c-b9d4-4ca6d9f09d52": {
        "text_answer": "No  The statement is not entailed by the evidence as the secondary trial does not involve any cancer treatment and has different",
        "label": "Contradiction"
    },
    "587e611a-9c3b-4557-b3ca-56a7dcc6ce1b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "8dd822a1-6d7b-4dca-b3fb-4841442aff93": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not support the statement that ",
        "label": "Contradiction"
    },
    "79923aba-be0b-476d-ae86-733fce590db1": {
        "text_answer": "No  Explanation  The statement Is the statement entailed by the Evidence is not",
        "label": "Contradiction"
    },
    "b2059651-24e7-4b6c-aeee-403ff32cf725": {
        "text_answer": "No  Explanation  The statement Women with Newly diagnosed stage IV breast cancer confirmed",
        "label": "Contradiction"
    },
    "66dff58d-73c8-46c8-afa7-9fe6e1231624": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that there were no cardiac or psychiatric adverse",
        "label": "Entailment"
    },
    "4bd8fa53-08b5-4b80-868a-4b535432f2e2": {
        "text_answer": "No  The statement is not directly related to the inclusion or exclusion criteria for either trial The primary trial mentions",
        "label": "Contradiction"
    },
    "d10a9ae2-cb0c-49e8-924c-906e3f2eb5a5": {
        "text_answer": "No  Explanation The evidence states that women of childbearing potential WOCBP must",
        "label": "Contradiction"
    },
    "db7671cb-a230-402e-beda-738af0753332": {
        "text_answer": "No  The statement is not entailed by the evidence as the patient described in the statement has a life expectancy that",
        "label": "Contradiction"
    },
    "0fa2ee42-3800-49bc-838c-eb3dba41f01f": {
        "text_answer": "No  Explanation  The primary clinical trial includes patients with benign breast disease while the secondary",
        "label": "Contradiction"
    },
    "24b7127a-5d4d-4a7d-b64b-8b2e12396b04": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial specifically includes patients with breast cancer and the secondary",
        "label": "Contradiction"
    },
    "b395d278-bbad-4ba2-af5b-82dc8045482a": {
        "text_answer": "Yes The secondary clinical trial includes patients with diagnosed alterations in one or more of the listed genes",
        "label": "Entailment"
    },
    "9474451f-d601-4dcc-8304-50bc4d3ebf52": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial does not mention anything about previous use of gab",
        "label": "Contradiction"
    },
    "ead18343-9437-4aa4-9bbc-2e20f7c28025": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial reports the",
        "label": "Contradiction"
    },
    "951c2074-2100-4b9f-84e1-adec6a08c61b": {
        "text_answer": "Yes  Explanation The statement during multiple phases throughout the trials the trastuzumab",
        "label": "Entailment"
    },
    "a2fa7138-cba9-4720-91a0-eb12a7356fa2": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not mention anything",
        "label": "Contradiction"
    },
    "04067434-b300-40f1-9e6c-c986b4c602c5": {
        "text_answer": "No  Explanation  The statement hard palate squamous cell carcinoma is a squ",
        "label": "Contradiction"
    },
    "46cd405e-a401-4249-ad26-b48801b2c2c8": {
        "text_answer": "No  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Contradiction"
    },
    "c3503b5e-ef92-4e90-bc0f-5ef7690a5908": {
        "text_answer": "Yes  Explanation  The statement there are no reported cases of asthenia or pyre",
        "label": "Entailment"
    },
    "bcbeb637-d070-400b-a98e-e3380f009b21": {
        "text_answer": "No  Explanation  The statement in the primary trial observations revealed more instances of infection",
        "label": "Contradiction"
    },
    "62ecbc1b-eb8f-43ad-b997-a11c8d36b379": {
        "text_answer": "No  Explanation The evidence states that 13 out of 49 participants 26",
        "label": "Contradiction"
    },
    "00e018a5-5237-498b-8823-f47ac2d2697f": {
        "text_answer": "No  The statement about women suffering from both claustrophobia and IBS not being eligible for either",
        "label": "Contradiction"
    },
    "c5f56599-f5cb-46c4-ac69-e298d37f0883": {
        "text_answer": "Yes The patient with a secondary tumour of 35mm in size detected through MRI would not qualify for either",
        "label": "Entailment"
    },
    "fdc25a44-5f1f-4478-b1f4-78fbb95b112a": {
        "text_answer": "Yes The statement includes some of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "8127d46a-3a48-4173-8d00-75e949755a74": {
        "text_answer": "No  Explanation  The statement Prior treatment with gabapentin or herceptin within",
        "label": "Contradiction"
    },
    "40a16e0a-a4d4-49d0-8423-aa5b43688171": {
        "text_answer": "No   Explanation The statement there were 150 cases of hypertension de",
        "label": "Contradiction"
    },
    "1f10dd13-d27c-4ff0-bcac-67f0da0ac487": {
        "text_answer": "No  Explanation  The statement the primary trial uses the same inclusion and exclusion criteria for",
        "label": "Contradiction"
    },
    "0c72a56a-de46-498d-8706-04c1283bea04": {
        "text_answer": "No   Explanation  The statement cohort a of the primary clinical trial is administer",
        "label": "Contradiction"
    },
    "853967c7-51a1-4e08-88c0-d8e621129176": {
        "text_answer": "yes the primary and secondary trials both use pCR as an outcome measure However the statement does not directly compare the",
        "label": "Entailment"
    },
    "9a324039-2611-4433-821d-588c822c831f": {
        "text_answer": "Yes The evidence states that patients with significant cardiovascular impairment including congestive heart failure clinically",
        "label": "Entailment"
    },
    "849dbfea-186a-4983-b7a3-616679e3f2ec": {
        "text_answer": "  No The statement is not entailed by the evidence as the primary trial measures changes in pain intensity up to ",
        "label": "Contradiction"
    },
    "da01cb99-7533-4cb5-ae01-16453c94cc7e": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence only reports the",
        "label": "Contradiction"
    },
    "25f976a2-8a79-469f-90a3-6b9922382c76": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide information about",
        "label": "Contradiction"
    },
    "cbc96b9d-b39c-4fbe-b8a7-e7df7490881b": {
        "text_answer": "yes with the caveat that the statement specifically mentions PR Primary Breast Cancer while the evidence only ment",
        "label": "Entailment"
    },
    "d7f83dbb-ef9c-455b-a692-e99eefcddb05": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial records no aes as being general symptoms",
        "label": "Entailment"
    },
    "09819b6e-961a-47cf-9112-c43434e9ac19": {
        "text_answer": "No  Explanation  The statement birc5 antibody is any immunogl",
        "label": "Contradiction"
    },
    "0ad73758-1efb-46e4-85e7-57dbfb5eb96d": {
        "text_answer": "  Yes the patient is eligible for both trials based on the provided information However its important to note",
        "label": "Entailment"
    },
    "0eba9989-3611-49a8-958f-ea696ba94b3e": {
        "text_answer": "No  Explanation The evidence provides the median PFS for each treatment group not the longest PFS",
        "label": "Contradiction"
    },
    "85645da7-cf87-4b4d-a5eb-cab03a857cc4": {
        "text_answer": "Yes The primary trial and secondary trial have different outcome measurements TEAEs vs objective response",
        "label": "Entailment"
    },
    "b56bc509-6ed3-4125-9587-407192b9b597": {
        "text_answer": "No  Explanation The evidence provided in the trial results only reports the number of participants who were em",
        "label": "Contradiction"
    },
    "f319d5bf-32fd-4505-aff1-02caa718676a": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly reflects that no adverse events were recorded for both trials in",
        "label": "Entailment"
    },
    "30988df5-0397-4199-ba63-0b95f1c0f4f5": {
        "text_answer": "No  The evidence states that there have been no adverse events reported in either cohort of the primary clinical trial",
        "label": "Contradiction"
    },
    "21e44cc9-f3ce-47b3-ace5-69718677308e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ab9018bd-df48-4ece-81d0-d85fee09a2f5": {
        "text_answer": "No  Explanation  The statement provided is not entailed by the evidence because the evidence does not",
        "label": "Contradiction"
    },
    "25428be5-61e7-46d0-b713-8e831229abeb": {
        "text_answer": "Yes The secondary trial includes the requirement of a functional ECOG  2 status which is a performance status condition",
        "label": "Entailment"
    },
    "a7d9d7dd-1f13-4a0e-883c-b322ed8780dd": {
        "text_answer": "  No the statement is not entailed by the evidence The primary clinical trial excludes patients with potassium",
        "label": "Contradiction"
    },
    "6046015d-1954-4914-aa65-98ca575e4936": {
        "text_answer": "No  Explanation  The statement in the primary trial only a single cohort receives ar",
        "label": "Contradiction"
    },
    "e876c279-ae1c-4e26-a25b-4da7222957bf": {
        "text_answer": "No  The primary and secondary trials both have inclusion and exclusion criteria related to performance status Karnofsky score",
        "label": "Contradiction"
    },
    "593797dd-ff0f-46e5-ab50-0ea8d49fc4ad": {
        "text_answer": "Yes The evidence states that there are two interventions one for adult cancer patients and another for healthy volunteers The statement",
        "label": "Entailment"
    },
    "5d9fff0a-de7b-45a9-843f-7d083ef11b11": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not support the statement as it only reports",
        "label": "Contradiction"
    },
    "e2551c0f-9b6a-4d0c-9f11-b5e301d7ff3c": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial numerous psychiatric side effects were",
        "label": "Contradiction"
    },
    "abf0f2b7-e989-49e0-82a7-7a2c594e1185": {
        "text_answer": "No   Explanation   The statement patients with stage 1 cancer are not eligible",
        "label": "Contradiction"
    },
    "658a645c-05f8-456d-be67-c5b7b6d427da": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b8c7a9f1-a31e-4be6-a0ff-9452728c2e0c": {
        "text_answer": "  Yes for the primary trial pulmonary embolism is a reason for exclusion within 60",
        "label": "Entailment"
    },
    "f312eb67-0141-4a7b-a9a4-476a92c32484": {
        "text_answer": "No  Explanation  The statement the doses of lenalidomide used in the",
        "label": "Contradiction"
    },
    "2ecb5932-45c6-491c-9b9f-01ab02877f78": {
        "text_answer": "Yes  Explanation  The evidence does not report any psychiatric events in the adverse events for",
        "label": "Entailment"
    },
    "12954a74-e631-4318-ac00-0d09fd49e34a": {
        "text_answer": "Yes The evidence does not specify any requirement for abstinence for men who have undergone vasectomy",
        "label": "Entailment"
    },
    "4bcd8725-f138-49c8-b6a9-4f0c6eaa756f": {
        "text_answer": "No  The most frequently documented adverse event in the primary clinical trial was nausea or vomiting each occurring",
        "label": "Contradiction"
    },
    "2af8d00f-e0b6-4555-b649-796186334803": {
        "text_answer": "No   Explanation   The statement unresectable malignant glomus",
        "label": "Contradiction"
    },
    "a6ee28c9-2b3a-47a6-b576-8ca75d38fb67": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 100 times the",
        "label": "Contradiction"
    },
    "ad9fe1aa-9798-4c53-ab23-23ac2924918c": {
        "text_answer": "No  Explanation The statement patients participating in the primary trial receive 2000",
        "label": "Contradiction"
    },
    "fb67edbe-9758-4e64-acd0-263fe51ba74a": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 90mg",
        "label": "Entailment"
    },
    "1b4c8f0a-2d3e-40d3-b26a-426a4f32cb86": {
        "text_answer": "Yes The statement about grade 1 uveitis being an eligible condition and the mention of Women of ChildBearing",
        "label": "Entailment"
    },
    "b23563cf-e6c4-4279-92b7-39d5e4de96d2": {
        "text_answer": "Yes for the primary trial No for the secondary trial  Explanation  The statement ",
        "label": "Entailment"
    },
    "b6d2381f-f049-4747-ae82-5a9a321ec001": {
        "text_answer": "No  The statement is not entailed by the evidence as the inclusion criteria specify a BMI of 25 kg",
        "label": "Contradiction"
    },
    "2855e123-6fa3-44b7-9eda-09603be206aa": {
        "text_answer": "13 Yes but the percentage given in the statement is incorrect",
        "label": "Entailment"
    },
    "e00ad4a5-25b8-4343-a353-be8b2e0d6c1b": {
        "text_answer": "Yes The psychiatric condition is listed as an exclusion criterion in both the primary and secondary clinical trials",
        "label": "Entailment"
    },
    "62a0ed6c-dc2a-4223-9ee0-5b7422bf43da": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "d3fe482c-e694-474a-8ba6-f089ea532040": {
        "text_answer": "No  Explanation  The statement none of the adverse events in the secondary trial affected more",
        "label": "Contradiction"
    },
    "348c5cf5-0756-4860-a83f-c9ead81ea4b3": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial patients experienced only three adverse",
        "label": "Contradiction"
    },
    "e29a77b0-a7de-44b8-8941-df0979682e4e": {
        "text_answer": "No  Explanation  The statement the secondary trial recorded slightly more total adverse events in its",
        "label": "Contradiction"
    },
    "8849827d-af65-44ae-ad32-b325f502f945": {
        "text_answer": "Yes The primary clinical trial has identical exclusion criteria for all participants but the inclusion criteria vary between study groups",
        "label": "Entailment"
    },
    "b0c426df-6a70-4d19-a120-e3bc56c49918": {
        "text_answer": "No  Explanation The statement healthy individuals not diagnosed with any form of cancer may be",
        "label": "Contradiction"
    },
    "f9442384-0c19-4ffe-8906-c461b6dda9f7": {
        "text_answer": "No  Explanation  The statement aggravated neurofibromatosis is a condition",
        "label": "Contradiction"
    },
    "5abc6652-31bf-4ac6-a16b-432912aa6224": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts 25 more",
        "label": "Contradiction"
    },
    "2c95f252-a861-4569-a0b9-c214289da160": {
        "text_answer": "No   Explanation  The evidence provided states that there were no adverse events reported in the",
        "label": "Contradiction"
    },
    "9040286a-0801-494c-8c17-340323774082": {
        "text_answer": "Yes However its important to note that the statement is not a direct conclusion from the evidence but rather an",
        "label": "Entailment"
    },
    "d4fd7d7a-53f4-4f5d-9640-717e26cbbcd9": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9ab82516-ba60-4c36-908d-5e0e56ec5fba": {
        "text_answer": "Yes  Explanation The statement 2 of patients in the primary trial and the secondary trial suffered from",
        "label": "Entailment"
    },
    "a63b539f-034e-46c2-83e7-9cea8c282e1c": {
        "text_answer": "Yes  Explanation  The statement none of the patients in the primary clinical trial and secondary clinical",
        "label": "Entailment"
    },
    "46c7e5c7-0834-45dd-952c-872502314fea": {
        "text_answer": "Yes The evidence shows that 381 of participants in Arm 1 and 333",
        "label": "Entailment"
    },
    "8c14522c-67de-490a-9be1-1c16d9fca742": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial provides the total count of participants studied however",
        "label": "Entailment"
    },
    "dce7c1b2-0e43-4c7b-8cc8-6a443fee7135": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it makes an additional assumption",
        "label": "Contradiction"
    },
    "2028a7ad-b89f-4927-8e74-db17555763c8": {
        "text_answer": "No  Explanation The evidence describes the eligibility criteria for patients in a primary trial but",
        "label": "Contradiction"
    },
    "7df47095-163a-4062-9b5b-f2dfd02259fb": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as it contains an incorrect dosage",
        "label": "Contradiction"
    },
    "50ddb312-6c5e-476a-891e-95409d7239c5": {
        "text_answer": "No   Explanation   The primary clinical trial is focused on evaluating the toxicity of",
        "label": "Contradiction"
    },
    "18ff2056-f906-4f16-805f-76b4a51b77b7": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary trial reports the MTD of",
        "label": "Entailment"
    },
    "fc37e929-f3f3-43fb-b0c4-86521a18592f": {
        "text_answer": " Yes the statement is entailed by the evidence for cohort 1 as all 3 participants experienced an",
        "label": "Entailment"
    },
    "bdbbcf1d-df03-4ade-9967-5d9ca8bf9ce8": {
        "text_answer": "No   Explanation   The statement vector genomes per milliliter is a unit",
        "label": "Contradiction"
    },
    "69407358-a579-43ba-8b78-b75d7aebb163": {
        "text_answer": "Yes The statement is entailed by the evidence as the secondary trial reports the MTD of MM111",
        "label": "Entailment"
    },
    "21a1ddb1-0d37-41e5-a08f-a7e9dc5b15ef": {
        "text_answer": "Yes  Explanation  The primary trial and the secondary trial are studying different drugs Extimia",
        "label": "Entailment"
    },
    "d14fe83a-0130-4c37-a55d-30ec0ecacdb1": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly support the statement given",
        "label": "Contradiction"
    },
    "a1807b6a-6ee6-4c74-bf44-53d39c31c66f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the secondary trial does not",
        "label": "Contradiction"
    },
    "8d16932d-a485-4c58-828e-70f805bd82ef": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "2af38d73-ba19-4aa1-a571-5a576b4af7e3": {
        "text_answer": "No  Explanation The statement is not directly entailed by the evidence as it provides additional information not",
        "label": "Contradiction"
    },
    "504dd694-4978-41f0-bee5-ccc6dd199752": {
        "text_answer": "No   Explanation  The statement is not related to the inclusion or exclusion criteria of the",
        "label": "Contradiction"
    },
    "ea3a7d64-b464-4633-a198-794a4a45b201": {
        "text_answer": "Yes  Explanation The evidence states that there was a significant change in Ki67 expression in tumors",
        "label": "Entailment"
    },
    "ddafc0fa-fb54-4729-8c01-97cb30f293ed": {
        "text_answer": "Yes The evidence states that neither cohort received fulvestrant during the primary clinical trial and paclitaxel",
        "label": "Entailment"
    },
    "c638fd13-e832-4bc6-9b3a-ad9d8da4b1c4": {
        "text_answer": "No  Explanation  The statement there are 10 shared inclusionexclusion criteria between",
        "label": "Contradiction"
    },
    "a0e45f2f-6f88-496e-9b14-2fe595be1286": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial less than 10 of",
        "label": "Entailment"
    },
    "176093eb-7c7f-4bca-80e2-566d4a135c47": {
        "text_answer": "No  Explanation  The statement none of the adverse events in the secondary trial affected more",
        "label": "Contradiction"
    },
    "6654ce22-9470-43d1-9e51-a17f1a06f514": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "dd5fcab9-ef7e-4f25-8040-81c0dd57aab5": {
        "text_answer": "Yes  Explanation The statement the first subgroup in the primary clinical trial reported various cases of an",
        "label": "Entailment"
    },
    "0f0ccab9-517a-44e5-8dda-96d1cb9ead51": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the placebo in",
        "label": "Contradiction"
    },
    "4527cc06-b4b2-4ebe-bba4-6f4e845b2984": {
        "text_answer": "No  Explanation  The statement The intervention in the primary trial consists of a single drug",
        "label": "Contradiction"
    },
    "87a0c1c5-507a-4188-87cf-57f27add4cf6": {
        "text_answer": "No   Explanation   The statement Candidates for the secondary trial study group receive",
        "label": "Contradiction"
    },
    "a9faa655-1f16-41b0-911e-0a560a1c1dc0": {
        "text_answer": "Yes  Explanation  The statement in both the primary trial and the secondary trial there were ",
        "label": "Entailment"
    },
    "fc1a7234-bf6c-4c29-9a82-eccacb0d4766": {
        "text_answer": "Yes  Explanation The Contour Profile Tissue Expander intervention in the primary trial mentions ",
        "label": "Entailment"
    },
    "78cbe5c1-69a4-4194-9d3c-06b5f4b9af0b": {
        "text_answer": "yes but with qualification the statement implies a difference in percentage points while the evidence provides percentages as ranges",
        "label": "Entailment"
    },
    "46669c3d-c42d-4b23-b8c5-256374e53cf1": {
        "text_answer": "No  Explanation  The statement fewer than 10 subjects experienced adverse events",
        "label": "Contradiction"
    },
    "191f4ac8-16c9-4be8-895f-4383c3d6f7b5": {
        "text_answer": "Yes The primary clinical trial has a continuous approach to PF05212384 administration within a",
        "label": "Entailment"
    },
    "bf3034ec-679a-42d1-9d24-69b51c602233": {
        "text_answer": "No  Explanation  The statement Gender is not a determining factor for eligibility in",
        "label": "Contradiction"
    },
    "a220e90b-6fd7-449f-878a-f870cd360de6": {
        "text_answer": "No   Explanation   The primary trial includes a criterion for the primary tumour",
        "label": "Contradiction"
    },
    "51c9a1a4-9242-4880-b61e-b42a45b9017d": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions in the trial administer the same dosage of nab",
        "label": "Entailment"
    },
    "d09f927d-29c3-4370-a258-400c79f366fe": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention the number of patients who experienced no",
        "label": "Contradiction"
    },
    "421278d5-9ece-4425-b5b0-390cc6844de8": {
        "text_answer": "No  Explanation  The statement teenage pregnancy is a pregnancy in an adolescent between the",
        "label": "Contradiction"
    },
    "34b09027-2195-448e-ab3d-fb9d5a91301a": {
        "text_answer": "Yes  Explanation The statement in the patient groups of the primary and secondary clinical trials a total",
        "label": "Entailment"
    },
    "3de2cfe2-e886-45d3-a5fe-135005821732": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ef7f4f02-ea16-458a-a225-875758ac5d1f": {
        "text_answer": "No  Explanation  The statement there were no documented psychiatric adverse events in the primary",
        "label": "Contradiction"
    },
    "81651022-ae46-4e69-aa0b-1e1d576845ce": {
        "text_answer": "No  Explanation  The statement about the ERBB2 gene mutation is not directly related to",
        "label": "Contradiction"
    },
    "c0267bfa-8985-4097-b6ba-0b908f4c46c5": {
        "text_answer": "No  Explanation  The evidence provided in the inclusion criteria states that patients with some evidence of",
        "label": "Contradiction"
    },
    "7f128ec3-a88f-4cbe-9d79-0ef9e0f1d3bd": {
        "text_answer": "No  Explanation  The statement Patients diagnosed with breast cancer may be eligible for all study",
        "label": "Contradiction"
    },
    "58acb205-1f9d-4dd2-9405-720b28f8581f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence does not provide",
        "label": "Contradiction"
    },
    "fe4e3c5a-b190-4733-930a-abc0bfd29625": {
        "text_answer": "No  Explanation  The statement have felt unusual weakness is a question about whether an individual feels",
        "label": "Contradiction"
    },
    "a9292fc9-f444-4e0a-8db1-c2a6ad9a7062": {
        "text_answer": "No  Explanation  The statement The patient with the longest PFS in the primary trial survived",
        "label": "Contradiction"
    },
    "c5315113-8bc1-47d5-b1f7-ca7d59ab9cc4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "67a7f848-e9e5-46be-a37b-f0e46e643dcb": {
        "text_answer": "No  Explanation The statement patients participating in the primary trial receive 25 mm",
        "label": "Contradiction"
    },
    "57e2cf8a-6c67-4771-b180-70b613fff1cc": {
        "text_answer": "Yes The evidence states that patients in both trials will be receiving 4demethyl4cholest",
        "label": "Entailment"
    },
    "9b2a47ba-246e-4591-bf68-90c7124f800b": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial ment",
        "label": "Contradiction"
    },
    "45f78c14-258f-4db0-a0f4-10a46761ae2f": {
        "text_answer": "Yes The statement mentions the primary trial measuring changes in pain intensity and the secondary trial measuring changes in bone mineral density",
        "label": "Entailment"
    },
    "475a8280-5855-4c8c-a9ca-7720f9a9be7f": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the Karnofsky score requirement",
        "label": "Contradiction"
    },
    "dfc09a24-8631-4fa3-893e-4d10a9bac4b8": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide information",
        "label": "Contradiction"
    },
    "f5ae88a3-a083-405e-b3a8-282018d7f013": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions that individuals who have received",
        "label": "Entailment"
    },
    "80cb39bd-c370-4e7f-8f19-74725fed8805": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "64441aad-b959-41bb-aa81-2f594d00b70c": {
        "text_answer": "  No The statement is not entailed by the evidence The primary trial includes mammography as a requirement for participation",
        "label": "Contradiction"
    },
    "99942306-e4cf-4405-80ca-914e689aef75": {
        "text_answer": "No  Explanation The evidence provided states that 53 out of 60 participants or",
        "label": "Contradiction"
    },
    "d86f5f0a-32ec-4943-912f-9945c1cfe06f": {
        "text_answer": "Yes The statement that there were no cardiac or psychiatric AEs recorded during the primary trial and the secondary trial",
        "label": "Entailment"
    },
    "deba63cb-52ea-4b46-ad50-8cef93d8c5fd": {
        "text_answer": "No   Explanation  The statement there is evidence of anorexia hypother",
        "label": "Contradiction"
    },
    "3f15d923-bf66-4188-8714-c9ae4921de1f": {
        "text_answer": "Yes  The secondary trial includes patients undergoing lumpectomy a type of breast surgery also mentioned in the primary trial",
        "label": "Entailment"
    },
    "fd800c89-d30c-4a9a-970b-5385deeab52f": {
        "text_answer": "No  Explanation  The statement There were significantly more patients in cohort 2 of",
        "label": "Contradiction"
    },
    "5145d91d-ce46-4dda-961e-5bc7ddb6cda4": {
        "text_answer": "yes The primary trial measures treatmentemergent adverse events AEs while the secondary trial measures total sleep",
        "label": "Entailment"
    },
    "d8d5125b-399a-4b78-b033-9603bfe8011e": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "78865c57-db3b-4fbe-ab87-1f2d11f2c091": {
        "text_answer": "No  Explanation The statement patients participating in the primary trial receive 50 kg",
        "label": "Contradiction"
    },
    "ac14720a-7525-4fb0-b261-0ec5c818f85f": {
        "text_answer": "  No The primary trial only includes male patients but the secondary trial includes female patients",
        "label": "Contradiction"
    },
    "44daf0ed-4b1a-4e95-aae4-71722fad8f09": {
        "text_answer": "  Yes The evidence states that women of childbearing potential WOCBP and sexually active fert",
        "label": "Entailment"
    },
    "1da40d20-026a-4b22-8e6c-8943e0180ed7": {
        "text_answer": "Yes for the primary trial only as the secondary trial does not mention anything about pulmonary embolisms",
        "label": "Entailment"
    },
    "6b6d3087-435b-4129-b368-29d8879f7ff4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it introduces an",
        "label": "Contradiction"
    },
    "6acd26e7-8103-4b23-aa31-413998ccbde6": {
        "text_answer": "No   Explanation  The evidence states that the patient participants in the primary clinical trial receive oral",
        "label": "Contradiction"
    },
    "14954e3a-d984-46dc-af8d-29f22c0ca85e": {
        "text_answer": "  Yes The statement about clearcell adenocarcinoma or gestational trophoblastic disease",
        "label": "Entailment"
    },
    "f2bac26a-95c8-4ac8-8356-26c3d96e8797": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fdc7efac-ca90-4897-9660-a42dbba2bd84": {
        "text_answer": "Yes  Explanation The evidence shows that during the fourth week of the primary clinical trial the az",
        "label": "Entailment"
    },
    "32cc173a-b271-47c9-997d-df17ce1c7494": {
        "text_answer": "Yes   Explanation  The statement None of the individual adverse event types recorded in the",
        "label": "Entailment"
    },
    "74178d28-3c60-4439-944a-84318eff5c92": {
        "text_answer": "No  Explanation The statement a patient that has received an organ transplant within the last month",
        "label": "Contradiction"
    },
    "69959fb0-ee1c-4fb2-a968-677802eb1c82": {
        "text_answer": "No  Explanation  The statement 72 more participants in the ERpositive L",
        "label": "Contradiction"
    },
    "f43219f1-3807-4c37-9240-bf1d9f54d5e8": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial explicitly excludes patients with a pulmon",
        "label": "Contradiction"
    },
    "987667fb-e888-40d7-ab77-f0138d9295ba": {
        "text_answer": "No  Explanation  The statement the primary trial has a higher presence of biliary colic",
        "label": "Contradiction"
    },
    "02da2719-af96-4d84-bf69-ac1a2d6fd01c": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial less than 5 of the participants",
        "label": "Entailment"
    },
    "f3a4ac87-2a6b-476f-91e2-b056e231f20a": {
        "text_answer": "No  Explanation  The evidence provided in the given text does not indicate whether or not the patients",
        "label": "Contradiction"
    },
    "cfcfc39b-c969-474d-b85c-090dda68b1f1": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial and secondary clinical trial saw no instances of",
        "label": "Entailment"
    },
    "49c63fc5-be4b-4474-8bfc-0ddf9cf438db": {
        "text_answer": "No  Explanation  The statement There are more cases of Bronchopneumonia and General",
        "label": "Contradiction"
    },
    "4bebbb9f-9a62-4b07-b91a-1321f312229e": {
        "text_answer": "No  Explanation  The statement the findings from the primary clinical trial show that the arm c",
        "label": "Contradiction"
    },
    "5e7e3d88-6a13-4849-bad5-4ac52b100140": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial recorded a total of 0 aes for both",
        "label": "Entailment"
    },
    "bd6fc353-2823-4e35-b811-a19c8318fda4": {
        "text_answer": "No  Explanation  The statement the primary clinical trial had a larger participant count than the secondary",
        "label": "Contradiction"
    },
    "ef2352dc-a976-47c6-91cd-6666e3f7b55a": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial measures the",
        "label": "Contradiction"
    },
    "ef186582-5995-47ca-a190-616f94342715": {
        "text_answer": "  Children and adolescents are not explicitly excluded from the secondary trial Yes However they may not meet other",
        "label": "Entailment"
    },
    "53459054-8f8c-4fd1-9d1f-2f109c45c5b8": {
        "text_answer": "Yes  Explanation The statement the count of total adverse events in the secondary clinical trial was",
        "label": "Entailment"
    },
    "25c8668a-29f5-4bf0-9c35-89ba2e5e1776": {
        "text_answer": "Yes  Explanation  The statement ovarian rhabdomyosarcoma is a",
        "label": "Entailment"
    },
    "2cc63d25-8209-41a8-b9a3-fcc4af6d9caa": {
        "text_answer": "No  Explanation  The statement patients of any gender can be eligible for both phases of",
        "label": "Contradiction"
    },
    "fe0da901-6c2a-4ae8-b35f-a3090f93f12d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "eab52a37-149f-4b49-bf37-891e8e201956": {
        "text_answer": "Yes The statement does not explicitly mention the specific condition being studied in the trial but it does correctly describe the paced",
        "label": "Entailment"
    },
    "b17ff44f-d9dc-4be7-b087-4329493d1c95": {
        "text_answer": "No   Explanation   The statement 7q21q221",
        "label": "Contradiction"
    },
    "94ccff26-4026-4888-9ef8-2af5aaebefad": {
        "text_answer": "No  Explanation  The statement the frequency of palpitations pericardial eff",
        "label": "Contradiction"
    },
    "94e5871f-085c-4757-9941-3c83a71da6a4": {
        "text_answer": "No  Explanation  The statement the data from the primary clinical trial reveals that the arm d",
        "label": "Contradiction"
    },
    "c70735d3-1bc3-41d8-b0d3-15a49abe4862": {
        "text_answer": "No  Explanation The statement the participant with the highest PFS in the primary clinical trial was",
        "label": "Contradiction"
    },
    "f0278adc-ef45-43ab-b957-d26918e3a5e2": {
        "text_answer": "Yes for the secondary trial only The primary trial does not mention gabapentin or pregabalin as exclusion criteria",
        "label": "Entailment"
    },
    "11d451c7-7354-44f6-95b4-2b794a72fdbb": {
        "text_answer": "No  Explanation The statement the intervention in the secondary trial lasts 300",
        "label": "Contradiction"
    },
    "ef2bc415-dff4-4732-8e34-f538b570c671": {
        "text_answer": "Yes The evidence mentions that the intervention involves psychosocial interventions only without mentioning surgical or imaging",
        "label": "Entailment"
    },
    "2a3d4de3-5604-4959-8a60-2817faeee2b8": {
        "text_answer": "Yes  Explanation The evidence states that both the placebo and the alloMSCs",
        "label": "Entailment"
    },
    "8948d41b-0742-43f8-a34f-2e1cfcaba149": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts 252",
        "label": "Contradiction"
    },
    "6ca72b87-353a-4ef1-89d7-b9a5bad97c27": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "4d384e46-7119-49f9-a627-0301c32ee334": {
        "text_answer": "  No The primary trial measures changes in pain intensity up to 30 minutes after dosing while the secondary",
        "label": "Contradiction"
    },
    "20493bc1-bda8-4255-a1d4-40cb499bd845": {
        "text_answer": "Yes  Explanation The statement There was at least 1 case of infection in both the primary trial",
        "label": "Entailment"
    },
    "8b0efa30-40c4-408e-a91b-ded68b61d9ff": {
        "text_answer": "Yes The median survival times given in the evidence are both under 24 months but some patients in both groups survived",
        "label": "Entailment"
    },
    "8c07a493-66a5-4728-ae22-d6c45b2215a8": {
        "text_answer": "Yes The statement correctly identifies one difference between the two interventions in the trial However its important to",
        "label": "Entailment"
    },
    "e9ad9d15-a15f-4f20-85f4-5da69c7592d6": {
        "text_answer": "Yes The evidence states that patients with epilepsy andor cerebral metastasis thalasemic",
        "label": "Entailment"
    },
    "f05705d7-3be3-4d1d-9dca-c59c130446a1": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial specifically excludes",
        "label": "Contradiction"
    },
    "f8adadc4-67d0-42d2-bcc9-c032279bb470": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly describes the dosing regimen for sunitinib in",
        "label": "Entailment"
    },
    "d0e16cbb-09e6-4178-80c1-2004ac2239a0": {
        "text_answer": "No  Explanation  The statement nearly all participants of the second cohort experienced a",
        "label": "Contradiction"
    },
    "964e4947-27a1-435e-84c6-d28b91d0dabe": {
        "text_answer": "Yes Both trials require patients to have intact mobility functional ECOG  2 status for inclusion",
        "label": "Entailment"
    },
    "eba82ab1-0348-4090-81e6-fcb63ac45537": {
        "text_answer": "Yes The median survival times given in the evidence are less than 730 days for both groups but some patients",
        "label": "Entailment"
    },
    "4edb9b25-9a95-4a00-ae99-ebd722187d63": {
        "text_answer": "No   Explanation  The evidence provided only gives the median PFS for each treatment group",
        "label": "Contradiction"
    },
    "3426fcd0-2d5b-4d82-a9a1-93450b3336ee": {
        "text_answer": "No  The evidence does not support the statement that patients are eligible to participate in both the secondary and primary clinical trials con",
        "label": "Contradiction"
    },
    "62112a3e-48e6-4e53-bfe4-53f07c84b815": {
        "text_answer": "No  The evidence explicitly states that leptomeningeal carcinomas are not admissible for the clinical",
        "label": "Contradiction"
    },
    "7ba831e1-4027-4ae2-842f-d52409a73ddc": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary clinical trial",
        "label": "Contradiction"
    },
    "f9dfe1ca-aa97-4592-a67f-706e5453c822": {
        "text_answer": "No  Explanation  The statement cogstateassessed objective cognitive function scores are the",
        "label": "Contradiction"
    },
    "f994d3fb-5191-4800-beb7-02fdd6887e3e": {
        "text_answer": "No  Explanation  The statement it was reported that the secondary clinical trial had multiple adverse",
        "label": "Contradiction"
    },
    "282b67f4-97cb-4680-8f21-0102c1c7851f": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it introduces the",
        "label": "Contradiction"
    },
    "41b82c80-55fb-41c9-84c0-ae7f552c7cf8": {
        "text_answer": "No  The statement is not entailed by the evidence as epilepsy and thalasemic syndromes are",
        "label": "Contradiction"
    },
    "242dc321-0e46-4788-ac59-22120692fd8d": {
        "text_answer": "No  Explanation The statement Patients participating in the primary trial receive 100 mg",
        "label": "Contradiction"
    },
    "784e6940-fead-497a-8d68-2869d17385ea": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement is about es",
        "label": "Contradiction"
    },
    "27b7d06c-72ee-4a57-a88a-2654824853f2": {
        "text_answer": "No  Explanation  The statement 1 hectopascal is a si derived unit of",
        "label": "Contradiction"
    },
    "5e2e6057-0a23-4780-9994-a239d28aee3a": {
        "text_answer": "Yes   Explanation The primary trial reports results in percentage and the secondary trial reports results in number of",
        "label": "Entailment"
    },
    "cd0b8308-0c5c-4e7c-9f4f-9e1714fc7db2": {
        "text_answer": "Yes The evidence does not exclude patients with ER or PR factors from the trial for nonsmall cell lung cancer These",
        "label": "Entailment"
    },
    "c6b64745-922b-40cb-9476-b7b696d4c8c0": {
        "text_answer": "Yes  Explanation The evidence states that 20 out of 35 participants in coh",
        "label": "Entailment"
    },
    "11991b1b-f587-44fc-b675-603c06e680fe": {
        "text_answer": "Yes   Explanation  The primary trial examines the effects of eribulin mesylate",
        "label": "Entailment"
    },
    "5e0f26d8-5fcd-4187-9591-3508d99ffafc": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial provides the time to progression in months",
        "label": "Entailment"
    },
    "85815543-5f42-40bc-9ad1-98037b32433c": {
        "text_answer": "Yes  Explanation  The statement both the primary clinical trial and the secondary clinical trial reported zero",
        "label": "Entailment"
    },
    "2da35e9e-caa7-47b4-883e-5ef8c7868708": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "951e007d-202c-4cd4-8db0-0218a7c9f851": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes two",
        "label": "Contradiction"
    },
    "7e193fec-c5ef-4c86-8f5c-c7f6dffe11ec": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "2d0d88d5-08ba-4d77-abbc-d8df34efa630": {
        "text_answer": "Yes The statement does not mention any specific adverse events related to the look of the reconstructed nipples",
        "label": "Entailment"
    },
    "bb41bccb-2552-42ba-a5df-981bead7b941": {
        "text_answer": "No  Explanation  The statement proctitis ctcae is a disorder characterized",
        "label": "Contradiction"
    },
    "73b815f4-aae1-4202-a65e-5bba7b7c6676": {
        "text_answer": "  No   Explanation   The evidence states that individuals with a history of grade ",
        "label": "Contradiction"
    },
    "292d0d60-e861-47b2-9484-53b0cc80ffe1": {
        "text_answer": "No  Explanation  The statement the primary trial documented a higher number of patients experiencing chest pain",
        "label": "Contradiction"
    },
    "36eca12e-4e1f-4239-88bb-fdac29a6209c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the dosages mentioned in",
        "label": "Contradiction"
    },
    "b5701488-7b4a-4e1d-a318-4cc2f2b4df39": {
        "text_answer": "Yes The primary trial uses sublingual administration of Vitamin B12 while the secondary trial uses oral administration of",
        "label": "Entailment"
    },
    "dece1720-0c33-4000-b6e1-879b75541c33": {
        "text_answer": "No  Explanation  The statement Arimidex is used in both cohorts of",
        "label": "Contradiction"
    },
    "fa586070-5821-4a70-9812-9d7c6e5df330": {
        "text_answer": "No  Explanation  The statement 5 patients in the primary trial suffered 3 or more ad",
        "label": "Contradiction"
    },
    "5ad108af-177f-434d-b17a-67c11c484e9b": {
        "text_answer": "Yes  Explanation  The statement there were no recorded instances of syncope across the patient co",
        "label": "Entailment"
    },
    "ba202357-7330-4867-9527-10dee27a64b5": {
        "text_answer": "Yes  Explanation The evidence states that in Arm A of the clinical trial CUDC",
        "label": "Entailment"
    },
    "3eecf12f-23fb-45ab-bf91-cc84c01a1b6a": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary and secondary trials",
        "label": "Contradiction"
    },
    "0ab8abd1-3e9e-4c51-95c3-6a1114180100": {
        "text_answer": "No  Explanation The statement seem to get full quickly is a question about whether an individual gets",
        "label": "Contradiction"
    },
    "4dca77c0-d73d-4205-9d8e-8c2e897049d5": {
        "text_answer": "No  Explanation  The statement Over 50 of patients in cohort ",
        "label": "Contradiction"
    },
    "6668780b-0a4f-4c25-895f-3fb5fc7c604a": {
        "text_answer": "Yes  Explanation  The evidence states that the median IQR of Ki67",
        "label": "Entailment"
    },
    "05cd9540-60f6-4255-a4a5-fadff61801eb": {
        "text_answer": "  No The evidence provided does not mention any requirement for a dental examination record or a detailed eye examination report for the",
        "label": "Contradiction"
    },
    "b544a7fd-b1d9-402c-b003-22d14774531c": {
        "text_answer": "maybe  Explanation  The statement the primary clinical trial group with paclitaxel plus bev",
        "label": "Entailment"
    },
    "ba5f6986-4060-4bcb-92ab-6423657d51ba": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as there is no mention of",
        "label": "Contradiction"
    },
    "0cbbe925-cc6b-464a-b601-176c35b63a31": {
        "text_answer": "Yes  Explanation The evidence includes the exclusion criteria for women of childbearing potential W",
        "label": "Entailment"
    },
    "a6299338-84c5-469d-9bd0-eff13b90a7eb": {
        "text_answer": "No  Explanation  The statement the primary trial adminsters its intervention sublingually and",
        "label": "Contradiction"
    },
    "0bfa5116-f8a5-4bba-b279-bc071c6ff725": {
        "text_answer": "Yes The statement does not explicitly mention the trials but the individuals mentioned in the statement fall within the age range for both",
        "label": "Entailment"
    },
    "21400daa-b71d-43ac-9a54-fb9497b2a723": {
        "text_answer": "No  The statement is not entailed by the evidence as the clinical trial only includes patients with breast cancer and specific el",
        "label": "Contradiction"
    },
    "45741764-5967-4905-83dc-06481353f56b": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as the evidence only reports",
        "label": "Contradiction"
    },
    "74f1ae66-88fd-4508-ba6b-2ad19274d6e3": {
        "text_answer": "Yes  Explanation  The evidence shows that in both Arm 1 and Arm 2 of the",
        "label": "Entailment"
    },
    "9f402778-d71e-4f5b-9653-eed11679ecc9": {
        "text_answer": "No  Explanation The evidence provided in the form of the primary clinical trial consists of two interventions",
        "label": "Contradiction"
    },
    "1f54533d-d67f-4863-90a6-ebc13199f27e": {
        "text_answer": "Yes  Explanation  The statement no patients in the secondary clinical trial are given paclitax",
        "label": "Entailment"
    },
    "3add5ce6-4581-491c-b501-2c071860ece3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement mentions ",
        "label": "Contradiction"
    },
    "31dea0ef-a953-4217-9e00-bac1c96a7325": {
        "text_answer": "No  Explanation  The primary and secondary trials have different interventions although they both involve the",
        "label": "Contradiction"
    },
    "4b6d301f-d0c7-45c9-a39a-ff973e0b9d45": {
        "text_answer": "Yes The evidence does not specify that participants must be of a certain nationality or gender for either the primary or secondary clinical",
        "label": "Entailment"
    },
    "0655111b-b8fe-46c7-8332-433a747efbcc": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial are about different research topics The primary",
        "label": "Contradiction"
    },
    "282c18a2-64b1-47cf-8563-db8db40dadb6": {
        "text_answer": "Yes  Explanation The statement Patients in cohort 1 and 2 of the",
        "label": "Entailment"
    },
    "1af4d0ac-d0f2-402a-8bdb-0e10c0823b0f": {
        "text_answer": "No  Explanation  The statement The most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "9d196526-1000-4235-add7-49de8e168d3b": {
        "text_answer": "Yes  Explanation  The statement there are more cases of bronchopneumonia and general",
        "label": "Entailment"
    },
    "664f769a-791d-4188-8937-c3269d6e0dde": {
        "text_answer": "No  Explanation  The primary trial includes patients with a breast tumor of 1 cm in",
        "label": "Contradiction"
    },
    "22f97249-204f-4d0e-a76f-eb9b8441c8da": {
        "text_answer": "  No  Explanation  The statement is not entailed by the evidence because the evidence reports",
        "label": "Contradiction"
    },
    "de23d1f1-23e0-4f92-bdfd-b2bf37f08250": {
        "text_answer": "Yes  Explanation The statement cohort 1 in the primary clinical trial receives 0",
        "label": "Entailment"
    },
    "eb8dca8b-34a9-46d0-a845-80c4b5343ec6": {
        "text_answer": "  No  Explanation  The statement the results obtained from cohort 2 of",
        "label": "Contradiction"
    },
    "ae5ec938-2ef4-4533-9ab9-3314de8525a1": {
        "text_answer": "No  Explanation  The evidence provided in the text only gives the number of participants in each group",
        "label": "Contradiction"
    },
    "ea69e1bc-816a-4ba8-abd0-9882b12b70ea": {
        "text_answer": "No  Explanation  The statement basal cell of the squamous epithelium",
        "label": "Contradiction"
    },
    "fe6f8d5f-5105-4495-828f-f6ef19a7cc9d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial states that",
        "label": "Contradiction"
    },
    "deff33e5-6172-4caa-940e-4ca7aaca8d80": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence indicates that there were no adverse events in both",
        "label": "Contradiction"
    },
    "057e665a-1e29-4e11-866e-16483eeb0420": {
        "text_answer": "Yes The evidence states that patients with significant cardiovascular impairment are excluded from both trials Yellow fever virus is",
        "label": "Entailment"
    },
    "4dd24d14-3357-43a0-973f-d535802507cb": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence because the secondary trial",
        "label": "Contradiction"
    },
    "f59c5c18-e772-4c9b-a5f2-cdb3bdd812f2": {
        "text_answer": "Yes  The statement is entailed by the evidence as pericardial effusions had a higher frequency in the primary",
        "label": "Entailment"
    },
    "64d56259-f688-42c5-8946-0022bd4aa57c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the evidence only compares",
        "label": "Contradiction"
    },
    "fe5928a4-1a0c-4c41-9b85-8d7785a8ab4c": {
        "text_answer": "No  Explanation  The statement In the primary trial only one cohort receives Armod",
        "label": "Contradiction"
    },
    "e0cc56e6-9466-4d28-a94e-4a9dcceaee76": {
        "text_answer": "No  Explanation The statement participants of cohort b in the primary clinical trial",
        "label": "Contradiction"
    },
    "29eab9d1-1649-401a-8ff7-95fcd6a2c09a": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial only mentions",
        "label": "Contradiction"
    },
    "67dcd165-45dd-439f-980d-62c960f50c37": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria in the evidence which specifically mentions the exclusion of patients",
        "label": "Entailment"
    },
    "96042d49-2f5a-44af-8899-2d5ba24c0f6f": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial results does not directly address the statement regarding",
        "label": "Contradiction"
    },
    "4ceb3f73-8812-4534-9688-52e5d3db524f": {
        "text_answer": "Yes  Explanation The evidence states that participants in the primary trial receive epirubicin cycl",
        "label": "Entailment"
    },
    "f64f4990-f41a-49c2-ab74-5897b191c256": {
        "text_answer": "Yes Both trials involve the use of cyclophosphamide which is a chemotherapeutic agent Cycloph",
        "label": "Entailment"
    },
    "2c8bef4e-9452-4ff9-b04d-66b0f42196d8": {
        "text_answer": "No  Explanation  The statement over 185 of patients in the primary trial",
        "label": "Contradiction"
    },
    "e809d4b1-1730-49a2-aa9f-303afb27b175": {
        "text_answer": "No   Explanation  The statement provided in the question is not related to the evidence given in",
        "label": "Contradiction"
    },
    "e01e4e41-3577-4556-b481-de0d3777ba18": {
        "text_answer": "yes for the primary trial only The statement is not directly related to the secondary trial as it mentions mammography",
        "label": "Entailment"
    },
    "83e7efec-6077-4c3c-8ed6-ebe4f715da47": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials exclude patients with no evidence of metastasis M0",
        "label": "Entailment"
    },
    "bffaad67-a8e9-43bf-a2ca-bbcaec96218c": {
        "text_answer": "No  Explanation The evidence provided in the primary and secondary trials have different inclusion and exclusion criteria",
        "label": "Contradiction"
    },
    "201ec8b0-f2f0-4c60-8094-0f40761f6d88": {
        "text_answer": "No   Explanation  The statement the number of adverse events witnessed in the primary clinical",
        "label": "Contradiction"
    },
    "626b2407-ae7b-43ed-96b6-3ee9e3c290c8": {
        "text_answer": "Yes The evidence does not mention anything about pregnant individuals being eligible for the clinical trial",
        "label": "Entailment"
    },
    "6d595852-44de-4516-9ac8-441283808f1f": {
        "text_answer": "No  Explanation The evidence provided does not give information about the number of patients who experienced adverse",
        "label": "Contradiction"
    },
    "57d179a7-e550-486f-ba5b-40dcdc8927a0": {
        "text_answer": "No  Explanation  The statement is not directly related to the inclusion or exclusion criteria of the",
        "label": "Contradiction"
    },
    "b315a999-4315-4e95-95e7-9f402f9d979e": {
        "text_answer": "Yes  Explanation  The statement no cardiacrelated adverse events have been identified in",
        "label": "Entailment"
    },
    "ba6526b2-e565-4c7b-b931-42590bb703c0": {
        "text_answer": "Yes The evidence only mentions criteria related to cancer diagnosis and treatment not mental health bodyweight tumor size",
        "label": "Entailment"
    },
    "81ec9878-e668-49dd-99eb-49ea13337c8f": {
        "text_answer": "Yes The statement does not explicitly mention the patients ability to think and solve daytoday problems but",
        "label": "Entailment"
    },
    "ef95d23d-9dc6-494b-9085-b5ccc6822525": {
        "text_answer": "No  Explanation  The statement there were 75 cases of hypertension de",
        "label": "Contradiction"
    },
    "41bf82f2-9544-471f-88b0-418e6cd9b5e1": {
        "text_answer": "No  Explanation The statement The placebo and Trabectedin intervention in the primary",
        "label": "Contradiction"
    },
    "87d7f63c-5fa5-4820-af0e-391ef8986199": {
        "text_answer": "No  Explanation  The evidence provided in the results 1 does not mention the percentage of participants",
        "label": "Contradiction"
    },
    "41e9a0e8-3838-4609-86e7-dc9b798db67c": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the alloMSC",
        "label": "Contradiction"
    },
    "dc8d6268-fd08-4c31-b2d6-50e8a8e750c0": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial ment",
        "label": "Contradiction"
    },
    "20e20d13-e73f-4df9-b6f7-37df97b32917": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention the number of participants who experienced no",
        "label": "Contradiction"
    },
    "cdbca781-b6cd-42a1-acac-80617aa1af67": {
        "text_answer": "No   Explanation  The evidence describes the patient population and eligibility criteria for the primary",
        "label": "Contradiction"
    },
    "695ba633-5bf3-48ee-b6f9-f77657f827b7": {
        "text_answer": "Yes The inclusion criteria for both trials allow for patients with an ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "63c2b269-5155-4014-b033-2584a6773867": {
        "text_answer": "Yes The evidence does not mention Paclitaxel at all",
        "label": "Entailment"
    },
    "287c1319-d37b-4a6a-a0f3-2059ce18b07d": {
        "text_answer": "No The statement is not exactly entailed by the evidence as it mentions a time frame of 48 months instead",
        "label": "Contradiction"
    },
    "b639e0a1-6e1d-4940-9818-a268732ed88a": {
        "text_answer": "Yes  Explanation  The statement no recurrence of malignancies absence of graft",
        "label": "Entailment"
    },
    "0bd3433b-05d2-416a-b0c4-0a017f546dc2": {
        "text_answer": "Yes  Explanation  The primary clinical trial measures the change in serum levels of Follicle",
        "label": "Entailment"
    },
    "c6e636a5-7c18-47f4-9563-715fde497ee3": {
        "text_answer": "No  Explanation The statement margin status cannot be assessed is a result that the patient is",
        "label": "Contradiction"
    },
    "4f5fb0bf-e5bf-47ad-876c-e9aea07feaee": {
        "text_answer": "No   Explanation The evidence provided in the adverse events data does not mention anything about eating disorders",
        "label": "Contradiction"
    },
    "4d36fe39-7874-4174-853e-dc6406bf9e0b": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial does not report any instance of a patient",
        "label": "Entailment"
    },
    "43658af8-5289-485f-98ed-50d005e452e1": {
        "text_answer": "No  Explanation  The statement The results from the primary trial indicate that the Arm A intervention",
        "label": "Contradiction"
    },
    "c9d6f05e-40bd-49b1-8ba1-c5489208cede": {
        "text_answer": "No  Explanation  The statement the primary trial uses a 360 day cycle for",
        "label": "Contradiction"
    },
    "0c570cce-3180-45b9-a0b3-4dd7200fc890": {
        "text_answer": "Yes  Explanation  The statement nf1 gene mutation is a change in the nucleot",
        "label": "Entailment"
    },
    "04d76027-45a0-46e3-9308-acc4f8c02a73": {
        "text_answer": "No   The primary clinical trial measures the effect of a pain medication on pain intensity using the Summed Pain Int",
        "label": "Contradiction"
    },
    "d71c6377-89da-457d-acbc-827be4ddb8e5": {
        "text_answer": "Yes  Explanation The statement There was one psychiatric adverse event in the primary trial",
        "label": "Entailment"
    },
    "3afe5a55-731f-4015-85a2-e6df1caa2374": {
        "text_answer": " No the statement is not entailed by the evidence The evidence states that patients must have a potassium within",
        "label": "Contradiction"
    },
    "84859b73-1029-4815-a059-79c20cc06f91": {
        "text_answer": "Yes  Explanation  The statement no psychiatric disorders like eating disorder or schizophren",
        "label": "Entailment"
    },
    "e1069782-98e2-4db7-aeed-460b846781c3": {
        "text_answer": "No  Explanation The statement participants in the primary trial receive 4 different drugs throughout",
        "label": "Contradiction"
    },
    "53099f5c-4259-4ad7-bff2-65d2fe6250be": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as the primary trials intervention group receives",
        "label": "Entailment"
    },
    "41b6a327-e552-4e26-971f-25096f53e72d": {
        "text_answer": "No The statement is not entailed by the evidence as the percentage given in the statement is different from the percentage of patients",
        "label": "Contradiction"
    },
    "070ba2da-932a-4a62-861e-3f2c89630b4d": {
        "text_answer": "No  Explanation  The statement Most the primary trial candidates suffered from some kind of eating disorder",
        "label": "Contradiction"
    },
    "c38f4f43-886b-41e9-9d42-5ce12e838600": {
        "text_answer": "  No  Explanation  The statement is not entailed by the evidence as neither the primary",
        "label": "Contradiction"
    },
    "feb0cfe7-6bcf-4e82-82b7-460f9cc66a18": {
        "text_answer": "Yes The trial specifically states that patients with measurable or nonmeasurable disease are eligible but those",
        "label": "Entailment"
    },
    "a1a3cda8-7324-4270-aaf9-51ad1b40be07": {
        "text_answer": "Yes  Explanation The statement the secondary trial recorded 11 more AEs Adverse Events",
        "label": "Entailment"
    },
    "5caeaa69-840d-4a32-8279-416bbe1b570e": {
        "text_answer": "Yes The primary trial includes male subjects and excludes females who are of childbearing potential while the secondary trial includes",
        "label": "Entailment"
    },
    "1ff9cfe0-06e6-4f99-961c-7854ba9e2c46": {
        "text_answer": "  Yes for the primary trial parathyroid hormone is not mentioned in the inclusion or exclusion criteria",
        "label": "Entailment"
    },
    "3f87dd7c-b00d-4840-b075-70b65e5bf00c": {
        "text_answer": "No  Explanation  The statement the number of bronchopneumonia cases and instances of",
        "label": "Contradiction"
    },
    "13d0bb71-fc81-4ecf-8628-1321816e41ce": {
        "text_answer": "Yes The evidence does not report any cases of Hypertension Dehydration or Dyspnea in",
        "label": "Entailment"
    },
    "43e968bb-7167-4c0a-8105-8f3e854408af": {
        "text_answer": "Yes  Explanation  The statement nearly half more participants in the dalotuzumab",
        "label": "Entailment"
    },
    "cdd043e8-2430-409a-96b6-8e7b7a2d11f3": {
        "text_answer": "Yes  Explanation The evidence provides the inclusion and exclusion criteria for both the primary and secondary trials",
        "label": "Entailment"
    },
    "c44751aa-dc67-42de-a619-0f0834b88325": {
        "text_answer": "Yes  Explanation  The statement the primary trial and the secondary trial both use pCR as",
        "label": "Entailment"
    },
    "2d16916c-23f3-4638-8a1d-6638aeb46359": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly reflects the number of participants with stable disease at Week 1",
        "label": "Entailment"
    },
    "a24f59fe-0c4b-48bb-bbff-8dfb4b83ed6b": {
        "text_answer": "No   Explanation  The statement participants are required to get one injection on the",
        "label": "Contradiction"
    },
    "1e24905e-7bf9-4a79-8157-8948f108ecb7": {
        "text_answer": "Yes The evidence states that neither cohort received invasive surgery or Neratinib",
        "label": "Entailment"
    },
    "e4256cc3-09b7-4ad0-b1b1-467cd74b273c": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "50757da1-c674-43a7-a3ee-90750e166aa5": {
        "text_answer": "Yes The trial does not mention any exacerbating factor to the chief complaint for either the placebo or memantine",
        "label": "Entailment"
    },
    "2c4d4e4b-1b19-4a95-a18d-7d0585c90573": {
        "text_answer": "No  Explanation The statement on average patients from the primary trial survive under 2 months",
        "label": "Contradiction"
    },
    "3ff601a7-b05a-4cc4-94e3-bbea555889cb": {
        "text_answer": "Yes The evidence does not mention the use of paclitaxel in either intervention The statement is about paclitax",
        "label": "Entailment"
    },
    "28d5dbe8-5006-4735-8274-fc37e55dbbbd": {
        "text_answer": "No  Explanation  The statement The same percentage of patients suffered adverse events in both co",
        "label": "Contradiction"
    },
    "671c7966-67b4-4279-b246-a4e415679a2d": {
        "text_answer": "Yes The evidence states that there is no form of counselling risk assessment or cognitive behavioural therapy given as part",
        "label": "Entailment"
    },
    "8942c478-a2ec-4b68-8da0-7fbce5bb70f7": {
        "text_answer": "Yes  Explanation  The primary clinical trial and secondary clinical trial have different outcome assessments In",
        "label": "Entailment"
    },
    "0dd90e62-09f5-4282-9f52-c369a56ba3f5": {
        "text_answer": "Yes  Explanation The evidence shows that the median aAUCpa for the Sensory Ne",
        "label": "Entailment"
    },
    "fdf46294-f524-478f-9816-e13d7c7c3927": {
        "text_answer": "  Yes for the primary trial only No for the secondary trial   Explanation ",
        "label": "Entailment"
    },
    "f42c5f78-bcb9-46e9-8b77-a8b9cbb81b13": {
        "text_answer": "No  Explanation The statement on average patients from the primary trial survive over 3 years",
        "label": "Contradiction"
    },
    "a441e08e-affc-4228-bfac-18ab1ead4bce": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f9b21d3d-3d5d-4cc6-bf70-733083138b99": {
        "text_answer": "No  Explanation  The statement 100 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "13d5fd15-4fe1-4152-8987-050cfb32c8fb": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly give the recurrence",
        "label": "Contradiction"
    },
    "dd5c2791-351d-472f-8c50-a773aa9baa41": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as it is not related to the",
        "label": "Contradiction"
    },
    "b71e8f1d-2910-4ac7-9aaf-e709679b0083": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3ad0bf0d-7929-4d29-9629-4fea3e6c8fc5": {
        "text_answer": "No  Explanation The evidence provided in the primary and secondary trials does not mention vinblastine",
        "label": "Contradiction"
    },
    "2aa37ee1-47f4-4ee2-a2d5-b11181a89e78": {
        "text_answer": "Yes  Explanation The statement Cohort A and B of the primary trial are administered",
        "label": "Entailment"
    },
    "ea1d804d-bac9-4ebd-a6bd-0705c988927f": {
        "text_answer": "Yes The statement is entailed by the evidence as the intervention section does not provide any information about a treatment cycle or description",
        "label": "Entailment"
    },
    "5ab7ac4b-19cd-455c-8796-50680cedf7f1": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "4e5a04a1-2513-472b-b2a7-891d68a3b549": {
        "text_answer": "yes  Explanation  The statement 11 more Participants in the ERpositive",
        "label": "Entailment"
    },
    "36969517-2743-4fc8-970a-0846cebda02f": {
        "text_answer": "No  Explanation  The statement is about an individuals feelings regarding their ability to deal with",
        "label": "Contradiction"
    },
    "1b5d6416-bf6d-4d0b-8b9b-b982d1bbd8a8": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial does not have a requirement for Her2",
        "label": "Contradiction"
    },
    "aecffac5-b441-4cf6-b939-c7fb19ebac05": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial there was a minimum of ",
        "label": "Entailment"
    },
    "b907c117-661f-4078-956a-be5b2560b5f4": {
        "text_answer": "No  The evidence does not indicate that any patient in either trial developed shingles",
        "label": "Contradiction"
    },
    "263e2baf-2196-42fb-8d68-e6dea7cad9b5": {
        "text_answer": "No  The evidence states that there was an increase in blood bilirubin levels in 1 out of 1",
        "label": "Contradiction"
    },
    "864e3d0c-60fb-43bf-a272-1d590ff8795b": {
        "text_answer": "Yes  Explanation  The statement in the primary trial there is a reduction in both the",
        "label": "Entailment"
    },
    "1a71b35f-9b20-478b-863d-f7411015d6e8": {
        "text_answer": "  Yes but with a qualification The primary trial excludes patients with a pulmonary embolism within",
        "label": "Entailment"
    },
    "c5e1aaba-40f0-49e6-926b-2f28f74b2b1c": {
        "text_answer": "No  The primary clinical trial has different inclusion and exclusion criteria for its phases while the secondary clinical trial has the",
        "label": "Contradiction"
    },
    "6e4be816-3da7-4def-ab23-2a4fda805cd0": {
        "text_answer": "Yes The evidence states that laserassisted fluorescence angiography is used for monitoring perfusion at three",
        "label": "Entailment"
    },
    "01b56d67-6f6a-4102-959e-eb921954d268": {
        "text_answer": "Yes The evidence does not list allergies to cephalosporin or trimethoprimsulfam",
        "label": "Entailment"
    },
    "6b03d4f0-29bf-4a64-8136-2042e2a609ef": {
        "text_answer": "No  Explanation  The statement patients in cohort 2 show a decrease in",
        "label": "Contradiction"
    },
    "c216cb60-86c5-4ba4-9092-07bfe620c6ec": {
        "text_answer": "No  Explanation The statement somewhat forgetful is a response indicating that an individual is or",
        "label": "Contradiction"
    },
    "1645d8e9-78e0-42e0-b46e-945c3c8e7d89": {
        "text_answer": "No  Explanation  The statement in the first cohort of the primary clinical trial",
        "label": "Contradiction"
    },
    "fe6abe4b-e77b-4ab7-a52c-3157a90f7a2d": {
        "text_answer": "No  Explanation  The statement women aged 18 or 19 are eligible",
        "label": "Contradiction"
    },
    "b98c3e78-273c-46dd-ad36-db7aabf5f3a9": {
        "text_answer": "  No the statement is not directly entailed by the evidence The primary trial does show longer operative times in",
        "label": "Contradiction"
    },
    "74e35f39-c01b-435b-a5f8-cc1cc8204607": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "19e0531d-7907-46b0-ab0c-e616746498e9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the secondary trial does not mention",
        "label": "Contradiction"
    },
    "b6bd5750-21d0-4fcd-80af-749c6dc2a518": {
        "text_answer": "No  Explanation  The statement in the primary trial results there were more patients with stable disease",
        "label": "Contradiction"
    },
    "a0d11ea8-22ae-4af7-885c-40b9e3a98fac": {
        "text_answer": "Yes the statement does not contradict the evidence regarding inclusion criteria for mental health bodyweight age Karnof",
        "label": "Entailment"
    },
    "663f13bf-bbc7-49f2-926e-b88da56cc74a": {
        "text_answer": "No  Explanation  The statement not a single patient treated with sunitinib  doc",
        "label": "Contradiction"
    },
    "401f0d8c-4f4e-4693-8baa-3ae8664480d3": {
        "text_answer": "Yes The primary trial includes breast adenocarcinoma as a cancer type for phase 1 and the secondary",
        "label": "Entailment"
    },
    "fdce4005-3773-4350-b45b-1c1338e01a26": {
        "text_answer": "No  Explanation  The statement biliary colic and diarrhoea cases are relatively",
        "label": "Contradiction"
    },
    "3fd8d038-4c72-4f0f-b2d8-0e822f5b96a8": {
        "text_answer": "No  Explanation The evidence provided does not mention any specific requirement for AfricanAmerican patients to reside",
        "label": "Contradiction"
    },
    "7d818afc-93da-4098-a0f0-558bc0095687": {
        "text_answer": "No the statement is not entailed by the evidence for the secondary trial as it only includes patients with BRCA",
        "label": "Contradiction"
    },
    "4750e9e1-982d-4ca4-ab90-373832ed32d6": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial increased pleural effusion and",
        "label": "Contradiction"
    },
    "8393ad3d-8521-4316-b69e-64910d8af5e7": {
        "text_answer": "No  Explanation  The primary trial reports the percentage of participants while the secondary trial reports the",
        "label": "Contradiction"
    },
    "aeddc485-09b1-4ddc-9a45-3a8bf0bec2c3": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "49b3b463-a496-404a-a3a5-07cd7d4aaa92": {
        "text_answer": "  Yes for the Primary Trial only",
        "label": "Entailment"
    },
    "dd4715db-f06d-4168-962c-22cdd764f2b0": {
        "text_answer": "No  The statement about a patient being diagnosed with diffuse parenchymal lung disease 4 years ago is",
        "label": "Contradiction"
    },
    "d1d5671f-79dd-4fd3-a4aa-b5f81d8a944f": {
        "text_answer": "No  Explanation  The statement there were 4 more patients that suffered adverse events in",
        "label": "Contradiction"
    },
    "f5231a1f-83ff-458f-9dbd-40bd55daae92": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves den",
        "label": "Contradiction"
    },
    "b8b1d79d-ce73-4bf6-a67a-0aea38c604c5": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial will receive higher doses of",
        "label": "Contradiction"
    },
    "c724f8b4-74e9-4f48-ab39-cc8eb21890e6": {
        "text_answer": "Yes  Explanation The primary trial had a reflexology intervention period of 10 weeks",
        "label": "Entailment"
    },
    "f7cbcdf1-cee8-4b88-afff-45901ee871af": {
        "text_answer": "No   Explanation   The statement the secondary trial and the primary trial report results from",
        "label": "Contradiction"
    },
    "fd5337ee-4098-440b-9e22-0d8c52dbab5a": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the units of",
        "label": "Contradiction"
    },
    "b443ed89-9fcb-451a-b0f5-3f23183fbeb0": {
        "text_answer": "No  Explanation  The statement Over 50 of patients in cohort ",
        "label": "Contradiction"
    },
    "60df29e3-b115-4407-b1f9-dfc2c3d2d3d3": {
        "text_answer": "Yes The secondary clinical trial explicitly states that Women of childbearing potential must commit to the use of effective barrier",
        "label": "Entailment"
    },
    "d35e9b96-20fc-4778-a7db-e87c861c4938": {
        "text_answer": "Yes  Explanation The evidence shows that in both Arm 1 and Arm 2 of the primary",
        "label": "Entailment"
    },
    "8b59c6dc-98ec-4f07-9274-ba4cc1ff8950": {
        "text_answer": "No  Explanation  The statement provided does not mention any adverse events or trials It is",
        "label": "Contradiction"
    },
    "f5b7285d-3b0a-496a-84c8-012c4873a7be": {
        "text_answer": "No  Explanation  The statement secondary clinical trial stipulates that patients who have been subject",
        "label": "Contradiction"
    },
    "5dea6bbb-13c3-470c-98a6-3879f17de8c7": {
        "text_answer": "Yes  Explanation The statement the primary trial reports the total Number of Participants Analyzed",
        "label": "Entailment"
    },
    "242b1a1a-4a5e-459b-88ea-41ca86093348": {
        "text_answer": "Yes The statement is entailed by the evidence as both study groups undergo the same imaging processes with slightly different dos",
        "label": "Entailment"
    },
    "437d5311-f0fd-4d61-82a2-5db0d07415f6": {
        "text_answer": "Yes   Explanation  The primary trial involves the use of cabergoline which is given",
        "label": "Entailment"
    },
    "8180d5e0-b284-45fe-a390-0c3a54dc663f": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement ment",
        "label": "Contradiction"
    },
    "d2e448c0-852f-41cc-a53b-866f56e62967": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "c94fb60e-6f9e-48ed-b7b7-4468cb2aa6ee": {
        "text_answer": "  No The statement is not entailed by the evidence as the primary trial is for patients undergoing tissue expander",
        "label": "Contradiction"
    },
    "f5a6f0ee-22bd-4731-b973-e8c4736e4d18": {
        "text_answer": "No  The statement is not directly related to the inclusionexclusion criteria for either trial The statement is about lig",
        "label": "Contradiction"
    },
    "b12011c4-fa87-4249-97e3-635e6e6805a4": {
        "text_answer": "Yes The evidence does not mention anything about nationality ethnicity psychiatric condition or gender affecting eligibility",
        "label": "Entailment"
    },
    "7482499c-6836-4f68-83f4-4af09b14d566": {
        "text_answer": "Yes  Explanation The statement There were no deaths or Hospitalizations in cohort 2",
        "label": "Entailment"
    },
    "232d082f-2684-445e-8ca6-9cf32c3d1b34": {
        "text_answer": "Yes The primary trial tests eribulin mesylate and the secondary trial tests axitinib  docetax",
        "label": "Entailment"
    },
    "1fec40c0-4c6f-4e9d-ae16-a962eb45b4dd": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement is about",
        "label": "Contradiction"
    },
    "a7c5f410-1001-4c4c-884d-cdbb9e8d69e4": {
        "text_answer": "No  Explanation  The statement less than 005 of patients in the primary",
        "label": "Contradiction"
    },
    "32f5c37f-6752-4ebd-840b-d232b65bc138": {
        "text_answer": "No The evidence does not specify that only Australian nationals are eligible for participation in the clinical trials",
        "label": "Contradiction"
    },
    "635f6674-3151-46bc-8344-33ab60b59bd0": {
        "text_answer": "Yes However its important to note that the statement is not directly related to the inclusion or exclusion criteria provided",
        "label": "Entailment"
    },
    "8af457d5-2a04-43df-a661-2cf10402def6": {
        "text_answer": "Yes The primary trial had 000 anemia instances compared to 267 in",
        "label": "Entailment"
    },
    "7b2b8832-6e8f-4b56-88fa-5cee3c4e82bf": {
        "text_answer": "Yes  Explanation  The statement the number of aes disclosed was identical for the two",
        "label": "Entailment"
    },
    "42a51c2f-6b39-487e-989c-dcdc0ad231e1": {
        "text_answer": "No  Explanation  The statement is not directly related to the evidence provided in the primary trial",
        "label": "Contradiction"
    },
    "831e3999-7ce1-4af9-9a28-1282d641a376": {
        "text_answer": "No  Explanation  The statement the primary trial and the secondary trial report on the mtd",
        "label": "Contradiction"
    },
    "d0a08aeb-5c7c-44a9-a923-fd4e3b094ebd": {
        "text_answer": "Yes The ORR in the Paclitaxel Plus Bevacizumab group was 0489",
        "label": "Entailment"
    },
    "8bc20833-6293-47e3-aafe-c7a0ca3be9a6": {
        "text_answer": "No  Explanation  The statement patients that have suffered a pulmonary embolism",
        "label": "Contradiction"
    },
    "1cebe988-ac21-4b72-a652-36778fb2cccf": {
        "text_answer": "Yes The evidence shows that the Arm II Control group had a greater median aAUCpa for the EORT",
        "label": "Entailment"
    },
    "338fc59d-601e-42b6-8718-858ffe20928d": {
        "text_answer": "yes the statement is entailed by the evidence The only difference between the two interventions is the dose of durval",
        "label": "Entailment"
    },
    "77989b91-bbcc-401e-8cd9-bdd17c0d0e3a": {
        "text_answer": "No  The statement is not directly entailed by the evidence as the two trials investigate different outcomes The first trial investig",
        "label": "Contradiction"
    },
    "e82b4df2-47c8-41ed-9b54-9b3c6917ead3": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "f0f71529-7742-45c4-945f-ae4e51f9029d": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial no incidents of hypertension",
        "label": "Entailment"
    },
    "1a8ad1c5-284a-4398-9659-2cdbcb4492d8": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "c660c228-b490-4779-9ead-ad8b2be40520": {
        "text_answer": "No  Explanation The statement jug dosing unit is a dosing unit equal to the",
        "label": "Contradiction"
    },
    "9d7e5e1f-b92f-464d-94ea-a7eb3ae730b5": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the given inclusion criteria However the eligibility",
        "label": "Entailment"
    },
    "5be5cc6c-ba08-4d21-9939-4ccde58aa23e": {
        "text_answer": "No  Explanation  The statement regimen used to treat malignant ovarian ne",
        "label": "Contradiction"
    },
    "ca20d0df-b712-4bb0-b320-704d565a99a6": {
        "text_answer": "No  Explanation  The statement have cramps in feet is not directly related to the",
        "label": "Contradiction"
    },
    "a83ef28c-db79-4e1b-9ebd-f563905a9ac7": {
        "text_answer": "  Yes  Explanation  The statement the primary clinical trials acupuncture",
        "label": "Entailment"
    },
    "28061f9c-36e0-4f1f-9f51-1c01efd608a1": {
        "text_answer": "Yes The evidence does not mention nationality ethnicity weight or gender as eligibility criteria for either the",
        "label": "Entailment"
    },
    "c8556c5e-4962-4d9d-8f8d-3cdb07af0627": {
        "text_answer": "No  The evidence provided does not mention anything about cbt cognitivebehavioral therapy being a",
        "label": "Contradiction"
    },
    "0a418d49-392b-474e-ad3c-df66ab2566ab": {
        "text_answer": "No   Explanation   The statement the primary trial uses a 1 month cycle for",
        "label": "Contradiction"
    },
    "5de55575-82d9-461f-af89-ae41ff70ecb2": {
        "text_answer": "No  The evidence does not specify any nationality or ethnicity requirements for participation in the clinical trials",
        "label": "Contradiction"
    },
    "24523cd0-0fe8-455a-93b6-52367820879a": {
        "text_answer": "Yes The evidence states that patients with histologically proven DCIS are eligible for the trial The statement specifically mentions DC",
        "label": "Entailment"
    },
    "3ee347d0-3ba9-4dc8-8387-1fb15cf1e8b3": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "a7e7e8e0-d2c9-4eee-9aed-1d957044c7dc": {
        "text_answer": "  No the statement is not entailed by the evidence as the evidence does not mention anything about children and adolesc",
        "label": "Contradiction"
    },
    "760d8b66-18ea-4e33-b83a-b88173ed8574": {
        "text_answer": "Yes  Explanation  The statement there are zero shared inclusionexclusion criteria between the secondary",
        "label": "Entailment"
    },
    "eb19e1ef-0bad-4d95-8ebd-dcc1f403a946": {
        "text_answer": "Yes  Explanation The primary clinical trial lasted for 10 weeks of reflexology treatment",
        "label": "Entailment"
    },
    "29cbfa09-f98c-4991-a6ab-0dc8cca951d3": {
        "text_answer": "No   Explanation  The statement both the primary and secondary clinical trials have documented a number",
        "label": "Contradiction"
    },
    "8881c72a-24fc-48ab-86fb-a1d38392ec33": {
        "text_answer": "No  Explanation  The statement the secondary trial and the primary trial report results using the same",
        "label": "Contradiction"
    },
    "b5a078c6-afd5-427e-beab-c7c11cc96da2": {
        "text_answer": "Yes  Explanation The statement the dosage of Zoledronic Acid in Intervention",
        "label": "Entailment"
    },
    "5d44d70b-1163-4a55-9247-db7bf9a901fc": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fe0472bd-acfb-4a56-abed-20b0a4e6b48f": {
        "text_answer": "  Yes The evidence states that patients with measurable or nonmeasurable disease are eligible for the",
        "label": "Entailment"
    },
    "78c44e7a-6f94-4167-aafa-13c14da01bbf": {
        "text_answer": "Yes The statement is a more specific version of the exclusion criteria mentioned in the evidence",
        "label": "Entailment"
    },
    "f8a72a9e-357d-4786-8d5d-66ee4ce4d1b2": {
        "text_answer": "No  Explanation  The statement the primary trial participants are administered over 7 different types",
        "label": "Contradiction"
    },
    "c5ece9f7-9119-4fa2-b60d-f2f15c68ae02": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "a68ff0d2-ddc4-4db1-9371-21bec6159585": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "970f06b2-0935-4cde-a070-ddd7adb8ed5e": {
        "text_answer": "Yes The primary trial includes both male and female patients but the secondary trial only includes female patients",
        "label": "Entailment"
    },
    "f1f9d4b4-4877-49ad-a2e2-f53efbe40ef9": {
        "text_answer": "Yes  Explanation  The statement All but one of the patients treated with Sunitinib",
        "label": "Entailment"
    },
    "25c9b995-fedc-45ae-a3c8-d66c116711b0": {
        "text_answer": "Yes  Explanation The statement just one negative occurrence has been noted for the patient contingent",
        "label": "Entailment"
    },
    "1bf21a6b-6676-4da7-9b80-4fd67722e030": {
        "text_answer": "Yes  Explanation  The statement every inclusion criterion for the primary trial is distinct from",
        "label": "Entailment"
    },
    "08793821-1888-49b3-9117-f0548482b5f9": {
        "text_answer": "No  Explanation  The statement the secondary clinical trials second cohort significantly out",
        "label": "Contradiction"
    },
    "396eb2aa-c85e-4477-bdf5-a0926499350a": {
        "text_answer": "No  Explanation The statement a patient who underwent an organ transplant less than four weeks",
        "label": "Contradiction"
    },
    "071c3399-1525-4965-8a3e-b3dfac561b6b": {
        "text_answer": "Yes  The primary clinical trial only includes one cohort receiving preoperative dexamethasone in",
        "label": "Entailment"
    },
    "32d95cac-6a3d-4e4d-a8ac-3371ec9d0da4": {
        "text_answer": "No  The evidence provided relates to inclusion and exclusion criteria for two separate clinical trials one for postmen",
        "label": "Contradiction"
    },
    "d1118512-9c0b-4480-ab67-d4e0c7de390d": {
        "text_answer": "Yes for the primary trial pulmonary embolism is a reason for exclusion within the last 6 months",
        "label": "Entailment"
    },
    "ff258472-19f3-4dea-8edc-bc591c30fc37": {
        "text_answer": "Yes  Explanation  The statement adverse events such as recurrent cancers graft",
        "label": "Entailment"
    },
    "285b3905-8e47-4b26-8aa5-2d9d7f717a6c": {
        "text_answer": "No   Explanation  The statement Candidates for the secondary trial study group receive weekly",
        "label": "Contradiction"
    },
    "3b6f6c52-5713-45fd-823a-23ab1754539a": {
        "text_answer": "No  Explanation  The statement dietary palmitic acid measurement is a determination of",
        "label": "Contradiction"
    },
    "bbb61326-9879-44f0-af97-523e7dc2231a": {
        "text_answer": "Yes  Explanation The median aAUCpa values for both the Arm I Cryotherapy",
        "label": "Entailment"
    },
    "95036529-d29d-4425-90a4-d366664c99c5": {
        "text_answer": "No  Explanation  The statement Patients can not have a history of abdominal fist",
        "label": "Contradiction"
    },
    "1fa45a65-8a51-41e7-af9d-01ab8e0f3e1c": {
        "text_answer": "No  Explanation  The statement hepatotoxicity incidence was not higher compared to",
        "label": "Contradiction"
    },
    "2ad5cf58-daab-4432-8670-8964380a4fa9": {
        "text_answer": "No  Explanation  The statement 120 milligrams of denosumab",
        "label": "Contradiction"
    },
    "4cfe211a-a80a-48ee-993a-2b7c8a91b57c": {
        "text_answer": "No  Explanation  The primary clinical trial is investigating Eribulin Mesylate while",
        "label": "Contradiction"
    },
    "f27a6b09-cfd5-48ac-80d8-a70bd15bcb4d": {
        "text_answer": "No  Explanation  The statement no adverse events were observed in the primary trial and",
        "label": "Contradiction"
    },
    "668cbbc7-bc89-440f-8503-a7e273c4fab3": {
        "text_answer": "Yes The statement does not explicitly state that the symptom interference score is a requirement for trial eligibility but the",
        "label": "Entailment"
    },
    "b995d047-8aaf-48fd-9fd7-ebed843b0877": {
        "text_answer": "Yes  Explanation The statement in both the primary clinical trial and the secondary clinical trial a single",
        "label": "Entailment"
    },
    "f22196d4-1e0f-4626-9736-d78452dc650a": {
        "text_answer": "Yes However the statement goes beyond the given evidence as it includes all patients in both trials not just those who did",
        "label": "Entailment"
    },
    "abb25993-d191-4b47-99c1-fe3b53732dc1": {
        "text_answer": "No  Explanation  The statement ppp2r2a gene mutation is a change",
        "label": "Contradiction"
    },
    "6d0812b9-f9bd-4cd6-82aa-9c272eba23be": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial and the secondary trial suffered Th",
        "label": "Contradiction"
    },
    "aff21004-0238-46bb-b68b-99d1e3035947": {
        "text_answer": " Neither Yes nor No The evidence does not provide information about the inclusion or exclusion of morbidly obese",
        "label": "Entailment"
    },
    "3762bbcc-dcb8-4173-bf16-934f3c590566": {
        "text_answer": "Yes In the primary trial epacadostat is given twice daily BID while in the secondary trial",
        "label": "Entailment"
    },
    "1616266d-e1bf-4327-9523-f584f713b265": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "693c9e39-1648-4f3a-8a23-d642d7355b98": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not directly relate to squamous pap",
        "label": "Contradiction"
    },
    "9321cbe9-2f04-4751-90fd-47a92f424f04": {
        "text_answer": "  No   Explanation   The statement the primary clinical trial accepts patients with hist",
        "label": "Contradiction"
    },
    "e1c80f41-c3f0-49c8-8fc8-0bfc32e9936a": {
        "text_answer": "Yes  Explanation  The statement no deaths or hospital admissions were observed in the second co",
        "label": "Entailment"
    },
    "063f5147-ab53-4f22-b390-bdf6d6589a03": {
        "text_answer": "Yes  Explanation The evidence states that there are two interventions in the primary clinical trial each",
        "label": "Entailment"
    },
    "1f6d3870-934f-4a75-87a3-0e52c19cd010": {
        "text_answer": "No  Explanation The statement in the question is not entailed by the evidence as the evidence describes",
        "label": "Contradiction"
    },
    "6fd7b2ea-805b-45ad-b1e7-d073f9944d77": {
        "text_answer": "No  Explanation  The statement the primary trial uses higher doses of Lenalidom",
        "label": "Contradiction"
    },
    "4c926c31-8786-47b0-a032-1d59f759bca5": {
        "text_answer": "Yes  Both trials administer their interventions orally",
        "label": "Entailment"
    },
    "2278c029-239d-43ba-9da2-440281e4fd0e": {
        "text_answer": "Yes The evidence does not mention invasive surgeries or the administration of neratinib as part of the primary clinical",
        "label": "Entailment"
    },
    "f3345897-b99a-4ff2-8bcd-5d1aeb3b698d": {
        "text_answer": "Yes The statement is consistent with the information provided in the evidence that there are surgical and imaging procedures involved in the",
        "label": "Entailment"
    },
    "32f90f55-6faf-41ed-991a-6f8e9e158200": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the statement incorrectly equates",
        "label": "Contradiction"
    },
    "27aec260-8dcc-4611-8389-dc9c10d3518d": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence reports a change",
        "label": "Contradiction"
    },
    "6a83fd1d-9dde-419d-8342-ec1be514869e": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence specifies that candidates for the primary clinical trial must",
        "label": "Contradiction"
    },
    "91b35ed1-37f4-440a-a82d-99c639ad7e2a": {
        "text_answer": "No  Explanation  The statement the primary clinical trial had twice as many participants with chole",
        "label": "Contradiction"
    },
    "6e1489a6-3a42-4b52-b690-fb1dd8892749": {
        "text_answer": "Yes The statement is entailed by the evidence as all the adverse events mentioned in the statement occurred in cohort",
        "label": "Entailment"
    },
    "5ce47a02-7653-4be0-8747-cc04ae14145a": {
        "text_answer": "No  Explanation The evidence provided does not mention the percentage of participants who did not encounter any ad",
        "label": "Contradiction"
    },
    "84246007-e5dd-48da-b548-e0f6403bd67a": {
        "text_answer": "No  Explanation  The secondary clinical trial results do not provide any information about shifts in ki6",
        "label": "Contradiction"
    },
    "a3ab9532-5335-47ab-b19f-33ab64372ce2": {
        "text_answer": "No   Explanation   The statement the secondary trial and the primary trial use different units",
        "label": "Contradiction"
    },
    "19a043cf-96b9-4285-9e9c-1405403bf608": {
        "text_answer": "No  The statement is not entailed by the evidence as metastatic small cell lung cancer is not listed as a",
        "label": "Contradiction"
    },
    "d5abbde0-b23c-4e60-91fc-cb6a7735b68f": {
        "text_answer": "Yes The statement mentions anemia pneumonia and stupor which are mentioned in the",
        "label": "Entailment"
    },
    "7ebbbace-7ced-4e16-bfa7-681b1c6f00f3": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the primary clinical trial does not",
        "label": "Contradiction"
    },
    "5e38b301-c67d-47dc-8117-ad86b9eeb524": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because  1",
        "label": "Contradiction"
    },
    "db15e6cc-ceeb-4f48-b3a1-bca36a6b54f4": {
        "text_answer": "No  Explanation  The statement zero participants in group 1 of the primary trial were discovered",
        "label": "Contradiction"
    },
    "9f5587e3-ff70-42fa-9ddf-e59fc2729d77": {
        "text_answer": "No  The statement is not entailed by the evidence The evidence states that patients with severe intellectual impairment or",
        "label": "Contradiction"
    },
    "361464b0-c0ac-404a-8432-ff8100152bff": {
        "text_answer": "No  Explanation  The statement the primary trial reported an equal number of aes for both",
        "label": "Contradiction"
    },
    "094e7aec-88db-4ad0-b995-ece8587fd48b": {
        "text_answer": "Yes The evidence does not mention any Xrays transendocardial injections CT scans",
        "label": "Entailment"
    },
    "0c776d98-6a76-407b-9cc8-ded769af766e": {
        "text_answer": "Yes  Explanation The evidence states that in both the primary and secondary clinical trials there were no",
        "label": "Entailment"
    },
    "1d20e438-806f-4695-bc8f-d6a0ce1f0299": {
        "text_answer": "Yes The evidence states that adequate renal function is required for participation in the clinical trial but it does not explicitly state",
        "label": "Entailment"
    },
    "28002c57-ff24-4b59-9f0e-0dfdbaab7f88": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial intervention",
        "label": "Contradiction"
    },
    "55067973-6ec2-4cf7-b98a-6cd2210db8b0": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions different",
        "label": "Contradiction"
    },
    "84fe3c19-bee9-4639-9569-455cf74f8c64": {
        "text_answer": "No  Explanation  The statement numerous aes were reported by all participants in both co",
        "label": "Contradiction"
    },
    "c7fd3efb-5319-40f3-aba0-a54c76a50768": {
        "text_answer": "Yes  Explanation The evidence states that at Week 12 there were 12 participants",
        "label": "Entailment"
    },
    "c70623c3-85f0-4480-a772-349a89de7d43": {
        "text_answer": "No  Explanation  The statement all the adverse events recorded in the primary trial are linked",
        "label": "Contradiction"
    },
    "0f224562-3266-490d-9b52-10a4d84f5685": {
        "text_answer": "No  Explanation  The evidence provided does not mention any unexpected death incidents or hospital admissions",
        "label": "Contradiction"
    },
    "9c10ceed-9cc6-473d-87c0-fa0b51353222": {
        "text_answer": "Yes The primary clinical trial does not specify a fixed cycle arrangement while the secondary clinical trial follows a monthly cycle intervention",
        "label": "Entailment"
    },
    "e85599cc-08a6-4270-a168-cac94d5ce47d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e6a3ed43-5bb0-40b2-9c4b-8a60e2b201df": {
        "text_answer": "No  Explanation  The statement the primary trial includes the administration of fluciclatide",
        "label": "Contradiction"
    },
    "e21cdb34-eb9d-4439-81ff-6dae554954c6": {
        "text_answer": "Yes The statement there were 11 additional instances of intestinal perforation reported in the secondary clinical trial",
        "label": "Entailment"
    },
    "d0a60b09-e029-4c35-b896-3647ce468594": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there is no mention",
        "label": "Contradiction"
    },
    "fbda9d7c-12d9-4b04-8047-da25419e1c3b": {
        "text_answer": "No  Explanation The statement participants in the primary trial receive 8 different drugs throughout",
        "label": "Contradiction"
    },
    "bf1b6561-6731-457a-801d-8af93bc8857b": {
        "text_answer": "No  Explanation  The patient with a primary tumour of 33 cm diameter would",
        "label": "Contradiction"
    },
    "90c519e9-7981-4a72-af6a-cc032657458a": {
        "text_answer": "Yes The evidence mentions surgical and imaging procedures in the context of the primary trial intervention",
        "label": "Entailment"
    },
    "68be42cb-7fb2-491a-a6ad-8f37972f9500": {
        "text_answer": "Yes The evidence does not explicitly mention the ccnd3 gene mutation as a requirement for eligibility but it",
        "label": "Entailment"
    },
    "0ef9a5c8-1159-4147-a204-59a3ae183e7d": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "f13676ce-309e-4cf5-866d-542b2a214b27": {
        "text_answer": "No  Explanation  The evidence provided in the results does not allow for a direct comparison of the",
        "label": "Contradiction"
    },
    "ce9ff719-a4b1-4506-91ef-eea478339ced": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence states that sunitinib was administered",
        "label": "Contradiction"
    },
    "dc545712-7b34-41d2-9166-441ee0366105": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b358fb9c-1152-4e1a-88eb-743e965d58fc": {
        "text_answer": "Yes The evidence explicitly states that patients with a history of grade 3 or 4 allergic reactions attributed to trast",
        "label": "Entailment"
    },
    "b9b32a2d-94f0-413e-95f3-08177622a743": {
        "text_answer": "No  The evidence does not mention anything about a patent delivery system vial in relation to the elig",
        "label": "Contradiction"
    },
    "591794ae-5578-4bb4-a527-106947636ddb": {
        "text_answer": "No   Explanation  The statement in both the primary and secondary clinical trials more than",
        "label": "Contradiction"
    },
    "270f0f03-2316-40b0-8e7a-e42c499258da": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "fa12778d-4f82-4dd9-8ac0-decbef38472b": {
        "text_answer": "No  Explanation The statement On average patients from the primary trial survive over 2 years",
        "label": "Contradiction"
    },
    "32c2c3e7-4421-49e2-b1d0-2e9b125245e1": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the statement mentions ",
        "label": "Contradiction"
    },
    "b032a728-a998-4b78-945a-048dbc5126f5": {
        "text_answer": "No  Explanation  The evidence provided in the primary clinical trial only reports the percentage change in ser",
        "label": "Contradiction"
    },
    "bf5c5c27-0b57-4397-9ba9-3c2895bcbe5d": {
        "text_answer": "  Yes women aged 18 or older are eligible for the secondary trial which is included in the evidence",
        "label": "Entailment"
    },
    "e200f18a-ae9e-490f-a348-537187a65300": {
        "text_answer": "Yes  Explanation  The statement the primary trial recorded a higher incidence of palpitations",
        "label": "Entailment"
    },
    "d6716be9-247d-4c01-beb3-cd5bbbb6f9ec": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes the",
        "label": "Contradiction"
    },
    "61a20e23-7b57-4acc-b594-273f4536941c": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide any age restriction for the secondary",
        "label": "Contradiction"
    },
    "872c6392-9ba9-4224-a579-de0deb401842": {
        "text_answer": "yes for mucositis oral no for epileptic seizures and thromboembolic events",
        "label": "Entailment"
    },
    "ef4f8fe9-1d8e-464f-aa42-c33c073bb493": {
        "text_answer": "No  Explanation The statement there was one psychiatric adverse event in the primary trial",
        "label": "Contradiction"
    },
    "44cf1331-403a-4711-84e0-93f677307a6c": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial both involve determining the maximum toler",
        "label": "Contradiction"
    },
    "4a88976f-0af4-449e-97d9-5b3f1ce94668": {
        "text_answer": "Yes The statement is entailed by the exclusion criteria listed in the evidence",
        "label": "Entailment"
    },
    "97acf304-2707-4a1b-81e7-339fde2ed0ee": {
        "text_answer": "No  The evidence states that patients with some evidence of cognitive impairment are eligible but it does not specifically mention",
        "label": "Contradiction"
    },
    "2a9e682e-382c-4361-a76f-f4cf5c39819d": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "0c27bcc9-3108-4d4a-901a-22718c22d288": {
        "text_answer": "No  Explanation  The statement The majority of patients in the primary trial experienced complete response by",
        "label": "Contradiction"
    },
    "3153ffe1-3625-4900-8a12-861b575959b0": {
        "text_answer": "Yes  Explanation  The statement all groups in the primary clinical trial are administered equal dos",
        "label": "Entailment"
    },
    "eabae980-d833-47b7-8f0e-82242e662880": {
        "text_answer": "Yes for the secondary trial assuming the woman is 15 years posttreatment and meets other inclusion",
        "label": "Entailment"
    },
    "a8d30960-8533-42a5-949d-3fe706508806": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only specifies the",
        "label": "Contradiction"
    },
    "28368708-e1e6-416e-8119-0d2712a89380": {
        "text_answer": "Yes The evidence does not explicitly state that patients with severe obesity are excluded from either trial so it does not",
        "label": "Entailment"
    },
    "0b444449-045a-414d-be8e-1ff558525e83": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes the",
        "label": "Contradiction"
    },
    "84a23fa9-2758-4ea6-9eca-ca89b580378a": {
        "text_answer": "No  Explanation  The statement cohort 1 of the primary trial is given an",
        "label": "Contradiction"
    },
    "745a2452-3a24-4e39-971f-3f7fe661f999": {
        "text_answer": "Yes assuming the statement refers to all participants in the placebo group experiencing emesis during the study period",
        "label": "Entailment"
    },
    "a184cea4-fa4e-4548-a5d7-b3a94ab1130b": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as there is no mention of fe",
        "label": "Contradiction"
    },
    "552c79f8-3f17-4a7d-be66-d4cdc8749a66": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 00",
        "label": "Entailment"
    },
    "863f7074-fb4b-4c82-9e30-bb785f85f816": {
        "text_answer": "Yes Both trials involve the use of 4Demethyl4cholestryloxycarb",
        "label": "Entailment"
    },
    "70130418-63df-4ffb-9d78-7416daee50ba": {
        "text_answer": "No  Explanation  The statement all adverse events recorded in the primary clinical trial were solely",
        "label": "Contradiction"
    },
    "1a8cfb13-ebf0-48c4-a452-e26ac7a14863": {
        "text_answer": "No   Explanation  The statement Neither cohort of the primary trial receives any",
        "label": "Contradiction"
    },
    "dd27a6e7-3b83-4a84-bc40-5ba39617a1c1": {
        "text_answer": "No  The statement is not entailed by the evidence as there is no mention of SCBC small cell lung cancer",
        "label": "Contradiction"
    },
    "a4a2c0ba-3fa9-4fad-9258-7e517ae85e25": {
        "text_answer": "No  Explanation The statement alcoholic patients are excluded from the primary trial but may be eligible",
        "label": "Contradiction"
    },
    "fdb097f0-b7ba-4314-a865-c89b1179aeb4": {
        "text_answer": "Yes  Explanation The evidence states that there was an increase in pleural effusion in 25",
        "label": "Entailment"
    },
    "93e1969e-1e96-49b2-874f-6cba2e42a6e4": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly summarizes the inclusion criteria for the clinical trial",
        "label": "Entailment"
    },
    "95c7070d-76e7-4618-b95f-56b233dffb16": {
        "text_answer": "Yes The primary trial patients receive fewer total doses of MM121 and Paclitaxel combined than",
        "label": "Entailment"
    },
    "3592e711-ad4f-4f99-afde-3de2106ee5cd": {
        "text_answer": "Yes  Explanation  The statement the incidence of diarrhea was higher among participants",
        "label": "Entailment"
    },
    "595cee41-9cd2-4e9e-8ba5-2b3620985018": {
        "text_answer": "No  Explanation  The primary clinical trial does use units such as change in units on a scale",
        "label": "Contradiction"
    },
    "32cd31d2-605b-4419-89a7-a6881bb792dd": {
        "text_answer": "No   Explanation   The statement the secondary trial requires patients to be over a certain",
        "label": "Contradiction"
    },
    "e9941afc-cfd4-4bfa-bbce-eec2b84eb27d": {
        "text_answer": "Yes  The statement is entailed by the evidence as the primary clinical trial includes both epirubicin and cycl",
        "label": "Entailment"
    },
    "893a5337-2aa9-4a87-a020-4c2f03cd4aea": {
        "text_answer": "Yes  Explanation  The statement the secondary trial requires patients to be over a certain age",
        "label": "Entailment"
    },
    "cbcbfb22-0467-4ba0-b2dc-1f9bd073c27f": {
        "text_answer": "  Yes  Explanation  The statement in the primary trial results there were more patients with",
        "label": "Entailment"
    },
    "fe1ea6e0-dd6d-44d4-a9db-750c890f08c8": {
        "text_answer": "Yes The statement does not contradict the evidence The evidence only reports the occurrence of adverse events in two trials",
        "label": "Entailment"
    },
    "ab7fc69a-25c8-4bee-ad2b-526c6ea638e4": {
        "text_answer": "No  Explanation  The statement the majority of patients in the primary trial experienced complete response by",
        "label": "Contradiction"
    },
    "44b41322-9fb1-4a02-b2c5-4faead5489aa": {
        "text_answer": "Yes  Explanation  The statement Most patients in the secondary trial and the primary trial did not",
        "label": "Entailment"
    },
    "278549fe-1d04-44de-88dc-e0661e8f234b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "824add43-b242-4278-9be4-04f1566039cd": {
        "text_answer": "No   Explanation The statement one injection will be administered to the patients on the eighth",
        "label": "Contradiction"
    },
    "bd89597d-82f5-461f-aa6e-ef215afcc6a5": {
        "text_answer": "No  Explanation  The primary trial and the secondary trial involve different interventions In the primary",
        "label": "Contradiction"
    },
    "46a79c10-315b-4975-9949-508fc379af87": {
        "text_answer": "No  Explanation  The statement 12 adverse events were observed in the course of the",
        "label": "Contradiction"
    },
    "6e971275-b508-4627-9380-39dc63e90b3d": {
        "text_answer": "Yes The evidence does not mention any vaccines being administered to the participants in the primary trial",
        "label": "Entailment"
    },
    "ab6d9f92-0380-4e3a-9bff-032ad4d918ed": {
        "text_answer": "No  Explanation  The statement it was observed that 11000 patients",
        "label": "Contradiction"
    },
    "8d27bb53-e66e-4eab-bea4-0597fd5760b5": {
        "text_answer": "No  The statement is not entailed by the evidence provided for either the primary or secondary trial The primary trial excl",
        "label": "Contradiction"
    },
    "a793df3f-fa04-4d48-a2c6-006589d52e84": {
        "text_answer": "Yes The evidence shows that both cohorts had negative standardized scores indicating below average cognitive function on average but",
        "label": "Entailment"
    },
    "f54c9be8-81b3-4544-9e82-b7058b9911f5": {
        "text_answer": "Yes  Explanation The statement a crucial requirement for both the primary and secondary clinical trials is that candidates",
        "label": "Entailment"
    },
    "df43c972-9623-462c-9044-2d632e1daafb": {
        "text_answer": "No  Explanation  The statement patients with papillary carcinoma and controlled blood",
        "label": "Contradiction"
    },
    "026b062f-0ebf-4e02-9ff8-3bbd12f09ea7": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "70e1b8ee-05e4-4427-ba8b-c8762a677b9a": {
        "text_answer": "No  Explanation  The statement the primary trial participants receive whole breast radiation therapy and both",
        "label": "Contradiction"
    },
    "f96fa263-12b2-475c-926d-57b8588e85ef": {
        "text_answer": "Yes The statement the primary clinical trial welcomes patients diagnosed with tx nx mx t0 nx m0",
        "label": "Entailment"
    },
    "e9f1fcfa-40ed-4360-bf37-4260888d241b": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e21904b2-3e78-4f20-80e3-562a82fc9cfe": {
        "text_answer": "  No children are not explicitly included in the primary trial but they are not explicitly excluded from the secondary trial either",
        "label": "Contradiction"
    },
    "0ff4990d-1f43-4516-a7b4-62b59526439d": {
        "text_answer": "Yes regarding the requirement of HER2 positive tumor  Explanation The statement All the",
        "label": "Entailment"
    },
    "02ef43dd-1a1c-49c4-8ce0-01f03f733e81": {
        "text_answer": "Yes  Explanation  The statement subject status subcategory is a subdivision of subject status",
        "label": "Entailment"
    },
    "82080910-276d-4987-8d95-0a39b92ce3ee": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence pertains to breast cancer and the statement is about",
        "label": "Contradiction"
    },
    "159bf774-0488-4260-94ed-e106c3e02bf7": {
        "text_answer": "Yes  Explanation  The statement cohort 2 of the primary trial reported fewer inc",
        "label": "Entailment"
    },
    "224ad5d9-659b-474a-b9ff-7cb17e104ddf": {
        "text_answer": "No  Explanation The statement does not follow directly from the evidence provided The evidence only gives the",
        "label": "Contradiction"
    },
    "46299940-216a-446b-bab8-6005845f46c6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "f12f052d-fd1b-407b-a2d9-923f00111a45": {
        "text_answer": "Yes The evidence includes exclusion criteria for women of childbearing potential who are unwilling or unable to use an",
        "label": "Entailment"
    },
    "bd7ca920-80f7-4bf8-a09c-3f619056e700": {
        "text_answer": "Yes  Explanation  The statement there were minimal adverse events observed in the secondary clinical trial",
        "label": "Entailment"
    },
    "7e271bbd-26e8-422e-be5c-54d294da815a": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only includes patients with histologically proven DCIS or",
        "label": "Contradiction"
    },
    "8c002058-a160-4eab-bb58-5874ac1a86d4": {
        "text_answer": "Yes  Explanation The statement specific symptoms are predominantly reported as adverse events in the primary clinical",
        "label": "Entailment"
    },
    "6734e552-d882-446e-a02f-c6bbe2eeb6ed": {
        "text_answer": "  Yes the patient is eligible for the primary trial based on the given inclusion criteria However the eligibility",
        "label": "Entailment"
    },
    "f72c1fc3-cfdb-4aa3-a8a8-968f416e35b7": {
        "text_answer": "Yes  Explanation  The statement during the primary clinical trial and the secondary clinical trial",
        "label": "Entailment"
    },
    "8623aaca-7fb2-44d5-b968-a064007b7112": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only includes patients with histologically proven DCIS or",
        "label": "Contradiction"
    },
    "5df26e2d-1a55-4d02-b95b-1796c872a7ec": {
        "text_answer": "Yes  Explanation  The statement over 910ths of patients in the",
        "label": "Entailment"
    },
    "048dc5c5-ef7e-4717-850e-521e58feecf0": {
        "text_answer": "No  Explanation  The statement amyloid resorption induction is amylo",
        "label": "Contradiction"
    },
    "5ba46a49-9158-4409-815d-0830526da5c4": {
        "text_answer": "No  Explanation  The evidence provided in the text only states the number of participants analyzed in each",
        "label": "Contradiction"
    },
    "65130a82-a75f-4faa-85a9-5ec4535aa67b": {
        "text_answer": "No  Explanation  The statement provided is a mathematical definition and does not relate to the adverse",
        "label": "Contradiction"
    },
    "496667f2-e493-4b4e-a257-7b8de3833e8b": {
        "text_answer": "Yes  The placebo and Trabectedin interventions are both administered as intravenous infusions",
        "label": "Entailment"
    },
    "5b19b14f-2049-4c5f-8e3b-5d8dffa5d687": {
        "text_answer": "No  Explanation  The statement Patients with histologically documented metastatic or unresect",
        "label": "Contradiction"
    },
    "40d84c7b-e126-4d6f-9588-eb9c385ca716": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement incorrectly",
        "label": "Contradiction"
    },
    "18c09a69-f72b-42db-b15b-45e369db34e5": {
        "text_answer": "  No   Explanation   The statement patients with 45 cere",
        "label": "Contradiction"
    },
    "cd2cb8fc-7624-479c-b9ee-e2ca3cf5ea18": {
        "text_answer": "Yes  Explanation  The primary trial does not mention anything about the evaluation of Ki67",
        "label": "Entailment"
    },
    "6f4c1d2f-4b97-4f77-b25b-004addb58726": {
        "text_answer": "No  Explanation  The statement use of gabapentin or herceptin within the last",
        "label": "Contradiction"
    },
    "b9fd7445-fced-4f32-9efb-7e142d1963e2": {
        "text_answer": "No  Explanation The statement The same percentage of patients suffered adverse events in both coh",
        "label": "Contradiction"
    },
    "a52b9758-f769-4350-b617-5215621b815b": {
        "text_answer": "Yes The primary clinical trial involves two arms one with gemcitabine and the other with carboplatin",
        "label": "Entailment"
    },
    "bad327e8-73f2-4903-a0bf-ed5d08c81f69": {
        "text_answer": "No  Explanation  The primary clinical trial assesses patients progress by measuring the variation in ser",
        "label": "Contradiction"
    },
    "9bd8875f-ce04-496a-b039-6a84bb2e5548": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the primary trial",
        "label": "Contradiction"
    },
    "602c538d-9b6f-4a94-8423-b7d5427ee15e": {
        "text_answer": "No   Explanation  The statement is not directly related to the evidence provided The evidence describes",
        "label": "Contradiction"
    },
    "5e094086-297e-44c7-9119-aa451e326e8c": {
        "text_answer": "No  Explanation The statement women aged 18 or older are eligible for the secondary trial",
        "label": "Contradiction"
    },
    "fc16338c-2505-48c4-ab18-e7de394cab62": {
        "text_answer": "Yes The evidence does not explicitly state that AfricanAmerican patients are excluded from the trial so they are eligible to participate",
        "label": "Entailment"
    },
    "451c8e9e-03c1-4b7a-9b84-5129c5623f1b": {
        "text_answer": "Yes The statement is entailed by the evidence as the statement mentions breast cancer and requiring hormonal treatment",
        "label": "Entailment"
    },
    "e561775c-d739-405c-ac1e-a8a9ccca4530": {
        "text_answer": "No  Explanation  The statement the primary trial adminsters its intervention sublingually and",
        "label": "Contradiction"
    },
    "5ed2538b-155d-4527-aa80-b6a19c5a6602": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not directly measure primary tumor diameter",
        "label": "Contradiction"
    },
    "a680a9d1-387f-48e3-8e30-01b306c0b964": {
        "text_answer": "  Yes the statement is entailed by the evidence for the secondary trial regarding documented allergy to cephalos",
        "label": "Entailment"
    },
    "3d580aba-2e7b-44bc-a094-83f404ebbd6a": {
        "text_answer": "No   Explanation   The primary trial measures the change in units on a scale for vag",
        "label": "Contradiction"
    },
    "cf1b44d2-94e8-49b6-adbf-036a44f28402": {
        "text_answer": "Yes  Explanation  The statement primary clinical trial records a larger number of bronchopneum",
        "label": "Entailment"
    },
    "0c902de2-30b5-4ab8-9739-70be987d043a": {
        "text_answer": "Yes  Explanation The evidence states that 1 out of 4 patients in cohort 2",
        "label": "Entailment"
    },
    "86dd343d-01be-46f6-aed5-9ad9423aca98": {
        "text_answer": "No  Explanation  The statement 500 adverse events were observed in the primary trial",
        "label": "Contradiction"
    },
    "22a06af0-a4f9-4311-92e0-d2d13a24b9b1": {
        "text_answer": "Yes  Explanation  The statement the adverse events such as recurrent malignancies",
        "label": "Entailment"
    },
    "943f62ca-d87c-4a5e-9355-6750d7d9b58f": {
        "text_answer": "Yes  Explanation The statement The dosage of Denosumab in Intervention 1",
        "label": "Entailment"
    },
    "6e2f3c50-84c2-41e2-8188-a83c94b2704b": {
        "text_answer": "No  Explanation  The statement eyelid oedema upper gastrointest",
        "label": "Contradiction"
    },
    "bad8129b-64a4-4dfc-bb88-8bcea4fe2dc4": {
        "text_answer": "No  Explanation  The statement cohort 2 of the primary clinical trial experienced significantly",
        "label": "Contradiction"
    },
    "603ccef1-eacf-4053-85d3-106eda10ca83": {
        "text_answer": " No   Explanation  The inclusion criteria state that the breast cancer must be unilateral",
        "label": "Contradiction"
    },
    "4ac023d3-e86c-47bb-bbd5-1b6907e8cab3": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "ed3e6033-e499-4743-9aca-a275a80a1e4e": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence does not provide any",
        "label": "Contradiction"
    },
    "3c749ffd-27b3-473d-92c9-c4d3899c9689": {
        "text_answer": "Yes Both trials measure pCR as their outcome The primary trial has a small difference in pCR rates between the two",
        "label": "Entailment"
    },
    "5ce949a2-19fb-4580-8b0e-f0652dd064e3": {
        "text_answer": "No  The primary trial includes patients with a breast tumor of 1 cm in diameter while the secondary trial does",
        "label": "Contradiction"
    },
    "2f5d2e0a-6378-4b00-b5ed-760d021808c8": {
        "text_answer": "Yes The evidence does not directly address sacral intraspinal meningioma but it does not exclude individuals with",
        "label": "Entailment"
    },
    "96ee335e-d938-4b45-a22d-49b03dbb2af0": {
        "text_answer": "No  Explanation  The evidence provided in the trial results does not mention anything about Enterovirus",
        "label": "Contradiction"
    },
    "38e0b539-6f73-4e11-bb55-0b021f66ee84": {
        "text_answer": "No  Explanation  The statement patients in both cohort 1 and 2",
        "label": "Contradiction"
    },
    "ee03b5cc-6cfe-4b3a-8429-493f95c97b71": {
        "text_answer": "No  Explanation The primary clinical trial includes a requirement that the primary tumor size be greater than ",
        "label": "Contradiction"
    },
    "e9c0f175-b715-4b33-86a2-aa21c2990164": {
        "text_answer": "Yes  Explanation The evidence states that patients in Intervention 1 receive Active Breathing Coord",
        "label": "Entailment"
    },
    "827cb89b-a78f-49e9-b342-d00e7b46e61f": {
        "text_answer": "  No  Explanation  The evidence provided in the trial results does not directly measure primary tum",
        "label": "Contradiction"
    },
    "4bc6699d-0ac2-4358-9425-1d377151ffa8": {
        "text_answer": "Yes  Explanation  Both the primary and secondary clinical trials report the determination of the maximum toler",
        "label": "Entailment"
    },
    "a0ebcb11-7643-4861-b26c-8b1716fd00c1": {
        "text_answer": "No  Explanation  The statement there were no deaths or Hospitalizations in cohort ",
        "label": "Contradiction"
    },
    "13d13c8d-1d58-411f-943b-cbcd836b8d17": {
        "text_answer": "No  Explanation The statement mobilization clinical trial setting is a clinical trial or treatment setting",
        "label": "Contradiction"
    },
    "09f76c97-d8e4-45bd-9365-71e654770e39": {
        "text_answer": "Yes  Explanation The statement midline is a medial line especially the medial line",
        "label": "Entailment"
    },
    "1ccb499d-d126-4ec6-bed1-c121dfa13d2d": {
        "text_answer": "Yes  Explanation  Both trials include patients who are 18 years of age or older",
        "label": "Entailment"
    },
    "909d54ab-358d-4892-9bd1-e71d6d3bc24c": {
        "text_answer": "No  Explanation The statement the percentage of cells expressing ki67 increased by 8",
        "label": "Contradiction"
    },
    "15f4f1d2-c4db-403e-83ed-85e6958ee7ed": {
        "text_answer": "No  Explanation  The statement the number of adverse events in the secondary clinical trial was",
        "label": "Contradiction"
    },
    "0c4d0064-476e-426e-ae13-4f53c07ea0b4": {
        "text_answer": "No The statement is not entailed by the evidence as the primary trial excludes participants who have been previously treated with ful",
        "label": "Contradiction"
    },
    "34208e81-25b5-40a7-ba91-ffdece7c96e1": {
        "text_answer": "Yes The evidence states that there were 12 participants with SD at week 12 and 10 participants",
        "label": "Entailment"
    },
    "afa65be8-62bf-4c63-8670-a997a06c6943": {
        "text_answer": "No  The evidence does not mention any fatalities in either trial",
        "label": "Contradiction"
    },
    "c4ab76ed-d3ce-4368-b081-c39413094966": {
        "text_answer": "Yes The statement is entailed by the evidence as it correctly states that no adverse events occurred during the primary trial and",
        "label": "Entailment"
    },
    "cac3538f-89a2-4037-9928-4aaa708ae34f": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence because the secondary trial does",
        "label": "Contradiction"
    },
    "abd83d4d-ac75-4626-928d-1b511a61d2b7": {
        "text_answer": "No  Explanation The evidence provided does not give any information about the longest PFS observed in the",
        "label": "Contradiction"
    },
    "dc3aaeaa-d573-410b-a1f2-a55af755fc83": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence describes a",
        "label": "Contradiction"
    },
    "8a3619a4-4224-4451-b7f8-8fc2ff8ec26f": {
        "text_answer": "Yes The exclusion criteria state that individuals who have received antineoplastic chemotherapy androgens or est",
        "label": "Entailment"
    },
    "710206ba-d90c-4341-a1ae-b937ffc50a2f": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence reports that there were no participants with complete response at either week",
        "label": "Entailment"
    },
    "29fce0a9-c8ac-4851-afbf-a0fbd8357eb9": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only reports the Ki67 expression at",
        "label": "Contradiction"
    },
    "08d2198a-3bd7-453e-8ad1-0e35312cb348": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not indicate that at least one patient treated",
        "label": "Contradiction"
    },
    "d0856f66-d9fb-4bbd-906e-9602d9121c22": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "9ab1125f-0d0b-4480-b5c2-8a09378a8df4": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fb362bcb-d93e-4d35-9127-db0efd9012dc": {
        "text_answer": "Yes  Explanation  The evidence provided indicates that the primary and secondary clinical trials recorded all adverse",
        "label": "Entailment"
    },
    "dcb23a61-648b-4831-92e9-9e61cc596be3": {
        "text_answer": "No  The evidence mentions adequate liver function as an inclusion criterion but it does not state that there are",
        "label": "Contradiction"
    },
    "73876da9-0c79-43eb-9d1f-b7f2d729f43c": {
        "text_answer": "Yes  Explanation The primary trial had one intervention group Pyridoxine and one place",
        "label": "Entailment"
    },
    "2bf9e0d9-1195-4c03-b2bc-d491ff1cd174": {
        "text_answer": "Yes  Explanation The statement 3636 of the primary trial patients suffered an increase",
        "label": "Entailment"
    },
    "726f25cd-4611-43a5-b7c6-15f7393b67ee": {
        "text_answer": "No  Explanation  The statement 492 more Participants in the dalot",
        "label": "Contradiction"
    },
    "3670694c-a13e-4639-bc3d-e51db3bf8149": {
        "text_answer": "No  Explanation The statement Only 61 Cervical Cancer patients in cohort",
        "label": "Contradiction"
    },
    "a830799d-017f-4656-aed0-d428d5e0c73f": {
        "text_answer": "Yes The evidence shows that there were no adverse events reported in cohort 2 while all adverse events",
        "label": "Entailment"
    },
    "2d241b66-d0a0-4012-9d5b-1ef1a74bcd79": {
        "text_answer": "Yes  Explanation The primary clinical trial involved reflexology treatment given for 10 weeks",
        "label": "Entailment"
    },
    "67fc355a-1537-479d-b0fc-cd39bdb3cf6d": {
        "text_answer": "No  Explanation  The statement The dosage of Zoledronic Acid in Inter",
        "label": "Contradiction"
    },
    "ef3e540e-b8dc-4fd5-9eaa-f32a657a57c6": {
        "text_answer": "Yes Both trials require patients to have a functional ECOG status less than 2",
        "label": "Entailment"
    },
    "9b49f98a-af07-455e-af36-4f6a3f7e3e52": {
        "text_answer": "Yes The primary trial had a lower frequency of pericardial effusions 045 compared to the",
        "label": "Entailment"
    },
    "c6e42e3e-8900-43bb-b1de-61f1d1dcf075": {
        "text_answer": "No  Explanation  The statement The results from the primary trial indicate that the Arm A intervention",
        "label": "Contradiction"
    },
    "b181b889-6991-4710-a94c-536591db88fc": {
        "text_answer": "No  The statement is not entailed by the evidence as the inclusion criteria specify HER2 positive tumor e",
        "label": "Contradiction"
    },
    "d3302027-c157-4d58-8653-cf5053658fad": {
        "text_answer": "No  Explanation The evidence provided in the primary trial only mentions the administration of Dexam",
        "label": "Contradiction"
    },
    "e7203466-5ee1-4733-ac54-730489e348b2": {
        "text_answer": "No  The placebo intervention is administered via injections not orally and the dose is the same as",
        "label": "Contradiction"
    },
    "bb7c2e9b-0a9b-48da-97e8-3a78ca82966f": {
        "text_answer": "Yes  Explanation The evidence shows that the percentage of participants who were up to date for colorect",
        "label": "Entailment"
    },
    "90432ec4-8df5-408b-8998-39f2a698314d": {
        "text_answer": "No  Explanation The primary trial does not mention anything about heart transplant as an exclusion criter",
        "label": "Contradiction"
    },
    "a3b8086c-3eec-402c-8b95-4446b33673b6": {
        "text_answer": "  Yes for the primary trial No for the secondary trial with the additional requirement of Her2neu",
        "label": "Entailment"
    },
    "6fe2c751-a06e-4679-a13d-3335fe5887e2": {
        "text_answer": "No  Explanation The evidence provided in the trial description does not mention paclitaxel or any",
        "label": "Contradiction"
    },
    "ed6a6f04-0b3d-4dc7-96fd-2f0547d6fe17": {
        "text_answer": "No  Explanation The primary trial has a specific criterion for the number of cerebral met",
        "label": "Contradiction"
    },
    "213bae99-da68-4307-a7c9-71343afbcd39": {
        "text_answer": "Yes The primary clinical trial involves a threeweek cycle of treatment while the secondary clinical trial does not specify a cycl",
        "label": "Entailment"
    },
    "97e71457-8a63-4bf3-b1cf-b2743433e7f2": {
        "text_answer": "Yes The evidence does not mention any drugs radiotherapy or CBT being used in the interventions",
        "label": "Entailment"
    },
    "eb93eb13-978c-4f27-8c2b-c3ddddcbafcf": {
        "text_answer": "Yes The primary trial patients receive fewer total doses of MM121 and Paclitaxel per cycle",
        "label": "Entailment"
    },
    "783f37e2-d649-493a-9d0c-0de214ff8ad2": {
        "text_answer": "  No The statement is not entailed by the evidence as it incorrectly implies that patients with unstable angina",
        "label": "Contradiction"
    },
    "eae69c88-b4bc-4683-aacf-60d287e4eebc": {
        "text_answer": "No  The statement is not related to the evidence provided The evidence only discusses information about two clinical trials their",
        "label": "Contradiction"
    },
    "21a5f296-5b3c-4860-be64-77ffb8f76501": {
        "text_answer": "Yes Both cohorts had the same number of participants 1420 each",
        "label": "Entailment"
    },
    "f4fd9b7c-ccd9-4131-95d0-2a3a8071faf4": {
        "text_answer": "No  Explanation  The statement 11 more Participants in the ERpositive",
        "label": "Contradiction"
    },
    "8b2b5b8e-3723-4261-8fd5-a624c9367ef2": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the percentage change in ser",
        "label": "Contradiction"
    },
    "386a63a3-cd3f-4f8c-af45-cfe9b26e4bc6": {
        "text_answer": "No  The statement is not entailed by the evidence as the frequencies of pericardial effusions were different between",
        "label": "Contradiction"
    },
    "d3177b24-1a89-40d0-b3a5-e79870dc216e": {
        "text_answer": "No  Explanation  The statement the primary clinical trial reported a higher incidence of infection",
        "label": "Contradiction"
    },
    "bc03d7d7-65ed-4331-a5c9-997968a47547": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence reports the number of adverse events observed in patients of co",
        "label": "Entailment"
    },
    "ef73b41f-a188-41e1-af84-8ba9ee13d6c6": {
        "text_answer": "Yes  Explanation  The evidence provided in the results 1 and 2 indicates that there were",
        "label": "Entailment"
    },
    "f11744ff-fa1a-4d98-ad4a-03fe1fa9e519": {
        "text_answer": "Yes the statement is not entailed by the evidence as the evidence does not mention anything about life expectancy pregnancy",
        "label": "Entailment"
    },
    "205a0d18-ba5e-4efd-b403-557bf188daa2": {
        "text_answer": "Yes  Explanation The evidence states that under 50 of the participants in the High",
        "label": "Entailment"
    },
    "b29091a1-befa-4edc-9bc9-06263826bfdd": {
        "text_answer": "Yes  Explanation The primary trial includes women with locally advanced recurrent or metastatic",
        "label": "Entailment"
    },
    "70310501-6b9e-4283-9981-5f709b9517b6": {
        "text_answer": "Yes  Explanation The statement over 015 of patients in the primary trial and the",
        "label": "Entailment"
    },
    "5677aa15-f929-41ac-97e2-07857e792505": {
        "text_answer": "Yes  Explanation  The statement in their results the primary clinical trial and the secondary clinical",
        "label": "Entailment"
    },
    "a1c132f7-d56a-4d89-96eb-b37310cd37d6": {
        "text_answer": "Yes  Explanation  The statement in both the primary trial and the secondary trial there were ",
        "label": "Entailment"
    },
    "cbe273ac-6267-4827-8ba2-8c8c34d69115": {
        "text_answer": "Yes  Explanation The statement patients in the secondary trial experienced anemia pneumonia",
        "label": "Entailment"
    },
    "f2217745-3601-4f6e-b893-11ca72e32556": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence provided The primary trial mentions",
        "label": "Contradiction"
    },
    "9ddda9ad-0cb3-4ea8-8abe-59b227a8290d": {
        "text_answer": "No  Explanation  The statement the number of participants varied significantly between the two cohorts",
        "label": "Contradiction"
    },
    "2bf60bd1-4d11-4a7d-9d69-7f13e93df39c": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not provide",
        "label": "Contradiction"
    },
    "75e0a9f9-003d-4bfe-a720-4f84d2d0e7b4": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence reports a",
        "label": "Contradiction"
    },
    "7a4c195c-e5a6-49b5-b8de-842704bfe7f4": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "58c1c63d-fcf2-400d-af60-9f33c9820f1b": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the outcome measurements in the",
        "label": "Contradiction"
    },
    "49a7e9fa-4a0f-4bce-ab0c-c13056e98de2": {
        "text_answer": "Yes regarding the absence of UTI in the trial However the statement does not directly address the improvement aspect",
        "label": "Entailment"
    },
    "8665ed72-5c94-4c4f-8dbc-a6950275ca98": {
        "text_answer": "No  Explanation  The statement those patients with a history of chemotherapy or radiotherapy",
        "label": "Contradiction"
    },
    "505ccc8c-b07a-4902-b8c3-4d3b4891779a": {
        "text_answer": "Yes   Explanation The evidence states that patients will receive multiple injections of dendritic cells",
        "label": "Entailment"
    },
    "c20de03b-8eba-4546-8f77-5e54cf25dfb2": {
        "text_answer": "No  Explanation  The statement The dosage of Denosumab in Intervention ",
        "label": "Contradiction"
    },
    "f82d082e-896d-4d9e-ad92-d64b655dafb8": {
        "text_answer": "No  The patient described in the statement does not meet the eligibility criteria for the trial as they have a life",
        "label": "Contradiction"
    },
    "4bfe4376-ffad-4132-8604-b5afbc78429d": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the evidence only",
        "label": "Contradiction"
    },
    "0471ee43-16a7-417e-94db-0ef86bd5b0a9": {
        "text_answer": "No  Explanation  The statement a mastectomy for stage iv bc does not necessarily",
        "label": "Contradiction"
    },
    "8e19b7e1-e5ac-473f-a4e7-2c8ddfa7a496": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the evidence only discuss",
        "label": "Contradiction"
    },
    "2cff90dc-7bc3-4acb-a250-10de476d1d4c": {
        "text_answer": "Yes The evidence states that individuals with a history of interstitial lung disease or pneumonitis are excluded from",
        "label": "Entailment"
    },
    "b3b142e1-adad-429b-a7de-c852a74edaaa": {
        "text_answer": "Yes The evidence does not include any criteria related to nationality ethnicity mental health status or gender in the",
        "label": "Entailment"
    },
    "a5eb56c2-6fc0-45da-8a6a-2818cb64a7f0": {
        "text_answer": "No  Explanation  The evidence provided in the results only states that there were 5 participants in",
        "label": "Contradiction"
    },
    "a60a8f30-02a6-46a4-bb00-bea702d5103d": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial includes a breast tumor that is only ",
        "label": "Contradiction"
    },
    "d9f28f1f-3a09-4ef9-a80a-9caa02f9069b": {
        "text_answer": "yes for the ability to provide informed consent only The statement does not directly relate to the inclusionexclusion criteria for",
        "label": "Entailment"
    },
    "b581bb7b-6aaa-4c8a-81a0-c5e6a58ebcdf": {
        "text_answer": "No  Explanation The evidence provides the median PFS for each treatment group but it does not",
        "label": "Contradiction"
    },
    "4e56ec6c-1b0c-4d14-b53a-2695fb9dcb7d": {
        "text_answer": "Yes The evidence states that the intervention includes treated subjects with device placed and treated with partial breast irradiation and the",
        "label": "Entailment"
    },
    "2bd78232-4872-4d66-ade9-836190b86e1d": {
        "text_answer": "No  The evidence explicitly states that there should be no meningeal carcinomatosis for a patient to be",
        "label": "Contradiction"
    },
    "953b0337-0c43-42fb-a334-dad6900e2e0f": {
        "text_answer": "Yes  Explanation The evidence includes a statement that it was noted that on average patients in the",
        "label": "Entailment"
    },
    "464e2cd9-6c59-4692-a3fc-083c374f4a5c": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as there is no mention of Par",
        "label": "Contradiction"
    },
    "91e585c8-503f-4253-b749-80caa8ebc3e1": {
        "text_answer": "Yes The statement mentions ascites and Pneumocystis jirovecii pneumonia",
        "label": "Entailment"
    },
    "577f3aad-32c6-4a0b-8df1-615a9a58fa29": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial and the secondary clinical trial noted an identical",
        "label": "Entailment"
    },
    "13765ddf-3be9-411a-ae7a-24a0bdffe2d8": {
        "text_answer": "Yes  Explanation The statement both the primary clinical trial and the secondary clinical trial necessitate that",
        "label": "Entailment"
    },
    "55bcb170-5b8a-4a7d-b509-f2ab4a2f587a": {
        "text_answer": "No  Explanation  The statement afraid of being rejected is a question about whether an individual",
        "label": "Contradiction"
    },
    "06b2ed93-63bb-4ef0-964c-372ff9077cb4": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "c6408b0b-2cdc-4298-a7d5-9e6fe3d52925": {
        "text_answer": "No  Explanation  The statement for all of its participating individuals the secondary clinical trial applies",
        "label": "Contradiction"
    },
    "4cdd4dc9-e171-438b-8864-1f451af7c15e": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it makes an additional",
        "label": "Contradiction"
    },
    "2b24be38-efe1-4044-92ce-81cace8f239a": {
        "text_answer": "yes In the primary trial Armodafinil is given daily to one cohort while in the secondary",
        "label": "Entailment"
    },
    "3ac1baef-7e74-405c-ae5a-897ac2b2fd5f": {
        "text_answer": "No   Explanation The statement all 100 of patients in the primary trial suffered",
        "label": "Contradiction"
    },
    "c8990938-e3fe-470d-a6d2-d28a3fe89b0b": {
        "text_answer": "Yes  Explanation  The statement the primary clinical trial requires informed consent but there is no",
        "label": "Entailment"
    },
    "5ed2b8ad-5b6d-4397-80c5-48d08c8f51ed": {
        "text_answer": "Yes The statement is entailed by the evidence as both cohorts receive the same dosage of CUDC",
        "label": "Entailment"
    },
    "3df32fab-15e5-4536-908f-d9c76529702e": {
        "text_answer": "Yes  Explanation The evidence states that 13 participants received the vaccine in the primary clinical trial",
        "label": "Entailment"
    },
    "98e89253-c343-4f1f-b2a0-0e09e5cba8ee": {
        "text_answer": "No  Explanation  The statement the participants of cohort 1 of the primary clinical",
        "label": "Contradiction"
    },
    "66362fd1-8e4f-49ad-9098-a67f65cb91c2": {
        "text_answer": "Yes The evidence states that 13 out of 49 participants 265 developed imagable H",
        "label": "Entailment"
    },
    "2f7bae39-4081-4328-85e2-2a400ec72589": {
        "text_answer": "Yes The evidence does not provide any information that would exclude patients with a BMI less than 30 from either trial",
        "label": "Entailment"
    },
    "1bc6de92-961a-4a4f-8ead-8f5f6f496d70": {
        "text_answer": "No  Explanation The evidence provided in the results only gives the median with range change in",
        "label": "Contradiction"
    },
    "3c273853-f394-4550-9969-d476fff275db": {
        "text_answer": "No  Explanation  The statement there were 52 cases of febrile neutrop",
        "label": "Contradiction"
    },
    "cc2428b1-d508-406f-a59f-186d62e93600": {
        "text_answer": "No  Explanation  The evidence provided in the text does not directly support the statement that the",
        "label": "Contradiction"
    },
    "4c42491a-5ff2-41f8-bb40-6c7fe4dd5c99": {
        "text_answer": "No  Explanation  The statement the only types of adverse events observed in patients from the",
        "label": "Contradiction"
    },
    "27abad83-36b9-47a4-8d11-d08751d1d81a": {
        "text_answer": "No  Explanation The evidence provided in the text only reports the average pain intensity scores and the change",
        "label": "Contradiction"
    },
    "001da1c9-0fd7-4a15-baa5-9ee16f2a28bd": {
        "text_answer": "yes for the primary trial only The secondary trial does not mention anything about resistance to AI therapy",
        "label": "Entailment"
    },
    "5a6a1e08-4a0a-45ea-91f5-053182a352cc": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it introduces new",
        "label": "Contradiction"
    },
    "afa9c5da-71e1-4c40-80fa-bcc02199e395": {
        "text_answer": "No  Explanation  The statement the primary clinical trial was marked by numerous adverse events reported",
        "label": "Contradiction"
    },
    "37321416-91c4-4dd1-952b-6b23865d769c": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the evidence only describes the instruction",
        "label": "Contradiction"
    },
    "3a141563-97b8-4154-8c9c-f1f551ec7969": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "fe5d5e2f-2b54-48f4-b95b-278456d1db46": {
        "text_answer": "No  Explanation  Although the same medications FMX and lapatinib are used",
        "label": "Contradiction"
    },
    "a92239f6-9f31-4e7f-a8be-2792789ea5f1": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial does not include trastuzumab in",
        "label": "Entailment"
    },
    "c98e803e-a899-4ed8-aed0-0611eeef943d": {
        "text_answer": "  No the statement is not entailed by the evidence for the primary trial but it is for the secondary trial",
        "label": "Contradiction"
    },
    "49e29ec7-08a2-481d-9fc4-ecb66b09cdfe": {
        "text_answer": "No  Explanation  The statement Smokers are excluded from the primary trial but may be",
        "label": "Contradiction"
    },
    "804aa28f-b791-4a99-98e7-a443456de4b2": {
        "text_answer": "Yes The patients in the secondary trial are also eligible for the primary trial Therefore the statement about ct25",
        "label": "Entailment"
    },
    "045ad9d7-6830-4a3d-bba5-4e90ee838977": {
        "text_answer": "No  Explanation The statement provided is not related to the evidence given in the trial description The",
        "label": "Contradiction"
    },
    "610662cd-053e-4396-a6d6-8aaac67a7440": {
        "text_answer": "No  Explanation  The statement the secondary clinical trial necessitates the use of a minimum",
        "label": "Contradiction"
    },
    "10749f91-8743-4f6a-aa4b-6cc713e927c5": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement is about",
        "label": "Contradiction"
    },
    "9cd909a2-b826-4e0d-bbbd-3ad52978d1d9": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the trial includes patients with HER",
        "label": "Contradiction"
    },
    "ef0cf72d-6cc3-4589-8016-e96db1b9f33a": {
        "text_answer": "Yes  Explanation The statement not a single kind of adverse event registered in the primary clinical",
        "label": "Entailment"
    },
    "585bf6db-16c7-4433-8c98-30a6b5a88fc0": {
        "text_answer": "No  Explanation  The statement the primary trial involves administration of alisertib in both",
        "label": "Contradiction"
    },
    "31464efc-048a-451b-a02b-5576933a893a": {
        "text_answer": "No   Explanation  The evidence provided in the text does not mention anything about captopril",
        "label": "Contradiction"
    },
    "a0e47b7d-7f2d-43ba-8f93-dc5f9dcd648b": {
        "text_answer": "No  Explanation  The statement over 15 of patients in the primary trial and",
        "label": "Contradiction"
    },
    "ce5dd10f-dad3-46a4-93de-fe57c657f6d9": {
        "text_answer": "Yes The evidence shows a total of 3 vomiting incidents out of 149 participants in Adverse Events",
        "label": "Entailment"
    },
    "bb281225-8211-47ed-8789-a42a389fa379": {
        "text_answer": "No  The statement is not about the eligibility criteria for the primary trial It is about a different topic",
        "label": "Contradiction"
    },
    "be98ce03-a87b-4fe5-9058-a56259581c41": {
        "text_answer": "Yes  Explanation The statement the primary trial uses higher doses of Lenalidomide",
        "label": "Entailment"
    },
    "4db7f58c-f006-48d0-944f-a02b3231615c": {
        "text_answer": "No  Explanation  The statement Patients in the primary trial will receive higher doses of",
        "label": "Contradiction"
    },
    "bcdef75a-f013-4d65-84e1-6004a054d574": {
        "text_answer": "No  The evidence specifies that there should be no meningeal carcinomatosis for a patient to qualify",
        "label": "Contradiction"
    },
    "6962c2aa-4df2-4479-8744-5784fe8c9fcf": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a3be9d38-6897-4ead-9ada-790104f2de50": {
        "text_answer": "No The statement is not entailed by the evidence as individuals with a history of myocardial infarction",
        "label": "Contradiction"
    },
    "12a03716-0ec6-4ffe-abd8-02411c083ee5": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as the clinical trial involves the use",
        "label": "Contradiction"
    },
    "156b015d-e2bb-4f38-a312-62e1cf7583d6": {
        "text_answer": "No  Explanation  The statement Participants must be resistant to AI therapy and m",
        "label": "Contradiction"
    },
    "d3aeafa2-2963-4220-b80d-cd5cde582fe8": {
        "text_answer": "  No   Explanation   The statement is not entailed by the evidence as the",
        "label": "Contradiction"
    },
    "d0bfc2f3-c94f-4d4c-ae87-9f9744bd767a": {
        "text_answer": "No The statement is about a different topic TMN staging of appendiceal carcinoma than the ad",
        "label": "Contradiction"
    },
    "9a814107-778f-43ba-bd59-383ae14594ed": {
        "text_answer": "Yes The statement is entailed by the evidence as women with locally advanced ER breast cancer who are considering a",
        "label": "Entailment"
    },
    "2d007409-93ff-4753-a2e5-c5f94d4fe6dd": {
        "text_answer": "  Yes   Explanation   The statement is entailed by the evidence as the primary",
        "label": "Entailment"
    },
    "c51494ed-aee9-4219-b46b-ed47bc261788": {
        "text_answer": "Yes The primary trial patients receive fewer total doses of MM121 and Paclitaxel per week",
        "label": "Entailment"
    },
    "136f0a2e-563c-4085-b390-ac2db90f7aac": {
        "text_answer": "Yes The evidence shows that both cohorts had below average standardized scores for cognitive function indicating a decline compared to",
        "label": "Entailment"
    },
    "76eeb32c-d3c0-4ed0-91d4-104417af35e0": {
        "text_answer": "No  Explanation  The evidence provided in the clinical trial results does not state that all patients had",
        "label": "Contradiction"
    },
    "a402b1c9-c65b-48fb-a2d5-e08c0152e8c3": {
        "text_answer": "No  Explanation The statement requires that each participant gets at least 20mg of mcs",
        "label": "Contradiction"
    },
    "431b6222-3b82-4eb4-af82-ef98b513e649": {
        "text_answer": "Yes The evidence does not report any unexpected deaths or hospitalizations in either trial",
        "label": "Entailment"
    },
    "a5415a49-0b04-4f8f-a7ec-a8c276b2cf64": {
        "text_answer": "Yes  Explanation The statement There are more cases of Biliary colic and Diarrhoea",
        "label": "Entailment"
    },
    "a6d3fa8e-c521-4843-b4e7-0a9983acfad0": {
        "text_answer": "yes but with a caveat The statement is entailed by the evidence in the sense that pCR pathological",
        "label": "Entailment"
    },
    "71ba0864-5490-4e25-989c-4672afa15599": {
        "text_answer": "  No   Explanation   The statement describes a patient with a diagnosis of stage I",
        "label": "Contradiction"
    },
    "f41f7611-7c20-4f71-8b2d-433e36f840de": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence provided in the trial results",
        "label": "Contradiction"
    },
    "3264decd-0cee-4137-a5da-e9a27e3b7791": {
        "text_answer": "Yes The primary trial reports results in percentage and the secondary trial reports results in number of participants which are not the same",
        "label": "Entailment"
    },
    "5ac3610a-7854-4278-8a51-c1ef8c138ee9": {
        "text_answer": "No  Explanation The evidence provided in the primary trial does not mention anything about a pulse wave increase",
        "label": "Contradiction"
    },
    "08fb602d-3227-4329-98c8-7dc2a6135f5b": {
        "text_answer": "No  Explanation  The statement the most commonly occuring adverse event across the patient co",
        "label": "Contradiction"
    },
    "76c6b45f-5a4a-47bc-81b1-267a2981b096": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement is incorrect and the evidence clearly states that HER",
        "label": "Contradiction"
    },
    "95332a34-465b-4777-870b-e60e4c01e706": {
        "text_answer": "Yes  Explanation  The statement patients in the primary clinical trial saw a higher frequency of",
        "label": "Entailment"
    },
    "f6fbc102-de0c-44d5-943b-4baf66bc0d9b": {
        "text_answer": "No  Explanation The evidence provided in the primary clinical trial does not indicate that all 61",
        "label": "Contradiction"
    },
    "1c72bbf7-1c5b-4326-a9d1-9dc7677aeefd": {
        "text_answer": "No  Explanation  The statement Women with Newly diagnosed stage IV breast cancer confirmed",
        "label": "Contradiction"
    },
    "224b15b9-fc1d-4c8b-ae55-ec4731ae5d04": {
        "text_answer": "Yes  Explanation The statement it is dispensed more frequently to cohort 1",
        "label": "Entailment"
    },
    "bd6fc6e9-c2ad-4803-b9ef-5a92d10e4155": {
        "text_answer": "  No   Explanation   The patient does not meet the inclusion criteria for both primary",
        "label": "Contradiction"
    },
    "72de2f11-15c9-489a-aec1-5c5e0969f4b7": {
        "text_answer": "No  Explanation The evidence provided in the trial results does not include information about primary tumor diameter",
        "label": "Contradiction"
    },
    "0d58d43d-8edc-4846-9d16-b1573f00db28": {
        "text_answer": "Yes The evidence does not mention Paclitaxel or its effect on sexual arousal",
        "label": "Entailment"
    },
    "ea16ac84-1f11-45c6-a29a-b7159f4b49a1": {
        "text_answer": "Yes  Explanation  The statement more than half of the patients in the primary clinical trial suffered",
        "label": "Entailment"
    },
    "c69a6bb3-93f7-4597-9359-64fd2541b1aa": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial records and reports the number of participants in each",
        "label": "Entailment"
    },
    "db02f4a9-b294-40e7-861b-d2284c6155e6": {
        "text_answer": "No   Explanation The statement is not entailed by the evidence as Perjeta pertuz",
        "label": "Contradiction"
    },
    "1b9551eb-0a5d-4d74-a460-a97ea9161f7f": {
        "text_answer": "Yes The statement that there were 0 cases of Hypertension Edema and Dyspnea in either",
        "label": "Entailment"
    },
    "d6c5a9e6-8db3-44f7-b865-4250c057f194": {
        "text_answer": "No  The evidence provided pertains to breast cancer clinical trials with specific inclusion and exclusion criteria The statement is about",
        "label": "Contradiction"
    },
    "a7f11aff-801c-4f1f-bc03-dc205289964a": {
        "text_answer": "No  Explanation  The statement both primary and secondary clinical trials involved patients who suffered from four",
        "label": "Contradiction"
    },
    "3e629df7-48b7-4ca1-8987-250629ce3e26": {
        "text_answer": "  Yes   Explanation   The primary clinical trial did indeed consist of a test group",
        "label": "Entailment"
    },
    "4f3ab82f-b17b-45a0-803e-901d0a58bcc6": {
        "text_answer": "Yes The statement does not explicitly mention the sham comparator arm in the evidence but it is not contradicted by",
        "label": "Entailment"
    },
    "6dddad4e-4cde-4859-a518-897b16bdc042": {
        "text_answer": "No  Explanation  The statement abstinence or moderate drinking is not a criter",
        "label": "Contradiction"
    },
    "7ccd57f6-2147-4f27-a0a7-f9f7a573a3b5": {
        "text_answer": "No  Explanation  The statement cohort 2 of the secondary clinical trial yielded",
        "label": "Contradiction"
    },
    "86408afa-a3ca-41ee-ac9a-94aa3f2b203d": {
        "text_answer": "Yes  Explanation The statement is consistent with the information provided in the evidence as it acknowledges that",
        "label": "Entailment"
    },
    "7ebe69db-dbde-41d9-b1c8-b866b2bc9e4c": {
        "text_answer": "  Infection and Asymmetry  Yes the statement is entailed by the evidence   However",
        "label": "Entailment"
    },
    "b447258d-c4d1-4f98-8cc0-9868cd316a3c": {
        "text_answer": "yes with the caveat that the statement only applies to anemia pneumonia and stupor",
        "label": "Entailment"
    },
    "05772f95-990c-40ee-b29c-b5b2591d0e56": {
        "text_answer": "Yes the patient is eligible for both trials based on the given information However its important to note that the",
        "label": "Entailment"
    },
    "b7028956-b024-401f-b528-554559f8ce17": {
        "text_answer": "Yes The statement that patients with follicular thyroid carcinoma confirmed by thinprep cytology",
        "label": "Entailment"
    },
    "d2139fd7-7b3e-405a-a806-ca76d237c11f": {
        "text_answer": "yes for the secondary trial regarding documented allergy to cephalosporin or trimethoprimsulf",
        "label": "Entailment"
    },
    "039b25b3-517a-4663-9b95-94c941ffa30f": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence specifies different",
        "label": "Contradiction"
    },
    "a76b5162-0261-41d2-8d17-c88f5a0e21bc": {
        "text_answer": "Yes  Explanation The statement under 10 patients have encountered adverse events in the course of",
        "label": "Entailment"
    },
    "e4b2bcf4-85fa-499c-9d27-e1c3c46174bf": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "37e14df5-fd3b-4c30-bda4-6527febc5e2b": {
        "text_answer": "Yes Nonsmall cell and small cell lung cancer are listed as eligible tumor types in the inclusion criteria",
        "label": "Entailment"
    },
    "27d0d803-28d5-4b3d-a87e-8fbe577513a9": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the interventions described",
        "label": "Contradiction"
    },
    "1f755559-38fb-4edc-a41a-91252b1dfb54": {
        "text_answer": "  Partially The statement is partially entailed by the evidence as alcoholic patients are excluded from the primary trial but",
        "label": "Entailment"
    },
    "acf4a907-c58c-46df-aa75-666e643cef4f": {
        "text_answer": "No   Explanation   The statement The intervention in the secondary trial last 3 times",
        "label": "Contradiction"
    },
    "6d5ac8ed-53a0-4b48-a521-7a9b53e82017": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "256a6852-2768-4fc9-acae-f5fea437412c": {
        "text_answer": "No  Explanation  The statement There are more cases of Biliary colic and Clost",
        "label": "Contradiction"
    },
    "113abff0-a728-40a6-b637-8bd60a53e626": {
        "text_answer": "Yes  Explanation The statement Cohort 1 of the primary trial received the same dose",
        "label": "Entailment"
    },
    "9d447ab6-f75c-40b6-88ca-db2e904ef02d": {
        "text_answer": "No  Explanation  The statement the eligibility for the primary clinical trial imposes no",
        "label": "Contradiction"
    },
    "624aeeea-894f-4100-86a2-724ef4842002": {
        "text_answer": "yes the statement is entailed by the evidence as both cohorts receive the same radiation doses and undergo S",
        "label": "Entailment"
    },
    "647016e6-71d4-4169-801d-e58e9b20171f": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement makes a comparison between the number of adverse",
        "label": "Contradiction"
    },
    "5ff5980d-28e1-46a7-9300-20792ad3dffd": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "29b78196-3625-46f2-baa9-45b6ab4b3823": {
        "text_answer": "No  Explanation  The primary trial measures change from baseline in patientspecified and reported symptoms",
        "label": "Contradiction"
    },
    "afdafe17-63a8-4fca-b923-a2bb964493d1": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "f9a077fc-18cf-418a-ac86-ddc89ea4259b": {
        "text_answer": "Yes  Explanation The statement regardless of the cohort the primary clinical trial administer",
        "label": "Entailment"
    },
    "0c207e39-2335-46a1-8dbd-3be4b8d59a17": {
        "text_answer": "Yes both cohorts undergo a SPECT scan The question is not directly related to the presence or absence of",
        "label": "Entailment"
    },
    "520f44e8-b74b-44a6-a7cf-496275847af1": {
        "text_answer": "Yes  Explanation The statement Both cohorts of the primary trial recorded 0 Aes",
        "label": "Entailment"
    },
    "b51a60d1-5112-4972-a303-11b35ba07af1": {
        "text_answer": "No The primary trial includes women aged 20 and above while the secondary trial includes women and men aged 1",
        "label": "Contradiction"
    },
    "44bb4ead-0597-4544-9b2c-3d99ff0a099b": {
        "text_answer": "Yes  Explanation The statement during the primary clinical trial blood bilirubin levels increased",
        "label": "Entailment"
    },
    "caf14d83-76cb-4c21-b5c0-d83966973483": {
        "text_answer": "Yes The statement mentions the observation of Eyelid oedema Upper gastrointestinal haem",
        "label": "Entailment"
    },
    "0d984537-a1c8-486f-840d-1a09f2bfa961": {
        "text_answer": "No  Explanation  The statement fewer than a quarter of the patients have registered increased",
        "label": "Contradiction"
    },
    "77890255-16cc-4dfb-b374-f2eba38238ce": {
        "text_answer": "No  The statement about bone marrow eosinophilia is not mentioned in the evidence The evidence only provides",
        "label": "Contradiction"
    },
    "d0f95f01-4a54-4bdc-9059-50803485a1f5": {
        "text_answer": "No  Explanation The primary trial includes patients with a breast tumor 1 cm in diameter while",
        "label": "Contradiction"
    },
    "5628cfa9-df1b-4a19-9f6b-c513b1fb73db": {
        "text_answer": "No  Explanation  The statement the primary trial keeps record of the percentage of participants who have",
        "label": "Contradiction"
    },
    "9915c5ea-d327-4cd9-a3e2-26cfa75cadb7": {
        "text_answer": "No  Explanation  The statement Arm 2 of the primary trial had higher Operative Time",
        "label": "Contradiction"
    },
    "48262549-7f65-43b7-ac00-f11dfb93e900": {
        "text_answer": "Yes  The primary trial specifies that patients receive both suramin and paclitaxel and the secondary trial does",
        "label": "Entailment"
    },
    "06c2d2d2-93dc-44dd-a729-a11a4397db44": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "7ae48994-9b72-4bc5-aab2-adcc9f0e1735": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "adbb33ae-2076-4850-bfd7-967119d8e169": {
        "text_answer": "Yes The primary trial measures change in units on a scale and the secondary trial measures percentage of participants Neither trial uses",
        "label": "Entailment"
    },
    "846578ce-00a5-487a-80d0-c5922f2c0c20": {
        "text_answer": "Yes The evidence shows a reduction in Ki67 expression from a median of 15 at baseline to 1",
        "label": "Entailment"
    },
    "ba5d4784-f20f-4d77-b133-ab700624da3e": {
        "text_answer": "No  Explanation  The statement the primary trial presented fewer cases of intestinal perfor",
        "label": "Contradiction"
    },
    "638143cc-bcdc-422b-8695-ec836f17edae": {
        "text_answer": "No  Explanation  The statement patient in body sling is a position in which the subject",
        "label": "Contradiction"
    },
    "d80d13ef-0da7-4203-af51-52c08253aefe": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials reported no adverse events related to trouble moving bowels",
        "label": "Entailment"
    },
    "9730b1a6-e9cd-4fd6-b1e4-9916b5903c63": {
        "text_answer": "Yes  Explanation The evidence states that there were a total of 12 participants analyzed in the trial",
        "label": "Entailment"
    },
    "73feb437-66f3-44fd-8d9c-ab3204e6eac3": {
        "text_answer": "No  Explanation  The statement Several recorded AEs in the primary trial occurred to",
        "label": "Contradiction"
    },
    "e6954b69-b723-4a51-8a5b-6e7461028b60": {
        "text_answer": "Yes The trial mentions that both interventions Memantine and Placebo are administered twice daily BID",
        "label": "Entailment"
    },
    "5fbe4001-1044-4684-a2a2-e34bf233fafb": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "410a0a55-a31f-4a57-9de1-3eacd3da7650": {
        "text_answer": "Yes  Explanation The statement the primary clinical trial was devoid of any adverse psychiatric",
        "label": "Entailment"
    },
    "0585f6bd-d582-4fc9-b96b-1355fa083e33": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial involves the",
        "label": "Contradiction"
    },
    "2bc6306e-445f-459e-afab-b445eedd5711": {
        "text_answer": "No  The statement is not about the primary clinical trial but rather about a specific chemotherapy agent Paraplat",
        "label": "Contradiction"
    },
    "ecb7babe-941e-41bf-89a3-0b8387fdd239": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial relates to the percentage change in ser",
        "label": "Contradiction"
    },
    "4d77b4db-8260-4ec9-af60-660f7a2a4833": {
        "text_answer": "No  Warfarin is excluded in the primary clinical trial but is permitted in the secondary clinical trial under certain conditions",
        "label": "Contradiction"
    },
    "a3954ec9-3fdd-4183-844d-1a13f70350e8": {
        "text_answer": "No  Explanation  The statement in the primary clinical trial there were no reported cases of",
        "label": "Contradiction"
    },
    "5c14c797-4995-467f-a993-bc75ad197093": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the outcome measurement in the",
        "label": "Contradiction"
    },
    "00831e0c-eaad-4fe9-a791-f105815fa215": {
        "text_answer": "Yes The secondary trial excludes patients with severe insomnia which is defined as a score of 8 on",
        "label": "Entailment"
    },
    "c0151b24-14ab-4837-965d-88bb8115a560": {
        "text_answer": "No  Explanation The evidence provided does not indicate that the patient with the longest PFS was in",
        "label": "Contradiction"
    },
    "86da40aa-8994-4fb7-8628-098d347b5864": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention anything about patients experiencing no pain",
        "label": "Contradiction"
    },
    "e6b59a72-62ef-4752-8464-902ca8d09119": {
        "text_answer": "Yes  Explanation The statement both the primary and the secondary clinical trials registered just one death in the",
        "label": "Entailment"
    },
    "a1e54b35-4b25-4194-8a44-7c8e587a1c83": {
        "text_answer": "Yes Both interventions use equal doses of radioactive Tc99M sulfur colloid",
        "label": "Entailment"
    },
    "e9bc72c1-1933-4ac1-b21b-35bf90b82c48": {
        "text_answer": "Yes The statement does not contradict the evidence and the evidence does not indicate any deaths or hospitalizations in cohort",
        "label": "Entailment"
    },
    "1f400417-bb05-4885-a46b-d348c2353ae9": {
        "text_answer": "Yes  Explanation The evidence describes a neoadjuvant therapy regimen consisting of four cycles of",
        "label": "Entailment"
    },
    "e8e2db51-2ec2-4e88-9096-cbe5d5933286": {
        "text_answer": "No  Explanation  The primary trial measures the change in serum levels of Follicle St",
        "label": "Contradiction"
    },
    "86ee12d2-2095-4ece-a7d6-f9494b51f3a6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "b7d3d4f9-44da-4fba-9005-e650cf0e2bb8": {
        "text_answer": "No  Explanation  The statement patients in the primary trial will receive higher doses of",
        "label": "Contradiction"
    },
    "8ffe96d0-134e-438b-884e-8c4f05b57b03": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the primary trial involves",
        "label": "Contradiction"
    },
    "f9172aa9-f9ea-44cc-9669-f72874fcbef2": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary clinical trial is",
        "label": "Contradiction"
    },
    "42b44f03-de67-4d76-a566-2669f0768a23": {
        "text_answer": "No  Explanation The statement the most common adverse event in the secondary trial was ana",
        "label": "Contradiction"
    },
    "da1010e7-b58a-438b-b93d-cc53b6d4476e": {
        "text_answer": "No  Explanation  The statement 773 the primary trial participants and 1",
        "label": "Contradiction"
    },
    "a0428861-8e0f-42ca-889f-b2546ae3dbe6": {
        "text_answer": "No  Explanation The woman who has had a mastectomy for stage IV BC is not eligible",
        "label": "Contradiction"
    },
    "59017303-759d-4b61-a272-efd6364a0b93": {
        "text_answer": "Yes The statement does not specifically mention the type of patients in the trial but since the evidence provides information about a clinical",
        "label": "Entailment"
    },
    "88d91a58-834e-4e7b-8b8d-f9ef0d075dab": {
        "text_answer": "  No the statement is not entailed by the evidence as the evidence does not mention anything about children and adolesc",
        "label": "Contradiction"
    },
    "1defe036-8290-4a01-bec7-f75305d1e88e": {
        "text_answer": "Yes  Explanation  The statement Neither the secondary trial or the primary trial use cm",
        "label": "Entailment"
    },
    "1514ac93-96a8-4d16-a572-d2a829af84c4": {
        "text_answer": "No  Explanation The statement mentions cisplatintopotecan as a combination of",
        "label": "Contradiction"
    },
    "61c97e3c-0456-4a0f-a261-d8ab75386686": {
        "text_answer": "Yes  Explanation  The statement in the primary clinical trial cardiacrelated adverse",
        "label": "Entailment"
    },
    "1aa7e1a8-707d-4c18-bdec-a750f59ffd1b": {
        "text_answer": "Yes The evidence states that 53 out of 60 participants or approximately 883 in",
        "label": "Entailment"
    },
    "1f30e035-2441-4585-826a-9150678cb094": {
        "text_answer": "No  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Contradiction"
    },
    "7b0752c4-ecc6-426a-82c9-e14bb237cfdc": {
        "text_answer": "Yes The statement is entailed by the evidence as interstitial lung disease is listed as an exclusion criter",
        "label": "Entailment"
    },
    "34a95632-c79d-4704-8a4a-56c4ddce6070": {
        "text_answer": "No  The primary trial is for HER2negative breast cancer patients and the secondary trial is for ER",
        "label": "Contradiction"
    },
    "587de897-adb2-4752-bd48-c9240b9bd956": {
        "text_answer": "No  Explanation  The evidence provided in the results does not indicate the number of participants with an",
        "label": "Contradiction"
    },
    "fd0b6abb-37f4-4b91-9b9f-433cbced84a7": {
        "text_answer": "Yes  The statement is entailed by the evidence as both cohorts receive the same maximum tolerated dose of C",
        "label": "Entailment"
    },
    "2c3adca5-a150-4c23-aa83-2cc8caeb0deb": {
        "text_answer": "  Yes for the primary trial pulmonary embolism is a reason for exclusion within 4 weeks",
        "label": "Entailment"
    },
    "6ddf4b5b-69e2-46e1-b032-69c3173fd8ef": {
        "text_answer": "Yes The primary trial has a treatment cycle length of 21 days 1 month while the secondary trial does not",
        "label": "Entailment"
    },
    "e9602bad-7e97-41b5-9d08-f02f259a75e6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "1fa2d084-6a29-44c1-9e0f-53eb6d932247": {
        "text_answer": "Yes  Explanation The evidence provides the number of participants who experienced a reduction in circulating tumor cells",
        "label": "Entailment"
    },
    "ce232ee1-c38c-4eee-bb4a-eaa33f0c75a8": {
        "text_answer": "No The evidence states that a history of abdominal fistula gastrointestinal perforation or intr",
        "label": "Contradiction"
    },
    "26f39f2a-dad6-40ed-8fa4-5abd8847021f": {
        "text_answer": "No  The woman who has not undergone any radical surgical treatment for her stage II BC is eligible for the",
        "label": "Contradiction"
    },
    "b37fc6a3-d231-478b-a18e-aa3439a972f1": {
        "text_answer": "No  Explanation The evidence provided in the clinical trial outcome measurement describes the results of highd",
        "label": "Contradiction"
    },
    "e7af2ad2-7001-40c6-93cd-ddfd4d436170": {
        "text_answer": "No  The evidence provided describes inclusion and exclusion criteria for a clinical trial related to breast cancer and there is no",
        "label": "Contradiction"
    },
    "5abfa152-2c23-40b4-ba00-b28336b8b8b5": {
        "text_answer": "Yes  Explanation The statement is consistent with the information provided in the evidence The evidence states that the",
        "label": "Entailment"
    },
    "42c38d71-6a83-4967-ad81-ec38c6b5aafd": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "5e301f1c-087e-4ca4-b679-cc229d1c0d27": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "63a2b921-08f3-456f-9710-fc74ec13954e": {
        "text_answer": "Yes The evidence shows a 10 reduction in Ki67 expression after 6 weeks of TAK2",
        "label": "Entailment"
    },
    "bbc8e272-7c58-4e53-a78b-4b634add9932": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "a7382edb-9b99-468d-99f2-2030aa61005c": {
        "text_answer": "Yes The primary trial and secondary trial evaluate different patient populations in their results",
        "label": "Entailment"
    },
    "709bff7a-2384-4cac-ac70-00b4e91a6bce": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as it introduces a",
        "label": "Contradiction"
    },
    "7c192c20-49e2-4b5c-b4ac-1131b7e9e4d0": {
        "text_answer": "No  Explanation  The statement More Palpitations Pericardial effusions and",
        "label": "Contradiction"
    },
    "608a57fb-72d5-4837-a491-2d0bc83a7776": {
        "text_answer": "Yes  Explanation The statement the primary trial reports the Time to Progression in months for a total",
        "label": "Entailment"
    },
    "58f6494f-860a-4f94-9fa1-895637730938": {
        "text_answer": "No  Explanation  The statement the dosage of denosumab in intervention 1",
        "label": "Contradiction"
    },
    "a08b1e1e-385a-40e6-990d-05b9aebc7335": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial states that",
        "label": "Contradiction"
    },
    "a1eb1305-f49e-4773-aa30-033093afeb64": {
        "text_answer": "Yes  Explanation  The evidence provides the percentage of participants in each group ERpositive",
        "label": "Entailment"
    },
    "36c3d1c3-d4dc-49bf-97a8-49608799cc35": {
        "text_answer": "No  Explanation  The statement satisfied with treatment effects is a question about whether an",
        "label": "Contradiction"
    },
    "227071c8-f195-4c9c-993d-3f57a9062a6f": {
        "text_answer": "No  Explanation  The statement secondary glioblastoma is a glioblastoma ar",
        "label": "Contradiction"
    },
    "a06e0782-9249-48ae-a2a3-70dffa452aab": {
        "text_answer": "Yes The evidence does not specify any limitations concerning life expectancy pregnancy or age for individuals participating in the clinical trial",
        "label": "Entailment"
    },
    "7eb81981-e3ca-42f2-ba8f-d1582e00f54d": {
        "text_answer": "No  Explanation  Although both trials involve the use of FMX and MM3",
        "label": "Contradiction"
    },
    "b60cdaf1-5a83-4738-b15d-d857c6d0924a": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as it contains incorrect",
        "label": "Contradiction"
    },
    "43b9c2c8-0785-4885-901b-91a1f893858f": {
        "text_answer": "No   Explanation   The statement is not entailed by the evidence as the statement ment",
        "label": "Contradiction"
    },
    "7e232984-9a95-44b0-85b0-ecbeb50655b7": {
        "text_answer": "Yes The evidence does not include any restriction based on nationality ethnicity weight or gender in the inclusion criteria",
        "label": "Entailment"
    },
    "f5c83e99-e58f-4e5a-9fde-836480522184": {
        "text_answer": "Yes The statement does not contradict the evidence The evidence only reports the absence of adverse events related to squamous",
        "label": "Entailment"
    },
    "23727e9e-6589-475f-9c29-0a7880f6d8af": {
        "text_answer": "  No  Explanation  The evidence provided in the text only reports the mean standardized cognitive",
        "label": "Contradiction"
    },
    "05971ed1-8162-4f52-8361-6fae652d03e2": {
        "text_answer": "Yes regarding the comparison between acupuncture and no treatment in the given trial However the statement does not",
        "label": "Entailment"
    },
    "99b57587-ea7a-496f-a7f9-9b2a7837ccc7": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary clinical trial does",
        "label": "Contradiction"
    },
    "af9cfc7a-95f4-494a-b68f-128961cf1a5b": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence only specifies breast cancer as a requirement for the",
        "label": "Contradiction"
    },
    "55af1301-2370-48bf-8dde-50c589448da1": {
        "text_answer": "No  The evidence does not provide information about the presence or absence of eating disorders in the individuals in the clinical trial",
        "label": "Contradiction"
    },
    "7d0d3d69-d8ff-4671-9251-6f7a5f19a5ad": {
        "text_answer": "Yes The primary trial participants received lower doses of PF06647020 than the secondary",
        "label": "Entailment"
    },
    "9fcf0873-73d2-48e3-87ac-ee5df19f7810": {
        "text_answer": "No  Explanation The evidence provided in the text only gives the median PFS for each group",
        "label": "Contradiction"
    },
    "54c9c0a9-c38d-46b1-a96b-1335daaaef85": {
        "text_answer": "No  The statement is not entailed by the evidence as the primary trial specifies intravenous administration of zol",
        "label": "Contradiction"
    },
    "24493091-48f3-4e50-ae2c-5d23fb12c376": {
        "text_answer": "  No the statement is not entailed by the evidence as the primary trial includes various types of breast cancer not",
        "label": "Contradiction"
    },
    "64e0d68e-9fdb-4625-b179-316cf3772ee9": {
        "text_answer": "No  Explanation The evidence describes two different interventions each with a specific route of administration ",
        "label": "Contradiction"
    },
    "fed83886-1413-49c9-91ab-3f1bea54db23": {
        "text_answer": "Yes The secondary trial was halted due to the occurrence of significant adverse events as stated in the question",
        "label": "Entailment"
    },
    "7138e72c-d5e7-4c18-ba8c-b71be945ac2d": {
        "text_answer": "No   Explanation  The evidence provided in the given context does not mention anything about the participants",
        "label": "Contradiction"
    },
    "4db16d69-4db6-410a-a48a-215903320e43": {
        "text_answer": "Yes The statement mentions breast cancer patients with ER negative PR negative and HER2 tumors which",
        "label": "Entailment"
    },
    "bfe7b8a8-8d7d-404c-b369-9bf059ae079c": {
        "text_answer": "Yes The statement is entailed by the evidence as epilepsy thalasemic syndromes and an",
        "label": "Entailment"
    },
    "054618c6-0f9d-46de-94f3-e69e066a8432": {
        "text_answer": "No  Explanation  The statement 5 of the participants in group 1 of the primary",
        "label": "Contradiction"
    },
    "3db34e4f-ae01-424d-a8b8-7d1a16e2f898": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence explicitly states that individuals with interstitial lung",
        "label": "Contradiction"
    },
    "f300c26a-9ae0-4474-8fb3-34435ecdcf11": {
        "text_answer": "Yes for the primary trial No for the secondary trial  Explanation  For the primary",
        "label": "Entailment"
    },
    "5031f62e-54ed-4635-b136-7f90d6eb2535": {
        "text_answer": "Yes  Both trials use the unit of measure cm for tumor diameter and participants for the",
        "label": "Entailment"
    },
    "efdd9a96-8d0a-40ae-bcf7-f27abe59658d": {
        "text_answer": "Yes for the primary trial pulmonary embolism is a reason for exclusion within the last 6 months",
        "label": "Entailment"
    },
    "b89171bc-ed32-4c9b-91ee-545a95b809fc": {
        "text_answer": "Yes The evidence does not mention the use of drugs radiotherapy or CBT in the primary clinical trial",
        "label": "Entailment"
    },
    "b0a8feea-e233-4a75-992e-698a978045a5": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial shows variations in results between the two algorithms and",
        "label": "Entailment"
    },
    "1d8a752e-8628-40d5-b134-e523b5dead07": {
        "text_answer": "No  Explanation  The evidence provided in the text does not mention any information about severe discomfort",
        "label": "Contradiction"
    },
    "7c81475d-c4f3-45cd-8481-400d43c45a7e": {
        "text_answer": "Yes with the caveat that androgenbased therapy is excluded in the primary trial but the statement refers to someone",
        "label": "Entailment"
    },
    "9e5f5682-6d2b-40df-b271-a0da55928c97": {
        "text_answer": "Yes The statement oral administration once a day is entailed by the evidence as both interventions involve taking the",
        "label": "Entailment"
    },
    "40034c62-a8d9-424f-ac22-2d5fcab4dfc0": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as it contradicts the",
        "label": "Contradiction"
    },
    "711218ac-a329-4d4e-a66b-3c4b2d9116b5": {
        "text_answer": "Yes The statement does not directly address the adverse events but it is not in conflict with the evidence provided",
        "label": "Entailment"
    },
    "ba6548a1-7dbf-4924-91ed-da83ecb2e8ef": {
        "text_answer": "No  Explanation  The statement Diagnosis of 23 cerebral met",
        "label": "Contradiction"
    },
    "06008bc8-58da-4762-9c98-830f2bd92325": {
        "text_answer": "No  Explanation  The statement breast cancer patients in the primary trial are administered ",
        "label": "Contradiction"
    },
    "68fe8d71-5200-4e77-a560-0fb7e67127a6": {
        "text_answer": "  No The statement have problems with hearing loss that make me angry is not related to the inclusion or excl",
        "label": "Contradiction"
    },
    "cd18deca-a213-4d53-af34-88624163f68e": {
        "text_answer": "Yes  Explanation  The statement paclitaxel is given to participants in the primary",
        "label": "Entailment"
    },
    "f2006562-69ab-4062-a5be-943cb905ee95": {
        "text_answer": "No  The statement about monoallelic palb2 gene inactivation is not mentioned in the inclusion or excl",
        "label": "Contradiction"
    },
    "f3f438bb-2af4-44b9-9bf7-28dc232feacb": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes the administration of capecitabine",
        "label": "Contradiction"
    },
    "b0410aa1-2da2-4399-b673-45157d3c3fb7": {
        "text_answer": "Yes  Explanation The statement in the primary clinical trial there was a rise in blood bilir",
        "label": "Entailment"
    },
    "52db4188-de06-4a23-91e2-bc899f33f0e5": {
        "text_answer": "No  Explanation The statement all patients in the primary trial receive at least 130",
        "label": "Contradiction"
    },
    "33c89b93-d655-4154-9712-0803974c65f7": {
        "text_answer": "No  Explanation  The evidence provided in the results does not indicate that every participant in the trial",
        "label": "Contradiction"
    },
    "936d7822-fd4b-42fc-abc5-d5ad838f148c": {
        "text_answer": "Yes The primary trial includes individuals with locally advanced recurrent or metastatic ER breast cancer while the",
        "label": "Entailment"
    },
    "b99886d6-98a7-4746-bc6c-1f70c8cdd0c6": {
        "text_answer": "Yes  Explanation The statement The only types of AEs observed in patients from the secondary trial",
        "label": "Entailment"
    },
    "c2c4cbf5-1469-42bf-b243-9080648b458b": {
        "text_answer": "Yes  Explanation The evidence states that the median IQR of Ki67 expression at",
        "label": "Entailment"
    },
    "cc807530-f293-4c99-921b-f6e303d2b825": {
        "text_answer": "Yes The primary trial includes patients without a history of breast cancer while the secondary trial excludes such patients",
        "label": "Entailment"
    },
    "82c8c33d-a45b-4897-8ac5-407ec39564fd": {
        "text_answer": "No   Explanation   The statement one of the patient groups in the primary clinical trial",
        "label": "Contradiction"
    },
    "a4cc14a3-7e05-4f72-b2f1-c9bb11720917": {
        "text_answer": "Yes  Explanation The evidence states that 20 out of 35 participants in cohort",
        "label": "Entailment"
    },
    "bacab9f7-0d0a-49e1-a503-e959c33bfe6a": {
        "text_answer": "Yes  Explanation The statement despite a patient potentially fulfilling all exclusion and inclusion conditions of",
        "label": "Entailment"
    },
    "d11e7175-a122-475f-862e-c5215d821f34": {
        "text_answer": "  No the statement is not entailed by the evidence The statement is incorrect regarding the eligibility criteria for",
        "label": "Contradiction"
    },
    "99eb2e5a-77d2-4ab1-a25b-b6d8a8bcf412": {
        "text_answer": "Yes The statement acknowledges that the final eligibility for the clinical trial is determined by the health professionals conducting the trial",
        "label": "Entailment"
    },
    "c00fd72d-2cbe-4988-a861-60a707684af7": {
        "text_answer": "Yes The evidence shows a total of 3 vomiting events out of 149 participants in the trial",
        "label": "Entailment"
    },
    "7ade4e76-2f1d-452d-b9e4-499e0aabbe0c": {
        "text_answer": "No  Explanation  The statement mentions swelling hypothermia and confusion",
        "label": "Contradiction"
    },
    "652e7c7c-998b-4a7d-b170-bcbe79729d93": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as the primary trial uses a",
        "label": "Contradiction"
    },
    "d8d046cc-99cc-4a31-94de-6dd290f504e7": {
        "text_answer": "No  Explanation  The statement every patient in the primary clinical trial experienced at least five distinct",
        "label": "Contradiction"
    },
    "9b09c156-bc43-445b-83ca-3831b111056f": {
        "text_answer": "No  Explanation  The statement patient cohorts in the secondary clinical trial displayed marginally",
        "label": "Contradiction"
    },
    "8b3dbda5-ee27-4d74-b6ab-d4bb1cc5c86b": {
        "text_answer": "No  The primary trial excludes patients receiving warfarin as a coumarinderivative anticoag",
        "label": "Contradiction"
    },
    "e115c2a9-a31e-4a26-a96b-cd038666ced0": {
        "text_answer": "Yes  Explanation  The primary trial measures the severity of vaginal symptoms using a subjective",
        "label": "Entailment"
    },
    "4662f196-5472-4321-846e-c1576bc0be70": {
        "text_answer": "Yes  Explanation  The statement neither the primary trial participants nor the secondary trial participants experienced",
        "label": "Entailment"
    },
    "76032781-7c1c-4518-b9c5-13f8d7a5b443": {
        "text_answer": "No  Explanation  The statement is not directly entailed by the evidence as the evidence does not",
        "label": "Contradiction"
    },
    "2c29a565-bdcd-464c-85a4-361ab767c0d9": {
        "text_answer": "  No   Explanation   The statement the adverse events of the primary and",
        "label": "Contradiction"
    },
    "bd759cf8-b82f-496f-a8f7-1ab39f0d4724": {
        "text_answer": "No  Explanation  The statement have you been in low or very low spirits is a question",
        "label": "Contradiction"
    },
    "7531054e-9cf3-43a1-bba4-19e90a2c5ef0": {
        "text_answer": "No  Explanation  The outcome measures of the primary and secondary clinical trials are not directly related as",
        "label": "Contradiction"
    },
    "dd3d2183-d062-41ed-af63-ae475f2246ec": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as there were no ad",
        "label": "Contradiction"
    },
    "129d4bb1-11bc-4aa4-b75a-fa8d0832e2ff": {
        "text_answer": "  No  Explanation  The statement in the primary clinical trial the group taking az",
        "label": "Contradiction"
    },
    "4a21310d-d0b8-44c7-ac08-ca9164bdc49f": {
        "text_answer": "No   Explanation   The statement is not directly entailed by the evidence as the statement",
        "label": "Contradiction"
    },
    "57656a6d-8e1c-4cb8-b80d-605174d0577c": {
        "text_answer": "Yes  Explanation The statement is entailed by the evidence as both trials have fibromyalgia",
        "label": "Entailment"
    },
    "19dbbcf2-63e2-4f96-a672-8c184edb025b": {
        "text_answer": "No  The evidence provided does not mention anything about counseling risk assessment or CBT related to the statement about",
        "label": "Contradiction"
    },
    "3607f455-e990-4306-8b23-52d930ccbdff": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "db2684e9-bcdc-482b-bfe4-4d6b2f6862c0": {
        "text_answer": "Yes The statement does not contradict the evidence and the evidence does not provide any information that would contradict the statement",
        "label": "Entailment"
    },
    "40fceb75-d0d5-4926-8d3d-7e5f3c5b7931": {
        "text_answer": "No  The evidence does not mention any adverse events related to eating disorders",
        "label": "Contradiction"
    },
    "b72d4b5e-e31f-47aa-979a-8253ec455cd1": {
        "text_answer": "Yes  Explanation The statement the number of hepatotoxicity cases were equal to the",
        "label": "Entailment"
    },
    "fc9a9de5-319a-465e-82ce-3c95b9a42728": {
        "text_answer": "No  Explanation  The statement the primary clinical trial had zero infection cases whilst the secondary",
        "label": "Contradiction"
    },
    "3870c72e-cf9d-461b-9dfd-ef407d84e8cf": {
        "text_answer": "No  Explanation  The statement patients in the primary clinical trial undergo proton therapy",
        "label": "Contradiction"
    },
    "83e0c108-bbbe-4b9b-97b6-62ea72e374d8": {
        "text_answer": "Yes  Explanation  The statement infections and infestations cases in the primary clinical trial",
        "label": "Entailment"
    },
    "8b047df3-cd4b-4c75-97b5-4081f65512eb": {
        "text_answer": "No   Explanation  The statement is not entailed by the evidence as the statement mentions",
        "label": "Contradiction"
    },
    "e92e432c-9e5c-451c-9bb2-ff89a618126c": {
        "text_answer": "Yes for hyperkalemia as an exclusion criterion in both trials  Explanation The",
        "label": "Entailment"
    },
    "d7f818fb-a383-41c3-ac12-788228db7cf9": {
        "text_answer": "No  Explanation The statement The intervention in the primary trial consists of a single drug Z",
        "label": "Contradiction"
    },
    "d39e0799-d31d-4759-96ed-716b92f924a6": {
        "text_answer": "No  Explanation  The statement the intervention in the secondary trial lasts three times longer than",
        "label": "Contradiction"
    },
    "fbe81247-571c-43a1-a2eb-439e579cf229": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the evidence does not mention",
        "label": "Contradiction"
    },
    "952fd1e7-65a2-417f-b1b8-188bce187c04": {
        "text_answer": "No  Explanation  The statement the primary clinical trial uses uniform criteria for participant eligibility",
        "label": "Contradiction"
    },
    "551bc048-5bac-47a0-a2bf-17844970c8dc": {
        "text_answer": "yes injections are mentioned in the evidence However there is no mention of gas cylinders in the evidence",
        "label": "Entailment"
    },
    "03c087ae-9ad2-4db3-a913-e6ba85dc15b0": {
        "text_answer": "Yes The inclusion criteria for both trials state that candidates must have an ECOG performance status of 0 to 2",
        "label": "Entailment"
    },
    "9c459c1c-bfc4-4fef-ba9f-6052b9622c69": {
        "text_answer": "Yes The statement is about the calr gene mutation in general and the evidence provides information about adverse events un",
        "label": "Entailment"
    },
    "a79aa893-e44c-4077-8791-47fb56351b5e": {
        "text_answer": "No   Explanation  The evidence provided does not mention anything about radiation therapy being administered to",
        "label": "Contradiction"
    },
    "f3e56d1d-af35-462c-ac1e-7e995543f505": {
        "text_answer": "Yes The statement does not provide any new information about the adverse events but it is consistent with the information given in",
        "label": "Entailment"
    },
    "88574a43-d4c9-4db7-8f47-307722095b0d": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the primary trial examines the",
        "label": "Contradiction"
    },
    "c7e1e07a-e363-47f7-9ec3-21fbd1da79b3": {
        "text_answer": "  No The statement is not entailed by the evidence The evidence states that patients with a history of chemotherapy",
        "label": "Contradiction"
    },
    "eca608f4-6f65-4fc9-96cb-d1bb45749048": {
        "text_answer": "No   Explanation The evidence provided in the trial results does not indicate that several of",
        "label": "Contradiction"
    },
    "a8353a78-23fe-4aba-aaef-06d3fb8dd41a": {
        "text_answer": "No   Explanation The evidence provided does not give the length of PFS for the patient with the",
        "label": "Contradiction"
    },
    "cb591a65-2304-40bc-ad66-ddd4f3376bdc": {
        "text_answer": "Yes for the secondary trial only as the primary trial does not mention smoking as an exclusion criterion",
        "label": "Entailment"
    },
    "c566ae79-b43a-4e83-8336-da8613e19e7f": {
        "text_answer": "Yes The inclusion criteria state that subjects must have a Mini Mental State Examination MMSE score of 2",
        "label": "Entailment"
    },
    "b0bedf1c-a1ed-4bf5-9ad1-ac22f0681d03": {
        "text_answer": "Yes The evidence does not provide information on the number of participants with treatmentemergent adverse events for either trial",
        "label": "Entailment"
    },
    "a3fb7d8d-5911-41d4-b3da-9a018bb256f6": {
        "text_answer": "No  Explanation  The evidence provided in the text does not support the statement that each participant from",
        "label": "Contradiction"
    },
    "5ccd39fd-215e-4699-8d02-a13d68ec34d3": {
        "text_answer": "No  Explanation The statement does not mention Paraplatin at all and the evidence only ment",
        "label": "Contradiction"
    },
    "1304d51c-38a5-4851-9241-b0cb6993b013": {
        "text_answer": "No  Explanation  The primary clinical trial measures hot flash activity using a composite score of severity",
        "label": "Contradiction"
    },
    "5794c670-e60c-4d2a-8d09-744e644c3e34": {
        "text_answer": "Yes The evidence explicitly states that patients with a history of grade 3 or 4 allergic reactions attributed to trast",
        "label": "Entailment"
    },
    "cdc43061-760e-4de2-946e-93d74f8ab544": {
        "text_answer": "No   Explanation  The statement Every participant in the primary trial receives the same intervention",
        "label": "Contradiction"
    },
    "5758ac46-f46b-452f-aa99-5d9c86700447": {
        "text_answer": "Yes  Explanation  The statement Recurrent malignancies Graftversus",
        "label": "Entailment"
    },
    "42857f32-4798-4767-a0c7-f74cdcab7a9b": {
        "text_answer": "Yes  Explanation The statement participants in the primary trial receive 4 different drugs throughout the",
        "label": "Entailment"
    },
    "707a6e1b-520e-4052-bbd8-c932c4cc65e2": {
        "text_answer": "Yes The statement is entailed by the evidence as both interventions GBM and gynecological cancers",
        "label": "Entailment"
    },
    "0359c605-2a3a-4696-8d14-ba214c571f1b": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the statement mentions a",
        "label": "Contradiction"
    },
    "ed820c4c-4119-4e93-894f-8484407c9ce6": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "36cbd8dd-9c77-496c-ab43-af1942c86339": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the doses of Carb",
        "label": "Contradiction"
    },
    "14fdb2fc-e19d-4628-ada4-37ea935a2b4a": {
        "text_answer": "No  Explanation  The statement in the primary trial every adverse event was associated with",
        "label": "Contradiction"
    },
    "9783fc05-3652-41b2-8ba0-8a276889692a": {
        "text_answer": "  No the statement is not entailed by the evidence The primary trial has an exclusion criterion for",
        "label": "Contradiction"
    },
    "b6b71c5a-8d4b-4ae1-9b57-45a5c9112543": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence describes a medication regime of oral doses once",
        "label": "Contradiction"
    },
    "bed229d6-8924-4753-a297-d49d4c128166": {
        "text_answer": "Yes for the statement about nationality ethnicity psychiatric condition or gender not affecting eligibility Un",
        "label": "Entailment"
    },
    "a434b916-659c-46a6-81c3-1654f561a2c2": {
        "text_answer": "No  The evidence mentions anorexia in one participant but it does not indicate that most participants encountered an",
        "label": "Contradiction"
    },
    "3c96d823-bc6c-4c7e-b490-50a0870076c5": {
        "text_answer": "No   Explanation  The evidence describes the interventions as being administered through transendoc",
        "label": "Contradiction"
    },
    "f5e483ed-caec-4142-baa9-15ba42da5f03": {
        "text_answer": "Yes  Explanation  The statement All AE types in the primary trial affected less than ",
        "label": "Entailment"
    },
    "a993ae6a-f86f-478e-af30-584181f09531": {
        "text_answer": "Yes   Explanation  The statement both the placebo and memantine interventions are administer",
        "label": "Entailment"
    },
    "f119d419-b22b-4b4d-84ea-f7ab7dba7522": {
        "text_answer": "Yes The primary trial participants received lower doses of PF06647020 than the secondary",
        "label": "Entailment"
    },
    "d7750102-df82-4668-8c6d-60e73b3241b5": {
        "text_answer": "No  Explanation  The statement the secondary trial on the other hand does not have a",
        "label": "Contradiction"
    },
    "d269b697-c96f-4317-99c9-e465c7e935a7": {
        "text_answer": "No  Explanation  The statement the number of participants was identical in both groups of the primary",
        "label": "Contradiction"
    },
    "0a74e0af-2534-45f3-b003-ba68e6e52d94": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "c6788d02-11df-4099-a395-c1e3dbc17f35": {
        "text_answer": "No  Explanation  The statement The most common adverse event in the secondary trial was Ana",
        "label": "Contradiction"
    },
    "f1dca117-1368-4d17-bdb6-52d1b3816ed5": {
        "text_answer": "No The primary trial excludes patients with a pulmonary embolism within the last 4 weeks not ",
        "label": "Contradiction"
    },
    "b1d950c2-dbd9-4cb4-b291-9406d84cd8de": {
        "text_answer": "No The statement is not entailed by the evidence as the primary trial does not mention anything about AI therapy and mirt",
        "label": "Contradiction"
    },
    "1f63524b-443d-4382-9df4-ea83eda85940": {
        "text_answer": "Yes The evidence does not exclude normal weighted nonpregnant individuals from participating in either the primary or secondary",
        "label": "Entailment"
    },
    "ad1c4967-3600-4953-a7fb-e48c9f4aa01f": {
        "text_answer": "Yes for the secondary trial No for the primary trial The 20yearold female patient with",
        "label": "Entailment"
    },
    "6f4a77ce-3f70-4b57-ae45-e9825753d9ee": {
        "text_answer": "No   Explanation The primary trial defines each treatment cycle as 21 days not 3",
        "label": "Contradiction"
    },
    "73a0936e-5144-4b8c-b230-389d8ed451af": {
        "text_answer": "No  Androgens are listed as an exclusion criterion in the evidence",
        "label": "Contradiction"
    },
    "37c939aa-c2b0-4fcc-a90a-d7fa36fc8571": {
        "text_answer": "Yes The evidence states that neither cohort received neratinib and it does not mention any surgical procedures",
        "label": "Entailment"
    },
    "a12ed2c0-b402-445b-b21b-7497389b39ec": {
        "text_answer": "No   Explanation   The statement describes a specific genetic mutation erbb2 c",
        "label": "Contradiction"
    },
    "d4bd0ed2-5753-470c-b804-00bbebdfc2d7": {
        "text_answer": "Yes for the primary trial regarding pulmonary embolisms and No for the secondary trial regarding breast implants",
        "label": "Entailment"
    },
    "44b930a2-5810-41aa-a70c-e7eaa3730bc0": {
        "text_answer": "No  Explanation  The statement specify site if cm1b is a directive to",
        "label": "Contradiction"
    },
    "7c28d575-cd75-418e-83bb-fae7457d9428": {
        "text_answer": "No  Explanation  The evidence provided in the trial results only relates to changes in lym",
        "label": "Contradiction"
    },
    "9a9bd166-1319-4a61-a8c2-e42ee878bf83": {
        "text_answer": "No  Explanation  The statement In total two patients from the primary trial suffered an Incidence",
        "label": "Contradiction"
    },
    "b032dff4-0d5d-4ee3-a4b2-c22ab3b8823f": {
        "text_answer": "Yes The evidence does not indicate that participants in either trial are required to meet a preliminary performance indicator or that a performance",
        "label": "Entailment"
    },
    "dd52a82a-b788-4048-ba8d-525ee119a78f": {
        "text_answer": "Yes  Explanation The primary clinical trial involves the use of hormonal methods Estring and",
        "label": "Entailment"
    },
    "d93422f2-c5ab-4aa0-90a3-478b05a17c4e": {
        "text_answer": "No   Explanation  The evidence provided reports the number of adverse events for each trial and",
        "label": "Contradiction"
    },
    "480133d8-93ea-46f0-86e5-b92c380bb7f9": {
        "text_answer": "No  Explanation  The statement nonnodal regional disease indicator is an indication of whether",
        "label": "Contradiction"
    },
    "2ac85077-e695-40c7-a9a9-d9901eceaeb2": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "e4221b6d-f3d7-4299-bcba-19c02be74cdd": {
        "text_answer": "Yes The statement does not explicitly mention the phases of the trial but the evidence states that patients with a solid tumor",
        "label": "Entailment"
    },
    "a16ff39b-cc99-4214-9af5-910eb9384a97": {
        "text_answer": "No   Explanation  The statement in both the primary trial and the secondary trial there were",
        "label": "Contradiction"
    },
    "571d4650-e64b-4cb2-b719-0d7064e51745": {
        "text_answer": "Yes  Explanation The statement in the primary trial there were 10 times the number of",
        "label": "Entailment"
    },
    "f9d0c257-bd9a-484e-bae7-802c0246372c": {
        "text_answer": "  No  Explanation  The statement the arm A intervention proved to be the most successful",
        "label": "Contradiction"
    },
    "15a422cf-fc00-4451-bddc-af67f7437e83": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "cdcb40f6-994c-4085-869a-dab87e67ba04": {
        "text_answer": "No  Explanation The evidence provided in the text does not mention the percentage of patients who reported ad",
        "label": "Contradiction"
    },
    "8e661d16-bf69-4d02-a437-5a77f12c1bd0": {
        "text_answer": "Yes The evidence states that both trials involve the use of 4Demethyl4cholestry",
        "label": "Entailment"
    },
    "ac4c15e0-c711-4583-a9d4-1dbc682cd7f7": {
        "text_answer": "Yes  Explanation The statement mentions one instance each of anaemia and febrile neut",
        "label": "Entailment"
    },
    "fac10570-e1ed-4b0a-b847-55eb25265d25": {
        "text_answer": "Yes The statement mentions the presence of Anaemia and Febrile neutropenia in cohort 1",
        "label": "Entailment"
    },
    "1cab397e-60fd-460d-8f56-978ca8a2bb78": {
        "text_answer": "No  Explanation  The statement hepatotoxicity cases were ten times more frequent than",
        "label": "Contradiction"
    },
    "ed2174d9-375c-4ed0-b880-56d13f6fb069": {
        "text_answer": "No   Explanation  The evidence provided does not mention any adverse events related to ionizing",
        "label": "Contradiction"
    },
    "ac271988-c319-4b6f-b7bf-f3c86072cf93": {
        "text_answer": "Yes  Explanation The primary trial involves the use of PF066470",
        "label": "Entailment"
    },
    "915adcaa-4b9a-4df9-9803-4c5c0c52bf48": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "3cdc1ca9-f403-4e4b-878e-678d8dbc6090": {
        "text_answer": "Yes The evidence does not report any occurrences of hypertension dehydration or dyspnea",
        "label": "Entailment"
    },
    "c179d073-c910-42ab-9fde-85e976e52203": {
        "text_answer": "Yes for the primary trial only as morbidly obese patients are not explicitly mentioned in the secondary trials",
        "label": "Entailment"
    },
    "7e529d12-16a2-4711-b7f8-b454800447f2": {
        "text_answer": "  Yes for the primary trial but not exactly for the secondary trial The primary trial specifically includes a tum",
        "label": "Entailment"
    },
    "b71a1480-2037-4a01-8a4f-95a34aa172c2": {
        "text_answer": "No  Explanation  The statement the primary trial documented more instances of mucositis oral",
        "label": "Contradiction"
    },
    "6690be43-edee-4061-a850-47540cc49bee": {
        "text_answer": "No  Explanation  The statement No two patients in the primary trial suffered the same type of",
        "label": "Contradiction"
    },
    "13d879d7-e968-4de9-ad06-458eb72759d5": {
        "text_answer": "No   Explanation  The evidence states that there were no adverse events recorded in both trials",
        "label": "Contradiction"
    },
    "c46fb676-9060-4d56-9097-af79bb762f50": {
        "text_answer": "No  Explanation  The statement the final acceptance of a patient into the primary clinical trial rest",
        "label": "Contradiction"
    },
    "14be6911-9b8c-4eb2-bcb9-bb5e892a57d1": {
        "text_answer": "Yes The primary trial does not involve any drugbased interventions while the secondary trial tests different doses of a",
        "label": "Entailment"
    },
    "e1cb3a7c-2881-41b9-8dc5-c6a1d311afc6": {
        "text_answer": "Yes  Explanation The statement compared to the primary clinical trial the secondary clinical trial observed an",
        "label": "Entailment"
    },
    "2ce0537c-cd90-47dd-83e3-79a690cdc101": {
        "text_answer": "No  Explanation  The statement 90 more participants in the ERpositive L",
        "label": "Contradiction"
    },
    "ff1759ba-f09e-4ecf-8316-aac2a78d6c26": {
        "text_answer": "Yes The statement is entailed by the evidence as the primary trial has fewer total adverse events and fewer types of ad",
        "label": "Entailment"
    },
    "db493601-5dae-4077-a455-582cd9e28315": {
        "text_answer": "No  Explanation  The primary clinical trial and the secondary clinical trial have some overlapping inclusion criteria",
        "label": "Contradiction"
    },
    "e10d648e-a24d-4358-b81f-77b68fce3dc8": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence as it is not related to",
        "label": "Contradiction"
    },
    "df709118-7130-4d0e-8150-a05fa7f1a6d1": {
        "text_answer": "No  Explanation  The statement Patients diagnosed stage 4 invasive carcinoma of",
        "label": "Contradiction"
    },
    "077cc008-c777-4fa3-826b-8cc903eab60e": {
        "text_answer": "No   Explanation  The statement both cohort 1 and cohort ",
        "label": "Contradiction"
    },
    "a36a79c9-39aa-493e-a7f9-18771e4a50cf": {
        "text_answer": "Yes  Explanation The evidence shows that in both Arm 1 and Arm 2 of the clinical trial",
        "label": "Entailment"
    },
    "3a027890-3744-44b7-a008-b18f60b0fdd4": {
        "text_answer": "Yes  Explanation  The evidence provided in the primary trial does not report any information about the worst",
        "label": "Entailment"
    },
    "028e1c85-f23e-411f-bf70-3621480de375": {
        "text_answer": "Yes  Explanation  The statement the secondary trial patients suffered from anemia pneum",
        "label": "Entailment"
    },
    "634ef5d6-4281-4d39-b876-59be4ed256ec": {
        "text_answer": "No  Explanation  The primary clinical trial measures tumor response using RECIST criteria while",
        "label": "Contradiction"
    },
    "af0e8d9b-f748-424d-a4e7-6bb3bf0ee7a2": {
        "text_answer": "Yes The evidence does not explicitly state that AfricanAmerican patients are excluded so it is implied that they are eligible to",
        "label": "Entailment"
    },
    "42746679-44a5-4854-ba22-6557c0c34ff8": {
        "text_answer": "No   Explanation  The statement candidates for the secondary trial study group receive weekly",
        "label": "Contradiction"
    },
    "5af6aa8c-69f5-44a5-9c7c-6c94a0fda6e8": {
        "text_answer": "No  Explanation  The statement The only types of AEs observed in patients from the secondary",
        "label": "Contradiction"
    },
    "4138d4cd-bc5a-44db-8dc2-f64fbfb28b94": {
        "text_answer": "Yes The statement is entailed by the evidence as the evidence reports the number of adverse effects in patients belonging to a",
        "label": "Entailment"
    },
    "f51d8422-1f2c-45bf-8de8-ce554a19c011": {
        "text_answer": " No The statement is not entailed by the evidence as the evidence only mentions ER positive and HER2 negative",
        "label": "Contradiction"
    },
    "74b24825-1c77-48e6-a1ce-c5b7e60b2b61": {
        "text_answer": "No  The statement is not entailed by the evidence as the statement mentions an inhalation intervention which is",
        "label": "Contradiction"
    },
    "137bb76f-a37e-4339-af7e-f0c647a01baa": {
        "text_answer": "No  Explanation  The statement the Bevacizumab cohort of the primary",
        "label": "Contradiction"
    },
    "e0b061e1-ee74-46e0-a223-de370cfffc8a": {
        "text_answer": "No   Explanation  The statement in both the primary trial and the secondary trial there were",
        "label": "Contradiction"
    },
    "9625e56f-5de0-4cbd-8e30-a944bf6d6244": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the evidence only specifies the",
        "label": "Contradiction"
    },
    "cb88e277-c79d-4bb1-8d63-c637a14d0f48": {
        "text_answer": "No  Explanation  The statement additionally the secondary trial does not employ any form of",
        "label": "Contradiction"
    },
    "af615add-c0e4-4046-9968-9d5805d2620e": {
        "text_answer": "Yes The statement cancerfree patients are eligible for the primary clinical trial is entailed by the evidence as",
        "label": "Entailment"
    },
    "9477c88f-8957-4925-8c5d-0061409159f8": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "04e554aa-1522-4fd6-a508-e0f13fa38832": {
        "text_answer": "  No   Explanation   The evidence provided does not indicate that any participant in either",
        "label": "Contradiction"
    },
    "e762873d-0ab8-4732-8c17-fdab7712a8e5": {
        "text_answer": "Yes  Explanation The statement thromboembolic incidents were experienced by patients in both the",
        "label": "Entailment"
    },
    "c9514ddd-0486-4aca-a0b7-4e03a2effc90": {
        "text_answer": "Yes  Explanation The evidence does not provide a specific number of participants who did not report any pain during",
        "label": "Entailment"
    },
    "570f69cb-de78-48d6-916b-bcb3ef0a27a7": {
        "text_answer": "Yes",
        "label": "Entailment"
    },
    "54c9f3b4-b90f-4b60-a924-5a26c4097521": {
        "text_answer": "No   Explanation   The statement body fat measurement is a measurement of the total fat",
        "label": "Contradiction"
    },
    "f95613c7-63f9-4f97-adbd-176220391993": {
        "text_answer": "No  Explanation  The statement is not entailed by the evidence because the primary trial states that",
        "label": "Contradiction"
    },
    "4a7035e5-7fdf-461e-9d63-8e52be720d96": {
        "text_answer": "No   Explanation   The statement in order to take part in the primary clinical trial",
        "label": "Contradiction"
    },
    "29f65923-503d-402b-b0a3-150f741d8c2b": {
        "text_answer": "Yes  Explanation The statement confirmation of a HER2 positive tumor through positive FISH",
        "label": "Entailment"
    },
    "096f687a-6eec-4648-b8f8-6d423d84f3ae": {
        "text_answer": "No   Explanation  The statement all ae types in the primary trial affected more than",
        "label": "Contradiction"
    },
    "869ef7c8-edf9-4eb0-8654-3bb28fa1b4aa": {
        "text_answer": "No  Explanation  The statement Perjeta is used in both cohorts of the",
        "label": "Contradiction"
    },
    "df8057c4-0640-488f-9a63-9036703fbf83": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 2ml of",
        "label": "Entailment"
    },
    "4aae628e-86f0-4851-9319-0a7d44d488b9": {
        "text_answer": "Yes but with a qualification The primary trial excludes patients with potassium levels outside the normal range while",
        "label": "Entailment"
    },
    "9dd72932-f9f7-4ad7-8c3e-15f284d93d89": {
        "text_answer": "  No the statement is not entailed by the evidence for the primary trial The statement is only applicable to the",
        "label": "Contradiction"
    },
    "cc6d64c8-a841-4a6b-bf57-df451ad47edb": {
        "text_answer": "No   Explanation  The evidence states that there were no severe adverse events reported in co",
        "label": "Contradiction"
    },
    "d803d6fb-f2af-4470-8cf9-7f68d6c53baf": {
        "text_answer": "No The statement is not entailed by the evidence as it is about orthodontic treatment which is not mentioned in",
        "label": "Contradiction"
    },
    "9c7521a7-87fc-4dc0-8c1e-5720836763e2": {
        "text_answer": "Yes The primary trial has a specific eligibility criterion for resistance to aromatase inhibitors AI",
        "label": "Entailment"
    },
    "b2ef7c16-b0e9-48dd-be60-9243443535b7": {
        "text_answer": "  No  Explanation  The statement is not entailed by the evidence as patients with infl",
        "label": "Contradiction"
    },
    "0b659007-1edc-43da-aafe-0024c2bb233e": {
        "text_answer": "No  Explanation  The evidence provided in the primary trial does not mention anything about patients experiencing ",
        "label": "Contradiction"
    },
    "1d828a72-b303-4395-bab6-31865552caff": {
        "text_answer": "No  The statement about adult mixed glioma is not mentioned in the evidence at all and there is",
        "label": "Contradiction"
    },
    "13f17e45-4ce5-4de3-8a67-eee3ca98c4eb": {
        "text_answer": "No  The statement is not entailed by the evidence as the evidence does not provide information about a cohort ",
        "label": "Contradiction"
    },
    "d85fd7f3-2765-407e-a8a3-49c19d9a4311": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence because the primary and secondary trials have different",
        "label": "Contradiction"
    },
    "6efe0add-df04-4255-a81f-8a542c0b810f": {
        "text_answer": "Yes The evidence states that patients in the primary clinical trial do not receive fentanyl sublingual spray during their",
        "label": "Entailment"
    },
    "9a276dfa-f4f9-4abe-837e-18cca465967e": {
        "text_answer": "Yes The statement is entailed by the evidence as both trials have reported 0 adverse events related to cytome",
        "label": "Entailment"
    },
    "19ad39bd-9620-4ff6-8afe-a81348b4fada": {
        "text_answer": "No  Explanation The statement is not entailed by the evidence as the number of injections for the",
        "label": "Contradiction"
    },
    "773d939c-db89-4999-9903-89da67345b49": {
        "text_answer": "Yes Some patients in the trial had interruptions or reductions in sunitinib dosing",
        "label": "Entailment"
    },
    "a8f421ec-e3c7-43b4-96da-b6bca22d68ed": {
        "text_answer": "No   Explanation  The evidence provided in the primary trial results does not report any data on",
        "label": "Contradiction"
    },
    "c91a6c5a-27f1-4e7b-8f91-34e3d2236e8b": {
        "text_answer": "Yes The median survival times reported in the evidence are both over 2 years and over 50 patients from each",
        "label": "Entailment"
    },
    "6ee00118-66be-4e39-85a7-2dd1feaca87b": {
        "text_answer": "No  Explanation  The statement in the primary trial there were 15 the number",
        "label": "Contradiction"
    },
    "d1123c9b-e0d4-412d-bcf6-a69bbb07a0f4": {
        "text_answer": "Yes The evidence reports that two participants in each cohort experienced doselimiting toxicities",
        "label": "Entailment"
    },
    "8bc95ffe-c455-4563-bc81-a7530f6fb500": {
        "text_answer": "No  Explanation  The statement is not directly related to the evidence provided The evidence pertains",
        "label": "Contradiction"
    },
    "9f08a841-c0c4-42e4-984f-0700bb46f18f": {
        "text_answer": "Yes  Explanation The statement all patients in the primary trial receive at least 200",
        "label": "Entailment"
    },
    "921d278b-11fe-4f67-883a-cd10b15c20f2": {
        "text_answer": "No  Explanation  The statement grade 1 acoustic nerve disorder nos ctca",
        "label": "Contradiction"
    },
    "17ca93e8-5115-4f53-8d4a-b3ce6c43ea58": {
        "text_answer": "No The evidence provided does not allow for simultaneous participation in both trials for the same patient The primary trial has specific",
        "label": "Contradiction"
    },
    "04191593-f36e-4fc0-8af5-7591059640a4": {
        "text_answer": "No  Explanation  The statement primary clinical trials first cohort had numerous p",
        "label": "Contradiction"
    }
}